
<html lang="en"     class="pb-page"  data-request-id="2a7bbc6c-5f9f-483a-941f-54f245607173"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;issue:issue:10.1021/jmcmar.2020.63.issue-14;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.0c00347"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Topoisomerase Inhibitors Addressing Fluoroquinolone Resistance in Gram-Negative Bacteria" /></meta><meta name="dc.Creator" content="Colin K.  Skepper" /></meta><meta name="dc.Creator" content="Duncan  Armstrong" /></meta><meta name="dc.Creator" content="Carl J.  Balibar" /></meta><meta name="dc.Creator" content="Daniel  Bauer" /></meta><meta name="dc.Creator" content="Cornelia  Bellamacina" /></meta><meta name="dc.Creator" content="Bret M.  Benton" /></meta><meta name="dc.Creator" content="Dirksen  Bussiere" /></meta><meta name="dc.Creator" content="Gianfranco  De Pascale" /></meta><meta name="dc.Creator" content="Javier  De Vicente" /></meta><meta name="dc.Creator" content="Charles R.  Dean" /></meta><meta name="dc.Creator" content="Bhavesh  Dhumale" /></meta><meta name="dc.Creator" content="L. Mark  Fisher" /></meta><meta name="dc.Creator" content="John  Fuller" /></meta><meta name="dc.Creator" content="Mangesh  Fulsunder" /></meta><meta name="dc.Creator" content="Lauren M.  Holder" /></meta><meta name="dc.Creator" content="Cheng  Hu" /></meta><meta name="dc.Creator" content="Bhavin  Kantariya" /></meta><meta name="dc.Creator" content="Guillaume  Lapointe" /></meta><meta name="dc.Creator" content="Jennifer A.  Leeds" /></meta><meta name="dc.Creator" content="Xiaolin  Li" /></meta><meta name="dc.Creator" content="Peichao  Lu" /></meta><meta name="dc.Creator" content="Anatoli  Lvov" /></meta><meta name="dc.Creator" content="Sylvia  Ma" /></meta><meta name="dc.Creator" content="Shravanthi  Madhavan" /></meta><meta name="dc.Creator" content="Swapnil  Malekar" /></meta><meta name="dc.Creator" content="David  McKenney" /></meta><meta name="dc.Creator" content="Wosenu  Mergo" /></meta><meta name="dc.Creator" content="Louis  Metzger" /></meta><meta name="dc.Creator" content="Heinz E.  Moser" /></meta><meta name="dc.Creator" content="Daniel  Mutnick" /></meta><meta name="dc.Creator" content="Jonas  Noeske" /></meta><meta name="dc.Creator" content="Colin  Osborne" /></meta><meta name="dc.Creator" content="Ashish  Patel" /></meta><meta name="dc.Creator" content="Darshit  Patel" /></meta><meta name="dc.Creator" content="Tushar  Patel" /></meta><meta name="dc.Creator" content="Krunal  Prajapati" /></meta><meta name="dc.Creator" content="Katherine R.  Prosen" /></meta><meta name="dc.Creator" content="Folkert  Reck" /></meta><meta name="dc.Creator" content="Daryl L.  Richie" /></meta><meta name="dc.Creator" content="Alice  Rico" /></meta><meta name="dc.Creator" content="Mark R.  Sanderson" /></meta><meta name="dc.Creator" content="Shailesh  Satasia" /></meta><meta name="dc.Creator" content="William S.  Sawyer" /></meta><meta name="dc.Creator" content="Jogitha  Selvarajah" /></meta><meta name="dc.Creator" content="Nirav  Shah" /></meta><meta name="dc.Creator" content="Kartik  Shanghavi" /></meta><meta name="dc.Creator" content="Wei  Shu" /></meta><meta name="dc.Creator" content="Katherine V.  Thompson" /></meta><meta name="dc.Creator" content="Martin  Traebert" /></meta><meta name="dc.Creator" content="Anand  Vala" /></meta><meta name="dc.Creator" content="Lakhan  Vala" /></meta><meta name="dc.Creator" content="Dennis A.  Veselkov" /></meta><meta name="dc.Creator" content="Jason  Vo" /></meta><meta name="dc.Creator" content="Michael  Wang" /></meta><meta name="dc.Creator" content="Marcella  Widya" /></meta><meta name="dc.Creator" content="Sarah L.  Williams" /></meta><meta name="dc.Creator" content="Yongjin  Xu" /></meta><meta name="dc.Creator" content="Qin  Yue" /></meta><meta name="dc.Creator" content="Richard  Zang" /></meta><meta name="dc.Creator" content="Bo  Zhou" /></meta><meta name="dc.Creator" content="Alexey  Rivkin" /></meta><meta name="dc.Description" content="Since their discovery over 5 decades ago, quinolone antibiotics have found enormous success as broad spectrum agents that exert their activity through dual inhibition of bacterial DNA gyrase and to..." /></meta><meta name="Description" content="Since their discovery over 5 decades ago, quinolone antibiotics have found enormous success as broad spectrum agents that exert their activity through dual inhibition of bacterial DNA gyrase and to..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 7, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c00347" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00347" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c00347" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00347" /></link>
        
    
    

<title>Topoisomerase Inhibitors Addressing Fluoroquinolone Resistance in Gram-Negative Bacteria | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c00347" /></meta><meta property="og:title" content="Topoisomerase Inhibitors Addressing Fluoroquinolone Resistance in Gram-Negative Bacteria" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0136.jpeg" /></meta><meta property="og:description" content="Since their discovery over 5 decades ago, quinolone antibiotics have found enormous success as broad spectrum agents that exert their activity through dual inhibition of bacterial DNA gyrase and topoisomerase IV. Increasing rates of resistance, driven largely by target-based mutations in the GyrA/ParC quinolone resistance determining region, have eroded the utility and threaten the future use of this vital class of antibiotics. Herein we describe the discovery and optimization of a series of 4-(aminomethyl)quinolin-2(1H)-ones, exemplified by 34, that inhibit bacterial DNA gyrase and topoisomerase IV and display potent activity against ciprofloxacin-resistant Gram-negative pathogens. X-ray crystallography reveals that 34 occupies the classical quinolone binding site in the topoisomerase IV-DNA cleavage complex but does not form significant contacts with residues in the quinolone resistance determining region." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c00347"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00347">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c00347&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c00347&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c00347&amp;href=/doi/10.1021/acs.jmedchem.0c00347" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 14</span><span class="cit-fg-pageRange">, 7773-7816</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/14" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c00587" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c00596" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Topoisomerase Inhibitors Addressing Fluoroquinolone Resistance in Gram-Negative Bacteria</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Colin K. Skepper</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Colin K. Skepper</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Emeryville, California 94608, United States</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#e5868a898c8bcb968e8095958097a58b8a938497918c96cb868a88"><span class="__cf_email__" data-cfemail="fb9894979295d588909e8b8b9e89bb95948d9a898f9288d5989496">[email protected]</span></a>. Phone: +1 510 879 9317.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Colin+K.++Skepper">Colin K. Skepper</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6771-2024" title="Orcid link">http://orcid.org/0000-0002-6771-2024</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Duncan Armstrong</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Duncan Armstrong</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Duncan++Armstrong">Duncan Armstrong</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Carl J. Balibar</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Carl J. Balibar</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Emeryville, California 94608, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Carl+J.++Balibar">Carl J. Balibar</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Daniel Bauer</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Daniel Bauer</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, 4002 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Daniel++Bauer">Daniel Bauer</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Cornelia Bellamacina</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Cornelia Bellamacina</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Emeryville, California 94608, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Cornelia++Bellamacina">Cornelia Bellamacina</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Bret M. Benton</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Bret M. Benton</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Emeryville, California 94608, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Bret+M.++Benton">Bret M. Benton</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dirksen Bussiere</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dirksen Bussiere</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Emeryville, California 94608, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dirksen++Bussiere">Dirksen Bussiere</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5623-5648" title="Orcid link">http://orcid.org/0000-0002-5623-5648</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Gianfranco De Pascale</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gianfranco De Pascale</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Emeryville, California 94608, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gianfranco++De+Pascale">Gianfranco De Pascale</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Javier De Vicente</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Javier De Vicente</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Emeryville, California 94608, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Javier++De+Vicente">Javier De Vicente</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Charles R. Dean</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Charles R. Dean</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Emeryville, California 94608, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Charles+R.++Dean">Charles R. Dean</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Bhavesh Dhumale</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Bhavesh Dhumale</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Piramal Discovery Solutions, Pharmaceutical Special Economic Zone, Sarkhej Bavla Highway, Ahmedabad, Gujarat 382213, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Bhavesh++Dhumale">Bhavesh Dhumale</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">L. Mark Fisher</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">L. Mark Fisher</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Molecular and Clinical Sciences Research Institute, St George’s University of London, London SW17 0RE, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=L.+Mark++Fisher">L. Mark Fisher</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">John Fuller</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">John Fuller</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Emeryville, California 94608, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=John++Fuller">John Fuller</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mangesh Fulsunder</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mangesh Fulsunder</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Piramal Discovery Solutions, Pharmaceutical Special Economic Zone, Sarkhej Bavla Highway, Ahmedabad, Gujarat 382213, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mangesh++Fulsunder">Mangesh Fulsunder</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lauren M. Holder</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lauren M. Holder</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Emeryville, California 94608, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lauren+M.++Holder">Lauren M. Holder</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8585-8169" title="Orcid link">http://orcid.org/0000-0001-8585-8169</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Cheng Hu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Cheng Hu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Emeryville, California 94608, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Cheng++Hu">Cheng Hu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Bhavin Kantariya</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Bhavin Kantariya</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Piramal Discovery Solutions, Pharmaceutical Special Economic Zone, Sarkhej Bavla Highway, Ahmedabad, Gujarat 382213, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Bhavin++Kantariya">Bhavin Kantariya</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Guillaume Lapointe</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Guillaume Lapointe</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Emeryville, California 94608, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Guillaume++Lapointe">Guillaume Lapointe</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jennifer A. Leeds</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jennifer A. Leeds</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Emeryville, California 94608, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jennifer+A.++Leeds">Jennifer A. Leeds</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-2244-4713" title="Orcid link">http://orcid.org/0000-0003-2244-4713</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Xiaolin Li</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xiaolin Li</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Emeryville, California 94608, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xiaolin++Li">Xiaolin Li</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Peichao Lu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Peichao Lu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Emeryville, California 94608, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Peichao++Lu">Peichao Lu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Anatoli Lvov</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Anatoli Lvov</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Anatoli++Lvov">Anatoli Lvov</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sylvia Ma</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sylvia Ma</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Emeryville, California 94608, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sylvia++Ma">Sylvia Ma</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Shravanthi Madhavan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Shravanthi Madhavan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Emeryville, California 94608, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Shravanthi++Madhavan">Shravanthi Madhavan</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Swapnil Malekar</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Swapnil Malekar</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Emeryville, California 94608, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Swapnil++Malekar">Swapnil Malekar</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">David McKenney</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">David McKenney</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Emeryville, California 94608, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=David++McKenney">David McKenney</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Wosenu Mergo</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Wosenu Mergo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Emeryville, California 94608, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Wosenu++Mergo">Wosenu Mergo</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Louis Metzger</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Louis Metzger</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Emeryville, California 94608, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Louis++Metzger">Louis Metzger</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Heinz E. Moser</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Heinz E. Moser</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Emeryville, California 94608, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Heinz+E.++Moser">Heinz E. Moser</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Daniel Mutnick</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Daniel Mutnick</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Emeryville, California 94608, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Daniel++Mutnick">Daniel Mutnick</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jonas Noeske</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jonas Noeske</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Emeryville, California 94608, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jonas++Noeske">Jonas Noeske</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Colin Osborne</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Colin Osborne</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Emeryville, California 94608, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Colin++Osborne">Colin Osborne</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ashish Patel</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ashish Patel</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Piramal Discovery Solutions, Pharmaceutical Special Economic Zone, Sarkhej Bavla Highway, Ahmedabad, Gujarat 382213, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ashish++Patel">Ashish Patel</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Darshit Patel</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Darshit Patel</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Piramal Discovery Solutions, Pharmaceutical Special Economic Zone, Sarkhej Bavla Highway, Ahmedabad, Gujarat 382213, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Darshit++Patel">Darshit Patel</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Tushar Patel</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tushar Patel</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Piramal Discovery Solutions, Pharmaceutical Special Economic Zone, Sarkhej Bavla Highway, Ahmedabad, Gujarat 382213, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tushar++Patel">Tushar Patel</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Krunal Prajapati</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Krunal Prajapati</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Piramal Discovery Solutions, Pharmaceutical Special Economic Zone, Sarkhej Bavla Highway, Ahmedabad, Gujarat 382213, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Krunal++Prajapati">Krunal Prajapati</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Katherine R. Prosen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Katherine R. Prosen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Emeryville, California 94608, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Katherine+R.++Prosen">Katherine R. Prosen</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6301-8089" title="Orcid link">http://orcid.org/0000-0001-6301-8089</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Folkert Reck</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Folkert Reck</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Emeryville, California 94608, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Folkert++Reck">Folkert Reck</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7250-2526" title="Orcid link">http://orcid.org/0000-0001-7250-2526</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Daryl L. Richie</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Daryl L. Richie</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Emeryville, California 94608, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Daryl+L.++Richie">Daryl L. Richie</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Alice Rico</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Alice Rico</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Emeryville, California 94608, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Alice++Rico">Alice Rico</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mark R. Sanderson</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mark R. Sanderson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Randall Centre for Cell and Molecular Biophysics, King’s College, Guy’s Campus, London Bridge, London SE1 1UL, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mark+R.++Sanderson">Mark R. Sanderson</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Shailesh Satasia</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Shailesh Satasia</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Piramal Discovery Solutions, Pharmaceutical Special Economic Zone, Sarkhej Bavla Highway, Ahmedabad, Gujarat 382213, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Shailesh++Satasia">Shailesh Satasia</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">William S. Sawyer</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">William S. Sawyer</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Emeryville, California 94608, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=William+S.++Sawyer">William S. Sawyer</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jogitha Selvarajah</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jogitha Selvarajah</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Molecular and Clinical Sciences Research Institute, St George’s University of London, London SW17 0RE, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jogitha++Selvarajah">Jogitha Selvarajah</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Nirav Shah</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nirav Shah</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Piramal Discovery Solutions, Pharmaceutical Special Economic Zone, Sarkhej Bavla Highway, Ahmedabad, Gujarat 382213, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nirav++Shah">Nirav Shah</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kartik Shanghavi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kartik Shanghavi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Piramal Discovery Solutions, Pharmaceutical Special Economic Zone, Sarkhej Bavla Highway, Ahmedabad, Gujarat 382213, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kartik++Shanghavi">Kartik Shanghavi</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Wei Shu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Wei Shu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Emeryville, California 94608, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Wei++Shu">Wei Shu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Katherine V. Thompson</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Katherine V. Thompson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Emeryville, California 94608, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Katherine+V.++Thompson">Katherine V. Thompson</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Martin Traebert</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Martin Traebert</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, 4002 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Martin++Traebert">Martin Traebert</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Anand Vala</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Anand Vala</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Piramal Discovery Solutions, Pharmaceutical Special Economic Zone, Sarkhej Bavla Highway, Ahmedabad, Gujarat 382213, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Anand++Vala">Anand Vala</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lakhan Vala</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lakhan Vala</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Piramal Discovery Solutions, Pharmaceutical Special Economic Zone, Sarkhej Bavla Highway, Ahmedabad, Gujarat 382213, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lakhan++Vala">Lakhan Vala</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dennis A. Veselkov</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dennis A. Veselkov</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Randall Centre for Cell and Molecular Biophysics, King’s College, Guy’s Campus, London Bridge, London SE1 1UL, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dennis+A.++Veselkov">Dennis A. Veselkov</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jason Vo</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jason Vo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Emeryville, California 94608, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jason++Vo">Jason Vo</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Michael Wang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michael Wang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Emeryville, California 94608, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Wang">Michael Wang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Marcella Widya</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Marcella Widya</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Emeryville, California 94608, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Marcella++Widya">Marcella Widya</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sarah L. Williams</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sarah L. Williams</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Emeryville, California 94608, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sarah+L.++Williams">Sarah L. Williams</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yongjin Xu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yongjin Xu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Emeryville, California 94608, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yongjin++Xu">Yongjin Xu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Qin Yue</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Qin Yue</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Emeryville, California 94608, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Qin++Yue">Qin Yue</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Richard Zang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Richard Zang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Emeryville, California 94608, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Richard++Zang">Richard Zang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Bo Zhou</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Bo Zhou</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Emeryville, California 94608, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Bo++Zhou">Bo Zhou</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Alexey Rivkin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Alexey Rivkin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Emeryville, California 94608, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Alexey++Rivkin">Alexey Rivkin</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00347&amp;href=/doi/10.1021%2Facs.jmedchem.0c00347" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 14</span><span class="cit-pageRange">, 7773–7816</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">July 7, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>10 April 2020</li><li><span class="item_label"><b>Published</b> online</span>7 July 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 23 July 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c00347" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00347</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7773%26pageCount%3D44%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DColin%2BK.%2BSkepper%252C%2BDuncan%2BArmstrong%252C%2BCarl%2BJ.%2BBalibar%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D14%26contentID%3Dacs.jmedchem.0c00347%26title%3DTopoisomerase%2BInhibitors%2BAddressing%2BFluoroquinolone%2BResistance%2Bin%2BGram-Negative%2BBacteria%26numPages%3D44%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7816%26publicationDate%3DJuly%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c00347"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2087</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">6</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c00347" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Topoisomerase Inhibitors Addressing Fluoroquinolone Resistance in Gram-Negative Bacteria&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Colin&quot;,&quot;last_name&quot;:&quot;K. Skepper&quot;},{&quot;first_name&quot;:&quot;Duncan&quot;,&quot;last_name&quot;:&quot;Armstrong&quot;},{&quot;first_name&quot;:&quot;Carl&quot;,&quot;last_name&quot;:&quot;J. Balibar&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;Bauer&quot;},{&quot;first_name&quot;:&quot;Cornelia&quot;,&quot;last_name&quot;:&quot;Bellamacina&quot;},{&quot;first_name&quot;:&quot;Bret&quot;,&quot;last_name&quot;:&quot;M. Benton&quot;},{&quot;first_name&quot;:&quot;Dirksen&quot;,&quot;last_name&quot;:&quot;Bussiere&quot;},{&quot;first_name&quot;:&quot;Gianfranco&quot;,&quot;last_name&quot;:&quot;De Pascale&quot;},{&quot;first_name&quot;:&quot;Javier&quot;,&quot;last_name&quot;:&quot;De Vicente&quot;},{&quot;first_name&quot;:&quot;Charles&quot;,&quot;last_name&quot;:&quot;R. Dean&quot;},{&quot;first_name&quot;:&quot;Bhavesh&quot;,&quot;last_name&quot;:&quot;Dhumale&quot;},{&quot;first_name&quot;:&quot;L.&quot;,&quot;last_name&quot;:&quot;Mark Fisher&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Fuller&quot;},{&quot;first_name&quot;:&quot;Mangesh&quot;,&quot;last_name&quot;:&quot;Fulsunder&quot;},{&quot;first_name&quot;:&quot;Lauren&quot;,&quot;last_name&quot;:&quot;M. Holder&quot;},{&quot;first_name&quot;:&quot;Cheng&quot;,&quot;last_name&quot;:&quot;Hu&quot;},{&quot;first_name&quot;:&quot;Bhavin&quot;,&quot;last_name&quot;:&quot;Kantariya&quot;},{&quot;first_name&quot;:&quot;Guillaume&quot;,&quot;last_name&quot;:&quot;Lapointe&quot;},{&quot;first_name&quot;:&quot;Jennifer&quot;,&quot;last_name&quot;:&quot;A. Leeds&quot;},{&quot;first_name&quot;:&quot;Xiaolin&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Peichao&quot;,&quot;last_name&quot;:&quot;Lu&quot;},{&quot;first_name&quot;:&quot;Anatoli&quot;,&quot;last_name&quot;:&quot;Lvov&quot;},{&quot;first_name&quot;:&quot;Sylvia&quot;,&quot;last_name&quot;:&quot;Ma&quot;},{&quot;first_name&quot;:&quot;Shravanthi&quot;,&quot;last_name&quot;:&quot;Madhavan&quot;},{&quot;first_name&quot;:&quot;Swapnil&quot;,&quot;last_name&quot;:&quot;Malekar&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;McKenney&quot;},{&quot;first_name&quot;:&quot;Wosenu&quot;,&quot;last_name&quot;:&quot;Mergo&quot;},{&quot;first_name&quot;:&quot;Louis&quot;,&quot;last_name&quot;:&quot;Metzger&quot;},{&quot;first_name&quot;:&quot;Heinz&quot;,&quot;last_name&quot;:&quot;E. Moser&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;Mutnick&quot;},{&quot;first_name&quot;:&quot;Jonas&quot;,&quot;last_name&quot;:&quot;Noeske&quot;},{&quot;first_name&quot;:&quot;Colin&quot;,&quot;last_name&quot;:&quot;Osborne&quot;},{&quot;first_name&quot;:&quot;Ashish&quot;,&quot;last_name&quot;:&quot;Patel&quot;},{&quot;first_name&quot;:&quot;Darshit&quot;,&quot;last_name&quot;:&quot;Patel&quot;},{&quot;first_name&quot;:&quot;Tushar&quot;,&quot;last_name&quot;:&quot;Patel&quot;},{&quot;first_name&quot;:&quot;Krunal&quot;,&quot;last_name&quot;:&quot;Prajapati&quot;},{&quot;first_name&quot;:&quot;Katherine&quot;,&quot;last_name&quot;:&quot;R. Prosen&quot;},{&quot;first_name&quot;:&quot;Folkert&quot;,&quot;last_name&quot;:&quot;Reck&quot;},{&quot;first_name&quot;:&quot;Daryl&quot;,&quot;last_name&quot;:&quot;L. Richie&quot;},{&quot;first_name&quot;:&quot;Alice&quot;,&quot;last_name&quot;:&quot;Rico&quot;},{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;R. Sanderson&quot;},{&quot;first_name&quot;:&quot;Shailesh&quot;,&quot;last_name&quot;:&quot;Satasia&quot;},{&quot;first_name&quot;:&quot;William&quot;,&quot;last_name&quot;:&quot;S. Sawyer&quot;},{&quot;first_name&quot;:&quot;Jogitha&quot;,&quot;last_name&quot;:&quot;Selvarajah&quot;},{&quot;first_name&quot;:&quot;Nirav&quot;,&quot;last_name&quot;:&quot;Shah&quot;},{&quot;first_name&quot;:&quot;Kartik&quot;,&quot;last_name&quot;:&quot;Shanghavi&quot;},{&quot;first_name&quot;:&quot;Wei&quot;,&quot;last_name&quot;:&quot;Shu&quot;},{&quot;first_name&quot;:&quot;Katherine&quot;,&quot;last_name&quot;:&quot;V. Thompson&quot;},{&quot;first_name&quot;:&quot;Martin&quot;,&quot;last_name&quot;:&quot;Traebert&quot;},{&quot;first_name&quot;:&quot;Anand&quot;,&quot;last_name&quot;:&quot;Vala&quot;},{&quot;first_name&quot;:&quot;Lakhan&quot;,&quot;last_name&quot;:&quot;Vala&quot;},{&quot;first_name&quot;:&quot;Dennis&quot;,&quot;last_name&quot;:&quot;A. Veselkov&quot;},{&quot;first_name&quot;:&quot;Jason&quot;,&quot;last_name&quot;:&quot;Vo&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Marcella&quot;,&quot;last_name&quot;:&quot;Widya&quot;},{&quot;first_name&quot;:&quot;Sarah&quot;,&quot;last_name&quot;:&quot;L. Williams&quot;},{&quot;first_name&quot;:&quot;Yongjin&quot;,&quot;last_name&quot;:&quot;Xu&quot;},{&quot;first_name&quot;:&quot;Qin&quot;,&quot;last_name&quot;:&quot;Yue&quot;},{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;Zang&quot;},{&quot;first_name&quot;:&quot;Bo&quot;,&quot;last_name&quot;:&quot;Zhou&quot;},{&quot;first_name&quot;:&quot;Alexey&quot;,&quot;last_name&quot;:&quot;Rivkin&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;07&quot;,&quot;issue&quot;:&quot;14&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;7773-7816&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c00347&quot;},&quot;abstract&quot;:&quot;Since their discovery over 5 decades ago, quinolone antibiotics have found enormous success as broad spectrum agents that exert their activity through dual inhibition of bacterial DNA gyrase and topoisomerase IV. Increasing rates of resistance, driven largely by target-based mutations in the GyrA/ParC quinolone resistance determining region, have eroded the utility and threaten the future use of this vital class of antibiotics. Herein we describe the discovery and optimization of a series of 4-(aminomethyl)quinolin-2(1H)-ones, exemplified by 34, that inhibit bacterial DNA gyrase and topoisomerase IV and display potent activity against ciprofloxacin-resistant Gram-negative pathogens. X-ray crystallography reveals that 34 occupies the classical quinolone binding site in the topoisomerase IV-DNA cleavage complex but does not form significant contacts with residues in the quinolone resistance determining region.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00347&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00347" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00347&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00347" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00347&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00347" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00347&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00347&amp;href=/doi/10.1021/acs.jmedchem.0c00347" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c00347" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c00347" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (9 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00347&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c00347%26sid%3Dliteratum%253Aachs%26pmid%3D32634310%26genre%3Darticle%26aulast%3DSkepper%26date%3D2020%26atitle%3DTopoisomerase%2BInhibitors%2BAddressing%2BFluoroquinolone%2BResistance%2Bin%2BGram-Negative%2BBacteria%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D14%26spage%3D7773%26epage%3D7816%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291362" title="Antimicrobial agents">Antimicrobial agents</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291181" title="Amines">Amines</a>,</li><li><a href="/action/doSearch?ConceptID=291439" title="Genetics">Genetics</a>,</li><li><a href="/action/doSearch?ConceptID=290676" title="Substituents">Substituents</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/14" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/jmcmar.2020.63.issue-14/20200723/jmcmar.2020.63.issue-14.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0136.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0136.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00347&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Since their discovery over 5 decades ago, quinolone antibiotics have found enormous success as broad spectrum agents that exert their activity through dual inhibition of bacterial DNA gyrase and topoisomerase IV. Increasing rates of resistance, driven largely by target-based mutations in the GyrA/ParC quinolone resistance determining region, have eroded the utility and threaten the future use of this vital class of antibiotics. Herein we describe the discovery and optimization of a series of 4-(aminomethyl)quinolin-2(1<i>H</i>)-ones, exemplified by <b>34</b>, that inhibit bacterial DNA gyrase and topoisomerase IV and display potent activity against ciprofloxacin-resistant Gram-negative pathogens. X-ray crystallography reveals that <b>34</b> occupies the classical quinolone binding site in the topoisomerase IV-DNA cleavage complex but does not form significant contacts with residues in the quinolone resistance determining region.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25351" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25351" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Quinolone antibiotics trace their history to two parallel discovery efforts at Imperial Chemical Industries (ICI) and Sterling Drug over 50 years ago.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> From these landmark studies emerged one of the most successful classes of antibacterial agents with nearly 30 analogs approved for clinical use and more still in the pipeline at various pharmaceutical companies.<a onclick="showRef(event, 'ref2 ref3 ref4 ref5 ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4 ref5 ref6 ref7 ref8">(2−8)</a></div><div class="NLM_p">Quinolone antibiotics exert their activity by binding to and stabilizing DNA cleavage complexes formed by two essential bacterial enzymes: DNA gyrase and topoisomerase IV. This results in blockade of DNA replication. Subsequent downstream events lead to induction of the SOS response, chromosome fragmentation, and cell death.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9,10)</a> Structural characterization of DNA–enzyme–quinolone ternary complexes has revealed that quinolones intercalate between DNA base pairs at two neighboring cleavage sites in the gyrase or topoisomerase IV heterotetramer complex.<a onclick="showRef(event, 'ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13">(11−13)</a> Additional studies support a binding mode in which the keto acid functionality of bound quinolones is chelated to a Mg<sup>2+</sup> cation which in turn forms water mediated hydrogen bonds to residues in the quinolone resistance determining region (QRDR) of GyrA and ParC (e.g., Ser83 and Asp87 in <i>Escherichia coli</i> GyrA).<a onclick="showRef(event, 'ref14 ref15 ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref14 ref15 ref16 ref17 ref18">(14−18)</a> This interaction appears to be critical for the quinolone mechanism of action and may account for the fact that despite 50 years of medicinal chemistry research, the overwhelming majority of quinolone antibiotics retain a carbonyl at C4 and carboxylate at C3 (as suggested by Wohlkonig et al.).<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> In fact, this arrangement of substituents at C3 and C4 has been widely regarded as optimal and essential for the antibacterial activity of quinolones.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> As with all classes of antibiotics, resistance to quinolones has emerged and continues to develop. While several mechanisms have been described, a major driver of high-level resistance is amino acid substitutions in DNA gyrase and topoisomerase IV at residues that are responsible for mediating the water–metal ion bridge interaction described above.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> As a result, the current and long-term utility of quinolones for treatment of many infections caused by both Gram-positive and Gram-negative bacteria has already been eroded.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div><div class="NLM_p">The global problem of antibiotic resistance and the need for new and effective antibiotic drug candidates are well-documented.<a onclick="showRef(event, 'ref22 ref23 ref24 ref25 ref26 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref22 ref23 ref24 ref25 ref26 ref27 ref28">(22−28)</a> Bacterial DNA gyrase and topoisomerase IV are clinically validated targets for chemotherapy, and quinolone antibiotics possess many attractive features including bactericidal activity against a broad spectrum of pathogens, rapid killing kinetics, and oral bioavailability. As such, there is significant interest in identifying inhibitors of these enzymes that are able to overcome target-based resistance to quinolones.<a onclick="showRef(event, 'ref29 ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref29 ref30 ref31">(29−31)</a> In a series of seminal publications and patents Pfizer described the discovery and optimization of 3-aminoquinazolinediones<a onclick="showRef(event, 'ref32 ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref32 ref33 ref34">(32−34)</a> (e.g., compound <b>2</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) that are capable of binding to and stabilizing DNA gyrase/topoisomerase IV cleavage complexes in the absence of the key water–metal ion bridge interaction that characterizes classical quinolone binding.<a onclick="showRef(event, 'ref14 ref15 ref16 ref17 ref18 ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref14 ref15 ref16 ref17 ref18 ref35 ref36">(14−18,35,36)</a> Lead compounds in this series exhibited little or no cross-resistance with quinolones. Importantly, these results demonstrated that the C3 carboxylate/C4 carbonyl arrangement present in nearly all quinolone antibiotics (see ciprofloxacin, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) is not strictly required for antibacterial activity. More recently, researchers from the Innovative Medicines Initiative European Gram-Negative Antibacterial Engine (IMI-ENABLE) consortium reported a series of imidazopyrazinones (IPYs) that target the quinolone binding pocket of bacterial DNA gyrase and topoisomerase IV without formation of the water–metal ion bridge.<a onclick="showRef(event, 'ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref37 ref38">(37,38)</a> Representative compounds from this series showed partial cross-resistance with quinolones. Interestingly, the influence of QRDR mutations on the activity of IPYs was found to be intermediate between 3-aminoquinazolinediones and quinolone antibiotics.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of the fluoroquinolone antibiotic ciprofloxacin, quinazolinedione PD 0305970 (Pfizer), Novartis phenotypic hit <b>3</b>, and initial lead compounds <b>4</b> and <b>5</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00347&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Within Novartis, antibacterial drug discovery efforts were broadly focused on pathogens and resistance phenotypes identified as major threats to human health by the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO).<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22,23)</a> As a part of these efforts, we initiated an early stage medicinal chemistry program around compound <b>3</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), which was identified as a hit during phenotypic screening for inhibitors of bacterial cell growth. Target identification efforts indicated that compounds in this series were inhibitors of DNA gyrase/topoisomerase IV; however the SAR proved to be extremely steep and we were unable to improve antibacterial potency to levels sufficient for a lead optimization program. The structural similarity to Pfizer’s quinazolinediones, however, led us to consider a scaffold-morphing approach with the classical quinolone scaffold (e.g., <b>1</b>, ciprofloxacin).<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></div><div class="NLM_p last">Structural and biochemical studies with quinazolinediones suggest that while this chemotype is incapable of forming a water–metal ion bridge with the target enzymes, it derives potency and affinity through additional interactions around the C7 amine moiety and a hydrogen bond between the C2 carbonyl oxygen and Arg117 (<i>Streptococcus pneumoniae</i> ParC numbering).<a onclick="showRef(event, 'ref12 ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref12 ref35 ref36">(12,35,36)</a> We hypothesized that by simply moving the C4 carbonyl of quinolones such as <b>1</b> to the C2 position (e.g., <b>4</b>,<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), we would be able to generate compounds that take advantage of similar interactions and thus retain potency against both wild type (WT) and quinolone-resistant bacteria. We further postulated that completely removing the C3 carboxylate (e.g., <b>5</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) could generate compounds that make no binding interactions at all with the GyrA/ParC QRDR region. Importantly, if this strategy proved successful, it would provide a unique opportunity to explore SAR at the C3 and C4 positions of the quinolone scaffold which have remained largely untouched over 50 years of research.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63435" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63435" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> SAR Development of the Quinolin-2(1<i>H</i>)-one Scaffold</h3><div class="NLM_p">Our efforts commenced with the synthesis and profiling of compounds <b>4</b> and <b>5</b>. Biochemical assays were established that used size-exclusion chromatography to monitor the introduction of supercoils into relaxed DNA and decatenation of kinetoplast DNA by <i>E. coli</i> DNA gyrase and topoisomerase IV respectively (see <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> for details). Against DNA gyrase from <i>E. coli</i>, compound <b>4</b> was less potent than both ciprofloxacin (<b>1</b>) and PD 0305970 (<b>2</b>), while <b>5</b> (which lacks the C3 carboxylic acid) exhibited potency more comparable to <b>1</b> and <b>2</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Against <i>E. coli</i> topoisomerase IV, compound <b>5</b> was again more potent than <b>4</b> and approached the activity seen with compound <b>2</b>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Biochemical and Cellular Activity of <b>1</b>, <b>2</b>, <b>4</b>, and <b>5</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center">compounds</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"><b>1</b></th><th class="colsep0 rowsep0" align="center"><b>2</b></th><th class="colsep0 rowsep0" align="center"><b>4</b></th><th class="colsep0 rowsep0" align="center"><b>5</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left">biochemical IC<sub>50</sub>(μM)</td><td class="colsep0 rowsep0" align="left"><i>E. coli</i> DNA gyrase</td><td class="colsep0 rowsep0" align="left">0.49</td><td class="colsep0 rowsep0" align="left">0.20</td><td class="colsep0 rowsep0" align="left">2.91</td><td class="colsep0 rowsep0" align="left">0.43</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>E. coli</i> topoisomerase IV</td><td class="colsep0 rowsep0" align="left">2.71</td><td class="colsep0 rowsep0" align="left">0.22</td><td class="colsep0 rowsep0" align="left">4.80</td><td class="colsep0 rowsep0" align="left">0.39</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="5" align="left">MIC (μg/mL)</td><td class="colsep0 rowsep0" align="left"><i>E. coli</i> WT</td><td class="colsep0 rowsep0" align="left">0.008</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>K. pneumoniae</i> WT</td><td class="colsep0 rowsep0" align="left">0.03</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>P. aeruginosa</i> WT</td><td class="colsep0 rowsep0" align="left">0.125</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">32</td><td class="colsep0 rowsep0" align="left">16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>P. aeruginosa</i> Δ<i>mexB</i>/Δ<i>mexX</i></td><td class="colsep0 rowsep0" align="left">0.03</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>P. aeruginosa</i> Δ<i>mexB</i>/Δ<i>mexX</i> FQ-R<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">64</td><td class="colsep0 rowsep0" align="left">8</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">GyrA T83I, ParC S87L.</p></div></div></div><div class="NLM_p">Against a selection of clinically relevant Gram-negative bacteria, compounds <b>4</b> and <b>5</b> exhibited encouraging levels of cell growth inhibition (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Robust activity was observed, in particular, against <i>E. coli</i> and <i>Klebsiella pneumoniae</i>. Importantly, both <b>4</b> and <b>5</b> exhibited a minimal shift in MIC against an engineered efflux-deficient <i>Pseudomonas aeruginosa</i> strain harboring QRDR mutations in gyrase and topoisomerase IV (MIC values increased by 8× for <b>4</b> and 2× for <b>5</b> compared to 128× for ciprofloxacin). However, there was clearly a significant loss of intrinsic cellular activity for compounds <b>4</b> and <b>5</b> relative to fluoroquinolones such as ciprofloxacin (<b>1</b>). We thus embarked upon a program that was focused upon optimization of activity against Gram-negative bacteria.</div><div class="NLM_p">Historically, achieving sufficient cellular activity against Gram-negative bacteria has been one of the major hurdles limiting the success of many preclinical antibacterial research programs.<a onclick="showRef(event, 'ref40 ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref40 ref41 ref42">(40−42)</a> This is due in part to the complexity of the Gram-negative cell envelope which includes an outer membrane that restricts permeation of large and/or lipophilic molecules and an inner membrane that opposes influx of more polar molecules. These physical barriers work in concert with multidrug efflux pumps to create a significant barrier to the accumulation of small molecule drugs in Gram-negative microorganisms.<a onclick="showRef(event, 'ref43 ref44 ref45 ref46 ref47 ref48 ref49 ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref43 ref44 ref45 ref46 ref47 ref48 ref49 ref50 ref51">(43−51)</a> This is a particularly acute problem for inhibitors that must reach targets within the cytoplasm. Simultaneous optimization of cell permeability, efflux, on-target potency, and drug-like properties continues to be a major challenge for the field.<a onclick="showRef(event, 'ref52 ref53 ref54 ref55 ref56 ref57'); return false;" href="javascript:void(0);" class="ref ref52 ref53 ref54 ref55 ref56 ref57">(52−57)</a></div><div class="NLM_p">With this in mind, compound <b>5</b> was selected as the starting point for our efforts based on its superior baseline cellular activity and reduced impact of QRDR mutations on antimicrobial activity relative to <b>4</b>. Compound <b>5</b> also provided a unique opportunity to explore SAR at both the C3 and C4 positions of the scaffold. At the time this work was initiated there was scant knowledge about the characteristics of this region of the binding pocket in the absence of the water–metal ion bridge since the Pfizer quinazolinedione series maintained a C4 carbonyl group.</div><div class="NLM_p">Small lipophilic substituents such as chlorine were well tolerated at C4 (e.g., <b>6</b>, <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>); however compound <b>7</b> was substantially less active. The latter may be ascribed to the relatively acidic nature and hydration of the hydroxyl (p<i>K</i><sub>a</sub> = 5.7), which unlike the carboxylic acid of <b>4</b> cannot be masked by an internal hydrogen bond to the C2 carbonyl and may contribute to poor inner membrane permeability. Alternatively, while spectroscopic data for compound <b>7</b> were qualitatively similar to related C4-<i>O</i>-alkoxy derivatives, we cannot rule out the possibility that the C2-hydroxy/C4-carbonyl tautomer of <b>7</b> could exist in the bacterial cellular environment and may contribute to the poor antibacterial activity observed. Capping the hydroxyl of <b>7</b> with a methyl group (<b>8</b>) restored some potency, while the nitrile (<b>9</b>) was 2- to 4-fold more potent against Gram-negative bacteria than compound <b>5</b>. The corresponding aminomethyl analog <b>10</b>, accessed by reduction of the nitrile, proved to be the most potent compound of the series. The introduction of a second, weakly basic amine at C4 often served to improve Gram-negative potency, particularly against <i>P. aeruginosa</i> (see <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a> for additional examples of this effect). MIC values for <b>10</b> and related analogs against <i>E</i>. <i>coli</i> Δ<i>acrB</i> revealed a moderate efflux liability that was later partially addressed through modifications at the C7 position (see <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a> below). Replacing the C4 amine with an alcohol (<b>11</b>) was detrimental to antibacterial activity and appeared to further increase susceptibility to efflux in <i>E. coli</i>. The weakly basic amine could, however, be accommodated on a longer chain which presumably projects further into the binding pocket without significant loss of potency (<b>12</b>). A carboxylic acid (<b>13</b>) was deleterious to antimicrobial activity, possibly due to poor inner membrane permeability (carboxylate p<i>K</i><sub>a</sub> = 2.2). While smaller substituents at C4 were generally preferred for Gram-negative antibacterial activity, some larger groups were tolerated as exemplified by <b>14</b>, which retained some weak activity against <i>E. coli</i>WT.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Antibacterial SAR at Position 4 of the Quinolin-2(1<i>H</i>)-one Scaffold</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0010.gif" alt="" id="GRAPHIC-d7e1406-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0011.gif" alt="" id="gr10" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">GyrA T83I, ParC S87L.</p></div></div><div></div></div><div class="NLM_p">Upon additional profiling of compound <b>10</b> it became apparent that the advantages conveyed by the presence of a weakly basic amine at C4 extended beyond an improvement in Gram-negative antibacterial potency. Relative to compound <b>5</b>, <b>10</b> displayed improved solubility and a reduction in plasma protein binding and hERG inhibition (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Both compounds exhibited low to moderate intrinsic clearance in liver microsomes; however <b>10</b> suffered from reduced permeability across mammalian cell membranes as gauged by CACO-2 <i>P</i><sub>app</sub>. Despite this, the aminomethyl substituent at C4 appeared to provide a good balance of potency and <i>in vitro</i> properties, prompting us to retain this group for subsequent SAR studies.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. <i>In Vitro</i> Profile of Compounds <b>5</b> and <b>10</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"><b>5</b></th><th class="colsep0 rowsep0" align="center"><b>10</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">log <i>D</i><sub>7.4</sub></td><td class="colsep0 rowsep0" align="left">0.74</td><td class="colsep0 rowsep0" align="left">–0.29</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">solubility (μg/mL, PBS)</td><td class="colsep0 rowsep0" align="left">498</td><td class="colsep0 rowsep0" align="left">>555</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">plasma protein binding (% bound, mouse/rat/human)</td><td class="colsep0 rowsep0" align="left">81/75/90</td><td class="colsep0 rowsep0" align="left">56/18/17</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hERG IC<sub>50</sub> (μM)</td><td class="colsep0 rowsep0" align="left">48.8<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">>300<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CACO-2 <i>P</i><sub>app</sub> A–B (efflux ratio)</td><td class="colsep0 rowsep0" align="left">16.7 (1.5)</td><td class="colsep0 rowsep0" align="left">0.44 (<b>18</b>)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL<sub>int</sub> in liver microsomes (μL min<sup>–1</sup> mg<sup>–1</sup>, rat/human)</td><td class="colsep0 rowsep0" align="left">10/<7.7</td><td class="colsep0 rowsep0" align="left"><7.7/14</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Determined using manual patch clamp electrophysiology (see <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> for details).</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">Determined using QPatch automated electrophysiology (see <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> for details).</p></div></div></div><div class="NLM_p">The C7 position of the classical quinolone scaffold is remarkably tolerant of a wide variety of substituents. Similarly, we found the C7 position of our scaffold to be more tolerant of structural changes than other positions. However, the scope of substituents that provided highly active compounds was significantly smaller than that described for quinolone antibiotics.</div><div class="NLM_p">In general, substituted pyrrolidines proved to be the most suitable substituents at C7. 3<i>S</i>-Aminopyrrolidine <b>15</b> was almost equally active relative to <b>10</b>; however inversion of the amine stereocenter resulted in ≥4-fold loss of <i>in vitro</i> potency (<b>16</b>, <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). Hydroxypyrrolidine <b>17</b> was also well tolerated and provided a boost in potency against <i>E. coli</i> and <i>K. pneumoniae</i>. An unsubstituted pyrrolidine at the C7 position provided a compound (<b>18</b>) with comparable potency against <i>E</i>. <i>coli</i> and <i>K. pneumoniae</i> but substantially reduced activity against <i>P</i>. <i>aeruginosa</i>. Aromatic substituents (e.g., <b>19</b>) often provided potent compounds, but this came at the expense of higher log <i>D</i><sub>7.4</sub> and poor solubility (data not shown). Compounds <b>18</b> and <b>19</b> support the observation that compounds with only a single basic amine often exhibited reduced activity against <i>P. aeruginosa</i> compared to compounds with two (e.g., <b>10</b>) despite equal or better activity against <i>E. coli</i>. Six-membered saturated rings (e.g., piperazine, compound <b>20</b>) offered no improvement in antimicrobial activity despite the fact that this group is present in ciprofloxacin. This result suggested a divergence in SAR from known quinolone antibiotics. A minor breakthrough was realized with the identification of [3.1.0] bicyclic amines <b>21</b> and <b>22</b>, which were the most potent compounds of this series against <i>E. coli</i>. Compound <b>21</b> also showed reduced susceptibility to efflux relative to <b>10</b> as evidenced by a 4-fold shift between MIC values against <i>E</i>. <i>coli</i> WT and Δ<i>acrB</i> (compared to 16-fold for <b>10</b>). Further modification of the [3.1.0] azabicyclic moiety generally led to loss of antibacterial activity, which was strongly dependent on appropriate positioning of the amine. For example, the related [4.1.0] and [3.2.0] bicyclic amines (<b>23</b> and <b>24</b>) were much less potent, and moving the amine to alternative locations on the [3.1.0] ring system provided similar results (<b>25</b> and <b>26</b>). Given the comparable <i>in vitro</i> activity of <b>21</b> and <b>22</b>, we elected to retain the less lipophilic [3.1.0] moiety of <b>21</b> for subsequent SAR studies.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Antibacterial SAR at Position 7 of the Quinolin-2(1<i>H</i>)-one Scaffold</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0012.gif" alt="" id="GRAPHIC-d7e1729-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0013.gif" alt="" id="gr11" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">GyrA T83I, ParC S87L.</p></div></div><div></div></div><div class="NLM_p">With an optimized C7 moiety established, we explored the C3 and C8 positions in the hope of deriving additional antibacterial potency. Removal of the methyl group from the C8 position resulted in a 4-fold reduction in potency (<b>27</b>, <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>), and switching the methyl group for other small, polar groups provided similar results (<b>28</b>–<b>30</b>). The C3 position was tolerant of a variety of small substituents including CH<sub>3</sub>, Cl, and OH (although activity was lost with groups larger than CH<sub>3</sub>). However, addition of a fluorine substituent led to a further 4- to 8-fold improvement in the MICs against WT <i>E. coli</i>, <i>K. pneumoniae</i>, and <i>P. aeruginosa</i> (<b>34</b>). Whether this improvement in activity was due to an increase in on-target potency, an increase in intracellular accumulation, or a combination of both factors was not immediately clear.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Optimization of Substitution at Positions 3 and 8 of the Quinolin-2(1<i>H</i>)-one Scaffold</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0014.gif" alt="" id="GRAPHIC-d7e1780-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="6" align="center">MIC (μg/mL)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cmpd</th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">R<sub>3</sub></th><th class="colsep0 rowsep0" align="center">R<sub>8</sub></th><th class="colsep0 rowsep0" align="center"><i>E. coli</i></th><th class="colsep0 rowsep0" align="center"><i>E. coli</i></th><th class="colsep0 rowsep0" align="center"><i>K. pneumoniae</i></th><th class="colsep0 rowsep0" align="center"><i>P. aeruginosa</i></th><th class="colsep0 rowsep0" align="center"><i>P. aeruginosa</i></th><th class="colsep0 rowsep0" align="center"><i>P. aeruginosa</i></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" valign="top"> </th><th class="colsep0 rowsep0" align="center" valign="top"> </th><th class="colsep0 rowsep0" align="center" valign="top"> </th><th class="colsep0 rowsep0" align="center" valign="top"> </th><th class="colsep0 rowsep0" align="center" valign="top">WT</th><th class="colsep0 rowsep0" align="center" valign="top">Δ<i>acrB</i></th><th class="colsep0 rowsep0" align="center" valign="top">WT</th><th class="colsep0 rowsep0" align="center" valign="top">WT</th><th class="colsep0 rowsep0" align="center" valign="top">Δ<i>mexB</i> Δ<i>mexX</i></th><th class="colsep0 rowsep0" align="center" valign="top">Δ<i>mexB</i> Δ<i>mexX</i> FQ-R<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">0.25</td><td class="colsep0 rowsep0" align="left">0.06</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">0.125</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">0.25</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">32</td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OCF<sub>2</sub>H</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">>32</td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">32</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">0.25</td><td class="colsep0 rowsep0" align="left">0.125</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">0.25</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">0.25</td><td class="colsep0 rowsep0" align="left">0.06</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">0.06</td><td class="colsep0 rowsep0" align="left">≤0.03</td><td class="colsep0 rowsep0" align="left">0.125</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">0.25</td><td class="colsep0 rowsep0" align="left">0.5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">GyrA T83I, ParC S87L.</p></div></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Structural Characterization of the Binding Mode of <b>34</b> to <i>K. pneumoniae</i> topoisomerase IV</h3><div class="NLM_p">During the course of the optimization campaign, we developed a cocrystallization system with topoisomerase IV from <i>K. pneumoniae</i>. Topoisomerase IV is a tetrameric enzyme formed by two ParC and two ParE subunits. For structural studies, we followed a previously employed approach to generate a fusion protein, ParE-ParC, from the respective subunits of <i>K. pneumoniae.</i><a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> The resulting single polypeptide is a fusion protein from the C-terminal portion of the ParE (residues 390–631) and N-terminal portion of the ParC (residues 1–490) subunits of <i>K. pneumoniae</i> topoisomerase IV.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> This enabled us to solve several cocrystal structures with inhibitor and DNA bound, including compound <b>34</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a> and <a href="/doi/suppl/10.1021/acs.jmedchem.0c00347/suppl_file/jm0c00347_si_001.pdf" class="ext-link">Supplementary Figures 1 and 2</a>). The DNA duplex was an uninterrupted 26-mer of the symmetrized E-site DNA.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Because of the size and inherent flexibility of the complex, achieving near-atomic level diffraction proved very challenging and most data sets had diffraction limits between 3.0 and 3.5 Å.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Binding site view of the topoisomerase IV cleavage complex from <i>K. pneumoniae</i> with compound <b>34</b> bound (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6WAA">6WAA</a>). DNA nucleotides of the cleavage site are shown in gray. ParC and ParE residues of one ParE-ParC fusion protein are shown in green and cyan, respectively. ParC residues from the second ParE-ParC fusion protein, which provide the catalytic tyrosine, are shown in magenta. Residues further out from the binding site were omitted for clarity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00347&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The complex formed between the ParE-ParC fusion protein, the homoduplex DNA, and compound <b>34</b> resulted in crystals that diffracted to 3.2 Å resolution and contained two copies of a ParE-ParC fusion protein dimer in the asymmetric unit, each bound to one homoduplex DNA. Unbiased electron density for compound <b>34</b> was observed in all four compound binding sites (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00347/suppl_file/jm0c00347_si_001.pdf" class="ext-link">Supplementary Figure 1</a>). The following description is based on observations made of the compound binding site with the best electron density. Only small variations in the binding mode are observed in the other copies present in the asymmetric unit.</div><div class="NLM_p last">Inspection of the electron density revealed that <b>34</b> occupies the quinolone binding site as expected with the compound intercalating between base pairs and stabilizing the cleaved DNA. A covalent phosphotyrosine bond was observed between the catalytic Tyr120 of ParC and the 5′-phosphate of the bound DNA at the break site, thus affording a view of the biologically relevant cleavage complex (in contrast to structures of ternary complexes formed with precut DNA; see D. A. Veselkov et al.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> for a comparison of structures solved with intact and precut DNA). Binding affinity for compound <b>34</b> is driven in part by π-stacking interactions with the base pairs located above and below the ligand. A number of suboptimal intermolecular interactions between <b>34</b> and neighboring residues of topoisomerase IV are also present, generally characterized by relatively large interatomic distances. The C2 carbonyl oxygen is posed to interact with the side chain of Arg119 (ParC subunit), similar to the reported <i>S. pneumoniae</i> topoisomerase IV-DNA co-structure with PD 0305970.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> In this case, however, the interatomic distance is too long to invoke a productive interaction. The C4 aminomethyl substituent occupies a relatively open portion of the binding pocket that would normally accommodate the water–metal ion bridge interaction involved in classical fluoroquinolone binding. Only poor electron density is observed for the C4 aminomethyl substituent, which does not permit placing this group accurately, and therefore no direct intermolecular interactions can be postulated. No specific interactions were observed between the nearby C3 fluorine atom and the protein; however its close proximity to Ser80 of ParC could explain the detrimental effect of a larger substituent at this position. It is possible that the fluorine atom contributes to an improved stacking interaction with DNA through electronic effects on the quinolin-2(1<i>H</i>)-one core, which would explain the boost in potency conveyed by that substituent. With respect to the crucial C7 amine, the moderate resolution of the structure (3.2 Å) meant that the preferred stereochemistry and precise orientation were difficult to determine. Finally, the primary amine is positioned to form weak interactions with the backbone carbonyl of K442 and the side chain of E461 (ParE subunit). The boost in potency observed for the [3.1.0] bicyclic group (as compared to a simple aminopyrrolidine such as <b>15</b>, for example) is potentially driven by a conformational preference that places the primary amine in an optimal location for binding. However, improved bacterial inner membrane permeability due to the reduced p<i>K</i><sub>a</sub> of the amine may also have a significant impact.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> <i>In Vitro</i> ADMET Profile of Compound <b>34</b></h3><div class="NLM_p">Further <i>in vitro</i> profiling data for <b>34</b> are shown in <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>. Biochemical activity against DNA gyrase and topoisomerase IV from <i>E. coli</i> was comparable to ciprofloxacin and well balanced (IC<sub>50</sub> = 1.25 and 0.81 μM, respectively). The two amines proved to be weakly basic as expected with experimentally determined p<i>K</i><sub>a</sub> values of 8.0 and 7.6. Over the course of our optimization effort, this p<i>K</i><sub>a</sub> range was generally associated with good Gram-negative antibacterial potency. Solubility and plasma protein binding values were comparable to clinically used fluoroquinolone antibiotics. Importantly, <b>34</b> displayed CACO-2 permeability that was significantly higher than starting point <b>10</b>, likely driven by a reduction in the amine p<i>K</i><sub>a</sub> of the C7 moiety and an associated increase in log <i>D</i><sub>7.4</sub>. Unfortunately, it appeared that this increase in lipophilicity was also associated with a reduction in microsomal stability (particularly in rat microsomes) and a marginal <i>in vitro</i> safety profile.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. <i>In Vitro</i> ADMET Profile of <b>34</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">assay</th><th class="colsep0 rowsep0" align="center"><b>34</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>E. coli</i> DNA gyrase IC<sub>50</sub> (μM)</td><td class="colsep0 rowsep0" align="left">1.25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>E. coli</i> topoisomerase IV IC<sub>50</sub> (μM)</td><td class="colsep0 rowsep0" align="left">0.81</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">log <i>D</i><sub>7.4</sub></td><td class="colsep0 rowsep0" align="left">1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">p<i>K</i><sub>a</sub></td><td class="colsep0 rowsep0" align="left">8.0, 7.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">solubility (μg/mL, PBS)</td><td class="colsep0 rowsep0" align="left">1276</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL<sub>int</sub> in liver microsomes (μL min<sup>–1</sup> mg<sup>–1</sup>, mouse/rat/human)</td><td class="colsep0 rowsep0" align="left">40/117/18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">plasma protein binding (% bound, mouse/rat/human)</td><td class="colsep0 rowsep0" align="left">32/58/35</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CACO-2 <i>P</i><sub>app</sub> A–B (cm/s) [efflux ratio]</td><td class="colsep0 rowsep0" align="left">10.4 [1.8]</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hERG IC<sub>50</sub> (μM)</td><td class="colsep0 rowsep0" align="left">114<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cytotoxicity EC<sub>50</sub> (μM, HepG2/K562/MT4)</td><td class="colsep0 rowsep0" align="left">82/40/29</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PIF (3T3 NRU)</td><td class="colsep0 rowsep0" align="left">621</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">Determined using QPatch automated electrophysiology with a long incubation protocol (see <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> for details).</p></div></div></div><div class="NLM_p">Compound <b>34</b> was found to exhibit moderate levels of cytotoxicity against three human cell lines (EC<sub>50</sub> = 82, 40, and 29 μM, respectively, against HepG2, K562, and MT4 cells). Further <i>in vitro</i> evaluation of <b>34</b> for phototoxicity potential using the 3T3 neutral red uptake (NRU) test produced a photoirritation factor (PIF) value of 621. The measured cellular IC<sub>50</sub> in the presence of irradiation with simulated sunlight was 1.61 μM, while in the absence of irradiation the IC<sub>50</sub> exceeded the solubility limit of the compound (1000 μM). The solubility limit was thus used in lieu of a measured IC<sub>50</sub> in the absence of irradiation to calculate the PIF (PIF = IC<sub>50(−irr)</sub>/IC<sub>50(+irr)</sub>). While a PIF value of 621 was considered high, it also reflected the very high solubility of compound <b>34</b>. Although <b>34</b> was not evaluated <i>in vivo</i> for phototoxicity, Schümann et al. have demonstrated that for a range of systemic drug candidates, the probability of <i>in vivo</i> phototoxicity correlates well with the magnitude of the PIF value obtained from the 3T3 NRU assay.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> Notably, this study made use of the fluoroquinolone sparfloxacin as a positive control. Sparfloxacin produced an <i>in vitro</i> PIF value of >82 and was found to produce significant and dose-dependent phototoxicity in mice. Phototoxicity has also been observed clinically with a number of fluoroquinolones and has severely limited the use of certain members of this class (e.g., clinafloxacin, sparfloxacin).<a onclick="showRef(event, 'ref59 ref60'); return false;" href="javascript:void(0);" class="ref ref59 ref60">(59,60)</a></div><div class="NLM_p">Fluoroquinolones exhibit a range of photochemical activation and degradation pathways that depend strongly on substitution pattern and on the reaction medium.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> It has been suggested that fluoroquinolone phototoxicity may be caused by toxic photochemical degradation products, the generation of reactive oxygen species, or reactive intermediates such as aryl cations (arising from dehalogenation) and/or radicals (arising from oxidation reactions induced by fluoroquinolones in the triplet state).<a onclick="showRef(event, 'ref62 ref63 ref64'); return false;" href="javascript:void(0);" class="ref ref62 ref63 ref64">(62−64)</a> Compared with quinolones that have a single fluorine at the C6 position, difluorinated quinolones (i.e., fluorine at C6 and C8) are markedly more photolabile, with unimolecular defluorination constituting a major photodegradation pathway. The pendant alkyl groups at C7 and N1 can also participate in secondary intramolecular reactions with excited state species and reactive intermediates, thereby influencing the photochemical fate of quinolones.</div><div class="NLM_p">Without further experimental data it is not possible to confirm if compound <b>34</b> exhibits comparable photochemical reactivity patterns. However, in order to derive additional SAR around phototoxicity for this series, compounds <b>15</b> and <b>21</b> were evaluated in the 3T3 NRU test. Compound <b>21</b>, which lacks the C3 fluorine atom present in <b>34</b>, produced a PIF value of 104. Like <b>34</b>, the IC<sub>50</sub> of <b>21</b> in the absence of irradiation exceeded the solubility limit of the compound (316 μM). In the presence of irradiation, however, compound <b>21</b> produced an IC<sub>50</sub> of 3.03 μM, only marginally higher than <b>34</b> (IC<sub>50(+irr)</sub> = 1.61 μM). Interestingly, compound <b>15</b>, which lacks the C3 fluorine and features a simple 3-aminopyrrolidine at C7, produced a PIF value of 1.7 (IC<sub>50(+irr)</sub> = 288 μM). Thus, it appears that phototoxicity of this series (as assessed by the 3T3 NRU test) is strongly influenced by the nature of the C7 substituent and to a lesser extent by halogenation at C3.</div><div class="NLM_p last">Compound <b>34</b> also exhibited increased hERG channel inhibition relative to <b>10</b> (IC<sub>50</sub> = 114 μM compared to >300 μM).<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> Like the <i>in vitro</i> phototoxicity results, the observed <i>in vitro</i> hERG inhibition data were viewed with some concern given the clinical history of certain members of the quinolone class. Moxifloxacin, for example, has a similar reported hERG IC<sub>50</sub> and produces QT prolongation in humans at therapeutic doses.<a onclick="showRef(event, 'ref66 ref67 ref68'); return false;" href="javascript:void(0);" class="ref ref66 ref67 ref68">(66−68)</a> On the basis of reported data for fluoroquinolones, we anticipated that the plasma free <i>C</i><sub>max</sub> for an efficacious gyrase/topoisomerase IV inhibitor would be roughly 5–10 μM. A hERG IC<sub>50</sub> of 114 μM would thus fall significantly short of the preferred 100-fold safety margin.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> Many compounds in this series (including compound <b>34</b>) feature a basic amine flanked by a lipophilic aromatic group, which broadly fits the accepted hERG pharmacophore model for channel blockers. The reduced hERG inhibition exhibited by compound <b>10</b> is likely driven by reduced lipophilicity (log <i>D</i><sub>7.4</sub> = −0.29 for <b>10</b>, compared with 1.1 for <b>34</b>). Increasing polarity represents a reasonable strategy for addressing hERG inhibition in future analogs and one which has been applied successfully in the context of many drug discovery efforts.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> Other well-known strategies, including removal of basic amines and aromatic groups, reduction of amine p<i>K</i><sub>a</sub>, and introduction of acidic groups (cf. fluoroquinolones) may also be successful in reducing hERG inhibition but come with the risk of undesirable effects on other compound properties (e.g., antibacterial activity, solubility, lipophilicity, and fluoroquinolone cross-resistance). Although analogs with improved ADMET properties were identified during the course of the optimization effort, we were unable to identify compounds that combined these attributes with the necessary antibacterial potency or spectrum.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Microbiological Profile of Compound <b>34</b></h3><div class="NLM_p"><a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a> shows the microbiological profile of <b>34</b> and ciprofloxacin against a panel of 126 clinical isolates, 70% of which were resistant to ciprofloxacin.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> Against <i>Enterobacteriaceae</i> (<i>n</i> = 96) <b>34</b> displayed a MIC<sub>90</sub> of 8 μg/mL, whereas the ciprofloxacin MIC<sub>90</sub> was >32 μg/mL. Against isolates of <i>E. coli</i> (<i>n</i> = 30) and <i>K. pneumoniae</i> (<i>n</i> = 30) MIC<sub>90</sub> values were 2 and 16 μg/mL, respectively. This level of <i>in vitro</i> activity was again substantially better than ciprofloxacin (MIC<sub>90</sub> ≥ 32 μg/mL against <i>E. coli</i> and <i>K. pneumoniae</i>). As expected, <b>34</b> was less active against <i>P. aeruginosa</i> (MIC<sub>90</sub> = 32 μg/mL). The frequency of single step mutant selection was low; no resistant mutants were selected when >10<sup>10</sup> cells of <i>E. coli</i> ATCC 25922 were plated on Mueller–Hinton agar containing 2× (0.12 μg/mL), 4× (0.25 μg/mL), or 8× (0.5 μg/mL) multiples of the MIC of compound <b>34</b> (mutant frequency of <10<sup>–10</sup>). The low frequency of single step resistance for <b>34</b> may reflect balanced targeting of both DNA gyrase and topoisomerase IV in <i>E. coli</i>, consistent with similar levels of activity against both enzymes in the biochemical assay (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>).<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a></div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Microbiological Profile of <b>34</b>: Performance against a Gram-Negative Challenge Panel (126 Clinical Isolates, 70% Ciprofloxacin-Resistant)</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="6" align="center">MIC (μg/mL)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center"><b>1</b> (ciprofloxacin)</th><th class="rowsep1 colsep0" colspan="3" align="center"><b>34</b></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">organism</th><th class="colsep0 rowsep0" align="center">no. isolates</th><th class="colsep0 rowsep0" align="center">range</th><th class="colsep0 rowsep0" align="center" char=".">MIC<sub>50</sub></th><th class="colsep0 rowsep0" align="center" char=".">MIC<sub>90</sub></th><th class="colsep0 rowsep0" align="center">range</th><th class="colsep0 rowsep0" align="center" char=".">MIC<sub>50</sub></th><th class="colsep0 rowsep0" align="center" char=".">MIC<sub>90</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="3" align="left"><i>Enterobacteriaceae</i><a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">all species (96)</td><td class="colsep0 rowsep0" align="left">≤0.03−>32</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">>32</td><td class="colsep0 rowsep0" align="left">0.06−>32</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>E. coli</i> (30)</td><td class="colsep0 rowsep0" align="left">≤0.03−>32</td><td class="colsep0 rowsep0" align="char" char=".">>32</td><td class="colsep0 rowsep0" align="char" char=".">>32</td><td class="colsep0 rowsep0" align="left">0.06–8</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>K. pneumoniae</i> (30)</td><td class="colsep0 rowsep0" align="left">≤0.03−>32</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">>32</td><td class="colsep0 rowsep0" align="left">0.25–32</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>P. aeruginosa</i></td><td class="colsep0 rowsep0" align="left">30</td><td class="colsep0 rowsep0" align="left">0.125−>32</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">>32</td><td class="colsep0 rowsep0" align="left">1−>32</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">32</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup><sup>a</sup></sup><p class="last">6 <i>Citrobacter</i> spp., 10 <i>Enterobacter</i> spp., 30 <i>E. coli</i>, 30 <i>K. pneumoniae</i>, 5 <i>Klebsiella oxytoca</i>, 4 <i>Morganella morganii</i>, 5 <i>Proteus mirabilis</i>, 6 <i>Serratia marcescens</i>.</p></div></div></div><div class="NLM_p">Given the promising potency of <b>34</b> against <i>Enterobacteriaceae</i>, we anticipated that a primary indication for a putative clinical candidate would be in complicated urinary tract infections (cUTI). It has been shown previously that <i>in vitro</i> antibacterial activity of some fluoroquinolone antibiotics is influenced by the pH of the test medium.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> It therefore became a priority to assess the antibacterial activity of <b>34</b> at a slightly acidic pH in order to mimic the environment in the urinary tract. As shown in <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a></a>, ciprofloxacin is 16-fold less active against <i>E</i>. <i>coli</i> WT at pH 5.8 compared to pH 7.4 (MIC = 0.125 μg/mL vs 0.008 μg/mL respectively). Analogs such as <b>5</b> and <b>17</b>, which feature a single basic amine, displayed a similar loss of activity at pH 5.8. Compounds with two basic amines, however, were affected to a greater extent. The pH-dependent reduction of activity was particularly severe for <b>34</b>, which was 512-fold less active against <i>E</i>. <i>coli</i> WT at pH 5.8 compared to pH 7.4 (MIC = 32 μg/mL vs 0.06 μg/mL). Although monobasic compounds were more tolerant of acidic pH, such compounds had insufficient antibacterial potency and spectrum to be progressed further.</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Effect of pH on Antimicrobial Activity of Selected Compounds</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center"><i>E. coli</i> WT MIC (μg/mL)</th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cmpd</th><th class="colsep0 rowsep0" align="center">pH 7.4</th><th class="colsep0 rowsep0" align="center">pH 5.8</th><th class="colsep0 rowsep0" align="center">MIC fold shift</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b> (ciprofloxacin)</td><td class="colsep0 rowsep0" align="left">0.008</td><td class="colsep0 rowsep0" align="left">0.125</td><td class="colsep0 rowsep0" align="left">16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">>32</td><td class="colsep0 rowsep0" align="left">≥64</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">>32</td><td class="colsep0 rowsep0" align="left">≥32</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">0.25</td><td class="colsep0 rowsep0" align="left">32</td><td class="colsep0 rowsep0" align="left">128</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">0.06</td><td class="colsep0 rowsep0" align="left">32</td><td class="colsep0 rowsep0" align="left">512</td></tr></tbody></table></div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> <i>In Vivo</i> Profile of Compound <b>34</b></h3><div class="NLM_p">The <i>in vivo</i> PK and efficacy of compound <b>34</b> are shown in <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a></a>. In both rat and mouse PK studies compound <b>34</b> exhibited moderate to high CL, consistent with <i>in vitro</i> microsomal stability results. This likely drives the low oral bioavailability observed with <b>34</b>. However, dose-normalized oral exposure was broadly similar to ciprofloxacin and was somewhat higher in mice. In a neutropenic mouse thigh infection model using fluoroquinolone-sensitive <i>E. coli</i> ATCC 25922, the static dose was determined. At the initiation of therapy, mice had a cfu/thigh of approximately log<sub>10</sub> 6 which increased to >log<sub>10</sub> 9.5 cfu/thigh 24 h later in vehicle treated animals (see <a href="/doi/suppl/10.1021/acs.jmedchem.0c00347/suppl_file/jm0c00347_si_001.pdf" class="ext-link">Supplementary Figure 3</a>). <b>34</b> resulted in a static dose of 45.5 mg kg<sup>–1</sup> day<sup>–1</sup> compared to 6.4 mg kg<sup>–1</sup> day<sup>–1</sup> for ciprofloxacin. This closely parallels the difference in <i>in vitro</i> potency (MIC) between the two compounds and demonstrates that compounds in this series are capable of achieving <i>in vivo</i> efficacy against Gram-negative bacteria.</div><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. PK and <i>in Vivo</i> Efficacy of <b>34</b> in Comparison to Ciprofloxacin (<b>1</b>)<a class="ref internalNav" href="#t9fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" colspan="5" align="center">Pharmacokinetics (PK)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center"><b>1</b> (ciprofloxacin)</th><th class="rowsep1 colsep0" colspan="2" align="center"><b>34</b></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">mouse<a class="ref internalNav" href="#t9fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">rat<a class="ref internalNav" href="#t9fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">mouse<a class="ref internalNav" href="#t9fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center">rat<a class="ref internalNav" href="#t9fn5" aria-label="e">e</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL (mL min<sup>–1</sup> kg<sup>–1</sup>)</td><td class="colsep0 rowsep0" align="left">63</td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">71</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>V</i><sub>ss</sub> (L/kg)</td><td class="colsep0 rowsep0" align="left">2.2</td><td class="colsep0 rowsep0" align="left">3.4</td><td class="colsep0 rowsep0" align="left">5.1</td><td class="colsep0 rowsep0" align="left">24.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>1/2 term iv</sub> (h)</td><td class="colsep0 rowsep0" align="left">0.46</td><td class="colsep0 rowsep0" align="left">1.2</td><td class="colsep0 rowsep0" align="left">1.7</td><td class="colsep0 rowsep0" align="left">8.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC (μM·h)/dose (mg/kg) po</td><td class="colsep0 rowsep0" align="left">0.13</td><td class="colsep0 rowsep0" align="left">0.29</td><td class="colsep0 rowsep0" align="left">0.31</td><td class="colsep0 rowsep0" align="left">0.10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> (μM)/dose (mg/kg) po</td><td class="colsep0 rowsep0" align="left">0.06</td><td class="colsep0 rowsep0" align="left">0.14</td><td class="colsep0 rowsep0" align="left">0.10</td><td class="colsep0 rowsep0" align="left">0.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>max</sub> po (h)</td><td class="colsep0 rowsep0" align="left">0.25</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">1.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">oral BA (%F)</td><td class="colsep0 rowsep0" align="left">19</td><td class="colsep0 rowsep0" align="left">23</td><td class="colsep0 rowsep0" align="left">36</td><td class="colsep0 rowsep0" align="left">15</td></tr></tbody></table><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" colspan="3" align="center">Neutropenic Murine Thigh Infection Model</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"><b>1</b><a class="ref internalNav" href="#t9fn6" aria-label="f">f</a></th><th class="colsep0 rowsep0" align="center"><b>34</b><a class="ref internalNav" href="#t9fn7" aria-label="g">g</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MIC (<i>E. coli</i> ATCC 25922, μg/mL)</td><td class="colsep0 rowsep0" align="left">0.008</td><td class="colsep0 rowsep0" align="left">0.06</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">static dose (mg kg<sup>–1</sup> day<sup>–1</sup>)</td><td class="colsep0 rowsep0" align="left">6.4</td><td class="colsep0 rowsep0" align="left">45.5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t9fn1"><div class="footnote" id="t9fn1"><sup><sup>a</sup></sup><p class="last">Compounds were administered as hydrochloride salts in solution using the following vehicles and doses.</p></div><div class="footnote" id="t9fn2"><sup><sup>b</sup></sup><p class="last">Vehicle = 0.9% NaCl; dose = 5 mg/kg iv and 10 mg/kg po.</p></div><div class="footnote" id="t9fn3"><sup><sup>c</sup></sup><p class="last">Vehicle = DI water; dose = 5 mg/kg iv and 10 mg/kg po.</p></div><div class="footnote" id="t9fn4"><sup><sup>d</sup></sup><p class="last">Vehicle = 20% PEG300 + 5% Solutol in D5W; dose = 5 mg/kg iv and po.</p></div><div class="footnote" id="t9fn5"><sup><sup>e</sup></sup><p class="last">Vehicle = 20% PEG300 + 5% Solutol in D5W; dose = 5 mg/kg iv and 10 mg/kg po.</p></div><div class="footnote" id="t9fn6"><sup><sup>f</sup></sup><p class="last">Vehicle = DI water; multiple dose levels, subcutaneous route of administration.</p></div><div class="footnote" id="t9fn7"><sup><sup>g</sup></sup><p class="last">Vehicle = 40% PEG300 + 10% Solutol HS-15 in D5W; multiple dose levels, subcutaneous route of administration. See <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> for further details.</p></div></div></div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Chemistry</h3><div class="NLM_p">A detailed description of the synthesis of compounds <b>4</b> and <b>5</b> is provided in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> and followed synthetic routes similar to those described below. Initial SAR exploration at C4 was enabled by the synthesis of key intermediate <b>43</b>, equipped with an oxidative handle for further functionalization (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). Starting from commercially available arene <b>35</b>, standard protocols were employed to effect sequential esterification, nitration, reduction, and halogenation to provide iodide <b>37</b> in four steps and 57% overall yield. The methyl group at C8 was next installed by Suzuki reaction with methylboronic acid, while the aniline in <b>38</b> was engaged in a Chan–Lam coupling to provide cyclopropylamine <b>39</b>.<a onclick="showRef(event, 'ref74 ref75 ref76'); return false;" href="javascript:void(0);" class="ref ref74 ref75 ref76">(74−76)</a> Following acetylation, bromide <b>40</b> was leveraged to append functionalized pyrrolidine <b>41</b> at C7 via Buchwald–Hartwig coupling, catalyzed by the combination of Pd<sub>2</sub>(dba)<sub>3</sub> and xantphos in toluene at 110 °C.<a onclick="showRef(event, 'ref77 ref78 ref79 ref80'); return false;" href="javascript:void(0);" class="ref ref77 ref78 ref79 ref80">(77−80)</a> Construction of the quinolin-2(1<i>H</i>)-one core was then accomplished by subjection of <b>42</b> to base-mediated cyclization, delivering <b>43</b> in an overall nine-step sequence.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Key Intermediate toward C4-Substituted Analogs</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00347&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">With a robust route to access <b>43</b>, analogs containing oxidation at C4 were prepared in short order as shown in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. Boc deprotection gave hydroxy derivative <b>7</b>, while treatment with POCl<sub>3</sub> effected chlorination and concomitant deprotection to provide <b>6</b>. Ethers <b>8</b> and <b>12</b> were accessed via alkylations with methyl iodide and 2-dimethylaminoethyl chloride, respectively.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Direct Functionalization of C4-OH</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00347&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The divergent synthesis of analogs with carbon-based functionality at C4 is illustrated in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. Conversion of <b>43</b> to triflate <b>44</b> enabled installation of an ethyl ester (<b>45</b>, obtained as a partially deprotected mixture) via palladium-catalyzed carbonylation,<a onclick="showRef(event, 'ref81 ref82'); return false;" href="javascript:void(0);" class="ref ref81 ref82">(81,82)</a> or a nitrile (<b>46</b>) via a Negishi-type cyanation reaction.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> Reduction of the deprotected ester (<b>45</b>, R = H) afforded hydroxymethyl derivative <b>11</b>. Alternatively, heating the protected ester with hydrazine in EtOH provided the acyl hydrazide <b>47</b>, which was cyclized with CDI in dioxane at 90 °C to give oxadiazolone <b>14</b> after Boc deprotection. The versatile nitrile <b>46</b> was used to access <b>10</b> (via deprotection and hydrogenation) and <b>13</b> (via hydrolysis of the cyano group and Boc deprotection with TFA).</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Generation of C4-Carbon-Based Analogs via Triflate Functionalization</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00347&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Having established the C4 aminomethyl substituent as optimal, attention turned to adapting the synthetic route to facilitate rapid SAR exploration at the C7 position by introducing the amine at a later stage in the synthesis (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). To this end, N-acetylated bromide <b>40</b> was cyclized to form the quinolin-2(1<i>H</i>)-one core as before, followed by treatment with <i>N</i>-phenyl triflamide to give <b>48</b> in 77% yield over the two steps. Triflate <b>48</b> underwent chemoselective Negishi cyanation, leaving the bromide in <b>49</b> intact and poised for subsequent Buchwald–Hartwig coupling. A variety of C7 amine derivatives were prepared in this manner as exemplified by <b>50</b>, obtained in 60% yield after reaction with <i>tert</i>-butyl (<i>S</i>)-pyrrolidin-3-ylcarbamate. The reaction conditions shown in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a> were slightly modified as necessary to accommodate more difficult amine substrates (see <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> for details).<a onclick="showRef(event, 'ref79 ref84 ref85'); return false;" href="javascript:void(0);" class="ref ref79 ref84 ref85">(79,84,85)</a> Next, the aminomethyl substituent at C4 was revealed upon hydrogenation of the cyano group, for which the best results were consistently obtained when ammonia/methanol was used as solvent. A final Boc deprotection efficiently generated a series of differentially functionalized C7 analogs <b>15</b>–<b>26</b> (see <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). Compound <b>19</b> was prepared via Suzuki coupling with the appropriate arylboronic acid.<a onclick="showRef(event, 'ref86 ref87'); return false;" href="javascript:void(0);" class="ref ref86 ref87">(86,87)</a> The requisite azabicyclic amines for compounds <b>22</b> and <b>23</b> were prepared using an intramolecular Kulinkovich-style reaction reported by Laroche et al.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> (see <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> for details).</div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Divergent Synthesis of C7 Analogs</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00347&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Whereas the C7 position was ultimately amenable to SAR exploration in a divergent fashion, the preparation of compounds with alternative substituents at C3 and C8 required multiple adaptations at an earlier point in the synthetic route. However, efforts directed at developing new sequences also provided an opportunity to improve upon the previously established strategy. For instance, an alternative two-step procedure was identified to afford <b>55</b> by conversion of aniline <b>52</b> (see <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, intermediate not drawn) to iodide <b>53</b> via Sandmeyer reaction,<a onclick="showRef(event, 'ref89 ref90'); return false;" href="javascript:void(0);" class="ref ref89 ref90">(89,90)</a> followed by Buchwald–Hartwig coupling with cyclopropylamine, which proved higher yielding and generally more reliable than the previously utilized Chan–Lam reaction (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>a). Likewise, it was found that Suzuki reaction with triflate <b>57</b> and <i>N</i>-Boc aminomethyl potassium trifluoroborate proceeded smoothly to afford <b>58</b> in 53% yield, thus establishing a more convenient protocol for direct introduction of the aminomethyl group at C4.<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> Compound <b>27</b> lacking the C8 methyl group was then obtained by coupling with pyrrolidine <b>59</b> and double Boc deprotection.</div><figure id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Adapted Synthetic Routes toward C8 Analogs</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00347&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The synthetic routes toward C8 analogs <b>28</b> and <b>29</b> diverge at an early stage. Aryl cyanide <b>60</b> was produced in 77% yield by exposure of iodide <b>37</b> to CuCN in DMSO at elevated temperature (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>b). In this case, Chan–Lam coupling was utilized, albeit in low yield to access intermediate <b>61</b>, which was elaborated to <b>28</b> through a sequence analogous to that described in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> (see <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> for details). Aryl iodide <b>37</b> was also used to prepare C8-methoxy intermediate <b>62</b>, which was converted to cyclopropylamine <b>64</b> using the same strategy employed for <b>27</b>. Compound <b>29</b> was then accessed by carrying <b>64</b> through the seven-step synthetic sequence outlined in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>. Fortunately, iodide <b>63</b> could also be leveraged toward the synthesis of analog <b>30</b>; demethylation and SEM protection gave <b>65</b>, which was elaborated to <b>66</b> in 7 steps (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>c). The free phenol was then reacted with difluorocarbene generated from PhCOCF<sub>2</sub>Cl to produce <b>67</b> in serviceable yield.<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> Finally, coupling with pyrrolidine <b>59</b> under our standard conditions and double Boc deprotection delivered C8 difluoromethoxy analog <b>30</b>.</div><div class="NLM_p">The syntheses of C3 analogs <b>31</b> and <b>33</b> are shown in <a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>. Pyrrolidine <b>59</b> was coupled to aryl bromide <b>49</b> in 85% yield, followed by conversion of the C4 cyano group to the corresponding aminomethyl via hydrogenation in NH<sub>3</sub>/MeOH with subsequent Boc protection to give <b>69</b>. This common intermediate was chlorinated at C3 upon exposure to NCS in acetonitrile, leading to <b>33</b>. Alternatively, <b>69</b> could be brominated and subjected to a Suzuki reaction with methylboronic acid, affording <b>31</b> after deprotection.</div><figure id="sch6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of C3-Cl and Me Analogs</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00347&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Incorporation of either OH or F substituents at C3 required yet another synthetic route modification to build in an additional oxidation state prior to formation of the quinolin-2(1<i>H</i>)-one core; this was accomplished from cyclopropylamine <b>39</b> via acylation with either 2-benzyloxy or 2-fluoroacetyl chloride to generate <b>71</b> and <b>75</b>, respectively (<a class="ref internalNav" href="#sch7" aria-label="Scheme 7">Scheme 7</a>a,b). Each of these intermediates was progressed through the established four-step sequence involving cyclization, triflation, Suzuki, and Buchwald–Hartwig coupling reactions to yield advanced intermediates <b>74</b> (C3-OH) and <b>79</b> (C3-F), respectively. Fluoride <b>34</b> was obtained after Boc deprotection of <b>79</b>, while hydrogenolysis was required to remove the benzyl group from <b>74</b>, thus providing <b>32</b> after Boc deprotection.</div><figure id="sch7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of C3-OH and C3-F Analogs <b>32</b> and <b>34</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00347&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i26">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05183" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05183" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">After decades of clinical success quinolone antibiotics remain a crucial component of our antibacterial armamentarium. Unfortunately, resistance (driven by target-based QRDR mutations that disrupt quinolone binding) poses a serious threat to their continued use. In an effort to address this situation we elected to prioritize the discovery of small molecules that target WT and QRDR mutant forms of bacterial DNA gyrase and topoisomerase IV. On the basis of a scaffold-morphing approach, we were ultimately able to identify inhibitors that lacked both the C3 carboxylate and the C4 carbonyl responsible for engaging in the key water–metal ion bridge that anchors classical quinolones in the gyrase/topoisomerase IV cleavage complex. Compounds in this series displayed minimal cross-resistance with quinolones in spite of an intrinsic loss of potency. Through a concerted SAR exploration effort we were successful in optimizing activity against Gram-negative bacteria en route to <b>34</b>, which demonstrated promising activity against Gram-negative bacteria and <i>in vivo</i> efficacy against <i>E</i>. <i>coli</i>. Unfortunately, however, further optimization of antibacterial potency proved extremely challenging. A number of <i>in vitro</i> safety issues were subsequently identified for compound <b>34</b>, including hERG inhibition, cytotoxicity, and phototoxicity. Compound <b>34</b>, and related analogs, also suffered from a severe loss of antibacterial potency at pH 5.8, suggesting that clinical utility in the cUTI setting would be compromised. Although some of these issues were resolved in other analogs from this series, we were ultimately unable to identify compounds that married such properties with sufficient antibacterial potency and spectrum of activity. These challenges prompted us to halt further development of the series. It is our hope, however, that these studies may point the way toward development of more efficacious inhibitors that can help to address the ever-growing need for new agents to treat drug-resistant Gram-negative infections.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71882" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71882" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Chemistry. General</h3><div class="NLM_p">Unless otherwise noted, all key compounds possess a purity of at least 95% as assessed by analytical reversed phase HPLC and/or LC/MS.</div><div class="NLM_p"><i>Typical Conditions for Analytical HPLC</i>. High performance liquid chromatography (HPLC) used a Waters UPLC instrument (Milford, MA). HPLC solvent A was 100% water with 0.1% trifluoroacetic acid (TFA), and solvent B was 100% acetonitrile with 0.1% TFA from EMD Chemicals Inc. The instrument was a Waters ACQUITY UPLC system with 1.2 mL/min flow rate; column Kinetex-C18, 2.6 μm, 2.1 mm × 50 mm from Phenomenex, column temperature 50 °C; gradient, 2–88% solvent B over 9.79 min. Compounds were detected by ultraviolet light (UV) absorption at either 220 or 254 nm.</div><div class="NLM_p"><i>Typical Conditions for LC/MS Analysis</i>. HPLC/mass spectrometric analysis (LC/MS) was performed on a Waters ACQUITY UPLC system equipped with a ZQ 2000 or SQD MS system. Column: Kinetex by Phenomenex, 2.6 μm, 2.1 mm × 50 mm. Column temperature: 50 °C. Gradient: 2–88% (or 0–45% or 65–95%) solvent B over a 1.29 or 9.79 min period; flow rate 1.2 mL/min. Compounds were detected by a Waters photodiode array detector. All masses were reported as those of the protonated parent ions, molecular weight range 150–850; cone voltage 20 V. For select bromine-containing intermediates, MS data are reported as [M + 2]<sup>+</sup>, reflecting the mass of the heavier isotope [M + H]<sup>+</sup>.</div><div class="NLM_p"><i>Alternative LC/MS Method (Compounds <b>27</b>, <b>30</b>, <b>32</b>)</i>. BEH 1.7 μm C18 50 mm × 2.1 mm; column temperature, ambient; mobile phase, 5 mM ammonium acetate in 0.1% formic acid in water (solvent A) and 0.1% formic acid in MeCN (solvent B); gradient, 5%–100% solvent B over 2.5 min and holding at 100% for 0.8 min with a flow rate of 0.55 mL/min. Compounds were detected by ESI-MS in positive ion mode and UV absorption at 254 nm.</div><div class="NLM_p">High resolution ESI-MS data were recorded using a LTQ Orbitrap mass spectrometer (Thermo Fisher Scientific) with electrospray ionization source. The resolution of the MS system was approximately 30 000. The analyte compound was infused into the mass spectrometer by UPLC (Acquity, Waters) from the sample probe. The separation was performed on Acquity UPLC BEH C18 1 mm × 50 mm column at 0.15 mL/min flow rate with the gradient from 5% to 95% in 2.8 min. Solvent A was water with 0.1% trifluoroacetic acid, and solvent B was 75% methanol and 25% isopropyl alcohol with 0.1% trifluoroacetic acid. The mass accuracy of the system was found to be <5 ppm.</div><div class="NLM_p">NMR spectra were run on Varian 400 or Bruker 400 and 500 MHz NMR spectrometers. Spectra were measured at 298 K and were referenced using the solvent peak.</div><div class="NLM_p last">Preparative separations were carried out using a Combiflash Rf system (Teledyne Isco, Lincoln, NE) with RediSep silica gel cartridges (Teledyne Isco, Lincoln, NE) or SiliaSep silica gel cartridges (Silicycle Inc., Quebec City, Canada) or by flash column chromatography using silica gel (230–400 mesh) packing material or by HPLC using a Waters 2767 Sample Manager, C-18 reversed phase Sunfire column, 30 mm × 50 mm, flow 75 mL/min. Typical solvents employed for the Combiflash Rf system and flash column chromatography were dichloromethane, methanol, ethyl acetate, hexane, heptane, acetone, aqueous ammonia (or ammonium hydroxide), and triethylamine. Typical solvents employed for the reverse phase HPLC are varying concentrations of acetonitrile and water with 0.1% trifluoroacetic acid.</div></div><div id="sec4_1_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Synthesis of 7-((<i>R</i>)-3-((<i>S</i>)-1-Aminoethyl)pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-8-methyl-2-oxo-1,2-dihydroquinoline-3-carboxylic Acid Hydrochloride (<b>4</b>)</h3><div class="NLM_p">The overall synthesis is depicted in <a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>.</div><figure id="cht1" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0015.jpeg" id="gr12" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00347&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_1_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 3-Bromo-4-fluoro-2-methylbenzoic Acid (<b>S2</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0016.gif" alt="" id="gr13" /></img><div class="NLM_p last">To a stirred solution of <i>n</i>-butyllithium (1024 mL, 2560 mmol, 2.5 M in hexanes) was added 2,2,6,6-tetramethylpiperidine (436.0 mL, 2560 mmol) in THF (2300 mL) at −5 °C. After stirring for 15 min the mixture was cooled to −60 °C. A solution of 3-bromo-4-fluorobenzoic acid (255.0 g, 1160 mmol) in THF (700 mL) was added dropwise, and the mixture was stirred at this temperature for 2.5 h. The mixture was then treated with MeI (291.0 mL, 4640 mmol) at −70 °C. The resulting solution was allowed to warm to 20 °C within 30 min. Water was added to quench the reaction, and the resulting solution was washed with EtOAc and then acidified with 4 M HCl. The resulting mixture was extracted with EtOAc, the organic layer dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to give the crude benzoic acid, which was recrystallized from toluene to give the title compound (114 g, 42% yield) as a yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.81 (dd, <i>J</i> = 8.8, 5.6 Hz, 1H), 7.28 (t, <i>J</i> = 8.4 Hz, 1H), 2.60 (s, 3H).</div></div><div id="sec4_1_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> <i>tert</i>-Butyl (3-Bromo-4-fluoro-2-methylphenyl)carbamate (<b>S3</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0017.gif" alt="" id="gr14" /></img><div class="NLM_p last">To a solution of 3-bromo-4-fluoro-2-methylbenzoic acid (6.00 g, 25.8 mmol) in <i>t</i>-BuOH (49 mL) were added TEA (7.20 mL, 51.6 mmol) and DPPA (6.30 mL, 28.4 mmol) at 15 °C. The mixture was then allowed to reflux for 1 h. After the reaction was complete, the reaction mixture was concentrated to give the crude product, which was purified by chromatography on silica gel (10% EtOAc/PE) to afford the title compound (6.20 g, 79% yield) as a white solid. LCMS (<i>m</i>/<i>z</i>): 248.0 [M – 55]. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.82 (br s, 1H), 7.27 (dd, <i>J</i> = 9.2, 5.6 Hz, 1H), 7.16 (t, <i>J</i> = 8.4 Hz, 1H), 2.26 (s, 3H), 1.43 (s, 9H).</div></div><div id="sec4_1_1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 3-Bromo-4-fluoro-2-methylaniline (<b>S4</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0018.gif" alt="" id="gr15" /></img><div class="NLM_p last">To a mixture of <i>tert</i>-butyl (3-bromo-4-fluoro-2-methylphenyl)carbamate (6.20 g, 20.4 mmol) in MeOH (5.00 mL) was added HCl (4 M in MeOH, 25.5 mL, 102 mmol) at 0 °C. The reaction mixture was stirred at rt for 30 min. The reaction mixture was quenched with saturated aqueous NaHCO<sub>3</sub> (20 mL). The slurry was extracted with EtOAc, the organic layer dried with Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to give the title compound (3.80 g, 91% yield) as a white solid. LCMS (<i>m</i>/<i>z</i>): 204.0 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 6.91 (t, <i>J</i> = 8.4 Hz, 1H), 6.63 (dd, <i>J</i> = 8.8, 5.2 Hz, 1H), 5.04 (br s, 2H), 2.18 (s, 3H).</div></div><div id="sec4_1_1_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 3-Bromo-4-fluoro-6-iodo-2-methylaniline (<b>S5</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0019.gif" alt="" id="gr16" /></img><div class="NLM_p last">A solution of 3-bromo-4-fluoro-2-methylaniline (2.30 g, 11.3 mmol) in EtOH (15 mL) was added dropwise to a mixture of I<sub>2</sub> (2.90 g, 11.3 mmol) and Ag<sub>2</sub>SO<sub>4</sub> (3.50 g, 11.3 mmol) in EtOH (35 mL) at rt. The resulting solution was then stirred at rt for 2 h. After completion the reaction mixture was filtered and the filtrate was concentrated. The residue was redissolved in DCM. The organic phase was washed with 5% aq NaOH and water, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to give a residue, which was purified by column chromatography on silica gel (0–10% EtOAc/PE), providing the title compound (2.10 g, 56% yield) as a black solid. LCMS (<i>m</i>/<i>z</i>): 329.9 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.34 (d, <i>J</i> = 7.6 Hz, 1H), 4.02 (br s, 2H), 2.36 (s, 3H).</div></div><div id="sec4_1_1_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Methyl 2-Amino-4-bromo-5-fluoro-3-methylbenzoate (<b>38</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0020.gif" alt="" id="gr17" /></img><div class="NLM_p last">To a solution of 3-bromo-4-fluoro-6-iodo-2-methylaniline (2.00 g, 6.10 mmol) in MeOH (20 mL) were added Pd(PPh<sub>3</sub>)<sub>4</sub> (36.0 mg, 0.031 mmol) and TEA (1.70 mL, 12.2 mmol). The mixture was stirred under a CO (40 psi) atmosphere for 30 min. After completion the reaction mixture was concentrated to give a crude product which was purified by chromatography on silica gel (0–5% EtOAc/PE) affording the title compound (1.40 g, 84% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.53 (d, <i>J</i> = 9.6 Hz, 1H), 5.83 (br s, 2H), 3.87 (s, 3H), 2.32 (s, 3H).</div></div><div id="sec4_1_1_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> (2-Amino-4-bromo-5-fluoro-3-methylphenyl)methanol (<b>S6</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0021.gif" alt="" id="gr18" /></img><div class="NLM_p last">To a solution of methyl 2-amino-4-bromo-5-fluoro-3-methylbenzoate (1.47 g, 5.61 mmol) in THF (10 mL) was added LAH (234 mg, 6.17 mmol) at 0 °C. After stirring at 0 °C for 20 min, another batch of LAH (117 mg, 3.09 mmol) was added. The reaction mixture was further stirred at 0 °C for 30 min. After completion of the reaction, water was added, the resulting suspension dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and the solid filtered. The filtrate was concentrated to give the desired product (1.32 g, quantitative yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 6.99 (d, <i>J</i> = 9.6 Hz, 1H), 5.29 (t, <i>J</i> = 5.6 Hz, 1H), 4.83 (br s, 2H), 4.38 (d, <i>J</i> = 9.6 Hz, 1H), 2.23 (s, 3H).</div></div><div id="sec4_1_1_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 2-Amino-4-bromo-5-fluoro-3-methylbenzaldehyde (<b>S7</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0022.gif" alt="" id="gr19" /></img><div class="NLM_p last">To a solution of (2-amino-4-bromo-5-fluoro-3-methylphenyl)methanol (1.32 g, 5.64 mmol) in DCM (60 mL) was added MnO<sub>2</sub> (3.68 g, 42.3 mmol) at 0 °C. After stirring at 10 °C for 30 min, another batch of MnO<sub>2</sub> (1.84 g, 21.2 mmol) was added. The reaction mixture was further stirred at 0 °C for 30 min. The suspension was filtered and the filtrate was concentrated to give the desired product (1.17 g, 89% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.80 (s, 1H), 7.52 (d, <i>J</i> = 8.8 Hz, 1H), 7.15 (br s, 2H), 2.23 (s, 3H).</div></div><div id="sec4_1_1_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 4-Bromo-2-(cyclopropylamino)-5-fluoro-3-methylbenzaldehyde (<b>S8</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0023.gif" alt="" id="gr20" /></img><div class="NLM_p last">To a solution of 2-amino-4-bromo-5-fluoro-3-methylbenzaldehyde (1.70 g, 7.30 mmol) in DCE (30 mL) were added cyclopropylboronic acid (1.25 g, 14.6 mmol), Cu(OAc)<sub>2</sub> (1.33 g, 7.30 mmol), bipyridine (1.14 g, 7.30 mmol), and Na<sub>2</sub>CO<sub>3</sub> (1.55 g, 14.6 mmol). The mixture was stirred at 80 °C for 40 min. After completion the mixture was filtered and the filtrate was concentrated to give the crude product, which was purified by flash chromatography (5% EtOAc/PE), providing the title compound as a yellow oil (400 mg, 20% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.02 (s, 1H), 7.49 (d, <i>J</i> = 8.8 Hz, 1H), 7.31 (br s, 1H), 2.95–2.85 (m, 1H), 2.50 (s, 3H), 0.75–0.70 (m, 2H), 0.50–0.45 (m, 2H).</div></div><div id="sec4_1_1_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> Ethyl 7-Bromo-1-cyclopropyl-6-fluoro-8-methyl-2-oxo-1,2-dihydroquinoline-3-carboxylate (<b>S9</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0024.gif" alt="" id="gr21" /></img><div class="NLM_p last">To a solution of 4-bromo-2-(cyclopropylamino)-5-fluoro-3-methylbenzaldehyde (1.40 g, 5.20 mmol) in EtOH (30 mL) were added diethyl malonate (1.67 g, 10.4 mmol) and piperidine (1.77 g, 20.8 mmol). The mixture was refluxed at 100 °C for 16 h. The mixture was concentrated to give the crude product, which was purified by flash chromatography (20% EtOAc/PE) to give the title compound as a yellow solid (840 mg, 44% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.13 (s, 1H), 7.17 (d, <i>J</i> = 7.2 Hz, 1H), 4.40 (q, <i>J</i> = 7.2 Hz, 2H), 3.52–3.45 (m, 1H), 2.78 (s, 3H), 1.41 (t, <i>J</i> = 7.2 Hz, 3H), 1.28–1.20 (m, 2H), 0.60–0.50 (m, 2H).</div></div><div id="sec4_1_1_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> Ethyl 7-((<i>R</i>)-3-((<i>S</i>)-1-((<i>tert</i>-Butoxycarbonyl)amino)ethyl)pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-8-methyl-2-oxo-1,2-dihydroquinoline-3-carboxylate (<b>S10</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0025.gif" alt="" id="gr22" /></img><div class="NLM_p last">To a solution of ethyl 7-bromo-1-cyclopropyl-6-fluoro-8-methyl-2-oxo-1,2- dihydroquinoline-3-carboxylate (250 mg, 0.68 mmol) in toluene (50 mL) were added <i>tert</i>-butyl ((<i>S</i>)-1-((<i>R</i>)-pyrrolidin-3-yl)ethyl)carbamate (291 mg, 1.36 mmol), Cs<sub>2</sub>CO<sub>3</sub> (666 mg, 2.04 mmol), xantphos (59.0 mg, 0.10 mmol), and Pd<sub>2</sub>(dba)<sub>3</sub> (31.1 mg, 0.03 mmol) at rt. The reaction mixture was stirred at 110 °C for 12 h. After completion the mixture was dissolved in water (20 mL) and extracted with EtOAc. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated to give a crude product, which was purified by column chromatography on silica gel (0–50% EtOAc/PE) affording the desired product (280 mg, 82% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.16 (s, 1H), 7.05 (d, <i>J</i> = 12.4 Hz, 1H), 4.51 (br s, 1H), 4.41 (q, <i>J</i> = 7.2 Hz, 2H), 3.80–3.70 (m, 1H), 3.68–3.60 (m, 1H), 3.54–3.45 (m, 4H), 2.45 (s, 3H), 2.12–2.10 (m, 1H), 2.11–2.07 (m, 1H), 1.80–1.70 (m, 1H), 1.47–1.40 (m, 12H), 1.30–1.26 (m, 5H), 0.60–0.56 (m, 2H).</div></div><div id="sec4_1_1_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 7-((<i>R</i>)-3-((<i>S</i>)-1-((<i>tert</i>-Butoxycarbonyl)amino)ethyl)pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-8-methyl-2-oxo-1,2-dihydroquinoline-3-carboxylic Acid (<b>S11</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0026.gif" alt="" id="gr23" /></img><div class="NLM_p last">To a solution of ethyl 7-((<i>R</i>)-3-((<i>S</i>)-1-((<i>tert</i>-butoxycarbonyl)amino)ethyl)pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-8-methyl-2-oxo-1,2-dihydroquinoline-3-carboxylate (200 mg, 0.40 mmol) in THF/H<sub>2</sub>O (8 mL, 1:1) was added NaOH (32.0 mg, 0.80 mmol). The reaction mixture was stirred at 45 °C for 4 h. After the reaction was complete, the reaction mixture was acidified to pH = 5 and extracted with EtOAc. The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated to give the desired product (175 mg, 93% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.64 (s, 1H), 7.64 (d, <i>J</i> = 13.6 Hz, 1H), 7.20–7.17 (m, 1H), 4.48–4.40 (m, 2H), 4.20–4.10 (m, 2H), 3.69–3.60 (m, 1H), 3.35–3.25 (m, 2H), 2.89–2.75 (m, 1H), 2.60–2.50 (m, 1H), 2.38 (s, 3H), 1.50–1.40 (s, 11H), 1.30–1.24 (m, 3H), 0.70–0.62 (m, 2H).</div></div><div id="sec4_1_1_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 7-((<i>R</i>)-3-((<i>S</i>)-1-Aminoethyl)pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-8-methyl-2-oxo-1,2-dihydroquinoline-3-carboxylic Acid Hydrochloride (<b>4</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0027.gif" alt="" id="gr24" /></img><div class="NLM_p last">To a solution of 7-((<i>R</i>)-3-((<i>S</i>)-1-((<i>tert</i>-butoxycarbonyl)amino)ethyl)pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-8-methyl-2-oxo-1,2-dihydroquinoline-3-carboxylic acid (180 mg, 0.38 mmol) in EtOAc (10 mL) was added HCl (1 M in EtOAc, 10 mL) at 0 °C. The reaction mixture was stirred at rt for 3 h. After completion of the reaction, the organic layer was concentrated to give a crude product which was purified by reverse phase HPLC, affording the product (140 mg, 99% yield). HRMS (ESI) calcd for C<sub>20</sub>H<sub>25</sub>FN<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup> 374.1874, found 374.1869. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.67 (s, 1H), 8.25 (br s, 3H), 7.66 (d, <i>J</i> = 13.6 Hz, 1H), 3.78–3.70 (m, 1H), 3.60–3.40 (m, 4H), 3.30–3.20 (m, 1H), 2.45–2.35 (m, 4H), 2.20–2.10 (m, 1H), 1.80–1.70 (m, 1H), 1.30–1.20 (m, 5H), 0.62–050 (m, 2H).</div></div><div id="sec4_1_1_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> Synthesis of 7-((<i>R</i>)-3-((<i>S</i>)-1-Aminoethyl)pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-8-methylquinolin-2(1<i>H</i>)-one Hydrochloride (<b>5</b>)</h3><div class="NLM_p">The overall synthesis is shown in <a class="ref internalNav" href="#cht2" aria-label="Chart 2">Chart 2</a>.</div><figure id="cht2" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Chart 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0028.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0028.jpeg" id="gr25" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00347&amp;id=cht2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_1_1_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 7-Bromo-1-cyclopropyl-6-fluoro-8-methyl-2-oxo-1,2-dihydroquinoline-3-carboxylic Acid (<b>S12</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0029.gif" alt="" id="gr26" /></img><div class="NLM_p last">To a solution of ethyl 7-bromo-1-cyclopropyl-6-fluoro-8-methyl-2-oxo-1,2- dihydroquinoline-3-carboxylate (300 mg, 0.81 mmol) in MeOH (12 mL) and H<sub>2</sub>O (3 mL) was added KOH (91.4 mg, 1.63 mmol) at 10 °C. The resulting mixture was stirred at 40 °C for 2 h. After completion the reaction mixture was acidified to pH 4 by the addition of 2 N HCl. The resulting solution was extracted with DCM, and the organic layer was washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to give the title compound (230 mg, 83% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 14.16 (br s, 1H), 8.68 (s, 1H), 7.33 (d, <i>J</i> = 6.4 Hz, 1H), 3.65–3.60 (m, 1H), 2.86 (s, 3H), 1.40–1.30 (m, 2H), 0.70–0.60 (m, 2H).</div></div><div id="sec4_1_1_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 7-Bromo-1-cyclopropyl-6-fluoro-8-methylquinolin-2(1<i>H</i>)-one (<b>S13</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0030.gif" alt="" id="gr27" /></img><div class="NLM_p last">To a solution of 7-bromo-1-cyclopropyl-6-fluoro-8-methyl-2-oxo-1,2-dihydroquinoline-3-carboxylic acid (230 mg, 0.68 mmol) in quinoline (2 mL) was added Cu (42.9 mg, 0.68 mmol) at 10 °C. The resulting mixture was stirred at 240 °C for 30 min. The reaction mixture was cooled to 10 °C, and water was added. The resulting suspension was extracted with EtOAc, and the organic layer was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The crude product was purified by column chromatography on silica gel (0–50% EtOAc/PE) to give the title compound as a yellow solid (120 mg, 60% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.44 (d, <i>J</i> = 9.6 Hz, 1H), 7.08 (d, <i>J</i> = 7.6 Hz, 1H), 6.61 (d, <i>J</i> = 9.6 Hz, 1H), 3.53–3.48 (m, 1H), 2.78 (s, 3H), 1.30–1.20 (m, 2H), 0.58–0.54 (m, 2H).</div></div><div id="sec4_1_1_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> <i>tert</i>-Butyl ((<i>S</i>)-1-((<i>R</i>)-1-(1-Cyclopropyl-6-fluoro-8-methyl-2-oxo-1,2-dihydroquinolin-7-yl)pyrrolidin-3-yl)ethyl)carbamate (<b>S14</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0031.gif" alt="" id="gr28" /></img><div class="NLM_p last">To a solution of 7-bromo-1-cyclopropyl-6-fluoro-8-methylquinolin-2(1<i>H</i>)-one (50.0 mg, 0.17 mmol) in toluene (3 mL) were added <i>tert</i>-butyl ((<i>S</i>)-1-((<i>R</i>)-pyrrolidin-3-yl)ethyl)carbamate (45.4 mg, 0.21 mmol) and Cs<sub>2</sub>CO<sub>3</sub> (138.0 mg, 0.42 mmol), followed by xantphos (12.3 mg, 0.021 mmol) and Pd<sub>2</sub>(dba)<sub>3</sub> (6.5 mg, 0.007 mmol). The resulting mixture was stirred at 110 °C under nitrogen for 16 h. The reaction mixture was concentrated, the residue was dissolved in water, and the slurry was extracted with DCM. The organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to afford a crude product, which was purified by preparative TLC to give the title compound (35.0 mg, 48% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.38 (d, <i>J</i> = 9.2 Hz, 1H), 6.94 (d, <i>J</i> = 12.4 Hz, 1H), 6.45 (d, <i>J</i> = 9.6 Hz, 1H), 4.63 (d, <i>J</i> = 8.0 Hz, 1H), 3.80–3.73 (m, 1H), 3.60–3.35 (m, 5H), 2.76–2.68 (m, 1H), 2.49 (s, 3H), 2.32–2.27 (m, 1H), 2.10–2.00 (m, 1H), 1.43 (s, 9H), 1.22 (d, <i>J</i> = 6.8 Hz, 3H), 1.25–1.15 (m, 2H), 0.60–0.50 (m, 2H).</div></div><div id="sec4_1_1_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 7-((<i>R</i>)-3-((<i>S</i>)-1-Aminoethyl)pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-8-methylquinolin-2(1<i>H</i>)-one Hydrochloride (<b>5</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0032.gif" alt="" id="gr29" /></img><div class="NLM_p last">To a solution of <i>tert</i>-butyl ((<i>S</i>)-1-((<i>R</i>)-1-(1-cyclopropyl-6-fluoro-8-methyl-2-oxo-1,2- dihydroquinolin-7-yl)pyrrolidin-3-yl)ethyl)carbamate (35.0 mg, 0.08 mmol) in MeOH (2 mL) was added HCl (4 M in MeOH, 2 mL) at 10 °C. The resulting mixture was stirred at rt for 1 h. The reaction mixture was concentrated, and the residue was purified by reverse phase HPLC to give the title compound (10.9 mg, 37% yield). HRMS (ESI) calcd for C<sub>19</sub>H<sub>25</sub>FN<sub>3</sub>O [M + H]<sup>+</sup> 330.1976, found 330.1972. <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ 7.63 (d, <i>J</i> = 9.2 Hz, 1H), 7.25 (d, <i>J</i> = 12.0 Hz, 1H), 6.49 (d, <i>J</i> = 9.2 Hz, 1H), 3.90–3.83 (m, 1H), 3.82–3.75 (m, 2H), 3.70–3.60 (m, 1H), 3.55–3.40 (m, 2H), 2.90–2.80 (m, 1H), 2.56 (s, 3H), 2.40–2.30 (m, 1H), 2.07–1.96 (m, 1H), 1.40 (d, <i>J</i> = 6.4 Hz, 3H), 1.20–1.15 (m, 2H), 0.50–0.40 (m, 2H).</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> Preparation of Compounds <b>6</b>–<b>15</b></h3><div class="NLM_p">Compounds <b>6</b>–<b>15</b> were prepared from intermediate <b>43</b>, which was synthesized according to <a class="ref internalNav" href="#cht3" aria-label="Chart 3">Chart 3</a>.</div><figure id="cht3" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Chart 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0033.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0033.jpeg" id="gr30" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0033.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00347&amp;id=cht3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_1_2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> Methyl 4-Bromo-3-fluorobenzoate (<b>S15</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0034.gif" alt="" id="gr31" /></img><div class="NLM_p last">A solution of 4-bromo-3-fluorobenzoic acid (350 g, 1.60 mol) in HCl (4 M in MeOH, 2 L) was stirred at 50 °C for 3 h. The reaction mixture was concentrated to give the title compound (372 g, quant yield) as a gray solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.78–7.64 (m, 3H), 3.93 (s, 3H).</div></div><div id="sec4_1_2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> Methyl 4-Bromo-5-fluoro-2-nitrobenzoate (<b>36</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0035.gif" alt="" id="gr32" /></img><div class="NLM_p last">To a solution of methyl 4-bromo-3-fluorobenzoate (372 g, 1.60 mol) in H<sub>2</sub>SO<sub>4</sub>(1000 mL) was added KNO<sub>3</sub>(170 g, 1.68 mol) at 0 °C. The mixture was then stirred at rt for 2 h. The reaction mixture was quenched with ice–water and then extracted with EtOAc. The organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> and concentrated to give the crude product, which was purified by column chromatography on silica gel (5% EtOAc/PE) affording the title compound (380 g, 86% yield) as a yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.21 (d, <i>J</i> = 5.6 Hz, 1H), 7.45 (d, <i>J</i> = 7.6 Hz, 1H), 3.94 (s, 3H).</div></div><div id="sec4_1_2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> Methyl 2-Amino-4-bromo-5-fluorobenzoate (<b>S16</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0036.gif" alt="" id="gr33" /></img><div class="NLM_p last">To a solution of methyl 4-bromo-5-fluoro-2-nitrobenzoate (95.0 g, 0.34 mol) in MeOH (1000 mL) was added AcOH(102 g, 1.70 mol). Fe power (95.4 g, 1.70 mol) was added slowly at 0 °C. After being stirred at rt for 1 h, the reaction mixture was filtered. The filtrate was concentrated, and the residue was purified by column chromatography on silica gel (5% EtOAc/PE) to give the title compound (62.5 g, 74% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.59 (d, <i>J</i> = 9.6 Hz, 1H), 6.88 (d, <i>J</i> = 5.6 Hz, 1H), 5.62 (br s, 2H), 3.88 (s, 3H).</div></div><div id="sec4_1_2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> Methyl 2-Amino-4-bromo-5-fluoro-3-iodobenzoate (<b>37</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0037.gif" alt="" id="gr34" /></img><div class="NLM_p last">To a solution of methyl 2-amino-4-bromo-5-fluorobenzoate (50.0 g, 0.20 mol) in MeOH (480 mL) were added water (400 mL) and Ag<sub>2</sub>SO<sub>4</sub>(100 g, 0.32 mol). A solution of I<sub>2</sub> (81.2 g, 0.32 mol) in THF (480 mL) was added at rt. After stirring at rt for 30 min, the solvent was evaporated and the resulting suspension was filtered. The filtrate was extracted with EtOAc, and the organic phase was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> and concentrated to give the crude product, which was purified by column chromatography on silica gel (5% EtOAc/PE) affording the title compound (68.0 g, 90% yield) as a yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.75 (d, <i>J</i> = 9.6 Hz, 1H), 6.55 (br s, 2H), 3.90 (s, 3H).</div></div><div id="sec4_1_2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> Methyl 2-Amino-4-bromo-5-fluoro-3-methylbenzoate (<b>38</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0038.gif" alt="" id="gr35" /></img><div class="NLM_p last">To a solution of methyl 2-amino-4-bromo-5-fluoro-3-iodobenzoate (80.0 g, 214 mmol) in DME (1170 mL) were added water (200 mL), CH<sub>3</sub>B(OH)<sub>2</sub> (77.0 g, 1.28 mol), K<sub>2</sub>CO<sub>3</sub> (59.0 g, 428 mmol), and Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub> (15.0 g, 2.14 mol). The reaction mixture was stirred at 60 °C for 18 h and then at 90 °C for 6 h. The reaction was quenched with water and extracted with EtOAc. The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub>, concentrated, and then purified by column chromatography on silica gel (2% EtOAc/PE), followed by recrystallization with PE/EtOAc to give the title compound (29.0 g, 52% yield) as a yellow solid. LCMS (<i>m</i>/<i>z</i>): 262.0 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.52 (d, <i>J</i> = 9.6 Hz, 1H), 5.83 (br s, 2H), 3.87 (s, 3H), 2.32 (s, 3H).</div></div><div id="sec4_1_2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> Methyl 4-Bromo-2-(cyclopropylamino)-5-fluoro-3-methylbenzoate (<b>39</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0039.gif" alt="" id="gr36" /></img><div class="NLM_p last">To a solution of methyl 2-amino-4-bromo-5-fluoro-3-methylbenzoate (5.00 g, 19.2 mmol) in DCE (50 mL) were added Na<sub>2</sub>CO<sub>3</sub> (4.07 g, 38.4 mmol), 2,2′-bipyridine (2.90 g, 19.2 mmol), Cu(OAc)<sub>2</sub> (3.50 g, 19.2 mmol), and cyclopropylboronic acid (3.50 g, 19.2 mmol) at 10 °C. The reaction mixture was stirred at 10 °C for 20 min and then at 70 °C for 5 h. The reaction mixture was filtered and concentrated. The residue was purified by column chromatography on silica gel (2% EtOAc/PE) to give the title compound (2.40 g, 42% yield) as a yellow oil. LCMS (<i>m</i>/<i>z</i>): 302.2 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.52 (d, <i>J</i> = 9.0 Hz, 1H), 7.22 (br s, 1H), 3.85 (s, 3H), 2.71 (tt, <i>J</i> = 6.8, 3.5 Hz, 1H), 2.57 (s, 3H), 0.68–0.62 (m, 2H), 0.49–0.45 (m, 2H).</div></div><div id="sec4_1_2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> Methyl 4-Bromo-2-(<i>N</i>-cyclopropylacetamido)-5-fluoro-3-methylbenzoate (<b>40</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0040.gif" alt="" id="gr37" /></img><div class="NLM_p last">To a solution of methyl 4-bromo-2-(cyclopropylamino)-5-fluoro-3-methylbenzoate (13.0 g, 43.0 mmol) in DCM (260 mL) were added DIPEA (27.8 g, 215 mmol) and acetyl chloride (33.8 g, 430 mmol). The reaction mixture was stirred at rt for 20 min. The reaction mixture was poured into ice–water, and the phases were separated. The organic layer was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The residue was purified by column chromatography on silica gel (0–50% EtOAc/PE) to give the title compound (10.5 g, 71% yield) as a brown oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.63–7.53 (m, 1H), 3.90–3.80 (m, 3H), 3.15–3.01 (m, 1H), 2.41 (s, 2H), 2.34 (s, 1H), 2.27 (s, 2H), 1.76 (s, 1H), 0.93–0.83 (m, 1H), 0.79–0.60 (m, 3H), 0.47–0.27 (m, 1H).</div></div><div id="sec4_1_2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> Methyl 4-((<i>R</i>)-3-((<i>S</i>)-1-((<i>tert</i>-Butoxycarbonyl)amino)ethyl)pyrrolidin-1-yl)-2-(<i>N</i>-cyclopropylacetamido)-5-fluoro-3-methylbenzoate (<b>42</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0041.gif" alt="" id="gr38" /></img><div class="NLM_p last">To a suspension of methyl 4-bromo-2-(<i>N</i>-cyclopropylacetamido)-5-fluoro-3-methylbenzoate (6.00 g, 17.5 mmol) in toluene (180 mL) were added <i>tert</i>-butyl ((<i>S</i>)-1-((<i>R</i>)-pyrrolidin-3-yl)ethyl)carbamate (6.72 g, 31.5 mol), Cs<sub>2</sub>CO<sub>3</sub>(11.4 g, 35.0 mmol), xantphos (3.00 g, 5.25 mmol), and Pd<sub>2</sub>(dba)<sub>3</sub> (1.60 g, 1.75 mmol) at 10 °C. The resulting mixture was purged with nitrogen for 5 min and heated to 110 °C for 24 h. The reaction mixture was filtered, and the filtrate was concentrated. The residue was purified by column chromatography on silica gel (50% EtOAc/PE) to give the title compound (5.00 g, 60% yield) as a brown oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.54–7.45 (m, 1H), 4.61 (br s, 1H), 3.85–3.80 (m, 3H), 3.75–3.65 (m, 1H), 3.40–3.26 (m, 3H), 3.12–3.05 (m, 1H), 2.44–2.37 (m, 2H), 2.29–2.23 (m, 1H), 2.13 (s, 2H), 2.08–2.02 (m, 3H), 1.79–1.72 (m, 2H), 1.66 (s, 1H), 1.43 (s, 9H), 1.22–1.16 (m, 3H), 0.89–0.79 (m, 1H), 0.75–0.61 (m, 3H), 0.45–0.30 (m, 1H).</div></div><div id="sec4_1_2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> <i>tert</i>-Butyl ((<i>S</i>)-1-((<i>R</i>)-1-(1-Cyclopropyl-6-fluoro-4-hydroxy-8-methyl-2-oxo-1, 2-dihydroquinolin-7-yl)pyrrolidin-3-yl)ethyl)carbamate (<b>43</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0042.gif" alt="" id="gr39" /></img><div class="NLM_p last">To a solution of methyl 4-((<i>R</i>)-3-((<i>S</i>)-1-((<i>tert</i>-butoxycarbonyl)amino)ethyl)pyrrolidin-1-yl)-2-(<i>N</i>-cyclopropylacetamido)-5-fluoro-3-methylbenzoate (5.00 g, 10.5 mmol) in THF (150 mL) was added NaHMDS (52.4 mL, 52.4 mmol, 1 M in THF) at 10 °C followed by stirring for 20 min. The mixture was quenched with water and acidified to pH 4 with 1 M HCl. The resulting suspension was extracted with EtOAc, and the organic layer was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The residue was purified by HPLC to give the title compound (2.30 g, 49% yield) as a yellow solid. LCMS (<i>m</i>/<i>z</i>): 447.2 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD)δ 7.40 (d, <i>J</i> = 13.6 Hz, 1H), 6.71 (d, <i>J</i> = 8.8 Hz, 1H), 5.79 (s, 1H), 3.62 (d, <i>J</i> = 6.5 Hz, 2H), 3.48–3.38 (m, 4H), 2.54 (s, 3H), 2.40–2.29 (m, 1H), 2.11 (ddd, <i>J</i> = 11.4, 7.3, 3.9 Hz, 1H), 1.80–1.68 (m, 1H), 1.45 (s, 9H), 1.25–1.10 (m, 5H), 0.55–0.44 (m, 2H).</div></div><div id="sec4_1_2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> 7-((<i>R</i>)-3-((<i>S</i>)-1-Aminoethyl)pyrrolidin-1-yl)-4-chloro-1-cyclopropyl-6-fluoro-8-methylquinolin-2(1<i>H</i>)-one Trifluoroacetic Acid (<b>6</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0043.gif" alt="" id="gr40" /></img><div class="NLM_p last">A solution of <i>tert</i>-butyl ((<i>S</i>)-1-((<i>R</i>)-1-(1-cyclopropyl-6-fluoro-4-hydroxy-8-methyl-2-oxo-1,2-dihydroquinolin-7-yl)pyrrolidin-3-yl)ethyl)carbamate (65.0 mg, 0.15 mmol) and phosphoryl trichloride (0.03 mL, 0.15 mmol) in dioxane (2 mL) was stirred at room temperature for 2 min and then heated to 120 °C via microwave for 20 min. The reaction was cooled to room temperature and treated with ice and 6 N NaOH. The reaction was extracted with ethyl acetate, and the organic phase was collected, dried over MgSO<sub>4</sub>, filtered, concentrated, and purified by prep HPLC to afford the title compound (16.0 mg, 18% yield). HRMS (ESI) calcd for C<sub>19</sub>H<sub>24</sub>ClFN<sub>3</sub>O [M + H]<sup>+</sup> 364.1586, found 364.1582. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.83 (br s, 2H), 7.39 (d, <i>J</i> = 13.6 Hz, 1H), 6.67 (s, 1H), 3.58 (q, <i>J</i> = 8.2 Hz, 1H), 3.51–3.35 (m, 4H), 3.32–3.25 (m, 1H), 2.44 (s, 3H), 2.38 (q, <i>J</i> = 8.6, 8.5 Hz, 1H), 2.15–2.05 (m, 1H), 1.80–1.68 (m, 1H), 1.27 (d, <i>J</i> = 6.4 Hz, 3H), 1.19–1.07 (m, 2H), 0.46–0.38 (m, 2H).</div></div><div id="sec4_1_2_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> 7-((<i>R</i>)-3-((<i>S</i>)-1-Aminoethyl)pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-hydroxy-8-methylquinolin-2(1<i>H</i>)-one trifluoroacetic Acid (<b>7</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0044.gif" alt="" id="gr41" /></img><div class="NLM_p last">To a solution of <i>tert</i>-butyl ((<i>S</i>)-1-((<i>R</i>)-1-(1-cyclopropyl-6-fluoro-4-hydroxy-8-methyl-2-oxo-1,2-dihydroquinolin-7-yl)pyrrolidin-3-yl)ethyl)carbamate (50.0 mg, 0.11 mmol) in MeOH (1.1 mL) was added HCl (4 M in dioxane, 1.1 mL), and the solution was stirred at rt for 16 h. The reaction solution was concentrated and purified by reverse phase HPLC to give the desired product (42.0 mg, 64% yield). HRMS (ESI) calcd for C<sub>19</sub>H<sub>25</sub>FN<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup> 346.1925, found 346.1922. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.27 (s, 1H), 7.82 (s, 3H), 7.28 (d, <i>J</i> = 13.3 Hz, 1H), 5.65 (s, 1H), 3.51–3.39 (m, 2H), 3.36–3.29 (m, 3H), 3.29–3.21 (m, 1H), 2.43 (s, 3H), 2.41–2.32 (m, 1H), 2.12–2.04 (m, 1H), 2.07 (s, 3H), 1.80–1.66 (m, 1H), 1.26 (d, <i>J</i> = 6.6 Hz, 3H), 1.13–1.00 (m, 2H), 0.34 (p, <i>J</i> = 4.8 Hz, 2H).</div></div><div id="sec4_1_2_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> 7-((<i>R</i>)-3-((<i>S</i>)-1-Aminoethyl)pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-methoxy-8-methylquinolin-2(1<i>H</i>)-one Trifluoroacetic Acid (<b>8</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0045.gif" alt="" id="gr42" /></img><div class="NLM_p last">A mixture of <i>tert</i>-butyl ((<i>S</i>)-1-((<i>R</i>)-1-(1-cyclopropyl-6-fluoro-4-hydroxy-8-methyl-2-oxo-1,2-dihydroquinolin-7-yl)pyrrolidin-3-yl)ethyl)carbamate (17.0 mg, 0.04 mmol), iodomethane (10.9 mg, 0.08 mmol), potassium carbonate (10.6 mg, 0.08 mmol), and 18-crown-6 (41.0 mg, 0.15 mmol) in DMA (1 mL) was stirred at rt overnight. The reaction was poured into brine and extracted with ethyl acetate. The organic phase was collected, dried over MgSO<sub>4</sub>, filtered, and concentrated. The crude material was diluted with dichloromethane (1 mL) and treated with trifluoroacetic acid (1 mL) for 30 min. The reaction was concentrated and purified by prep HPLC to afford the desired material (6.0 mg, 34% yield). HRMS (ESI) calcd for C<sub>20</sub>H<sub>27</sub>FN<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup> 360.2082, found 360.2077. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.79 (br s, 2H), 7.29 (d, <i>J</i> = 13.5 Hz, 1H), 5.83 (s, 1H), 3.86 (s, 3H), 3.53–3.45 (m, 2H), 3.44–3.23 (m, 4H), 2.55 (p, <i>J</i> = 2.0 Hz, 2H), 2.44 (s, 3H), 2.42–2.31 (m, 1H), 2.13–2.01 (m, 1H), 1.79–1.66 (m, 1H), 1.26 (d, <i>J</i> = 6.5 Hz, 3H), 1.14–0.99 (m, 2H), 0.43–0.29 (m, 2H).</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> Preparation of Compounds <b>9</b> and <b>10</b></h3><div class="NLM_p">The overall synthesis is shown in <a class="ref internalNav" href="#cht4" aria-label="Chart 4">Chart 4</a>.</div><figure id="cht4" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Chart 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0046.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0046.jpeg" id="gr43" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0046.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00347&amp;id=cht4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_1_3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> 7-((<i>R</i>)-3-((<i>S</i>)-1-((<i>tert</i>-Butoxycarbonyl)amino)ethyl)pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-8-methyl-2-oxo-1,2-dihydroquinolin-4-yl trifluoromethanesulfonate (<b>44</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0047.gif" alt="" id="gr44" /></img><div class="NLM_p last">To an ice-cold solution of <i>tert</i>-butyl ((<i>S</i>)-1-((<i>R</i>)-1-(1-cyclopropyl-6-fluoro-4-hydroxy-8-methyl-2-oxo-1,2-dihydroquinolin-7-yl)pyrrolidin-3-yl)ethyl)carbamate (170 mg, 0.38 mmol) and triethylamine (160 μL, 1.15 mmol) in DMF (1.2 mL) was added dropwise 1,1,1-trifluoro-<i>N</i>-phenyl-<i>N</i>-((trifluoromethyl)sulfonyl)methanesulfonamide (164 mg, 0.46 mmol) in DMF (1 mL). The reaction was stirred for 1 h and then poured into water, extracted with ethyl acetate, and washed with brine. The organic phase was collected, dried over MgSO<sub>4</sub>, filtered, and concentrated. The crude material was purified by silica gel column chromatography (0–100% EtOAc/heptane) to afford the desired material (202 mg, 92% yield). LCMS (<i>m</i>/<i>z</i>): 478.2 [M – Boc + H]. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.16 (d, <i>J</i> = 12.9 Hz, 1H), 6.49 (s, 1H), 4.48 (d, <i>J</i> = 7.1 Hz, 1H), 3.84–3.70 (m, 1H), 3.65 (q, <i>J</i> = 8.8 Hz, 1H), 3.55–3.39 (m, 4H), 2.47 (s, 3H), 2.33–2.23 (m, 1H), 2.09 (dtd, <i>J</i> = 14.0, 6.8, 2.8 Hz, 1H), 1.80–1.69 (m, 1H), 1.44 (s, 9H), 1.30–1.24 (m, 2H), 1.23 (d, <i>J</i> = 6.7 Hz, 3H), 1.19–1.10 (m, 1H), 0.66–0.52 (m, 2H).</div></div><div id="sec4_1_3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> <i>tert</i>-Butyl ((<i>S</i>)-1-((<i>R</i>)-1-(4-Cyano-1-cyclopropyl-6-fluoro-8-methyl-2-oxo-1,2-dihydroquinolin-7-yl)pyrrolidin-3-yl)ethyl)carbamate (<b>46</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0048.gif" alt="" id="gr45" /></img><div class="NLM_p last">A solution of 7-((<i>R</i>)-3-((<i>S</i>)-1-((<i>tert</i>-butoxycarbonyl)amino)ethyl)pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-8-methyl-2-oxo-1,2-dihydroquinolin-4-yl trifluoromethanesulfonate (113 mg, 0.20 mmol), tetrakis(triphenylphosphine)palladium (2.25 mg, 1.95 μmol), and dicyanozinc (13.7 mg, 0.12 mmol) in DMF (650 μL) was heated at 80 °C for 2 days. The reaction was cooled to room temperature and partitioned between brine and ethyl acetate. The organic phase was collected, dried over MgSO<sub>4</sub>, filtered, concentrated, and purified by silica gel chromatography (0–100% EtOAc/heptane) to afford the desired material (54.5 mg, 60% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.31 (d, <i>J</i> = 12.7 Hz, 1H), 6.85 (s, 1H), 4.48 (d, <i>J</i> = 9.2 Hz, 1H), 3.81–3.70 (m, 1H), 3.65 (q, <i>J</i> = 7.1 Hz, 1H), 3.54–3.40 (m, 4H), 2.46 (s, 3H), 2.29 (q, <i>J</i> = 8.3 Hz, 1H), 2.14–3.05 (m, 1H), 1.75 (dq, <i>J</i> = 12.0, 8.9 Hz, 1H), 1.44 (s, 9H), 1.32–1.24 (m, 2H), 1.23 (d, <i>J</i> = 6.6 Hz, 3H), 0.62–0.48 (m, 2H).</div></div><div id="sec4_1_3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> 7-((<i>R</i>)-3-((<i>S</i>)-1-Aminoethyl)pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-8-methyl-2-oxo-1,2-dihydroquinoline-4-carbonitrile Trifluoroacetic Acid (<b>9</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0049.gif" alt="" id="gr46" /></img><div class="NLM_p last">A solution of <i>tert</i>-butyl ((<i>S</i>)-1-((<i>R</i>)-1-(4-cyano-1-cyclopropyl-6-fluoro-8-methyl-2-oxo-1,2-dihydroquinolin-7-yl)pyrrolidin-3-yl)ethyl)carbamate (26.4 mg, 0.06 mmol) in dichloromethane (1 mL) was treated with trifluoroacetic acid (1 mL) and stirred for 30 min at room temperature. The reaction was concentrated and purified by prep HPLC to afford the title compound (13.0 mg, 60% yield). HRMS (ESI) calcd for C<sub>20</sub>H<sub>24</sub>FN<sub>4</sub>O [M + H]<sup>+</sup> 355.1929, found 355.1924. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ7.84 (br s, 2H), 7.24 (d, <i>J</i> = 12.9 Hz, 1H), 7.12 (s, 1H), 3.65–3.56 (m, 1H), 3.54–3.44 (m, 3H), 3.39 (t, <i>J</i> = 9.0 Hz, 1H), 3.33–3.24 (m, 1H), 2.43 (s, 3H), 2.43–2.31 (m, 2H), 2.15–2.07 (m, 1H), 1.81–1.68 (m, 1H), 1.27 (d, <i>J</i> = 6.5 Hz, 3H), 1.21–1.10 (m, 1H), 0.44 (ddd, <i>J</i> = 10.5, 6.2, 4.5 Hz, 2H).</div></div><div id="sec4_1_3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> 7-((<i>R</i>)-3-((<i>S</i>)-1-Aminoethyl)pyrrolidin-1-yl)-4-(aminomethyl)-1-cyclopropyl-6-fluoro-8-methylquinolin-2(1<i>H</i>)-one Trifluoroacetic Acid (<b>10</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0050.gif" alt="" id="gr47" /></img><div class="NLM_p last">A mixture of 7-((<i>R</i>)-3-((<i>S</i>)-1-aminoethyl)pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-8-methyl-2-oxo-1,2-dihydroquinoline-4-carbonitrile (13.7 mg, 0.020 mmol), Pd/C (10%, 50% in water, 10.0 mg), and acetic acid (100 μL) in methanol (2.00 mL) was sparged with H2 (g) for 5 min and then left under an atmosphere of H<sub>2</sub> (g) for 4 h. The suspension was filtered over Celite, concentrated, and purified by prep HPLC to give the title compound (3.0 mg, 32% yield). LCMS (<i>m</i>/<i>z</i>): 359.5 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.33 (br s, 2H), 7.86 (br s, 2H), 7.38 (d, <i>J</i> = 14.1 Hz, 1H), 6.44 (s, 1H), 4.23 (dd, <i>J</i> = 5.4, 4.7 Hz, 2H), 3.55 (dd, <i>J</i> = 8.6, 7.5 Hz 1H), 3.50–3.24 (m, 6H), 2.45 (s, 3H), 2.43–2.35 (m, 1H), 2.14–2.05 (m, 1H), 1.79–1.68 (m, 1H), 1.27 (d, <i>J</i> = 6.5 Hz, 3H), 1.22–1.09 (m, 2H), 0.38–0.26 (m, 2H).</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> Preparation of 7-((<i>R</i>)-3-((<i>S</i>)-1-Aminoethyl)pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-(hydroxymethyl)-8-methylquinolin-2(1<i>H</i>)-one Trifluoroacetic Acid (<b>11</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0051.gif" alt="" id="gr48" /></img></div><div id="sec4_1_4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> Ethyl 7-((<i>R</i>)-3-((<i>S</i>)-1-Aminoethyl)pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-8-methyl-2-oxo-1,2-dihydroquinoline-4-carboxylate (<b>45</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0052.gif" alt="" id="gr49" /></img><div class="NLM_p last">A solution of 7-((<i>R</i>)-3-((<i>S</i>)-1-((<i>tert</i>-butoxycarbonyl)amino)ethyl)pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-8-methyl-2-oxo-1,2-dihydroquinolin-4-yl trifluoromethanesulfonate (193 mg, 0.34 mmol), palladium acetate (7.50 mg, 0.03 mmol), dppf (18.5 mg, 0.03 mmol), molybdenum hexacarbonyl (44.0 mg, 0.17 mmol), EtOH (1.00 mL), and pyridine (0.250 mL) was heated at 150 °C via microwave for 20 min. The reaction was concentrated, diluted with ethyl acetate, and washed with water. The organic phase was collected, dried over MgSO<sub>4</sub>, filtered, concentrated, and purified by silica gel column chromatography (0–100% EtOAc/heptane, then 0–10% MeOH/DCM) to afford deprotected ester <b>45</b> (34.0 mg, 25% yield) along with the corresponding Boc protected amine <b>S17</b> (64.0 mg, 38% yield). LCMS (<i>m</i>/<i>z</i>) for <b>45</b>: 402.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> 7-((<i>R</i>)-3-((<i>S</i>)-1-Aminoethyl)pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-(hydroxymethyl)-8-methylquinolin-2(1<i>H</i>)-one Trifluoroacetic Acid (<b>11</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0053.gif" alt="" id="gr50" /></img><div class="NLM_p last">A solution of the ester (<b>45</b>, 34.0 mg, 0.08 mmol) in <i>i</i>-PrOH (0.7 mL)/water (0.15 mL) was treated with sodium borohydride (11.3 mg, 0.30 mmol) and stirred at rt for 4 h. The reaction was quenched with acetic acid, concentrated under reduced pressure, and purified by reverse phase prep HPLC to afford the title compound (4.0 mg, 8% yield). LCMS (<i>m</i>/<i>z</i>): 360.4 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.79 (br s, 2H), 7.24 (d, <i>J</i> = 13.9 Hz, 1H), 6.42 (s, 1H), 4.59 (s, 2H), 3.53–3.22 (m, 6H), 3.17 (s, 1H), 2.45 (s, 3H), 2.43–2.33 (m, 1H), 2.09 (ddt, <i>J</i> = 14.9, 7.4, 3.0 Hz, 1H), 1.78–1.68 (m, 1H), 1.26 (d, <i>J</i> = 6.5 Hz, 3H), 1.11 (tq, <i>J</i> = 10.1, 5.1 Hz, 2H), 0.40–0.29 (m, 2H).</div></div><div id="sec4_1_4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> 7-((<i>R</i>)-3-((<i>S</i>)-1-Aminoethyl)pyrrolidin-1-yl)-1-cyclopropyl-4-(2-(dimethylamino)ethoxy)-6-fluoro-8-methylquinolin-2(1<i>H</i>)-one Trifluoroacetic Acid (<b>12</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0054.gif" alt="" id="gr51" /></img><div class="NLM_p last">A suspension of <i>tert</i>-butyl ((<i>S</i>)-1-((<i>R</i>)-1-(1-cyclopropyl-6-fluoro-4-hydroxy-8-methyl-2-oxo-1,2-dihydroquinolin-7-yl)pyrrolidin-3-yl)ethyl)carbamate (59.4 mg, 0.133 mmol), 2-chloro-<i>N</i>,<i>N</i>-dimethylethanamine hydrochloride (19.2 mg, 0.13 mmol), potassium carbonate (55.3 mg, 0.40 mmol), and 18-crown-6 (211 mg, 0.80 mmol) in DMA (444 μL) was heated at 85 °C and stirred overnight. The reaction was poured into brine and extracted with ethyl acetate. The organic phase was collected, dried over MgSO<sub>4</sub>, filtered, and concentrated. The crude residue was dissolved in DCM (0.5 mL) and treated with TFA (1 mL). The reaction was stirred for 1 h and then concentrated under reduced pressure. The crude residue was purified by prep HPLC to afford the title compound (45.2 mg, 45% yield). LCMS (<i>m</i>/<i>z</i>): 417.1 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.61 (d, <i>J</i> = 13.3 Hz, 1H), 5.95 (s, 1H), 4.47 (dd, <i>J</i> = 5.6, 4.0 Hz, 2H), 3.74–3.68 (m, 2H), 3.65–3.54 (m, 2H), 3.50–3.40 (m, 3H), 3.40–3.33 (m, 1H), 3.01 (s, 6H), 2.56 (s, 3H), 2.49 (q, <i>J</i> = 8.5 Hz, 1H), 2.28–2.18 (m, 1H), 1.89–1.78 (m, 1H), 1.40 (d, <i>J</i> = 6.6 Hz, 3H), 1.27–1.14 (m, 2H), 0.55–0.41 (m, 2H).</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> Preparation of 7-((<i>R</i>)-3-((<i>S</i>)-1-Aminoethyl)pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-8-methyl-2-oxo-1,2-dihydroquinoline-4-carboxylic Acid Trifluoroacetic Acid (<b>13</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0055.gif" alt="" id="gr52" /></img><div class="NLM_p last">A solution of <i>tert</i>-butyl ((<i>S</i>)-1-((<i>R</i>)-1-(4-cyano-1-cyclopropyl-6-fluoro-8-methyl-2-oxo-1,2-dihydroquinolin-7-yl)pyrrolidin-3-yl)ethyl)carbamate (27.7 mg, 0.06 mmol) in 10% aqueous ethanol (2.00 mL) was treated with sodium hydroxide (12.2 mg, 0.30 mmol) and stirred at 120 °C for 30 min. The reaction was concentrated under reduced pressure, dissolved in DCM (1.00 mL), and treated with TFA (1.00 mL). After 30 min, the reaction was concentrated and the desired product was isolated by prep HPLC (4.0 mg, 19% yield, purity = 87%) along with the corresponding primary amide (8.0 mg, 38% yield). LCMS (<i>m</i>/<i>z</i>) for <b>13</b>: 374.0 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.83 (br s, 2H), 7.73 (d, <i>J</i> = 14.7 Hz, 1H), 6.74 (s, 1H), 3.60–3.51 (m, 1H), 3.53–3.44 (m, 2H), 3.43–3.30 (m, 2H), 3.30–3.20 (m, 1H), 2.44 (s, 3H), 2.42–2.34 (m, 2H), 2.14–2.04 (m, 1H), 1.80–1.68 (m, 1H), 1.27 (d, <i>J</i> = 6.5 Hz, 3H), 1.17–1.06 (m, 2H), 0.43–0.33 (m, 2H).</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> Preparation of 7-((<i>R</i>)-3-((<i>S</i>)-1-Aminoethyl)pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-8-methyl-4-(5-oxo-4,5-dihydro-1<i>H</i>-1,2,4-triazol-3-yl)quinolin-2(1<i>H</i>)-one Trifluoroacetic Acid (<b>14</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0056.gif" alt="" id="gr53" /></img></div><div id="sec4_1_6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> <i>tert</i>-Butyl ((<i>S</i>)-1-((<i>R</i>)-1-(1-Cyclopropyl-6-fluoro-4-(hydrazinecarbonyl)-8-methyl-2-oxo-1,2-dihydroquinolin-7-yl)pyrrolidin-3-yl)ethyl)carbamate (<b>47</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0057.gif" alt="" id="gr54" /></img><div class="NLM_p last">A solution of ethyl 7-((<i>R</i>)-3-((<i>S</i>)-1-((<i>tert</i>-butoxycarbonyl)amino)ethyl)pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-8-methyl-2-oxo-1,2-dihydroquinoline-4-carboxylate (48.1 mg, 0.096 mmol) and hydrazine (0.015 mL, 0.479 mmol) in ethanol (2 mL) was stirred for 12 h at 60 °C. The reaction cooled to room temperature and was concentrated under reduced pressure to afford the desired material, which was used without further purification. LCMS (<i>m</i>/<i>z</i>): 488.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> 7-((<i>R</i>)-3-((<i>S</i>)-1-Aminoethyl)pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-8-methyl-4-(5-oxo-4,5-dihydro-1<i>H</i>-1,2,4-triazol-3-yl)quinolin-2(1<i>H</i>)-one Trifluoroacetic Acid (<b>14</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0058.gif" alt="" id="gr55" /></img><div class="NLM_p last">A solution of <b>47</b> (51.6 mg, 0.106 mmol) and carbonyldiimidazole (34.32 mg, 0.212 mmol) in dioxane (1 mL) was stirred for 2 days at 90 °C. The reaction was concentrated and then diluted with dichloromethane (1 mL) and treated with trifluoroacetic acid (1 mL) and aged for 30 min. The reaction was concentrated under reduced pressure and then purified by prep HPLC to afford the title compound (4.9 mg, 6% yield, 2 steps, purity = 90%). LCMS (<i>m</i>/<i>z</i>): 414.1 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.03 (s, 1H), 8.08 (d, <i>J</i> = 15.0 Hz, 1H), 7.80 (bs, 2H), 6.72 (s, 1H), 3.68–3.16 (m, 6H), 2.45 (s, 3H), 2.42–2.34 (m, 1H), 2.10 (m, 1H), 1.75 (m, 1H), 1.27 (d, <i>J</i> = 6.5 Hz, 3H), 1.15 (m, 2H), 0.42 (m, 2H).</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> Preparation of (<i>S</i>)-4-(Aminomethyl)-7-(3-aminopyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-8-methylquinolin-2(1<i>H</i>)-one Hydrochloride (<b>15</b>)</h3><div class="NLM_p">The overall synthesis is shown in <a class="ref internalNav" href="#cht5" aria-label="Chart 5">Chart 5</a>.</div><figure id="cht5" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Chart 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0059.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0059.jpeg" id="gr56" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0059.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00347&amp;id=cht5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_1_7_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> 7-Bromo-1-cyclopropyl-6-fluoro-4-hydroxy-8-methylquinolin-2(1<i>H</i>)-one (<b>S18</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0060.gif" alt="" id="gr57" /></img><div class="NLM_p last">To an ice-cold solution of methyl 4-bromo-2-(<i>N</i>-cyclopropylacetamido)-5-fluoro-3-methylbenzoate (595 mg, 1.73 mmol) in THF (12 mL) was added dropwise NaHMDS (8.64 mL, 8.64 mmol, 1 M in THF). After 30 min of stirring, 1 N HCl was added dropwise until pH 2 was reached. A solid precipitated, was filtered and washed with water. The aqueous phase was extracted with ethyl acetate and the organic phase collected, dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure. The extracted material was combined with the solid filtrate to give the title compound (461 mg, 85% yield). LCMS (<i>m</i>/<i>z</i>): 313.9 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.60 (br s, 1H), 7.50 (d, <i>J</i> = 8.6 Hz, 1H), 5.78 (s, 1H), 3.39 (tt, <i>J</i> = 6.8, 4.0 Hz, 1H), 2.71 (s, 3H), 1.11–1.03 (m, 2H), 0.38–0.32 (m, 2H).</div></div><div id="sec4_1_7_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> 7-Bromo-1-cyclopropyl-6-fluoro-8-methyl-2-oxo-1,2-dihydroquinolin-4-yl Trifluoromethanesulfonate (<b>48</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0061.gif" alt="" id="gr58" /></img><div class="NLM_p last">An ice-cold mixture of 7-bromo-1-cyclopropyl-6-fluoro-4-hydroxy-8-methylquinolin-2(1<i>H</i>)-one (287 mg, 0.92 mmol) and triethylamine (384 μL, 2.76 mmol) in DMF (2.5 mL) was treated dropwise with 1,1,1-trifluoro-<i>N</i>-phenyl-<i>N</i>-((trifluoromethyl)sulfonyl)methanesulfonamide (394 mg, 1.10 mmol) in DMF (1 mL) followed by stirring for 1 h. The reaction was poured into water, extracted with ethyl acetate, and washed with brine. The organic phase was collected, dried over MgSO<sub>4</sub>, filtered, and concentrated. The crude material was purified by silica gel column chromatography (0–100% EtOAc/heptane) to afford the desired material (369 mg, 90% yield). LCMS (<i>m</i>/<i>z</i>): 446.0 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ7.32 (d, <i>J</i> = 7.8 Hz, 1H), 6.68 (s, 1H), 3.51 (tt, <i>J</i> = 6.8, 4.0 Hz, 1H), 2.81 (s, 3H), 1.30–1.22 (m, 2H), 0.63–0.56 (m, 2H).</div></div><div id="sec4_1_7_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> 7-Bromo-1-cyclopropyl-6-fluoro-8-methyl-2-oxo-1,2-dihydroquinoline-4-carbonitrile (<b>49</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0062.gif" alt="" id="gr59" /></img><div class="NLM_p last">A solution of 7-bromo-1-cyclopropyl-6-fluoro-8-methyl-2-oxo-1,2-dihydroquinolin-4-yl trifluoromethanesulfonate (238 mg, 0.54 mmol), tetrakis(triphenylphosphine)palladium (31.0 mg, 0.03 mmol), and dicyanozinc (33.0 mg, 0.28 mmol) in DMF (1.8 mL) was heated at 85 °C for 18 h. The reaction was treated with water and extracted with ethyl acetate. The organic phase was collected, washed with brine, dried over MgSO<sub>4</sub>, filtered, concentrated, and purified by silica gel column chromatography (0–100% EtOAc/heptane) to afford the desired material (125 mg, 72% yield). LCMS (<i>m</i>/<i>z</i>): 322.9 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_7_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> (<i>S</i>)-<i>tert</i>-Butyl (1-(4-Cyano-1-cyclopropyl-6-fluoro-8-methyl-2-oxo-1,2-dihydroquinolin-7-yl)pyrrolidin-3-yl)carbamate (<b>50</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0063.gif" alt="" id="gr60" /></img><div class="NLM_p last">A solution of 7-bromo-1-cyclopropyl-6-fluoro-8-methyl-2-oxo-1,2-dihydroquinoline-4-carbonitrile (159 mg, 0.50 mmol), xantphos (43.0 mg, 0.07 mmol), (<i>S</i>)-<i>tert</i>-butyl pyrrolidin-3-ylcarbamate (138 mg, 0.74 mmol), tris(dibenzylideneacetone)dipalladium(0) (22.7 mg, 25.0 μmol), and cesium carbonate (323 mg, 0.99 mmol) in toluene (1.65 mL) was heated at 110 °C overnight. The reaction was poured into water and extracted with ethyl acetate. The organic phase was washed with brine, dried over MgSO<sub>4</sub>, filtered, concentrated, and purified by silica gel column chromatography (0–80% EtOAc/heptane) to afford the desired compound (126 mg, 60% yield). LCMS (<i>m</i>/<i>z</i>): 427.1 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.34 (d, <i>J</i> = 12.5 Hz, 1H), 6.87 (s, 1H), 4.75 (s, 1H), 4.35 (s, 1H), 3.81–3.73 (m, 1H), 3.61 (q, <i>J</i> = 8.0 Hz, 1H), 3.49 (tt, <i>J</i> = 7.4, 4.2 Hz, 2H), 3.30 (dd, <i>J</i> = 10.0, 4.3 Hz, 1H), 2.48 (s, 3H), 2.33 (dq, <i>J</i> = 13.5, 6.9 Hz, 1H), 1.92 (td, <i>J</i> = 12.9, 5.6 Hz, 1H), 1.47 (s, 9H), 0.88 (t, <i>J</i> = 6.9 Hz, 2H), 0.56 (q, <i>J</i> = 4.1 Hz, 2H).</div></div><div id="sec4_1_7_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> (<i>S</i>)-4-(Aminomethyl)-7-(3-aminopyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-8-methylquinolin-2(1<i>H</i>)-one Hydrochloride (<b>15</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0064.gif" alt="" id="gr61" /></img><div class="NLM_p last">A mixture of (<i>S</i>)-<i>tert</i>-butyl (1-(4-cyano-1-cyclopropyl-6-fluoro-8-methyl-2-oxo-1,2-dihydroquinolin-7-yl)pyrrolidin-3-yl)carbamate (126 mg, 0.30 mmol) in 2 M NH<sub>3</sub> in EtOH (5 mL) was treated with Pd/C (10% dry wt, 50% water, 95.0 mg, 0.09 mmol) and sparged with hydrogen for 5 min. The reaction was left under an atmosphere of H<sub>2</sub> for 2 h. The reaction was filtered over Celite, concentrated under reduced pressure, diluted with DCM (1 mL), and treated with TFA (2 mL). After 1 h, the reaction was concentrated under reduced pressure and purified by reverse phase HPLC to give the title compound (44.0 mg, 33% yield, 2 steps). Relyophilizing with 1 N HCl provided the HCl salt. HRMS (ESI) calcd for C<sub>18</sub>H<sub>24</sub>FN<sub>4</sub>O [M + H]<sup>+</sup> 331.1929, found 331.1925. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.38 (d, <i>J</i> = 13.5 Hz, 1H), 6.54 (s, 1H), 4.34 (s, 2H), 3.99 (p, <i>J</i> = 5.7 Hz, 1H), 3.82 (ddd, <i>J</i> = 10.8, 6.3, 1.8 Hz, 1H), 3.63 (q, <i>J</i> = 8.1, 7.5 Hz, 1H), 3.53 (dt, <i>J</i> = 10.2, 3.4 Hz, 3H), 2.60 (s, 3H), 2.49 (dtd, <i>J</i> = 13.6, 7.9, 5.9 Hz, 1H), 2.09 (ddt, <i>J</i> = 13.3, 8.0, 5.5 Hz, 1H), 1.27–1.15 (m, 2H), 0.51–0.42 (m, 2H).</div></div><div id="sec4_1_7_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> (<i>R</i>)-4-(Aminomethyl)-7-(3-aminopyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-8-methylquinolin-2(1<i>H</i>)-one Trifluoroacetic Acid (<b>16</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0065.gif" alt="" id="gr62" /></img><div class="NLM_p last"><b>16</b> (0.09 g, 10% yield, 2 steps) was prepared from 7-bromo-1-cyclopropyl-6-fluoro-8-methyl-2-oxo-1,2-dihydroquinoline-4-carbonitrile <b>49</b> (105 mg, 0.33 mmol) and (<i>R</i>)-<i>tert</i>-butyl pyrrolidin-3-ylcarbamate (91.0 mg, 0.49 mmol) according to the procedure used for compound <b>15</b>. LCMS (<i>m</i>/<i>z</i>): 331.2 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.35 (br s, 2H), 8.10 (br s, 2H), 7.41 (d, <i>J</i> = 14.1 Hz, 1H), 6.46 (s, 1H), 4.23 (q, <i>J</i> = 6.9 Hz, 2H), 3.95–3.87 (m, 1H), 3.71–3.65 (m, 1H), 3.56–3.44 (m, 4H), 2.50 (s, 3H), 2.37–2.30 (m, 1H), 2.02–1.96 (m, 1H), 1.18–1.11 (m, 2H), 0.34–0.30 (m, 2H).</div></div><div id="sec4_1_7_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> (<i>S</i>)-4-(Aminomethyl)-1-cyclopropyl-6-fluoro-7-(3-hydroxypyrrolidin-1-yl)-8-methylquinolin-2(1<i>H</i>)-one Hydrochloride (<b>17</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0066.gif" alt="" id="gr63" /></img><div class="NLM_p last"><b>17</b> (62.2 mg, 18% yield, 2 steps) was prepared from 7-bromo-1-cyclopropyl-6-fluoro-8-methyl-2-oxo-1,2-dihydroquinoline-4-carbonitrile <b>49</b> (300 mg, 0.93 mmol) and (<i>S</i>)-3-((<i>tert</i>-butyldimethylsilyl)oxy)pyrrolidine (376 mg, 1.87 mmol) according to the procedure used for compound <b>15</b> (omitting the Boc deprotection step). HRMS (ESI) calcd for C<sub>18</sub>H<sub>23</sub>FN<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup> 332.1769, found 332.1767. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.30 (d, <i>J</i> = 13.9 Hz, 1H), 6.46 (s, 1H), 4.53 (tt, <i>J</i> = 5.1, 2.8 Hz, 1H), 4.36–4.28 (m, 2H), 3.84 (p, <i>J</i> = 6.3, 5.2 Hz, 2H), 3.58–3.35 (m, 2H), 2.53 (s, 3H), 2.27–2.12 (m, 1H), 1.99 (ddd, <i>J</i> = 11.6, 6.8, 3.6 Hz, 1H), 1.34–1.17 (m, 2H), 0.54–0.41 (m, 2H).</div></div><div id="sec4_1_7_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> 4-(Aminomethyl)-1-cyclopropyl-6-fluoro-8-methyl-7-(pyrrolidin-1-yl)quinolin-2(1<i>H</i>)-one (<b>18</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0067.gif" alt="" id="gr64" /></img><div class="NLM_p last"><b>18</b> (17.8 mg, 14% yield, 2 steps) was prepared from 7-bromo-1-cyclopropyl-6-fluoro-8-methyl-2-oxo-1,2-dihydroquinoline-4-carbonitrile <b>49</b> (75 mg, 0.23 mmol) and pyrrolidine (39 μL, 0.47 mmol) according to the procedure used for compound <b>15</b> (omitting the Boc deprotection step). HRMS (ESI) calcd for C<sub>18</sub>H<sub>23</sub>FN<sub>3</sub>O [M + H]<sup>+</sup> 316.1820, found 316.1820. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.33 (br s, 3H), 7.35 (d, J = 14.2 Hz, 1H), 6.41 (s, 1H), 4.26–4.17 (m, 2H), 2.42 (s, 3H), 1.98–1.88 (m, 4H), 1.21–1.09 (m, 2H), 0.35–0.28 (m, 2H).</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> Preparation of 7-(4-Amino-2,5-difluorophenyl)-4-(aminomethyl)-1-cyclopropyl-6-fluoro-8-methylquinolin-2(1<i>H</i>)-one Trifluoroacetic Acid (<b>19</b>)</h3><div class="NLM_p">The overall synthesis is shown in <a class="ref internalNav" href="#cht6" aria-label="Chart 6">Chart 6</a>.</div><figure id="cht6" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Chart 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0068.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0068.jpeg" id="gr65" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0068.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00347&amp;id=cht6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_1_8_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> 7-(4-Amino-2,5-difluorophenyl)-1-cyclopropyl-6-fluoro-8-methyl-2-oxo-1,2-dihydroquinoline-4-carbonitrile (<b>S21</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0069.gif" alt="" id="gr66" /></img><div class="NLM_p last">A mixture of 7-bromo-1-cyclopropyl-6-fluoro-8-methyl-2-oxo-1,2-dihydroquinoline-4-carbonitrile (85.0 mg, 0.20 mmol), 2,5-difluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline (68.0 mg, 0.26 mmol), tetrakis(triphenylphosphine)palladium (92.0 mg, 0.08 mmol), and sodium carbonate (84.0 mg, 0.80 mmol) in toluene (1 mL)/water (0.35 mL)/ethanol (0.35 mL) was sealed and maintained at 110 °C for 18 h. The reaction was cooled to room temperature, diluted with water, ethyl acetate, and the phases were separated. The organic phase was washed with brine, dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (0–100% EtOAc/heptane) to afford the product (16.0 mg, 21% yield) along with an equimolar amount of the dehalogenated starting material. LCMS (<i>m</i>/<i>z</i>): 369.9 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_8_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> 7-(4-Amino-2,5-difluorophenyl)-4-(aminomethyl)-1-cyclopropyl-6-fluoro-8-methylquinolin-2(1<i>H</i>)-one Trifluoroacetic Acid (<b>19</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0070.gif" alt="" id="gr67" /></img><div class="NLM_p last">A mixture of 7-(4-amino-2,5-difluorophenyl)-1-cyclopropyl-6-fluoro-8-methyl-2-oxo-1,2-dihydroquinoline-4-carbonitrile (41.0 mg, 0.05 mmol) in 2 M NH<sub>3</sub> in EtOH (4 mL) was treated with Pd/C (10% dry wt, 50% water, 17.4 mg, 0.02 mmol) and sparged with hydrogen for 5 min. The reaction was left under an atmosphere of H<sub>2</sub> for 2 h. The reaction was then filtered over Celite and concentrated under reduced pressure. The residue was purified by reverse phase HPLC to give the desired compound (6.0 mg, 30% yield). LCMS (<i>m</i>/<i>z</i>): 374.1 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.46 (d, <i>J</i> = 9.6 Hz, 1H), 6.93 (dd, <i>J</i> = 11.1, 6.4 Hz, 1H), 6.69 (dd, <i>J</i> = 11.1, 7.5 Hz, 1H), 6.65 (s, 1H), 4.41 (s, 2H), 3.58 (dq, <i>J</i> = 6.8, 3.4 Hz, 1H), 2.52 (s, 3H), 1.36–1.17 (m, 2H), 0.60–0.49 (m, 2H).</div></div><div id="sec4_1_8_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> 4-(Aminomethyl)-1-cyclopropyl-6-fluoro-8-methyl-7-(piperazin-1-yl)quinolin-2(1<i>H</i>)-one Trifluoroacetic Acid (<b>20</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0071.gif" alt="" id="gr68" /></img><div class="NLM_p last"><b>20</b> (7.5 mg, 6% yield, 2 steps) was prepared from 7-bromo-1-cyclopropyl-6-fluoro-8-methyl-2-oxo-1,2-dihydroquinoline-4-carbonitrile <b>49</b> (81 mg, 0.25 mmol) and benzyl piperazine-1-carboxylate (83 mg, 0.38 mmol) according to the procedure used for compound <b>15</b>. LCMS (<i>m</i>/<i>z</i>): 331.1 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.84 (br s, 1H), 8.36 (br s, 2H), 7.45 (d, <i>J</i> = 13.1 Hz, 1H), 6.49 (s, 1H), 4.22 (s, 2H), 3.53–3.42 (m, 4H), 3.30–3.17 (m, 5H), 2.58 (s, 3H), 1.20–1.10 (m, 2H), 0.35–0.22 (m, 2H).</div></div><div id="sec4_1_8_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> 7-(1-Amino-3-azabicyclo[3.1.0]hexan-3-yl)-4-(aminomethyl)-1-cyclopropyl-6-fluoro-8-methylquinolin-2(1<i>H</i>)-one Trifluoroacetic Acid (<b>21</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0072.gif" alt="" id="gr69" /></img><div class="NLM_p last"><b>21</b> (7.0 mg, 6% yield, 2 steps) was prepared from 7-bromo-1-cyclopropyl-6-fluoro-8-methyl-2-oxo-1,2-dihydroquinoline-4-carbonitrile <b>49</b> (60.0 mg, 0.30 mmol) and <i>tert</i>-butyl (3-azabicyclo[3.1.0]hexan-1-yl)carbamate (75.0 mg, 0.23 mmol) according to the procedure used for compound <b>15</b>. HRMS (ESI) calcd for C<sub>19</sub>H<sub>24</sub>FN<sub>4</sub>O [M + H]<sup>+</sup> 343.1929, found 343.1929. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.65 (br s, 2H), 8.37 (br s, 2H), 7.43 (d, <i>J</i> = 13.6 Hz, 1H), 6.55 (br s, 2H), 4.23 (s, 2H), 3.73 (d, <i>J</i> = 8.9 Hz, 1H), 3.69–3.60 (m, 1H), 3.54 (d, <i>J</i> = 9.1 Hz, 1H), 3.50–3.42 (m, 1H), 3.23–3.19 (m, 1H), 2.43 (s, 3H), 1.94 (ddd, <i>J</i> = 8.5, 4.6, 3.4 Hz, 1H), 1.24 (dd, <i>J</i> = 8.8, 5.7 Hz, 1H), 1.18–1.07 (m, 3H), 0.36–0.27 (m, 2H).</div></div><div id="sec4_1_8_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> <i>rac</i>-7-((1<i>S</i>,5<i>R</i>)-1-Amino-5-methyl-3-azabicyclo[3.1.0]hexan-3-yl)-4-(aminomethyl)-1-cyclopropyl-6-fluoro-8-methylquinolin-2(1<i>H</i>)-one Trifluoroacetic Acid (<b>22</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0073.gif" alt="" id="gr70" /></img><div class="NLM_p last"><b>22</b> (9.0 mg, 5% yield, 2 steps) was prepared from 7-bromo-1-cyclopropyl-6-fluoro-8-methyl-2-oxo-1,2-dihydroquinoline-4-carbonitrile <b>49</b> (80.0 mg, 0.22 mmol), BINAP (21 mg, 0.03 mmol) as ligand instead of xantphos, and <i>tert</i>-butyl <i>rac</i>-((1<i>S</i>,5<i>R</i>)-5-methyl-3-azabicyclo[3.1.0]hexan-1-yl)carbamate (66.0 mg, 0.31 mmol) according to the procedure used for compound <b>15</b>. <i>tert</i>-Butyl <i>rac</i>-((1<i>S</i>,5<i>R</i>)-5-methyl-3-azabicyclo[3.1.0]hexan-1-yl)carbamate was prepared using procedures analogous to those described for <b>23</b> below. LCMS (<i>m</i>/<i>z</i>): 357.4 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.32 (d, <i>J</i> = 13.5 Hz, 1H), 6.55 (s, 1H), 4.13 (s, 2H), 3.63 (d, <i>J</i> = 9.0 Hz, 1H), 3.59–3.47 (m, 3H), 3.38 (d, <i>J</i> = 9.2 Hz, 1H), 2.53 (s, 3H), 1.32 (s, 3H), 1.25–1.17 (m, 2H), 1.13 (d, <i>J</i> = 5.2 Hz, 1H), 0.67 (d, <i>J</i> = 5.1 Hz, 1H), 0.52–0.42 (m, 2H).</div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i88" class="anchor-spacer"></div><h3 class="article-section__title" id="_i88"> Preparation of 7-(1-Amino-3-azabicyclo[4.1.0]heptan-3-yl)-4-(aminomethyl)-1-cyclopropyl-6-fluoro-8-methylquinolin-2(1<i>H</i>)-one (<b>23</b>)</h3><div class="NLM_p">The overall synthesis is shown in <a class="ref internalNav" href="#cht7" aria-label="Chart 7">Chart 7</a>.</div><figure id="cht7" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Chart 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0074.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0074.jpeg" id="gr71" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0074.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00347&amp;id=cht7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_1_9_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i89" class="anchor-spacer"></div><h3 class="article-section__title" id="_i89"> <i>tert</i>-Butyl (3-Benzyl-3-azabicyclo[4.1.0]heptan-1-yl)carbamate (<b>S22</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0075.gif" alt="" id="gr72" /></img><div class="NLM_p last">A solution of 2-(benzyl(but-3-en-1-yl)amino)acetonitrile (500 mg, 2.50 mmol) and titanium(IV) isopropoxide (1.48 mL, 4.99 mmol) in ether (15 mL) was slowly treated with a 2 M solution of cyclohexylmagnesium chloride (9.99 mL, 9.99 mmol) over 1 h. The reaction mixture was then stirred at rt for 1 more hour. The crude product was then cooled to 0 °C and treated with 2 M NaOH (15 mL) and allowed to stir for 1 h. Inorganic precipitates were filtered off through a pad of Celite, and the filter cake was washed thoroughly with ether. The combined filtrates were washed with brine and dried with MgSO<sub>4</sub>. The solvent was removed under reduced pressure. The residue was dissolved in dioxane (2.5 mL) and then treated with 1 N NaOH (2 mL) and di-<i>tert</i>-butyl dicarbonate (1079 mg, 4.94 mmol), and the mixture was stirred at room temperature overnight. The reaction was diluted with ethyl acetate and water. Phases were separated, and the organic phase collected, dried (MgSO<sub>4</sub>), filtered, concentrated, and purified by silica gel column chromatography eluting with a linear gradient of 0–60% ethyl acetate in heptane to afford the desired product (157 mg, 21% yield, 2 steps). LCMS (<i>m</i>/<i>z</i>): 303.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_9_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i90" class="anchor-spacer"></div><h3 class="article-section__title" id="_i90"> <i>tert</i>-Butyl (3-Azabicyclo[4.1.0]heptan-1-yl)carbamate (<b>S23</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0076.gif" alt="" id="gr73" /></img><div class="NLM_p last">A mixture of <i>tert</i>-butyl (3-benzyl-3-azabicyclo[4.1.0]heptan-1-yl)carbamate (155 mg, 0.513 mmol) and 10% Pd/C (54.5 mg, 0.051 mmol) in MeOH (5 mL) was sparged with H<sub>2</sub> for 5 min and then left under an atmosphere (balloon) of H<sub>2</sub> overnight. The reaction was then filtered over an Acrodisc filter and concentrated under reduced pressure to give the desired amine, which was used without further purification. LCMS (<i>m</i>/<i>z</i>): 213.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_9_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i91" class="anchor-spacer"></div><h3 class="article-section__title" id="_i91"> <i>tert</i>-Butyl (3-(4-Cyano-1-cyclopropyl-6-fluoro-8-methyl-2-oxo-1,2-dihydroquinolin-7-yl)-3-azabicyclo[4.1.0]heptan-1-yl)carbamate (<b>S24</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0077.gif" alt="" id="gr74" /></img><div class="NLM_p last">A microwave vial was charged with <b>49</b> (100 mg, 0.311 mmol), <i>tert</i>-butyl (3-azabicyclo[4.1.0]heptan-1-yl)carbamate (99 mg, 0.467 mmol), cesium carbonate (304 mg, 0.934 mmol), Pd<sub>2</sub>(dba)<sub>3</sub> (57.0 mg, 0.062 mmol), and BINAP (78 mg, 0.125 mmol). The vial was placed under vacuum and backfilled with N<sub>2</sub> 3 times, and then toluene (2 mL) was added. The mixture was stirred at 90 °C overnight. The crude reaction mixture was filtered through a disposable filter funnel, and volatiles were evaporated under reduced pressure. SiO<sub>2</sub> flash chromatography (0–100% EtOAc/heptane) provided the desired product (46.3 mg, 33% yield, 2 steps) as a yellow dense oil. LCMS (<i>m</i>/<i>z</i>): 453.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_9_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i92" class="anchor-spacer"></div><h3 class="article-section__title" id="_i92"> <i>tert</i>-Butyl (3-(4-(Aminomethyl)-1-cyclopropyl-6-fluoro-8-methyl-2-oxo-1,2-dihydroquinolin-7-yl)-3-azabicyclo[4.1.0]heptan-1-yl)carbamate (<b>S25</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0078.gif" alt="" id="gr75" /></img><div class="NLM_p last">A mixture of <i>tert</i>-butyl (3-(4-cyano-1-cyclopropyl-6-fluoro-8-methyl-2-oxo-1,2-dihydroquinolin-7-yl)-3-azabicyclo[4.1.0]heptan-1-yl)carbamate (45 mg, 0.099 mmol) in 2 M NH<sub>3</sub> in MeOH (2 mL) was treated with Pd/C (10% dry wt, 50% water, 63.5 mg, 0.030 mmol). The flask was partially evacuated and backfilled with H<sub>2</sub> 5 times, then stirred under a balloon of hydrogen for ∼60 min. The flask was partially evacuated and backfilled with N<sub>2</sub> 5 times, then the reaction mixture was passed through a 1 μm syringe filter and concentrated under reduced pressure to give the desired product (45 mg, 99% yield) as a yellow oil, which was used without further purification. LCMS (<i>m</i>/<i>z</i>): 457.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_9_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i93" class="anchor-spacer"></div><h3 class="article-section__title" id="_i93"> 7-(1-Amino-3-azabicyclo[4.1.0]heptan-3-yl)-4-(aminomethyl)-1-cyclopropyl-6-fluoro-8-methylquinolin-2(1<i>H</i>)-one Trifluoroacetic Acid (<b>23</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0079.gif" alt="" id="gr76" /></img><div class="NLM_p last">A mixture of <i>tert</i>-butyl (3-(4-(aminomethyl)-1-cyclopropyl-6-fluoro-8-methyl-2-oxo-1,2-dihydroquinolin-7-yl)-3-azabicyclo[4.1.0]heptan-1-yl)carbamate (45.7 mg, 0.1 mmol) in DCM (1 mL) and TFA (1 mL) was stirred for 30 min. Volatiles were evaporated under reduced pressure. The residue was dissolved in water/H<sub>2</sub>O and purified by preparative RP-HPLC (0.1% TFA in MeCN/H<sub>2</sub>O) to give the desired product (11 mg, 23% yield). HRMS (ESI) calcd for C<sub>20</sub>H<sub>25</sub>FN<sub>4</sub>O [M + H]<sup>+</sup> 357.2085, found 357.2080. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 7.40 (d, <i>J</i> = 12.8 Hz, 1H), 6.56 (s, 1H), 4.35 (s, 2H), 3.73–3.60 (m, 2H), 3.60–3.52 (m, 1H), 3.10–3.02 (m, 1H), 2.65 (s, 3H), 2.27–2.16 (m, 1H), 2.05–1.92 (m, 1H), 1.61–1.51 (m, 1H), 1.35–1.18 (m, 4H), 0.50–0.42 (m, 2H).</div></div><div id="sec4_1_9_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i94" class="anchor-spacer"></div><h3 class="article-section__title" id="_i94"> <i>rac</i>-7-((1<i>S</i>,5<i>R</i>)-1-Amino-3-azabicyclo[3.2.0]heptan-3-yl)-4-(aminomethyl)-1-cyclopropyl-6-fluoro-8-methylquinolin-2(1<i>H</i>)-one Trifluoroacetic Acid (<b>24</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0080.gif" alt="" id="gr77" /></img><div class="NLM_p last"><b>24</b> (13.5 mg, 7% yield, 2 steps) was prepared from 7-bromo-1-cyclopropyl-6-fluoro-8-methyl-2-oxo-1,2-dihydroquinoline-4-carbonitrile <b>49</b> (80.0 mg, 0.22 mmol), BINAP (21.0 mg, 0.03 mmol) as ligand instead of xantphos, and benzyl <i>rac</i>-((1<i>S</i>,5<i>R</i>)-3-azabicyclo[3.2.0]heptan-1-yl)carbamate (55.0 mg, 0.22 mmol) according to the procedure used for compound <b>15</b>. HRMS (ESI) calcd for C<sub>20</sub>H<sub>26</sub>FN<sub>4</sub>O [M + H]<sup>+</sup> 357.2085, found 357.2080. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.41 (d, <i>J</i> = 13.3 Hz, 1H), 6.57 (s, 1H), 4.37 (d, <i>J</i> = 1.2 Hz, 2H), 3.78–3.71 (m, 1H), 3.71–3.55 (m, 5H), 3.54–3.45 (m, 1H), 3.11–3.00 (m, 1H), 2.77 (s, 3H), 2.45–2.36 (m, 3H), 1.93 (dd, <i>J</i> = 10.5, 3.6 Hz, 1H), 1.29–1.20 (m, 2H), 0.56–0.44 (m, 2H).</div></div><div id="sec4_1_9_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i95" class="anchor-spacer"></div><h3 class="article-section__title" id="_i95"> <i>rac</i>-4-(Aminomethyl)-7-(1-(aminomethyl)-3-azabicyclo[3.1.0]hexan-3-yl)-1-cyclopropyl-6-fluoro-8-methylquinolin-2(1<i>H</i>)-one Trifluoroacetic Acid (<b>25</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0081.gif" alt="" id="gr78" /></img><div class="NLM_p last"><b>25</b> (4.0 mg, 3% yield, 2 steps) was prepared from 7-bromo-1-cyclopropyl-6-fluoro-8-methyl-2-oxo-1,2-dihydroquinoline-4-carbonitrile <b>49</b> (80.0 mg, 0.22 mmol), BINAP (21.0 mg, 0.03 mmol) as ligand instead of xantphos, and <i>tert</i>-butyl ((3-azabicyclo[3.1.0]hexan-1-yl)methyl)carbamate hydrochloride (78.0 mg, 0.31 mmol) according to the procedure used for compound <b>15</b>. HRMS (ESI) calcd for C<sub>20</sub>H<sub>26</sub>FN<sub>4</sub>O [M + H]<sup>+</sup> 357.2085, found 357.2080. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.34 (d, <i>J</i> = 13.3 Hz, 1H), 6.52 (s, 1H), 4.34 (d, <i>J</i> = 1.2 Hz, 2H), 3.72 (d, <i>J</i> = 9.6 Hz, 1H), 3.68–3.57 (m, 2H), 3.57–3.50 (m, 1H), 3.46–3.36 (m, 2H), 3.08 (d, <i>J</i> = 13.6 Hz, 1H), 2.54 (s, 3H), 1.70 (dt, <i>J</i> = 7.8, 3.9 Hz, 1H), 1.30–1.19 (m, 2H), 1.10 (t, <i>J</i> = 4.7 Hz, 1H), 0.93 (dt, <i>J</i> = 8.1, 4.2 Hz, 2H), 0.52–0.42 (m, 2H).</div></div><div id="sec4_1_9_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i96" class="anchor-spacer"></div><h3 class="article-section__title" id="_i96"> <i>rac-</i>7-((1<i>R</i>,5<i>S</i>,6<i>s</i>)-6-Amino-3-azabicyclo[3.1.0]hexan-3-yl)-4-(aminomethyl)-1-cyclopropyl-6-fluoro-8-methylquinolin-2(1<i>H</i>)-one Trifluoroacetic Acid (<b>26</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0082.gif" alt="" id="gr79" /></img><div class="NLM_p last"><b>26</b> (14.3 mg, 11% yield, 2 steps) was prepared from 7-bromo-1-cyclopropyl-6-fluoro-8-methyl-2-oxo-1,2-dihydroquinoline-4-carbonitrile <b>49</b> (75.0 mg, 0.22 mmol), BINAP (58.0 mg, 0.09 mmol) as ligand instead of xantphos, and <i>tert</i>-butyl 3-azabicyclo[3.1.0]hexan-1-ylcarbamate (70.0 mg, 0.35 mmol) according to the procedure used for compound <b>15</b>. HRMS (ESI) calcd for C<sub>19</sub>H<sub>24</sub>FN<sub>4</sub>O [M + H]<sup>+</sup> 343.1929, found 343.1923. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.38 (d, <i>J</i> = 13.2 Hz, 1H), 6.56 (s, 1H), 4.37 (d, <i>J</i> = 1.2 Hz, 2H), 3.70 (d, <i>J</i> = 9.4 Hz, 2H), 3.62–3.52 (m, 3H), 2.86 (t, <i>J</i> = 2.2 Hz, 1H), 2.57 (s, 3H), 2.08 (q, <i>J</i> = 1.9 Hz, 2H), 1.30–1.17 (m, 2H), 0.56–0.42 (m, 2H).</div></div><div id="sec4_1_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i97" class="anchor-spacer"></div><h3 class="article-section__title" id="_i97"> Preparation of 7-(1-Amino-3-azabicyclo[3.1.0]hexan-3-yl)-4-(aminomethyl)-1-cyclopropyl-6-fluoroquinolin-2(1<i>H</i>)-one Hydrochloride (<b>27</b>)</h3><div class="NLM_p">The overall synthesis is shown in <a class="ref internalNav" href="#cht8" aria-label="Chart 8">Chart 8</a>.</div><figure id="cht8" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Chart 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0083.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0083.jpeg" id="gr80" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0083.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00347&amp;id=cht8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_1_10_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i98" class="anchor-spacer"></div><h3 class="article-section__title" id="_i98"> Methyl 4-Bromo-5-fluoro-2-iodobenzoate (<b>53</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0084.gif" alt="" id="gr81" /></img><div class="NLM_p last">Methyl 2-amino-4-bromo-5-fluorobenzoate (2.37 g, 9.54 mmol) was dissolved in acetonitrile (15 mL) and 6 M HCl (48 mL). To the heterogeneous yellow mixture at 0 °C was added dropwise a solution of sodium nitrite (0.69 g, 10.0 mmol) in water (20 mL). The resulting mixture was stirred for 1 h at 0 °C to give an almost clear, yellow solution. A solution of potassium iodide (3.17 g, 19.1 mmol) in water (20 mL) was added dropwise, and the mixture was allowed to warm slowly to rt overnight. The reaction mixture was diluted with water and extracted with EtOAc. The combined organic extracts were washed with saturated aqueous Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub>, brine, dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure. The desired product was purified silica gel column chromatography (0–5% EtOAc/heptane) to give the desired product (2.40 g, 70% yield).</div></div><div id="sec4_1_10_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i99" class="anchor-spacer"></div><h3 class="article-section__title" id="_i99"> Methyl 4-Bromo-2-(cyclopropylamino)-5-fluorobenzoate (<b>55</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0085.gif" alt="" id="gr82" /></img><div class="NLM_p last">To methyl 4-bromo-5-fluoro-2-iodobenzoate (5.00 g, 13.9 mmol) in dioxane (50 mL) were added Cs<sub>2</sub>CO<sub>3</sub> (9.05 g, 27.8 mmol), xantphos (1.21 g, 2.01 mmol), Pd<sub>2</sub>(dba)<sub>3</sub> (0.64 g, 0.70 mmol), cyclopropylamine (1.59 g, 27.8 mmol), and the reaction mixture was stirred at 85 °C for 7 h. The reaction mixture was cooled to room temperature, diluted with water, and extracted with EtOAc. The organic layer was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated to afford a crude residue. The crude residue was purified by silica gel column chromatography (0–5% EtOAc/hexanes) to afford the desired product (2.75 g, 69% yield). LCMS (<i>m</i>/<i>z</i>): 290.3 [M + 2]<sup>+</sup>.</div></div><div id="sec4_1_10_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i100" class="anchor-spacer"></div><h3 class="article-section__title" id="_i100"> Methyl 4-Bromo-2-(<i>N</i>-cyclopropylacetamido)-5-fluorobenzoate (<b>S26</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0086.gif" alt="" id="gr83" /></img><div class="NLM_p last">Methyl 4-bromo-2-(cyclopropylamino)-5-fluorobenzoate (2.75 g, 9.55 mmol) was dissolved in toluene (30 mL) at room temperature. Acetyl chloride (1.49 g, 19.1 mmol) was added and the reaction mixture was stirred at 110 °C for 3 h. The reaction mixture was cooled to room temperature, diluted with water, and extracted with EtOAc. The organic layer was washed with brine, dried over sodium sulfate, and concentrated to afford a crude residue. The crude residue was purified by silica gel column chromatography (0–5% EtOAc/hexanes) to afford the desired product (2.00 g, 64% yield). LCMS (<i>m</i>/<i>z</i>): 332.3 [M + 2]<sup>+</sup>.</div></div><div id="sec4_1_10_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i101" class="anchor-spacer"></div><h3 class="article-section__title" id="_i101"> 7-Bromo-1-cyclopropyl-6-fluoro-4-hydroxyquinolin-2(1<i>H</i>)-one (<b>56</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0087.gif" alt="" id="gr84" /></img><div class="NLM_p last">Methyl 4-bromo-2-(<i>N</i>-cyclopropylacetamido)-5-fluorobenzoate (1.00 g, 3.03 mmol) was dissolved in dry THF (10 mL), and the reaction mixture was cooled to −78 °C. LiHMDS (1.0 M solution in THF, 6.06 mL, 6.06 mmol) was added dropwise, and the reaction mixture was stirred at −78 °C for 1 h. The reaction mixture was quenched with water at 0 °C, acidified with HCl, and extracted with EtOAc. The organic layer was washed with water and concentrated to afford the desired product (0.62 g, 69% yield). LCMS (<i>m</i>/<i>z</i>): 299.9 [M + 2]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.67 (s, 1H), 8.05 (d, <i>J</i> = 6.0 Hz, 1H), 7.67 (d, <i>J</i> = 9.0 Hz, 1H), 5.84 (s, 1H), 2.85 (ddd, <i>J</i> = 10.8, 7.0, 4.1 Hz, 1H), 1.24 (q, <i>J</i> = 7.2 Hz, 2H), 0.76–0.66 (m, 2H).</div></div><div id="sec4_1_10_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i102" class="anchor-spacer"></div><h3 class="article-section__title" id="_i102"> 7-Bromo-1-cyclopropyl-6-fluoro-2-oxo-1,2-dihydroquinolin-4-yl Trifluoromethanesulfonate (<b>57</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0088.gif" alt="" id="gr85" /></img><div class="NLM_p last">7-Bromo-1-cyclopropyl-6-fluoro-4-hydroxyquinolin-2(1<i>H</i>)-one (0.62 g, 2.08 mmol) and TEA (0.63 g, 6.25 mmol) were dissolved in DMF (8 mL), and the reaction mixture was stirred at 0 °C for 30 min. A solution of <i>N</i>-phenyl-bis(trifluoromethanesulfonimide) (0.59 g, 1.66 mmol) in DMF (1 mL) was added dropwise, and the reaction mixture was stirred at room temperature for 2 h. The reaction mixture was quenched with water and extracted with EtOAc. The organic layer was washed with brine, dried over sodium sulfate, and concentrated to afford the product (0.57 g, 64% yield). LCMS (<i>m</i>/<i>z</i>): 432.4 [M + 2]<sup>+</sup>.</div></div><div id="sec4_1_10_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i103" class="anchor-spacer"></div><h3 class="article-section__title" id="_i103"> <i>tert</i>-Butyl ((7-Bromo-1-cyclopropyl-6-fluoro-2-oxo-1,2-dihydroquinolin-4-yl)methyl)carbamate (<b>58</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0089.gif" alt="" id="gr86" /></img><div class="NLM_p last">A mixture of 7-bromo-1-cyclopropyl-6-fluoro-2-oxo-1,2-dihydroquinolin-4-yl trifluoromethanesulfonate (0.47 g, 1.09 mmol), potassium (((<i>tert</i>-butoxycarbonyl)amino)methyl)trifluoroborate (0.52 g, 2.19 mmol), and Na<sub>2</sub>CO<sub>3</sub> (0.35 g, 3.28 mmol) in toluene (10 mL) and water (0.5 mL) was degassed with nitrogen for 5 min. PdCl<sub>2</sub>(dppf) (0.08 g, 0.11 mmol) was added, and the reaction mixture was stirred at 110 °C for 5 h. The reaction mixture was diluted with water and extracted with EtOAc. The organic layer was washed with brine, dried over sodium sulfate, and concentrated to afford the crude residue. The crude residue was purified by silica gel column chromatography (45–60% EtOAc/hexanes) to afford the desired product (0.24 g, 53% yield). LCMS (<i>m</i>/<i>z</i>): 413.5 [M + 2]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.10 (d, <i>J</i> = 6.1 Hz, 1H), 7.45 (d, <i>J</i> = 9.1 Hz, 1H), 6.67 (s, 1H), 4.93 (s, 1H), 4.47 (d, <i>J</i> = 6.0 Hz, 2H), 2.97–2.88 (m, 1H), 1.48 (d, <i>J</i> = 11.7 Hz, 9H), 1.44–1.37 (m, 2H), 0.91 (q, <i>J</i> = 7.3 Hz, 2H).</div></div><div id="sec4_1_10_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i104" class="anchor-spacer"></div><h3 class="article-section__title" id="_i104"> 7-(1-Amino-3-azabicyclo[3.1.0]hexan-3-yl)-4-(aminomethyl)-1-cyclopropyl-6-fluoroquinolin-2(1<i>H</i>)-one Hydrochloride (<b>27</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0090.gif" alt="" id="gr87" /></img><div class="NLM_p last"><i>tert</i>-Butyl ((7-bromo-1-cyclopropyl-6-fluoro-2-oxo-1,2-dihydroquinolin-4-yl)methyl)carbamate (0.210 g, 0.51 mmol), <i>tert</i>-butyl (3-azabicyclo[3.1.0]hexan-1-yl)carbamate (0.20 g, 1.02 mmol), cesium carbonate (0.50 g, 1.53 mmol), Pd<sub>2</sub> dba<sub>3</sub> (0.09 g, 0.10 mmol), and BINAP (0.13 g, 0.20 mmol) were combined in a sealed tube, which was evacuated and backfilled with nitrogen. Previously degassed toluene (5 mL) was added, and the reaction mixture was stirred at 110 °C for 5 h in a sealed tube. The reaction mixture was quenched with water and extracted with EtOAc. The organic layer was washed with brine, dried over sodium sulfate, and concentrated to afford a crude residue. The crude product was purified by silica gel column chromatography (45–60% EtOAc/hexane) to afford the desired protected amine. The Boc protected material was dissolved in DCM (5 mL) and cooled to 0 °C. HCl (4 M in dioxane, 1.0 mL) was added, and the reaction mixture was stirred at room temperature for 2 h. The reaction mixture was concentrated to afford a crude product, which was triturated with diethyl ether to afford the title compound (0.140 g, 69% yield, 2 steps). HRMS (ESI) calcd for C<sub>18</sub>H<sub>22</sub>FN<sub>4</sub>O [M + H]<sup>+</sup> 329.1772, found 329.1771. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.53 (d, <i>J</i> = 14.8 Hz, 1H), 7.22 (d, <i>J</i> = 8.0 Hz, 1H), 6.47 (s, 1H), 4.38 (s, 2H), 4.26 (dd, <i>J</i> = 9.5, 2.8 Hz, 1H), 3.87 (d, <i>J</i> = 8.1 Hz, 1H), 3.76–3.67 (m, 2H), 3.04–2.97 (m, 1H), 2.18 (dt, <i>J</i> = 8.9, 4.4 Hz, 1H), 1.48–1.35 (m, 3H), 1.18–1.10 (m, 1H), 0.86 (dd, <i>J</i> = 8.9, 7.4 Hz, 2H).</div></div><div id="sec4_1_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i105" class="anchor-spacer"></div><h3 class="article-section__title" id="_i105"> Preparation of 7-(1-Amino-3-azabicyclo[3.1.0]hexan-3-yl)-4-(aminomethyl)-1-cyclopropyl-6-fluoro-2-oxo-1,2-dihydroquinoline-8-carbonitrile Trifluoroacetic Acid (<b>28</b>)</h3><div class="NLM_p">The overall synthesis is shown in <a class="ref internalNav" href="#cht9" aria-label="Chart 9">Chart 9</a>.</div><figure id="cht9" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Chart 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0091.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0091.jpeg" id="gr88" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0091.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00347&amp;id=cht9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_1_11_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i106" class="anchor-spacer"></div><h3 class="article-section__title" id="_i106"> Methyl 2-Amino-4-bromo-3-cyano-5-fluorobenzoate (<b>60</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0092.gif" alt="" id="gr89" /></img><div class="NLM_p last">To methyl 2-amino-4-bromo-5-fluoro-3-iodobenzoate (5.00 g, 13.4 mmol) in DMSO (50 mL) was added CuCN (2.40 g, 26.7 mmol) followed by stirring at 90 °C overnight. The reaction mixture was diluted with cold water, filtered through Celite, and extracted with EtOAc. The organic layer was washed with brine, dried over sodium sulfate, and concentrated. The crude residue was purified by silica gel column chromatography (2.5% EtOAc/hexanes) to afford the desired product (2.80 g, 77% yield). LCMS (<i>m</i>/<i>z</i>): 273.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_11_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i107" class="anchor-spacer"></div><h3 class="article-section__title" id="_i107"> Methyl 4-Bromo-3-cyano-2-(cyclopropylamino)-5-fluorobenzoate (<b>61</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0093.gif" alt="" id="gr90" /></img><div class="NLM_p last">To methyl 2-amino-4-bromo-3-cyano-5-fluorobenzoate (2.80 g, 10.2 mmol) in DCM (60 mL) were added cyclopropylboronic acid (1.80 g, 20.4 mmol), 2,2′-bipyridine (3.20 g, 20.4 mmol), Cu(OAc)<sub>2</sub> (3.70 g, 20.4 mmol), and Na<sub>2</sub>CO<sub>3</sub>(3.2 g, 30.7 mmol). Oxygen (gas) was purged continuously, and the reaction mixture was stirred at room temperature for 3 days. The reaction mixture was filtered through Celite, washed with DCM, and the filtrate was concentrated. The crude residue was purified by silica gel column chromatography (0–5% EtOAc/hexanes) to afford the desired product (0.50 g, 16% yield). 1.5 g of starting material was recovered. LCMS (<i>m</i>/<i>z</i>): 313.1 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.36 (s, 1H), 7.98 (d, <i>J</i> = 9.1 Hz, 1H), 3.83 (d, <i>J</i> = 3.9 Hz, 3H), 3.06 (dd, <i>J</i> = 6.4, 3.5 Hz, 1H), 0.92–0.86 (m, 2H), 0.71–0.66 (m, 2H).</div></div><div id="sec4_1_11_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i108" class="anchor-spacer"></div><h3 class="article-section__title" id="_i108"> Methyl 4-(1-((<i>tert</i>-Butoxycarbonyl)amino)-3-azabicyclo[3.1.0]hexan-3-yl)-3-cyano-2-(cyclopropylamino)-5-fluorobenzoate (<b>S27</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0094.gif" alt="" id="gr91" /></img><div class="NLM_p last">A suspension of methyl 4-bromo-3-cyano-2-(cyclopropylamino)-5-fluorobenzoate (280 mg, 0.89 mmol), Cs<sub>2</sub>CO<sub>3</sub> (870 mg, 2.68 mmol), <i>tert</i>-butyl (azabicyclo[3.1.0]hexan-1-yl)carbamate (354 mg, 1.79 mmol) in toluene (6 mL) was degassed for 5 min. Pd<sub>2</sub>(dba)<sub>3</sub> (163 mg, 0.18 mmol) and BINAP (222 mg, 0.36 mmol) were added, and the reaction mixture was stirred at 110 °C for 15 h. The reaction mixture was quenched with cold water and extracted with EtOAc. The combined organic layers were washed with brine, dried over sodium sulfate, and concentrated to afford a crude residue, which was purified by silica gel column chromatography (0–10% EtOAc/hexanes) giving the desired product (210 mg, 51% yield). LCMS (<i>m</i>/<i>z</i>): 431.6 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.44 (s, 1H), 7.61 (d, <i>J</i> = 15.2 Hz, 1H), 5.06 (s, 1H), 4.03–4.00 (m, 2H), 3.84–3.80 (m, 5H), 3.14–3.10 (m, 1H), 1.74–1.71 (m, 1H), 1.50 (s, 9H), 1.05–1.02 (m, 2H), 0.95–0.85 (m, 2H), 0.63–0.60 (m, 2H).</div></div><div id="sec4_1_11_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i109" class="anchor-spacer"></div><h3 class="article-section__title" id="_i109"> Methyl 4-(1-((<i>tert</i>-Butoxycarbonyl)amino)-3-azabicyclo[3.1.0]hexan-3-yl)-3-cyano-2-(<i>N</i>-cyclopropylacetamido)-5-fluorobenzoate (<b>S28</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0095.gif" alt="" id="gr92" /></img><div class="NLM_p last">Methyl 4-(1-((<i>tert</i>-butoxycarbonyl)amino)-3-azabicyclo[3.1.0]hexan-3-yl)-3-cyano-2-(cyclopropylamino)-5-fluorobenzoate (190 mg, 0.44 mmol) was dissolved in toluene (2 mL), acetyl chloride (0.06 mL, 0.88 mmol) was added, and the reaction mixture was stirred at 110 °C for 4 h. The reaction mixture was quenched with water and extracted with EtOAc. The organic layer was washed with NaHCO<sub>3</sub>, dried over sodium sulfate, and concentrated to afford the desired product.</div></div><div id="sec4_1_11_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i110" class="anchor-spacer"></div><h3 class="article-section__title" id="_i110"> <i>tert</i>-Butyl (3-(8-Cyano-1-cyclopropyl-6-fluoro-4-hydroxy-2-oxo-1,2-dihydroquinolin-7-yl)-3-azabicyclo[3.1.0]hexan-1-yl)carbamate (<b>S29</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0096.gif" alt="" id="gr93" /></img><div class="NLM_p last">NaHMDS (1 M in THF, 0.31 mL, 0.31 mmol) was added dropwise to a solution of methyl 4-(1-((<i>tert</i>-butoxycarbonyl)amino)-3-azabicyclo[3.1.0]hexan-3-yl)-3-cyano-2-(<i>N</i>-cyclopropylacetamido)-5-fluorobenzoate (48.0 mg, 0.10 mmol) in THF (2 mL) at −78 °C. After 3 h at this temperature, the reaction mixture was allowed to warm to −20 °C over the next 45 min. The reaction was quenched by dropwise addition of saturated aqueous NH<sub>4</sub>Cl at −78 °C. Upon warming to rt, the mixture was diluted with water and extracted with EtOAc. The combined organic layers were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure. LCMS (<i>m</i>/<i>z</i>): 441.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_11_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i111" class="anchor-spacer"></div><h3 class="article-section__title" id="_i111"> 7-(1-((<i>tert</i>-Butoxycarbonyl)amino)-3-azabicyclo[3.1.0]hexan-3-yl)-8-cyano-1-cyclopropyl-6-fluoro-2-oxo-1,2-dihydroquinolin-4-yl Trifluoromethanesulfonate (<b>S30</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0097.gif" alt="" id="gr94" /></img><div class="NLM_p last"><i>tert</i>-Butyl (3-(8-cyano-1-cyclopropyl-6-fluoro-4-hydroxy-2-oxo-1,2-dihydroquinolin-7-yl)-3-azabicyclo[3.1.0]hexan-1-yl)carbamate (92.0 mg, 0.21 mmol) and Et<sub>3</sub>N (63.0 mg, 0.63 mmol) were dissolved in DMF (1 mL), and the reaction mixture was stirred at 0 °C for 10 min. A solution of <i>N</i>-phenyl-bis(trifluoromethanesulfonimide) (89.0 mg, 0.25 mmol) in DMF (1 mL) was added dropwise, and the reaction mixture was stirred at room temperature for 1 h. The reaction mixture was quenched with water and extracted with EtOAc. The organic layer was washed with brine, dried over sodium sulfate, and concentrated. The crude residue was purified by silica gel column chromatography (0–100% EtOAc/hexanes) to afford the desired product (69.0 mg, 58% yield, 3 steps). LCMS (<i>m</i>/<i>z</i>): 573.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_11_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i112" class="anchor-spacer"></div><h3 class="article-section__title" id="_i112"> 7-(1-Amino-3-azabicyclo[3.1.0]hexan-3-yl)-4-(aminomethyl)-1-cyclopropyl-6-fluoro-2-oxo-1,2-dihydroquinoline-8-carbonitrile Trifluoroacetic Acid (<b>28</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0098.gif" alt="" id="gr95" /></img><div class="NLM_p last">A mixture of 7-(1-((<i>tert</i>-butoxycarbonyl)amino)-3-azabicyclo[3.1.0]hexan-3-yl)-8-cyano-1-cyclopropyl-6-fluoro-2-oxo-1,2-dihydroquinolin-4-yl trifluoromethanesulfonate (69.0 mg, 0.12 mmol), potassium (((<i>tert</i>-butoxycarbonyl)amino)methyl)trifluoroborate (57.0 mg, 0.24 mmol), and Na<sub>2</sub>CO<sub>3</sub> (38.0 mg, 0.36 mmol) in toluene (1.2 mL) and water (0.05 mL) was degassed with nitrogen for 5 min. PdCl<sub>2</sub>(dppf) (20.0 mg, 0.02 mmol) was added, and the reaction mixture was stirred at 70 °C overnight. The reaction mixture was diluted with water and extracted with EtOAc. The organic layer was washed with brine, dried over sodium sulfate, and concentrated to afford the crude residue. The crude residue was purified by silica gel column chromatography (0–100% EtOAc/heptane) to afford the protected amine. The Boc protected material was dissolved in DCM (1 mL), and TFA (0.5 mL) was added. The reaction mixture was stirred at room temperature for 20 min. The reaction mixture was concentrated to afford a crude product, which was purified by prep-HPLC to afford the title compound (14.0 mg, 19% yield, 2 steps). HRMS (ESI) calcd for C<sub>19</sub>H<sub>21</sub>FN<sub>5</sub>O [M + H]<sup>+</sup> 354.1725, found 354.1722. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.76 (d, <i>J</i> = 14.1 Hz, 1H), 6.60 (s, 1H), 4.36 (d, <i>J</i> = 0.9 Hz, 2H), 4.16 (d, <i>J</i> = 10.1 Hz, 1H), 4.04 (d, <i>J</i> = 9.8 Hz, 2H), 3.90 (d, <i>J</i> = 10.5 Hz, 1H), 3.55–3.47 (m, 1H), 2.11–2.04 (m, 1H), 1.48–1.39 (m, 2H), 1.37–1.30 (m, 1H), 1.27–1.20 (m, 1H), 0.78–0.70 (m, 2H).</div></div><div id="sec4_1_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i113" class="anchor-spacer"></div><h3 class="article-section__title" id="_i113"> Preparation of 7-(1-Amino-5-methyl-3-azabicyclo[3.1.0]hexan-3-yl)-4-(aminomethyl)-1-cyclopropyl-6-fluoro-8-methoxyquinolin-2(1<i>H</i>)-one Trifluoroacetic Acid (<b>29</b>)</h3><div class="NLM_p">The overall synthesis is shown in <a class="ref internalNav" href="#cht10" aria-label="Chart 10">Chart 10</a>.</div><figure id="cht10" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Chart 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0099.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0099.jpeg" id="gr96" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0099.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00347&amp;id=cht10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_1_12_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i114" class="anchor-spacer"></div><h3 class="article-section__title" id="_i114"> Methyl 2-Amino-4-bromo-5-fluoro-3-methoxybenzoate (<b>62</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0100.gif" alt="" id="gr97" /></img><div class="NLM_p last">Methyl 2-amino-4-bromo-5-fluoro-3-iodobenzoate (1.00 g, 2.65 mmol) was dissolved in methanol (15 mL), and CuI (0.10 g, 0.53 mmol) was added, followed by stirring for 5 min. NaOMe (1.43 g, 26.5 mmol) and pyridine (2 mL) were added, and the reaction mixture was stirred at 110 °C for 1 h under microwave irradiation. The reaction mixture was quenched with cold water, acidified to pH 2 by the addition of 1 N HCl, and the suspension was extracted with EtOAc. The organic layer was washed with brine, dried over sodium sulfate, and concentrated to afford the corresponding acid which was triturated with pentane/diethyl ether (1:1). The acid was dissolved in methanol (120 mL), concentrated H<sub>2</sub>SO<sub>4</sub> (12 mL) was added, and the reaction mixture was stirred at 85 °C for 24 h. The reaction mixture was quenched with ice–water and extracted with DCM. The organic layer was washed with brine, dried over sodium sulfate, and concentrated to give a crude residue, which was purified by column chromatography (0–20% EtOAc/hexanes), affording the desired product (4.50 g, 71% yield). LCMS (<i>m</i>/<i>z</i>): 279.9 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.41 (d, <i>J</i> = 9.7 Hz, 1H), 6.69 (s, 2H), 3.82 (s, 3H), 3.75 (s, 3H).</div></div><div id="sec4_1_12_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i115" class="anchor-spacer"></div><h3 class="article-section__title" id="_i115"> Methyl 4-Bromo-5-fluoro-2-iodo-3-methoxybenzoate (<b>63</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0101.gif" alt="" id="gr98" /></img><div class="NLM_p last">Methyl 2-amino-4-bromo-5-fluoro-3-methoxybenzoate (4.50 g, 16.2 mmol) was dissolved in acetonitrile (27 mL), 6 M HCl (58.5 mL) was added, and the reaction mixture was stirred at room temperature for 10 min. The reaction mixture was cooled to 0 °C, and NaNO<sub>2</sub> (1.17 g, 17.0 mmol) in water (18 mL) was added followed by stirring at 0 °C for 1 h. KI (5.37 g, 32.4 mmol) in water (36 mL) was added dropwise, and the reaction mixture was stirred at 0 °C for 30 min. The reaction mixture was quenched with cold water and extracted with EtOAc. The organic layer was washed with saturated aqueous sodium thiosulfate solution, dried over sodium sulfate, and concentrated to afford a crude residue. The crude residue was purified by silica gel column chromatography (10% EtOAc/hexanes) to afford the desired product (1.80 g, 29% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.55 (d, <i>J</i> = 8.5 Hz, 1H), 3.87 (s, 3H), 3.83 (s, 3H).</div></div><div id="sec4_1_12_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i116" class="anchor-spacer"></div><h3 class="article-section__title" id="_i116"> Methyl 4-Bromo-2-(cyclopropylamino)-5-fluoro-3-methoxybenzoate (<b>64</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0102.gif" alt="" id="gr99" /></img><div class="NLM_p last">Methyl 4-bromo-5-fluoro-2-iodo-3-methoxybenzoate (6.00 g, 15.4 mmol) and Cs<sub>2</sub>CO<sub>3</sub> (15.0 g, 46.3 mmol) were suspended in dioxane (60 mL) and degassed with nitrogen for 10 min. Pd<sub>2</sub>dba<sub>3</sub> (0.70 g, 0.70 mmol), xantphos (1.30 g, 2.30 mmol), and cyclopropylamine (2.20 mL, 30.8 mmol) were added, and the reaction mixture was stirred at 100 °C for 16 h. The reaction mixture was quenched with water and extracted with EtOAc. The organic layer was washed with brine, dried over sodium sulfate, and concentrated to afford a crude residue, which was purified by silica gel column chromatography (0–10% EtOAc/hexanes), providing the desired product (4.20 g, 86% yield). LCMS (<i>m</i>/<i>z</i>): 320.13 [M + 2]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.48 (d, <i>J</i> = 9.2 Hz, 1H), 3.86 (s, 3H), 3.83 (s, 3H), 3.03–3.00 (m, 1H), 0.74–0.69 (m, 2H), 0.52–0.48 (m, 2H).</div></div><div id="sec4_1_12_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i117" class="anchor-spacer"></div><h3 class="article-section__title" id="_i117"> Methyl 4-Bromo-2-(<i>N</i>-cyclopropylacetamido)-5-fluoro-3-methoxybenzoate (<b>S31</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0103.gif" alt="" id="gr100" /></img><div class="NLM_p last">Methyl 4-bromo-2-(cyclopropylamino)-5-fluoro-3-methoxybenzoate (2.90 g, 9.10 mmol) was dissolved in DCM (45 mL) and cooled to 0 °C. DIPEA (7.92 mL, 45.5 mmol) and acetyl chloride (6.50 mL, 91.1 mmol) were added, and the reaction mixture was stirred at room temperature for 1 h. The reaction mixture was quenched with saturated NaHCO<sub>3</sub> solution and extracted with DCM. The combined organic layers were washed with brine, dried over sodium sulfate, and concentrated to afford a crude residue, which was purified by silica gel column chromatography (25–40% EtOAc/hexanes) providing the desired product (2.60 g, 79% yield). LCMS (<i>m</i>/<i>z</i>): 362.4 [M + 2]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.54 (d, <i>J</i> = 6.8 Hz, 1H), 3.88 (s, 3H), 3.85 (s, 3H), 3.19–3.15 (m, 1H), 2.42 (s, 3H), 0.99–0.97 (m, 1H), 0.90–0.79 (m, 2H), 0.68–0.65 (m, 1H).</div></div><div id="sec4_1_12_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i118" class="anchor-spacer"></div><h3 class="article-section__title" id="_i118"> 7-Bromo-1-cyclopropyl-6-fluoro-8-methoxy-2-oxo-1,2-dihydroquinolin-4-yl Trifluoromethanesulfonate (<b>S32</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0104.gif" alt="" id="gr101" /></img><div class="NLM_p last">Methyl 4-bromo-2-(<i>N</i>-cyclopropylacetamido)-5-fluoro-3-methoxybenzoate (2.30 g, 6.30 mmol) was dissolved in THF (25 mL) and cooled to −78 °C. NaHMDS (1.0 M in THF, 19.2 mL, 19.2 mmol) was added dropwise, and the reaction mixture was stirred at −78 °C for 1 h. The reaction mixture was quenched with ice–water, acidified to pH 2 by the addition of 1 N HCl, and extracted with 5% MeOH in DCM solution. The combined organic layer was dried over sodium sulfate and concentrated to afford the desired cyclized product. The quinolone was dissolved in DMF (20 mL) and cooled to 0 °C. TEA (2.56 mL, 18.3 mmol) and PhNTf<sub>2</sub> (2.61 g, 7.31 mmol) were added, and the reaction mixture was stirred at room temperature for 3 h. The reaction mixture was quenched with cold water and extracted with EtOAc. The organic layer was washed with cold water, brine, dried over sodium sulfate, and concentrated to give a crude residue, which was purified by silica gel column chromatography (0–15% EtOAc/hexanes) providing the desired product (1.50 g, 50% yield, 2 steps). LCMS (<i>m</i>/<i>z</i>): 462.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.69 (d, <i>J</i> = 8.4 Hz, 1H), 6.90 (s, 1H), 3.75 (s, 3H), 3.40–3.38 (m, 1H), 1.16–1.10 (m, 2H), 0.54–0.50 (m, 2H).</div></div><div id="sec4_1_12_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i119" class="anchor-spacer"></div><h3 class="article-section__title" id="_i119"> 7-Bromo-1-cyclopropyl-6-fluoro-8-methoxy-2-oxo-1,2-dihydroquinoline-4-carbonitrile (<b>S33</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0105.gif" alt="" id="gr102" /></img><div class="NLM_p last">A solution of 7-bromo-1-cyclopropyl-6-fluoro-8-methoxy-2-oxo-1,2-dihydroquinolin-4-yl trifluoromethanesulfonate (0.80 g, 1.74 mmol) and Zn(CN)<sub>2</sub> (0.22 g, 1.91 mmol) in DMF (12 mL) was degassed with nitrogen for 10 min. Pd(PPh<sub>3</sub>)<sub>4</sub> (0.10 g, 0.09 mmol) was added, and the reaction mixture was stirred at 100 °C for 16 h. The reaction mixture was quenched with cold water and extracted with EtOAc. The combined organic layers were washed with brine, dried over sodium sulfate, and concentrated to give a crude residue, which was purified by silica gel column chromatography (0–15% EtOAc/hexanes), affording the desired product (0.58 g, 58% yield). LCMS (<i>m</i>/<i>z</i>): 339.3 [M + 2]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.48 (d, <i>J</i> = 7.6 Hz, 1H), 7.10 (s, 1H), 3.80 (s, 3H), 3.46–3.40 (m, 1H), 1.31–1.26 (m, 2H), 0.65–0.60 (m, 2H).</div></div><div id="sec4_1_12_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i120" class="anchor-spacer"></div><h3 class="article-section__title" id="_i120"> <i>tert</i>-Butyl (3-(4-Cyano-1-cyclopropyl-6-fluoro-8-methoxy-2-oxo-1,2-dihydroquinolin-7-yl)-5-methyl-3-azabicyclo[3.1.0]hexan-1-yl)carbamate (<b>S35</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0106.gif" alt="" id="gr103" /></img><div class="NLM_p last">A vial containing 7-bromo-1-cyclopropyl-6-fluoro-8-methoxy-2-oxo-1,2-dihydroquinoline-4-carbonitrile (100 mg, 0.30 mmol), <i>tert</i>-butyl (5-methyl-3-azabicyclo[3.1.0]hexan-1-yl)carbamate (94.0 mg, 0.45 mmol), BINAP (74.0 mg, 0.12 mmol), tris(dibenzylideneacetone)dipalladium(0) (54.3 mg, 0.06 mmol), and cesium carbonate (290 mg, 0.89 mmol) was sealed, evacuated, and backfilled with N<sub>2</sub>. Toluene (3 mL) was added, and the mixture was heated to 100 °C for 6 h. Upon cooling to room temperature, the mixture was filtered and volatiles were evaporated under reduced pressure. Silica gel flash chromatography (0–100% EtOAc/heptane) provided the desired product (200 mg). LCMS (<i>m</i>/<i>z</i>): 469.4 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_12_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i121" class="anchor-spacer"></div><h3 class="article-section__title" id="_i121"> 7-(1-Amino-5-methyl-3-azabicyclo[3.1.0]hexan-3-yl)-4-(aminomethyl)-1-cyclopropyl-6-fluoro-8-methoxyquinolin-2(1<i>H</i>)-one Trifluoroacetic Acid (<b>29</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0139.gif" alt="" id="GRAPHIC-d7e7850-autogenerated" /></img><div class="NLM_p last">A mixture of <i>tert</i>-butyl (3-(4-cyano-1-cyclopropyl-6-fluoro-8-methoxy-2-oxo-1,2-dihydroquinolin-7-yl)-5-methyl-3-azabicyclo[3.1.0]hexan-1-yl)carbamate (200 mg, 0.43 mmol) in 2 M NH<sub>3</sub> in MeOH (8.5 mL) was treated with Pd/C (10%, 50% in water, 136 mg, 0.06 mmol). The flask was partially evacuated and backfilled with H<sub>2</sub> several times, then stirred under a balloon of H<sub>2</sub> for 1 h. The reaction mixture was then filtered, and volatiles were evaporated under reduced pressure. The crude product was dissolved in a mixture of DCM (2 mL) and TFA (2 mL) and stirred at room temperature for 45 min. Volatiles were evaporated under reduced pressure. The residue was concentrated twice from MeOH-toluene. Preparative prep-HPLC provided the product (14.9 mg, 7% yield, 3 steps) as a dark yellow powder. HRMS (ESI) calcd for C<sub>20</sub>H<sub>26</sub>FN<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup> 373.2034, found 373.2030. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.72 (s, 3H), 8.37 (s, 3H), 7.37 (d, <i>J</i> = 13.9 Hz, 1H), 6.45 (s, 1H), 4.25–4.17 (m, 2H), 3.80 (d, <i>J</i> = 9.4 Hz, 1H), 3.71 (d, <i>J</i> = 9.3 Hz, 1H), 3.64 (d, <i>J</i> = 9.8 Hz, 1H), 3.48 (s, 3H), 3.42 (d, <i>J</i> = 8.8 Hz, 1H), 3.36–3.29 (m, 1H), 1.36 (s, 3H), 1.10–0.98 (m, 4H), 0.42–0.31 (m, 2H).</div></div><div id="sec4_1_12_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i122" class="anchor-spacer"></div><h3 class="article-section__title" id="_i122"> Synthesis of 7-(1-Amino-3-azabicyclo[3.1.0]hexan-3-yl)-4-(aminomethyl)-1-cyclopropyl-8-(difluoromethoxy)-6-fluoroquinolin-2(1<i>H</i>)-one Hydrochloride (<b>30</b>)</h3><div class="NLM_p">The overall synthesis is shown in <a class="ref internalNav" href="#cht11" aria-label="Chart 11">Chart 11</a>.</div><figure id="cht11" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Chart 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0107.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0107.jpeg" id="gr105" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0107.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00347&amp;id=cht11"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_1_12_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i123" class="anchor-spacer"></div><h3 class="article-section__title" id="_i123"> Methyl 4-Bromo-5-fluoro-2-iodo-3-((2- (trimethylsilyl)ethoxy)methoxy)benzoate (<b>65</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0108.gif" alt="" id="gr106" /></img><div class="NLM_p last">Methyl 4-bromo-5-fluoro-2-iodo-3-methoxybenzoate (1.80 g, 4.60 mmol) was dissolved in DCM (20 mL) and cooled to −78 °C. BBr<sub>3</sub> (1 M in DCM, 36.8 mL, 36.8 mmol) was added, and the reaction mixture was stirred at room temperature for 18 h. The reaction mixture was quenched with ice–water and extracted with EtOAc. The organic layer was washed with brine, dried over sodium sulfate, and concentrated to afford the crude residue. The crude residue was purified by silica gel column chromatography (0–10% EtOAc/hexanes) to afford the demethylated product. The corresponding phenol was dissolved in acetonitrile (6 mL). K<sub>2</sub>CO<sub>3</sub> (0.73 g, 5.30 mmol) and SEM-Cl (0.42 g, 2.50 mmol) were added, and the reaction mixture was stirred at 100 °C for 1 h. The reaction mixture was filtered, washed with EtOAc, and concentrated to afford the crude desired product (0.90 g, 39% yield, 2 steps). The crude product was used in the next step without further purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.37 (d, <i>J</i> = 8.6 Hz, 1H), 5.30 (s, 2H), 4.11–4.01 (m, 2H), 3.96 (s, 3H), 1.11–1.00 (m, 2H), 0.06 (s, 9H).</div></div><div id="sec4_1_12_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i124" class="anchor-spacer"></div><h3 class="article-section__title" id="_i124"> Methyl 4-Bromo-2-(<i>N</i>-cyclopropylacetamido)-5-fluoro-3-((2-(trimethylsilyl)ethoxy)methoxy)benzoate (<b>S36</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0109.gif" alt="" id="gr107" /></img><div class="NLM_p last">Methyl 4-bromo-5-fluoro-2-iodo-3-((2-(trimethylsilyl)ethoxy)methoxy)benzoate (0.90 g, 1.78 mmol), Cs<sub>2</sub>CO<sub>3</sub> (0.86 g, 2.65 mmol), and xantphos (0.15 g, 0.27 mmol) were suspended in dioxane (28 mL). Pd<sub>2</sub>(dba)<sub>3</sub> (0.08 g, 0.09 mmol) and cyclopropylamine (0.20 g, 3.50 mmol) were added, and the reaction mixture was stirred at 110 °C for 8 h. The reaction mixture was quenched with water and extracted with EtOAc. The organic layer was washed with brine, dried over sodium sulfate, and concentrated. The crude residue was purified by silica gel column chromatography (0–5% EtOAc/hexanes) affording the cyclopropylaniline. The aniline was dissolved in DCM (10 mL) and cooled to 0 °C. DIPEA (0.44 g, 3.46 mmol) and acetyl chloride (0.27 g, 3.46 mmol) were added, and the reaction mixture was stirred at room temperature for 4 h. The reaction mixture was quenched with water and extracted with DCM. The organic layer was washed with brine, dried over sodium sulfate, and concentrated to afford the crude residue. The crude residue was purified by silica gel column chromatography (20–30% EtOAc/hexanes) to afford the desired product (0.30 g, 35% yield, 2 steps). LCMS (<i>m</i>/<i>z</i>): 346.2 [M – SEM + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.55 (d, <i>J</i> = 8.6 Hz, 1H), 5.10 (d, <i>J</i> = 5.0 Hz, 1H), 5.02 (d, <i>J</i> = 5.0 Hz, 1H), 3.90 (d, <i>J</i> = 1.9 Hz, 2H), 3.85 (s, 3H), 3.22–3.19 (m, 1H), 2.41 (s, 3H), 1.28 (d, <i>J</i> = 2.8 Hz, 2H), 1.03 (d, <i>J</i> = 3.3 Hz, 2H), 0.84–0.81 (m, 1H), 0.68–0.64 (m, 1H), 0.06 (s, 9H).</div></div><div id="sec4_1_12_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i125" class="anchor-spacer"></div><h3 class="article-section__title" id="_i125"> 7-Bromo-1-cyclopropyl-6-fluoro-2-oxo-8-((2-(trimethylsilyl)ethoxy)methoxy)-1,2-dihydroquinolin-4-yl Trifluoromethanesulfonate (<b>S37</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0110.gif" alt="" id="gr108" /></img><div class="NLM_p last">Methyl 4-bromo-2-(<i>N</i>-cyclopropylacetamido)-5-fluoro-3-((2-(trimethylsilyl)ethoxy)methoxy)benzoate (0.30 g, 0.63 mmol) was dissolved in THF (10 mL) and cooled to −78 °C. NaHMDS (1.0 M in THF, 1.90 mL, 1.90 mmol) was added dropwise, and the reaction mixture was stirred at −78 °C for 1 h. The reaction mixture was quenched with ice–water, acidified to pH 2 by the addition of 1 N HCl, and extracted with EtOAc. The organic layer was washed with brine, dried over sodium sulfate, and concentrated to afford the desired cyclized product. The crude heterocycle was dissolved in DMF (5 mL) and cooled to 0 °C. Et<sub>3</sub>N (0.10 g, 1.00 mmol) and PhNTf<sub>2</sub> (0.19 g, 0.50 mmol) were added, and the reaction mixture was stirred at room temperature for 1.5 h. The reaction mixture was quenched with cold water and extracted with EtOAc. The organic layer was washed with cold water, brine, dried over sodium sulfate, and concentrated to afford a crude residue. The crude residue was purified by silica gel column chromatography (0–20% EtOAc/hexanes) to afford the desired product (0.19 g, 94% yield, 2 steps). LCMS (<i>m</i>/<i>z</i>): 578.4 [M + 2]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.40 (d, <i>J</i> = 8.6 Hz, 1H), 6.72 (s, 1H), 5.12 (s, 2H), 3.87–3.82 (m, 2H), 3.45 (s, 1H), 1.28–1.26 (m, 2H), 0.97–0.91 (m, 2H), 0.64 (s, 2H), 0.02 (s, 9H).</div></div><div id="sec4_1_12_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i126" class="anchor-spacer"></div><h3 class="article-section__title" id="_i126"> <i>tert</i>-Butyl ((7-Bromo-1-cyclopropyl-6-fluoro-2-oxo-8-((2-(trimethylsilyl)ethoxy)methoxy)-1,2-dihydroquinolin-4-yl)methyl)carbamate (<b>S38</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0111.gif" alt="" id="gr109" /></img><div class="NLM_p last">7-Bromo-1-cyclopropyl-6-fluoro-2-oxo-8-((2-(trimethylsilyl)ethoxy)methoxy)-1,2-dihydroquinolin-4-yl trifluoromethanesulfonate (0.59 g, 10.2 mmol), potassium (((<i>tert</i>-butoxycarbonyl)amino)methyl)trifluoroborate (0.49 g, 20.5 mmol), and Na<sub>2</sub>CO<sub>3</sub> (0.27 g, 2.56 mmol) were suspended in toluene (18 mL) and water (0.1 mL), and the reaction mixture was degassed with nitrogen for 5 min. PdCl<sub>2</sub>(dppf) (0.04 g, 0.51 mmol) was added, and the reaction mixture was stirred at 110 °C for 9 h. The reaction mixture was diluted with water and extracted with EtOAc. The organic layer was washed with brine, dried over sodium sulfate, and concentrated to afford a crude residue, which was purified silica gel column chromatography (20–25% EtOAc/hexanes), providing the desired product (0.24 g, 42% yield). LCMS (<i>m</i>/<i>z</i>): 559.6 [M + 2]<sup>+</sup>.</div></div><div id="sec4_1_12_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i127" class="anchor-spacer"></div><h3 class="article-section__title" id="_i127"> 4-(Aminomethyl)-7-bromo-1-cyclopropyl-6-fluoro-8-hydroxyquinolin-2(1<i>H</i>)-one (<b>S39</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0112.gif" alt="" id="gr110" /></img><div class="NLM_p last"><i>tert</i>-Butyl ((7-bromo-1-cyclopropyl-6-fluoro-2-oxo-8-((2-(trimethylsilyl)ethoxy)methoxy)-1,2-dihydroquinolin-4-yl)methyl)carbamate (0.12 g, 9.55 mmol) was dissolved in DCM (2 mL) at room temperature. HCl (4 M in dioxane, 1 mL) was added, and the reaction mixture was stirred at room temperature for 2 h. The reaction mixture was concentrated to afford a crude residue, which was purified by trituration with pentane, affording the desired product (65.0 mg, 93% yield). LCMS (<i>m</i>/<i>z</i>): 329.4 [M + 2]<sup>+</sup>.</div></div><div id="sec4_1_12_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i128" class="anchor-spacer"></div><h3 class="article-section__title" id="_i128"> <i>tert</i>-Butyl ((7-Bromo-1-cyclopropyl-6-fluoro-8-hydroxy-2-oxo-1,2-dihydro quinolin-4-yl)methyl)carbamate (<b>66</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0113.gif" alt="" id="gr111" /></img><div class="NLM_p last">4-(Aminomethyl)-7-bromo-1-cyclopropyl-6-fluoro-8-hydroxyquinolin-2(1<i>H</i>)-one (65.0 mg, 0.20 mmol) was dissolved in DCM (2 mL), and the reaction mixture was cooled to 0 °C. Et<sub>3</sub>N (0.12 g, 1.22 mmol) and (Boc)<sub>2</sub>O (59.0 mg, 0.27 mmol) were added, and the reaction mixture was stirred at room temperature for 2 h. The reaction mixture was concentrated to afford a crude residue which was purified by trituration with pentane, affording the desired product (80.0 mg, 94% yield). LCMS (<i>m</i>/<i>z</i>): 429.5 [M + 2]<sup>+</sup>.</div></div><div id="sec4_1_12_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i129" class="anchor-spacer"></div><h3 class="article-section__title" id="_i129"> <i>tert</i>-Butyl ((7-Bromo-1-cyclopropyl-8-(difluoromethoxy)-6-fluoro-2-oxo-1,2-dihydroquinolin-4-yl)methyl)carbamate (<b>67</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0114.gif" alt="" id="gr112" /></img><div class="NLM_p last"><i>tert</i>-Butyl ((7-bromo-1-cyclopropyl-6-fluoro-8-hydroxy-2-oxo-1,2-dihydroquinolin-4-yl)methyl)carbamate (100 mg, 0.23 mmol) was dissolved in acetonitrile at room temperature. K<sub>2</sub>CO<sub>3</sub> (1.29 g, 9.36 mmol) in water (3 mL) and 2-chloro-2,2-difluoro-1-phenylethan-1-one (178 mg, 0.94 mmol) were added, and the reaction mixture was stirred at 120 °C for 24 h. The reaction mixture was quenched with cool water and extracted with EtOAc. The organic layer was washed with brine, dried over sodium sulfate, and concentrated to afford a crude residue, which was purified by silica gel column chromatography (15–20% EtOAc/hexane), providing the desired product (0.03 g, 27% yield). LCMS (<i>m</i>/<i>z</i>): 479.1 [M + 2]<sup>+</sup>.</div></div><div id="sec4_1_12_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i130" class="anchor-spacer"></div><h3 class="article-section__title" id="_i130"> <i>tert</i>-Butyl ((7-(1-((<i>tert</i>-Butoxycarbonyl)amino)-3-azabicyclo[3.1.0]hexan-3-yl)-1-cyclopropyl-8-(difluoromethoxy)-6-fluoro-2-oxo-1,2-dihydroquinolin-4-yl)methyl)carbamate (<b>S40</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0115.gif" alt="" id="gr113" /></img><div class="NLM_p last"><i>tert</i>-Butyl ((7-bromo-1-cyclopropyl-8-(difluoromethoxy)-6-fluoro-2-oxo-1,2-dihydroquinolin-4-yl)methyl)carbamate (30.0 mg, 0.06 mmol), <i>tert</i>-butyl (3-azabicyclo[3.1.0]hexan-1-yl)carbamate (25.0 mg, 0.13 mmol), cesium carbonate (61.0 mg, 0.19 mmol), Pd<sub>2</sub>(dba)<sub>3</sub> (11.0 mg, 0.01 mmol), and BINAP (16.0 mg, 0.03 mmol) were combined in a sealed tube which was evacuated and backfilled with nitrogen. Toluene (0.6 mL) was added, and the reaction mixture was stirred at 110 °C for 12 h. The reaction mixture was quenched with water and extracted with EtOAc. The organic layer was washed with brine, dried over sodium sulfate, and concentrated to afford a crude residue, which was purified by prep TLC (50% EtOAc/hexanes), affording the desired product (15.0 mg, 40% yield). LCMS (<i>m</i>/<i>z</i>): 595.9 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_12_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i131" class="anchor-spacer"></div><h3 class="article-section__title" id="_i131"> 7-(1-Amino-3-azabicyclo[3.1.0]hexan-3-yl)-4-(aminomethyl)-1-cyclopropyl-8-(difluoromethoxy)-6-fluoroquinolin-2(1<i>H</i>)-one Hydrochloride (<b>30</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0116.gif" alt="" id="gr114" /></img><div class="NLM_p last"><i>tert</i>-Butyl ((7-(1-((<i>tert</i>-butoxycarbonyl)amino)-3-azabicyclo[3.1.0]hexan-3-yl)-1-cyclopropyl-8-(difluoromethoxy)-6-fluoro-2-oxo-1,2-dihydroquinolin-4-yl)methyl)carbamate (15.0 mg, 0.03 mmol) was dissolved in DCM (1 mL) and cooled at 0 °C. HCl (4 M in dioxane, 0.5 mL) was added, and the reaction mixture was stirred at room temperature for 3 h. The reaction mixture was concentrated to afford the crude product, which was triturated with diethyl ether, providing the desired product (10.0 mg, 85% yield, purity = 82%). HRMS (ESI) calcd for C<sub>19</sub>H<sub>22</sub>F<sub>3</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup> 395.1689, found 395.1682. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.53 (d, <i>J</i> = 13.6 Hz, 1H), 6.57 (s, 1H), 4.38 (s, 2H), 4.00 (d, <i>J</i> = 9.6 Hz, 1H), 3.88–3.80 (m, 2H), 3.73 (d, <i>J</i> = 10.1 Hz, 1H), 3.47 (s, 1H), 2.03 (d, <i>J</i> = 4.2 Hz, 1H), 1.35–1.27 (m, 2H), 1.23–1.18 (m, 2H), 0.57 (d, <i>J</i> = 2.9 Hz, 2H).</div></div><div id="sec4_1_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i132" class="anchor-spacer"></div><h3 class="article-section__title" id="_i132"> Preparation of 7-(1-Amino-3-azabicyclo[3.1.0]hexan-3-yl)-4-(aminomethyl)-1-cyclopropyl-6-fluoro-3,8-dimethylquinolin-2(1<i>H</i>)-one Trifluoroacetic Acid (<b>31</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0117.gif" alt="" id="gr115" /></img></div><div id="sec4_1_13_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i133" class="anchor-spacer"></div><h3 class="article-section__title" id="_i133"> <i>tert</i>-Butyl ((3-Bromo-7-(1-((<i>tert</i>-butoxycarbonyl)amino)-3-azabicyclo[3.1.0]hexan-3-yl)-1-cyclopropyl-6-fluoro-8-methyl-2-oxo-1,2-dihydroquinolin-4-yl)methyl)carbamate (<b>70</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0118.gif" alt="" id="gr116" /></img><div class="NLM_p last">A mixture of <i>tert</i>-butyl ((7-(1-((<i>tert</i>-butoxycarbonyl)amino)-3-azabicyclo[3.1.0]hexan-3-yl)-1-cyclopropyl-6-fluoro-8-methyl-2-oxo-1,2-dihydroquinolin-4-yl)methyl)carbamate (100 mg, 0.18 mmol) in MeCN (1 mL) was treated with <i>N</i>-bromosuccinimide (49.0 mg, 0.24 mmol). After stirring for 30 min at rt, the reaction was concentrated and the crude material was purified by silica gel flash chromatography (0–100% EtOAc/heptane) to provide the desired product (27.0 mg, 24% yield) as a yellow oil. LCMS (<i>m</i>/<i>z</i>): 623.4 [M + 2]<sup>+</sup>.</div></div><div id="sec4_1_13_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i134" class="anchor-spacer"></div><h3 class="article-section__title" id="_i134"> 7-(1-Amino-3-azabicyclo[3.1.0]hexan-3-yl)-4-(aminomethyl)-1-cyclopropyl-6-fluoro-3,8-dimethylquinolin-2(1<i>H</i>)-one Trifluoroacetic Acid (<b>31</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0119.gif" alt="" id="gr117" /></img><div class="NLM_p last">A solution of <i>tert</i>-butyl ((3-bromo-7-(1-((<i>tert</i>-butoxycarbonyl)amino)-3-azabicyclo[3.1.0]hexan-3-yl)-1-cyclopropyl-6-fluoro-8-methyl-2-oxo-1,2-dihydroquinolin-4-yl)methyl)carbamate (27.0 mg, 0.04 mmol), methylboronic acid (13.0 mg, 0.22 mmol), PdCl<sub>2</sub>(dppf)–CH<sub>2</sub>Cl<sub>2</sub> adduct (7.10 mg, 8.69 μmol), and K<sub>3</sub>PO<sub>4</sub> (18.4 mg, 0.09 mmol) in dioxane (0.9 mL) was stirred at 90 °C for 18 h. Upon cooling to rt, the mixture was diluted with water and extracted with EtOAc. The combined organic extracts were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to give a dark brown oil. To a mixture of the protected bis-amine in DCM (0.5 mL) was added TFA (0.5 mL), followed by stirring at rt for 1 h. The solution was concentrated, and the crude material was purified by prep HPLC, affording the desired product (9.3 mg, 36% yield, 2 steps) as an off-white powder. LCMS (<i>m</i>/<i>z</i>): 357.4 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.47 (d, <i>J</i> = 13.6 Hz, 1H), 4.38 (s, 2H), 3.83 (d, <i>J</i> = 8.8 Hz, 1H), 3.77 (dd, <i>J</i> = 9.4, 2.8 Hz, 1H), 3.66 (d, <i>J</i> = 8.9 Hz, 1H), 3.62–3.53 (m, 1H), 3.37 (d, <i>J</i> = 9.5 Hz, 1H), 2.56 (s, 3H), 2.30 (s, 3H), 2.03–1.96 (m, 1H), 1.38–1.33 (m, 1H), 1.32–1.25 (m, 1H), 1.25–1.18 (m, 2H), 0.45–0.38 (m, 2H).</div></div><div id="sec4_1_14_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i135" class="anchor-spacer"></div><h3 class="article-section__title" id="_i135"> Preparation of 7-(1-Amino-3-azabicyclo[3.1.0]hexan-3-yl)-4-(aminomethyl)-1-cyclopropyl-6-fluoro-3-hydroxy-8-methylquinolin-2(1<i>H</i>)-one Trifluoroacetic Acid (<b>32</b>). Methyl 2-(2-(Benzyloxy)-<i>N</i>-cyclopropylacetamido)-4-bromo-5-fluoro-3-methylbenzoate (<b>71</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0120.gif" alt="" id="gr118" /></img><div class="NLM_p last">Benzyloxyacetyl chloride (0.39 mL, 2.48 mmol) was added dropwise to a mixture of methyl 2-(<i>N</i>-cyclopropylacetamido)-4-bromo-5-fluoro-3-methylbenzoate (150 mg, 0.50 mmol) and pyridine (0.20 mL, 2.48 mmol) in DCM (3 mL) at 0 °C. The solution was stirred at rt for 3 h. The mixture was diluted with DCM and washed with saturated aqueous NH<sub>4</sub>Cl, saturated NaHCO<sub>3</sub>, and brine, then dried over MgSO<sub>4</sub> and concentrated under reduced pressure. Purification by silica gel column chromatography (0–60% EtOAc/heptane) provided the desired product as a yellow oil (209 mg, 93% yield). LCMS (<i>m</i>/<i>z</i>): 452.2 [M + 2]<sup>+</sup>.</div></div><div id="sec4_1_14_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i136" class="anchor-spacer"></div><h3 class="article-section__title" id="_i136"> 3-(Benzyloxy)-7-bromo-1-cyclopropyl-6-fluoro-8-methyl-2-oxo-1,2-dihydroquinolin-4-yl Trifluoromethanesulfonate (<b>72</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0121.gif" alt="" id="gr119" /></img><div class="NLM_p last">Methyl 2-(2-(benzyloxy)-<i>N</i>-cyclopropylacetamido)-4-bromo-5-fluoro-3-methylbenzoate (113 mg, 0.25 mmol) was dissolved in THF (2.5 mL) and cooled to −78 °C. NaHMDS (1 M in THF, 0.75 mL, 0.75 mmol) was added dropwise, and the reaction mixture was stirred at −78 °C for 30 min. The reaction mixture was quenched with ice–water, acidified to pH 2 by the addition of 1 N HCl, and extracted with EtOAc. The organic layer was washed with brine, dried over sodium sulfate, and concentrated to afford the desired heterocycle. The crude material was dissolved in DMF (1.25 mL) and cooled to 0 °C. Et<sub>3</sub>N (76.0 mg, 0.75 mmol) and PhNTf<sub>2</sub>(107 mg, 0.30 mmol) were added, and the reaction mixture was stirred at room temperature for 2 h. The reaction mixture was quenched with cold water and extracted with EtOAc. The organic layer was washed with cold water, brine, dried over sodium sulfate, and concentrated to afford a crude residue, which was purified by silica gel column chromatography (0–40% EtOAc/hexanes), providing the desired product (0.071 g, 52% yield). LCMS (<i>m</i>/<i>z</i>): 551.9 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.50 (dd, <i>J</i> = 9.1, 7.3 Hz, 2H), 7.41–7.32 (m, 3H), 7.19 (d, <i>J</i> = 8.1 Hz, 1H), 5.54 (s, 2H), 3.55 (tt, <i>J</i> = 7.0, 4.0 Hz, 1H), 2.79 (s, 3H), 1.26 (q, <i>J</i> = 6.9 Hz, 2H), 0.62–0.48 (m, 2H).</div></div><div id="sec4_1_14_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i137" class="anchor-spacer"></div><h3 class="article-section__title" id="_i137"> <i>tert</i>-Butyl ((3-(Benzyloxy)-7-bromo-1-cyclopropyl-6-fluoro-8-methyl-2-oxo-1,2-dihydroquinolin-4-yl)methyl)carbamate (<b>73</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0122.gif" alt="" id="gr120" /></img><div class="NLM_p last">A suspension of 3-(benzyloxy)-7-bromo-1-cyclopropyl-6-fluoro-8-methyl-2-oxo-1,2-dihydroquinolin-4-yl trifluoromethanesulfonate (0.50 g, 0.90 mmol), K<sub>3</sub>PO<sub>4</sub> (0.58 g, 2.70 mmol), potassium (((<i>tert</i>-butoxycarbonyl)amino)methyl)trifluoroborate (0.43 g, 1.81 mmol) in THF (5 mL) and water (0.05 mL) was degassed with argon for 30 min. PdCl<sub>2</sub>(dppf)·DCM adduct (22.0 mg, 0.03 mmol) was added, and the reaction mixture was stirred at 90 °C for 7 h. The reaction mixture was quenched with cold water and extracted with EtOAc. The combined organic layers were washed with brine, dried over sodium sulfate, and concentrated to afford a crude residue, which was purified by silica gel column chromatography (0–25% EtOAc/hexanes), providing the desired product (0.14 g, 15% yield). LCMS (<i>m</i>/<i>z</i>): 431.4 [M – Boc + H]. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.50–7.30 (m, 6H), 5.35 (s, 2H), 4.30 (d, <i>J</i> = 6.0 Hz, 2H), 3.81–3.79 (m, 1H), 3.61–3.59 (m, 1H), 2.80 (s, 3H), 1.45 (s, 9H), 0.90–0.88 (m, 2H), 0.57–0.55 (m, 2H).</div></div><div id="sec4_1_14_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i138" class="anchor-spacer"></div><h3 class="article-section__title" id="_i138"> <i>tert</i>-Butyl (3-(3-(Benzyloxy)-4-(((<i>tert</i>-butoxycarbonyl)amino)methyl)-1-cyclopropyl-6-fluoro-8-methyl-2-oxo-1,2-dihydroquinolin-7-yl)-3-azabicyclo[3.1.0]hexan-1-yl)carbamate (<b>74</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0123.gif" alt="" id="gr121" /></img><div class="NLM_p last">A suspension of <i>tert</i>-butyl ((3-(benzyloxy)-7-bromo-1-cyclopropyl-6-fluoro-8-methyl-2-oxo-1,2-dihydroquinolin-4-yl)methyl)carbamate (130 mg, 0.24 mmol), Cs<sub>2</sub>CO<sub>3</sub>(240 mg, 0.73 mmol), <i>tert</i>-butyl (azabicyclo[3.1.0]hexan-1-yl)carbamate (73.0 mg, 0.37 mmol) in toluene (5 mL) was degassed for 5 min. Pd<sub>2</sub>(dba)<sub>3</sub> (11.0 mg, 0.01 mmol) and BINAP (15.0 mg, 0.02 mmol) were added, and the reaction mixture was stirred at 100 °C for 15 h. The reaction mixture was quenched with cold water and extracted with EtOAc. The organic layer was washed with brine, dried over sodium sulfate, and concentrated to afford a crude residue, which was purified by silica gel column chromatography (50% EtOAc/hexanes), providing the desired product (55.0 mg, 35% yield). LCMS (<i>m</i>/<i>z</i>): 649.5 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.43–7.28 (m, 6H), 5.32 (s, 2H), 4.28 (d, <i>J</i> = 5.6 Hz, 2H), 3.93–3.91 (m, 1H), 3.81–3.79 (m, 1H), 3.68–3.66 (m, 1H), 3.57–3.55 (m, 1H), 3.26–3.23 (m 1H), 2.47 (s, 3H), 1.71–1.68 (m, 1H), 1.57 (s, 9H), 1.49 (s, 9H), 1.30–1.20 (m, 2H), 0.91–0.88 (m, 2H), 0.59–0.56 (m, 2H).</div></div><div id="sec4_1_14_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i139" class="anchor-spacer"></div><h3 class="article-section__title" id="_i139"> 7-(1-Amino-3-azabicyclo[3.1.0]hexan-3-yl)-4-(aminomethyl)-1-cyclopropyl-6-fluoro-3-hydroxy-8-methylquinolin-2(1<i>H</i>)-one Trifluoroacetic Acid (<b>32</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0124.gif" alt="" id="gr122" /></img><div class="NLM_p last"><i>tert</i>-Butyl (3-(3-(benzyloxy)-4-(((<i>tert</i>-butoxycarbonyl)amino)methyl)-1-cyclopropyl-6-fluoro-8-methyl-2-oxo-1,2-dihydroquinolin-7-yl)-3-azabicyclo[3.1.0]hexan-1-yl)carbamate (55.0 mg, 0.08 mmol) was dissolved in MeOH (0.5 mL). Pd/C (10%, 50% in water, 6.00 mg) was added, and the reaction mixture was stirred at room temperature for 2 h under a hydrogen atmosphere. The reaction mixture was filtered through Celite and the filtrate was concentrated to afford the deprotected hydroxyl. The protected bis-amine was dissolved in DCM (0.5 mL) and cooled to 0 °C. HCl (4.0 M in dioxane, 0.3 mL) was added, and the reaction mixture was stirred at room temperature for 2 h. The reaction mixture was concentrated to afford a crude residue, which was purified by prep HPLC providing the desired product (3.50 mg, 15% yield, purity = 91%). LCMS (<i>m</i>/<i>z</i>): 359.4 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.38 (d, <i>J</i> = 13.2 Hz, 1H), 4.32 (s, 2H), 3.82–3.57 (m 4H), 3.37 (s, 2H), 2.54 (s, 3H), 2.01–1.99 (m, 1H), 1.40–1.20 (m 4H), 0.57–0.54 (m, 2H).</div></div><div id="sec4_1_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i140" class="anchor-spacer"></div><h3 class="article-section__title" id="_i140"> Preparation of 7-(1-Amino-3-azabicyclo[3.1.0]hexan-3-yl)-4-(aminomethyl)-3-chloro-1-cyclopropyl-6-fluoro-8-methylquinolin-2(1<i>H</i>)-one Trifluoroacetic Acid (<b>33</b>)</h3><div class="NLM_p">The overall synthesis is shown in <a class="ref internalNav" href="#cht12" aria-label="Chart 12">Chart 12</a>.</div><figure id="cht12" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Chart 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0125.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0125.jpeg" id="gr123" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0125.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00347&amp;id=cht12"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_1_15_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i141" class="anchor-spacer"></div><h3 class="article-section__title" id="_i141"> <i>tert</i>-Butyl (3-(4-Cyano-1-cyclopropyl-6-fluoro-8-methyl-2-oxo-1,2-dihydroquinolin-7-yl)-3-azabicyclo[3.1.0]hexan-1-yl)carbamate (<b>68</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0126.gif" alt="" id="gr124" /></img><div class="NLM_p last">A suspension of 7-bromo-1-cyclopropyl-6-fluoro-8-methyl-2-oxo-1,2-dihydroquinoline-4-carbonitrile (250 mg, 0.78 mmol), <i>tert</i>-butyl 3-azabicyclo[3.1.0]hexan-1-ylcarbamate (309 mg, 1.56 mmol), BINAP (194 mg, 0.31 mmol), Pd<sub>2</sub> dba<sub>3</sub> (143 mg, 0.16 mmol), and cesium carbonate (761 mg, 2.34 mmol) in toluene (7.8 mL) was heated to 100 °C for 5.5 h. Upon cooling to room temperature, the mixture was filtered and concentrated. The crude material was purified by silica gel column chromatography (0–100% EtOAc/heptane) to give the product (650 mg, 85% yield). LCMS (<i>m</i>/<i>z</i>): 439.4 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.32 (d, <i>J</i> = 12.1 Hz, 1H), 6.87 (s, 1H), 3.94–3.82 (m, 1H), 3.75–3.67 (m, 1H), 3.59–3.52 (m, 1H), 3.52–3.44 (m, 1H), 3.40–3.30 (m, 1H), 2.45 (s, 3H), 1.73 (s, 1H), 1.54 (s, 9H), 1.27–1.20 (m, 2H), 1.17–1.10 (m, 1H), 1.06–0.97 (m, 1H), 0.60–0.47 (m, 2H).</div></div><div id="sec4_1_15_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i142" class="anchor-spacer"></div><h3 class="article-section__title" id="_i142"> <i>tert</i>-Butyl (3-(4-(((<i>tert</i>-Butoxycarbonyl)amino)methyl)-1-cyclopropyl-6-fluoro-8-methyl-2-oxo-1,2-dihydroquinolin-7-yl)-3-azabicyclo[3.1.0]hexan-1-yl)carbamate (<b>69</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0127.gif" alt="" id="gr125" /></img><div class="NLM_p last">A mixture of <i>tert</i>-butyl (3-(4-cyano-1-cyclopropyl-6-fluoro-8-methyl-2-oxo-1,2-dihydroquinolin-7-yl)-3-azabicyclo[3.1.0]hexan-1-yl)carbamate (650 mg, 1.48 mmol) in 2 M NH<sub>3</sub> in MeOH (60 mL) was treated with Pd/C (10%, 50% water, 947 mg, 0.45 mmol). The flask was partially evacuated and backfilled with H<sub>2</sub> 5 times, then stirred under a balloon of H<sub>2</sub> for 1 h. The reaction mixture was filtered through a plug of Celite and concentrated under reduced pressure to give the desired primary amine as a yellow-brown oil. The amine was dissolved in THF (7.4 mL) and was treated with DIPEA (0.8 mL, 4.45 mmol) and Boc anhydride (0.45 mL, 1.93 mmol) followed by stirring at room temperature for 1 h. The mixture was diluted with saturated aqueous NH<sub>4</sub>Cl and extracted with EtOAc. The combined organic extracts were washed with saturated brine, dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure. Silica gel column chromatography (0–100% EtOAc/heptane) provided the title compound (448 mg, 50% yield, 2 steps) as a yellow foam. LCMS (<i>m</i>/<i>z</i>): 543.4 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.10 (d, <i>J</i> = 13.2 Hz, 1H), 6.47 (s, 1H), 5.04 (s, 1H), 4.86–4.74 (m, 1H), 4.44–4.31 (m, 2H), 3.88–3.75 (m, 1H), 3.67 (d, <i>J</i> = 8.6 Hz, 1H), 3.56–3.39 (m, 2H), 3.28 (d, <i>J</i> = 9.3 Hz, 1H), 2.45 (s, 3H), 1.69 (s, 1H), 1.47 (s, 18H), 1.21–1.12 (m, 3H), 1.03–0.96 (m, 1H), 0.54–0.47 (m, 2H).</div></div><div id="sec4_1_15_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i143" class="anchor-spacer"></div><h3 class="article-section__title" id="_i143"> <i>tert</i>-Butyl (3-(4-(((<i>tert</i>-Butoxycarbonyl)amino)methyl)-3-chloro-1-cyclopropyl-6-fluoro-8-methyl-2-oxo-1,2-dihydroquinolin-7-yl)-3-azabicyclo[3.1.0]hexan-1-yl)carbamate (<b>S43</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0128.gif" alt="" id="gr126" /></img><div class="NLM_p last">A mixture of <i>tert</i>-butyl (3-(4-(((<i>tert</i>-butoxycarbonyl)amino)methyl)-1-cyclopropyl-6-fluoro-8-methyl-2-oxo-1,2-dihydroquinolin-7-yl)-3-azabicyclo[3.1.0]hexan-1-yl)carbamate (176 mg, 0.32 mmol) in MeCN (1.6 mL) was treated with <i>N</i>-chlorosuccinimide (130 mg, 0.97 mmol) followed by stirring for 4 h at room temperature. Volatiles were evaporated under reduced pressure. The residue was dissolved in EtOAc and washed with 10% aqueous citric acid, saturated aqueous NaHCO<sub>3</sub>, and brine, then dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. Silica gel column chromatography (0–100% EtOAc/heptane) provided the title compound (127 mg, 61% yield) as a pale yellow foam. LCMS (<i>m</i>/<i>z</i>): 577.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.55–7.44 (m, 1H), 5.04 (br s, 1H), 4.83 (br s, 1H), 4.62 (d, <i>J</i> = 5.7 Hz, 2H), 3.83 (br s, 1H), 3.68 (d, <i>J</i> = 8.7 Hz, 1H), 3.61–3.45 (m, 2H), 3.31 (d, <i>J</i> = 9.3 Hz, 1H), 2.44 (s, 3H), 1.70 (br s, 1H), 1.55–1.38 (m, 18H), 1.22–1.14 (m, 3H), 1.04–0.96 (m, 1H), 0.56–0.48 (m, 2H).</div></div><div id="sec4_1_15_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i144" class="anchor-spacer"></div><h3 class="article-section__title" id="_i144"> 7-(1-Amino-3-azabicyclo[3.1.0]hexan-3-yl)-4-(aminomethyl)-3-chloro-1-cyclopropyl-6-fluoro-8-methylquinolin-2(1<i>H</i>)-one Trifluoroacetic Acid (<b>33</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0129.gif" alt="" id="gr127" /></img><div class="NLM_p last">A mixture of <i>tert</i>-butyl (3-(4-(((<i>tert</i>-butoxycarbonyl)amino)methyl)-3-chloro-1-cyclopropyl-6-fluoro-8-methyl-2-oxo-1,2-dihydroquinolin-7-yl)-3-azabicyclo[3.1.0]hexan-1-yl)carbamate (67 mg, 0.12 mmol) in DCM (0.6 mL) and TFA (0.6 mL) was stirred for 20 min at room temperature. Volatiles were evaporated under reduced pressure, and the oily residue was concentrated twice from MeOH–toluene and then subjected to preparative HPLC to give the product (22.8 mg, 32% yield). LCMS (<i>m</i>/<i>z</i>): 377.2 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 7.55 (d, <i>J</i> = 13.5 Hz, 1H), 4.52 (s, 2H), 3.87–3.82 (m, 1H), 3.82–3.76 (m, 1H), 3.74–3.69 (m, 1H), 3.69–3.63 (m, 1H), 3.44–3.40 (m, 1H), 2.56 (s, 3H), 2.03–1.97 (m, 1H), 1.36–1.22 (m, 4H), 0.52–0.42 (m, 2H).</div></div><div id="sec4_1_16_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i145" class="anchor-spacer"></div><h3 class="article-section__title" id="_i145"> Preparation of 7-(1-Amino-3-azabicyclo[3.1.0]hexan-3-yl)-4-(aminomethyl)-1-cyclopropyl-3,6-difluoro-8-methylquinolin-2(1<i>H</i>)-one Hydrochloride (<b>34</b>). Methyl 4-Bromo-2-(<i>N</i>-cyclopropyl-2-fluoroacetamido)-5-fluoro-3-methylbenzoate (<b>75</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0130.gif" alt="" id="gr128" /></img><div class="NLM_p last">Methyl 4-bromo-2-(cyclopropylamino)-5-fluoro-3-methylbenzoate (3.50 g, 11.6 mmol) was dissolved in toluene (15 mL) at 0 °C. 2-Fluoroacetyl chloride (1.11 g, 11.6 mmol) was added, and the reaction mixture was stirred at 85 °C for 4 h. The reaction mixture was quenched with water and extracted with EtOAc. The organic layer was washed with saturated NaHCO<sub>3</sub> solution and brine, then dried over sodium sulfate, and concentrated. The crude residue was purified by silica gel column chromatography (25–30% EtOAc/hexanes) to afford the desired product (3.00 g, 62% yield). LCMS (<i>m</i>/<i>z</i>): 364.4 [M + 2]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.71–7.55 (m, 1H), 5.40 (ddd, <i>J</i> = 47.0, 37.4, 14.2 Hz, 1H), 4.53 (ddd, <i>J</i> = 76.7, 47.1, 13.5 Hz, 1H), 3.97–3.84 (m, 3H), 3.19–3.03 (m, 1H), 2.48–2.22 (m, 3H), 0.97–0.38 (m, 4H).</div></div><div id="sec4_1_16_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i146" class="anchor-spacer"></div><h3 class="article-section__title" id="_i146"> 7-Bromo-1-cyclopropyl-3,6-difluoro-4-hydroxy-8-methylquinolin-2(1<i>H</i>)-one (<b>76</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0131.gif" alt="" id="gr129" /></img><div class="NLM_p last">Methyl 4-bromo-2-(<i>N</i>-cyclopropyl-2-fluoroacetamido)-5-fluoro-3-methylbenzoate (3.00 g, 8.20 mmol) was dissolved in THF (20 mL) and cooled to −78 °C. NaHMDS (1 M in THF, 24.9 mL, 24.9 mmol) was added dropwise, and the reaction mixture was stirred at −78 °C for 30 min. The reaction mixture was then stirred at room temperature for 1 h. The reaction mixture was quenched with ice–water and washed with EtOAc. The aqueous layer was acidified with 1 N HCl and extracted with EtOAc. The organic layer was washed with brine, dried over sodium sulfate, and concentrated to afford a crude residue, which was purified by trituration with pentane, providing the desired product (2.50 g, 91% yield). LCMS (<i>m</i>/<i>z</i>): 332.3 [M + 2]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.03 (s, 1H), 7.59 (d, <i>J</i> = 8.7 Hz, 1H), 3.50 (s, 1H), 2.73 (s, 3H), 1.12 (d, <i>J</i> = 6.2 Hz, 2H), 0.43 (s, 2H).</div></div><div id="sec4_1_16_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i147" class="anchor-spacer"></div><h3 class="article-section__title" id="_i147"> 7-Bromo-1-cyclopropyl-3,6-difluoro-8-methyl-2-oxo-1,2-dihydroquinolin-4-yl Trifluoromethanesulfonate (<b>77</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0132.gif" alt="" id="gr130" /></img><div class="NLM_p last">7-Bromo-1-cyclopropyl-3,6-difluoro-4-hydroxy-8-methylquinolin-2(1<i>H</i>)-one (2.50 g, 7.50 mmol) was dissolved in DMF (14 mL) at 0 °C. Triethylamine (2.29 g, 22.7 mmol) and PhNTf<sub>2</sub> (4.00 g, 11.4 mmol) in DMF (14 mL) were added at 0 °C, and the reaction mixture was stirred at room temperature for 4 h. The reaction mixture was quenched with ice–water and extracted with EtOAc. The organic layer was washed with cold water and brine, then dried over sodium sulfate, and concentrated to afford a crude residue, which was purified by silica gel column chromatography (0–5% EtOAc/hexanes), providing the desired product (3.00 g, 85% yield). LCMS (<i>m</i>/<i>z</i>): 464.4 [M + 2]<sup>+</sup>.</div></div><div id="sec4_1_16_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i148" class="anchor-spacer"></div><h3 class="article-section__title" id="_i148"> <i>tert</i>-Butyl ((7-Bromo-1-cyclopropyl-3,6-difluoro-8-methyl-2-oxo-1,2-dihydroquinolin-4-yl)methyl)carbamate (<b>78</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0133.gif" alt="" id="gr131" /></img><div class="NLM_p last">A solution of 7-bromo-1-cyclopropyl-3,6-difluoro-8-methyl-2-oxo-1,2-dihydroquinolin-4-yl trifluoromethanesulfonate (1.50 g, 3.20 mmol), potassium (((<i>tert</i>-butoxycarbonyl)amino)methyl)trifluoroborate (1.53 g, 6.40 mmol), and Na<sub>2</sub>CO<sub>3</sub> (0.86 g, 8.10 mmol) in toluene (45 mL) and water (0.15 mL) was degassed with nitrogen for 5 min. PdCl<sub>2</sub>(dppf) (0.12 g, 0.16 mmol) was added, and the reaction mixture was stirred at 85 °C for 5 h. The reaction mixture was diluted with water and extracted with EtOAc. The organic layer was washed with brine, dried over sodium sulfate, and concentrated. The crude residue was purified by silica gel column chromatography (0–50% EtOAc/hexanes) to afford the desired product (0.50 g, 17% yield). LCMS (<i>m</i>/<i>z</i>): 445.5 [M + 2]<sup>+</sup>.</div></div><div id="sec4_1_16_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i149" class="anchor-spacer"></div><h3 class="article-section__title" id="_i149"> <i>tert</i>-Butyl ((7-(1-((<i>tert</i>-Butoxycarbonyl)amino)-3-azabicyclo[3.1.0]hexan-3-yl)-1-cyclopropyl-3,6-difluoro-8-methyl-2-oxo-1,2-dihydroquinolin-4-yl)methyl)carbamate (<b>79</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0134.gif" alt="" id="gr132" /></img><div class="NLM_p last">A suspension of <i>tert</i>-butyl ((7-bromo-1-cyclopropyl-3,6-difluoro-8-methyl-2-oxo-1,2-dihydroquinolin-4-yl)methyl)carbamate (0.22 g, 0.50 mmol), <i>tert</i>-butyl (3-azabicyclo[3.1.0]hexan-1-yl)carbamate (0.20 g, 0.99 mmol), cesium carbonate (0.49 g, 1.49 mmol), Pd<sub>2</sub>dba<sub>3</sub> (0.09 g, 0.10 mmol), and BINAP (0.12 g, 0.20 mmol) in dioxane (3.6 mL) was stirred at 100 °C for 6 h. The reaction mixture was quenched with water and extracted with EtOAc. The organic layer was washed with brine, dried over sodium sulfate, and concentrated. The crude residue was purified by prep HPLC purification to afford the desired product (0.08 g, 40% yield). LCMS (<i>m</i>/<i>z</i>): 561.8 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, MeOD) δ 7.47 (d, <i>J</i> = 13.2 Hz, 1H), 4.46 (s, 2H), 3.84 (s, 1H), 3.61 (d, <i>J</i> = 20.3 Hz, 3H), 3.35 (s, 1H), 2.54 (s, 3H), 1.67 (s, 1H), 1.46 (s, 18H), 1.21 (d, <i>J</i> = 19.9 Hz, 3H), 0.98 (s, 1H), 0.53 (s, 2H).</div></div><div id="sec4_1_16_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i150" class="anchor-spacer"></div><h3 class="article-section__title" id="_i150"> 7-(1-Amino-3-azabicyclo[3.1.0]hexan-3-yl)-4-(aminomethyl)-1-cyclopropyl-3,6-difluoro-8-methylquinolin-2(1<i>H</i>)-one Hydrochloride (<b>34</b>)</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0135.gif" alt="" id="GRAPHIC-d7e8998-autogenerated" /></img><div class="NLM_p last"><i>tert</i>-Butyl ((7-(1-((<i>tert</i>-butoxycarbonyl)amino)-3-azabicyclo[3.1.0]hexan-3-yl)-1-cyclopropyl-3,6-difluoro-8-methyl-2-oxo-1,2-dihydroquinolin-4-yl)methyl)carbamate (50.0 mg, 0.01 mmol) was dissolved in dioxane (3 mL) at 0 °C. HCl (4 M in dioxane, 3.0 mL) was added, and the reaction mixture was stirred at room temperature for 2 h. The reaction mixture was concentrated and the crude residue was triturated with diethyl ether to afford the desired product (35.0 mg, 90% yield). HRMS (ESI) calcd for C<sub>19</sub>H<sub>23</sub>F<sub>2</sub>N<sub>4</sub>O [M + H]<sup>+</sup> 361.1834, found 361.1832. <sup>1</sup>H NMR (400 MHz, MeOD) δ 7.54 (d, <i>J</i> = 13.2 Hz, 1H), 4.41 (s, 2H), 3.86 (d, <i>J</i> = 8.9 Hz, 1H), 3.80 (d, <i>J</i> = 9.9 Hz, 1H), 3.66 (s, 1H), 3.43–3.36 (m, 2H), 2.60 (s, 3H), 2.03 (s, 1H), 1.38–1.26 (m, 4H), 0.54 (s, 2H).</div></div><div id="sec4_2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i151" class="anchor-spacer"></div><h3 class="article-section__title" id="_i151"> <i>In Vitro</i> and <i>in Vivo</i> Biology. General</h3><div class="NLM_p last">IC<sub>50</sub> values obtained from the GyrA/B and ParC/E biochemical assays are reported as the geometric mean of 2 or more replicates, with the exception of compound <b>34</b> against <i>E. coli</i> GyrA/B (single replicate). For MIC data, the most frequently occurring value from three or more replicates is reported. In cases where only two replicates were available or where two values occurred with identical frequency, the higher of the two values is reported. MIC data are based on two or more separate experiments with the exception of compounds <b>6</b>–<b>8</b>, <b>11</b>–<b>14</b>, and <b>18</b>.</div></div><div id="sec4_3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i152" class="anchor-spacer"></div><h3 class="article-section__title" id="_i152"> Biochemical Assay. Purification of <i>E. coli</i> GyrA, GyrB, ParC, and ParE</h3><div class="NLM_p">Large scale expression cultures of <i>E. coli</i> cells carrying expression plasmid of recombinant full-length GyrA, GyrB, ParC, and ParE (T7 promoter C-terminal 6xHis tag) were grown separately using standard procedures (1–6 L). When cultures reached late log-phase, incubation temperature was lowered to 18 °C and protein expression was induced by adding IPTG to 1 mM with growth continuing overnight. Cells were collected by centrifugation, resuspended in 5× volume of IMAC buffer A (50 mM Tris-HCl, pH 7.5; 300 mM NaCl; 2 mM MgCl<sub>2</sub>; 10% (v/v) glycerol; 1 mM TCEP) containing 15 mM imidazole, Benzonase endonuclease (EMD Millipore), and protease inhibitors (Roche cOmplete, EDTA-free), and lysed by sonication. The total lysate was centrifuged to obtain the soluble lysate, which was applied to a column of Ni Sepharose FF (GE Healthcare Life Sciences) equilibrated with 6% (v/v) IMAC buffer B (50 mM Tris-HCl, pH 7.5; 300 mM NaCl; 2 mM MgCl; 10% (v/v) glycerol; 1 mM TCEP; 250 mM imidazole). The column was washed with the same buffer and developed with a linear gradient to 100% (v/v) IMAC buffer B over 20 column volumes.</div><div class="NLM_p last">Fractions were analyzed by SDS–PAGE and pooled accordingly, concentrated, and applied to a Superdex 200 (GE Healthcare Life Sciences) size-exclusion column equilibrated with 50 mM Tris-HCl, pH 7.5, 50 mM KCl, 2 mM MgCl<sub>2</sub>, 10% (v/v) glycerol; 1 mM TCEP. Fractions were pooled based on analysis by SDS–PAGE, made to 2 mM spermidine, quantified by Bradford assay, aliquoted, flash-frozen in liquid nitrogen, and stored at −80 °C for reconstitution prior to biochemical assays.</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i153" class="anchor-spacer"></div><h3 class="article-section__title" id="_i153"> <i>E. coli</i> Gyrase DNA Supercoiling Assay</h3><div class="NLM_p">Tetrameric <i>E. coli</i> GyrAB was prepared by incubation of 10 μM of each subunit in GyrAB assay buffer (50 mM Tris-HCl, pH 7.5, 10 mM MgCl<sub>2</sub>, 30 mM KCl, 10% glycerol, 0.005% BSA, 0.005% CHAP, 75 mM ammonium acetate, 0.5 mM EDTA, and 1 mM DTT) at room temperature for 60 min.</div><div class="NLM_p">10 nM tetramer of <i>E. coli</i> GyrAB was preincubated with compound for 30 min at room temperature before 40 μg/mL (final concentration) relaxed DNA (TopoGEN TG2035–3) and 1 mM (final concentration) ATP in GyrAB assay buffer were added for a reaction time of 2 h. The reaction was quenched with 0.1% (final) SDS.</div><div class="NLM_p">Supercoiled DNA generated by <i>E. coli</i> GyrAB was monitored by size exclusion chromatography. An Agilent 1100 HPLC containing a diode array detector was used to acquire data. The instrument was controlled using the Agilent Chemstation software. A 10 μL aliquot of each sample was injected onto a Waters Acquity BEH200 (1.7 μm particle, 4.6 mm × 300 mm) column. Separation occurred using an isocratic gradient with 100 mM sodium phosphate, pH 6.8, as mobile phase. Detection was by diode array at 260 nm. To increase assay throughput, the SEC analysis was multiplexed by staggering injections of samples to effectively analyze four samples in one run. Samples were injected every 4 min using separate 4 min long isocratic gradient, with the fourth sample injected being subjected to a full 40 min gradient to elute all peaks (see HPLC conditions in <a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">Table <a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">10</a></a>). Peak height was used to calculate percent inhibition.</div><div class="NLM_table-wrap" id="tbl10"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 10. Multiplexed HPLC Pump and Autosampler Conditions</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">time (min)</th><th class="colsep0 rowsep0" align="center">flow rate (mL/min)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="center">For Sample 1<i>n</i>–3<i>n</i> Pump Parameters</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="left">NOTE: injection overlap at 2.5 min</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="center">For Sample 4<i>n</i> Pump Parameters</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">20.1</td><td class="colsep0 rowsep0" align="left">0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">37</td><td class="colsep0 rowsep0" align="left">0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">37.1</td><td class="colsep0 rowsep0" align="left">0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">0.1</td></tr></tbody></table></div></div><div class="NLM_p last">To reduce column degradation and clogging, two 10 μL injections of Pierce universal nuclease (100 kU) were run through the column on a 120 min isocratic gradient at a flow rate of 10 μL/min, followed by 3 blank injections using the same gradient.</div></div><div id="sec4_3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i155" class="anchor-spacer"></div><h3 class="article-section__title" id="_i155"> <i>E. coli</i> Topoisomerase IV DNA Decatenation Assay</h3><div class="NLM_p"><i>E. coli</i> ParCE tetramer was prepared by incubation of 10 μM of each subunit in ParCE assay buffer (50 mM Tris-HCl, pH 7.5, 10 mM MgCl<sub>2</sub>, 50 mM KCl, 100 mM KGlu, 1 mM EDTA, 0.01% Tween 20, 4 mM DTT, 0.01% BSA) at room temperature for 60 min.</div><div class="NLM_p">1.25 nM <i>E. coli</i> ParCE tetramer was preincubated with compound for 30 min at room temperature before 10 μg/mL (final concentration) kinetoplast DNA (TopoGEN TG2013-3) and 1 mM (final concentration) ATP in ParCE assay buffer were added for a reaction time of 1 h. The reaction was quenched with 0.1% (final) SDS.</div><div class="NLM_p">Decatenated kinetoplast DNA generated by <i>E. coli</i> ParCE was monitored by size exclusion chromatography. An Agilent 1200 capillary HPLC containing a variable wavelength detector was used to acquire data. The instrument was controlled using the Agilent MassHunter Acquisition software. An 8 μL aliquot of each sample was injected onto a Sepax Zenix size exclusion chromatography guard column (3 μm particle, 4.6 mm × 50 mm). The separation of the decatenated DNA from the UV sensitive buffer components was achieved on a 7 min isocratic gradient at 600 μL per minute. 100 mM sodium phosphate, pH 6.8, was used as the mobile phase. Diode array detector (DAD) detection was performed at 260 nm.</div><div class="NLM_p last">Data were analyzed and LC peaks integrated using Agilent ChemStation software (revision B.0.03.02-SR2). Manual integration was used to adjust integration in the event of additional peak integration. Area under the curve of decatenated kDNA was used to calculate percent inhibition.</div></div><div id="sec4_4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i156" class="anchor-spacer"></div><h3 class="article-section__title" id="_i156"> Antibacterial Susceptibility Testing</h3><div class="NLM_p last">Antibacterial activity was assessed using a broth microdilution assay following the recommended methodology of the Clinical and Laboratories Institute (CLSI M07).<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> Performance of the assay was monitored by testing ciprofloxacin against laboratory quality control strains in accordance with guidelines of the CLSI (CLSI M100).<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a></div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i157" class="anchor-spacer"></div><h3 class="article-section__title" id="_i157"> Selection of Single Step Spontaneous Mutants</h3><div class="NLM_p last"><i>E. coli</i> ATCC 25922 was used for selection experiments. Single-step selection was performed on cation-adjusted Mueller–Hinton agar plates containing test compounds at 2×, 4×, and 8× multiples of the MIC. Dilutions of cell suspension were also plated on drug-free medium to enumerate CFU/mL. Plates were incubated at 37 °C for up to 72 h, and CFUs were counted. Mutant frequencies were calculated by dividing the number of colonies on drug containing plates by the number of CFU plated.</div></div><div id="sec4_4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i158" class="anchor-spacer"></div><h3 class="article-section__title" id="_i158"> Bacterial Strains</h3><div class="NLM_p">Wild type and laboratory engineered mutant strains are described in <a class="ref showTableEvent internalNav" data-ID="tbl11" href="#tbl11">Table <a class="ref showTableEvent internalNav" data-ID="tbl11" href="#tbl11">11</a></a>. In <i>P. aeruginosa</i>, a C248T mutation in <i>gyrA</i> (encoding T83I) together with a C260G mutation in <i>parC</i> (encoding S87L) imparts a 256-fold decrease in susceptibility to ciprofloxacin.<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> These mutations were introduced onto the genome of the efflux deficient <i>P. aeruginosa</i> strain NB52023 as follows: first, a 1 kb <i>gyrA</i> fragment encompassing the C248T mutation was amplified from a genome sequenced <i>P. aeruginosa</i> clinical isolate using primers SR73 (5′-ggccagtgccaagctattgaacgaggcgactgga-3′) and SR75 (5′-acgaattcgagctcgggcagctcggtgatgataa-3′). This was inserted into the gene replacement vector pEX18Ap,<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> that had been digested with HindIII/KpnI, using the In-Fusion HD cloning kit (Takara) according to the supplied instructions. The resulting vector was mobilized into strain NB52023 as described previously,<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> and merodiploids were selected on L-agar containing irgasan and carbenicillin. Merodiploids were resolved on L-agar containing sucrose and 0.125 μg/mL ciprofloxacin, and the presence of the <i>gyrA</i> C248T mutation was confirmed by PCR and sequencing. Next, a 1 kb <i>parC</i> fragment encompassing C260G was amplified from a genome sequenced <i>P. aeruginosa</i> clinical isolate using primers SR80 (5′-ggccagtgccaagcttgaccttcctgctcgatacc-3′) and SR82 (5′-acgaattcgagctcgccggtctcgtagaccttctg-3′), which was inserted into pEXAp. The resulting suicide vector was used to introduce the mutation into NB52023 <i>gyrA</i> C248T as described above except that merodiploids were resolved on L-agar containing sucrose and 2 μg/mL ciprofloxacin. The presence of <i>parC</i> C260G was confirmed by PCR and sequencing. The resulting <i>gyrA parC</i> double mutant was designated NB52023-CDK0006.</div><div class="NLM_table-wrap" id="tbl11"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 11. Wild Type and Mutant Bacterial Strains Used in This Study</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Novartis strain code</th><th class="colsep0 rowsep0" align="center">referred to as</th><th class="colsep0 rowsep0" align="center">description</th><th class="colsep0 rowsep0" align="center">source or ref</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>E. coli</i></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NB27001</td><td class="colsep0 rowsep0" align="left"><i>E. coli</i> WT</td><td class="colsep0 rowsep0" align="left">ATCC 25922</td><td class="colsep0 rowsep0" align="left">ATCC</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NB27178</td><td class="colsep0 rowsep0" align="left"><i>E. coli</i> Δ<i>acrB</i></td><td class="colsep0 rowsep0" align="left">BW25113 Δ<i>acrB</i>, JW0451-2</td><td class="colsep0 rowsep0" align="left">ref <a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>K. pneumoniae</i></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NB29002</td><td class="colsep0 rowsep0" align="left"><i>K. pneumoniae</i> WT</td><td class="colsep0 rowsep0" align="left">ATCC 43816</td><td class="colsep0 rowsep0" align="left">ATCC</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>P. aeruginosa</i></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NB52019</td><td class="colsep0 rowsep0" align="left"><i>P. aeruginosa</i> WT</td><td class="colsep0 rowsep0" align="left">K767; PAO1, prototroph</td><td class="colsep0 rowsep0" align="left">ref <a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NB52023</td><td class="colsep0 rowsep0" align="left"><i>P. aeruginosa</i> Δ<i>mexB</i> Δ<i>mexXY</i></td><td class="colsep0 rowsep0" align="left">K1542; K767 Δ<i>mexB</i> Δ<i>mexXY</i></td><td class="colsep0 rowsep0" align="left">ref <a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NB52023-CDK0006</td><td class="colsep0 rowsep0" align="left"><i>P. aeruginosa</i> Δ<i>mexB</i> Δ<i>mexX</i> FQ-R</td><td class="colsep0 rowsep0" align="left">NB52023 <i>gyrA</i> T83I <i>parC</i> S87L</td><td class="colsep0 rowsep0" align="left">this study (also see ref <a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a>)</td></tr></tbody></table></div></div></div><div id="sec4_4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i160" class="anchor-spacer"></div><h3 class="article-section__title" id="_i160"> MIC<sub>50/90</sub> Panel</h3><div class="NLM_p last">A panel consisting of 126 Gram-negative clinical isolates, including 96 <i>Enterobacteriaceae</i> and 30 <i>P. aeruginosa</i>, was assembled from the Novartis collection. The isolates were acquired between 2000 and 2016 from various geographic regions and included the following Enterobacteriaceae species: <i>Citrobacter</i> spp., <i>Enterobacter</i> spp., <i>Escherichia coli</i>, <i>Klebsiella oxytoca</i>, <i>K. pneumoniae</i>, <i>Morganella morganii</i>, <i>Proteus mirabilis</i>, and <i>Serratia marcescens</i>.</div></div><div id="sec4_4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i161" class="anchor-spacer"></div><h3 class="article-section__title" id="_i161"> Animal Studies</h3><div class="NLM_p last">All studies were approved by the Institutional Animal Care and Use Committee of Novartis Institutes for BioMedical Research, Inc. (Emeryville, CA, USA). Female CD-1 mice (17–20 g; Envigo, Livermore, CA, USA) and male Wistar–Han rats (250–300 g, CRL, Raleigh, NC, USA) were kept under controlled conditions with food and water ad libitum. Pharmacokinetic studies were performed in mice and rat with drug concentrations determined by LC–MS/MS. All analyses were performed using Phoenix WinNonLin 6.4 to generate PK parameters. The AUC was obtained from the measured plasma concentrations versus time using the trapezoidal method.</div></div><div id="sec4_4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i162" class="anchor-spacer"></div><h3 class="article-section__title" id="_i162"> <i>In Vivo</i> PK Studies</h3><div class="NLM_p last">All animal studies were conducted under a Novartis-Emeryville IACUC approved protocol in compliance with Animal Welfare Act regulations and the Guide for the Care and Use of Laboratory Animals. Animals were fasted overnight and dosed iv and po at the targeted doses in a solution of 20% PEG300 and 5% Solutol in D5W or saline water. The whole blood was collected into vials containing EDTA at postdose 0.083, 0.25, 0.5, 1, 2, 4, 6, 8, and 24 h and immediately placed on dry ice until all samples were stored in −80 °C freezer. Prior to analysis, the samples were thawed on ice. An amount of 10 μL of each blood sample was added to 80 μL of acetonitrile containing internal standard (CHIRO73911) and centrifuged 3450<i>g</i> at 10 °C for 20 min. A 70 μL aliquot of the supernatant was transferred into a microtiter plate and dried down at 40 °C, and the residue was reconstituted with 100 μL of 0.1% FA in water. An aliquot of each sample was injected into the liquid chromatography/mass spectrometry/mass spectrometry (LC–MS/MS) system for analysis. Noncompartmental PK analysis was conducted using Phoenix WinNonLin 6.4 Professional  (6.4) (Certara, inc., Menlo Park, CA) to generate pharmacokinetic parameters.</div></div><div id="sec4_5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i163" class="anchor-spacer"></div><h3 class="article-section__title" id="_i163"> <i>In Vivo</i> Pharmacology Studies. Inoculum Preparation</h3><div class="NLM_p last">An overnight culture of <i>E. coli</i> ATCC 25922 was prepared by inoculating 25 mL of Mueller–Hinton broth with 20 μL of bacterial strain from frozen stock. The culture was allowed to grow for 16–18 h at 37 °C with agitation at 150 rpm (I2400 incubator shaker; New Brunswick Scientific). An aliquot was taken, centrifuged and the bacterial pellet resuspended in sterile saline (0.9% w/v). Using optical density and CFU correlations, the inoculum was prepared at 2 × 10<sup>7</sup>CFU/mL by diluting with sterile saline.</div></div><div id="sec4_5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i164" class="anchor-spacer"></div><h3 class="article-section__title" id="_i164"> Neutropenic Murine Thigh Infection</h3><div class="NLM_p last">Animals (4 mice/group) were rendered neutropenic by intraperitoneal injections of 150 and 100 mg/kg cyclophosphamide (Sigma-Aldrich, St. Louis, MO, USA), on days −4 and −1, respectively, prior to infection. Two hours prior to treatment (−2 h), 50 μL of bacterial inoculum was administered into the left gastrocnemius muscle via an intramuscular injection. At time 0 h, animals were treated via the subcutaneous (sc) route of administration with doses from 2.5 to 120 mg/kg. At 0 h a cohort of animals was sacrificed via CO<sub>2</sub> to determine the bacterial levels at the start of treatment. The remaining animals were euthanized 24 h after the start of therapy. The infected thighs were excised and homogenized in sterile saline (0.9% w/v) until the tissue was completely homogenized. The homogenates were serially diluted in sterile saline before dilutions were plated on TSA plates, incubated overnight at 37 °C and the colonies and CFU/thigh determined.</div></div><div id="sec4_5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i165" class="anchor-spacer"></div><h3 class="article-section__title" id="_i165"> Calculation of Static Dose</h3><div class="NLM_p last">The static dose (mg kg<sup>–1</sup> day<sup>–1</sup>) is that which is required to keep the bacterial load at the same level as when therapy was initiated. Dose/day was plotted against log<sub>10</sub> CFU and analyzed using a four parametric logistic curve (SigmaPlot 12.0; SyStat Software, San Jose, CA, USA). The static dose was calculated using the following equation: log<sub>10</sub> static dose = {log<sub>10</sub>[<i>E</i>/(<i>E</i><sub>max</sub> – <i>E</i>)]/<i>N</i>} + log<sub>10</sub> ED<sub>50</sub>, where <i>E</i> is the control growth (log<sub>10</sub> change in CFU per thigh in untreated controls after the 24 h period of study), <i>E</i><sub>max</sub> is the maximum effect, ED<sub>50</sub> is the dose required to achieve 50% of <i>E</i><sub>max</sub>, and <i>N</i> is the slope of the dose–effect curve.</div></div><div id="sec4_6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i166" class="anchor-spacer"></div><h3 class="article-section__title" id="_i166"> <i>In Vitro</i> ADMET Assays. log <i>D</i><sub>7.4</sub> Determination</h3><div class="NLM_p">Compound stock solutions (10 μL, 10 mM in DMSO) were placed in each well of a 96-well plate. 5 μL of 2 mM Halodipine (log <i>D</i> = 3.00) was added to each well as an internal standard (IS) and mixed. DMSO was removed using a lyophilizer (overnight). 250 μL of water (PBS, pH = 7.4)–saturated octanol was added to each well followed by 250 μL of octanol–saturated water (PBS, pH = 7.4), and the plate was vortexed overnight. 100 μL of the octanol phase was removed from each well, diluted 1:100 with DMSO, and 1 μL was injected into a LC/UV/qTOF system (RP column). 100 μL of the water phase was removed from each well, and 10 μL was injected into the LC/UV/qTOF system (RP column). Data were processed with ProfileLynx. Mass chromatograms were integrated, corrected for dilution and injection volumes, and finally, corrected using area ratio of internal standard. IS peak areas were adjusted to fit the theoretical concentration for aqueous and octanol phases for the known log <i>D</i> value.</div><div class="NLM_p last">The log D was calculated according to the following:<span class="NLM_disp-formula" id="ueq1"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_m001.gif" alt="" id="_i167" /></img></span><span class="NLM_disp-formula"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_m002.gif" alt="" id="_i168" /></img></span><span class="NLM_disp-formula"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_m003.gif" alt="" id="_i169" /></img></span></div></div><div id="sec4_6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i170" class="anchor-spacer"></div><h3 class="article-section__title" id="_i170"> Solubility Determination</h3><div class="NLM_p last">20 μL of 10 mM DMSO compound stock solution was transferred into a 96 deep well “sample plate”. 5 μL of 10 mM DMSO stock solution was transferred to a second “compound standard plate”. The sample plate was placed in a Multi-Tainer MT-4 container (FTS Systems) and freeze-dried overnight to remove DMSO. 100 μL of PBS (pH 7.0) was added to the dried compound in the sample plate and 95 μL of DMSO to the standard plate. The sample plate was sonicated in a water bath for 10 min. The two plates were then placed onto a VWR orbital shaker to equilibrate for 24 h at room temperature, then centrifuged at 4000 rpm for 30 min. 10 μL aliquots of supernatant from the sample plate were removed and diluted 5-fold. Compound standard and sample were injected into a UPLC/UV/CLND/MS system to generate multidetector qualitative and quantitive analytical data. Data were processed with Xcalibur. CLND equimolar response was used for measuring compound concentration of DMSO solution, and UV 270 nm or MS relative ratio was used for solubility determination.</div></div><div id="sec4_6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i171" class="anchor-spacer"></div><h3 class="article-section__title" id="_i171"> p<i>K</i><sub>a</sub> Measurements</h3><div class="NLM_p last">p<i>K</i><sub>a</sub> values were determined using the UV-metric method as described previously.<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> UV-metric ionization constants were determined on the commercial spectral gradient analyzer (SGA) or T3 instrument (Sirius Analytical Ltd.) as described by Allen et al.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> Test compounds were diluted to 0.04 mM in a cosolvent mixture and titrated three times in 20–40 wt % methanol. The titrations were performed at 25 °C and 0.15 M ionic strength, from pH 2 to 12 or 12 to 2 (with Δ pH of 0.2) depending on the acidic or basic nature of the test compound. A linear buffer was added to allow fast pH stabilization after each titrant addition. Wavelengths from 230 to 450 nm were typically monitored for UV absorbance change due to the ionization state of the compound. Target factor analysis (TFA) was used to calculate apparent p<i>K</i><sub>a</sub> values from the multiwavelength absorption data at a given percent of cosolvent (psK<sub>a</sub>), followed by Yasuda–Shedlovsky extrapolation to 0% methanol to provide the aqueous p<i>K</i><sub>a</sub>. Acid/base assignment was performed based on the slope of extrapolation.</div></div><div id="sec4_6_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i172" class="anchor-spacer"></div><h3 class="article-section__title" id="_i172"> Metabolic Stability in Liver Microsomes</h3><div class="NLM_p">Test compounds at 1 μM in duplicate were incubated at 37 °C in the presence of 0.5 mg/mL liver microsomal protein suspension, 1 mM NADPH, 1 mM UDPGA, 3 mM MgCl2, and 25 μg of alamethicine per mg of microsomal protein. Sequential samples were collected at 0, 5, 15, and 30 min of the incubation. DMSO final concentration in the incubation was 0.01%. Bioanalysis was carried out using the semiquantitative LC–MS/MS method in MRM mode. Then compound concentration (peak area ratio to internal standard) against time is plotted to obtain the elimination rate constant (<i>k</i>) for intrinsic clearance estimation: Intrinsic Clearance = (−<i>k</i>)/[microsome protein].</div><div class="NLM_p last">Compounds were tested in the following number of individual experiments (replicates). For compounds with more than one replicate, data are presented as an average: compound <b>5</b>, 4 replicates; compound <b>10</b>, 2 replicates; compound <b>34</b>, 1 replicate.</div></div><div id="sec4_6_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i173" class="anchor-spacer"></div><h3 class="article-section__title" id="_i173"> <i>In Vitro</i> Plasma Protein Binding</h3><div class="NLM_p">Compounds were spiked into plasma of selected species (male CD-1 mouse, male Sprague Dawley rat, or pooled human plasma, all in lithium heparin preparations, BioreclamationIVT) in the “plasma chamber” of a rapid equilibrium device (RED, Thermo Scientific) plate at a final concentration of 10 μM (1% DMSO in the incubation) and allowed to reach equilibrium between the “plasma chamber” and “buffer chamber” (100 mM PBS) for 4 h in a shaking incubator (37 °C, 800 rpm). Compounds were tested in duplicates. At the end of incubation, samples were collected from plasma and buffer chambers followed by bioanalysis using LC–MS/MS. The percent plasma protein binding of a test compound was estimated using the following equation:<span class="NLM_disp-formula" id="ueq2"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_m004.gif" alt="" id="_i174" /></img></span>where <i>C</i><sub>buffer</sub> and <i>C</i><sub>plasma</sub> are compound concentrations in the buffer and plasma chambers at equilibrium, respectively.</div><div class="NLM_p">Recovery of a compound after the incubation was also calculated as % Recovery:<span class="NLM_disp-formula" id="ueq3"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_m005.gif" alt="" id="_i175" /></img></span>where <i>V</i><sub>buffer</sub> and <i>V</i><sub>plasma</sub> are incubation volumes in buffer and plasma chambers, respectively. <i>C</i><sub>0</sub> is the initial compound concentration in plasma at the beginning of the incubation.</div><div class="NLM_p last">The data presented for compounds <b>5</b> and <b>10</b> represent the results of a single experiment. Data for compound <b>34</b> represent the average of two individual experiments (replicates).</div></div><div id="sec4_6_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i176" class="anchor-spacer"></div><h3 class="article-section__title" id="_i176"> CACO-2 Permeability</h3><div class="NLM_p">CACO-2 cells were cultured for 21 days on 96-well Transwell plates. Test compound solutions were prepared by diluting 7 μL of 2 mM DMSO stock solution in transport buffer to a final volume of 1.4 mL (final compound concentration was 10 μM). Test compound solutions were transferred to either the apical or basolateral chambers of the 96-well Transwell plates (the donor wells). Transport buffer was then added to the respective receiver wells. Plates were then incubated for 2 h at 37 °C with shaking/vortex. Donor wells were sampled at <i>t</i> = 0. Apical and basolateral wells were sampled at <i>t</i> = 2 h. Samples were analyzed by LC–MS–MS. Transport from A–B and B–A was measured in triplicate. Apparent compound permeability is calculated as follows:<span class="NLM_disp-formula" id="ueq4"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_m006.gif" alt="" id="_i177" /></img></span>where ∂<i>Q</i>/∂<i>t</i> is the total amount of compound transported to the recipient chamber per unit time (e.g., nmol/s), <i>A</i> is the surface area of the transport membrane (cm<sup>2</sup>), and <i>C</i><sub>0</sub> is the initial compound concentration in the donor chamber (e.g., nmol/mL). <i>P</i><sub>app</sub> is expressed as cm/s.</div><div class="NLM_p last">Compounds were tested in the following number of individual experiments (replicates). For compounds with more than one replicate, data are presented as an average: compound <b>5</b>, 2 replicates; compound <b>10</b>, 2 replicates; compound <b>34</b>, 1 replicate.</div></div><div id="sec4_6_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i178" class="anchor-spacer"></div><h3 class="article-section__title" id="_i178"> hERG Manual Patch Clamp Electrophysiology</h3><div class="NLM_p">HEK293 cells stably transfected with the α-subunits of the hERG (University of Wisconsin, USA) were continuously maintained and passaged using standard cell culture media (Gibco-BRL, Switzerland). For experiments, the cells were plated onto sterile glass coverslips in 35 mm<sup>2</sup> dishes at a density of (1.1–1.5) × 10<sup>5</sup> cells per dish. The dishes were stored in a humidified and gassed (5% CO<sub>2</sub>) incubator at 37 °C until use.</div><div class="NLM_p">The effect on hERG currents was assessed by means of the patch clamp technique in the whole-cell configuration at 35 ± 2 °C. The corresponding vehicle for all superfusion concentrations was 0.1% DMSO. The vehicle effect was investigated in 5 cells. The effect of the positive controls 100 nM E-4031 (Calbiochem, Switzerland) was investigated in 2 cells. Cells were exposed to the test item for approximately 10 min. hERG tail currents were elicited by voltage jumps from −75 mV to +10 mV (500 ms) and then to −40 mV (500 ms) at 0.1 Hz. The composition of the extracellular solutions was the following [mM]: NaCl 137; KCl 4; CaCl<sub>2</sub> 1.8; MgCl<sub>2</sub> 1.0; <span class="smallcaps smallerCapital">d</span>-glucose 10; <i>N</i>-2-hydroxyethylpiperazine-<i>N</i>′-2-ethanesulfonic acid (HEPES) 10; pH 7.4 (adjusted with 5 M NaOH). The composition of the pipet solutions was the following (mM): KCl 130; MgCl<sub>2</sub> 1.0; ethylene glycol-bis(ß-aminoethyl ether)-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetraacetic acid (EGTA) 5; Mg-ATP 5; HEPES 10; pH 7.2 (adjusted with 1 M KOH). The compound effect on the currents was corrected by the mean vehicle rundown which was observed (<i>n</i> = 5) by the treatment with extracellular solution containing 0.1% DMSO. Data capturing and analysis were performed by using Pulse (Heka Electronics, Germany) and Excel.</div><div class="NLM_p last">The data presented for compounds <b>5</b> represent the results of a single experiment.</div></div><div id="sec4_6_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i179" class="anchor-spacer"></div><h3 class="article-section__title" id="_i179"> Automated Electrophysiology</h3><div class="NLM_p"><i>hERG</i> expressing cell lines were produced in-house at Novartis using CHO-K1 T-Rex inducible plasmid system (Invitrogen) as described previously.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> Cell lines were maintained in Ham’s F12 nutrient mixture containing 10% FBS, blasticidin (10 mg/mL; InvivoGen), hygromycin B (200 mg/mL; InvivoGen), Zeocin (200 mg/mL, Invitrogen), and neomycin (200 mg/mL, Invitrogen) using SelecT automated cell culture system (TAP Biosystems, Cambridge, U.K.). <i>hERG</i> and <i>hCa</i><sub><i>v</i></sub><i>1.2</i> channels expression was induced with tetracycline (0.25–1 μg/mL, Invitrogen) at least 24 h prior to the experiment.</div><div class="NLM_p"><i>hERG</i> currents were recorded using the Qpatch automated patch clamp systems (Sophion Bioscience Inc., North Brunswick, NJ) in the whole (single) cell configuration. hERG expressing CHO-K1 cells were harvested with Detachin (Genlantis) and stored in the modified serum-free SFM-2 media (Life Technologies) at room temperature. The extracellular solution contained (in mM) NaCl (145), KCl (4), MgCl<sub>2</sub> (1), CaCl<sub>2</sub> (2), and HEPES (10), pH 7.4, with NaOH. The intracellular solution contained KCl (135), MgCl<sub>2</sub> (1.75), CaCl<sub>2</sub> (5.4), EGTA (10), K2-ATP (4), and HEPES (10), pH 7.2, with KOH. After whole cell configuration was achieved, the cell was held at −90 mV, and a 0.1 s pulse to −50 mV was delivered to measure the leaking current, which was subtracted from the tail current online. Then the cell was depolarized to +20 mV for 4 s (prepulse), followed by a 4 s test pulse to −50 mV to reveal the hERG tail current. To monitor changes in the current amplitude, this voltage protocol was repeatedly applied every 20 s. Test compounds were first diluted in DMSO for six dose–response experiments and then dissolved in the extracellular solution using Freedom EVO liquid handling robotic system (Tecan, Männedorf, Switzerland). The final DMSO concentration in samples was 0.3% v/v. Amitriptyline (Sigma) was tested as a positive control. Data were analyzed using in-house developed MatLab-based program (MathWorks, Natick, MA).</div><div class="NLM_p">hERG QPatch testing for compound <b>34</b> was performed using a long incubation protocol (10 min per concentration point). To avoid current rundown during prolonged incubation, current was measured in duplicate ([11 and 100 μM] and [33 and 300 μM] concentration pairs) in different cells simultaneously. The results of these measurements were combined into one DR plot. Data were analyzed manually using Sophion QPatch Assay software.</div><div class="NLM_p last">The data presented for compounds <b>10</b> and <b>34</b> represent the results of a single experiment.</div></div><div id="sec4_6_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i180" class="anchor-spacer"></div><h3 class="article-section__title" id="_i180"> Cytotoxicity Assay</h3><div class="NLM_p">K562 (human leukemia cells), Molt-4 (T-lymphoblast derived from acute lymphoblastic leukemia), and HepG2 (human hepatocellular carcinoma cells) were used to determine compound cytotoxicity. Cell viability was quantified by using CellTiter-Glo, which measures ATP release based on the mono-oxygenation of luciferin catalyzed by Mg<sup>2+</sup>, ATP, and molecular oxygen.</div><div class="NLM_p">For cell line maintenance media, K562 cells were maintained in Iscove’s modification of Dulbecco’s modified Eagle’s medium (IMDM) supplemented with 1% penicillin/streptomycin and 10% heat-inactivated fetal bovine serum (FBS). Molt-4 cells were maintained in Roswell Park Memorial Institute (RPMI 1640) culture medium supplemented with 1% penicillin/streptomycin and 10% heat-inactivated FBS. HepG2 cells were maintained in Dulbecco’s modified Eagle’s medium (DMEM)-F12 supplemented with 1% penicillin/streptomycin and 10% heat-inactivated FBS.</div><div class="NLM_p last">Cells were counted using a hemocytometer and diluted to 2 × 10<sup>4</sup> cells/mL for K562, 1 × 10<sup>5</sup> cells/mL for Molt-4, and 5 × 10<sup>4</sup> cells/mL for HepG2 in the appropriate culture media. An amount of 50 μL of cell suspension was added to each well of the 384-well assay plate containing 1 μL of serial diluted compound (100 μM top concentration, 3.16× dilution factor) using the BioTek Multiflo-Stacker liquid dispenser. Plates were incubated 72 h at 37 °C, 5% CO<sub>2</sub>, and 90% humidity. An amount of 25 μL of 1× CellTiter-Glo was then added to each well of the assay plate. Plates were incubated for 10 min at room temperature before reading on the PolarStar-Omega plate reader using the luminescence settings and a gain of 3300. The 50% cytotoxic concentrations (CC<sub>50</sub>) were determined. When multiple CC<sub>50</sub> values were determined for the same compound, the average is reported. If one or more CC<sub>50</sub> for the same compound showed a value of >100 μM (top concentration tested), 100 μM was used as the value in the average calculation. Compound <b>34</b> was tested in the following number of individual experiments (replicates): 3 (HepG2 and K562), 2 (MT4).</div></div><div id="sec4_6_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i181" class="anchor-spacer"></div><h3 class="article-section__title" id="_i181"> <i>In Vitro</i> 3T3 NRU Phototoxicity Test</h3><div class="NLM_p last"><i>In vitro</i> phototoxicity assessment was conducted as described previously.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> Mouse Balb/c 3T3 fibroblast cells were treated with the test item for 1 h and, subsequently, either irradiated with simulated sunlight for 50 min (normalized to 1.7 ± 0.1 mW/cm<sup>2</sup> of UVA, resulting in a normalized radiation dose of 5.1 ± 0.3 J/cm<sup>2</sup> UVA) or kept in the dark for 50 min. After medium replacement and approximately 24 h recovery cell viability was assessed using the Neutral Red Uptake (NRU) end point. IC<sub>50</sub> values were derived from the concentration–response curves obtained with and without irradiation and used to calculate the PIF (photoirritation factor, PIF) as follows:<span class="NLM_disp-formula" id="ueq5"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_m007.gif" alt="" id="_i182" /></img></span>In the case of compounds <b>15</b>, <b>21</b>, and <b>34</b>, an IC<sub>50</sub> was not achieved in the absence of irradiation. As a surrogate, the solubility limit during incubation was used (500 μM for <b>15</b>, 316 μM for <b>21</b>, and 1000 μM for <b>34</b>). In parallel, the known phototoxic compound chlorpromazine was tested as a positive control.</div></div><div id="sec4_7_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i183" class="anchor-spacer"></div><h3 class="article-section__title" id="_i183"> X-ray Crystallography Studies. Cloning, Protein Expression, and Purification</h3><div class="NLM_p last">A <i>K. pneumoniae</i> topoisomerase IV ParE-ParC fusion gene was made by fusing the C-terminal domain of <i>parE</i> (residues 390–631) and the N-terminal domain of <i>parC</i> (residues 1–490) linked by a 2 amino acid Glu-Phe linker. The resulting construct (Kp ParEC) was inserted into a pETite vector (Lucigen) harboring a C-terminal 6X-histidine tag. OverExpress C41 (DE3) cells (Lucigen) were then transformed with this construct and grown at 37 °C in Terrific Broth. Protein expression was induced with 100 μM IPTG. Cells were pelleted and resuspended in 20 mM Tris, pH 8.0, 200 mM NaCl, 10% glycerol, 2 mM TCEP, 1 mM EDTA, and Roche protease inhibitor and lysed in a pneumatic cell homogenizer. The cleared lysate was supplemented with imidazole and MgCl<sub>2</sub> to final concentrations of 10 mM and 1.5 mM, respectively, and loaded on a immobilized metal chelate affinity column and eluted with increasing imidazole concentrations. The fusion protein was then further purified on a Q Sepharose ion exchange column equilibrated with 20 mM Tris, pH 8.0, 10% glycerol, and 2 mM TCEP and eluted with column equilibration buffer including 1 M NaCl. Protein containing fractions were pooled and further purified on a Superdex 200 SEC column equilibrated with 20 mM Tris, pH 7.5, 100 mM NaCl, and 2 mM TCEP. The fusion protein (MW ∼ 84 kDa) was concentrated to 7.6 mg/mL, flash frozen in liquid nitrogen, and stored in −80 °C for up to 6 months. A total of 22 mg of Kp ParEC with >95% purity was purified from 2 L of cell culture.</div></div><div id="sec4_7_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i184" class="anchor-spacer"></div><h3 class="article-section__title" id="_i184"> Crystallography</h3><div class="NLM_p last">HPLC purified symmetric DNA oligo 5′-TTACGTTGTATGATCATACAACGTAA-3′ was ordered from IDT and dissolved in 10 mM Tris-HCl, pH 7.5, and 50 mM NaCl. The DNA was annealed by denaturing at 95 °C and slow cooling to room temperature in a thermos flask over 48 h to form a 1 mM solution of symmetric duplex DNA. The protein–DNA–compound ternary complex was made by mixing 23 μM (4 mg/mL) Kp ParEC dimer with 28 μM duplex DNA and 0.2 mM compound <b>34</b> and incubated overnight at 17 °C. Complex crystals were grown by the sitting drop vapor diffusion method at 18 °C and appeared after 24–48 h. 200 nL complex solution was mixed with 100 nL of crystallization solution (20 mM MgCl<sub>2</sub>, 40 mM LiCl, 2 mM hexamine cobalt chloride, 40 mM sodium cacodylate trihydrate, pH 5.5, and 30% MPD), and crystals were frozen in liquid nitrogen directly from the drop. Diffraction data were collected at the beamline 5.0.2 at the Advanced Light Source in Berkeley and processed with XDS. The structure was solved by molecular replacement using PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EIX">5EIX</a> as starting model using Phaser.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> The model was improved to convergence by iterative rounds of model rebuilding in Coot<a onclick="showRef(event, 'ref105 ref106'); return false;" href="javascript:void(0);" class="ref ref105 ref106">(105,106)</a> and refinement using phenix.refine of the Phenix suite.<a onclick="showRef(event, 'ref107 ref108'); return false;" href="javascript:void(0);" class="ref ref107 ref108">(107,108)</a></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i185"><a href="/doi/suppl/10.1021/acs.jmedchem.0c00347" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46036" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46036" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c00347?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00347</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Crystallographic data table for the structure of <i>K. pneumoniae</i> topoisomerase IV bound to compound <b>34</b>; unbiased electron-density difference map (<i>F</i><sub>obs</sub> – <i>F</i><sub>calc</sub>) for <b>34</b> bound to <i>K. pneumoniae</i> topoisomerase IV; interaction diagram of compound <b>34</b> bound to topoisomerase IV from <i>K. pneumoniae</i>; plot of CFU/thigh determined for each dose of compound <b>34</b> in the neutropenic murine thigh infection model; SEC chromatograms showing separation of supercoiled and relaxed DNA and detection of decatenated kDNA; LC/MS traces of all final compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00347/suppl_file/jm0c00347_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00347/suppl_file/jm0c00347_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00347/suppl_file/jm0c00347_si_001.pdf">jm0c00347_si_001.pdf (3.03 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00347/suppl_file/jm0c00347_si_002.csv">jm0c00347_si_002.csv (2.73 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Structural coordinates for compound <b>34</b> have been deposited in the RCSB Protein Data Bank under the accession code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6WAA">6WAA</a>. Authors will release the atomic coordinates and experimental data upon article publication.</p><div class="testing" data-doi="10.1021/acs.jmedchem.0c00347" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50470" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50470" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Colin K. Skepper</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Emeryville, California 94608, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6771-2024" title="Orcid link">http://orcid.org/0000-0002-6771-2024</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#34575b585d5a1a475f5144445146745a5b425546405d471a575b59"><span class="__cf_email__" data-cfemail="25464a494c4b0b564e4055554057654b4a534457514c560b464a48">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Duncan Armstrong</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carl J. Balibar</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Emeryville, California 94608, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel Bauer</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, 4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cornelia Bellamacina</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Emeryville, California 94608, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bret M. Benton</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Emeryville, California 94608, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dirksen Bussiere</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Emeryville, California 94608, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5623-5648" title="Orcid link">http://orcid.org/0000-0002-5623-5648</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gianfranco De Pascale</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Emeryville, California 94608, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Javier De Vicente</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Emeryville, California 94608, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Charles R. Dean</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Emeryville, California 94608, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bhavesh Dhumale</span> - <span class="hlFld-Affiliation affiliation">Piramal
Discovery Solutions, Pharmaceutical Special Economic Zone, Sarkhej Bavla Highway, Ahmedabad, Gujarat 382213, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">L. Mark Fisher</span> - <span class="hlFld-Affiliation affiliation">Molecular
and Clinical Sciences Research Institute, St George’s University of London, London SW17 0RE, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Fuller</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Emeryville, California 94608, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mangesh Fulsunder</span> - <span class="hlFld-Affiliation affiliation">Piramal
Discovery Solutions, Pharmaceutical Special Economic Zone, Sarkhej Bavla Highway, Ahmedabad, Gujarat 382213, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lauren M. Holder</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Emeryville, California 94608, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8585-8169" title="Orcid link">http://orcid.org/0000-0001-8585-8169</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cheng Hu</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Emeryville, California 94608, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bhavin Kantariya</span> - <span class="hlFld-Affiliation affiliation">Piramal
Discovery Solutions, Pharmaceutical Special Economic Zone, Sarkhej Bavla Highway, Ahmedabad, Gujarat 382213, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Guillaume Lapointe</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Emeryville, California 94608, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jennifer A. Leeds</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Emeryville, California 94608, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-2244-4713" title="Orcid link">http://orcid.org/0000-0003-2244-4713</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaolin Li</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Emeryville, California 94608, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peichao Lu</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Emeryville, California 94608, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anatoli Lvov</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sylvia Ma</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Emeryville, California 94608, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shravanthi Madhavan</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Emeryville, California 94608, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Swapnil Malekar</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Emeryville, California 94608, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David McKenney</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Emeryville, California 94608, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wosenu Mergo</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Emeryville, California 94608, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Louis Metzger</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Emeryville, California 94608, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Heinz E. Moser</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Emeryville, California 94608, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel Mutnick</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Emeryville, California 94608, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jonas Noeske</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Emeryville, California 94608, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Colin Osborne</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Emeryville, California 94608, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ashish Patel</span> - <span class="hlFld-Affiliation affiliation">Piramal
Discovery Solutions, Pharmaceutical Special Economic Zone, Sarkhej Bavla Highway, Ahmedabad, Gujarat 382213, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Darshit Patel</span> - <span class="hlFld-Affiliation affiliation">Piramal
Discovery Solutions, Pharmaceutical Special Economic Zone, Sarkhej Bavla Highway, Ahmedabad, Gujarat 382213, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tushar Patel</span> - <span class="hlFld-Affiliation affiliation">Piramal
Discovery Solutions, Pharmaceutical Special Economic Zone, Sarkhej Bavla Highway, Ahmedabad, Gujarat 382213, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Krunal Prajapati</span> - <span class="hlFld-Affiliation affiliation">Piramal
Discovery Solutions, Pharmaceutical Special Economic Zone, Sarkhej Bavla Highway, Ahmedabad, Gujarat 382213, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Katherine R. Prosen</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Emeryville, California 94608, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6301-8089" title="Orcid link">http://orcid.org/0000-0001-6301-8089</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Folkert Reck</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Emeryville, California 94608, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7250-2526" title="Orcid link">http://orcid.org/0000-0001-7250-2526</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daryl L. Richie</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Emeryville, California 94608, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alice Rico</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Emeryville, California 94608, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark R. Sanderson</span> - <span class="hlFld-Affiliation affiliation">Randall Centre
for Cell and Molecular Biophysics, King’s
College, Guy’s Campus, London Bridge, London SE1 1UL, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shailesh Satasia</span> - <span class="hlFld-Affiliation affiliation">Piramal
Discovery Solutions, Pharmaceutical Special Economic Zone, Sarkhej Bavla Highway, Ahmedabad, Gujarat 382213, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">William S. Sawyer</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Emeryville, California 94608, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jogitha Selvarajah</span> - <span class="hlFld-Affiliation affiliation">Molecular
and Clinical Sciences Research Institute, St George’s University of London, London SW17 0RE, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nirav Shah</span> - <span class="hlFld-Affiliation affiliation">Piramal
Discovery Solutions, Pharmaceutical Special Economic Zone, Sarkhej Bavla Highway, Ahmedabad, Gujarat 382213, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kartik Shanghavi</span> - <span class="hlFld-Affiliation affiliation">Piramal
Discovery Solutions, Pharmaceutical Special Economic Zone, Sarkhej Bavla Highway, Ahmedabad, Gujarat 382213, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wei Shu</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Emeryville, California 94608, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Katherine V. Thompson</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Emeryville, California 94608, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Martin Traebert</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, 4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anand Vala</span> - <span class="hlFld-Affiliation affiliation">Piramal
Discovery Solutions, Pharmaceutical Special Economic Zone, Sarkhej Bavla Highway, Ahmedabad, Gujarat 382213, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lakhan Vala</span> - <span class="hlFld-Affiliation affiliation">Piramal
Discovery Solutions, Pharmaceutical Special Economic Zone, Sarkhej Bavla Highway, Ahmedabad, Gujarat 382213, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dennis A. Veselkov</span> - <span class="hlFld-Affiliation affiliation">Randall Centre
for Cell and Molecular Biophysics, King’s
College, Guy’s Campus, London Bridge, London SE1 1UL, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jason Vo</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Emeryville, California 94608, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Wang</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Emeryville, California 94608, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marcella Widya</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Emeryville, California 94608, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sarah L. Williams</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Emeryville, California 94608, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yongjin Xu</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Emeryville, California 94608, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qin Yue</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Emeryville, California 94608, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard Zang</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Emeryville, California 94608, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bo Zhou</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Emeryville, California 94608, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alexey Rivkin</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Emeryville, California 94608, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>Alexey Rivkin was the Project Team Leader for this drug discovery program. The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li><span class="author-information-subsection-header">Funding</span><p>This work was funded by Novartis AG.</p></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): Colin K. Skepper, Duncan Armstrong, Carl J. Balibar, Daniel Bauer, Cornelia Bellamacina, Bret M. Benton, Dirksen Bussiere, Gianfranco De Pascale, Javier De Vicente, Charles R. Dean, John Fuller, Lauren M. Holder, Cheng Hu, Guillaume Lapointe, Jennifer A. Leeds, Xiaolin Li, Peichao Lu, Anatoli Lvov, Sylvia Ma, Shravanthi Madhavan, Swapnil Malekar, David McKenney, Wosenu Mergo, Louis Metzger, Heinz E. Moser, Daniel Mutnick, Jonas Noeske, Colin Osborne, Katherine R. Prosen, Folkert Reck, Daryl L. Richie, Alice Rico, William S. Sawyer, Wei Shu, Katherine V. Thompson, Martin Traebert, Jason Vo, Michael Wang, Marcella Widya, Sarah L. Williams, Yongjin Xu, Qin Yue, Richard Zang, Bo Zhou, and Alexey Rivkin are or were employees of Novartis.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i188">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10067" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10067" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank Haiying He, Zhigan Jiang, and Jianhua Xia (WuXi AppTec) for synthesis of early compounds in this series including <b>4</b> and <b>5</b>; Shengtian Yang for NMR structure elucidation support; Weiping Jia, Heidi Struble, Dazhi Tang, and Alice Wan Wang for analytical and separations support; Linhong Yang for pKa determination; Colin Lorentzen, Kent Wong, and Linda Xiao for <i>in vitro</i> ADME assays; Srijan Ranjitkar for construction of the bacterial strain <i>P. aeruginosa</i> Δ<i>mexB</i>Δ<i>mexX</i> FQ-R. Johanne Blais is gratefully acknowledged for assistance in writing and editing this manuscript.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">ADMET</td><td class="NLM_def"><p class="first last">absorption, distribution, metabolism, excretion, toxicity</p></td></tr><tr><td class="NLM_term">BA</td><td class="NLM_def"><p class="first last">bioavailability</p></td></tr><tr><td class="NLM_term">BINAP</td><td class="NLM_def"><p class="first last">2,2′-bis(diphenylphosphino)-1,1′-binaphthalene</p></td></tr><tr><td class="NLM_term"><i>C</i><sub>max</sub></td><td class="NLM_def"><p class="first last">maximum plasma concentration</p></td></tr><tr><td class="NLM_term">CDI</td><td class="NLM_def"><p class="first last">carbonyl diimidazole</p></td></tr><tr><td class="NLM_term">CL</td><td class="NLM_def"><p class="first last">clearance</p></td></tr><tr><td class="NLM_term">CL<sub>int</sub></td><td class="NLM_def"><p class="first last">intrinsic clearance</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">DPPF</td><td class="NLM_def"><p class="first last">1,1′-ferrocenediyl-bis(diphenylphosphine)</p></td></tr><tr><td class="NLM_term">FQ</td><td class="NLM_def"><p class="first last">fluoroquinolone</p></td></tr><tr><td class="NLM_term">FQ-R</td><td class="NLM_def"><p class="first last">fluoroquinolone resistant</p></td></tr><tr><td class="NLM_term">%F</td><td class="NLM_def"><p class="first last">percent orally bioavailable</p></td></tr><tr><td class="NLM_term">fAUC</td><td class="NLM_def"><p class="first last">free (unbound) area under the curve</p></td></tr><tr><td class="NLM_term">LiHMDS</td><td class="NLM_def"><p class="first last">lithium bis(trimethylsilyl)amide</p></td></tr><tr><td class="NLM_term">MeCN</td><td class="NLM_def"><p class="first last">acetonitrile</p></td></tr><tr><td class="NLM_term">NaHMDS</td><td class="NLM_def"><p class="first last">sodium bis(trimethylsilyl)amide</p></td></tr><tr><td class="NLM_term">QRDR</td><td class="NLM_def"><p class="first last">quinolone resistance determining region</p></td></tr><tr><td class="NLM_term">QT interval</td><td class="NLM_def"><p class="first last">the time that elapses between the beginning of the Q wave and the end of the T wave in an electrocardiogram</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">SEMCl</td><td class="NLM_def"><p class="first last">2-(trimethylsilyl)ethoxymethyl chloride</p></td></tr><tr><td class="NLM_term"><i>T</i><sub>max</sub></td><td class="NLM_def"><p class="first last">time at which maximum plasma concentration was reached</p></td></tr><tr><td class="NLM_term"><i>V</i><sub>ss</sub></td><td class="NLM_def"><p class="first last">volume of distribution</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i190">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21148" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21148" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 108 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bisacchi, G. S.</span></span> <span> </span><span class="NLM_article-title">Origins of the quinolone class of antibacterials: an expanded “discovery story”</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">4874</span>– <span class="NLM_lpage">4882</span>, <span class="refDoi"> DOI: 10.1021/jm501881c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501881c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjslOlt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=4874-4882&author=G.+S.+Bisacchi&title=Origins+of+the+quinolone+class+of+antibacterials%3A+an+expanded+%E2%80%9Cdiscovery+story%E2%80%9D&doi=10.1021%2Fjm501881c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Origins of the Quinolone Class of Antibacterials: An Expanded "Discovery Story"</span></div><div class="casAuthors">Bisacchi, Gregory S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4874-4882</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Published descriptions of the specific lines of research leading to the discovery of therapeutically important medicines, esp. major new class medicines, have long provided value to the biopharmaceutical community as models of success, often influencing the strategies and methods of subsequent drug research.  Quinolone antibacterials represent one of medicine's most important classes of anti-infective agents; yet in contrast to many other classes of anti-infectives, astonishingly few details concerning the origin of the class or the rationale leading to the selection of the first clin. agent, nalidixic acid, were ever published by the discoverers.  Moreover, earlier disclosures of an independent discovery of the quinolone class of antibacterials have been almost entirely overlooked by the scientific literature.  This review brings together all the available information from primary literature sources relating to both discoveries and provides for the first time a much fuller, if still partially speculative, story of the earliest years of this important class of drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRfBwGtmGfYLVg90H21EOLACvtfcHk0lj4Sm9kiRoMPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjslOlt7w%253D&md5=080b765f4cce8d28967de2d3dcdbab0f</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Fjm501881c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501881c%26sid%3Dliteratum%253Aachs%26aulast%3DBisacchi%26aufirst%3DG.%2BS.%26atitle%3DOrigins%2520of%2520the%2520quinolone%2520class%2520of%2520antibacterials%253A%2520an%2520expanded%2520%25E2%2580%259Cdiscovery%2520story%25E2%2580%259D%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D4874%26epage%3D4882%26doi%3D10.1021%2Fjm501881c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Da
Silva, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Almeida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Souza, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Couri, M.</span></span> <span> </span><span class="NLM_article-title">Biological activity and synthetic methodologies for the preparation of fluoroquinolones, a class of potent antibacterial agents</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">21</span>– <span class="NLM_lpage">39</span>, <span class="refDoi"> DOI: 10.2174/0929867033368637</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.2174%2F0929867033368637" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=12570719" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BD3sXisVSrtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2003&pages=21-39&author=A.+Da%0ASilvaauthor=M.+De+Almeidaauthor=M.+De+Souzaauthor=M.+Couri&title=Biological+activity+and+synthetic+methodologies+for+the+preparation+of+fluoroquinolones%2C+a+class+of+potent+antibacterial+agents&doi=10.2174%2F0929867033368637"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Biological activity and synthetic methodologies for the preparation of fluoroquinolones, a class of potent antibacterial agents</span></div><div class="casAuthors">Da Silva, Adilson D.; De Almeida, Mauro V.; De Souza, Marcus V. N.; Couri, Mara R. C.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">21-39</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers</span>)
        </div><div class="casAbstract">A review.  We report different synthetic methodologies for the prepn. of fluoroquinolones and their biol. properties.  The appearance of the fluoroquinolones, a new class of antibacterial agents (based on nalidixic acid, 4-quinolone-3-carboxylates), in early 1980s, gave a new impulse for the international competition to synthesize more effective drugs.  Fluoroquinolones have a broad spectrum of activity against Gram-pos., Gram-neg. and mycobacterial organisms as well as anaerobes.  The fluoroquinolone ciprofloxacin HCl is an important bioterrorist weapon and also an antibiotic used to treat bacterial infection in many different parts of the body, approved for use in patients who have been exposed to the inhaled form of anthrax.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoU6ea4ovoJJLVg90H21EOLACvtfcHk0lj4Sm9kiRoMPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXisVSrtg%253D%253D&md5=7e8364559400f76239f6c7eb7c1a9526</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.2174%2F0929867033368637&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867033368637%26sid%3Dliteratum%253Aachs%26aulast%3DDa%2BSilva%26aufirst%3DA.%26aulast%3DDe%2BAlmeida%26aufirst%3DM.%26aulast%3DDe%2BSouza%26aufirst%3DM.%26aulast%3DCouri%26aufirst%3DM.%26atitle%3DBiological%2520activity%2520and%2520synthetic%2520methodologies%2520for%2520the%2520preparation%2520of%2520fluoroquinolones%252C%2520a%2520class%2520of%2520potent%2520antibacterial%2520agents%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2003%26volume%3D10%26spage%3D21%26epage%3D39%26doi%3D10.2174%2F0929867033368637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emmerson, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, A. M.</span></span> <span> </span><span class="NLM_article-title">The quinolones: decades of development and use</span>. <i>J. Antimicrob. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>51</i></span> (<span class="NLM_issue">Suppl. 1</span>),  <span class="NLM_fpage">13</span>– <span class="NLM_lpage">20</span>, <span class="refDoi"> DOI: 10.1093/jac/dkg208</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1093%2Fjac%2Fdkg208" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=12702699" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BD3sXktlOqu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2003&pages=13-20&issue=Suppl.+1&author=A.+M.+Emmersonauthor=A.+M.+Jones&title=The+quinolones%3A+decades+of+development+and+use&doi=10.1093%2Fjac%2Fdkg208"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The quinolones: Decades of development and use</span></div><div class="casAuthors">Emmerson, A. M.; Jones, A. M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">Suppl. S1</span>),
    <span class="NLM_cas:pages">13-20</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  The discovery of nalidixic acid in 1962, and its introduction for clin. use in 1967, marks the beginning of five decades of quinolone development and use.  It was not until the discovery and licensing of the fluoroquinolones in the 1970s and 1980s that these drugs began to establish their place in the armamentarium of clin. useful antimicrobials.  At the beginning of the 21st century, in their fifth decade of discovery and use, our understanding of structure-function relationships has improved, and better compds., in terms of both spectrum of antimicrobial cover and pharmacokinetics, have been developed.  The clin. utility of this expanding class of anti-microbial agents, and the lower propensity for the development of resistance with the "newer" fluoroquinolones will need to be continually monitored in the changing therapeutic environment.  Antibiotic drug choice will remain difficult in the presence of increasing resistance, but the introduction of the new fluoroquinolones has created a new and exciting era in antimicrobial treatment.  The role of these agents has already been acknowledged in a no. of clin. guidelines, and appropriate use of these agents may help to preserve their clin. utility, enabling them to realize their full therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0RRLOgvTYNLVg90H21EOLACvtfcHk0lj4Sm9kiRoMPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXktlOqu74%253D&md5=04ad837d0f1be12fa7e9944cc9502301</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkg208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkg208%26sid%3Dliteratum%253Aachs%26aulast%3DEmmerson%26aufirst%3DA.%2BM.%26aulast%3DJones%26aufirst%3DA.%2BM.%26atitle%3DThe%2520quinolones%253A%2520decades%2520of%2520development%2520and%2520use%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2003%26volume%3D51%26issue%3DSuppl.%25201%26spage%3D13%26epage%3D20%26doi%3D10.1093%2Fjac%2Fdkg208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mitscher, L. A.</span></span> <span> </span><span class="NLM_article-title">Bacterial topoisomerase inhibitors: quinolone and pyridone antibacterial agents</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">559</span>– <span class="NLM_lpage">592</span>, <span class="refDoi"> DOI: 10.1021/cr030101q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr030101q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmsValuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2005&pages=559-592&author=L.+A.+Mitscher&title=Bacterial+topoisomerase+inhibitors%3A+quinolone+and+pyridone+antibacterial+agents&doi=10.1021%2Fcr030101q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Bacterial Topoisomerase Inhibitors: Quinolone and Pyridone Antibacterial Agents</span></div><div class="casAuthors">Mitscher, Lester A.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">559-592</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review of synthesis, structure activity relationships, toxicity, mechanism of action, modes of resistance, clin. indications and pharmacokinetics of bacterial topoisomerase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcTa9lSZGTm7Vg90H21EOLACvtfcHk0lgNBwIoWg_6qw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmsValuw%253D%253D&md5=d2545ce13157e6e5600cf13ea7866025</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Fcr030101q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr030101q%26sid%3Dliteratum%253Aachs%26aulast%3DMitscher%26aufirst%3DL.%2BA.%26atitle%3DBacterial%2520topoisomerase%2520inhibitors%253A%2520quinolone%2520and%2520pyridone%2520antibacterial%2520agents%26jtitle%3DChem.%2520Rev.%26date%3D2005%26volume%3D105%26spage%3D559%26epage%3D592%26doi%3D10.1021%2Fcr030101q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Andriole, V. T.</span></span> <span> </span><span class="NLM_article-title">The quinolones: past, present, and future</span>. <i>Clin. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>41</i></span> (<span class="NLM_issue">Suppl. 2</span>),  <span class="NLM_fpage">S113</span>– <span class="NLM_lpage">S119</span>, <span class="refDoi"> DOI: 10.1086/428051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1086%2F428051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=15942877" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmvVylsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2005&pages=S113-S119&issue=Suppl.+2&author=V.+T.+Andriole&title=The+quinolones%3A+past%2C+present%2C+and+future&doi=10.1086%2F428051"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The quinolones: Past, present, and future</span></div><div class="casAuthors">Andriole, Vincent T.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Infectious Diseases</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">Suppl. 2</span>),
    <span class="NLM_cas:pages">S113-S119</span>CODEN:
                <span class="NLM_cas:coden">CIDIEL</span>;
        ISSN:<span class="NLM_cas:issn">1058-4838</span>.
    
            (<span class="NLM_cas:orgname">University of Chicago Press</span>)
        </div><div class="casAbstract">A review.  The quinolone class of antimicrobial agents has generated considerable interest since its discovery >40 years ago.  Substantial progress has been made in our understanding of the mol. mechanisms of the action of quinolones against pathogenic bacteria, the induction of resistance to quinolones in these organisms, and the potential of each quinolone compd. to induce toxicity in treated patients.  Here, these key discoveries are reviewed; the present indications approved by regulatory agencies are described in detail, with comments on adverse events caused by quinolones in treated patients; and speculation about the future of the quinolones is proffered, even though their future is difficult to predict, because many factors may affect their clin. usefulness.  However, the emergence of bacterial resistance to the quinolones is a major factor that will det. the future clin. effectiveness of these agents, so that intense investigation of mechanisms to either prevent or curtail resistance to quinolones is of prime importance to their future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfPETsYPc-FbVg90H21EOLACvtfcHk0lgNBwIoWg_6qw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmvVylsLg%253D&md5=f56dda06e86c1ff0f041a2be2f86cdcc</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1086%2F428051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F428051%26sid%3Dliteratum%253Aachs%26aulast%3DAndriole%26aufirst%3DV.%2BT.%26atitle%3DThe%2520quinolones%253A%2520past%252C%2520present%252C%2520and%2520future%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2005%26volume%3D41%26issue%3DSuppl.%25202%26spage%3DS113%26epage%3DS119%26doi%3D10.1086%2F428051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wagman, A. S.</span>; <span class="NLM_string-name">Wentland, M. P.</span></span> <span> </span><span class="NLM_article-title">Quinolone antibacterial agents</span>. In  <i>Comprehensive Medicinal Chemistry II</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, J. B.</span>, <span class="NLM_string-name">Triggle, D. J.</span></span>, Eds.; <span class="NLM_publisher-name">Elsevier</span>: <span class="NLM_publisher-loc">Oxford, U.K.</span>, <span class="NLM_year">2007</span>; pp  <span class="NLM_fpage">567</span>– <span class="NLM_lpage">596</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1016%2FB0-08-045044-X%2F00220-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=567-596&author=A.+S.+Wagman&author=M.+P.+Wentlandauthor=J.+B.+Taylor&author=D.+J.+Triggle&title=Comprehensive+Medicinal+Chemistry+II"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FB0-08-045044-X%2F00220-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB0-08-045044-X%252F00220-0%26sid%3Dliteratum%253Aachs%26aulast%3DWagman%26aufirst%3DA.%2BS.%26atitle%3DQuinolone%2520antibacterial%2520agents%26btitle%3DComprehensive%2520Medicinal%2520Chemistry%2520II%26aulast%3DTaylor%26aufirst%3DJ.%2BB.%26pub%3DElsevier%26date%3D2007%26spage%3D567%26epage%3D596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jacoby, G. A.</span>; <span class="NLM_string-name">Hooper, D. C.</span></span> <span> </span><span class="NLM_article-title">Review of the quinolone family</span>. In  <i>Antibiotic Discovery and Development</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dougherty, T. J.</span>, <span class="NLM_string-name">Pucci, M. J.</span></span>, Eds.; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Boston, MA</span>, <span class="NLM_year">2012</span>; pp  <span class="NLM_fpage">119</span>– <span class="NLM_lpage">146</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1007%2F978-1-4614-1400-1_4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&pages=119-146&author=G.+A.+Jacoby&author=D.+C.+Hooperauthor=T.+J.+Dougherty&author=M.+J.+Pucci&title=Antibiotic+Discovery+and+Development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1007%2F978-1-4614-1400-1_4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-4614-1400-1_4%26sid%3Dliteratum%253Aachs%26aulast%3DJacoby%26aufirst%3DG.%2BA.%26atitle%3DReview%2520of%2520the%2520quinolone%2520family%26btitle%3DAntibiotic%2520Discovery%2520and%2520Development%26aulast%3DDougherty%26aufirst%3DT.%2BJ.%26pub%3DSpringer%26date%3D2012%26spage%3D119%26epage%3D146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Naeem, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badshah, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muska, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, K.</span></span> <span> </span><span class="NLM_article-title">The current case of quinolones: synthetic approaches and antibacterial activity</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">268</span>, <span class="refDoi"> DOI: 10.3390/molecules21040268</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.3390%2Fmolecules21040268" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=27043501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A280%3ADC%252BC28fmvV2ktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=268&author=A.+Naeemauthor=S.+L.+Badshahauthor=M.+Muskaauthor=N.+Ahmadauthor=K.+Khan&title=The+current+case+of+quinolones%3A+synthetic+approaches+and+antibacterial+activity&doi=10.3390%2Fmolecules21040268"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The Current Case of Quinolones: Synthetic Approaches and Antibacterial Activity</span></div><div class="casAuthors">Naeem Abdul; Badshah Syed Lal; Muska Mairman; Badshah Syed Lal; Ahmad Nasir; Khan Khalid</div><div class="citationInfo"><span class="NLM_cas:title">Molecules (Basel, Switzerland)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">268</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Quinolones are broad-spectrum synthetic antibacterial drugs first obtained during the synthesis of chloroquine.  Nalidixic acid, the prototype of quinolones, first became available for clinical consumption in 1962 and was used mainly for urinary tract infections caused by Escherichia coli and other pathogenic Gram-negative bacteria.  Recently, significant work has been carried out to synthesize novel quinolone analogues with enhanced activity and potential usage for the treatment of different bacterial diseases.  These novel analogues are made by substitution at different sites--the variation at the C-6 and C-8 positions gives more effective drugs.  Substitution of a fluorine atom at the C-6 position produces fluroquinolones, which account for a large proportion of the quinolones in clinical use.  Among others, substitution of piperazine or methylpiperazine, pyrrolidinyl and piperidinyl rings also yields effective analogues.  A total of twenty six analogues are reported in this review.  The targets of quinolones are two bacterial enzymes of the class II topoisomerase family, namely gyrase and topoisomerase IV.  Quinolones increase the concentration of drug-enzyme-DNA cleavage complexes and convert them into cellular toxins; as a result they are bactericidal.  High bioavailability, relative low toxicity and favorable pharmacokinetics have resulted in the clinical success of fluoroquinolones and quinolones.  Due to these superior properties, quinolones have been extensively utilized and this increased usage has resulted in some quinolone-resistant bacterial strains.  Bacteria become resistant to quinolones by three mechanisms: (1) mutation in the target site (gyrase and/or topoisomerase IV) of quinolones; (2) plasmid-mediated resistance; and (3) chromosome-mediated quinolone resistance.  In plasmid-mediated resistance, the efflux of quinolones is increased along with a decrease in the interaction of the drug with gyrase (topoisomerase IV).  In the case of chromosome-mediated quinolone resistance, there is a decrease in the influx of the drug into the cell.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS8xPmZ_CaUiIqdXsLcGTEUfW6udTcc2eYxGcs1HsDdrrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28fmvV2ktg%253D%253D&md5=c36d558a9ff78e34c09ff7d725abdd5b</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.3390%2Fmolecules21040268&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules21040268%26sid%3Dliteratum%253Aachs%26aulast%3DNaeem%26aufirst%3DA.%26aulast%3DBadshah%26aufirst%3DS.%2BL.%26aulast%3DMuska%26aufirst%3DM.%26aulast%3DAhmad%26aufirst%3DN.%26aulast%3DKhan%26aufirst%3DK.%26atitle%3DThe%2520current%2520case%2520of%2520quinolones%253A%2520synthetic%2520approaches%2520and%2520antibacterial%2520activity%26jtitle%3DMolecules%26date%3D2016%26volume%3D21%26spage%3D268%26doi%3D10.3390%2Fmolecules21040268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Drlica, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerns, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X.</span></span> <span> </span><span class="NLM_article-title">Quinolone-mediated bacterial death</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">385</span>– <span class="NLM_lpage">392</span>, <span class="refDoi"> DOI: 10.1128/AAC.01617-06</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1128%2FAAC.01617-06" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=17724149" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlSqtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=385-392&author=K.+Drlicaauthor=M.+Malikauthor=R.+J.+Kernsauthor=X.+Zhao&title=Quinolone-mediated+bacterial+death&doi=10.1128%2FAAC.01617-06"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Quinolone-mediated bacterial death</span></div><div class="casAuthors">Drlica, Karl; Malik, Muhammad; Kerns, Robert J.; Zhao, Xilin</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">385-392</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A review.  In the present review we consider cell death through a two-part "poison" hypothesis in which quinolones form reversible drug-topoisomerase-DNA complexes that subsequently lead to several types of irreversible (lethal) damage.  Topics discussed include: quinolone-topoisomerase-DNA complexes; inhibition of DNA replication; SOS response and cell filamentation; toxin-antitoxin modules and programmed cell death; chromosome fragmentation; and destabilization of cleaved complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowBOqyJ-TV4bVg90H21EOLACvtfcHk0lhFPnZiw0R0Fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlSqtLc%253D&md5=eef420d64b9f28336fb0cc5f6c42a803</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1128%2FAAC.01617-06&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01617-06%26sid%3Dliteratum%253Aachs%26aulast%3DDrlica%26aufirst%3DK.%26aulast%3DMalik%26aufirst%3DM.%26aulast%3DKerns%26aufirst%3DR.%2BJ.%26aulast%3DZhao%26aufirst%3DX.%26atitle%3DQuinolone-mediated%2520bacterial%2520death%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D385%26epage%3D392%26doi%3D10.1128%2FAAC.01617-06" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Drlica, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiasa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerns, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mustaev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X.</span></span> <span> </span><span class="NLM_article-title">Quinolones: action and resistance updated</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">981</span>– <span class="NLM_lpage">998</span>, <span class="refDoi"> DOI: 10.2174/156802609789630947</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.2174%2F156802609789630947" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=19747119" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFWisb%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=981-998&author=K.+Drlicaauthor=H.+Hiasaauthor=R.+Kernsauthor=M.+Malikauthor=A.+Mustaevauthor=X.+Zhao&title=Quinolones%3A+action+and+resistance+updated&doi=10.2174%2F156802609789630947"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Quinolones: action and resistance updated</span></div><div class="casAuthors">Drlica, Karl; Hiasa, Hiroshi; Kerns, Robert; Malik, Muhammad; Mustaev, Arkady; Zhao, Xilin</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">981-998</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The quinolones trap DNA gyrase and DNA topoisomerase IV on DNA as complexes in which the DNA is broken but constrained by protein.  Early studies suggested that drug binding occurs largely along helix-4 of the GyrA (gyrase) and ParC (topoisomerase IV) proteins.  However, recent X-ray crystallog. shows drug intercalating between the -1 and +1 nucleotides of cut DNA, with only one end of the drug extending to helix-4.  These two models may reflect distinct structural steps in complex formation.  A consequence of drug-enzyme-DNA complex formation is reversible inhibition of DNA replication; cell death arises from subsequent events in which bacterial chromosomes are fragmented through two poorly understood pathways.  In one pathway, chromosome fragmentation stimulates excessive accumulation of highly toxic reactive oxygen species that are responsible for cell death.  Quinolone resistance arises stepwise through selective amplification of mutants when drug concns. are above the MIC and below the MPC, as obsd. with static agar plate assays, dynamic in vitro systems, and exptl. infection of rabbits.  The gap between MIC and MPC can be narrowed by compd. design that should restrict the emergence of resistance.  Resistance is likely to become increasingly important, since three types of plasmid-borne resistance have been reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwqmNnQ2e72rVg90H21EOLACvtfcHk0lhFPnZiw0R0Fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFWisb%252FF&md5=e8f8b87460d826d75acd11efceb1a7f4</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2174%2F156802609789630947&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802609789630947%26sid%3Dliteratum%253Aachs%26aulast%3DDrlica%26aufirst%3DK.%26aulast%3DHiasa%26aufirst%3DH.%26aulast%3DKerns%26aufirst%3DR.%26aulast%3DMalik%26aufirst%3DM.%26aulast%3DMustaev%26aufirst%3DA.%26aulast%3DZhao%26aufirst%3DX.%26atitle%3DQuinolones%253A%2520action%2520and%2520resistance%2520updated%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2009%26volume%3D9%26spage%3D981%26epage%3D998%26doi%3D10.2174%2F156802609789630947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laponogov, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sohi, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veselkov, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, X.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawhney, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McAuley, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanderson, M. R.</span></span> <span> </span><span class="NLM_article-title">Structural insight into the quinolone–DNA cleavage complex of type IIA topoisomerases</span>. <i>Nat. Struct. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">667</span>, <span class="refDoi"> DOI: 10.1038/nsmb.1604</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1038%2Fnsmb.1604" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=19448616" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtVOqsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=667&author=I.+Laponogovauthor=M.+K.+Sohiauthor=D.+A.+Veselkovauthor=X.-S.+Panauthor=R.+Sawhneyauthor=A.+W.+Thompsonauthor=K.+E.+McAuleyauthor=L.+M.+Fisherauthor=M.+R.+Sanderson&title=Structural+insight+into+the+quinolone%E2%80%93DNA+cleavage+complex+of+type+IIA+topoisomerases&doi=10.1038%2Fnsmb.1604"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Structural insight into the quinolone-DNA cleavage complex of type IIA topoisomerases</span></div><div class="casAuthors">Laponogov, Ivan; Sohi, Maninder K.; Veselkov, Dennis A.; Pan, Xiao-Su; Sawhney, Ritica; Thompson, Andrew W.; McAuley, Katherine E.; Fisher, L. Mark; Sanderson, Mark R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">667-669</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Type II topoisomerases alter DNA topol. by forming a covalent DNA-cleavage complex that allows DNA transport through a double-stranded DNA break.  We present the structures of cleavage complexes formed by the Streptococcus pneumoniae ParC breakage-reunion and ParE TOPRIM domains of topoisomerase IV stabilized by moxifloxacin and clinafloxacin, two antipneumococcal fluoroquinolones.  These structures reveal two drug mols. intercalated at the highly bent DNA gate and help explain antibacterial quinolone action and resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDXhjTPq1GlrVg90H21EOLACvtfcHk0lgxmXd2wO3LWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtVOqsrc%253D&md5=cd4c757dbb5d50c8113e658837d44a34</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.1604&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.1604%26sid%3Dliteratum%253Aachs%26aulast%3DLaponogov%26aufirst%3DI.%26aulast%3DSohi%26aufirst%3DM.%2BK.%26aulast%3DVeselkov%26aufirst%3DD.%2BA.%26aulast%3DPan%26aufirst%3DX.-S.%26aulast%3DSawhney%26aufirst%3DR.%26aulast%3DThompson%26aufirst%3DA.%2BW.%26aulast%3DMcAuley%26aufirst%3DK.%2BE.%26aulast%3DFisher%26aufirst%3DL.%2BM.%26aulast%3DSanderson%26aufirst%3DM.%2BR.%26atitle%3DStructural%2520insight%2520into%2520the%2520quinolone%25E2%2580%2593DNA%2520cleavage%2520complex%2520of%2520type%2520IIA%2520topoisomerases%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2009%26volume%3D16%26spage%3D667%26doi%3D10.1038%2Fnsmb.1604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laponogov, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, X.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veselkov, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McAuley, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanderson, M. R.</span></span> <span> </span><span class="NLM_article-title">Structural basis of gate-DNA breakage and resealing by type II topoisomerases</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>5</i></span>, <span class="NLM_elocation-id">e11338</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0011338</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1371%2Fjournal.pone.0011338" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=20596531" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A280%3ADC%252BC3cnksVagsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&author=I.+Laponogovauthor=X.-S.+Panauthor=D.+A.+Veselkovauthor=K.+E.+McAuleyauthor=L.+M.+Fisherauthor=M.+R.+Sanderson&title=Structural+basis+of+gate-DNA+breakage+and+resealing+by+type+II+topoisomerases&doi=10.1371%2Fjournal.pone.0011338"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of gate-DNA breakage and resealing by type II topoisomerases</span></div><div class="casAuthors">Laponogov Ivan; Pan Xiao-Su; Veselkov Dennis A; McAuley Katherine E; Fisher L Mark; Sanderson Mark R</div><div class="citationInfo"><span class="NLM_cas:title">PloS one</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e11338</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Type II DNA topoisomerases are ubiquitous enzymes with essential functions in DNA replication, recombination and transcription.  They change DNA topology by forming a transient covalent cleavage complex with a gate-DNA duplex that allows transport of a second duplex though the gate.  Despite its biological importance and targeting by anticancer and antibacterial drugs, cleavage complex formation and reversal is not understood for any type II enzyme.  To address the mechanism, we have used X-ray crystallography to study sequential states in the formation and reversal of a DNA cleavage complex by topoisomerase IV from Streptococcus pneumoniae, the bacterial type II enzyme involved in chromosome segregation.  A high resolution structure of the complex captured by a novel antibacterial dione reveals two drug molecules intercalated at a cleaved B-form DNA gate and anchored by drug-specific protein contacts.  Dione release generated drug-free cleaved and resealed DNA complexes in which the DNA gate instead adopts an unusual A/B-form helical conformation with a Mg(2+) ion repositioned to coordinate each scissile phosphodiester group and promote reversible cleavage by active-site tyrosines.  These structures, the first for putative reaction intermediates of a type II topoisomerase, suggest how a type II enzyme reseals DNA during its normal reaction cycle and illuminate aspects of drug arrest important for the development of new topoisomerase-targeting therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcShiG7Hb50Ehd0Q2ypr7jHkfW6udTcc2ebZS5d1HkS_2Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cnksVagsA%253D%253D&md5=fcddd6c8ad69c0bc09137d484aad638d</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0011338&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0011338%26sid%3Dliteratum%253Aachs%26aulast%3DLaponogov%26aufirst%3DI.%26aulast%3DPan%26aufirst%3DX.-S.%26aulast%3DVeselkov%26aufirst%3DD.%2BA.%26aulast%3DMcAuley%26aufirst%3DK.%2BE.%26aulast%3DFisher%26aufirst%3DL.%2BM.%26aulast%3DSanderson%26aufirst%3DM.%2BR.%26atitle%3DStructural%2520basis%2520of%2520gate-DNA%2520breakage%2520and%2520resealing%2520by%2520type%2520II%2520topoisomerases%26jtitle%3DPLoS%2520One%26date%3D2010%26volume%3D5%26doi%3D10.1371%2Fjournal.pone.0011338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bax, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eggleston, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fosberry, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gentry, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorrec, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giordano, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hann, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hennessy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hibbs, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">May, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saunders, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spitzfaden, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shillings, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Theobald, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wohlkonig, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearson, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gwynn, M. N.</span></span> <span> </span><span class="NLM_article-title">Type IIA topoisomerase inhibition by a new class of antibacterial agents</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>466</i></span>,  <span class="NLM_fpage">935</span>, <span class="refDoi"> DOI: 10.1038/nature09197</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1038%2Fnature09197" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=20686482" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A280%3ADC%252BC3cjmtFaktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=466&publication_year=2010&pages=935&author=B.+D.+Baxauthor=P.+F.+Chanauthor=D.+S.+Egglestonauthor=A.+Fosberryauthor=D.+R.+Gentryauthor=F.+Gorrecauthor=I.+Giordanoauthor=M.+M.+Hannauthor=A.+Hennessyauthor=M.+Hibbsauthor=J.+Huangauthor=E.+Jonesauthor=J.+Jonesauthor=K.+K.+Brownauthor=C.+J.+Lewisauthor=E.+W.+Mayauthor=M.+R.+Saundersauthor=O.+Singhauthor=C.+E.+Spitzfadenauthor=C.+Shenauthor=A.+Shillingsauthor=A.+J.+Theobaldauthor=A.+Wohlkonigauthor=N.+D.+Pearsonauthor=M.+N.+Gwynn&title=Type+IIA+topoisomerase+inhibition+by+a+new+class+of+antibacterial+agents&doi=10.1038%2Fnature09197"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Type IIA topoisomerase inhibition by a new class of antibacterial agents</span></div><div class="casAuthors">Bax Benjamin D; Chan Pan F; Eggleston Drake S; Fosberry Andrew; Gentry Daniel R; Gorrec Fabrice; Giordano Ilaria; Hann Michael M; Hennessy Alan; Hibbs Martin; Huang Jianzhong; Jones Emma; Jones Jo; Brown Kristin Koretke; Lewis Ceri J; May Earl W; Saunders Martin R; Singh Onkar; Spitzfaden Claus E; Shen Carol; Shillings Anthony; Theobald Andrew J; Wohlkonig Alexandre; Pearson Neil D; Gwynn Michael N</div><div class="citationInfo"><span class="NLM_cas:title">Nature</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">466</span>
        (<span class="NLM_cas:issue">7309</span>),
    <span class="NLM_cas:pages">935-40</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Despite the success of genomics in identifying new essential bacterial genes, there is a lack of sustainable leads in antibacterial drug discovery to address increasing multidrug resistance.  Type IIA topoisomerases cleave and religate DNA to regulate DNA topology and are a major class of antibacterial and anticancer drug targets, yet there is no well developed structural basis for understanding drug action.  Here we report the 2.1 A crystal structure of a potent, new class, broad-spectrum antibacterial agent in complex with Staphylococcus aureus DNA gyrase and DNA, showing a new mode of inhibition that circumvents fluoroquinolone resistance in this clinically important drug target.  The inhibitor 'bridges' the DNA and a transient non-catalytic pocket on the two-fold axis at the GyrA dimer interface, and is close to the active sites and fluoroquinolone binding sites.  In the inhibitor complex the active site seems poised to cleave the DNA, with a single metal ion observed between the TOPRIM (topoisomerase/primase) domain and the scissile phosphate.  This work provides new insights into the mechanism of topoisomerase action and a platform for structure-based drug design of a new class of antibacterial agents against a clinically proven, but conformationally flexible, enzyme class.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTzBPk2FYUX-kBuFdjgVNKSfW6udTcc2eYaEabl8_jx6rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cjmtFaktA%253D%253D&md5=006fef200c7a44f0671829b2a5fbddef</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnature09197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09197%26sid%3Dliteratum%253Aachs%26aulast%3DBax%26aufirst%3DB.%2BD.%26aulast%3DChan%26aufirst%3DP.%2BF.%26aulast%3DEggleston%26aufirst%3DD.%2BS.%26aulast%3DFosberry%26aufirst%3DA.%26aulast%3DGentry%26aufirst%3DD.%2BR.%26aulast%3DGorrec%26aufirst%3DF.%26aulast%3DGiordano%26aufirst%3DI.%26aulast%3DHann%26aufirst%3DM.%2BM.%26aulast%3DHennessy%26aufirst%3DA.%26aulast%3DHibbs%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DJones%26aufirst%3DE.%26aulast%3DJones%26aufirst%3DJ.%26aulast%3DBrown%26aufirst%3DK.%2BK.%26aulast%3DLewis%26aufirst%3DC.%2BJ.%26aulast%3DMay%26aufirst%3DE.%2BW.%26aulast%3DSaunders%26aufirst%3DM.%2BR.%26aulast%3DSingh%26aufirst%3DO.%26aulast%3DSpitzfaden%26aufirst%3DC.%2BE.%26aulast%3DShen%26aufirst%3DC.%26aulast%3DShillings%26aufirst%3DA.%26aulast%3DTheobald%26aufirst%3DA.%2BJ.%26aulast%3DWohlkonig%26aufirst%3DA.%26aulast%3DPearson%26aufirst%3DN.%2BD.%26aulast%3DGwynn%26aufirst%3DM.%2BN.%26atitle%3DType%2520IIA%2520topoisomerase%2520inhibition%2520by%2520a%2520new%2520class%2520of%2520antibacterial%2520agents%26jtitle%3DNature%26date%3D2010%26volume%3D466%26spage%3D935%26doi%3D10.1038%2Fnature09197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wohlkonig, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fosberry, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Homes, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kranz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leydon, V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miles, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearson, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perera, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shillings, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gwynn, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bax, B. D.</span></span> <span> </span><span class="NLM_article-title">Structural basis of quinolone inhibition of type IIA topoisomerases and target-mediated resistance</span>. <i>Nat. Struct. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1152</span>, <span class="refDoi"> DOI: 10.1038/nsmb.1892</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1038%2Fnsmb.1892" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=20802486" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVyiu7zM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=1152&author=A.+Wohlkonigauthor=P.+F.+Chanauthor=A.+P.+Fosberryauthor=P.+Homesauthor=J.+Huangauthor=M.+Kranzauthor=V.+R.+Leydonauthor=T.+J.+Milesauthor=N.+D.+Pearsonauthor=R.+L.+Pereraauthor=A.+J.+Shillingsauthor=M.+N.+Gwynnauthor=B.+D.+Bax&title=Structural+basis+of+quinolone+inhibition+of+type+IIA+topoisomerases+and+target-mediated+resistance&doi=10.1038%2Fnsmb.1892"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of quinolone inhibition of type IIA topoisomerases and target-mediated resistance</span></div><div class="casAuthors">Wohlkonig, Alexandre; Chan, Pan F.; Fosberry, Andrew P.; Homes, Paul; Huang, Jianzhong; Kranz, Michael; Leydon, Vaughan R.; Miles, Timothy J.; Pearson, Neil D.; Perera, Rajika L.; Shillings, Anthony J.; Gwynn, Michael N.; Bax, Benjamin D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1152-1153</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Quinolone antibacterials have been used to treat bacterial infections for over 40 years.  A crystal structure of moxifloxacin in complex with Acinetobacter baumannii topoisomerase IV now shows the wedge-shaped quinolone stacking between base pairs at the DNA cleavage site and binding conserved residues in the DNA cleavage domain through chelation of a noncatalytic magnesium ion.  This provides a mol. basis for the quinolone inhibition mechanism, resistance mutations and invariant quinolone antibacterial structural features.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpI2l3ADVYI8LVg90H21EOLACvtfcHk0lgSq_V0e1u-iA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVyiu7zM&md5=f976bba2c8333f7a59eacd8833fddcec</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.1892&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.1892%26sid%3Dliteratum%253Aachs%26aulast%3DWohlkonig%26aufirst%3DA.%26aulast%3DChan%26aufirst%3DP.%2BF.%26aulast%3DFosberry%26aufirst%3DA.%2BP.%26aulast%3DHomes%26aufirst%3DP.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DKranz%26aufirst%3DM.%26aulast%3DLeydon%26aufirst%3DV.%2BR.%26aulast%3DMiles%26aufirst%3DT.%2BJ.%26aulast%3DPearson%26aufirst%3DN.%2BD.%26aulast%3DPerera%26aufirst%3DR.%2BL.%26aulast%3DShillings%26aufirst%3DA.%2BJ.%26aulast%3DGwynn%26aufirst%3DM.%2BN.%26aulast%3DBax%26aufirst%3DB.%2BD.%26atitle%3DStructural%2520basis%2520of%2520quinolone%2520inhibition%2520of%2520type%2520IIA%2520topoisomerases%2520and%2520target-mediated%2520resistance%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2010%26volume%3D17%26spage%3D1152%26doi%3D10.1038%2Fnsmb.1892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aldred, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McPherson, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerns, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graves, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turnbough, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osheroff, N.</span></span> <span> </span><span class="NLM_article-title">Drug interactions with <i>Bacillus anthracis</i> topoisomerase IV: biochemical basis for quinolone action and resistance</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">370</span>– <span class="NLM_lpage">381</span>, <span class="refDoi"> DOI: 10.1021/bi2013905</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi2013905" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFCmsrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=370-381&author=K.+J.+Aldredauthor=S.+A.+McPhersonauthor=P.+Wangauthor=R.+J.+Kernsauthor=D.+E.+Gravesauthor=C.+L.+Turnboughauthor=N.+Osheroff&title=Drug+interactions+with+Bacillus+anthracis+topoisomerase+IV%3A+biochemical+basis+for+quinolone+action+and+resistance&doi=10.1021%2Fbi2013905"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Drug Interactions with Bacillus anthracis Topoisomerase IV: Biochemical Basis for Quinolone Action and Resistance</span></div><div class="casAuthors">Aldred, Katie J.; McPherson, Sylvia A.; Wang, Pengfei; Kerns, Robert J.; Graves, David E.; Turnbough, Charles L., Jr.; Osheroff, Neil</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">370-381</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Bacillus anthracis, the causative agent of anthrax, is considered a serious threat as a bioweapon.  The drugs most commonly used to treat anthrax are quinolones, which act by increasing the levels of DNA cleavage mediated by topoisomerase IV and gyrase.  Quinolone resistance most often is assocd. with specific serine mutations in these enzymes.  Therefore, to det. the basis for quinolone action and resistance, we characterized wild-type B. anthracis topoisomerase IV, the GrlAS81F and GrlAS81Y quinolone-resistant mutants, and the effects of quinolones and a related quinazolinedione on these enzymes.  Ser81 is believed to anchor a water-Mg2+ bridge that coordinates quinolones to the enzyme through the C3/C4 keto acid.  Consistent with this hypothesized bridge, ciprofloxacin required increased Mg2+ concns. to support DNA cleavage by GrlAS81F topoisomerase IV.  The three enzymes displayed similar catalytic activities in the absence of drugs.  However, the resistance mutations decreased the affinity of topoisomerase IV for ciprofloxacin and other quinolones, diminished quinolone-induced inhibition of DNA religation, and reduced the stability of the enzyme-quinolone-DNA ternary complex.  Wild-type DNA cleavage levels were generated by mutant enzymes at high quinolone concns., suggesting that increased drug potency could overcome resistance.  8-Methyl-quinazoline-2,4-dione, which lacks the quinolone keto acid (and presumably does not require the water-Mg2+ bridge to mediate protein interactions), was more potent than quinolones against wild-type topoisomerase IV and was equally efficacious.  Moreover, it maintained high potency and efficacy against the mutant enzymes, effectively inhibited DNA religation, and formed stable ternary complexes.  Our findings provide an underlying biochem. basis for the ability of quinazolinediones to overcome clin. relevant quinolone resistance mutations in bacterial type II topoisomerases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvcIuUvZ7BNbVg90H21EOLACvtfcHk0lj-31-rlwAgMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFCmsrbM&md5=0be648ba3469ab016e6d52ee18b8ea94</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fbi2013905&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi2013905%26sid%3Dliteratum%253Aachs%26aulast%3DAldred%26aufirst%3DK.%2BJ.%26aulast%3DMcPherson%26aufirst%3DS.%2BA.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DKerns%26aufirst%3DR.%2BJ.%26aulast%3DGraves%26aufirst%3DD.%2BE.%26aulast%3DTurnbough%26aufirst%3DC.%2BL.%26aulast%3DOsheroff%26aufirst%3DN.%26atitle%3DDrug%2520interactions%2520with%2520Bacillus%2520anthracis%2520topoisomerase%2520IV%253A%2520biochemical%2520basis%2520for%2520quinolone%2520action%2520and%2520resistance%26jtitle%3DBiochemistry%26date%3D2012%26volume%3D51%26spage%3D370%26epage%3D381%26doi%3D10.1021%2Fbi2013905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aldred, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McPherson, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turnbough, C. L.,  Jr</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerns, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osheroff, N.</span></span> <span> </span><span class="NLM_article-title">Topoisomerase IV-quinolone interactions are mediated through a water-metal ion bridge: mechanistic basis of quinolone resistance</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">4628</span>– <span class="NLM_lpage">4639</span>, <span class="refDoi"> DOI: 10.1093/nar/gkt124</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1093%2Fnar%2Fgkt124" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=23460203" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmt1Ogtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2013&pages=4628-4639&author=K.+J.+Aldredauthor=S.+A.+McPhersonauthor=C.+L.+Turnboughauthor=R.+J.+Kernsauthor=N.+Osheroff&title=Topoisomerase+IV-quinolone+interactions+are+mediated+through+a+water-metal+ion+bridge%3A+mechanistic+basis+of+quinolone+resistance&doi=10.1093%2Fnar%2Fgkt124"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Topoisomerase IV-quinolone interactions are mediated through a water-metal ion bridge: mechanistic basis of quinolone resistance</span></div><div class="casAuthors">Aldred, Katie J.; McPherson, Sylvia A.; Turnbough, Charles L., Jr.; Kerns, Robert J.; Osheroff, Neil</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4628-4639</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Although quinolones are the most commonly prescribed antibacterials, their use is threatened by an increasing prevalence of resistance.  The most common causes of quinolone resistance are mutations of a specific serine or acidic residue in the A subunit of gyrase or topoisomerase IV.  These amino acids are proposed to serve as a crit. enzyme-quinolone interaction site by anchoring a water-metal ion bridge that coordinates drug binding.  To probe the role of the proposed water-metal ion bridge, we characterized wild-type, GrlAE85K, GrlAS81F/E85K, GrlAE85A, GrlAS81F/E85A and GrlAS81F Bacillus anthracis topoisomerase IV, their sensitivity to quinolones and related drugs and their use of metal ions.  Mutations increased the Mg2+ concn. required to produce maximal quinolone-induced DNA cleavage and restricted the divalent metal ions that could support quinolone activity.  Individual mutation of Ser81 or Glu85 partially disrupted bridge function, whereas simultaneous mutation of both residues abrogated protein-quinolone interactions.  Results provide functional evidence for the existence of the water-metal ion bridge, confirm that the serine and glutamic acid residues anchor the bridge, demonstrate that the bridge is the primary conduit for interactions between clin. relevant quinolones and topoisomerase IV and provide a likely mechanism for the most common causes of quinolone resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPSuOqUa7W0rVg90H21EOLACvtfcHk0lj-31-rlwAgMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmt1Ogtrs%253D&md5=0fa21970393a30f462874f0f1e8ee381</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkt124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkt124%26sid%3Dliteratum%253Aachs%26aulast%3DAldred%26aufirst%3DK.%2BJ.%26aulast%3DMcPherson%26aufirst%3DS.%2BA.%26aulast%3DTurnbough%26aufirst%3DC.%2BL.%26aulast%3DKerns%26aufirst%3DR.%2BJ.%26aulast%3DOsheroff%26aufirst%3DN.%26atitle%3DTopoisomerase%2520IV-quinolone%2520interactions%2520are%2520mediated%2520through%2520a%2520water-metal%2520ion%2520bridge%253A%2520mechanistic%2520basis%2520of%2520quinolone%2520resistance%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2013%26volume%3D41%26spage%3D4628%26epage%3D4639%26doi%3D10.1093%2Fnar%2Fgkt124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aldred, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breland, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vlckova, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strub, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neuman, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerns, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osheroff, N.</span></span> <span> </span><span class="NLM_article-title">Role of the water-metal ion bridge in mediating interactions between quinolones and <i>Escherichia coli</i> topoisomerase IV</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">5558</span>– <span class="NLM_lpage">5567</span>, <span class="refDoi"> DOI: 10.1021/bi500682e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi500682e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlagu7jJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=5558-5567&author=K.+J.+Aldredauthor=E.+J.+Brelandauthor=V.+Vlckovaauthor=M.+P.+Strubauthor=K.+C.+Neumanauthor=R.+J.+Kernsauthor=N.+Osheroff&title=Role+of+the+water-metal+ion+bridge+in+mediating+interactions+between+quinolones+and+Escherichia+coli+topoisomerase+IV&doi=10.1021%2Fbi500682e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Role of the Water-Metal Ion Bridge in Mediating Interactions between Quinolones and Escherichia coli Topoisomerase IV</span></div><div class="casAuthors">Aldred, Katie J.; Breland, Erin J.; Vlckova, Vladislava; Strub, Marie-Paule; Neuman, Keir C.; Kerns, Robert J.; Osheroff, Neil</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">5558-5567</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Although quinolones have been in clin. use for decades, the mechanism underlying drug activity and resistance has remained elusive.  However, recent studies indicate that clin. relevant quinolones interact with Bacillus anthracis (Gram-pos.) topoisomerase IV through a crit. water-metal ion bridge and that the most common quinolone resistance mutations decrease drug activity by disrupting this bridge.  As a first step toward detg. whether the water-metal ion bridge is a general mechanism of quinolone-topoisomerase interaction, the authors characterized drug interactions with wild-type Escherichia coli (Gram-neg.) topoisomerase IV and a series of ParC enzymes with mutations (S80L, S80I, S80F, and E84K) in the predicted bridge-anchoring residues.  Results strongly suggest that the water-metal ion bridge is essential for quinolone activity against E. coli topoisomerase IV.  Although the bridge represents a common and crit. mechanism that underlies broad-spectrum quinolone function, it appears to play different roles in B. anthracis and E. coli topoisomerase IV.  The water-metal ion bridge is the most important binding contact of clin. relevant quinolones with the Gram-pos. enzyme.  However, it primarily acts to properly align clin. relevant quinolones with E. coli topoisomerase IV.  Finally, even though ciprofloxacin is unable to increase levels of DNA cleavage mediated by several of the Ser 80 and Glu 84 mutant E. coli enzymes, the drug still retains the ability to inhibit the overall catalytic activity of these topoisomerase IV proteins.  Inhibition parallels drug binding, suggesting that the presence of the drug in the active site is sufficient to diminish DNA relaxation rates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUy9fHVTEfFrVg90H21EOLACvtfcHk0ljOkQrzxbYz5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlagu7jJ&md5=a8f8cdb8a0930907dc398b69dda65449</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fbi500682e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi500682e%26sid%3Dliteratum%253Aachs%26aulast%3DAldred%26aufirst%3DK.%2BJ.%26aulast%3DBreland%26aufirst%3DE.%2BJ.%26aulast%3DVlckova%26aufirst%3DV.%26aulast%3DStrub%26aufirst%3DM.%2BP.%26aulast%3DNeuman%26aufirst%3DK.%2BC.%26aulast%3DKerns%26aufirst%3DR.%2BJ.%26aulast%3DOsheroff%26aufirst%3DN.%26atitle%3DRole%2520of%2520the%2520water-metal%2520ion%2520bridge%2520in%2520mediating%2520interactions%2520between%2520quinolones%2520and%2520Escherichia%2520coli%2520topoisomerase%2520IV%26jtitle%3DBiochemistry%26date%3D2014%26volume%3D53%26spage%3D5558%26epage%3D5567%26doi%3D10.1021%2Fbi500682e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Veselkov, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laponogov, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, X.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selvarajah, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skamrova, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Branstrom, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narasimhan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prasad, J. V. N. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanderson, M. R.</span></span> <span> </span><span class="NLM_article-title">Structure of a quinolone-stabilized cleavage complex of topoisomerase IV from <i>Klebsiella pneumoniae</i> and comparison with a related <i>Streptococcus pneumoniae</i> complex</span>. <i>Acta Cryst. D Struct. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">488</span>– <span class="NLM_lpage">496</span>, <span class="refDoi"> DOI: 10.1107/S2059798316001212</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1107%2FS2059798316001212" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=27050128" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC28XlsFSkuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2016&pages=488-496&author=D.+A.+Veselkovauthor=I.+Laponogovauthor=X.-S.+Panauthor=J.+Selvarajahauthor=G.+B.+Skamrovaauthor=A.+Branstromauthor=J.+Narasimhanauthor=J.+V.+N.+V.+Prasadauthor=L.+M.+Fisherauthor=M.+R.+Sanderson&title=Structure+of+a+quinolone-stabilized+cleavage+complex+of+topoisomerase+IV+from+Klebsiella+pneumoniae+and+comparison+with+a+related+Streptococcus+pneumoniae+complex&doi=10.1107%2FS2059798316001212"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of a quinolone-stabilized cleavage complex of topoisomerase IV from Klebsiella pneumoniae and comparison with a related Streptococcus pneumoniae complex</span></div><div class="casAuthors">Veselkov, Dennis A.; Laponogov, Ivan; Pan, Xiao-Su; Selvarajah, Jogitha; Skamrova, Galyna B.; Branstrom, Arthur; Narasimhan, Jana; Prasad, Josyula V. N. Vara; Fisher, L. Mark; Sanderson, Mark R.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Structural Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">488-496</span>CODEN:
                <span class="NLM_cas:coden">ACSDAD</span>;
        ISSN:<span class="NLM_cas:issn">2059-7983</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">K. pneumoniae is a Gram-neg. bacterium that is responsible for a range of common infections, including pulmonary pneumonia, bloodstream infections, and meningitis.  Certain strains of Klebsiella have become highly resistant to antibiotics.  Despite the vast amt. of research carried out on this class of bacteria, the mol. structure of its DNA topoisomerase IV, a type II topoisomerase essential for catalyzing chromosomal segregation, has remained unknown.  Here, the structure of its DNA-cleavage complex is reported at 3.35 Å resoln.  The complex was comprised of ParC breakage-reunion and ParE TOPRIM domains of K. pneumoniae topoisomerase IV with DNA stabilized by levofloxacin, a broad-spectrum fluoroquinolone antimicrobial agent.  This complex was compared with a similar complex from S. pneumoniae, which was recently solved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUi0Htw72iMrVg90H21EOLACvtfcHk0ljOkQrzxbYz5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlsFSkuro%253D&md5=82280462273a279587a0c279ea7104e0</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1107%2FS2059798316001212&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS2059798316001212%26sid%3Dliteratum%253Aachs%26aulast%3DVeselkov%26aufirst%3DD.%2BA.%26aulast%3DLaponogov%26aufirst%3DI.%26aulast%3DPan%26aufirst%3DX.-S.%26aulast%3DSelvarajah%26aufirst%3DJ.%26aulast%3DSkamrova%26aufirst%3DG.%2BB.%26aulast%3DBranstrom%26aufirst%3DA.%26aulast%3DNarasimhan%26aufirst%3DJ.%26aulast%3DPrasad%26aufirst%3DJ.%2BV.%2BN.%2BV.%26aulast%3DFisher%26aufirst%3DL.%2BM.%26aulast%3DSanderson%26aufirst%3DM.%2BR.%26atitle%3DStructure%2520of%2520a%2520quinolone-stabilized%2520cleavage%2520complex%2520of%2520topoisomerase%2520IV%2520from%2520Klebsiella%2520pneumoniae%2520and%2520comparison%2520with%2520a%2520related%2520Streptococcus%2520pneumoniae%2520complex%26jtitle%3DActa%2520Cryst.%2520D%2520Struct.%2520Biol.%26date%3D2016%26volume%3D72%26spage%3D488%26epage%3D496%26doi%3D10.1107%2FS2059798316001212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Domagala, J. M.</span>; <span class="NLM_string-name">Hagen, S. E.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationships of the quinolone antibacterials in the new millenium: some things change and some do not</span>. In  <i>Quinolone Antimicrobial Agents</i>, <span class="NLM_edition">3</span>rd ed.; <span class="NLM_contrib-group"><span class="NLM_string-name">Hooper, D. C.</span>, <span class="NLM_string-name">Rubinstein, E.</span></span>, Eds.; <span class="NLM_publisher-name">ASM Press</span>: <span class="NLM_publisher-loc">Washington, D.C.</span>, <span class="NLM_year">2003</span>; pp  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">18</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1128%2F9781555817817.ch1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&pages=3-18&author=J.+M.+Domagala&author=S.+E.+Hagenauthor=D.+C.+Hooper&author=E.+Rubinstein&title=Quinolone+Antimicrobial+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1128%2F9781555817817.ch1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1128%252F9781555817817.ch1%26sid%3Dliteratum%253Aachs%26aulast%3DDomagala%26aufirst%3DJ.%2BM.%26atitle%3DStructure-activity%2520relationships%2520of%2520the%2520quinolone%2520antibacterials%2520in%2520the%2520new%2520millenium%253A%2520some%2520things%2520change%2520and%2520some%2520do%2520not%26btitle%3DQuinolone%2520Antimicrobial%2520Agents%26aulast%3DHooper%26aufirst%3DD.%2BC.%26pub%3DASM%2520Press%26date%3D2003%26spage%3D3%26epage%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aldred, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerns, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osheroff, N.</span></span> <span> </span><span class="NLM_article-title">Mechanism of quinolone action and resistance</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">1565</span>– <span class="NLM_lpage">1574</span>, <span class="refDoi"> DOI: 10.1021/bi5000564</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi5000564" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjt1ymtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=1565-1574&author=K.+J.+Aldredauthor=R.+J.+Kernsauthor=N.+Osheroff&title=Mechanism+of+quinolone+action+and+resistance&doi=10.1021%2Fbi5000564"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of quinolone action and resistance</span></div><div class="casAuthors">Aldred, Katie J.; Kerns, Robert J.; Osheroff, Neil</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1565-1574</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Quinolones are one of the most commonly prescribed classes of antibacterials in the world and are used to treat a variety of bacterial infections in humans.  Because of the wide use (and overuse) of these drugs, the no. of quinolone-resistant bacterial strains has been growing steadily since the 1990s.  As is the case with other antibacterial agents, the rise in quinolone resistance threatens the clin. utility of this important drug class.  Quinolones act by converting their targets, gyrase and topoisomerase IV, into toxic enzymes that fragment the bacterial chromosome.  This review describes the development of the quinolones as antibacterials, the structure and function of gyrase and topoisomerase IV, and the mechanistic basis for quinolone action against their enzyme targets.  It will then discuss the following three mechanisms that decrease the sensitivity of bacterial cells to quinolones.  Target-mediated resistance is the most common and clin. significant form of resistance.  It is caused by specific mutations in gyrase and topoisomerase IV that weaken interactions between quinolones and these enzymes.  Plasmid-mediated resistance results from extrachromosomal elements that encode proteins that disrupt quinolone-enzyme interactions, alter drug metab., or increase quinolone efflux.  Chromosome-mediated resistance results from the underexpression of porins or the overexpression of cellular efflux pumps, both of which decrease cellular concns. of quinolones.  Finally, this review discusses recent advancements in our understanding of how quinolones interact with gyrase and topoisomerase IV and how mutations in these enzymes cause resistance.  These last findings suggest approaches to designing new drugs that display improved activity against resistant strains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro57dziddbmLVg90H21EOLACvtfcHk0liI1oGIJdkf-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjt1ymtrk%253D&md5=38134014d5acd1d5c807095eaba34e3b</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fbi5000564&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi5000564%26sid%3Dliteratum%253Aachs%26aulast%3DAldred%26aufirst%3DK.%2BJ.%26aulast%3DKerns%26aufirst%3DR.%2BJ.%26aulast%3DOsheroff%26aufirst%3DN.%26atitle%3DMechanism%2520of%2520quinolone%2520action%2520and%2520resistance%26jtitle%3DBiochemistry%26date%3D2014%26volume%3D53%26spage%3D1565%26epage%3D1574%26doi%3D10.1021%2Fbi5000564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hooper, D. C.</span>; <span class="NLM_string-name">Jacoby, G. A.</span></span> <span> </span><span class="NLM_article-title">Topoisomerase inhibitors: fluoroquinolone mechanisms of action and resistance</span>.  <i>Cold Spring Harbor Perspect. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume">6</span>, <span class="refDoi"> DOI: 10.1101/cshperspect.a025320</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1101%2Fcshperspect.a025320" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=27449972" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&author=D.+C.+Hooper&author=G.+A.+Jacoby&title=Topoisomerase+inhibitors%3A+fluoroquinolone+mechanisms+of+action+and+resistance&doi=10.1101%2Fcshperspect.a025320"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1101%2Fcshperspect.a025320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fcshperspect.a025320%26sid%3Dliteratum%253Aachs%26aulast%3DHooper%26aufirst%3DD.%2BC.%26atitle%3DTopoisomerase%2520inhibitors%253A%2520fluoroquinolone%2520mechanisms%2520of%2520action%2520and%2520resistance%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspect.%2520Med.%26date%3D2016%26volume%3D6%26doi%3D10.1101%2Fcshperspect.a025320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span> </span><span class="NLM_article-title">Antibiotic Resistance Threats in the United
States. 2019</span>. <a href="https://www.cdc.gov/drugresistance/pdf/threats-report/2019-ar-threats-report-508.pdf" class="extLink">https://www.cdc.gov/drugresistance/pdf/threats-report/2019-ar-threats-report-508.pdf</a> (accessed Mar 25, <span class="NLM_year">2020</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Antibiotic+Resistance+Threats+in+the+United%0AStates.+2019.+https%3A%2F%2Fwww.cdc.gov%2Fdrugresistance%2Fpdf%2Fthreats-report%2F2019-ar-threats-report-508.pdf+%28accessed+Mar+25%2C+2020%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DAntibiotic%2520Resistance%2520Threats%2520in%2520the%2520United%250AStates.%25202019%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span> </span><span class="NLM_article-title">Antimicrobial
Resistance: Global Report on Surveillance 2014</span>. <a href="http://www.who.int/drugresistance/documents/surveillancereport/en/" class="extLink">http://www.who.int/drugresistance/documents/surveillancereport/en/</a> (accessed May 24, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Antimicrobial%0AResistance%3A+Global+Report+on+Surveillance+2014.+http%3A%2F%2Fwww.who.int%2Fdrugresistance%2Fdocuments%2Fsurveillancereport%2Fen%2F+%28accessed+May+24%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DAntimicrobial%250AResistance%253A%2520Global%2520Report%2520on%2520Surveillance%25202014%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span> </span><span class="NLM_article-title">A Scientific
Roadmap for Antibiotic Discovery</span>. <a href="https://www.pewtrusts.org/en/research-and-analysis/reports/2016/05/a-scientific-roadmap-for-antibiotic-discovery" class="extLink">https://www.pewtrusts.org/en/research-and-analysis/reports/2016/05/a-scientific-roadmap-for-antibiotic-discovery</a> (accessed Mar 20, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=A+Scientific%0ARoadmap+for+Antibiotic+Discovery.+https%3A%2F%2Fwww.pewtrusts.org%2Fen%2Fresearch-and-analysis%2Freports%2F2016%2F05%2Fa-scientific-roadmap-for-antibiotic-discovery+%28accessed+Mar+20%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DA%2520Scientific%250ARoadmap%2520for%2520Antibiotic%2520Discovery%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alanis, A. J.</span></span> <span> </span><span class="NLM_article-title">Resistance to antibiotics: are we in the post-antibiotic era?</span>. <i>Arch. Med. Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">697</span>– <span class="NLM_lpage">705</span>, <span class="refDoi"> DOI: 10.1016/j.arcmed.2005.06.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1016%2Fj.arcmed.2005.06.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=16216651" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A280%3ADC%252BD2MrktVCjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2005&pages=697-705&author=A.+J.+Alanis&title=Resistance+to+antibiotics%3A+are+we+in+the+post-antibiotic+era%3F&doi=10.1016%2Fj.arcmed.2005.06.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Resistance to antibiotics: are we in the post-antibiotic era?</span></div><div class="casAuthors">Alanis Alfonso J</div><div class="citationInfo"><span class="NLM_cas:title">Archives of medical research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">697-705</span>
        ISSN:<span class="NLM_cas:issn">0188-4409</span>.
    </div><div class="casAbstract">Serious infections caused by bacteria that have become resistant to commonly used antibiotics have become a major global healthcare problem in the 21st century.  They not only are more severe and require longer and more complex treatments, but they are also significantly more expensive to diagnose and to treat.  Antibiotic resistance, initially a problem of the hospital setting associated with an increased number of hospital-acquired infections usually in critically ill and immunosuppressed patients, has now extended into the community causing severe infections difficult to diagnose and treat.  The molecular mechanisms by which bacteria have become resistant to antibiotics are diverse and complex.  Bacteria have developed resistance to all different classes of antibiotics discovered to date.  The most frequent type of resistance is acquired and transmitted horizontally via the conjugation of a plasmid.  In recent times new mechanisms of resistance have resulted in the simultaneous development of resistance to several antibiotic classes creating very dangerous multidrug-resistant (MDR) bacterial strains, some also known as "superbugs".  The indiscriminate and inappropriate use of antibiotics in outpatient clinics, hospitalized patients and in the food industry is the single largest factor leading to antibiotic resistance.  In recent years, the number of new antibiotics licensed for human use in different parts of the world has been lower than in the recent past.  In addition, there has been less innovation in the field of antimicrobial discovery research and development.  The pharmaceutical industry, large academic institutions or the government are not investing the necessary resources to produce the next generation of newer safe and effective antimicrobial drugs.  In many cases, large pharmaceutical companies have terminated their anti-infective research programs altogether due to economic reasons.  The potential negative consequences of all these events are relevant because they put society at risk for the spread of potentially serious MDR bacterial infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRgpn0xJW6vgQpJitSxOdIlfW6udTcc2eb-SbaI3dVULbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MrktVCjuw%253D%253D&md5=f743e06f1cb080a86bebf66a6b6e6eec</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.arcmed.2005.06.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.arcmed.2005.06.009%26sid%3Dliteratum%253Aachs%26aulast%3DAlanis%26aufirst%3DA.%2BJ.%26atitle%3DResistance%2520to%2520antibiotics%253A%2520are%2520we%2520in%2520the%2520post-antibiotic%2520era%253F%26jtitle%3DArch.%2520Med.%2520Res.%26date%3D2005%26volume%3D36%26spage%3D697%26epage%3D705%26doi%3D10.1016%2Fj.arcmed.2005.06.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gums, J. G.</span></span> <span> </span><span class="NLM_article-title">The emergence and evolution of antimicrobial resistance: Impact on a global scale</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">6440</span>– <span class="NLM_lpage">6445</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2016.04.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1016%2Fj.bmc.2016.04.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=27117692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC28XmslSntbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=6440-6445&author=A.+Y.+Hwangauthor=J.+G.+Gums&title=The+emergence+and+evolution+of+antimicrobial+resistance%3A+Impact+on+a+global+scale&doi=10.1016%2Fj.bmc.2016.04.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">The emergence and evolution of antimicrobial resistance: Impact on a global scale</span></div><div class="casAuthors">Hwang, Andrew Y.; Gums, John G.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6440-6445</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The evolution of antimicrobial resistance is a multifaceted issue that is influenced by numerous factors.  This growing healthcare problem has significantly impacted the public welfare and has substantially burdened the economic system on a global scale.  In an effort to combat this rising problem, several strategies have been implemented in the recent years to stall the progression and decrease the emergence of antimicrobial resistance.  The aim of this review article is to describe the various factors that have contributed to the current state of antimicrobial resistance and to evaluate potential strategies developed to reduce the burden of antimicrobial resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCVm82PSc2ybVg90H21EOLACvtfcHk0liKiOiebU2Dig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmslSntbg%253D&md5=895c0fe91316bd399483d2c76f67242d</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.04.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.04.027%26sid%3Dliteratum%253Aachs%26aulast%3DHwang%26aufirst%3DA.%2BY.%26aulast%3DGums%26aufirst%3DJ.%2BG.%26atitle%3DThe%2520emergence%2520and%2520evolution%2520of%2520antimicrobial%2520resistance%253A%2520Impact%2520on%2520a%2520global%2520scale%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26spage%3D6440%26epage%3D6445%26doi%3D10.1016%2Fj.bmc.2016.04.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Overbye, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrett, J.</span></span> <span> </span><span class="NLM_article-title">Antibiotics: Where did we go wrong?</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">45</span>– <span class="NLM_lpage">52</span>, <span class="refDoi"> DOI: 10.1016/S1359-6446(04)03285-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1016%2FS1359-6446%2804%2903285-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=15676298" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A280%3ADC%252BD2M%252FkvFOhtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2005&pages=45-52&author=K.+Overbyeauthor=J.+Barrett&title=Antibiotics%3A+Where+did+we+go+wrong%3F&doi=10.1016%2FS1359-6446%2804%2903285-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Antibiotics: where did we go wrong?</span></div><div class="casAuthors">Overbye Karen M; Barrett John F</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45-52</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">In the late 1960s, the medical need for new antibiotics began to be questioned, and the pharmaceutical industry shifted its emphasis of antibacterials from that of a therapeutic leader to a low-priority research area.  Although infectious diseases, in particular those caused by bacterial infections, are still among the top causes of mortality in the world, industrial support continues to wane.  The shift from this important area of antimicrobial research has been attributed to a combination of science, medical, marketing and business reasons.  This decline in antibacterial drug discovery, coupled with increasing risk as a result of infections caused by drug-resistant bacterial pathogens, represents a clear public health threat.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS--fo71XGN1X6CEoQgWY10fW6udTcc2eaG8_YeB1AL27ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2M%252FkvFOhtA%253D%253D&md5=9d48b7cd2b497d8db69f0fae744f7baf</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903285-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903285-4%26sid%3Dliteratum%253Aachs%26aulast%3DOverbye%26aufirst%3DK.%26aulast%3DBarrett%26aufirst%3DJ.%26atitle%3DAntibiotics%253A%2520Where%2520did%2520we%2520go%2520wrong%253F%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2005%26volume%3D10%26spage%3D45%26epage%3D52%26doi%3D10.1016%2FS1359-6446%2804%2903285-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spellberg, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guidos, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boucher, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheld, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartlett, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, J.,  Jr</span></span> <span> </span><span class="NLM_article-title">The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America</span>. <i>Clin. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">155</span>– <span class="NLM_lpage">164</span>, <span class="refDoi"> DOI: 10.1086/524891</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1086%2F524891" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=18171244" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A280%3ADC%252BD1c%252FgslGitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2008&pages=155-164&author=B.+Spellbergauthor=R.+Guidosauthor=D.+Gilbertauthor=J.+Bradleyauthor=H.+W.+Boucherauthor=W.+M.+Scheldauthor=J.+G.+Bartlettauthor=J.+Edwards&title=The+epidemic+of+antibiotic-resistant+infections%3A+a+call+to+action+for+the+medical+community+from+the+Infectious+Diseases+Society+of+America&doi=10.1086%2F524891"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America</span></div><div class="casAuthors">Spellberg Brad; Guidos Robert; Gilbert David; Bradley John; Boucher Helen W; Scheld W Michael; Bartlett John G; Edwards John Jr</div><div class="citationInfo"><span class="NLM_cas:title">Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">155-64</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The ongoing explosion of antibiotic-resistant infections continues to plague global and US health care.  Meanwhile, an equally alarming decline has occurred in the research and development of new antibiotics to deal with the threat.  In response to this microbial "perfect storm," in 2001, the federal Interagency Task Force on Antimicrobial Resistance released the "Action Plan to Combat Antimicrobial Resistance; Part 1: Domestic" to strengthen the response in the United States.  The Infectious Diseases Society of America (IDSA) followed in 2004 with its own report, "Bad Bugs, No Drugs: As Antibiotic Discovery Stagnates, A Public Health Crisis Brews," which proposed incentives to reinvigorate pharmaceutical investment in antibiotic research and development.  The IDSA's subsequent lobbying efforts led to the introduction of promising legislation in the 109 th US Congress (January 2005-December 2006).  Unfortunately, the legislation was not enacted.  During the 110 th Congress, the IDSA has continued to work with congressional leaders on promising legislation to address antibiotic-resistant infection.  Nevertheless, despite intensive public relations and lobbying efforts, it remains unclear whether sufficiently robust legislation will be enacted.  In the meantime, microbes continue to become more resistant, the antibiotic pipeline continues to diminish, and the majority of the public remains unaware of this critical situation.  The result of insufficient federal funding; insufficient surveillance, prevention, and control; insufficient research and development activities; misguided regulation of antibiotics in agriculture and, in particular, for food animals; and insufficient overall coordination of US (and international) efforts could mean a literal return to the preantibiotic era for many types of infections.  If we are to address the antimicrobial resistance crisis, a concerted, grassroots effort led by the medical community will be required.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ5IgYdIVkSKVf1XRtfYM0dfW6udTcc2eaG8_YeB1AL27ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c%252FgslGitw%253D%253D&md5=52bb108e9c29dc9da3031f7127cba99f</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1086%2F524891&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F524891%26sid%3Dliteratum%253Aachs%26aulast%3DSpellberg%26aufirst%3DB.%26aulast%3DGuidos%26aufirst%3DR.%26aulast%3DGilbert%26aufirst%3DD.%26aulast%3DBradley%26aufirst%3DJ.%26aulast%3DBoucher%26aufirst%3DH.%2BW.%26aulast%3DScheld%26aufirst%3DW.%2BM.%26aulast%3DBartlett%26aufirst%3DJ.%2BG.%26aulast%3DEdwards%26aufirst%3DJ.%26atitle%3DThe%2520epidemic%2520of%2520antibiotic-resistant%2520infections%253A%2520a%2520call%2520to%2520action%2520for%2520the%2520medical%2520community%2520from%2520the%2520Infectious%2520Diseases%2520Society%2520of%2520America%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2008%26volume%3D46%26spage%3D155%26epage%3D164%26doi%3D10.1086%2F524891" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tse-Dinh, Y. C.</span></span> <span> </span><span class="NLM_article-title">Targeting bacterial topoisomerases: how to counter mechanisms of resistance</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1085</span>– <span class="NLM_lpage">1100</span>, <span class="refDoi"> DOI: 10.4155/fmc-2016-0042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.4155%2Ffmc-2016-0042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=27285067" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVyns7nP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=1085-1100&author=Y.+C.+Tse-Dinh&title=Targeting+bacterial+topoisomerases%3A+how+to+counter+mechanisms+of+resistance&doi=10.4155%2Ffmc-2016-0042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting bacterial topoisomerases: how to counter mechanisms of resistance</span></div><div class="casAuthors">Tse-Dinh, Yuk-Ching</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1085-1100</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">DNA gyrase and topoisomerase IV are type IIA bacterial topoisomerases that are targeted by highly effective antibiotics.  However, resistance via multiple mechanisms arises to limit the efficacies of these drugs.  Continued research on type IIA bacterial topoisomerases has provided novel approaches to counter the most common resistance mechanism for utilization of these proven targets in antibacterial therapy.  Bacterial topoisomerase I is being explored as an alternative target that is not expected to show cross-resistance.  Dual targeting or combination therapy could be strategies for circumventing the development of resistance to topoisomerase-targeting antibiotics.  Bacterial topoisomerases are high-value bactericidal targets that could continue to be exploited for antibacterial therapy, if new tactics to counter resistance can be adopted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6tp1yqm4-ZLVg90H21EOLACvtfcHk0liZjCrNNmLHPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVyns7nP&md5=1fa7d5675deea48e8a61581000818365</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.4155%2Ffmc-2016-0042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc-2016-0042%26sid%3Dliteratum%253Aachs%26aulast%3DTse-Dinh%26aufirst%3DY.%2BC.%26atitle%3DTargeting%2520bacterial%2520topoisomerases%253A%2520how%2520to%2520counter%2520mechanisms%2520of%2520resistance%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2016%26volume%3D8%26spage%3D1085%26epage%3D1100%26doi%3D10.4155%2Ffmc-2016-0042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Basarab, G. S.</span></span> <span> </span><span class="NLM_article-title">Four ways to skin a cat: inhibition of bacterial topoisomerases leading to the clinic</span>. In  <i>Topics in Medicinal Chemistry: Antibacterials</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, J. F.</span>, <span class="NLM_string-name">Mobashery, S.</span>, <span class="NLM_string-name">Miller, M. J.</span></span>, Eds.; <span class="NLM_publisher-name">Springer International Publishing</span>: <span class="NLM_publisher-loc">Cham, Switzerland</span>, <span class="NLM_year">2017</span>; Vol.  <span class="NLM_volume">25</span>, pp  <span class="NLM_fpage">165</span>– <span class="NLM_lpage">188</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&pages=165-188&author=G.+S.+Basarabauthor=J.+F.+Fisher&author=S.+Mobashery&author=M.+J.+Miller&title=Topics+in+Medicinal+Chemistry%3A+Antibacterials"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DBasarab%26aufirst%3DG.%2BS.%26atitle%3DFour%2520ways%2520to%2520skin%2520a%2520cat%253A%2520inhibition%2520of%2520bacterial%2520topoisomerases%2520leading%2520to%2520the%2520clinic%26btitle%3DTopics%2520in%2520Medicinal%2520Chemistry%253A%2520Antibacterials%26aulast%3DFisher%26aufirst%3DJ.%2BF.%26pub%3DSpringer%2520International%2520Publishing%26date%3D2017%26volume%3D25%26spage%3D165%26epage%3D188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mayer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janin, Y. L.</span></span> <span> </span><span class="NLM_article-title">Non-quinolone inhibitors of bacterial type IIA topoisomerases: a feat of bioisosterism</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">2313</span>– <span class="NLM_lpage">2342</span>, <span class="refDoi"> DOI: 10.1021/cr4003984</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr4003984" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFegsrfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2014&pages=2313-2342&author=C.+Mayerauthor=Y.+L.+Janin&title=Non-quinolone+inhibitors+of+bacterial+type+IIA+topoisomerases%3A+a+feat+of+bioisosterism&doi=10.1021%2Fcr4003984"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Non-quinolone Inhibitors of Bacterial Type IIA Topoisomerases: A Feat of Bioisosterism</span></div><div class="casAuthors">Mayer, Claudine; Janin, Yves L.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2313-2342</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  DNA gyrase and topoisomerase IV are the bacterial type IIA topoisomerases.  These are ubiquitous nucleic acid-dependent nanomachines, essential to cell life, that solve DNA topol. problems resulting from the replication, transcription, and recombination of DNA.  From the discovery that novobiocin and fluoroquinolone antibiotics were selectively acting on bacterial type IIA topoisomerases, a remarkable no. of series of inhibitors of these enzymes has been reported.  The design of biochem. or cellular assays, amenable to high-throughput screenings, along with X-ray-derived structures of the early inhibitors bound to DNA gyrase, were instrumental in this.  From these structures, an array of strategies, which are today called fragment-based approaches, provided quite a no. of addnl. starting points for medicinal chemists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF-y7YT9Lg6rVg90H21EOLACvtfcHk0liZjCrNNmLHPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFegsrfO&md5=8559c27866d96e85cc08763e0cae1c01</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fcr4003984&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr4003984%26sid%3Dliteratum%253Aachs%26aulast%3DMayer%26aufirst%3DC.%26aulast%3DJanin%26aufirst%3DY.%2BL.%26atitle%3DNon-quinolone%2520inhibitors%2520of%2520bacterial%2520type%2520IIA%2520topoisomerases%253A%2520a%2520feat%2520of%2520bioisosterism%26jtitle%3DChem.%2520Rev.%26date%3D2014%26volume%3D114%26spage%3D2313%26epage%3D2342%26doi%3D10.1021%2Fcr4003984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tran, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellsworth, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stier, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Domagala, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollis
Showalter, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gracheck, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shapiro, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joannides, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, R.</span></span> <span> </span><span class="NLM_article-title">Synthesis and structural–activity relationships of 3-hydroxyquinazoline-2,4-dione antibacterial agents</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">4405</span>– <span class="NLM_lpage">4409</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2004.06.063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1016%2Fj.bmcl.2004.06.063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=15357962" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmt1KitLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=4405-4409&author=T.+P.+Tranauthor=E.+L.+Ellsworthauthor=M.+A.+Stierauthor=J.+M.+Domagalaauthor=H.+D.+Hollis%0AShowalterauthor=S.+J.+Gracheckauthor=M.+A.+Shapiroauthor=T.+E.+Joannidesauthor=R.+Singh&title=Synthesis+and+structural%E2%80%93activity+relationships+of+3-hydroxyquinazoline-2%2C4-dione+antibacterial+agents&doi=10.1016%2Fj.bmcl.2004.06.063"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and structural-activity relationships of 3-hydroxyquinazoline-2,4-dione antibacterial agents</span></div><div class="casAuthors">Tran, Tuan P.; Ellsworth, Edmund L.; Stier, Michael A.; Domagala, John M.; Showalter, H. D. Hollis; Gracheck, Stephen J.; Shapiro, Martin A.; Joannides, Themis E.; Singh, Rajeshwar</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4405-4409</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of 3-hydroxyquinazoline-2,4-diones, e.g., I, was synthesized and evaluated for antibacterial activity.  This series represents an addn. to the DNA gyrate inhibitor class of antibacterials.  Appropriated substitution onto the core template yielded compds. with excellent potency against E. coli gyrate and significant in vitro Gram-neg. and Gram-pos. antibacterial activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0oq3x_pGYZ7Vg90H21EOLACvtfcHk0liZjCrNNmLHPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmt1KitLk%253D&md5=7a3899e210962634fe181c8c5c13853d</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2004.06.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2004.06.063%26sid%3Dliteratum%253Aachs%26aulast%3DTran%26aufirst%3DT.%2BP.%26aulast%3DEllsworth%26aufirst%3DE.%2BL.%26aulast%3DStier%26aufirst%3DM.%2BA.%26aulast%3DDomagala%26aufirst%3DJ.%2BM.%26aulast%3DHollis%2BShowalter%26aufirst%3DH.%2BD.%26aulast%3DGracheck%26aufirst%3DS.%2BJ.%26aulast%3DShapiro%26aufirst%3DM.%2BA.%26aulast%3DJoannides%26aufirst%3DT.%2BE.%26aulast%3DSingh%26aufirst%3DR.%26atitle%3DSynthesis%2520and%2520structural%25E2%2580%2593activity%2520relationships%2520of%25203-hydroxyquinazoline-2%252C4-dione%2520antibacterial%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D4405%26epage%3D4409%26doi%3D10.1016%2Fj.bmcl.2004.06.063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ellsworth, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Showalter, H. D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stier, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Domagala, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gracheck, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joannides, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shapiro, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunham, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanna, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huband, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gage, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bronstein, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, D. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, R.</span></span> <span> </span><span class="NLM_article-title">3-Aminoquinazolinediones as a new class of antibacterial agents demonstrating excellent antibacterial activity against wild-type and multidrug resistant organisms</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">6435</span>– <span class="NLM_lpage">6438</span>, <span class="refDoi"> DOI: 10.1021/jm060505l</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060505l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVegtrnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6435-6438&author=E.+L.+Ellsworthauthor=T.+P.+Tranauthor=H.+D.+H.+Showalterauthor=J.+P.+Sanchezauthor=B.+M.+Watsonauthor=M.+A.+Stierauthor=J.+M.+Domagalaauthor=S.+J.+Gracheckauthor=E.+T.+Joannidesauthor=M.+A.+Shapiroauthor=S.+A.+Dunhamauthor=D.+L.+Hannaauthor=M.+D.+Hubandauthor=J.+W.+Gageauthor=J.+C.+Bronsteinauthor=J.+Y.+Liuauthor=D.+Q.+Nguyenauthor=R.+Singh&title=3-Aminoquinazolinediones+as+a+new+class+of+antibacterial+agents+demonstrating+excellent+antibacterial+activity+against+wild-type+and+multidrug+resistant+organisms&doi=10.1021%2Fjm060505l"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">3-Aminoquinazolinediones as a New Class of Antibacterial Agents Demonstrating Excellent Antibacterial Activity Against Wild-Type and Multidrug Resistant Organisms</span></div><div class="casAuthors">Ellsworth, Edmund L.; Tran, Tuan P.; Showalter, H. D. Hollis; Sanchez, Joseph P.; Watson, Brian M.; Stier, Michael A.; Domagala, John M.; Gracheck, Stephen J.; Joannides, E. Themis; Shapiro, Martin A.; Dunham, Steve A.; Hanna, Debra L.; Huband, Michael D.; Gage, Jeffrey W.; Bronstein, Joel C.; Liu, Jia Yeu; Nguyen, Dai Q.; Singh, Rajeshwar</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6435-6438</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The 3-aminoquinzolinediones represent a new series of antibacterial agents structurally related to the fluoroquinolones.  They are inhibitors of bacterial gyrase and topoisomerase IV and demonstrate clin. useful antibacterial activity against fastidious Gram-neg. and Gram-pos. organisms, including multidrug- and fluoroquinolone-resistant organisms.  These agents also demonstrate in vivo efficacy in murine systemic infection models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4grB_LlTcb7Vg90H21EOLACvtfcHk0ljAuH_Xyb3WwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVegtrnL&md5=d1628ee7be9b48db5c785c5d6b8c1611</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm060505l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060505l%26sid%3Dliteratum%253Aachs%26aulast%3DEllsworth%26aufirst%3DE.%2BL.%26aulast%3DTran%26aufirst%3DT.%2BP.%26aulast%3DShowalter%26aufirst%3DH.%2BD.%2BH.%26aulast%3DSanchez%26aufirst%3DJ.%2BP.%26aulast%3DWatson%26aufirst%3DB.%2BM.%26aulast%3DStier%26aufirst%3DM.%2BA.%26aulast%3DDomagala%26aufirst%3DJ.%2BM.%26aulast%3DGracheck%26aufirst%3DS.%2BJ.%26aulast%3DJoannides%26aufirst%3DE.%2BT.%26aulast%3DShapiro%26aufirst%3DM.%2BA.%26aulast%3DDunham%26aufirst%3DS.%2BA.%26aulast%3DHanna%26aufirst%3DD.%2BL.%26aulast%3DHuband%26aufirst%3DM.%2BD.%26aulast%3DGage%26aufirst%3DJ.%2BW.%26aulast%3DBronstein%26aufirst%3DJ.%2BC.%26aulast%3DLiu%26aufirst%3DJ.%2BY.%26aulast%3DNguyen%26aufirst%3DD.%2BQ.%26aulast%3DSingh%26aufirst%3DR.%26atitle%3D3-Aminoquinazolinediones%2520as%2520a%2520new%2520class%2520of%2520antibacterial%2520agents%2520demonstrating%2520excellent%2520antibacterial%2520activity%2520against%2520wild-type%2520and%2520multidrug%2520resistant%2520organisms%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6435%26epage%3D6438%26doi%3D10.1021%2Fjm060505l" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tran, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellsworth, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stier, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Showalter, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Domagala, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shapiro, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joannides, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gracheck, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, D. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bird, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yip, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharadendu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ha, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramezani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, R.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationships of 3-aminoquinazolinediones, a new class of bacterial type-2 topoisomerase (DNA gyrase and topo IV) inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1312</span>– <span class="NLM_lpage">1320</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2006.12.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1016%2Fj.bmcl.2006.12.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=17196390" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvVyjtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=1312-1320&author=T.+P.+Tranauthor=E.+L.+Ellsworthauthor=J.+P.+Sanchezauthor=B.+M.+Watsonauthor=M.+A.+Stierauthor=H.+D.+Showalterauthor=J.+M.+Domagalaauthor=M.+A.+Shapiroauthor=E.+T.+Joannidesauthor=S.+J.+Gracheckauthor=D.+Q.+Nguyenauthor=P.+Birdauthor=J.+Yipauthor=A.+Sharadenduauthor=C.+Haauthor=S.+Ramezaniauthor=X.+Wuauthor=R.+Singh&title=Structure-activity+relationships+of+3-aminoquinazolinediones%2C+a+new+class+of+bacterial+type-2+topoisomerase+%28DNA+gyrase+and+topo+IV%29+inhibitors&doi=10.1016%2Fj.bmcl.2006.12.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationships of 3-aminoquinazolinediones, a new class of bacterial type-2 topoisomerase (DNA gyrase and topo IV) inhibitors</span></div><div class="casAuthors">Tran, Tuan P.; Ellsworth, Edmund L.; Sanchez, Joseph P.; Watson, Brian M.; Stier, Michael A.; Showalter, H. D. Hollis; Domagala, John M.; Shapiro, Martin A.; Joannides, E. Themis; Gracheck, Stephen J.; Nguyen, Dai Q.; Bird, Paul; Yip, Judy; Sharadendu, Anurag; Ha, Chan; Ramezani, Saeed; Wu, Xiujuan; Singh, Rajeshwar</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1312-1320</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A series of 3-aminoquinazolinediones was synthesized and evaluated for its antibacterial and DNA gyrase activity.  The SAR around the quinazolinedione core was explored and the optimal substitutions were combined to give two compds., I (R = H, Me), with exceptional enzyme potency (IC50 = 0.2 μM) and activity against Gram-pos. organisms (MIC's = 0.015-0.06 μ g/mL).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfmuSmpkFLIrVg90H21EOLACvtfcHk0ljAuH_Xyb3WwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvVyjtr4%253D&md5=321843f9392b62fd1ba0f44dc8d00e66</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DTran%26aufirst%3DT.%2BP.%26aulast%3DEllsworth%26aufirst%3DE.%2BL.%26aulast%3DSanchez%26aufirst%3DJ.%2BP.%26aulast%3DWatson%26aufirst%3DB.%2BM.%26aulast%3DStier%26aufirst%3DM.%2BA.%26aulast%3DShowalter%26aufirst%3DH.%2BD.%26aulast%3DDomagala%26aufirst%3DJ.%2BM.%26aulast%3DShapiro%26aufirst%3DM.%2BA.%26aulast%3DJoannides%26aufirst%3DE.%2BT.%26aulast%3DGracheck%26aufirst%3DS.%2BJ.%26aulast%3DNguyen%26aufirst%3DD.%2BQ.%26aulast%3DBird%26aufirst%3DP.%26aulast%3DYip%26aufirst%3DJ.%26aulast%3DSharadendu%26aufirst%3DA.%26aulast%3DHa%26aufirst%3DC.%26aulast%3DRamezani%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DSingh%26aufirst%3DR.%26atitle%3DStructure-activity%2520relationships%2520of%25203-aminoquinazolinediones%252C%2520a%2520new%2520class%2520of%2520bacterial%2520type-2%2520topoisomerase%2520%2528DNA%2520gyrase%2520and%2520topo%2520IV%2529%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D1312%26epage%3D1320%26doi%3D10.1016%2Fj.bmcl.2006.12.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pan, X. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gould, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, L. M.</span></span> <span> </span><span class="NLM_article-title">Probing the differential interactions of quinazolinedione PD 0305970 and quinolones with gyrase and topoisomerase IV</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">3822</span>– <span class="NLM_lpage">3831</span>, <span class="refDoi"> DOI: 10.1128/AAC.00113-09</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1128%2FAAC.00113-09" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=19564360" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFCjsrzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2009&pages=3822-3831&author=X.+S.+Panauthor=K.+A.+Gouldauthor=L.+M.+Fisher&title=Probing+the+differential+interactions+of+quinazolinedione+PD+0305970+and+quinolones+with+gyrase+and+topoisomerase+IV&doi=10.1128%2FAAC.00113-09"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Probing the differential interactions of quinazolinedione PD 0305970 and quinolones with gyrase and topoisomerase IV</span></div><div class="casAuthors">Pan, Xiao-Su; Gould, Katherine A.; Fisher, L. Mark</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3822-3831</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Quinazoline-2,4-diones, such as PD 0305970, are new DNA gyrase and topoisomerase IV (topo IV) inhibitors with potent activity against gram-pos. pathogens, including quinolone-resistant isolates.  The mechanistic basis of dione activity vis-a-vis quinolones is not understood.  We present evidence for Streptococcus pneumoniae gyrase and topo IV that PD 0305970 and quinolones interact differently with the enzyme breakage-reunion and Toprim domains, DNA, and Mg2+-four components that are juxtaposed in the topoisomerase cleavage complex to effect DNA scission.  First, PD 0305970 targets primarily gyrase in Streptococcus pneumoniae.  However, unlike quinolones, which select predominantly for gyrA (or topo IV parC) mutations in the brekage-reunion domain, unusually the dione selected for novel mutants with alterations that map to a region of the Toprim domain of GyrB (R456H and E474A or E474D) or ParE (D435H and E475A).  This "dione resistance-detg. region" overlaps the GyrB quinolone resistance-detg. region and the region that binds essential Mg2+ ions, each function involving conserved EGDSA and PLRGK motifs.  Second, dione-resistant gyrase and topo IV were inhibited by ciprofloxacin, whereas quinolone-resistant enzymes (GyrA S81F and ParC S79F) remained susceptible to PD 0305970.  Third, dione-promoted DNA cleavage by gyrase occurred at a distinct repertoire of sites, implying that structural differences with quinolones are sensed at the DNA level.  Fourth, unlike the situation with quinolones, the Mg2+ chelator EDTA did not reverse dione-induced gyrase cleavage nor did the dione promote Mg2+-dependent DNA unwinding.  It appears that PD 0305970 interacts uniquely to stabilize the cleavage complex of gyrase/topo IV perhaps via an altered orientation directed by the bidentate 3-amino-2,4-dione moiety.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfRlrk-S-cDrVg90H21EOLACvtfcHk0liRgUMQ73mmnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFCjsrzN&md5=d4cc5ca7b61989280fa11287afb79ba1</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1128%2FAAC.00113-09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00113-09%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DX.%2BS.%26aulast%3DGould%26aufirst%3DK.%2BA.%26aulast%3DFisher%26aufirst%3DL.%2BM.%26atitle%3DProbing%2520the%2520differential%2520interactions%2520of%2520quinazolinedione%2520PD%25200305970%2520and%2520quinolones%2520with%2520gyrase%2520and%2520topoisomerase%2520IV%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2009%26volume%3D53%26spage%3D3822%26epage%3D3831%26doi%3D10.1128%2FAAC.00113-09" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aldred, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwanz, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McPherson, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turnbough, C. L.,  Jr</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerns, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osheroff, N.</span></span> <span> </span><span class="NLM_article-title">Overcoming target-mediated quinolone resistance in topoisomerase IV by introducing metal-ion-independent drug-enzyme interactions</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">2660</span>– <span class="NLM_lpage">2668</span>, <span class="refDoi"> DOI: 10.1021/cb400592n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb400592n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVOhurvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=2660-2668&author=K.+J.+Aldredauthor=H.+A.+Schwanzauthor=G.+Liauthor=S.+A.+McPhersonauthor=C.+L.+Turnboughauthor=R.+J.+Kernsauthor=N.+Osheroff&title=Overcoming+target-mediated+quinolone+resistance+in+topoisomerase+IV+by+introducing+metal-ion-independent+drug-enzyme+interactions&doi=10.1021%2Fcb400592n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Overcoming target-mediated quinolone resistance in topoisomerase IV by introducing metal-ion-independent drug-enzyme interactions</span></div><div class="casAuthors">Aldred, Katie J.; Schwanz, Heidi A.; Li, Gangqin; McPherson, Sylvia A.; Turnbough, Charles L.; Kerns, Robert J.; Osheroff, Neil</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2660-2668</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Quinolones, which target gyrase and topoisomerase IV, are the most widely prescribed antibacterials worldwide.  Unfortunately, their use is threatened by the increasing prevalence of target-mediated drug resistance.  Greater than 90% of mutations that confer quinolone resistance act by disrupting enzyme-drug interactions coordinated by a crit. water-metal ion bridge.  Quinazolinediones are quinolone-like drugs but lack the skeletal features necessary to support the bridge interaction.  These compds. are of clin. interest, however, because they retain activity against the most common quinolone resistance mutations.  We utilized a chem. biol. approach to det. how quinazolinediones overcome quinolone resistance in Bacillus anthracis topoisomerase IV.  Quinazolinediones that retain activity against quinolone-resistant topoisomerase IV do so primarily by establishing novel interactions through the C7 substituent, rather than the drug skeleton.  Because some quinolones are highly active against human topoisomerase IIα, we also detd. how clin. relevant quinolones discriminate between the bacterial and human enzymes.  Clin. relevant quinolones display poor activity against topoisomerase IIα because the human enzyme cannot support drug interactions mediated by the water-metal ion bridge.  However, the inclusion of substituents that allow quinazolinediones to overcome topoisomerase IV-mediated quinolone resistance can cause cross-reactivity against topoisomerase IIα.  Therefore, a major challenge in designing drugs that overcome quinolone resistance lies in the ability to identify substituents that mediate strong interactions with the bacterial, but not the human, enzymes.  On the basis of our understanding of quinolone-enzyme interactions, we have prepd. and identified three compds. that display high activity against quinolone-resistant B. anthracis topoisomerase IV but low activity against human topoisomerase IIα.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXYps-i9N2OrVg90H21EOLACvtfcHk0liRgUMQ73mmnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVOhurvK&md5=d6aa61519a35422aecd686253ded7787</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fcb400592n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb400592n%26sid%3Dliteratum%253Aachs%26aulast%3DAldred%26aufirst%3DK.%2BJ.%26aulast%3DSchwanz%26aufirst%3DH.%2BA.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DMcPherson%26aufirst%3DS.%2BA.%26aulast%3DTurnbough%26aufirst%3DC.%2BL.%26aulast%3DKerns%26aufirst%3DR.%2BJ.%26aulast%3DOsheroff%26aufirst%3DN.%26atitle%3DOvercoming%2520target-mediated%2520quinolone%2520resistance%2520in%2520topoisomerase%2520IV%2520by%2520introducing%2520metal-ion-independent%2520drug-enzyme%2520interactions%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26spage%3D2660%26epage%3D2668%26doi%3D10.1021%2Fcb400592n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jeannot, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taillier, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Despeyroux, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mourez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poeverlein, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khichane, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrin, M.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Versluys, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stavenger, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Germe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maxwell, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huseby, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bacqué, E.</span></span> <span> </span><span class="NLM_article-title">Imidazopyrazinones (IPYs): non-quinolone bacterial topoisomerase inhibitors showing partial cross-resistance with quinolones</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">3565</span>– <span class="NLM_lpage">3581</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01892</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01892" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC1cXms1aru7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=3565-3581&author=F.+Jeannotauthor=T.+Taillierauthor=P.+Despeyrouxauthor=S.+Renardauthor=A.+Reyauthor=M.+Mourezauthor=C.+Poeverleinauthor=I.+Khichaneauthor=M.-A.+Perrinauthor=S.+Versluysauthor=R.+A.+Stavengerauthor=J.+Huangauthor=T.+Germeauthor=A.+Maxwellauthor=S.+Caoauthor=D.+L.+Husebyauthor=D.+Hughesauthor=E.+Bacqu%C3%A9&title=Imidazopyrazinones+%28IPYs%29%3A+non-quinolone+bacterial+topoisomerase+inhibitors+showing+partial+cross-resistance+with+quinolones&doi=10.1021%2Facs.jmedchem.7b01892"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones</span></div><div class="casAuthors">Jeannot, Frederic; Taillier, Thomas; Despeyroux, Pierre; Renard, Stephane; Rey, Astrid; Mourez, Michael; Poeverlein, Christoph; Khichane, Imene; Perrin, Marc-Antoine; Versluys, Stephanie; Stavenger, Robert A.; Huang, Jianzhong; Germe, Thomas; Maxwell, Anthony; Cao, Sha; Huseby, Douglas L.; Hughes, Diarmaid; Bacque, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3565-3581</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In the authors' quest for new antibiotics able to address the growing threat of multidrug resistant infections caused by Gram-neg. bacteria, the authors have investigated an unprecedented series of non-quinolone bacterial topoisomerase inhibitors from the Sanofi patrimony, named IPYs for imidazopyrazinones, as part of the Innovative Medicines Initiative (IMI) European Gram Neg. Antibacterial Engine (ENABLE) organization.  Hybridization of these historical compds. with the quinazolinediones, a known series of topoisomerase inhibitors, led the authors to a novel series of tricyclic IPYs that demonstrated potential for broad spectrum activity, in vivo efficacy, and a good developability profile, although later profiling revealed a genotoxicity risk.  Resistance studies revealed partial cross-resistance with fluoroquinolones (FQs) suggesting that IPYs bind to the same region of bacterial topoisomerases as FQs and interact with at least some of the keys residues involved in FQ binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZQnHBuh7YdbVg90H21EOLACvtfcHk0lhDbC-NYHfTvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXms1aru7w%253D&md5=d88d4fe5b177e8f6f6399766687ac366</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01892&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01892%26sid%3Dliteratum%253Aachs%26aulast%3DJeannot%26aufirst%3DF.%26aulast%3DTaillier%26aufirst%3DT.%26aulast%3DDespeyroux%26aufirst%3DP.%26aulast%3DRenard%26aufirst%3DS.%26aulast%3DRey%26aufirst%3DA.%26aulast%3DMourez%26aufirst%3DM.%26aulast%3DPoeverlein%26aufirst%3DC.%26aulast%3DKhichane%26aufirst%3DI.%26aulast%3DPerrin%26aufirst%3DM.-A.%26aulast%3DVersluys%26aufirst%3DS.%26aulast%3DStavenger%26aufirst%3DR.%2BA.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DGerme%26aufirst%3DT.%26aulast%3DMaxwell%26aufirst%3DA.%26aulast%3DCao%26aufirst%3DS.%26aulast%3DHuseby%26aufirst%3DD.%2BL.%26aulast%3DHughes%26aufirst%3DD.%26aulast%3DBacqu%25C3%25A9%26aufirst%3DE.%26atitle%3DImidazopyrazinones%2520%2528IPYs%2529%253A%2520non-quinolone%2520bacterial%2520topoisomerase%2520inhibitors%2520showing%2520partial%2520cross-resistance%2520with%2520quinolones%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D3565%26epage%3D3581%26doi%3D10.1021%2Facs.jmedchem.7b01892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Germe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vörös, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeannot, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taillier, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stavenger, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bacqué, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maxwell, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bax, B. D.</span></span> <span> </span><span class="NLM_article-title">A new class of antibacterials, the imidazopyrazinones, reveal structural transitions involved in DNA gyrase poisoning and mechanisms of resistance</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">4114</span>– <span class="NLM_lpage">4128</span>, <span class="refDoi"> DOI: 10.1093/nar/gky181</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1093%2Fnar%2Fgky181" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=29538767" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitlKhur3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2018&pages=4114-4128&author=T.+Germeauthor=J.+V%C3%B6r%C3%B6sauthor=F.+Jeannotauthor=T.+Taillierauthor=R.+A.+Stavengerauthor=E.+Bacqu%C3%A9author=A.+Maxwellauthor=B.+D.+Bax&title=A+new+class+of+antibacterials%2C+the+imidazopyrazinones%2C+reveal+structural+transitions+involved+in+DNA+gyrase+poisoning+and+mechanisms+of+resistance&doi=10.1093%2Fnar%2Fgky181"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">A new class of antibacterials, the imidazopyrazinones, reveal structural transitions involved in DNA gyrase poisoning and mechanisms of resistance</span></div><div class="casAuthors">Germe, Thomas; Voros, Judit; Jeannot, Frederic; Taillier, Thomas; Stavenger, Robert A.; Bacque', Eric; Maxwell, Anthony; Bax, Benjamin D.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4114-4128</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">1362-4962</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Imidazopyrazinones (IPYs) are a new class of compds. that target bacterial topoisomerases as a basis for their antibacterial activity.  We have characterized the mechanism of these compds. through structural/mechanistic studies showing they bind and stabilize a cleavage complex between DNA gyrase and DNA ('poisoning') in an analogous fashion to fluoroquinolones, but without the requirement for the water-metal-ion bridge.  Biochem. expts. and structural studies of cleavage complexes of IPYs compared with an uncleaved gyrase-DNA complex, reveal conformational transitions coupled to DNA cleavage at the DNA gate.  These involve movement at the GyrA interface and tilting of the TOPRIM domains toward the scissile phosphate coupled to capture of the catalytic metal ion.  Our expts. show that these structural transitions are involved generally in poisoning of gyrase by therapeutic compds. and resemble those undergone by the enzyme during its ATP-coupled strand-passage cycle.  In addn. to resistance mutations affecting residues that directly interact with the compds., we characterized a mutant (D82N) that inhibits formation of the cleavage complex by the unpoisoned enzyme.  The D82N mutant appears to act by stabilizing the binary conformation of DNA gyrase with uncleaved DNA without direct interaction with the compds.  This provides general insight into the resistance mechanisms to antibiotics targeting bacterial type II topoisomerases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZU-FTcML6jbVg90H21EOLACvtfcHk0lhDbC-NYHfTvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitlKhur3I&md5=63afb73c75db0b4aa7fd7e43e97314fb</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgky181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgky181%26sid%3Dliteratum%253Aachs%26aulast%3DGerme%26aufirst%3DT.%26aulast%3DV%25C3%25B6r%25C3%25B6s%26aufirst%3DJ.%26aulast%3DJeannot%26aufirst%3DF.%26aulast%3DTaillier%26aufirst%3DT.%26aulast%3DStavenger%26aufirst%3DR.%2BA.%26aulast%3DBacqu%25C3%25A9%26aufirst%3DE.%26aulast%3DMaxwell%26aufirst%3DA.%26aulast%3DBax%26aufirst%3DB.%2BD.%26atitle%3DA%2520new%2520class%2520of%2520antibacterials%252C%2520the%2520imidazopyrazinones%252C%2520reveal%2520structural%2520transitions%2520involved%2520in%2520DNA%2520gyrase%2520poisoning%2520and%2520mechanisms%2520of%2520resistance%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2018%26volume%3D46%26spage%3D4114%26epage%3D4128%26doi%3D10.1093%2Fnar%2Fgky181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de Vicente Fidalgo, J.</span>; <span class="NLM_string-name">He, H.</span>; <span class="NLM_string-name">Hu, C.</span>; <span class="NLM_string-name">Jiang, Z.</span>; <span class="NLM_string-name">Li, X.</span>; <span class="NLM_string-name">Lu, P.</span>; <span class="NLM_string-name">Mergo, W.</span>; <span class="NLM_string-name">Mutnick, D.</span>; <span class="NLM_string-name">Reck, F.</span>; <span class="NLM_string-name">Rivkin, A.</span>; <span class="NLM_string-name">Skepper, C. K.</span>; <span class="NLM_string-name">Wang, X. M.</span>; <span class="NLM_string-name">Xia, J.</span>; <span class="NLM_string-name">Xu, Y.</span></span> <span> </span><span class="NLM_article-title">Quinolone derivatives as antibacterials</span>. U.S. Patent <span class="NLM_patent">10160726 B2</span>, December 25, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=J.+de+Vicente+Fidalgo&author=H.+He&author=C.+Hu&author=Z.+Jiang&author=X.+Li&author=P.+Lu&author=W.+Mergo&author=D.+Mutnick&author=F.+Reck&author=A.+Rivkin&author=C.+K.+Skepper&author=X.+M.+Wang&author=J.+Xia&author=Y.+Xu&title=Quinolone+derivatives+as+antibacterials"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BVicente%2BFidalgo%26aufirst%3DJ.%26atitle%3DQuinolone%2520derivatives%2520as%2520antibacterials%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Payne, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gwynn, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmes, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pompliano, D. L.</span></span> <span> </span><span class="NLM_article-title">Drugs for bad bugs: confronting the challenges of antibacterial discovery</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">29</span>– <span class="NLM_lpage">40</span>, <span class="refDoi"> DOI: 10.1038/nrd2201</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1038%2Fnrd2201" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=17159923" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlGktbfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=29-40&author=D.+J.+Payneauthor=M.+N.+Gwynnauthor=D.+J.+Holmesauthor=D.+L.+Pompliano&title=Drugs+for+bad+bugs%3A+confronting+the+challenges+of+antibacterial+discovery&doi=10.1038%2Fnrd2201"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Drugs for bad bugs: confronting the challenges of antibacterial discovery</span></div><div class="casAuthors">Payne, David J.; Gwynn, Michael N.; Holmes, David J.; Pompliano, David L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">29-40</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The sequencing of the first complete bacterial genome in 1995 heralded a new era of hope for antibacterial drug discoverers, who now had the tools to search entire genomes for new antibacterial targets.  Several companies, including GlaxoSmithKline, moved back into the antibacterials area and embraced a genomics-derived, target-based approach to screen for new classes of drugs with novel modes of action.  Here, we share our experience of evaluating more than 300 genes and 70 high-throughput screening campaigns over a period of 7 years, and look at what we learned and how that has influenced GlaxoSmithKline's antibacterials strategy going forward.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqH1tM2BSZbWLVg90H21EOLACvtfcHk0lgwLONUIcnDAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlGktbfM&md5=18100253f9868af578ea621ab98a5c86</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1038%2Fnrd2201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2201%26sid%3Dliteratum%253Aachs%26aulast%3DPayne%26aufirst%3DD.%2BJ.%26aulast%3DGwynn%26aufirst%3DM.%2BN.%26aulast%3DHolmes%26aufirst%3DD.%2BJ.%26aulast%3DPompliano%26aufirst%3DD.%2BL.%26atitle%3DDrugs%2520for%2520bad%2520bugs%253A%2520confronting%2520the%2520challenges%2520of%2520antibacterial%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D29%26epage%3D40%26doi%3D10.1038%2Fnrd2201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Silver, L. L.</span></span> <span> </span><span class="NLM_article-title">Challenges of antibacterial discovery</span>. <i>Clin. Microbiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">71</span>– <span class="NLM_lpage">109</span>, <span class="refDoi"> DOI: 10.1128/CMR.00030-10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1128%2FCMR.00030-10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=21233508" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjtFSgu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2011&pages=71-109&author=L.+L.+Silver&title=Challenges+of+antibacterial+discovery&doi=10.1128%2FCMR.00030-10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Challenges of antibacterial discovery</span></div><div class="casAuthors">Silver, Lynn L.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Microbiology Reviews</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">71-109</span>CODEN:
                <span class="NLM_cas:coden">CMIREX</span>;
        ISSN:<span class="NLM_cas:issn">0893-8512</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A review.  The discovery of novel small-mol. antibacterial drugs has been stalled for many years.  The purpose of this review is to underscore and illustrate those scientific problems unique to the discovery and optimization of novel antibacterial agents that have adversely affected the output of the effort.  The major challenges fall into two areas: (i) proper target selection, particularly the necessity of pursuing mol. targets that are not prone to rapid resistance development, and (ii) improvement of chem. libraries to overcome limitations of diversity, esp. that which is necessary to overcome barriers to bacterial entry and proclivity to be effluxed, esp. in Gram-neg. organisms.  Failure to address these problems has led to a great deal of misdirected effort.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsTDYwtK6vHbVg90H21EOLACvtfcHk0lgwLONUIcnDAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjtFSgu7s%253D&md5=a77b7a1f2763b73d4bd63daf67f78cc7</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1128%2FCMR.00030-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FCMR.00030-10%26sid%3Dliteratum%253Aachs%26aulast%3DSilver%26aufirst%3DL.%2BL.%26atitle%3DChallenges%2520of%2520antibacterial%2520discovery%26jtitle%3DClin.%2520Microbiol.%2520Rev.%26date%3D2011%26volume%3D24%26spage%3D71%26epage%3D109%26doi%3D10.1128%2FCMR.00030-10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tommasi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walkup, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manchester, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, A. A.</span></span> <span> </span><span class="NLM_article-title">ESKAPEing the labyrinth of antibacterial discovery</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">529</span>– <span class="NLM_lpage">542</span>, <span class="refDoi"> DOI: 10.1038/nrd4572</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1038%2Fnrd4572" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=26139286" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFyks77M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=529-542&author=R.+Tommasiauthor=D.+G.+Brownauthor=G.+K.+Walkupauthor=J.+I.+Manchesterauthor=A.+A.+Miller&title=ESKAPEing+the+labyrinth+of+antibacterial+discovery&doi=10.1038%2Fnrd4572"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">ESKAPEing the labyrinth of antibacterial discovery</span></div><div class="casAuthors">Tommasi, Ruben; Brown, Dean G.; Walkup, Grant K.; Manchester, John I.; Miller, Alita A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">529-542</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Antimicrobial drug resistance is a growing threat to global public health.  Multidrug resistance among the 'ESKAPE' organisms - encompassing Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp. - is of particular concern because they are responsible for many serious infections in hospitals.  Although some promising agents are in the pipeline, there is an urgent need for new antibiotic scaffolds.  However, antibacterial researchers have struggled to identify new small mols. with meaningful cellular activity, esp. those effective against multidrug-resistant Gram-neg. pathogens.  This difficulty ultimately stems from an incomplete understanding of efflux systems and compd. permeation through bacterial membranes.  This Opinion article describes findings from target-based and phenotypic screening efforts carried out at AstraZeneca over the past decade, discusses some of the subsequent chem. challenges and concludes with a description of new approaches comprising a combination of computational modeling and advanced biol. tools which may pave the way towards the discovery of new antibacterial agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolJg6HXnn7BLVg90H21EOLACvtfcHk0lgwLONUIcnDAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFyks77M&md5=0d3159250e27926ab280c305ea5fb9ef</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1038%2Fnrd4572&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4572%26sid%3Dliteratum%253Aachs%26aulast%3DTommasi%26aufirst%3DR.%26aulast%3DBrown%26aufirst%3DD.%2BG.%26aulast%3DWalkup%26aufirst%3DG.%2BK.%26aulast%3DManchester%26aufirst%3DJ.%2BI.%26aulast%3DMiller%26aufirst%3DA.%2BA.%26atitle%3DESKAPEing%2520the%2520labyrinth%2520of%2520antibacterial%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2015%26volume%3D14%26spage%3D529%26epage%3D542%26doi%3D10.1038%2Fnrd4572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nikaido, H.</span></span> <span> </span><span class="NLM_article-title">Prevention of drug access to bacterial targets: permeability barriers and active efflux</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>264</i></span>,  <span class="NLM_fpage">382</span>– <span class="NLM_lpage">388</span>, <span class="refDoi"> DOI: 10.1126/science.8153625</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1126%2Fscience.8153625" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=8153625" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADyaK2cXis1Ggurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=264&publication_year=1994&pages=382-388&author=H.+Nikaido&title=Prevention+of+drug+access+to+bacterial+targets%3A+permeability+barriers+and+active+efflux&doi=10.1126%2Fscience.8153625"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Prevention of drug access to bacterial targets: permeability barriers and active efflux</span></div><div class="casAuthors">Nikaido, Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">264</span>
        (<span class="NLM_cas:issue">5157</span>),
    <span class="NLM_cas:pages">382-8</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">A review with 79 refs.  Some species of bacteria have low-permeability membrane barriers and are thereby intrinsically resistant to many antibiotics.  Some strains of originally antibiotic-susceptible species may also acquire resistance through decreases in the permeability of membrane barriers.  Another mechanism for preventing access of drugs to targets is the membrane-assocd. energy-driven efflux, which plays a major role in drug resistance, esp. in combination with the permeation barrier.  Recent results indicate the existence of bacterial efflux systems of extremely broad substrate specificity, in many ways reminiscent of the multidrug resistance pump of mammalian cells.  One such system seems to play a major role in the intrinsic resistance of Pseudomonas aeruginosa, a common opportunistic pathogen.  As the pharmacol. industry succeeds in producing agents that can overcome specific mechanisms of bacterial resistance, less specific resistance mechanisms such as permeability barriers and multidrug active efflux may become increasingly significant in the clin. setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYpbgrhsj0ZrVg90H21EOLACvtfcHk0ljSguPpFOg9Zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXis1Ggurc%253D&md5=84eedec2b82bfc061f17d0d5b4e6973d</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1126%2Fscience.8153625&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.8153625%26sid%3Dliteratum%253Aachs%26aulast%3DNikaido%26aufirst%3DH.%26atitle%3DPrevention%2520of%2520drug%2520access%2520to%2520bacterial%2520targets%253A%2520permeability%2520barriers%2520and%2520active%2520efflux%26jtitle%3DScience%26date%3D1994%26volume%3D264%26spage%3D382%26epage%3D388%26doi%3D10.1126%2Fscience.8153625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hancock, R. E. W.</span></span> <span> </span><span class="NLM_article-title">The bacterial outer membrane as a drug barrier</span>. <i>Trends Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">37</span>– <span class="NLM_lpage">42</span>, <span class="refDoi"> DOI: 10.1016/S0966-842X(97)81773-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1016%2FS0966-842X%2897%2981773-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=9025234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A280%3ADyaK2s7nslOhug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1997&pages=37-42&author=R.+E.+W.+Hancock&title=The+bacterial+outer+membrane+as+a+drug+barrier&doi=10.1016%2FS0966-842X%2897%2981773-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">The bacterial outer membrane as a drug barrier</span></div><div class="casAuthors">Hancock R E</div><div class="citationInfo"><span class="NLM_cas:title">Trends in microbiology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">37-42</span>
        ISSN:<span class="NLM_cas:issn">0966-842X</span>.
    </div><div class="casAbstract">The outer membranes of Gram-negative bacteria constitute a semi-permeable barrier, as indicated by the corresponding alterations in outer membrane permeability and in antibiotic susceptibility resulting from mutation or polycation action.  Restricted outer membrane permeability works in synergy with co-determinant resistance mechanisms, such as the periplasmic enzyme beta-lactamase or active efflux mechanisms, bringing about antibiotic resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR01tkjdQJB8hpyrDyM_m9cfW6udTcc2eY290XrbFk0Lrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2s7nslOhug%253D%253D&md5=84cb78b3dd93745be4923d8bc6e297c7</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2FS0966-842X%2897%2981773-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0966-842X%252897%252981773-8%26sid%3Dliteratum%253Aachs%26aulast%3DHancock%26aufirst%3DR.%2BE.%2BW.%26atitle%3DThe%2520bacterial%2520outer%2520membrane%2520as%2520a%2520drug%2520barrier%26jtitle%3DTrends%2520Microbiol.%26date%3D1997%26volume%3D5%26spage%3D37%26epage%3D42%26doi%3D10.1016%2FS0966-842X%2897%2981773-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nikaido, H.</span></span> <span> </span><span class="NLM_article-title">Molecular basis of bacterial outer membrane permeability revisited</span>. <i>Microbiol. Mol. Biol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">593</span>– <span class="NLM_lpage">656</span>, <span class="refDoi"> DOI: 10.1128/MMBR.67.4.593-656.2003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1128%2FMMBR.67.4.593-656.2003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=14665678" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmt1Sqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2003&pages=593-656&author=H.+Nikaido&title=Molecular+basis+of+bacterial+outer+membrane+permeability+revisited&doi=10.1128%2FMMBR.67.4.593-656.2003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular basis of bacterial outer membrane permeability revisited</span></div><div class="casAuthors">Nikaido, Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Microbiology and Molecular Biology Reviews</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">593-656</span>CODEN:
                <span class="NLM_cas:coden">MMBRF7</span>;
        ISSN:<span class="NLM_cas:issn">1092-2172</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A review.  Gram-neg. bacteria characteristically are surrounded by an addnl. membrane layer, the outer membrane.  Although outer membrane components often play important roles in the interaction of symbiotic or pathogenic bacteria with their host organisms, the major role of this membrane must usually be to serve as a permeability barrier to prevent the entry of noxious compds. and at the same time to allow the influx of nutrient mols.  This review summarizes the development in the field since our previous review (H. Nikaido and M. Vaara, Microbiol. Rev. 49:1-32, 1985) was published.  With the discovery of protein channels, structural knowledge enables us to understand in mol. detail how porins, specific channels, TonB-linked receptors, and other proteins function.  We are now beginning to see how the export of large proteins occurs across the outer membrane.  With our knowledge of the lipopolysaccharide phospholipid asym. bilayer of the outer membrane, we are finally beginning to understand how this bilayer can retard the entry of lipophilic compds., owing to our increasing knowledge about the chem. of lipopolysaccharide from diverse organisms and the way in which lipopolysaccharide structure is modified by environmental conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroTpomI_d5ErVg90H21EOLACvtfcHk0ljSguPpFOg9Zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmt1Sqsg%253D%253D&md5=6b2e709a18bc697e20070aafb412b06f</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1128%2FMMBR.67.4.593-656.2003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMMBR.67.4.593-656.2003%26sid%3Dliteratum%253Aachs%26aulast%3DNikaido%26aufirst%3DH.%26atitle%3DMolecular%2520basis%2520of%2520bacterial%2520outer%2520membrane%2520permeability%2520revisited%26jtitle%3DMicrobiol.%2520Mol.%2520Biol.%2520Rev.%26date%3D2003%26volume%3D67%26spage%3D593%26epage%3D656%26doi%3D10.1128%2FMMBR.67.4.593-656.2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.-Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikaido, H.</span></span> <span> </span><span class="NLM_article-title">Efflux-mediated drug resistance in bacteria</span>. <i>Drugs</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">159</span>– <span class="NLM_lpage">204</span>, <span class="refDoi"> DOI: 10.2165/00003495-200464020-00004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.2165%2F00003495-200464020-00004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=14717618" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhvVGntL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=159-204&author=X.-Z.+Liauthor=H.+Nikaido&title=Efflux-mediated+drug+resistance+in+bacteria&doi=10.2165%2F00003495-200464020-00004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Efflux-mediated drug resistance in bacteria</span></div><div class="casAuthors">Li, Xian-Zhi; Nikaido, Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Drugs</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">159-204</span>CODEN:
                <span class="NLM_cas:coden">DRUGAY</span>;
        ISSN:<span class="NLM_cas:issn">0012-6667</span>.
    
            (<span class="NLM_cas:orgname">Adis International Ltd.</span>)
        </div><div class="casAbstract">A review.  Drug resistance in bacteria, and esp. resistance to multiple antibacterials, has attracted much attention in recent years.  In addn. to the well known mechanisms, such as inactivation of drugs and alteration of targets, active efflux is now known to play a major role in the resistance of many species to antibacterials.  Drug-specific efflux (e.g., that of tetracycline) has been recognized as the major mechanism of resistance to this drug in Gram-neg. bacteria.  In addn., we now recognize that multidrug efflux pumps are becoming increasingly important.  Such pumps play major roles in the antiseptic resistance of Staphylococcus aureus, and fluoroquinolone resistance of S. aureus and Streptococcus pneumoniae.  Multidrug pumps, often with very wide substrate specificity, are not only essential for the intrinsic resistance of many Gram-neg. bacteria but also produce elevated levels of resistance when overexpressed.  Paradoxically, 'advanced' agents for which resistance is unlikely to be caused by traditional mechanisms, such as fluoroquinolones and β-lactams of the latest generations, are likely to select for overprodn. mutants of these pumps and make the bacteria resistant in one step to practically all classes of antibacterial agents.  Such overprodn. mutants are also selected for by the use of antiseptics and biocides, increasingly incorporated into consumer products, and this is also of major concern.  We can consider efflux pumps as potentially effective antibacterial targets.  Inhibition of efflux pumps by an efflux pump inhibitor would restore the activity of an agent subject to efflux.  An alternative approach is to develop antibacterials that would bypass the action of efflux pumps.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr748rN_mRyP7Vg90H21EOLACvtfcHk0lgzDnehNiookQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhvVGntL0%253D&md5=a8e38065f32933d3d92b09995cbb6d42</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.2165%2F00003495-200464020-00004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00003495-200464020-00004%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.-Z.%26aulast%3DNikaido%26aufirst%3DH.%26atitle%3DEfflux-mediated%2520drug%2520resistance%2520in%2520bacteria%26jtitle%3DDrugs%26date%3D2004%26volume%3D64%26spage%3D159%26epage%3D204%26doi%3D10.2165%2F00003495-200464020-00004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schweizer, H. P.</span></span> <span> </span><span class="NLM_article-title">Bacterial resistance to antibiotics: active efflux and reduced uptake</span>. <i>Adv. Drug Delivery Rev.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">1486</span>– <span class="NLM_lpage">1513</span>, <span class="refDoi"> DOI: 10.1016/j.addr.2005.04.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1016%2Fj.addr.2005.04.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=15939505" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlvFant70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2005&pages=1486-1513&author=A.+Kumarauthor=H.+P.+Schweizer&title=Bacterial+resistance+to+antibiotics%3A+active+efflux+and+reduced+uptake&doi=10.1016%2Fj.addr.2005.04.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Bacterial resistance to antibiotics: Active efflux and reduced uptake</span></div><div class="casAuthors">Kumar, Ayush; Schweizer, Herbert P.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1486-1513</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Antibiotic resistance of bacterial pathogens is a fast emerging global crisis and an understanding of the underlying resistance mechanisms is paramount for the design and development of new therapeutic strategies.  Permeability barriers for and active efflux of drug mols. are 2 resistance mechanisms that have been implicated in various infectious outbreaks of antibiotic-resistant pathogens, suggesting that these mechanisms may be good targets for new drugs.  The synergism of reduced uptake and efflux is most evident in the multiplicative action of the outer membrane permeability barrier and active efflux, which results in high-level intrinsic and(or) acquired resistance in many clin. important gram-neg. bacteria.  This review summarizes the current knowledge of these 2 important resistance mechanisms and potential strategies to overcome them.  Recent advances in understanding the phys. structures, function, and regulation of efflux systems will facilitate exploitation of pumps as new drug targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDE1hxxbXPQrVg90H21EOLACvtfcHk0lgzDnehNiookQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlvFant70%253D&md5=b1b9bed1deab6c70f83062d73abafc4f</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.addr.2005.04.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.addr.2005.04.004%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DA.%26aulast%3DSchweizer%26aufirst%3DH.%2BP.%26atitle%3DBacterial%2520resistance%2520to%2520antibiotics%253A%2520active%2520efflux%2520and%2520reduced%2520uptake%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2005%26volume%3D57%26spage%3D1486%26epage%3D1513%26doi%3D10.1016%2Fj.addr.2005.04.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lomovskaya, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zgurskaya, H. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Totrov, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watkins, W. J.</span></span> <span> </span><span class="NLM_article-title">Waltzing transporters and ‘the dance macabre’ between humans and bacteria</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">56</span>– <span class="NLM_lpage">65</span>, <span class="refDoi"> DOI: 10.1038/nrd2200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1038%2Fnrd2200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=17159924" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlGktbbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=56-65&author=O.+Lomovskayaauthor=H.+I.+Zgurskayaauthor=M.+Totrovauthor=W.+J.+Watkins&title=Waltzing+transporters+and+%E2%80%98the+dance+macabre%E2%80%99+between+humans+and+bacteria&doi=10.1038%2Fnrd2200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Waltzing transporters and 'the dance macabre' between humans and bacteria</span></div><div class="casAuthors">Lomovskaya, Olga; Zgurskaya, Helen I.; Totrov, Maxim; Watkins, William J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">56-65</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Multi-drug-resistance efflux pumps - in particular those belonging to the resistance-nodulation-cell-division (RND) family of transporters, with their unusually high degree of substrate promiscuity - significantly restrict the effectiveness of antibacterial therapy.  Recent years have heralded remarkable insights into the structure and mechanisms of these fascinating mol. machines.  Here, we review recent advances in the field and describe various approaches used in combating efflux-mediated resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovMk_rinojGLVg90H21EOLACvtfcHk0lgzDnehNiookQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlGktbbF&md5=8acc67c9ee16f8853ba52f4a667181a2</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1038%2Fnrd2200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2200%26sid%3Dliteratum%253Aachs%26aulast%3DLomovskaya%26aufirst%3DO.%26aulast%3DZgurskaya%26aufirst%3DH.%2BI.%26aulast%3DTotrov%26aufirst%3DM.%26aulast%3DWatkins%26aufirst%3DW.%2BJ.%26atitle%3DWaltzing%2520transporters%2520and%2520%25E2%2580%2598the%2520dance%2520macabre%25E2%2580%2599%2520between%2520humans%2520and%2520bacteria%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D56%26epage%3D65%26doi%3D10.1038%2Fnrd2200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Delcour, A. H.</span></span> <span> </span><span class="NLM_article-title">Outer membrane permeability and antibiotic resistance</span>. <i>Biochim. Biophys. Acta, Proteins Proteomics</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>1794</i></span>,  <span class="NLM_fpage">808</span>– <span class="NLM_lpage">816</span>, <span class="refDoi"> DOI: 10.1016/j.bbapap.2008.11.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1016%2Fj.bbapap.2008.11.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=19100346" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkvVSrtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1794&publication_year=2009&pages=808-816&author=A.+H.+Delcour&title=Outer+membrane+permeability+and+antibiotic+resistance&doi=10.1016%2Fj.bbapap.2008.11.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Outer membrane permeability and antibiotic resistance</span></div><div class="casAuthors">Delcour, Anne H.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Proteins and Proteomics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">1794</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">808-816</span>CODEN:
                <span class="NLM_cas:coden">BBAPBW</span>;
        ISSN:<span class="NLM_cas:issn">1570-9639</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">A review.  To date most antibiotics are targeted at intracellular processes, and must be able to penetrate the bacterial cell envelope.  In particular, the outer membrane of gram-neg. bacteria provides a formidable barrier that must be overcome.  There are essentially two pathways that antibiotics can take through the outer membrane: a lipid-mediated pathway for hydrophobic antibiotics, and general diffusion porins for hydrophilic antibiotics.  The lipid and protein compns. of the outer membrane have a strong impact on the sensitivity of bacteria to many types of antibiotics, and drug resistance involving modifications of these macromols. is common.  This review describes the mol. mechanisms for permeation of antibiotics through the outer membrane, and the strategies that bacteria have deployed to resist antibiotics by modifications of these pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnujySVWxi3bVg90H21EOLACvtfcHk0lhroKr-4eOLeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkvVSrtr4%253D&md5=b32db36960e4c0d122bef0c3648462e8</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.bbapap.2008.11.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbapap.2008.11.005%26sid%3Dliteratum%253Aachs%26aulast%3DDelcour%26aufirst%3DA.%2BH.%26atitle%3DOuter%2520membrane%2520permeability%2520and%2520antibiotic%2520resistance%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Proteins%2520Proteomics%26date%3D2009%26volume%3D1794%26spage%3D808%26epage%3D816%26doi%3D10.1016%2Fj.bbapap.2008.11.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zgurskaya, H. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gnanakaran, S.</span></span> <span> </span><span class="NLM_article-title">Permeability barrier of Gram-negative cell envelopes and approaches to bypass it</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">512</span>– <span class="NLM_lpage">522</span>, <span class="refDoi"> DOI: 10.1021/acsinfecdis.5b00097</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.5b00097" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFWqur%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2015&pages=512-522&author=H.+I.+Zgurskayaauthor=C.+A.+Lopezauthor=S.+Gnanakaran&title=Permeability+barrier+of+Gram-negative+cell+envelopes+and+approaches+to+bypass+it&doi=10.1021%2Facsinfecdis.5b00097"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Permeability Barrier of Gram-Negative Cell Envelopes and Approaches To Bypass It</span></div><div class="casAuthors">Zgurskaya, Helen I.; Lopez, Cesar A.; Gnanakaran, S.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">512-522</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Gram-neg. bacteria are intrinsically resistant to many antibiotics.  Species that have acquired multidrug resistance and cause infections that are effectively untreatable present a serious threat to public health.  The problem is broadly recognized and tackled at both the fundamental and applied levels.  This paper summarizes current advances in understanding the mol. bases of the low permeability barrier of Gram-neg. pathogens, which is the major obstacle in discovery and development of antibiotics effective against such pathogens.  Gaps in knowledge and specific strategies to break this barrier and to achieve potent activities against difficult Gram-neg. bacteria are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0vgfVHZir5bVg90H21EOLACvtfcHk0lhroKr-4eOLeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFWqur%252FM&md5=fd65ac8b7277ad540733ede53e168d9a</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.5b00097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.5b00097%26sid%3Dliteratum%253Aachs%26aulast%3DZgurskaya%26aufirst%3DH.%2BI.%26aulast%3DLopez%26aufirst%3DC.%2BA.%26aulast%3DGnanakaran%26aufirst%3DS.%26atitle%3DPermeability%2520barrier%2520of%2520Gram-negative%2520cell%2520envelopes%2520and%2520approaches%2520to%2520bypass%2520it%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2015%26volume%3D1%26spage%3D512%26epage%3D522%26doi%3D10.1021%2Facsinfecdis.5b00097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Silver, L. L.</span></span> <span> </span><span class="NLM_article-title">A Gestalt approach to Gram-negative entry</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">6379</span>– <span class="NLM_lpage">6389</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2016.06.044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1016%2Fj.bmc.2016.06.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=27381365" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVaqur%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=6379-6389&author=L.+L.+Silver&title=A+Gestalt+approach+to+Gram-negative+entry&doi=10.1016%2Fj.bmc.2016.06.044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">A Gestalt approach to Gram-negative entry</span></div><div class="casAuthors">Silver, Lynn L.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6379-6389</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  A major obstacle confronting the discovery and development of new antibacterial agents to combat resistant Gram-neg. (GN) organisms is the lack of a rational process for endowing compds. with properties that allow (or promote) entry into the bacterial cytoplasm.  The major permeability difference between GN and Gram-pos. (GP) bacteria is the GN outer membrane (OM) which is a permeability barrier itself and potentiates efflux pumps that expel compds.  Based on the fact that OM-permeable and efflux-deleted GNs are sensitive to many anti-GP drugs, recent efforts to approach the GN entry problem have focused on ways of avoiding efflux and transiting or compromising the OM, with the tacit assumption that this could allow entry of compds. into the GN cytoplasm.  But bypassing the OM and efflux obstacles does not take into account the addnl. requirement of penetrating the cytoplasmic membrane (CM) whose sieving properties appear to be orthogonal to that of the OM.  That is, tailoring compds. to transit the OM may well compromise their ability to enter the cytoplasm.  Thus, a Gestalt approach to understanding the chem. requirements for GN entry seems a useful adjunct.  This might consist of characterizing compds. which reach the cytoplasm, grouping (or binning) by routes of entry and formulating chem. rules for those bins.  This will require acquisition of data on large nos. of compds., using non-activity-dependent methods of measuring accumulation in the cytoplasm.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqs-T6vYmkrrVg90H21EOLACvtfcHk0lhvWTWqkd2asA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVaqur%252FP&md5=08ca97526e7f3c8c8781307e52e96e9a</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.06.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.06.044%26sid%3Dliteratum%253Aachs%26aulast%3DSilver%26aufirst%3DL.%2BL.%26atitle%3DA%2520Gestalt%2520approach%2520to%2520Gram-negative%2520entry%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26spage%3D6379%26epage%3D6389%26doi%3D10.1016%2Fj.bmc.2016.06.044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Shea, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moser, H. E.</span></span> <span> </span><span class="NLM_article-title">Physicochemical properties of antibacterial compounds: implications for drug discovery</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">2871</span>– <span class="NLM_lpage">2878</span>, <span class="refDoi"> DOI: 10.1021/jm700967e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm700967e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlvFCrsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=2871-2878&author=R.+O%E2%80%99Sheaauthor=H.+E.+Moser&title=Physicochemical+properties+of+antibacterial+compounds%3A+implications+for+drug+discovery&doi=10.1021%2Fjm700967e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Physicochemical properties of antibacterial compounds: implications for drug discovery</span></div><div class="casAuthors">O'Shea, Rosemarie; Moser, Heinz E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2871-2878</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">With the rise of multidrug-resistant pathogens and the need for novel antibiotics, it is crit. to understand as much as possible from prior efforts and to apply learned lessons to the discovery of future antibiotics.  One important parameter in particular has previously been mentioned but, in the view, not sufficiently analyzed: the physicochem. property space of antibacterial drugs.  The authors selected 147 antibacterially active compds. that encompass both currently used drugs and compds. that are still under clin. investigation (see Methods for details).  Where available, other property values were extd. from the literature, including protein binding and oral bioavailability in humans.  This anal. suggests that natural products should be increasingly investigated again to identify novel antibacterial hits.  Besides their high level of structural diversity, they are likely to better cover the required physicochem. property space for antibacterial compds. compared to synthetic mols. because of an increased d. of polar functionalities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo25EGWMkWdk7Vg90H21EOLACvtfcHk0ljUu8iSh2QR6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlvFCrsLw%253D&md5=8aae7d962df53b70113e0fe6169abd68</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjm700967e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm700967e%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DR.%26aulast%3DMoser%26aufirst%3DH.%2BE.%26atitle%3DPhysicochemical%2520properties%2520of%2520antibacterial%2520compounds%253A%2520implications%2520for%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D2871%26epage%3D2878%26doi%3D10.1021%2Fjm700967e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Manchester, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buurman, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bisacchi, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLaughlin, R. E.</span></span> <span> </span><span class="NLM_article-title">Molecular determinants of AcrB-mediated bacterial efflux implications for drug discovery</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">2532</span>– <span class="NLM_lpage">2537</span>, <span class="refDoi"> DOI: 10.1021/jm201275d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201275d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC38XktVKhsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=2532-2537&author=J.+I.+Manchesterauthor=E.+T.+Buurmanauthor=G.+S.+Bisacchiauthor=R.+E.+McLaughlin&title=Molecular+determinants+of+AcrB-mediated+bacterial+efflux+implications+for+drug+discovery&doi=10.1021%2Fjm201275d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Determinants of AcrB-Mediated Bacterial Efflux Implications for Drug Discovery</span></div><div class="casAuthors">Manchester, John I.; Buurman, Ed T.; Bisacchi, Gregory S.; McLaughlin, Robert E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2532-2537</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Retrospective anal. on antibacterial compds. from discovery programs targeting Gram-neg. pathogens. We used antimicrobial activities, measured as minimal inhibitory concns. Important implication for drug discovery is that targeting specific ranges of phys. properties is not enough to guarantee antibacterial activity. We incorporated structural motifs that exploit one or more avenues for circumventing efflux in the design and selection of novel compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVBaNXOZf6j7Vg90H21EOLACvtfcHk0ljUu8iSh2QR6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktVKhsw%253D%253D&md5=2e2b7f1fb2d4a3c84b91ecb11b24c999</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fjm201275d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201275d%26sid%3Dliteratum%253Aachs%26aulast%3DManchester%26aufirst%3DJ.%2BI.%26aulast%3DBuurman%26aufirst%3DE.%2BT.%26aulast%3DBisacchi%26aufirst%3DG.%2BS.%26aulast%3DMcLaughlin%26aufirst%3DR.%2BE.%26atitle%3DMolecular%2520determinants%2520of%2520AcrB-mediated%2520bacterial%2520efflux%2520implications%2520for%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D2532%26epage%3D2537%26doi%3D10.1021%2Fjm201275d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">May-Dracka, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gagnon, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tommasi, R.</span></span> <span> </span><span class="NLM_article-title">Trends and exceptions of physical properties on antibacterial activity for Gram-positive and Gram-negative pathogens</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">10144</span>– <span class="NLM_lpage">10161</span>, <span class="refDoi"> DOI: 10.1021/jm501552x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501552x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFehtbvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=10144-10161&author=D.+G.+Brownauthor=T.+L.+May-Drackaauthor=M.+M.+Gagnonauthor=R.+Tommasi&title=Trends+and+exceptions+of+physical+properties+on+antibacterial+activity+for+Gram-positive+and+Gram-negative+pathogens&doi=10.1021%2Fjm501552x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Trends and Exceptions of Physical Properties on Antibacterial Activity for Gram-Positive and Gram-Negative Pathogens</span></div><div class="casAuthors">Brown, Dean G.; May-Dracka, Tricia L.; Gagnon, Moriah M.; Tommasi, Ruben</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10144-10161</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To better understand the difficulties surrounding the identification of novel antibacterial compds. from corporate screening collections, phys. properties of ∼3200 antibacterial project compds. with whole cell activity against Gram-neg. or Gram-pos. pathogens were profiled and compared to actives found from high throughput (HTS) screens conducted on both biochem. and phenotypic bacterial targets.  The output from 23 antibacterial HTS screens illustrated that when compared to the properties of the antibacterial project compds., the HTS actives were significantly more hydrophobic than antibacterial project compds. (typically 2-4 log units higher), and furthermore, for 14/23 HTS screens, the av. clogD was higher than the screening collection av. (screening collection clogD = 2.45).  It was found that the consequences of this were the following: (a) lead identification programs often further gained hydrophobic character with increased biochem. potency, making the sepn. even larger between the physicochem. properties of known antibacterial agents and the HTS active starting point, (b) the probability of plasma protein binding and cytotoxicity are often increased, and (c) cell-based activity in Gram-neg. bacteria was severely limited or, if present, demonstrated significant efflux.  Our anal. illustrated that compds. least susceptible to efflux were those which were highly polar and small in MW or very large and typically zwitterionic.  Hydrophobicity was often the dominant driver for HTS actives but, more often than not, precluded whole cell antibacterial activity.  However, simply designing polar compds. was not sufficient for antibacterial activity and pointed to a lack of understanding of complex and specific bacterial penetration mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-f01NZg_bsbVg90H21EOLACvtfcHk0ljUu8iSh2QR6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFehtbvN&md5=e107961414dc8cbf696e2287ddf9362d</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fjm501552x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501552x%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DD.%2BG.%26aulast%3DMay-Dracka%26aufirst%3DT.%2BL.%26aulast%3DGagnon%26aufirst%3DM.%2BM.%26aulast%3DTommasi%26aufirst%3DR.%26atitle%3DTrends%2520and%2520exceptions%2520of%2520physical%2520properties%2520on%2520antibacterial%2520activity%2520for%2520Gram-positive%2520and%2520Gram-negative%2520pathogens%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D10144%26epage%3D10161%26doi%3D10.1021%2Fjm501552x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tommasi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iyer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, A. A.</span></span> <span> </span><span class="NLM_article-title">Antibacterial drug discovery: some assembly required</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">686</span>– <span class="NLM_lpage">695</span>, <span class="refDoi"> DOI: 10.1021/acsinfecdis.8b00027</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.8b00027" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjtlOqurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2018&pages=686-695&author=R.+Tommasiauthor=R.+Iyerauthor=A.+A.+Miller&title=Antibacterial+drug+discovery%3A+some+assembly+required&doi=10.1021%2Facsinfecdis.8b00027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Antibacterial Drug Discovery: Some Assembly Required</span></div><div class="casAuthors">Tommasi, Ruben; Iyer, Ramkumar; Miller, Alita A.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">686-695</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Our limited understanding of the mol. basis for compd. entry into and efflux out of Gram-neg. bacteria is now recognized as a key bottleneck for the rational discovery of novel antibacterial compds.  Traditional, large-scale biochem. or target-agnostic phenotypic antibacterial screening efforts have, as a result, not been very fruitful.  A main driver of this knowledge gap has been the historical lack of predictive cellular assays, tools, and models that provide structure-activity relationships to inform optimization of compd. accumulation.  A variety of recent approaches has recently been described to address this conundrum.  This Perspective explores these approaches and considers ways in which their integration could successfully redirect antibacterial drug discovery efforts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonfRBE2Xs8GrVg90H21EOLACvtfcHk0ljXs4UtVRGCIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjtlOqurk%253D&md5=57ab82ebe1d0d39199581344414e6c94</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.8b00027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.8b00027%26sid%3Dliteratum%253Aachs%26aulast%3DTommasi%26aufirst%3DR.%26aulast%3DIyer%26aufirst%3DR.%26aulast%3DMiller%26aufirst%3DA.%2BA.%26atitle%3DAntibacterial%2520drug%2520discovery%253A%2520some%2520assembly%2520required%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2018%26volume%3D4%26spage%3D686%26epage%3D695%26doi%3D10.1021%2Facsinfecdis.8b00027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Richter, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hergenrother, P. J.</span></span> <span> </span><span class="NLM_article-title">The challenge of converting Gram-positive-only compounds into broad-spectrum antibiotics</span>. <i>Ann. N. Y. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>1435</i></span>,  <span class="NLM_fpage">18</span>– <span class="NLM_lpage">38</span>, <span class="refDoi"> DOI: 10.1111/nyas.13598</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1111%2Fnyas.13598" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=29446459" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlyktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1435&publication_year=2019&pages=18-38&author=M.+F.+Richterauthor=P.+J.+Hergenrother&title=The+challenge+of+converting+Gram-positive-only+compounds+into+broad-spectrum+antibiotics&doi=10.1111%2Fnyas.13598"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">The challenge of converting Gram-positive-only compounds into broad-spectrum antibiotics</span></div><div class="casAuthors">Richter, Michelle F.; Hergenrother, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the New York Academy of Sciences</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">1435</span>
        (<span class="NLM_cas:issue">1, Antimicrobial Therapeutics Reviews</span>),
    <span class="NLM_cas:pages">18-38</span>CODEN:
                <span class="NLM_cas:coden">ANYAA9</span>;
        ISSN:<span class="NLM_cas:issn">0077-8923</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Multidrug resistant Gram-neg. bacterial infections are on the rise, and there is a lack of new classes of drugs to treat these pathogens.  This drug shortage is largely due to the challenge of finding antibiotics that can permeate and persist inside Gram-neg. species.  Efforts to understand the mol. properties that enable certain compds. to accumulate in Gram-neg. bacteria based on retrospective studies of known antibiotics have not been generally actionable in the development of new antibiotics.  A recent assessment of the ability of >180 diverse small mols. to accumulate in Escherichia coli led to predictive guidelines for compd. accumulation in E. coli.  These "eNTRy rules" state that compds. are most likely to accumulate if they contain a nonsterically encumbered ionizable Nitrogen (primary amines are the best), have low Three-dimensionality (globularity ≤ 0.25), and are relatively Rigid (rotatable bonds ≤ 5).  In this review, we look back through 50+ years of antibacterial research and 1000s of derivs. and assess this historical data set through the lens of these predictive guidelines.  The results are consistent with the eNTRy rules, suggesting that the eNTRy rules may provide an actionable and general roadmap for the conversion of Gram-pos.-only compds. into broad-spectrum antibiotics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqX3zbgiAcHdbVg90H21EOLACvtfcHk0ljXs4UtVRGCIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlyktw%253D%253D&md5=12fffe0d10e7d3e5c134ac28ce929ab3</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1111%2Fnyas.13598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fnyas.13598%26sid%3Dliteratum%253Aachs%26aulast%3DRichter%26aufirst%3DM.%2BF.%26aulast%3DHergenrother%26aufirst%3DP.%2BJ.%26atitle%3DThe%2520challenge%2520of%2520converting%2520Gram-positive-only%2520compounds%2520into%2520broad-spectrum%2520antibiotics%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2019%26volume%3D1435%26spage%3D18%26epage%3D38%26doi%3D10.1111%2Fnyas.13598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reck, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jansen, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moser, H. E.</span></span> <span> </span><span class="NLM_article-title">Challenges of antibacterial drug discovery</span>. <i>ARKIVOC</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">227</span>– <span class="NLM_lpage">244</span>, <span class="refDoi"> DOI: 10.24820/ark.5550190.p010.955</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.24820%2Fark.5550190.p010.955" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2020&pages=227-244&author=F.+Reckauthor=J.+M.+Jansenauthor=H.+E.+Moser&title=Challenges+of+antibacterial+drug+discovery&doi=10.24820%2Fark.5550190.p010.955"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.24820%2Fark.5550190.p010.955&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.24820%252Fark.5550190.p010.955%26sid%3Dliteratum%253Aachs%26aulast%3DReck%26aufirst%3DF.%26aulast%3DJansen%26aufirst%3DJ.%2BM.%26aulast%3DMoser%26aufirst%3DH.%2BE.%26atitle%3DChallenges%2520of%2520antibacterial%2520drug%2520discovery%26jtitle%3DARKIVOC%26date%3D2020%26volume%3D4%26spage%3D227%26epage%3D244%26doi%3D10.24820%2Fark.5550190.p010.955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schümann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boudon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulrich, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loll, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaffner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Streich, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kittel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, D.</span></span> <span> </span><span class="NLM_article-title">Integrated preclinical photosafety testing strategy for systemically applied pharmaceuticals</span>. <i>Toxicol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>139</i></span>,  <span class="NLM_fpage">245</span>– <span class="NLM_lpage">256</span>, <span class="refDoi"> DOI: 10.1093/toxsci/kfu026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1093%2Ftoxsci%2Fkfu026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=24519524" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmsVGktrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=2014&pages=245-256&author=J.+Sch%C3%BCmannauthor=S.+Boudonauthor=P.+Ulrichauthor=N.+Lollauthor=D.+Garciaauthor=R.+Schaffnerauthor=J.+Streichauthor=B.+Kittelauthor=D.+Bauer&title=Integrated+preclinical+photosafety+testing+strategy+for+systemically+applied+pharmaceuticals&doi=10.1093%2Ftoxsci%2Fkfu026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Integrated Preclinical Photosafety Testing Strategy for Systemically Applied Pharmaceuticals</span></div><div class="casAuthors">Schuemann, Jens; Boudon, Stephanie; Ulrich, Peter; Loll, Nathalie; Garcia, Deborah; Schaffner, Rene; Streich, Jeannine; Kittel, Birgit; Bauer, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Toxicological Sciences</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">139</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">245-256</span>CODEN:
                <span class="NLM_cas:coden">TOSCF2</span>;
        ISSN:<span class="NLM_cas:issn">1096-0929</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Phototoxic properties of systemically applied pharmaceuticals may be the cause of serious adverse drug reactions.  Therefore, a reliable preclin. photosafety assessment strategy, combining in vitro and in vivo approaches in a quant. manner, is important and has not been described so far.  Here, we report the establishment of an optimized modified murine local lymph node assay (LLNA), adapted for phototoxicity assessment of systemically applied compds., as well as the test results for 34 drug candidates in this in vivo photo-LLNA.  The drug candidates were selected based on their ability to absorb UV/visible light and the photo irritation factors (PIFs) detd. in the well-established in vitro 3T3 neutral red uptake phototoxicity test.  An in vivo phototoxic potential was identified for 13 of these drug candidates.  The use of multiple dose levels in the described murine in vivo phototoxicity studies enabled the establishment of no- and/or lowest-obsd.-adverse-effect levels (NOAELs/LOAELs), also supporting human photosafety assessment.  An in vitro-in vivo correlation demonstrated that a drug candidate classified as "phototoxic" in vitro is not necessarily phototoxic in vivo.  However, the probability for a drug candidate to cause phototoxicity in vivo clearly correlated with the magnitude of the phototoxicity identified in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp36qqelnD-u7Vg90H21EOLACvtfcHk0ljXs4UtVRGCIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmsVGktrw%253D&md5=4dd2cac32d7e03eae065b3b402f19187</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1093%2Ftoxsci%2Fkfu026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Ftoxsci%252Fkfu026%26sid%3Dliteratum%253Aachs%26aulast%3DSch%25C3%25BCmann%26aufirst%3DJ.%26aulast%3DBoudon%26aufirst%3DS.%26aulast%3DUlrich%26aufirst%3DP.%26aulast%3DLoll%26aufirst%3DN.%26aulast%3DGarcia%26aufirst%3DD.%26aulast%3DSchaffner%26aufirst%3DR.%26aulast%3DStreich%26aufirst%3DJ.%26aulast%3DKittel%26aufirst%3DB.%26aulast%3DBauer%26aufirst%3DD.%26atitle%3DIntegrated%2520preclinical%2520photosafety%2520testing%2520strategy%2520for%2520systemically%2520applied%2520pharmaceuticals%26jtitle%3DToxicol.%2520Sci.%26date%3D2014%26volume%3D139%26spage%3D245%26epage%3D256%26doi%3D10.1093%2Ftoxsci%2Fkfu026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Owens, R. C.,  Jr</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambrose, P. G.</span></span> <span> </span><span class="NLM_article-title">Antimicrobial safety: focus on fluoroquinolones</span>. <i>Clin. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">S144</span>– <span class="NLM_lpage">S157</span>, <span class="refDoi"> DOI: 10.1086/428055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1086%2F428055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=15942881" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmvVylsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2005&pages=S144-S157&author=R.+C.+Owensauthor=P.+G.+Ambrose&title=Antimicrobial+safety%3A+focus+on+fluoroquinolones&doi=10.1086%2F428055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Antimicrobial safety: Focus on fluoroquinolones</span></div><div class="casAuthors">Owens, Robert C., Jr.; Ambrose, Paul G.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Infectious Diseases</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">Suppl. 2</span>),
    <span class="NLM_cas:pages">S144-S157</span>CODEN:
                <span class="NLM_cas:coden">CIDIEL</span>;
        ISSN:<span class="NLM_cas:issn">1058-4838</span>.
    
            (<span class="NLM_cas:orgname">University of Chicago Press</span>)
        </div><div class="casAbstract">A review.  Background/purpose. Infrequent toxicities assocd. with certain drugs and drug classes have recently gained much attention from different health-care perspectives.  To protect the patient, continued surveillance of safety and tolerability data is essential.  Data from preclin. testing, phase 1-3 trials, and postmarketing surveillance may be used to objectively assess the risks assocd. with a specific drug or family of compds.  This review summarizes safety and tolerability data for the quinolones.  Main findings. The most common adverse events assocd. with the quinolone class involve the gastrointestinal tract (nausea and diarrhea) and central nervous system (CNS) (headache and dizziness).  These adverse events are usually mild and do not require discontinuation of therapy.  Uncommon and potentially serious quinolone-related adverse events involve the cardiovascular system (rate-cor. electrocardiog. QT interval prolongation), musculoskeletal system (tendinitis and tendon rupture), endocrine system (glucose homeostasis dysregulation), renal system (crystalluria, interstitial nephritis, and acute renal failure), and the CNS (seizures).  Severe idiosyncratic adverse events are specific to individual agents that may share some structural congruity, such as the 1-(2,4)-difluorophenyl group shared by trovafloxacin (assocd. with hepatitis), temafloxacin (assocd. with hemolytic-uremic syndrome), and tosufloxacin (assocd. with eosinophilic pneumonitis).  Overall, discontinuation rates from clin. trials were <4% for the currently marketed quinolones.  Quinolones with higher discontinuation rates, such as trovafloxacin (7.0%) and grepafloxacin (6.4%), are no longer available for general use.  Conclusions. The currently marketed quinolones are well tolerated, with safety profiles similar to those of other antimicrobial classes.  Although adverse effects are unusual, some, including tendinitis and CNS-related effects, are more common with quinolones than with other antimicrobial classes.  Rare adverse effects attributed to some members of the quinolone family (e.g., Torsades de Pointes, hepatotoxicity, and dysglycemias) are more likely to occur in select "susceptible" populations.  These adverse events can often be circumvented by avoiding exposure to the specific quinolone.  In some cases, the therapeutic value offered by a quinolone may outweigh its potential risks.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWdbldgEkRtrVg90H21EOLACvtfcHk0liGnbj1ybNUQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmvVylsb8%253D&md5=f721e7d77b8799baa96336ad54fa5d53</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1086%2F428055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F428055%26sid%3Dliteratum%253Aachs%26aulast%3DOwens%26aufirst%3DR.%2BC.%26aulast%3DAmbrose%26aufirst%3DP.%2BG.%26atitle%3DAntimicrobial%2520safety%253A%2520focus%2520on%2520fluoroquinolones%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2005%26volume%3D41%26spage%3DS144%26epage%3DS157%26doi%3D10.1086%2F428055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stahlmann, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lode, H.</span></span> <span> </span><span class="NLM_article-title">Toxicity of quinolones</span>. <i>Drugs</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">37</span>– <span class="NLM_lpage">42</span>, <span class="refDoi"> DOI: 10.2165/00003495-199958002-00007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.2165%2F00003495-199958002-00007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10553703" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADyaK1MXntFeiur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1999&pages=37-42&author=R.+Stahlmannauthor=H.+Lode&title=Toxicity+of+quinolones&doi=10.2165%2F00003495-199958002-00007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Toxicity of quinolones</span></div><div class="casAuthors">Stahlmann, Ralf; Lode, Hartmut</div><div class="citationInfo"><span class="NLM_cas:title">Drugs</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">Suppl. 2</span>),
    <span class="NLM_cas:pages">37-42</span>CODEN:
                <span class="NLM_cas:coden">DRUGAY</span>;
        ISSN:<span class="NLM_cas:issn">0012-6667</span>.
    
            (<span class="NLM_cas:orgname">Adis International Ltd.</span>)
        </div><div class="casAbstract">A review with 37 refs. Reactions of the gastrointestinal tract, the central nervous system and the skin are the most often obsd. adverse effects during therapy with fluoroquinolones.  At least for some of the newer fluoroquinolones a steep dose-response relationship of adverse effects seems to exist.  Pathogenesis of the neurotoxic effects of fluoroquinolones is still unknown.  Among the newer drugs, trovafloxacin causes mild central nervous reactions such as dizziness and lightheadedness in a considerable proportion of patients.  Young females seem to be esp. sensitive to this effect, which diminishes during treatment or if the drug is taken together with food.  Cardiotoxic potentials of sparfloxacin and grepafloxacin are higher than those of other fluoroquinolones, but during therapy no clear-cut drug-related serious reactions have been reported, apart from a slight prolongation of the QT interval.  However, to avoid risks these drugs should not be prescribed to patients with known prolongation of the QT interval (e.g., patients on antiarrhythmics).  Phototoxicity has been described for all the quinolones, but derivs. with a halogen atom at position 8 show the highest potential for such reactions.  Fleroxacin, sparfloxacin, clinafloxacin and lomefloxacin belong to this group of fluoroquinolones.  The phototoxic potential of the other new fluoroquinolones is considerably lower, but extensive exposure to UV light should generally be avoided during therapy with all quinolones.  Chondrotoxicity of quinolones, as obsd. in immature animals, can affect articular cartilage and/or the epiphyseal growth plate, depending on the developmental stage.  The chondrotoxicity can probably be explained by the magnesium-chelating properties of these drugs.  As juveniles are esp. sensitive, use of these drugs in pediatrics should be restricted to carefully selected indications (such as the use of ciprofloxacin in cystic fibrosis).  Another manifestation of the toxic effects of quinolones on connective tissue structures is tendopathies.  Tendonitis and tendon ruptures have occurred as late as several months after quinolone treatment.  Overall, quinolones are well-tolerated drugs.  Their specific toxic potentials have to be considered when they are chosen for treatment of bacterial infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGons4CApvryWrVg90H21EOLACvtfcHk0liGnbj1ybNUQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntFeiur8%253D&md5=bc0907936e9caf3803652f9580893e46</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.2165%2F00003495-199958002-00007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00003495-199958002-00007%26sid%3Dliteratum%253Aachs%26aulast%3DStahlmann%26aufirst%3DR.%26aulast%3DLode%26aufirst%3DH.%26atitle%3DToxicity%2520of%2520quinolones%26jtitle%3DDrugs%26date%3D1999%26volume%3D58%26spage%3D37%26epage%3D42%26doi%3D10.2165%2F00003495-199958002-00007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Albini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monti, S.</span></span> <span> </span><span class="NLM_article-title">Photophysics and photochemistry of fluoroquinolones</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">238</span>– <span class="NLM_lpage">250</span>, <span class="refDoi"> DOI: 10.1039/b209220b</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1039%2Fb209220b" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=12875030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkt1emt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2003&pages=238-250&author=A.+Albiniauthor=S.+Monti&title=Photophysics+and+photochemistry+of+fluoroquinolones&doi=10.1039%2Fb209220b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Photophysics and photochemistry of fluoroquinolones</span></div><div class="casAuthors">Albini, Angelo; Monti, Sandra</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">238-250</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  The photo-behavior of fluoroquinolone antibiotics, one of the most successful classes of drugs in therapeutic applications, has recently been the object of increasing interest due to the finding of their photo-toxic and photo-carcinogenic properties.  The main results obtained for a series of structurally related, representative fluoroquinolone drugs is reviewed.  Both activation of oxygen and various degrdn. pathways have been identified and the effects of medium and structure have been rationalized.  The results can help in the understanding of the photochem. occurring in biol. environments and in the assessing of the correlation between structural characteristics and biol. photo-damage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDMZr6DgpbOrVg90H21EOLACvtfcHk0liGnbj1ybNUQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkt1emt7Y%253D&md5=96bba8ea1c99cee9b5d77e9518b70d06</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1039%2Fb209220b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb209220b%26sid%3Dliteratum%253Aachs%26aulast%3DAlbini%26aufirst%3DA.%26aulast%3DMonti%26aufirst%3DS.%26atitle%3DPhotophysics%2520and%2520photochemistry%2520of%2520fluoroquinolones%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2003%26volume%3D32%26spage%3D238%26epage%3D250%26doi%3D10.1039%2Fb209220b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Soldevila, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuquerella, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosca, F.</span></span> <span> </span><span class="NLM_article-title">Understanding of the Photoallergic Properties of Fluoroquinolones: Photoreactivity of Lomefloxacin with Amino Acids and Albumin</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">514</span>– <span class="NLM_lpage">523</span>, <span class="refDoi"> DOI: 10.1021/tx400377s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx400377s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisFWqt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2014&pages=514-523&author=S.+Soldevilaauthor=M.+C.+Cuquerellaauthor=F.+Bosca&title=Understanding+of+the+Photoallergic+Properties+of+Fluoroquinolones%3A+Photoreactivity+of+Lomefloxacin+with+Amino+Acids+and+Albumin&doi=10.1021%2Ftx400377s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Understanding of the Photoallergic Properties of Fluoroquinolones: Photoreactivity of Lomefloxacin with Amino Acids and Albumin</span></div><div class="casAuthors">Soldevila, Sonia; Cuquerella, M. Consuelo; Bosca, Francisco</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">514-523</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Although the phototoxic and photoallergic properties of fluoroquinolone antibiotics (FQ) are remarkable, the mechanisms involved in these processes are not completely understood.  For this reason, it is considered worthwhile to study in detail the photochem. interactions of lomefloxacin (LFX) and its N-acetyl deriv. ALFX, two 6,8-dihalogenated fluoroquinolones, with the most abundant protein in human plasma (human serum albumin, HSA) to analyze their covalent binding.  Fluorescence measurements and laser flash photolysis expts. performed in this work have revealed that N-acetylation of the LFX piperazinyl moiety produces an important increase of the drug affinity to albumin.  Thus, while the assocn. const. (Ka) for the LFX···HSA complex is below 103 M-1, the Ka for the HSA···ALFX complex resulted in ca. 5 × 103 M-1.  Interestingly, LFX is mainly located at site I of HSA, while ALFX shows no preference for site I or II.  A high reactivity between the aryl cations generated from (A)LFX dehalogenation and Trp and Tyr together with the generation of covalent adducts between the FQ and these amino acids was obsd.  However, the interactions between the FQ singlet excited state and albumin in FQ···HSA complexes seem to be the key process of FQ covalent binding to albumin.  Moreover, our findings have shown a correlation between the photobinding properties of dihalogenated fluoroquinolones to HSA and their FQ···HSA assocn. consts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvoxf0eAejX7Vg90H21EOLACvtfcHk0li6d8xHS8uq-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisFWqt7k%253D&md5=35fb7ce63e89e2effeb25f80933d86d5</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Ftx400377s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx400377s%26sid%3Dliteratum%253Aachs%26aulast%3DSoldevila%26aufirst%3DS.%26aulast%3DCuquerella%26aufirst%3DM.%2BC.%26aulast%3DBosca%26aufirst%3DF.%26atitle%3DUnderstanding%2520of%2520the%2520Photoallergic%2520Properties%2520of%2520Fluoroquinolones%253A%2520Photoreactivity%2520of%2520Lomefloxacin%2520with%2520Amino%2520Acids%2520and%2520Albumin%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2014%26volume%3D27%26spage%3D514%26epage%3D523%26doi%3D10.1021%2Ftx400377s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Soldevila, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosca, F.</span></span> <span> </span><span class="NLM_article-title">Photoreactivity of Fluoroquinolones: Nature of Aryl Cations Generated in Water</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">3940</span>– <span class="NLM_lpage">3943</span>, <span class="refDoi"> DOI: 10.1021/ol301694p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol301694p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtV2gsb3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=3940-3943&author=S.+Soldevilaauthor=F.+Bosca&title=Photoreactivity+of+Fluoroquinolones%3A+Nature+of+Aryl+Cations+Generated+in+Water&doi=10.1021%2Fol301694p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Photoreactivity of Fluoroquinolones: Nature of Aryl Cations Generated in Water</span></div><div class="casAuthors">Soldevila, Sonia; Bosca, Francisco</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3940-3943</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The nature of stabilized aryl cations generated from photodehalogenations of fluoroquinolones in aq. media has been studied by comparing the photophys. and photochem. behavior of lomefloxacin (LFX) and its N(4')-acetylated form (ALFX).  Photoproduct studies, laser flash photolysis, and emission measurements have shown that this small peripheral modification produces important changes in the properties of the singlet aryl cations generated.  Also, in basic medium, a new photodehalogenation pathway for 6,8-dihalogenated fluoroquinolones has been obsd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKLNFDtAytZLVg90H21EOLACvtfcHk0li6d8xHS8uq-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtV2gsb3O&md5=619baa0f7d89af8abb18420a632f3c6f</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fol301694p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol301694p%26sid%3Dliteratum%253Aachs%26aulast%3DSoldevila%26aufirst%3DS.%26aulast%3DBosca%26aufirst%3DF.%26atitle%3DPhotoreactivity%2520of%2520Fluoroquinolones%253A%2520Nature%2520of%2520Aryl%2520Cations%2520Generated%2520in%2520Water%26jtitle%3DOrg.%2520Lett.%26date%3D2012%26volume%3D14%26spage%3D3940%26epage%3D3943%26doi%3D10.1021%2Fol301694p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cuquerella, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miranda, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boscá, F.</span></span> <span> </span><span class="NLM_article-title">Generation of Detectable Singlet Aryl Cations by Photodehalogenation of Fluoroquinolones</span>. <i>J. Phys. Chem. B</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">6441</span>– <span class="NLM_lpage">6443</span>, <span class="refDoi"> DOI: 10.1021/jp060634d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jp060634d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BD28XitVyns70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2006&pages=6441-6443&author=M.+C.+Cuquerellaauthor=M.+A.+Mirandaauthor=F.+Bosc%C3%A1&title=Generation+of+Detectable+Singlet+Aryl+Cations+by+Photodehalogenation+of+Fluoroquinolones&doi=10.1021%2Fjp060634d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Generation of Detectable Singlet Aryl Cations by Photodehalogenation of Fluoroquinolones</span></div><div class="casAuthors">Cuquerella, M. Consuelo; Miranda, Miguel A.; Bosca, Francisco</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physical Chemistry B</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">6441-6443</span>CODEN:
                <span class="NLM_cas:coden">JPCBFK</span>;
        ISSN:<span class="NLM_cas:issn">1520-6106</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Nanosecond laser flash photolysis (λexc = 355 nm) of neutral aq. solns. of lomefloxacin (LFX, a 8-fluorinated 7-amino-4-quinolone-3-carboxylic acid deriv.) produces a detectable transient species, which shows an absorption max. at 490 nm and can be assigned to an aryl cation.  This intermediate has a lifetime of ca.  200 Ns in net water, reacts with Br- and Cl- with rate consts. of 3.6 × 109 M-1 s-1 and 4.1 × 108 M-1 s-1, resp., and shows a lack of reactivity toward mol. oxygen.  From the photolysis of BAY y3118 (BAY, a 8-chlorinated analog), an aryl cation is also generated, showing absorption max. at 480 nm (lifetime of ca. 1 μs in net water) and a reaction rate const. of 9 × 109 M-1 s-1 with Br-.  The existence of these highly reactive species arising from direct photolysis of LFX and BAY can justify the photogenotoxic properties assocd. with these antibacterial drugs likely due to direct reaction of their cations with DNA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9HTFXNawsl7Vg90H21EOLACvtfcHk0li6d8xHS8uq-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XitVyns70%253D&md5=4cccf5653e80cfb01049a29d2021ab8c</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Fjp060634d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjp060634d%26sid%3Dliteratum%253Aachs%26aulast%3DCuquerella%26aufirst%3DM.%2BC.%26aulast%3DMiranda%26aufirst%3DM.%2BA.%26aulast%3DBosc%25C3%25A1%26aufirst%3DF.%26atitle%3DGeneration%2520of%2520Detectable%2520Singlet%2520Aryl%2520Cations%2520by%2520Photodehalogenation%2520of%2520Fluoroquinolones%26jtitle%3DJ.%2520Phys.%2520Chem.%2520B%26date%3D2006%26volume%3D110%26spage%3D6441%26epage%3D6443%26doi%3D10.1021%2Fjp060634d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="note"><p class="first last">Compound <b>34</b> was tested in the hERG QPatch assay using a nonstandard long incubation protocol (see <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> for details). Under the standard conditions, steady state was not reached for some recordings. This can result in underestimation of the true IC<sub>50</sub>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Triggle, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rampe, D.</span></span> <span> </span><span class="NLM_article-title">Interactions of a series of fluoroquinolone antibacterial drugs with the human cardiac K+ channel HERG</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">122</span>– <span class="NLM_lpage">126</span>, <span class="refDoi"> DOI: 10.1124/mol.59.1.122</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1124%2Fmol.59.1.122" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=11125032" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BD3MXns1CktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2001&pages=122-126&author=J.+Kangauthor=L.+Wangauthor=X.-L.+Chenauthor=D.+J.+Triggleauthor=D.+Rampe&title=Interactions+of+a+series+of+fluoroquinolone+antibacterial+drugs+with+the+human+cardiac+K%2B+channel+HERG&doi=10.1124%2Fmol.59.1.122"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Interactions of a series of fluoroquinolone antibacterial drugs with the human cardiac K+ channel HERG</span></div><div class="casAuthors">Kang, Jiesheng; Wang, Lin; Chen, Xiao-Liang; Triggle, David J.; Rampe, David</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">122-126</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Administration of certain fluoroquinolone antibacterials has been assocd. with prolongation of the QT interval on the ECG and, on rare occasions, ventricular arrhythmia.  Blockade of the human cardiac K+ channel HERG often underlies such clin. findings.  Therefore, we examd. a series of seven fluoroquinolones for their ability to interact with this channel.  Using patch-clamp electrophysiol., we found that all of the drugs tested inhibited HERG channel currents, but with widely differing potencies.  Sparfloxacin was the most potent compd., displaying an IC50 value of 18 μM, whereas ofloxacin was the least potent compd., with an IC50 value of 1420 μM.  Other IC50 values were as follows: grepafloxacin, 50 μM; moxifloxacin, 129 μM; gatifloxacin, 130 μM; levofloxacin, 915 μM; and ciprofloxacin, 966 μM.  Block of HERG by sparfloxacin displayed a pos. voltage dependence.  In contrast to HERG, the KvLQT1/minK K+ channel was not a target for block by the fluoroquinolones.  These results provide a mechanism for the QT prolongation obsd. clin. with administration of sparfloxacin and certain other fluoroquinolones because free plasma levels of these drugs after therapeutic doses approx. those concns. that inhibit HERG channel current.  In the cases of levofloxacin, ciprofloxacin, and ofloxacin, inhibition of HERG occurs at concns. much greater than those obsd. clin.  The data indicate that clin. relevant HERG channel inhibition is not a class effect of the fluoroquinolone antibacterials but is highly dependent upon specific substitutions within this series of compds.  HERG channel affinity should be an important criterion for the development of newer fluoroquinolones.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlnqmtGDeBjrVg90H21EOLACvtfcHk0lgdvt0ooV3thQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXns1CktA%253D%253D&md5=e566698168741c8ccd6cb2fccf3655aa</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1124%2Fmol.59.1.122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.59.1.122%26sid%3Dliteratum%253Aachs%26aulast%3DKang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DX.-L.%26aulast%3DTriggle%26aufirst%3DD.%2BJ.%26aulast%3DRampe%26aufirst%3DD.%26atitle%3DInteractions%2520of%2520a%2520series%2520of%2520fluoroquinolone%2520antibacterial%2520drugs%2520with%2520the%2520human%2520cardiac%2520K%252B%2520channel%2520HERG%26jtitle%3DMol.%2520Pharmacol.%26date%3D2001%26volume%3D59%26spage%3D122%26epage%3D126%26doi%3D10.1124%2Fmol.59.1.122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Culley, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lacy, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klutman, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, B.</span></span> <span> </span><span class="NLM_article-title">Moxifloxacin: clinical efficacy and safety</span>. <i>Am. J. Health-Syst. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">379</span>– <span class="NLM_lpage">388</span>, <span class="refDoi"> DOI: 10.1093/ajhp/58.5.379</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1093%2Fajhp%2F58.5.379" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=11258173" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhvFensbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2001&pages=379-388&author=C.+M.+Culleyauthor=M.+K.+Lacyauthor=N.+Klutmanauthor=B.+Edwards&title=Moxifloxacin%3A+clinical+efficacy+and+safety&doi=10.1093%2Fajhp%2F58.5.379"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Moxifloxacin: Clinical efficacy and safety</span></div><div class="casAuthors">Culley, Colleen M.; Lacy, Melinda K.; Klutman, Neil; Edwards, Brian</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Health-System Pharmacy</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">379-388</span>CODEN:
                <span class="NLM_cas:coden">AHSPEK</span>;
        ISSN:<span class="NLM_cas:issn">1079-2082</span>.
    
            (<span class="NLM_cas:orgname">American Society of Health-System Pharmacists</span>)
        </div><div class="casAbstract">A review with 84 refs.  The activity, pharmacokinetics, pharmacodynamics, efficacy, safety, drug interactions, and dosage and administration of moxifloxacin are reviewed.  Moxifloxacin is an oral 8-methoxyquinolone antimicrobial approved in Dec. 1999 for use in the treatment of acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and community-acquired pneumonia.  This fluoroquinolone is active against common community-acquired respiratory pathogens (Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis), atypical pathogens, and many anaerobes.  Moxifloxacin has an abs. bioavailability of 90% after oral administration and a mean elimination half-life of 12 h.  The drug is not a substrate or inhibitor of the hepatic cytochrome P 450 isoenzyme system, thereby avoiding many potential drug interactions.  Moxifloxacin has limited phototoxic potential.  In clin. trials, moxifloxacin had clin. success rates of 88-97% and bacteriol. eradication rates of 90-97%.  Reported adverse effects were primarily gastrointestinal (nausea, diarrhea) and were mild to moderate in severity.  Moxifloxacin prolongs the QT interval by a mean + S.D. of 6 ± 26 ms above baseline and should be used with caution in patients with proarrhythmic conditions and avoided in patients receiving antiarrhythmia agents, such as quinidine, procainamide, amiodarone, and sotalol.  The std. oral dosage is 400 mg once a day.  Dosage adjustment is unnecessary in patients with renal dysfunction or mild to moderate hepatic dysfunction.  Moxifloxacin is a safe and effective antimicrobial that will be useful for treating acute sinusitis, acute bacterial exacerbations of chronic bronchitis, and community-acquired pneumonia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7WYGx_emHprVg90H21EOLACvtfcHk0lgdvt0ooV3thQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhvFensbo%253D&md5=3ea3d2268a9b540e46dcd0a364a1415a</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1093%2Fajhp%2F58.5.379&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fajhp%252F58.5.379%26sid%3Dliteratum%253Aachs%26aulast%3DCulley%26aufirst%3DC.%2BM.%26aulast%3DLacy%26aufirst%3DM.%2BK.%26aulast%3DKlutman%26aufirst%3DN.%26aulast%3DEdwards%26aufirst%3DB.%26atitle%3DMoxifloxacin%253A%2520clinical%2520efficacy%2520and%2520safety%26jtitle%3DAm.%2520J.%2520Health-Syst.%2520Pharm.%26date%3D2001%26volume%3D58%26spage%3D379%26epage%3D388%26doi%3D10.1093%2Fajhp%2F58.5.379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Darpo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nebout, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sager, P. T.</span></span> <span> </span><span class="NLM_article-title">Clinical evaluation of QT/QTc prolongation and proarrhythmic potential for nonantiarrhythmic drugs: the international conference on harmonization of technical requirements for registration of pharmaceuticals for human use E14 guideline</span>. <i>J. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">498</span>– <span class="NLM_lpage">507</span>, <span class="refDoi"> DOI: 10.1177/0091270006286436</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1177%2F0091270006286436" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=16638733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BD28Xksl2ms7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2006&pages=498-507&author=B.+Darpoauthor=T.+Neboutauthor=P.+T.+Sager&title=Clinical+evaluation+of+QT%2FQTc+prolongation+and+proarrhythmic+potential+for+nonantiarrhythmic+drugs%3A+the+international+conference+on+harmonization+of+technical+requirements+for+registration+of+pharmaceuticals+for+human+use+E14+guideline&doi=10.1177%2F0091270006286436"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical evaluation of QT/QTc prolongation and proarrhythmic potential for nonantiarrhythmic drugs: the international conference on harmonization of technical requirements for registration of pharmaceuticals for human use E14 guideline</span></div><div class="casAuthors">Darpo, Borje; Nebout, Thierry; Sager, Philip T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">498-507</span>CODEN:
                <span class="NLM_cas:coden">JCPCBR</span>;
        ISSN:<span class="NLM_cas:issn">0091-2700</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">A review.  Proarrhythmias due to drug-induced QT prolongation are the second most common cause for drug withdrawal and have caused increasing concern.  Two new International Conference on Harmonization of Tech. Requirements for Registration of Pharmaceuticals for Human Use (ICH) guidelines were recently endorsed in which nonclin. (S7B) and clin. (E14) methodologies are discussed and guidance is given to the industry.  This commentary describes the key components of the E14 document, the impact of nonclin. testing on the clin. program, the thorough QT study, and the impact of its result on late-stage development.  The studies described in S7B and E14 will contribute to a better understanding of the link between nonclin. assays and QT prolongation in humans.  Differences in interpretation among individual regulators in the major regions with respect to measures proposed in the E14 guideline might impact regional regulatory decisions.  These differences include the value of nonclin. assays for the subsequent clin. testing and how predictive a neg. thorough QT study result is for proarrhythmic risk in patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKkKjZVVnnv7Vg90H21EOLACvtfcHk0lgdvt0ooV3thQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xksl2ms7w%253D&md5=973ab92f1528ecc5e09b85cb489fb269</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1177%2F0091270006286436&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0091270006286436%26sid%3Dliteratum%253Aachs%26aulast%3DDarpo%26aufirst%3DB.%26aulast%3DNebout%26aufirst%3DT.%26aulast%3DSager%26aufirst%3DP.%2BT.%26atitle%3DClinical%2520evaluation%2520of%2520QT%252FQTc%2520prolongation%2520and%2520proarrhythmic%2520potential%2520for%2520nonantiarrhythmic%2520drugs%253A%2520the%2520international%2520conference%2520on%2520harmonization%2520of%2520technical%2520requirements%2520for%2520registration%2520of%2520pharmaceuticals%2520for%2520human%2520use%2520E14%2520guideline%26jtitle%3DJ.%2520Clin.%2520Pharmacol.%26date%3D2006%26volume%3D46%26spage%3D498%26epage%3D507%26doi%3D10.1177%2F0091270006286436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Redfern, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlsson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacKenzie, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palethorpe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegl, P. K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strang, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camm, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, T. G.</span></span> <span> </span><span class="NLM_article-title">Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development</span>. <i>Cardiovasc. Res.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">32</span>– <span class="NLM_lpage">45</span>, <span class="refDoi"> DOI: 10.1016/S0008-6363(02)00846-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1016%2FS0008-6363%2802%2900846-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=12667944" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BD3sXit12gsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2003&pages=32-45&author=W.+S.+Redfernauthor=L.+Carlssonauthor=A.+S.+Davisauthor=W.+G.+Lynchauthor=I.+MacKenzieauthor=S.+Palethorpeauthor=P.+K.+S.+Sieglauthor=I.+Strangauthor=A.+T.+Sullivanauthor=R.+Wallisauthor=A.+J.+Cammauthor=T.+G.+Hammond&title=Relationships+between+preclinical+cardiac+electrophysiology%2C+clinical+QT+interval+prolongation+and+torsade+de+pointes+for+a+broad+range+of+drugs%3A+evidence+for+a+provisional+safety+margin+in+drug+development&doi=10.1016%2FS0008-6363%2802%2900846-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development</span></div><div class="casAuthors">Redfern, W. S.; Carlsson, L.; Davis, A. S.; Lynch, W. G.; MacKenzie, I.; Palethorpe, S.; Siegl, P. K. S.; Strang, I.; Sullivan, A. T.; Wallis, R.; Camm, A. J.; Hammond, T. G.</div><div class="citationInfo"><span class="NLM_cas:title">Cardiovascular Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">32-45</span>CODEN:
                <span class="NLM_cas:coden">CVREAU</span>;
        ISSN:<span class="NLM_cas:issn">0008-6363</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review discussing attempts to det. the relative value of preclin. cardiac electrophysiol. data (in vitro and in vivo) for predicting risk of torsades de pointes (TdP) in clin. use.  Published data on human ether-a-go-go-related gene-encoded voltage-dependent potassium channel (hERG) (or IKr) activity, cardiac action potential duration (at 90% repolarization; APD90), and QT prolongation in dogs were compared against QT effects and reports of TdP in humans for 100 drugs.  These data were set against the free plasma concns. attained during clin. use (effective therapeutic plasma concns.; ETPCunbound).  The drugs were divided into five categories: (1) Class Ia and III antiarrhythmics; (2) withdrawn from market due to TdP; (3) measurable incidence/numerous reports of TdP in humans; (4) isolated reports of TdP in humans; (5) no reports of TdP in humans.  Data from hERG (or IKr) assays in addn. to ETPCunbound data were available for 52 drugs.  For Category 1 drugs, data for hERG/IKr IC50, APD90, QTc in animals and QTc in humans were generally close to or superimposed on the ETPCunbound values.  This relationship was uncoupled in the other categories, with more complex relationships between the data.  In Category 1 (except amiodarone), the ratios between hERG/IKr IC50 and ETPCunbound (max) ranged 0.1-31-fold.  Similar ranges were obtained for drugs in Category 2 (0.31-13-fold) and Category 3 (0.03-35-fold).  A large spread was found for Category 4 drugs (0.13-35,700-fold); this category embraced an assortment of mechanisms ranging from drugs which may well be affecting IKr currents in clin. use (e.g., sparfloxacin) to others such as nifedipine (35,700-fold) where channel block is not involved.  Finally, for the majority of Category 5 drugs there was a >30-fold sepn. between hERG/IKr activity and ETPCunbound values, with the notable exception of verapamil (1.7-fold), which is free from QT prolongation in man; this is probably explained by its multiple interactions with cardiac ion channels.  The dataset confirms the widely held belief that most drugs assocd. with TdP in humans are also assocd. with hERG K+ channel block at concns. close to or superimposed upon the free plasma concns. found in clin. use.  A 30-fold margin between Cmax and hERG IC50 may suffice for drugs currently undergoing clin. evaluation, but for future drug discovery programs, pharmaceutical companies should consider increasing this margin, particularly for drugs aimed at nondebilitating diseases.  However, interactions with multiple cardiac ion channels can either mitigate or exacerbate the prolongation of APD and QT that would ensue from block of IKr currents alone, and delay of repolarization per se is not necessarily torsadogenic.  Clearly, an integrated assessment of in vitro and in vivo data is required in order to predict the torsadogenic risk of a new candidate drug in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkpRDUH0rhyrVg90H21EOLACvtfcHk0ljTi5rZ9f8SGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXit12gsb8%253D&md5=a236c07febd2e05fe70e61604619bf2e</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2FS0008-6363%2802%2900846-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0008-6363%252802%252900846-5%26sid%3Dliteratum%253Aachs%26aulast%3DRedfern%26aufirst%3DW.%2BS.%26aulast%3DCarlsson%26aufirst%3DL.%26aulast%3DDavis%26aufirst%3DA.%2BS.%26aulast%3DLynch%26aufirst%3DW.%2BG.%26aulast%3DMacKenzie%26aufirst%3DI.%26aulast%3DPalethorpe%26aufirst%3DS.%26aulast%3DSiegl%26aufirst%3DP.%2BK.%2BS.%26aulast%3DStrang%26aufirst%3DI.%26aulast%3DSullivan%26aufirst%3DA.%2BT.%26aulast%3DWallis%26aufirst%3DR.%26aulast%3DCamm%26aufirst%3DA.%2BJ.%26aulast%3DHammond%26aufirst%3DT.%2BG.%26atitle%3DRelationships%2520between%2520preclinical%2520cardiac%2520electrophysiology%252C%2520clinical%2520QT%2520interval%2520prolongation%2520and%2520torsade%2520de%2520pointes%2520for%2520a%2520broad%2520range%2520of%2520drugs%253A%2520evidence%2520for%2520a%2520provisional%2520safety%2520margin%2520in%2520drug%2520development%26jtitle%3DCardiovasc.%2520Res.%26date%3D2003%26volume%3D58%26spage%3D32%26epage%3D45%26doi%3D10.1016%2FS0008-6363%2802%2900846-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cavalluzzi, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imbrici, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gualdani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefanachi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mangiatordi, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lentini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicolotti, O.</span></span> <span> </span><span class="NLM_article-title">Human ether-à-go-go-related potassium channel: exploring SAR to improve drug design</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">344</span>– <span class="NLM_lpage">366</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2019.11.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1016%2Fj.drudis.2019.11.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=31756511" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitF2lsbrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2020&pages=344-366&author=M.+M.+Cavalluzziauthor=P.+Imbriciauthor=R.+Gualdaniauthor=A.+Stefanachiauthor=G.+F.+Mangiatordiauthor=G.+Lentiniauthor=O.+Nicolotti&title=Human+ether-%C3%A0-go-go-related+potassium+channel%3A+exploring+SAR+to+improve+drug+design&doi=10.1016%2Fj.drudis.2019.11.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Human ether-´a-go-go-related potassium channel: exploring SAR to improve drug design</span></div><div class="casAuthors">Cavalluzzi, Maria Maddalena; Imbrici, Paola; Gualdani, Roberta; Stefanachi, Angela; Mangiatordi, Giuseppe Felice; Lentini, Giovanni; Nicolotti, Orazio</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">344-366</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">HERG is best known as a primary anti-target, the inhibition of which is responsible for serious side effects.  A renewed interest in hERG as a desired target, esp. in oncol., was sparked because of its role in cellular proliferation and apoptosis.  In this study, we survey the most recent advances regarding hERG by focusing on SAR in the attempt to elucidate, at a mol. level, off-target and on-target actions of potential hERG binders, which are highly promiscuous and largely varying in structure.  Understanding the rationale behind hERG interactions and the mol. determinants of hERG activity is a real challenge and comprehension of this is of the utmost importance to prioritize compds. in early stages of drug discovery and to minimize cardiotoxicity attrition in preclin. and clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqz70JpKug31LVg90H21EOLACvtfcHk0ljTi5rZ9f8SGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitF2lsbrL&md5=08e27e9c7f92394046dbc9bbf72c76eb</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2019.11.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2019.11.005%26sid%3Dliteratum%253Aachs%26aulast%3DCavalluzzi%26aufirst%3DM.%2BM.%26aulast%3DImbrici%26aufirst%3DP.%26aulast%3DGualdani%26aufirst%3DR.%26aulast%3DStefanachi%26aufirst%3DA.%26aulast%3DMangiatordi%26aufirst%3DG.%2BF.%26aulast%3DLentini%26aufirst%3DG.%26aulast%3DNicolotti%26aufirst%3DO.%26atitle%3DHuman%2520ether-%25C3%25A0-go-go-related%2520potassium%2520channel%253A%2520exploring%2520SAR%2520to%2520improve%2520drug%2520design%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2020%26volume%3D25%26spage%3D344%26epage%3D366%26doi%3D10.1016%2Fj.drudis.2019.11.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span> <i>Performance Standards for Antimicrobial Susceptibility Testing</i>, <span class="NLM_edition">28</span>th ed.; <span class="NLM_publisher-name">Clinical Laboratory
Standards Institute (CLSI)</span>, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Performance+Standards+for+Antimicrobial+Susceptibility+Testing%2C+28th+ed.%3B+Clinical+Laboratory%0AStandards+Institute+%28CLSI%29%2C+2018."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DPerformance%2520Standards%2520for%2520Antimicrobial%2520Susceptibility%2520Testing%26pub%3DClinical%2520Laboratory%250AStandards%2520Institute%2520%2528CLSI%2529%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukuda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kishii, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosaka, M.</span></span> <span> </span><span class="NLM_article-title">Target preference of 15 quinolones against <i>Staphylococcus aureus</i> based on antibacterial activities and target inhibition</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">3544</span>– <span class="NLM_lpage">3547</span>, <span class="refDoi"> DOI: 10.1128/AAC.45.12.3544-3547.2001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1128%2FAAC.45.12.3544-3547.2001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=11709337" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BD3MXovVOlu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2001&pages=3544-3547&author=M.+Takeiauthor=H.+Fukudaauthor=R.+Kishiiauthor=M.+Hosaka&title=Target+preference+of+15+quinolones+against+Staphylococcus+aureus+based+on+antibacterial+activities+and+target+inhibition&doi=10.1128%2FAAC.45.12.3544-3547.2001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Target preference of 15 quinolones against Staphylococcus aureus, based on antibacterial activities and target inhibition</span></div><div class="casAuthors">Takei, Masaya; Fukuda, Hideyuki; Kishii, Ryuta; Hosaka, Masaki</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3544-3547</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The antibacterial activities and target inhibition of 15 quinolones against grlA and gyrA mutant strains were studied.  The strains were obtained from wild-type Staphylococcus aureus MS5935 by selection with norfloxacin and nadifloxacin, resp.  The antibacterial activities of most quinolones against both mutant strains were lower than those against the wild-type strain.  The ratios of MICs for the gyrA mutant strain to those for the grlA mutant strain (MIC ratio) varied from 0.125 to 4.  The ratios of 50% inhibitory concns. (IC50s) of quinolones against topoisomerase IV to those against DNA gyrase (IC50 ratios) also varied, from 0.177 to 5.52.  A significant correlation between the MIC ratios and the IC50 ratios was obsd. (r = 0.919; P < 0.001).  These results suggest that the antibacterial activities of quinolones against the wild-type strain are involved not only in topoisomerase IV inhibition but also in DNA gyrase inhibition and that the target preference in the wild-type strain can be anticipated by the MIC ratios.  Based on the MIC ratios, the quinolones were classified into three categories.  Type I quinolones (norfloxacin, enoxacin, fleroxacin, ciprofloxacin, lomefloxacin, trovafloxacin, grepafloxacin, ofloxacin, and levofloxacin) had MIC ratios of <1, type II quinolones (sparfloxacin and nadifloxacin) had MIC ratios of >1, and type III quinolones (gatifloxacin, pazufloxacin, moxifloxacin, and clinafloxacin) had MIC ratios of 1.  Type I and type II quinolones seem to prefer topoisomerase IV and DNA gyrase, resp.  Type III quinolones seem to target both enzymes at nearly the same level in bacterial cells (a phenomenon known as the dual-targeting property), and their IC50 ratios were approx. 2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRQ8VysHG-CLVg90H21EOLACvtfcHk0ljTAJmp-SSRqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXovVOlu70%253D&md5=01d6f8a5fb349338600a2c3656f2e0c8</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1128%2FAAC.45.12.3544-3547.2001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.45.12.3544-3547.2001%26sid%3Dliteratum%253Aachs%26aulast%3DTakei%26aufirst%3DM.%26aulast%3DFukuda%26aufirst%3DH.%26aulast%3DKishii%26aufirst%3DR.%26aulast%3DHosaka%26aufirst%3DM.%26atitle%3DTarget%2520preference%2520of%252015%2520quinolones%2520against%2520Staphylococcus%2520aureus%2520based%2520on%2520antibacterial%2520activities%2520and%2520target%2520inhibition%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2001%26volume%3D45%26spage%3D3544%26epage%3D3547%26doi%3D10.1128%2FAAC.45.12.3544-3547.2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emrich, N.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heisig, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stubbings, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labischinski, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heisig, P.</span></span> <span> </span><span class="NLM_article-title">Antibacterial activity of finafloxacin under different pH conditions against isogenic strains of <i>Escherichia coli</i> expressing combinations of defined mechanisms of fluoroquinolone resistance</span>. <i>J. Antimicrob. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">2530</span>– <span class="NLM_lpage">2533</span>, <span class="refDoi"> DOI: 10.1093/jac/dkq375</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1093%2Fjac%2Fdkq375" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=20940181" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVektrjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2010&pages=2530-2533&author=N.-C.+Emrichauthor=A.+Heisigauthor=W.+Stubbingsauthor=H.+Labischinskiauthor=P.+Heisig&title=Antibacterial+activity+of+finafloxacin+under+different+pH+conditions+against+isogenic+strains+of+Escherichia+coli+expressing+combinations+of+defined+mechanisms+of+fluoroquinolone+resistance&doi=10.1093%2Fjac%2Fdkq375"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Antibacterial activity of finafloxacin under different pH conditions against isogenic strains of Escherichia coli expressing combinations of defined mechanisms of fluoroquinolone resistance</span></div><div class="casAuthors">Emrich, Nadine-C.; Heisig, Anke; Stubbings, Will; Labischinski, Harald; Heisig, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2530-2533</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Finafloxacin is an investigational fluoroquinolone exhibiting broad-spectrum activity that is enhanced under slightly acidic conditions (pH 5.0-6.5).  The impact of individual and combinations of chromosomal mutations (gyrA, parC and marR) and the plasmid-mediated fluoroquinolone resistance mechanisms QepA1, QnrA1, QnrB1, QnrS1 and AAC(6')-Ib-cr were investigated.  The MICs of finafloxacin, compared with those of ciprofloxacin, levofloxacin and moxifloxacin, were detd. at pH 5.8 and 7.2.  MICs of finafloxacin compared with other fluoroquinolones at pH 5.8 were lower by a factor of 2-256.  MICs of finafloxacin were unaffected by QepA1.  Moreover, finafloxacin appeared not to be a substrate for AAC(6')-Ib-cr.  Compared with ciprofloxacin, levofloxacin and moxifloxacin, finafloxacin shows higher activity esp. at pH 5.8 against Escherichia coli mutants expressing known fluoroquinolone resistance determinants alone and in combinations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptfUqkmYZB0LVg90H21EOLACvtfcHk0ljTAJmp-SSRqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVektrjM&md5=bf41b4be27c1a2c16dbfbaf5d9402fe9</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkq375&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkq375%26sid%3Dliteratum%253Aachs%26aulast%3DEmrich%26aufirst%3DN.-C.%26aulast%3DHeisig%26aufirst%3DA.%26aulast%3DStubbings%26aufirst%3DW.%26aulast%3DLabischinski%26aufirst%3DH.%26aulast%3DHeisig%26aufirst%3DP.%26atitle%3DAntibacterial%2520activity%2520of%2520finafloxacin%2520under%2520different%2520pH%2520conditions%2520against%2520isogenic%2520strains%2520of%2520Escherichia%2520coli%2520expressing%2520combinations%2520of%2520defined%2520mechanisms%2520of%2520fluoroquinolone%2520resistance%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2010%26volume%3D65%26spage%3D2530%26epage%3D2533%26doi%3D10.1093%2Fjac%2Fdkq375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chan, D. M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monaco, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winters, M. P.</span></span> <span> </span><span class="NLM_article-title">New N- and O-arylations with phenylboronic acids and cupric acetate</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">2933</span>– <span class="NLM_lpage">2936</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(98)00503-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1016%2FS0040-4039%2898%2900503-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADyaK1cXjtVOlu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1998&pages=2933-2936&author=D.+M.+T.+Chanauthor=K.+L.+Monacoauthor=R.-P.+Wangauthor=M.+P.+Winters&title=New+N-+and+O-arylations+with+phenylboronic+acids+and+cupric+acetate&doi=10.1016%2FS0040-4039%2898%2900503-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">New N- and O-arylation with phenylboronic acids and cupric acetate</span></div><div class="casAuthors">Chan, Dominic M. T.; Monaco, Kevin L.; Wang, Ru-Ping; Winters, Michael P.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">2933-2936</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A new method of arylating N-H and O-H contg. compds. at room temp. with phenylboronic acids and cupric acetate in the presence of a tertiary amine promoter is described.  Substrates include phenols, amines, anilines, amides, imides, ureas, carbamates, and sulfonamides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQZxWi8FJntLVg90H21EOLACvtfcHk0ljTAJmp-SSRqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjtVOlu7w%253D&md5=56efb58adc883aba3ca4ab908f6864ec</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2898%2900503-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252898%252900503-6%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DD.%2BM.%2BT.%26aulast%3DMonaco%26aufirst%3DK.%2BL.%26aulast%3DWang%26aufirst%3DR.-P.%26aulast%3DWinters%26aufirst%3DM.%2BP.%26atitle%3DNew%2520N-%2520and%2520O-arylations%2520with%2520phenylboronic%2520acids%2520and%2520cupric%2520acetate%26jtitle%3DTetrahedron%2520Lett.%26date%3D1998%26volume%3D39%26spage%3D2933%26epage%3D2936%26doi%3D10.1016%2FS0040-4039%2898%2900503-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lam, P. Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saubern, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winters, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, D. M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Combs, A.</span></span> <span> </span><span class="NLM_article-title">New aryl/heteroaryl C-N bond cross-coupling reactions via arylboronic acid/cupric acetate arylation</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">2941</span>– <span class="NLM_lpage">2944</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(98)00504-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1016%2FS0040-4039%2898%2900504-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADyaK1cXjtVOlu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1998&pages=2941-2944&author=P.+Y.+S.+Lamauthor=C.+G.+Clarkauthor=S.+Saubernauthor=J.+Adamsauthor=M.+P.+Wintersauthor=D.+M.+T.+Chanauthor=A.+Combs&title=New+aryl%2Fheteroaryl+C-N+bond+cross-coupling+reactions+via+arylboronic+acid%2Fcupric+acetate+arylation&doi=10.1016%2FS0040-4039%2898%2900504-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">New aryl/heteroaryl C-N bond cross-coupling reactions via arylboronic acid/cupric acetate arylation</span></div><div class="casAuthors">Lam, Patrick Y. S.; Clark, Charles G.; Saubern, Simon; Adams, Jessica; Winters, Michael P.; Chan, Dominic M. T.; Combs, Andrew</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">2941-2944</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A new aryl/heteroaryl C-N bond cross-coupling reaction via the arylboronic acid/cupric acetate arylation of N-H contg. heteroarenes has been discovered.  This new methodol. is mild, proceeds at room temp. exposed to air, and works for many heteroarenes and arylboronic acid providing good yields of N-arylated heteroarenes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFzQpNQ18m0LVg90H21EOLACvtfcHk0ljxVoFfLcRvNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjtVOlu7k%253D&md5=86155b6f6d3f9765b3270cb3aa9fd509</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2898%2900504-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252898%252900504-8%26sid%3Dliteratum%253Aachs%26aulast%3DLam%26aufirst%3DP.%2BY.%2BS.%26aulast%3DClark%26aufirst%3DC.%2BG.%26aulast%3DSaubern%26aufirst%3DS.%26aulast%3DAdams%26aufirst%3DJ.%26aulast%3DWinters%26aufirst%3DM.%2BP.%26aulast%3DChan%26aufirst%3DD.%2BM.%2BT.%26aulast%3DCombs%26aufirst%3DA.%26atitle%3DNew%2520aryl%252Fheteroaryl%2520C-N%2520bond%2520cross-coupling%2520reactions%2520via%2520arylboronic%2520acid%252Fcupric%2520acetate%2520arylation%26jtitle%3DTetrahedron%2520Lett.%26date%3D1998%26volume%3D39%26spage%3D2941%26epage%3D2944%26doi%3D10.1016%2FS0040-4039%2898%2900504-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Evans, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katz, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, T. R.</span></span> <span> </span><span class="NLM_article-title">Synthesis of diaryl ethers through the copper-promoted arylation of phenols with arylboronic acids. An expedient synthesis of thyroxine</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">2937</span>– <span class="NLM_lpage">2940</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(98)00502-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1016%2FS0040-4039%2898%2900502-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADyaK1cXjtVOlu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1998&pages=2937-2940&author=D.+A.+Evansauthor=J.+L.+Katzauthor=T.+R.+West&title=Synthesis+of+diaryl+ethers+through+the+copper-promoted+arylation+of+phenols+with+arylboronic+acids.+An+expedient+synthesis+of+thyroxine&doi=10.1016%2FS0040-4039%2898%2900502-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of diaryl ethers through the copper-promoted arylation of phenols with arylboronic acids. An expedient synthesis of thyroxine</span></div><div class="casAuthors">Evans, David A.; Katz, Jeffrey L.; West, Theodore R.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">2937-2940</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Diaryl ethers are readily synthesized in high yield at room temp. through the copper(II)-promoted coupling of arylboronic acids and phenols.  The reaction is tolerant of a wide range of substituents on both coupling partners.  These reaction conditions permit the racemization-free arylation of phenolic amino acids, methodol. that has been applied to an efficient synthesis of thyroxine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGof3Tcq7LBLpLVg90H21EOLACvtfcHk0ljxVoFfLcRvNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjtVOlu7o%253D&md5=201a8d8742f73d5249058a91dc2f6309</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2898%2900502-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252898%252900502-4%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DD.%2BA.%26aulast%3DKatz%26aufirst%3DJ.%2BL.%26aulast%3DWest%26aufirst%3DT.%2BR.%26atitle%3DSynthesis%2520of%2520diaryl%2520ethers%2520through%2520the%2520copper-promoted%2520arylation%2520of%2520phenols%2520with%2520arylboronic%2520acids.%2520An%2520expedient%2520synthesis%2520of%2520thyroxine%26jtitle%3DTetrahedron%2520Lett.%26date%3D1998%26volume%3D39%26spage%3D2937%26epage%3D2940%26doi%3D10.1016%2FS0040-4039%2898%2900502-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guram, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rennels, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchwald, S. L.</span></span> <span> </span><span class="NLM_article-title">A simple catalytic method for the conversion of aryl bromides to arylamines</span>. <i>Angew. Chem., Int. Ed. Engl.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">1348</span>– <span class="NLM_lpage">1350</span>, <span class="refDoi"> DOI: 10.1002/anie.199513481</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1002%2Fanie.199513481" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADyaK2MXmvV2msr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1995&pages=1348-1350&author=A.+S.+Guramauthor=R.+A.+Rennelsauthor=S.+L.+Buchwald&title=A+simple+catalytic+method+for+the+conversion+of+aryl+bromides+to+arylamines&doi=10.1002%2Fanie.199513481"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">A simple catalytic method for the conversion of aryl bromides to arylamines</span></div><div class="casAuthors">Guram, Anil S.; Rennels, Roger A.; Buchwald, Stephen L.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition in English</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1348-50</span>CODEN:
                <span class="NLM_cas:coden">ACIEAY</span>;
        ISSN:<span class="NLM_cas:issn">0570-0833</span>.
    
            (<span class="NLM_cas:orgname">VCH</span>)
        </div><div class="casAbstract">Aryl bromides reacted with amines in the presence of NaOCMe3 and a catalytic amt. of PdCl2[P(o-tolyl)3]2 or Pd(dba)2/2P(o-tolyl)3 to give arylamines in good yields.  Also, cyclization of 2-XC6H4CH2(CH2)nNHCH2Ph (X = Br, iodo; n = 1, 2, 3) in the presence of NaOCMe3 and a catalytic amt. of Pd(PPh3)4 gave good yields of the N heterocycles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXDC5Vhs2d57Vg90H21EOLACvtfcHk0ljxVoFfLcRvNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmvV2msr8%253D&md5=d435e21c3f535757455d53e12417596b</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1002%2Fanie.199513481&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.199513481%26sid%3Dliteratum%253Aachs%26aulast%3DGuram%26aufirst%3DA.%2BS.%26aulast%3DRennels%26aufirst%3DR.%2BA.%26aulast%3DBuchwald%26aufirst%3DS.%2BL.%26atitle%3DA%2520simple%2520catalytic%2520method%2520for%2520the%2520conversion%2520of%2520aryl%2520bromides%2520to%2520arylamines%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%2520Engl.%26date%3D1995%26volume%3D34%26spage%3D1348%26epage%3D1350%26doi%3D10.1002%2Fanie.199513481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Louie, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartwig, J. F.</span></span> <span> </span><span class="NLM_article-title">Palladium-catalyzed synthesis of arylamines from aryl halides. Mechanistic studies lead to coupling in the absence of tin reagents</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">3609</span>– <span class="NLM_lpage">3612</span>, <span class="refDoi"> DOI: 10.1016/0040-4039(95)00605-C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1016%2F0040-4039%2895%2900605-C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADyaK2MXmtFCjtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1995&pages=3609-3612&author=J.+Louieauthor=J.+F.+Hartwig&title=Palladium-catalyzed+synthesis+of+arylamines+from+aryl+halides.+Mechanistic+studies+lead+to+coupling+in+the+absence+of+tin+reagents&doi=10.1016%2F0040-4039%2895%2900605-C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium-catalyzed synthesis of arylamines from aryl halides. Mechanistic studies lead to coupling in the absence of tin reagents</span></div><div class="casAuthors">Louie, Janis; Hartwig, John F.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">3609-12</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The reaction of aryl halides with secondary amines in the presence of silylamide base and tri-o-tolyphospshine palladium complexes gives arylamine products.  This process provides a convenient method for performing these heterocross coupling reactions without the necessity for forming tin amides and disposing of tin halides.  This reaction follows from a mechanistic anal. of the coupling reaction with tin amides and occurs as a result of the cleavage of palladium aryl halide dimers with secondary amines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAKpHJAivoR7Vg90H21EOLACvtfcHk0linsrvVoYATNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmtFCjtLo%253D&md5=7c4567c3e54efc05049d539c682696b2</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1016%2F0040-4039%2895%2900605-C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0040-4039%252895%252900605-C%26sid%3Dliteratum%253Aachs%26aulast%3DLouie%26aufirst%3DJ.%26aulast%3DHartwig%26aufirst%3DJ.%2BF.%26atitle%3DPalladium-catalyzed%2520synthesis%2520of%2520arylamines%2520from%2520aryl%2520halides.%2520Mechanistic%2520studies%2520lead%2520to%2520coupling%2520in%2520the%2520absence%2520of%2520tin%2520reagents%26jtitle%3DTetrahedron%2520Lett.%26date%3D1995%26volume%3D36%26spage%3D3609%26epage%3D3612%26doi%3D10.1016%2F0040-4039%2895%2900605-C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wolfe, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagaw, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchwald, S. L.</span></span> <span> </span><span class="NLM_article-title">An improved catalyst system for aromatic carbon-nitrogen bond formation: the possible involvement of bis(phosphine) palladium complexes as key intermediates</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>118</i></span>,  <span class="NLM_fpage">7215</span>– <span class="NLM_lpage">7216</span>, <span class="refDoi"> DOI: 10.1021/ja9608306</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja9608306" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADyaK28XktFyitrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=1996&pages=7215-7216&author=J.+P.+Wolfeauthor=S.+Wagawauthor=S.+L.+Buchwald&title=An+improved+catalyst+system+for+aromatic+carbon-nitrogen+bond+formation%3A+the+possible+involvement+of+bis%28phosphine%29+palladium+complexes+as+key+intermediates&doi=10.1021%2Fja9608306"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">An Improved Catalyst System for Aromatic Carbon-Nitrogen Bond Formation: The Possible Involvement of Bis(Phosphine) Palladium Complexes as Key Intermediates</span></div><div class="casAuthors">Wolfe, John P.; Wagaw, Seble; Buchwald, Stephen L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">7215-7216</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The combination of Pd2(dba)3 (dba=dibenzylideneacetone) and BINAP in the presence of NaOtBu constitutes a superior catalyst system for the cross coupling of amines with aryl bromides.  Its success also suggests the viability of bis(phosphine)palladium intermediates in the key steps of the catalytic cycle.  Two complexes, (BINAP)Pd(dba) and (BINAP)Pd(4-t-butylphenyl)(Br), were prepd. and were found to be chem. and kinetically competent as intermediates in the catalytic sequence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgGvKEAtlQNLVg90H21EOLACvtfcHk0linsrvVoYATNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XktFyitrg%253D&md5=f88e68db1a437b9462e105d6d036bc68</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1021%2Fja9608306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja9608306%26sid%3Dliteratum%253Aachs%26aulast%3DWolfe%26aufirst%3DJ.%2BP.%26aulast%3DWagaw%26aufirst%3DS.%26aulast%3DBuchwald%26aufirst%3DS.%2BL.%26atitle%3DAn%2520improved%2520catalyst%2520system%2520for%2520aromatic%2520carbon-nitrogen%2520bond%2520formation%253A%2520the%2520possible%2520involvement%2520of%2520bis%2528phosphine%2529%2520palladium%2520complexes%2520as%2520key%2520intermediates%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1996%26volume%3D118%26spage%3D7215%26epage%3D7216%26doi%3D10.1021%2Fja9608306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guari, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Es, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reek, J. N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamer, P. C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van
Leeuwen, P. W. N. M.</span></span> <span> </span><span class="NLM_article-title">An efficient, palladium-catalysed, amination of aryl bromides</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">3789</span>– <span class="NLM_lpage">3790</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(99)00527-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1016%2FS0040-4039%2899%2900527-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADyaK1MXivFKis7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1999&pages=3789-3790&author=Y.+Guariauthor=D.+S.+van+Esauthor=J.+N.+H.+Reekauthor=P.+C.+J.+Kamerauthor=P.+W.+N.+M.+van%0ALeeuwen&title=An+efficient%2C+palladium-catalysed%2C+amination+of+aryl+bromides&doi=10.1016%2FS0040-4039%2899%2900527-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">An efficient, palladium-catalyzed amination of aryl bromides</span></div><div class="casAuthors">Guari, Yannick; Van Es, Daan S.; Reek, Joost N. H.; Kamer, Paul C. J.; Van Leeuwen, Piet W. N. M.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">3789-3790</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Aryl bromides are coupled to primary aliph. amines, anilines and cyclic secondary amines in an efficient and selective procedure using catalytic amts. of Pd(OAc)2 and the chelating ligand 9,9-dimethyl-4,6-bis(diphenylphosphino)xanthene (xantphos).  This catalyst system, accommodating low catalyst loadings (0.5 mol % Pd), allows amination of both electron-poor and electron-rich aryl bromides.  Even sterically crowded substrates show good reactivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9X_0uTjeHdrVg90H21EOLACvtfcHk0linsrvVoYATNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXivFKis7o%253D&md5=559ff08877c70c05f5a97ad6ee6118c3</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2899%2900527-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252899%252900527-4%26sid%3Dliteratum%253Aachs%26aulast%3DGuari%26aufirst%3DY.%26aulast%3Dvan%2BEs%26aufirst%3DD.%2BS.%26aulast%3DReek%26aufirst%3DJ.%2BN.%2BH.%26aulast%3DKamer%26aufirst%3DP.%2BC.%2BJ.%26aulast%3Dvan%2BLeeuwen%26aufirst%3DP.%2BW.%2BN.%2BM.%26atitle%3DAn%2520efficient%252C%2520palladium-catalysed%252C%2520amination%2520of%2520aryl%2520bromides%26jtitle%3DTetrahedron%2520Lett.%26date%3D1999%26volume%3D40%26spage%3D3789%26epage%3D3790%26doi%3D10.1016%2FS0040-4039%2899%2900527-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, N.-F. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hallberg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larhed, M.</span></span> <span> </span><span class="NLM_article-title">In situ generation of carbon monoxide from solid molybdenum hexacarbonyl. A convenient and fast route to palladium-catalyzed carbonylation reactions</span>. <i>J. Comb. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">109</span>– <span class="NLM_lpage">111</span>, <span class="refDoi"> DOI: 10.1021/cc010085f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cc010085f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BD38Xht1Gktr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2002&pages=109-111&author=N.-F.+K.+Kaiserauthor=A.+Hallbergauthor=M.+Larhed&title=In+situ+generation+of+carbon+monoxide+from+solid+molybdenum+hexacarbonyl.+A+convenient+and+fast+route+to+palladium-catalyzed+carbonylation+reactions&doi=10.1021%2Fcc010085f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">In Situ Generation of Carbon Monoxide from Solid Molybdenum Hexacarbonyl. A Convenient and Fast Route to Palladium-Catalyzed Carbonylation Reactions</span></div><div class="casAuthors">Kaiser, Nils-Fredrik K.; Hallberg, Anders; Larhed, Mats</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Combinatorial Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">109-111</span>CODEN:
                <span class="NLM_cas:coden">JCCHFF</span>;
        ISSN:<span class="NLM_cas:issn">1520-4766</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A protocol utilizing molybdenum hexacarbonyl (Mo(CO)6) as a condensed source of carbon monoxide has been developed for performing carbonylation reactions.  Under microwave heating in the presence of palladium and Mo(CO)6, aryl halides, e.g., I, underwent carbonylative coupling with unhindered aliph. primary and secondary amines to produce aryl amides, e.g., II, in moderate to good yields (66-83%).  Microwave heating liberates carbon monoxide from the solid Mo(CO)6 avoiding the trouble of using gaseous carbon monoxide in carbonylation reactions.  Substitution of water for amine provides a rapid process for making the corresponding benzoic acid.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3WYDAfNgvaLVg90H21EOLACvtfcHk0ljsWNimpbMofA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xht1Gktr0%253D&md5=6cbf95e36ea635b4fc58f5854c52b5ad</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1021%2Fcc010085f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcc010085f%26sid%3Dliteratum%253Aachs%26aulast%3DKaiser%26aufirst%3DN.-F.%2BK.%26aulast%3DHallberg%26aufirst%3DA.%26aulast%3DLarhed%26aufirst%3DM.%26atitle%3DIn%2520situ%2520generation%2520of%2520carbon%2520monoxide%2520from%2520solid%2520molybdenum%2520hexacarbonyl.%2520A%2520convenient%2520and%2520fast%2520route%2520to%2520palladium-catalyzed%2520carbonylation%2520reactions%26jtitle%3DJ.%2520Comb.%2520Chem.%26date%3D2002%26volume%3D4%26spage%3D109%26epage%3D111%26doi%3D10.1021%2Fcc010085f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Georgsson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hallberg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larhed, M.</span></span> <span> </span><span class="NLM_article-title">Rapid palladium-catalyzed synthesis of esters from aryl halides utilizing Mo(CO)6 as a solid carbon monoxide source</span>. <i>J. Comb. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">350</span>– <span class="NLM_lpage">352</span>, <span class="refDoi"> DOI: 10.1021/cc0201086</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cc0201086" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BD3sXktlaiurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=350-352&author=J.+Georgssonauthor=A.+Hallbergauthor=M.+Larhed&title=Rapid+palladium-catalyzed+synthesis+of+esters+from+aryl+halides+utilizing+Mo%28CO%296+as+a+solid+carbon+monoxide+source&doi=10.1021%2Fcc0201086"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid Palladium-Catalyzed Synthesis of Esters from Aryl Halides Utilizing Mo(CO)6 as a Solid Carbon Monoxide Source</span></div><div class="casAuthors">Georgsson, Jennie; Hallberg, Anders; Larhed, Mats</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Combinatorial Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">350-352</span>CODEN:
                <span class="NLM_cas:coden">JCCHFF</span>;
        ISSN:<span class="NLM_cas:issn">1520-4766</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of arom. esters R1CO2R2 (R1 = 3-BrC6H4, 2-MeC6H4, 4-MeOC6H4, 4-F3CC6H4, 1-naphthyl; R2 = Bu, Me3SiCH2CH2, PhCH2) was synthesized in moderate to high yields (52-89%) via palladium-catalyzed carbonylation of aryl halides R1X (X = Br, iodo) in the presence of excess of a primary alc. R2OH under microwave irradn. using Mo(CO)6 as a solid carbon monoxide source.  The reactions with sterically hindered tert-butanol as an alc. failed or gave low yields of the desired products.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqS1k1kMsuaA7Vg90H21EOLACvtfcHk0ljsWNimpbMofA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXktlaiurk%253D&md5=7ee6bd650c0c7cfd98b9fc83045e70d2</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1021%2Fcc0201086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcc0201086%26sid%3Dliteratum%253Aachs%26aulast%3DGeorgsson%26aufirst%3DJ.%26aulast%3DHallberg%26aufirst%3DA.%26aulast%3DLarhed%26aufirst%3DM.%26atitle%3DRapid%2520palladium-catalyzed%2520synthesis%2520of%2520esters%2520from%2520aryl%2520halides%2520utilizing%2520Mo%2528CO%25296%2520as%2520a%2520solid%2520carbon%2520monoxide%2520source%26jtitle%3DJ.%2520Comb.%2520Chem.%26date%3D2003%26volume%3D5%26spage%3D350%26epage%3D352%26doi%3D10.1021%2Fcc0201086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tschaen, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desmond, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, A. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fortin, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pipik, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhoeven, T. R.</span></span> <span> </span><span class="NLM_article-title">An improved procedure for aromatic cyanation</span>. <i>Synth. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">887</span>– <span class="NLM_lpage">890</span>, <span class="refDoi"> DOI: 10.1080/00397919408011310</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1080%2F00397919408011310" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADyaK2cXktVyrsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1994&pages=887-890&author=D.+M.+Tschaenauthor=R.+Desmondauthor=A.+O.+Kingauthor=M.+C.+Fortinauthor=B.+Pipikauthor=S.+Kingauthor=T.+R.+Verhoeven&title=An+improved+procedure+for+aromatic+cyanation&doi=10.1080%2F00397919408011310"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">An improved procedure for aromatic cyanation</span></div><div class="casAuthors">Tschaen, D. M.; Desmond, R.; King, A. O.; Fortin, M. C.; Pipik, B.; King, S.; Verhoeven, T. R.</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">887-90</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    </div><div class="casAbstract">An effective method for conversion of aryl bromides to aryl cyanides is described.  The procedure involves treatment of the aryl halide with zinc cyanide in the presence of a catalytic amt. of Pd(PPh3)4.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkwjVF7zhEyrVg90H21EOLACvtfcHk0ljsWNimpbMofA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXktVyrsb8%253D&md5=f56e0d59d6ff886e3d549832dce904f3</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1080%2F00397919408011310&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397919408011310%26sid%3Dliteratum%253Aachs%26aulast%3DTschaen%26aufirst%3DD.%2BM.%26aulast%3DDesmond%26aufirst%3DR.%26aulast%3DKing%26aufirst%3DA.%2BO.%26aulast%3DFortin%26aufirst%3DM.%2BC.%26aulast%3DPipik%26aufirst%3DB.%26aulast%3DKing%26aufirst%3DS.%26aulast%3DVerhoeven%26aufirst%3DT.%2BR.%26atitle%3DAn%2520improved%2520procedure%2520for%2520aromatic%2520cyanation%26jtitle%3DSynth.%2520Commun.%26date%3D1994%26volume%3D24%26spage%3D887%26epage%3D890%26doi%3D10.1080%2F00397919408011310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maiti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fors, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchwald, S. L.</span></span> <span> </span><span class="NLM_article-title">Palladium-catalyzed coupling of functionalized primary and secondary amines with aryl and heteroaryl halides: two ligands suffice in most cases</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">57</span>– <span class="NLM_lpage">68</span>, <span class="refDoi"> DOI: 10.1039/C0SC00330A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1039%2FC0SC00330A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=22384311" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFWqsbjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=57-68&author=D.+Maitiauthor=B.+P.+Forsauthor=J.+L.+Hendersonauthor=Y.+Nakamuraauthor=S.+L.+Buchwald&title=Palladium-catalyzed+coupling+of+functionalized+primary+and+secondary+amines+with+aryl+and+heteroaryl+halides%3A+two+ligands+suffice+in+most+cases&doi=10.1039%2FC0SC00330A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium-catalyzed coupling of functionalized primary and secondary amines with aryl and heteroaryl halides: two ligands suffice in most cases</span></div><div class="casAuthors">Maiti, Debabrata; Fors, Brett P.; Henderson, Jaclyn L.; Nakamura, Yoshinori; Buchwald, Stephen L.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-68</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A study on the use of two catalyst systems is reported here.  The ligands used in this study were BrettPhos [i.e., dicyclohexyl[3,6-dimethoxy-2',4',6'-tris(1-methylethyl)[1,1'-biphenyl]-2-yl]phosphine] and RuPhos [i.e., [2',6'-bis(1-methylethoxy)[1,1'-biphenyl]-2-yl]dicyclohexylphosphine].  These ligands provide a wide scope for Pd-catalyzed C-N cross-coupling reactions.  Often low catalyst loadings and short reaction times can be used with functionalized aryl and heteroaryl coupling partners.  The reactions are highly robust and can be set up and performed without the use of a glove box.  These catalysts should find wide application in the synthesis of complex mols. including pharmaceuticals, natural products and functional materials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7MMWmsn65tLVg90H21EOLACvtfcHk0liS5XA2DlDDHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFWqsbjF&md5=217f0d978b9cc44b2b3c468fd291c2b2</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1039%2FC0SC00330A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC0SC00330A%26sid%3Dliteratum%253Aachs%26aulast%3DMaiti%26aufirst%3DD.%26aulast%3DFors%26aufirst%3DB.%2BP.%26aulast%3DHenderson%26aufirst%3DJ.%2BL.%26aulast%3DNakamura%26aufirst%3DY.%26aulast%3DBuchwald%26aufirst%3DS.%2BL.%26atitle%3DPalladium-catalyzed%2520coupling%2520of%2520functionalized%2520primary%2520and%2520secondary%2520amines%2520with%2520aryl%2520and%2520heteroaryl%2520halides%253A%2520two%2520ligands%2520suffice%2520in%2520most%2520cases%26jtitle%3DChem.%2520Sci.%26date%3D2011%26volume%3D2%26spage%3D57%26epage%3D68%26doi%3D10.1039%2FC0SC00330A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bruno, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tudge, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchwald, S. L.</span></span> <span> </span><span class="NLM_article-title">Design and preparation of new palladium precatalysts for C–C and C–N cross-coupling reactions</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">916</span>– <span class="NLM_lpage">920</span>, <span class="refDoi"> DOI: 10.1039/C2SC20903A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1039%2FC2SC20903A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=23667737" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFKjtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=916-920&author=N.+C.+Brunoauthor=M.+T.+Tudgeauthor=S.+L.+Buchwald&title=Design+and+preparation+of+new+palladium+precatalysts+for+C%E2%80%93C+and+C%E2%80%93N+cross-coupling+reactions&doi=10.1039%2FC2SC20903A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Design and preparation of new palladium precatalysts for C-C and C-N cross-coupling reactions</span></div><div class="casAuthors">Bruno, Nicholas C.; Tudge, Matthew T.; Buchwald, Stephen L.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">916-920</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A series of easily prepd., phosphine-ligated palladium precatalysts based on the 2-aminobiphenyl scaffold have been prepd.  The role of the precatalyst-assocd. labile halide (or pseudohalide) in the formation and stability of the palladacycle has been examd.  It was found that replacing the chloride in the previous version of the precatalyst with a mesylate leads to a new class of precatalysts with improved soln. stability and that are readily prepd. from a wider range of phosphine ligands.  The differences between the previous version of precatalyst and that reported here are explored.  In addn., the reactivity of the latter is examd. in a range of C-C and C-N bond forming reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfHp6oyg4k_bVg90H21EOLACvtfcHk0liS5XA2DlDDHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFKjtr0%253D&md5=5b50ac18cb67251e5439199c6746dba8</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1039%2FC2SC20903A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC2SC20903A%26sid%3Dliteratum%253Aachs%26aulast%3DBruno%26aufirst%3DN.%2BC.%26aulast%3DTudge%26aufirst%3DM.%2BT.%26aulast%3DBuchwald%26aufirst%3DS.%2BL.%26atitle%3DDesign%2520and%2520preparation%2520of%2520new%2520palladium%2520precatalysts%2520for%2520C%25E2%2580%2593C%2520and%2520C%25E2%2580%2593N%2520cross-coupling%2520reactions%26jtitle%3DChem.%2520Sci.%26date%3D2013%26volume%3D4%26spage%3D916%26epage%3D920%26doi%3D10.1039%2FC2SC20903A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, A.</span></span> <span> </span><span class="NLM_article-title">Overview of the Suzuki protocol with B</span>. In  <i>Handbook of Organopalladium Chemistry for Organic Synthesis</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Negishi, E.</span></span>, Ed.; <span class="NLM_publisher-name">John Wiley & Sons</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">2003</span>; pp  <span class="NLM_fpage">249</span>– <span class="NLM_lpage">262</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&pages=249-262&author=A.+Suzukiauthor=E.+Negishi&title=Handbook+of+Organopalladium+Chemistry+for+Organic+Synthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DA.%26atitle%3DOverview%2520of%2520the%2520Suzuki%2520protocol%2520with%2520B%26btitle%3DHandbook%2520of%2520Organopalladium%2520Chemistry%2520for%2520Organic%2520Synthesis%26aulast%3DNegishi%26aufirst%3DE.%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%26date%3D2003%26spage%3D249%26epage%3D262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miyaura, N.</span></span> <span> </span><span class="NLM_article-title">Metal-catalyzed cross-coupling reactions of organoboron compounds with organic halides</span>. In  <i>Metal-Catalyzed Cross-Coupling Reactions</i>, <span class="NLM_edition">2</span>nd ed.; <span class="NLM_contrib-group"><span class="NLM_string-name">de Meijere, A.</span>, <span class="NLM_string-name">Diederich, F.</span></span>, Eds.; <span class="NLM_publisher-name">Wiley-VCH</span>: <span class="NLM_publisher-loc">Weinheim, Germany</span>, <span class="NLM_year">2004</span>; pp  <span class="NLM_fpage">41</span>– <span class="NLM_lpage">123</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1002%2F9783527619535.ch2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&pages=41-123&author=N.+Miyauraauthor=A.+de+Meijere&author=F.+Diederich&title=Metal-Catalyzed+Cross-Coupling+Reactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1002%2F9783527619535.ch2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9783527619535.ch2%26sid%3Dliteratum%253Aachs%26aulast%3DMiyaura%26aufirst%3DN.%26atitle%3DMetal-catalyzed%2520cross-coupling%2520reactions%2520of%2520organoboron%2520compounds%2520with%2520organic%2520halides%26btitle%3DMetal-Catalyzed%2520Cross-Coupling%2520Reactions%26aulast%3Dde%2BMeijere%26aufirst%3DA.%26pub%3DWiley-VCH%26date%3D2004%26spage%3D41%26epage%3D123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laroche, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertus, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szymoniak, J.</span></span> <span> </span><span class="NLM_article-title">Titanium-mediated synthesis of bicyclic cyclopropylamines from unsaturated nitriles</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">2485</span>– <span class="NLM_lpage">2487</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(03)00325-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1016%2FS0040-4039%2803%2900325-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhs1amu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2003&pages=2485-2487&author=C.+Larocheauthor=P.+Bertusauthor=J.+Szymoniak&title=Titanium-mediated+synthesis+of+bicyclic+cyclopropylamines+from+unsaturated+nitriles&doi=10.1016%2FS0040-4039%2803%2900325-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Titanium-mediated synthesis of bicyclic cyclopropylamines from unsaturated nitriles</span></div><div class="casAuthors">Laroche, Christophe; Bertus, Philippe; Szymoniak, Jan</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2485-2487</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">An easy synthesis of bicyclic primary cyclopropylamines directly from unsatd. nitriles was reported.  The described reaction involves Ti(II)-mediated intramol. coupling of alkene and nitrile moieties.  The titanium tetraisopropoxide-mediated coupling of [(phenylmethyl)-2-propenylamino]acetonitrile with ethylmagnesium bromide gave only N-[(1-aminocyclopropyl)methyl]-N-(2-propenyl)benzenemethanamine and none of the desired bicyclic amine, (1R,5S)-rel-3-(phenylmethyl)-3-azabicyclo[3.1.0]hexan-1-amine (I).  Under optimized conditions, the titanium tetraisopropoxide/trifluoroborate di-Et etherate-mediated coupling of [(phenylmethyl)-2-propenylamino]acetonitrile with cyclohexylmagnesium chloride gave I in 69% yield.  The reaction of β-(2-propenyl)benzenepropanenitrile gave (1R,3R,5S)-rel-3-phenylbicyclo[3.1.0]hexan-1-amine as major product.  The reaction of [3-butenyl(phenylmethyl)amino]acetonitrile gave (1R,6R)-rel-3-(phenylmethyl)-3-azabicyclo[4.1.0]heptan-1-amine.  The reaction of [(phenylmethyl)(4-pentenyl)amino]acetonitrile gave (1R,7R)-rel-3-(phenylmethyl)-3-azabicyclo[5.1.0]octan-1-amine.  Dichlorotitanium diisopropoxide and chlorotitanium triisopropoxide were also investigated as catalysts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAmQA2M74bMbVg90H21EOLACvtfcHk0li2Qp4-Ht2gng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhs1amu7k%253D&md5=5b083fb579bb3ad306a3d47ffd614e43</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2803%2900325-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252803%252900325-3%26sid%3Dliteratum%253Aachs%26aulast%3DLaroche%26aufirst%3DC.%26aulast%3DBertus%26aufirst%3DP.%26aulast%3DSzymoniak%26aufirst%3DJ.%26atitle%3DTitanium-mediated%2520synthesis%2520of%2520bicyclic%2520cyclopropylamines%2520from%2520unsaturated%2520nitriles%26jtitle%3DTetrahedron%2520Lett.%26date%3D2003%26volume%3D44%26spage%3D2485%26epage%3D2487%26doi%3D10.1016%2FS0040-4039%2803%2900325-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heaney, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millar, I. T.</span></span> <span> </span><span class="NLM_article-title">Triphenylene</span>. <i>Org. Synth.</i> <span class="NLM_year" style="font-weight: bold;">1960</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">105</span>, <span class="refDoi"> DOI: 10.15227/orgsyn.040.0105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.15227%2Forgsyn.040.0105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADyaF3MXit1ehsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1960&pages=105&author=H.+Heaneyauthor=I.+T.+Millar&title=Triphenylene&doi=10.15227%2Forgsyn.040.0105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Triphenylene</span></div><div class="casAuthors">Heaney, H.; Millar, I. T.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Syntheses</span>
        (<span class="NLM_cas:date">1960</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">105-8</span>CODEN:
                <span class="NLM_cas:coden">ORSYAT</span>;
        ISSN:<span class="NLM_cas:issn">0078-6209</span>.
    </div><div class="casAbstract">Reviews with many references.  Cf. CA 54, 3166h.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSdhlWJWjV7rVg90H21EOLACvtfcHk0li2Qp4-Ht2gng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF3MXit1ehsg%253D%253D&md5=167a27ba419a38572a6bacbb135eb5c7</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.15227%2Forgsyn.040.0105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.15227%252Forgsyn.040.0105%26sid%3Dliteratum%253Aachs%26aulast%3DHeaney%26aufirst%3DH.%26aulast%3DMillar%26aufirst%3DI.%2BT.%26atitle%3DTriphenylene%26jtitle%3DOrg.%2520Synth.%26date%3D1960%26volume%3D40%26spage%3D105%26doi%3D10.15227%2Forgsyn.040.0105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clive, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angoh, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, S. M.</span></span> <span> </span><span class="NLM_article-title">Radical spirocyclization: synthesis of an appropriately oxygenated spiro compound related to the antitumor antibiotic fredericamycin A</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">1339</span>– <span class="NLM_lpage">1342</span>, <span class="refDoi"> DOI: 10.1021/jo00383a032</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00383a032" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADyaL2sXhslKjs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1987&pages=1339-1342&author=D.+Cliveauthor=A.+G.+Angohauthor=S.+M.+Bennett&title=Radical+spirocyclization%3A+synthesis+of+an+appropriately+oxygenated+spiro+compound+related+to+the+antitumor+antibiotic+fredericamycin+A&doi=10.1021%2Fjo00383a032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Radical spirocyclization:  synthesis of an appropriately oxygenated spiro compound related to the antitumor antibiotic fredericamycin A</span></div><div class="casAuthors">Clive, Derrick, L. J.; Angoh, A. Gaetan; Bennett, Sharon M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1339-42</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">The spiro compd. I, that represents the central 4 rings of the antitumor agent, fredericamycin A, has been synthesized by using the general technique of radical spirocyclization.  The key intermediate II was assembled from 7-methoxyindancarboxaldehyde and 2,3,6-Br(MeO)2C6H2C≡CPh, followed by oxidn. of the resulting alc.  Phenylselenylation of II and treatment with Ph3SnH gave the spirocycle which on ozonolysis and deprotection with BBr3 gave I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIQK7qjibUxbVg90H21EOLACvtfcHk0lgO2gpKz8CnSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXhslKjs78%253D&md5=86fd8aabf82a87d5dd71c39e5c5de513</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1021%2Fjo00383a032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00383a032%26sid%3Dliteratum%253Aachs%26aulast%3DClive%26aufirst%3DD.%26aulast%3DAngoh%26aufirst%3DA.%2BG.%26aulast%3DBennett%26aufirst%3DS.%2BM.%26atitle%3DRadical%2520spirocyclization%253A%2520synthesis%2520of%2520an%2520appropriately%2520oxygenated%2520spiro%2520compound%2520related%2520to%2520the%2520antitumor%2520antibiotic%2520fredericamycin%2520A%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1987%26volume%3D52%26spage%3D1339%26epage%3D1342%26doi%3D10.1021%2Fjo00383a032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Molander, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, I.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Suzuki–Miyaura cross-coupling reactions of potassium Boc-protected aminomethyltrifluoroborate with aryl and hetaryl halides</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">3956</span>– <span class="NLM_lpage">3959</span>, <span class="refDoi"> DOI: 10.1021/ol2014768</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol2014768" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC3MXosFCnsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2011&pages=3956-3959&author=G.+A.+Molanderauthor=I.+Shin&title=Synthesis+and+Suzuki%E2%80%93Miyaura+cross-coupling+reactions+of+potassium+Boc-protected+aminomethyltrifluoroborate+with+aryl+and+hetaryl+halides&doi=10.1021%2Fol2014768"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Suzuki-Miyaura Cross-Coupling Reactions of Potassium Boc-Protected Aminomethyltrifluoroborate with Aryl and Heteroaryl Halides</span></div><div class="casAuthors">Molander, Gary A.; Shin, Inji</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3956-3959</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Potassium Boc-protected aminomethyltrifluoroborate, a primary aminomethyl equiv., was synthesized successfully through a "one-pot" process.  With this trifluoroborate, Suzuki-Miyaura cross-coupling reactions were investigated with a variety of both aryl and heteroaryl chlorides in good to excellent yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjZClUfp08GLVg90H21EOLACvtfcHk0lgO2gpKz8CnSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXosFCnsro%253D&md5=0a108d35646711c17294531a8942183d</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1021%2Fol2014768&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol2014768%26sid%3Dliteratum%253Aachs%26aulast%3DMolander%26aufirst%3DG.%2BA.%26aulast%3DShin%26aufirst%3DI.%26atitle%3DSynthesis%2520and%2520Suzuki%25E2%2580%2593Miyaura%2520cross-coupling%2520reactions%2520of%2520potassium%2520Boc-protected%2520aminomethyltrifluoroborate%2520with%2520aryl%2520and%2520hetaryl%2520halides%26jtitle%3DOrg.%2520Lett.%26date%3D2011%26volume%3D13%26spage%3D3956%26epage%3D3959%26doi%3D10.1021%2Fol2014768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J.</span></span> <span> </span><span class="NLM_article-title">2-Chloro-2,2-difluoroacetophenone: a non-ODS-based difluorocarbene precursor and its use in the difluoromethylation of phenol derivatives</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">9845</span>– <span class="NLM_lpage">9848</span>, <span class="refDoi"> DOI: 10.1021/jo061799l</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo061799l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Clu73K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2006&pages=9845-9848&author=L.+Zhangauthor=J.+Zhengauthor=J.+Hu&title=2-Chloro-2%2C2-difluoroacetophenone%3A+a+non-ODS-based+difluorocarbene+precursor+and+its+use+in+the+difluoromethylation+of+phenol+derivatives&doi=10.1021%2Fjo061799l"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">2-Chloro-2,2-difluoroacetophenone: A Non-ODS-based difluorocarbene precursor and its use in the difluoromethylation of phenol derivatives</span></div><div class="casAuthors">Zhang, Laijun; Zheng, Ji; Hu, Jinbo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">9845-9848</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel and non-ODS-based (ODS = ozone-depleting substance) prepn. of 2-chloro-2,2-difluoroacetophenone I was achieved in high yield by using 2,2,2-trifluoroacetophenone as the starting material.  Compd. I was found to act as a good difluorocarbene reagent, which readily reacted with a variety of structurally diverse phenol derivs. in the presence of potassium hydroxide or potassium carbonate to produce aryl difluoromethyl ethers II (R = H, Cl, Br, I or F) in good yields.  This new and easy-to-handle synthetic methodol. offered an environmentally friendly alternative to other Freon- or Halon-based difluoromethylating approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqC_65gXcPdsrVg90H21EOLACvtfcHk0lgO2gpKz8CnSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Clu73K&md5=785fc9ca8ee19a94ca9e61ef413fd349</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1021%2Fjo061799l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo061799l%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZheng%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DJ.%26atitle%3D2-Chloro-2%252C2-difluoroacetophenone%253A%2520a%2520non-ODS-based%2520difluorocarbene%2520precursor%2520and%2520its%2520use%2520in%2520the%2520difluoromethylation%2520of%2520phenol%2520derivatives%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2006%26volume%3D71%26spage%3D9845%26epage%3D9848%26doi%3D10.1021%2Fjo061799l" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span> <i>Methods for Dilution Antimicrobial Susceptibility
Tests for Bacteria
That Grow Aerobically</i>, <span class="NLM_edition">11</span>th ed.; <span class="NLM_publisher-name">Clinical Laboratory Standards Institute (CLSI)</span>, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Methods+for+Dilution+Antimicrobial+Susceptibility%0ATests+for+Bacteria%0AThat+Grow+Aerobically%2C+11th+ed.%3B+Clinical+Laboratory+Standards+Institute+%28CLSI%29%2C+2018."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DMethods%2520for%2520Dilution%2520Antimicrobial%2520Susceptibility%250ATests%2520for%2520Bacteria%250AThat%2520Grow%2520Aerobically%26pub%3DClinical%2520Laboratory%2520Standards%2520Institute%2520%2528CLSI%2529%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bruchmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dötsch, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nouri, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaberny, I. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Häussler, S.</span></span> <span> </span><span class="NLM_article-title">Quantitative contributions of target alteration and decreased drug accumulation to <i>Pseudomonas aeruginosa</i> fluoroquinolone resistance</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">1361</span>, <span class="refDoi"> DOI: 10.1128/AAC.01581-12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1128%2FAAC.01581-12" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=23274661" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC3sXltV2htLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2013&pages=1361&author=S.+Bruchmannauthor=A.+D%C3%B6tschauthor=B.+Nouriauthor=I.+F.+Chabernyauthor=S.+H%C3%A4ussler&title=Quantitative+contributions+of+target+alteration+and+decreased+drug+accumulation+to+Pseudomonas+aeruginosa+fluoroquinolone+resistance&doi=10.1128%2FAAC.01581-12"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative contributions of target alteration and decreased drug accumulation to Pseudomonas aeruginosa fluoroquinolone resistance</span></div><div class="casAuthors">Bruchmann, Sebastian; Doetsch, Andreas; Nouri, Bianka; Chaberny, Iris F.; Haeussler, Susanne</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1361-1368</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Quinolone antibiotics constitute a clin. successful and widely used class of broad-spectrum antibiotics; however, the emergence and spread of resistance increasingly limits the use of fluoroquinolones in the treatment and management of microbial disease.  In this study, the authors evaluated the quant. contributions of quinolone target alteration and efflux pump expression to fluoroquinolone resistance in Pseudomonas aeruginosa.  They generated isogenic mutations in hot spots of the quinolone resistance-detg. regions (QRDRs) of gyrA, gyrB, and parC and inactivated the efflux regulator genes so as to overexpress the corresponding multidrug resistance (MDR) efflux pumps.  They then introduced the resp. mutations into the ref. strain PA14 singly and in various combinations.  Whereas the combined inactivation of two efflux regulator-encoding genes did not lead to resistance levels higher than those obtained by inactivation of only one efflux regulator-encoding gene, the combination of mutations leading to increased efflux and target alteration clearly exhibited an additive effect.  This combination of target alteration and overexpression of efflux pumps was commonly obsd. in clin. P. aeruginosa isolates; however, these two mechanisms were frequently found not to be sufficient to explain the level of fluoroquinolone resistance.  The results suggest that there are addnl. mechanisms, independent of the expression of the MexAB-OprM, MexCD-OprJ, MexEF-OprN, and/or MexXY-OprM efflux pump, that increase ciprofloxacin resistance in isolates with mutations in the QRDRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVUhN1kwRgYrVg90H21EOLACvtfcHk0liYqaqJPh0iUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXltV2htLw%253D&md5=bba5206049b5a05ce76f08c84f11de99</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1128%2FAAC.01581-12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01581-12%26sid%3Dliteratum%253Aachs%26aulast%3DBruchmann%26aufirst%3DS.%26aulast%3DD%25C3%25B6tsch%26aufirst%3DA.%26aulast%3DNouri%26aufirst%3DB.%26aulast%3DChaberny%26aufirst%3DI.%2BF.%26aulast%3DH%25C3%25A4ussler%26aufirst%3DS.%26atitle%3DQuantitative%2520contributions%2520of%2520target%2520alteration%2520and%2520decreased%2520drug%2520accumulation%2520to%2520Pseudomonas%2520aeruginosa%2520fluoroquinolone%2520resistance%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2013%26volume%3D57%26spage%3D1361%26doi%3D10.1128%2FAAC.01581-12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoang, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karkhoff-Schweizer, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kutchma, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schweizer, H. P.</span></span> <span> </span><span class="NLM_article-title">A broad-host-range Flp-<i>FRT</i> recombination system for site-specific excision of chromosomally-located DNA sequences: application for isolation of unmarked <i>Pseudomonas aeruginosa</i> mutants</span>. <i>Gene</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>212</i></span>,  <span class="NLM_fpage">77</span>– <span class="NLM_lpage">86</span>, <span class="refDoi"> DOI: 10.1016/S0378-1119(98)00130-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1016%2FS0378-1119%2898%2900130-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=9661666" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADyaK1cXjvFSgu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=212&publication_year=1998&pages=77-86&author=T.+T.+Hoangauthor=R.+R.+Karkhoff-Schweizerauthor=A.+J.+Kutchmaauthor=H.+P.+Schweizer&title=A+broad-host-range+Flp-FRT+recombination+system+for+site-specific+excision+of+chromosomally-located+DNA+sequences%3A+application+for+isolation+of+unmarked+Pseudomonas+aeruginosa+mutants&doi=10.1016%2FS0378-1119%2898%2900130-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">A broad-host-range Flp-FRT recombination system for site-specific excision of chromosomally-located DNA sequences: application for isolation of unmarked Pseudomonas aeruginosa mutants</span></div><div class="casAuthors">Hoang, Tung T.; Karkhoff-Schweizer, RoxAnn R.; Kutchma, Alecksandr J.; Schweizer, Herbert P.</div><div class="citationInfo"><span class="NLM_cas:title">Gene</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">212</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">77-86</span>CODEN:
                <span class="NLM_cas:coden">GENED6</span>;
        ISSN:<span class="NLM_cas:issn">0378-1119</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">An improved method for gene replacement in Pseudomonas aeruginosa was developed.  The method employs several new gene replacement vectors that incorporate (1) the counter-selectable sacB marker, (2) a lacZα-allele for blue-white screening, (3) the pUC18/19 vectors multiple cloning site with 10 unique restriction sites, (4) an oriT for conjugation-mediated plasmid transfer and (5) carbenicillin, gentamicin (Gm) and tetracycline selectable markers.  A cassette was constructed that contains a GmR selectable marker next to the green fluorescent protein structural gene, with both markers being flanked by Flp recombinase target (FRT) sites.  The FRT cassette was used to insertionally inactivate the cloned P. aeruginosa pabC gene encoding aminodeoxychorismate lyase.  After conjugal transfer into P. aeruginosa, plasmid integrants were selected, and deletion of unwanted DNA sequences was promoted by sucrose counter-selection.  The FRT cassette was excised with high frequencies (close to 100%) from the chromosome after conjugal transfer of a Flp recombinase-expressing plasmid; this sacB-contg. plasmid was subsequently cured by sucrose counterselection, resulting in an unmarked P. aeruginosa ΔpabC strain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm-AkpBaY4U7Vg90H21EOLACvtfcHk0liYqaqJPh0iUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjvFSgu7Y%253D&md5=cd8b05d0fc01f93fa8db43e1332bdebc</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1016%2FS0378-1119%2898%2900130-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0378-1119%252898%252900130-9%26sid%3Dliteratum%253Aachs%26aulast%3DHoang%26aufirst%3DT.%2BT.%26aulast%3DKarkhoff-Schweizer%26aufirst%3DR.%2BR.%26aulast%3DKutchma%26aufirst%3DA.%2BJ.%26aulast%3DSchweizer%26aufirst%3DH.%2BP.%26atitle%3DA%2520broad-host-range%2520Flp-FRT%2520recombination%2520system%2520for%2520site-specific%2520excision%2520of%2520chromosomally-located%2520DNA%2520sequences%253A%2520application%2520for%2520isolation%2520of%2520unmarked%2520Pseudomonas%2520aeruginosa%2520mutants%26jtitle%3DGene%26date%3D1998%26volume%3D212%26spage%3D77%26epage%3D86%26doi%3D10.1016%2FS0378-1119%2898%2900130-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Caughlan, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sriram, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daigle, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woods, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buco, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dzink-Fox, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dean, C. R.</span></span> <span> </span><span class="NLM_article-title">Fmt bypass in <i>Pseudomonas aeruginosa</i> causes induction of MexXY efflux pump expression</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">5015</span>, <span class="refDoi"> DOI: 10.1128/AAC.00253-09</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1128%2FAAC.00253-09" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=19786597" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsF2gs7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2009&pages=5015&author=R.+E.+Caughlanauthor=S.+Sriramauthor=D.+M.+Daigleauthor=A.+L.+Woodsauthor=J.+Bucoauthor=R.+L.+Petersonauthor=J.+Dzink-Foxauthor=S.+Walkerauthor=C.+R.+Dean&title=Fmt+bypass+in+Pseudomonas+aeruginosa+causes+induction+of+MexXY+efflux+pump+expression&doi=10.1128%2FAAC.00253-09"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Fmt bypass in Pseudomonas aeruginosa causes induction of MexXY efflux pump expression</span></div><div class="casAuthors">Caughlan, Ruth E.; Sriram, Shubha; Daigle, Denis M.; Woods, Angela L.; Buco, Jennifer; Peterson, Ron L.; Dzink-Fox, JoAnn; Walker, Susan; Dean, Charles R.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5015-5022</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The intrinsic resistance of P. aeruginosa PAO1 to the peptide deformylase inhibitor (PDF-I) LBM415 was mediated by the MexAB-OprM and MexXY-OprM efflux pumps, the latter of which was strongly induced by LBM415.  Single-step exposure of PAO1 deleted for mexAB-oprM (therefore lacking both MexAB-OprM and MexXY-OprM functions) to PDF-Is selected for nfxB mutants, which express the MexCD-OprJ efflux pump, indicating that these compds. are also substrates for this pump.  Selection of resistant mutants by use of levels of LBM415 greater than that accommodated by efflux yielded two addnl. groups of mutations, in the methionyl-tRNAfmet formyltransferase (fmt) and folD genes.  Both mechanisms are known to impose an in vitro growth deficit (also obsd. here), presumably due to impairment of protein synthesis.  The authors surmised that this inherent impairment of protein synthesis would upregulate expression of mexXY in a fashion similar to upregulation by LBM415 or by ribosome inhibitory compds.  Transcriptional profiling and/or mexX::lux promoter fusion anal. revealed that fmt and folD mutants were strongly upregulated for mexXY and another gene known to be required for upregulation of the pump, PA5471.  Complementation of the fmt mutation in trans reversed this constitutive expression.  This supports the notion that MexXY has a natural physiol. function responding to impairment of ribosome function or protein synthesis and that fmt mutation (Fmt bypass) and folD mutation generate the intracellular mexXY-inducing signal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqc6UeDhofIMLVg90H21EOLACvtfcHk0liPZ_PUDkUW8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsF2gs7jN&md5=6b8360ce51719e13e9e376cdcb76fdff</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1128%2FAAC.00253-09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00253-09%26sid%3Dliteratum%253Aachs%26aulast%3DCaughlan%26aufirst%3DR.%2BE.%26aulast%3DSriram%26aufirst%3DS.%26aulast%3DDaigle%26aufirst%3DD.%2BM.%26aulast%3DWoods%26aufirst%3DA.%2BL.%26aulast%3DBuco%26aufirst%3DJ.%26aulast%3DPeterson%26aufirst%3DR.%2BL.%26aulast%3DDzink-Fox%26aufirst%3DJ.%26aulast%3DWalker%26aufirst%3DS.%26aulast%3DDean%26aufirst%3DC.%2BR.%26atitle%3DFmt%2520bypass%2520in%2520Pseudomonas%2520aeruginosa%2520causes%2520induction%2520of%2520MexXY%2520efflux%2520pump%2520expression%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2009%26volume%3D53%26spage%3D5015%26doi%3D10.1128%2FAAC.00253-09" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baba, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasegawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okumura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baba, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Datsenko, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wanner, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, H.</span></span> <span> </span><span class="NLM_article-title">Construction of <i>Escherichia coli</i> K-12 in-frame, single-gene knockout mutants: the Keio collection</span>. <i>Mol. Syst. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">2006.0008</span>, <span class="refDoi"> DOI: 10.1038/msb4100050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1038%2Fmsb4100050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=16738554" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2006&pages=2006.0008&author=T.+Babaauthor=T.+Araauthor=M.+Hasegawaauthor=Y.+Takaiauthor=Y.+Okumuraauthor=M.+Babaauthor=K.+A.+Datsenkoauthor=M.+Tomitaauthor=B.+L.+Wannerauthor=H.+Mori&title=Construction+of+Escherichia+coli+K-12+in-frame%2C+single-gene+knockout+mutants%3A+the+Keio+collection&doi=10.1038%2Fmsb4100050"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1038%2Fmsb4100050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fmsb4100050%26sid%3Dliteratum%253Aachs%26aulast%3DBaba%26aufirst%3DT.%26aulast%3DAra%26aufirst%3DT.%26aulast%3DHasegawa%26aufirst%3DM.%26aulast%3DTakai%26aufirst%3DY.%26aulast%3DOkumura%26aufirst%3DY.%26aulast%3DBaba%26aufirst%3DM.%26aulast%3DDatsenko%26aufirst%3DK.%2BA.%26aulast%3DTomita%26aufirst%3DM.%26aulast%3DWanner%26aufirst%3DB.%2BL.%26aulast%3DMori%26aufirst%3DH.%26atitle%3DConstruction%2520of%2520Escherichia%2520coli%2520K-12%2520in-frame%252C%2520single-gene%2520knockout%2520mutants%253A%2520the%2520Keio%2520collection%26jtitle%3DMol.%2520Syst.%2520Biol.%26date%3D2006%26volume%3D2%26spage%3D2006.0008%26doi%3D10.1038%2Fmsb4100050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Masuda, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohya, S.</span></span> <span> </span><span class="NLM_article-title">Cross-resistance to meropenem, cephems, and quinolones in Pseudomonas aeruginosa</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">1847</span>– <span class="NLM_lpage">1851</span>, <span class="refDoi"> DOI: 10.1128/AAC.36.9.1847</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1128%2FAAC.36.9.1847" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1416876" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADyaK38Xmt12qtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1992&pages=1847-1851&author=N.+Masudaauthor=S.+Ohya&title=Cross-resistance+to+meropenem%2C+cephems%2C+and+quinolones+in+Pseudomonas+aeruginosa&doi=10.1128%2FAAC.36.9.1847"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Cross-resistance to meropenem, cephems, and quinolones in Pseudomonas aeruginosa</span></div><div class="casAuthors">Masuda, Nobuhisa; Ohya, Satoshi</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1847-51</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    </div><div class="casAbstract">Multiple-drug-resistant mutants were isolated from P. aeruginosa PAO1 on agar plates contg. ofloxacin and cefsulodin.  These mutants were 4-8-times more resistant to meropenem, cephems, carbenicillin, quinolones, tetracycline, and chloramphenicol than the parent strain was.  In contrast, these mutants showed no significant changes in their susceptibilities to all carbapenems except meropenem.  In these mutants, the amts. of an outer membrane protein with an apparent mol. wt. of 49,000 (designated OprM) were increased compared with the amt. in PAO1.  Multiple-drug-resistant mutants of this type were also isolated from PAO1 on agar plates contg. meropenem.  Approx. 5% of clin. isolates showed cross-resistance to meropenem, cephems, and quinolones, concomitant with overprodn. of OprM.  Moreover, these two phenotypes, i.e., multiple-drug resistance and overprodn. of OprM, were cotransferable by transduction.  These data suggest that overprodn. of OprM is assocd. with cross-resistance to meropenem, cephems, and quinolones in P. aeruginosa.  The ofloxacin-cefsulodin-resistant mutant required higher concns. of meropenem to induce β-lactamase than PAO1 did, indicating the possibility that this mutation involves decreased outer membrane permeability to meropenem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZpPIJs2-HTLVg90H21EOLACvtfcHk0liPZ_PUDkUW8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xmt12qtLY%253D&md5=4a4b357437616267618772b0d6ba8d8c</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1128%2FAAC.36.9.1847&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.36.9.1847%26sid%3Dliteratum%253Aachs%26aulast%3DMasuda%26aufirst%3DN.%26aulast%3DOhya%26aufirst%3DS.%26atitle%3DCross-resistance%2520to%2520meropenem%252C%2520cephems%252C%2520and%2520quinolones%2520in%2520Pseudomonas%2520aeruginosa%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1992%26volume%3D36%26spage%3D1847%26epage%3D1851%26doi%3D10.1128%2FAAC.36.9.1847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fraud, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campigotto, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poole, K.</span></span> <span> </span><span class="NLM_article-title">MexCD-OprJ multidrug efflux system of <i>Pseudomonas aeruginosa</i>: involvement in chlorhexidine resistance and induction by membrane-damaging agents dependent upon the AlgU stress response sigma factor</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">4478</span>– <span class="NLM_lpage">4482</span>, <span class="refDoi"> DOI: 10.1128/AAC.01072-08</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1128%2FAAC.01072-08" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=18838593" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsV2mu7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=4478-4482&author=S.+Fraudauthor=A.+J.+Campigottoauthor=Z.+Chenauthor=K.+Poole&title=MexCD-OprJ+multidrug+efflux+system+of+Pseudomonas+aeruginosa%3A+involvement+in+chlorhexidine+resistance+and+induction+by+membrane-damaging+agents+dependent+upon+the+AlgU+stress+response+sigma+factor&doi=10.1128%2FAAC.01072-08"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">MexCD-OprJ multidrug efflux system of Pseudomonas aeruginosa: Involvement in chlorhexidine resistance and induction by membrane-damaging agents dependent upon the AlgU stress response sigma factor</span></div><div class="casAuthors">Fraud, Sebastien; Campigotto, Aaron J.; Chen, Zhilin; Poole, Keith</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4478-4482</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The biocide chlorhexidine (CHX) as well as addnl. membrane-active agents were shown to induce expression of the mexCD-oprJ multidrug efflux operon, dependent upon the AlgU stress response sigma factor.  Hyperexpression of this efflux system in nfxB mutants was also substantially AlgU dependent.  CHX resistance correlated with efflux gene expression in various mutants, consistent with MexCD-OprJ being a determinant of CHX resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNf6yoV0CAKrVg90H21EOLACvtfcHk0liPZ_PUDkUW8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsV2mu7%252FK&md5=3758ebcb9c7302486fe056d3345e56c5</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1128%2FAAC.01072-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01072-08%26sid%3Dliteratum%253Aachs%26aulast%3DFraud%26aufirst%3DS.%26aulast%3DCampigotto%26aufirst%3DA.%2BJ.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DPoole%26aufirst%3DK.%26atitle%3DMexCD-OprJ%2520multidrug%2520efflux%2520system%2520of%2520Pseudomonas%2520aeruginosa%253A%2520involvement%2520in%2520chlorhexidine%2520resistance%2520and%2520induction%2520by%2520membrane-damaging%2520agents%2520dependent%2520upon%2520the%2520AlgU%2520stress%2520response%2520sigma%2520factor%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D4478%26epage%3D4482%26doi%3D10.1128%2FAAC.01072-08" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ross, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benton, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Pascale, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leeds, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reck, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richie, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaMarche, M. J.</span></span> <span> </span><span class="NLM_article-title">Synthesis of ciprofloxacin dimers for evaluation of bacterial permeability in atypical chemical space</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">3468</span>– <span class="NLM_lpage">3475</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.07.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1016%2Fj.bmcl.2015.07.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=26189081" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFCqtb%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=3468-3475&author=A.+G.+Rossauthor=B.+M.+Bentonauthor=D.+Chinauthor=G.+De+Pascaleauthor=J.+Fullerauthor=J.+A.+Leedsauthor=F.+Reckauthor=D.+L.+Richieauthor=J.+Voauthor=M.+J.+LaMarche&title=Synthesis+of+ciprofloxacin+dimers+for+evaluation+of+bacterial+permeability+in+atypical+chemical+space&doi=10.1016%2Fj.bmcl.2015.07.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of ciprofloxacin dimers for evaluation of bacterial permeability in atypical chemical space</span></div><div class="casAuthors">Ross, Audrey G.; Benton, Bret M.; Chin, Donovan; De Pascale, Gianfranco; Fuller, John; Leeds, Jennifer A.; Reck, Folkert; Richie, Daryl L.; Vo, Jason; LaMarche, Matthew J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">3468-3475</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We describe the synthesis and evaluation of a library of variably-linked ciprofloxacin dimers.  These structures unify and expand on the use of fluoroquinolones as probes throughout the antibiotic literature.  A dimeric analog I showed enhanced inhibition of its intracellular target (DNA gyrase), and translation to antibacterial activity in whole cells was demonstrated.  Overall, cell permeation was governed by physicochem. properties and bacterial type.  A principal component anal. demonstrated that the dimers occupy a unique and privileged region of chem. space most similar to the macrolide class of antibiotics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDwllxOFolkbVg90H21EOLACvtfcHk0li75HZOka--vA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFCqtb%252FF&md5=43c68073c4bb423a1deb4ffacfe5557a</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.07.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.07.010%26sid%3Dliteratum%253Aachs%26aulast%3DRoss%26aufirst%3DA.%2BG.%26aulast%3DBenton%26aufirst%3DB.%2BM.%26aulast%3DChin%26aufirst%3DD.%26aulast%3DDe%2BPascale%26aufirst%3DG.%26aulast%3DFuller%26aufirst%3DJ.%26aulast%3DLeeds%26aufirst%3DJ.%2BA.%26aulast%3DReck%26aufirst%3DF.%26aulast%3DRichie%26aufirst%3DD.%2BL.%26aulast%3DVo%26aufirst%3DJ.%26aulast%3DLaMarche%26aufirst%3DM.%2BJ.%26atitle%3DSynthesis%2520of%2520ciprofloxacin%2520dimers%2520for%2520evaluation%2520of%2520bacterial%2520permeability%2520in%2520atypical%2520chemical%2520space%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D3468%26epage%3D3475%26doi%3D10.1016%2Fj.bmcl.2015.07.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gedeck, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skolnik, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodde, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dollinger, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berellini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vianello, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faller, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lombardo, F.</span></span> <span> </span><span class="NLM_article-title">Benefit of retraining pKa models studied using internally measured data</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">1449</span>– <span class="NLM_lpage">1459</span>, <span class="refDoi"> DOI: 10.1021/acs.jcim.5b00172</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jcim.5b00172" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVShtrvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2015&pages=1449-1459&author=P.+Gedeckauthor=Y.+Luauthor=S.+Skolnikauthor=S.+Roddeauthor=G.+Dollingerauthor=W.+Jiaauthor=G.+Berelliniauthor=R.+Vianelloauthor=B.+Fallerauthor=F.+Lombardo&title=Benefit+of+retraining+pKa+models+studied+using+internally+measured+data&doi=10.1021%2Facs.jcim.5b00172"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Benefit of Retraining pKa Models Studied Using Internally Measured Data</span></div><div class="casAuthors">Gedeck, Peter; Lu, Yipin; Skolnik, Suzanne; Rodde, Stephane; Dollinger, Gavin; Jia, Weiping; Berellini, Giuliano; Vianello, Riccardo; Faller, Bernard; Lombardo, Franco</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1449-1459</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The ionization state of drugs influences many pharmaceutical properties such as their soly., permeability, and biol. activity.  It is therefore important to understand the structure property relation for the acid-base dissocn. const. pKa during the lead optimization process to make better-informed design decisions.  Computational approaches, such as implemented in MoKa, can help with this; however, they often predict with too large error esp. for proprietary compds.  In this contribution, the authors look at how retraining helps to greatly improve prediction error.  Using a longitudinal study with data measured over 15 years in a drug discovery environment, the authors assess the impact of model training on prediction accuracy and look at model degrdn. over time.  Using the MoKa software, regular retraining is required to address changes in chem. space leading to model degrdn. over six to nine months.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNCUz-ylPu6bVg90H21EOLACvtfcHk0li75HZOka--vA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVShtrvJ&md5=6a178b50d5ac0a597391cc2b19af8e32</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1021%2Facs.jcim.5b00172&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jcim.5b00172%26sid%3Dliteratum%253Aachs%26aulast%3DGedeck%26aufirst%3DP.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DSkolnik%26aufirst%3DS.%26aulast%3DRodde%26aufirst%3DS.%26aulast%3DDollinger%26aufirst%3DG.%26aulast%3DJia%26aufirst%3DW.%26aulast%3DBerellini%26aufirst%3DG.%26aulast%3DVianello%26aufirst%3DR.%26aulast%3DFaller%26aufirst%3DB.%26aulast%3DLombardo%26aufirst%3DF.%26atitle%3DBenefit%2520of%2520retraining%2520pKa%2520models%2520studied%2520using%2520internally%2520measured%2520data%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2015%26volume%3D55%26spage%3D1449%26epage%3D1459%26doi%3D10.1021%2Facs.jcim.5b00172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Allen, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Box, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Comer, J. E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peake, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tam, K. Y.</span></span> <span> </span><span class="NLM_article-title">Multiwavelength spectrophotometric determination of acid dissociation constants of ionizable drugs</span>. <i>J. Pharm. Biomed. Anal.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">699</span>– <span class="NLM_lpage">712</span>, <span class="refDoi"> DOI: 10.1016/S0731-7085(98)00010-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1016%2FS0731-7085%2898%2900010-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=9682153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADyaK1cXkvFWhtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1998&pages=699-712&author=R.+I.+Allenauthor=K.+J.+Boxauthor=J.+E.+A.+Comerauthor=C.+Peakeauthor=K.+Y.+Tam&title=Multiwavelength+spectrophotometric+determination+of+acid+dissociation+constants+of+ionizable+drugs&doi=10.1016%2FS0731-7085%2898%2900010-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Multiwavelength spectrophotometric determination of acid dissociation constants of ionizable drugs</span></div><div class="casAuthors">Allen, R. I.; Box, K. J.; Comer, J. E. A.; Peake, C.; Tam, K. Y.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical and Biomedical Analysis</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4,5</span>),
    <span class="NLM_cas:pages">699-712</span>CODEN:
                <span class="NLM_cas:coden">JPBADA</span>;
        ISSN:<span class="NLM_cas:issn">0731-7085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A multiwavelength spectrophotometry was used to det. acid dissocn. consts. (pKa) of sparingly sol. drugs.  UV absorption spectra of the drug solns. were acquired using a versatile device based on a fiber optic dip probe, a light source, and a photodiode array (PDA) detector, while the pH and the ionic strength of the chem. system was manipulated by a com. available titrator.  Target factor anal. (TFA) was applied to deduce the pKa values from the multiwavelength UV absorption data recorded at different pH values.  We call this multiwavelength approach the WApH technique because the pKa values are detd. from changes in Wavelength and Absorbance as a function of pH (WApH).  The WApH technique is exemplified by using pure niflumic acid, nitrazepam, pyridoxine, quinine, and terbutaline.  The WApH pKa values obtained agree well with those derived from pH-metric titrns.  The WApH technique is able to deduce pKa values with high accuracy even if the absorption spectra of the reacting species are very similar.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqckQEYX9u_PLVg90H21EOLACvtfcHk0lhVH9PoxokPsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXkvFWhtrw%253D&md5=5a1b3d3d724ac3991dc14e571ac92834</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1016%2FS0731-7085%2898%2900010-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0731-7085%252898%252900010-7%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DR.%2BI.%26aulast%3DBox%26aufirst%3DK.%2BJ.%26aulast%3DComer%26aufirst%3DJ.%2BE.%2BA.%26aulast%3DPeake%26aufirst%3DC.%26aulast%3DTam%26aufirst%3DK.%2BY.%26atitle%3DMultiwavelength%2520spectrophotometric%2520determination%2520of%2520acid%2520dissociation%2520constants%2520of%2520ionizable%2520drugs%26jtitle%3DJ.%2520Pharm.%2520Biomed.%2520Anal.%26date%3D1998%26volume%3D17%26spage%3D699%26epage%3D712%26doi%3D10.1016%2FS0731-7085%2898%2900010-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmqvist, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ni, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikhailov, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hogan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Digan, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urban, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erdemli, G.</span></span> <span> </span><span class="NLM_article-title">Cardiac ion channel safety profiling on the IonWorks Quattro automated patch clamp system</span>. <i>Assay Drug Dev. Technol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">766</span>– <span class="NLM_lpage">780</span>, <span class="refDoi"> DOI: 10.1089/adt.2010.0333</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1089%2Fadt.2010.0333" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=21133679" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFOjsLrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2010&pages=766-780&author=X.+Caoauthor=Y.+T.+Leeauthor=M.+Holmqvistauthor=Y.+Linauthor=Y.+Niauthor=D.+Mikhailovauthor=H.+Zhangauthor=C.+Hoganauthor=L.+Zhouauthor=Q.+Luauthor=M.+E.+Diganauthor=L.+Urbanauthor=G.+Erdemli&title=Cardiac+ion+channel+safety+profiling+on+the+IonWorks+Quattro+automated+patch+clamp+system&doi=10.1089%2Fadt.2010.0333"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Cardiac Ion Channel Safety Profiling on the IonWorks Quattro Automated Patch Clamp System</span></div><div class="casAuthors">Cao, Xue-Ying; Lee, Yan Tony; Holmqvist, Mats; Lin, Ying-Xin; Ni, Yu-Cheng; Mikhailov, Dmitri; Zhang, Hai-Yan; Hogan, Christopher; Zhou, Li-Ping; Lu, Qiang; Digan, Mary Ellen; Urban, Laszlo; Erdemli, Gul</div><div class="citationInfo"><span class="NLM_cas:title">Assay and Drug Development Technologies</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">766-780</span>CODEN:
                <span class="NLM_cas:coden">ADDTAR</span>;
        ISSN:<span class="NLM_cas:issn">1540-658X</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">The normal electrophysiol. behavior of the heart is detd. by the integrated activity of specific cardiac ionic currents.  Mutations in genes encoding the mol. components of individual cardiac ion currents have been shown to result in multiple cardiac arrhythmia syndromes.  Presently, 12 genes assocd. with inherited long QT syndrome (LQTS) have been identified, and the most common mutations are in the hKCNQ1 (LQT1, Jervell and Lange-Nielson syndrome), hKCNH2 (LQT2), and hSCN5A (LQT3, Brugada syndrome) genes.  Several drugs have been withdrawn from the market or received black box labeling due to clin. cases of QT interval prolongation, ventricular arrhythmias, and sudden death.  Other drugs have been denied regulatory approval owing to their potential for QT interval prolongation.  Further, off-target activity of drugs on cardiac ion channels has been shown to be assocd. with increased mortality in patients with underlying cardiovascular diseases.  Since clin. arrhythmia risk is a major cause for compd. termination, preclin. profiling for off-target cardiac ion channel interactions early in the drug discovery process has become common practice in the pharmaceutical industry.  In the present study, we report assay development for three cardiac ion channels (hKCNQ1/minK, hCav1.2, and hNav1.5) on the IonWorks Quattro system.  We demonstrate that these assays can be used as reliable pharmacol. profiling tools for cardiac ion channel inhibition to assess compds. for cardiac liability during drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFmRplOzjI47Vg90H21EOLACvtfcHk0lhVH9PoxokPsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFOjsLrE&md5=a75376567e33156b80fd7632e163bf3d</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1089%2Fadt.2010.0333&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fadt.2010.0333%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DX.%26aulast%3DLee%26aufirst%3DY.%2BT.%26aulast%3DHolmqvist%26aufirst%3DM.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DNi%26aufirst%3DY.%26aulast%3DMikhailov%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DHogan%26aufirst%3DC.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DLu%26aufirst%3DQ.%26aulast%3DDigan%26aufirst%3DM.%2BE.%26aulast%3DUrban%26aufirst%3DL.%26aulast%3DErdemli%26aufirst%3DG.%26atitle%3DCardiac%2520ion%2520channel%2520safety%2520profiling%2520on%2520the%2520IonWorks%2520Quattro%2520automated%2520patch%2520clamp%2520system%26jtitle%3DAssay%2520Drug%2520Dev.%2520Technol.%26date%3D2010%26volume%3D8%26spage%3D766%26epage%3D780%26doi%3D10.1089%2Fadt.2010.0333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winn, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storoni, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span> <span> </span><span class="NLM_article-title">Phaser crystallographic software</span>. <i>J. Appl. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">658</span>– <span class="NLM_lpage">674</span>, <span class="refDoi"> DOI: 10.1107/S0021889807021206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1107%2FS0021889807021206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=19461840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2007&pages=658-674&author=A.+J.+McCoyauthor=R.+W.+Grosse-Kunstleveauthor=P.+D.+Adamsauthor=M.+D.+Winnauthor=L.+C.+Storoniauthor=R.+J.+Read&title=Phaser+crystallographic+software&doi=10.1107%2FS0021889807021206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Phaser crystallographic software</span></div><div class="casAuthors">McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.; Winn, Martyn D.; Storoni, Laurent C.; Read, Randy J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">658-674</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Phaser is a program for phasing macromol. crystal structures by both mol. replacement and exptl. phasing methods.  The novel phasing algorithms implemented in Phaser have been developed using max. likelihood and multivariate statistics.  For mol. replacement, the new algorithms have proved to be significantly better than traditional methods in discriminating correct solns. from noise, and for single-wavelength anomalous dispersion exptl. phasing, the new algorithms, which account for correlations between F+ and F-, give better phases (lower mean phase error with respect to the phases given by the refined structure) than those that use mean F and anomalous differences ΔF.  One of the design concepts of Phaser was that it be capable of a high degree of automation.  To this end, Phaser (written in C++) can be called directly from Python, although it can also be called using traditional CCP4 keyword-style input.  Phaser is a platform for future development of improved phasing methods and their release, including source code, to the crystallog. community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPeVyjN_FMGbVg90H21EOLACvtfcHk0lhVH9PoxokPsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D&md5=c63b722ae97e0a74e6a5a079d388f09f</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1107%2FS0021889807021206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889807021206%26sid%3Dliteratum%253Aachs%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DStoroni%26aufirst%3DL.%2BC.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26atitle%3DPhaser%2520crystallographic%2520software%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2007%26volume%3D40%26spage%3D658%26epage%3D674%26doi%3D10.1107%2FS0021889807021206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K.</span></span> <span> </span><span class="NLM_article-title">Coot: model-building tools for molecular graphics</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2126</span>– <span class="NLM_lpage">2132</span>, <span class="refDoi"> DOI: 10.1107/S0907444904019158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1107%2FS0907444904019158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=15572765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=2126-2132&author=P.+Emsleyauthor=K.+Cowtan&title=Coot%3A+model-building+tools+for+molecular+graphics&doi=10.1107%2FS0907444904019158"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Coot: model-building tools for molecular graphics</span></div><div class="casAuthors">Emsley, Paul; Cowtan, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">D60</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">2126-2132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">CCP4mg is a project that aims to provide a general-purpose tool for structural biologists, providing tools for x-ray structure soln., structure comparison and anal., and publication-quality graphics.  The map-fitting tools are available as a stand-alone package, distributed as 'Coot'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMisM42468k7Vg90H21EOLACvtfcHk0lj-8_txC426zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P&md5=1be390f3bb6fd584468499ad0921161e</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1107%2FS0907444904019158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904019158%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DCoot%253A%2520model-building%2520tools%2520for%2520molecular%2520graphics%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D2126%26epage%3D2132%26doi%3D10.1107%2FS0907444904019158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohkamp, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K.</span></span> <span> </span><span class="NLM_article-title">Features and development of Coot</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">486</span>– <span class="NLM_lpage">501</span>, <span class="refDoi"> DOI: 10.1107/S0907444910007493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=20383002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=486-501&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+development+of+Coot&doi=10.1107%2FS0907444910007493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0lj-8_txC426zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520development%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D486%26epage%3D501%26doi%3D10.1107%2FS0907444910007493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Afonine, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunkoczi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, I. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Echols, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Headd, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, L.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapral, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moriarty, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oeffner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terwilliger, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwart, P. H.</span></span> <span> </span><span class="NLM_article-title">PHENIX: a comprehensive Python-based system for macromolecular structure solution</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">213</span>– <span class="NLM_lpage">221</span>, <span class="refDoi"> DOI: 10.1107/S0907444909052925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1107%2FS0907444909052925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=20124702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=213-221&author=P.+D.+Adamsauthor=P.+V.+Afonineauthor=G.+Bunkocziauthor=V.+B.+Chenauthor=I.+W.+Davisauthor=N.+Echolsauthor=J.+J.+Headdauthor=L.-W.+Hungauthor=G.+J.+Kapralauthor=R.+W.+Grosse-Kunstleveauthor=A.+J.+McCoyauthor=N.+W.+Moriartyauthor=R.+Oeffnerauthor=R.+J.+Readauthor=D.+C.+Richardsonauthor=J.+S.+Richardsonauthor=T.+C.+Terwilligerauthor=P.+H.+Zwart&title=PHENIX%3A+a+comprehensive+Python-based+system+for+macromolecular+structure+solution&doi=10.1107%2FS0907444909052925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">PHENIX: a comprehensive Python-based system for macromolecular structure solution</span></div><div class="casAuthors">Adams, Paul D.; Afonine, Pavel V.; Bunkoczi, Gabor; Chen, Vincent B.; Davis, Ian W.; Echols, Nathaniel; Headd, Jeffrey J.; Hung, Li Wei; Kapral, Gary J.; Grosse-Kunstleve, Ralf W.; McCoy, Airlie J.; Moriarty, Nigel W.; Oeffner, Robert; Read, Randy J.; Richardson, David C.; Richardson, Jane S.; Terwilliger, Thomas C.; Zwart, Peter H.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">213-221</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  Macromol. X-ray crystallog. is routinely applied to understand biol. processes at a mol. level.  However, significant time and effort are still required to solve and complete many of these structures because of the need for manual interpretation of complex numerical data using many software packages and the repeated use of interactive three-dimensional graphics.  PHENIX has been developed to provide a comprehensive system for macromol. crystallog. structure soln. with an emphasis on the automation of all procedures.  This has relied on the development of algorithms that minimize or eliminate subjective input, the development of algorithms that automate procedures that are traditionally performed by hand and, finally, the development of a framework that allows a tight integration between the algorithms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm_HgKRpa-ObVg90H21EOLACvtfcHk0lj-8_txC426zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D&md5=67b439ff4bd61c659cae37ca4209b7bc</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1107%2FS0907444909052925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909052925%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DAfonine%26aufirst%3DP.%2BV.%26aulast%3DBunkoczi%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DV.%2BB.%26aulast%3DDavis%26aufirst%3DI.%2BW.%26aulast%3DEchols%26aufirst%3DN.%26aulast%3DHeadd%26aufirst%3DJ.%2BJ.%26aulast%3DHung%26aufirst%3DL.-W.%26aulast%3DKapral%26aufirst%3DG.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DOeffner%26aufirst%3DR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DRichardson%26aufirst%3DD.%2BC.%26aulast%3DRichardson%26aufirst%3DJ.%2BS.%26aulast%3DTerwilliger%26aufirst%3DT.%2BC.%26aulast%3DZwart%26aufirst%3DP.%2BH.%26atitle%3DPHENIX%253A%2520a%2520comprehensive%2520Python-based%2520system%2520for%2520macromolecular%2520structure%2520solution%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D213%26epage%3D221%26doi%3D10.1107%2FS0907444909052925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liebschner, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Afonine, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunkoczi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Croll, T. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hintze, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, L.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moriarty, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oeffner, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poon, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prisant, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sammito, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sobolev, O. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stockwell, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terwilliger, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urzhumtsev, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Videau, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span> <span> </span><span class="NLM_article-title">Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix</span>. <i>Acta Cryst. D Struct. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">861</span>– <span class="NLM_lpage">877</span>, <span class="refDoi"> DOI: 10.1107/S2059798319011471</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1107%2FS2059798319011471" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=31588918" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvFWkurrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2019&pages=861-877&author=D.+Liebschnerauthor=P.+V.+Afonineauthor=M.+L.+Bakerauthor=G.+Bunkocziauthor=V.+B.+Chenauthor=T.+I.+Crollauthor=B.+Hintzeauthor=L.-W.+Hungauthor=S.+Jainauthor=A.+J.+McCoyauthor=N.+W.+Moriartyauthor=R.+D.+Oeffnerauthor=B.+K.+Poonauthor=M.+G.+Prisantauthor=R.+J.+Readauthor=J.+S.+Richardsonauthor=D.+C.+Richardsonauthor=M.+D.+Sammitoauthor=O.+V.+Sobolevauthor=D.+H.+Stockwellauthor=T.+C.+Terwilligerauthor=A.+G.+Urzhumtsevauthor=L.+L.+Videauauthor=C.+J.+Williamsauthor=P.+D.+Adams&title=Macromolecular+structure+determination+using+X-rays%2C+neutrons+and+electrons%3A+recent+developments+in+Phenix&doi=10.1107%2FS2059798319011471"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix</span></div><div class="casAuthors">Liebschner, Dorothee; Afonine, Pavel V.; Baker, Matthew L.; Bunkoczi, Gabor; Chen, Vincent B.; Croll, Tristan I.; Hintze, Bradley; Hung, Li-Wei; Jain, Swati; McCoy, Airlie J.; Moriarty, Nigel W.; Oeffner, Robert D.; Poon, Billy K.; Prisant, Michael G.; Read, Randy J.; Richardson, Jane S.; Richardson, David C.; Sammito, Massimo D.; Sobolev, Oleg V.; Stockwell, Duncan H.; Terwilliger, Thomas C.; Urzhumtsev, Alexandre G.; Videau, Lizbeth L.; Williams, Christopher J.; Adams, Paul D.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Structural Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">861-877</span>CODEN:
                <span class="NLM_cas:coden">ACSDAD</span>;
        ISSN:<span class="NLM_cas:issn">2059-7983</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Diffraction (X-ray, neutron and electron) and electron cryo-microscopy are powerful methods to det. three-dimensional macromol. structures, which are required to understand biol. processes and to develop new therapeutics against diseases.  The overall structure-soln. workflow is similar for these techniques, but nuances exist because the properties of the reduced exptl. data are different.  Software tools for structure detn. should therefore be tailored for each method.  Phenix is a comprehensive software package for macromol. structure detn. that handles data from any of these techniques.  Tasks performed with Phenix include data-quality assessment, map improvement, model building, the validation/rebuilding/refinement cycle and deposition.  Each tool caters to the type of exptl. data.  The design of Phenix emphasizes the automation of procedures, where possible, to minimize repetitive and time-consuming manual tasks, while default parameters are chosen to encourage best practice.  A graphical user interface provides access to many command-line features of Phenix and streamlines the transition between programs, project tracking and re-running of previous tasks.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolHnU8ECe2CrVg90H21EOLACvtfcHk0ljQQlVAl69WUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvFWkurrO&md5=e60be65abece48923abf937a4c2640a6</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1107%2FS2059798319011471&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS2059798319011471%26sid%3Dliteratum%253Aachs%26aulast%3DLiebschner%26aufirst%3DD.%26aulast%3DAfonine%26aufirst%3DP.%2BV.%26aulast%3DBaker%26aufirst%3DM.%2BL.%26aulast%3DBunkoczi%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DV.%2BB.%26aulast%3DCroll%26aufirst%3DT.%2BI.%26aulast%3DHintze%26aufirst%3DB.%26aulast%3DHung%26aufirst%3DL.-W.%26aulast%3DJain%26aufirst%3DS.%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DOeffner%26aufirst%3DR.%2BD.%26aulast%3DPoon%26aufirst%3DB.%2BK.%26aulast%3DPrisant%26aufirst%3DM.%2BG.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DRichardson%26aufirst%3DJ.%2BS.%26aulast%3DRichardson%26aufirst%3DD.%2BC.%26aulast%3DSammito%26aufirst%3DM.%2BD.%26aulast%3DSobolev%26aufirst%3DO.%2BV.%26aulast%3DStockwell%26aufirst%3DD.%2BH.%26aulast%3DTerwilliger%26aufirst%3DT.%2BC.%26aulast%3DUrzhumtsev%26aufirst%3DA.%2BG.%26aulast%3DVideau%26aufirst%3DL.%2BL.%26aulast%3DWilliams%26aufirst%3DC.%2BJ.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26atitle%3DMacromolecular%2520structure%2520determination%2520using%2520X-rays%252C%2520neutrons%2520and%2520electrons%253A%2520recent%2520developments%2520in%2520Phenix%26jtitle%3DActa%2520Cryst.%2520D%2520Struct.%2520Biol.%26date%3D2019%26volume%3D75%26spage%3D861%26epage%3D877%26doi%3D10.1107%2FS2059798319011471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':[],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 6 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Guillaume Lapointe, Colin K. Skepper, Lauren M. Holder, Duncan Armstrong, Cornelia Bellamacina, Johanne Blais, Dirksen Bussiere, Jianwei Bian, Cody Cepura, Helen Chan, Charles R. Dean, Gianfranco De Pascale, Bhavesh Dhumale, L. Mark Fisher, Mangesh Fulsunder, Bhavin Kantariya, Julie Kim, Sean King, Lauren Kossy, Upendra Kulkarni, Jay Lakshman, Jennifer A. Leeds, Xiaolan Ling, Anatoli Lvov, Sylvia Ma, Swapnil Malekar, David McKenney, Wosenu Mergo, Louis Metzger, Keshav Mhaske, Heinz E. Moser, Mina Mostafavi, Sunil Namballa, Jonas Noeske, Colin Osborne, Ashish Patel, Darshit Patel, Tushar Patel, Philippe Piechon, Valery Polyakov, Krunal Prajapati, Katherine R. Prosen, Folkert Reck, Daryl L. Richie, Mark R. Sanderson, Shailesh Satasia, Bhautik Savani, Jogitha Selvarajah, Vijay Sethuraman, Wei Shu, Kyuto Tashiro, Katherine V. Thompson, Krishniah Vaarla, Lakhan Vala, Dennis A. Veselkov, Jason Vo, Bhavesh Vora, Trixie Wagner, Laura Wedel, Sarah L. Williams, Satya Yendluri, Qin Yue, Aregahegn Yifru, Yong Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Alexey Rivkin</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and Optimization of DNA Gyrase and Topoisomerase IV Inhibitors with Potent Activity against Fluoroquinolone-Resistant Gram-Positive Bacteria. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (9)
                                     , 6329-6357. <a href="https://doi.org/10.1021/acs.jmedchem.1c00375" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00375</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00375&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00375%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BOptimization%252Bof%252BDNA%252BGyrase%252Band%252BTopoisomerase%252BIV%252BInhibitors%252Bwith%252BPotent%252BActivity%252Bagainst%252BFluoroquinolone-Resistant%252BGram-Positive%252BBacteria%26aulast%3DLapointe%26aufirst%3DGuillaume%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D02032021%26date%3D30042021%26volume%3D64%26issue%3D9%26spage%3D6329%26epage%3D6357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Dingkun Lu, Menghan Qin, Chang Liu, Jingjing Deng, Guoyue Shi, <span class="NLM_string-name hlFld-ContribAuthor">Tianshu Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Ionic Liquid-Functionalized Magnetic Metal–Organic Framework Nanocomposites for Efficient Extraction and Sensitive Detection of Fluoroquinolone Antibiotics in Environmental Water. </span><span class="cited-content_cbyCitation_journal-name">ACS Applied Materials & Interfaces</span><span> <strong>2021,</strong> <em>13 </em>
                                    (4)
                                     , 5357-5367. <a href="https://doi.org/10.1021/acsami.0c17310" title="DOI URL">https://doi.org/10.1021/acsami.0c17310</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsami.0c17310&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsami.0c17310%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Applied%2520Materials%2520%2526%2520Interfaces%26atitle%3DIonic%252BLiquid-Functionalized%252BMagnetic%252BMetal%2525E2%252580%252593Organic%252BFramework%252BNanocomposites%252Bfor%252BEfficient%252BExtraction%252Band%252BSensitive%252BDetection%252Bof%252BFluoroquinolone%252BAntibiotics%252Bin%252BEnvironmental%252BWater%26aulast%3DLu%26aufirst%3DDingkun%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D26092020%26date%3D11012021%26date%3D20012021%26volume%3D13%26issue%3D4%26spage%3D5357%26epage%3D5367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jianye Li, <span class="NLM_string-name hlFld-ContribAuthor">Benjamin R. Clark</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Natural and Unnatural Quinolones Inhibiting the Growth and Motility of Bacteria. </span><span class="cited-content_cbyCitation_journal-name">Journal of Natural Products</span><span> <strong>2020,</strong> <em>83 </em>
                                    (10)
                                     , 3181-3190. <a href="https://doi.org/10.1021/acs.jnatprod.0c00865" title="DOI URL">https://doi.org/10.1021/acs.jnatprod.0c00865</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jnatprod.0c00865&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jnatprod.0c00865%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Natural%2520Products%26atitle%3DSynthesis%252Bof%252BNatural%252Band%252BUnnatural%252BQuinolones%252BInhibiting%252Bthe%252BGrowth%252Band%252BMotility%252Bof%252BBacteria%26aulast%3DLi%26aufirst%3DJianye%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D03082020%26date%3D13102020%26volume%3D83%26issue%3D10%26spage%3D3181%26epage%3D3190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jana  Hirsch</span>, <span class="hlFld-ContribAuthor ">Dagmar  Klostermeier</span>. </span><span class="cited-content_cbyCitation_article-title">What makes a type IIA topoisomerase a gyrase or a Topo IV?. </span><span class="cited-content_cbyCitation_journal-name">Nucleic Acids Research</span><span> <strong>2021,</strong> <em>49 </em>
                                    (11)
                                     , 6027-6042. <a href="https://doi.org/10.1093/nar/gkab270" title="DOI URL">https://doi.org/10.1093/nar/gkab270</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/nar/gkab270&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fnar%2Fgkab270%26sid%3Dliteratum%253Aachs%26jtitle%3DNucleic%2520Acids%2520Research%26atitle%3DWhat%252Bmakes%252Ba%252Btype%252BIIA%252Btopoisomerase%252Ba%252Bgyrase%252Bor%252Ba%252BTopo%252BIV%25253F%26aulast%3DHirsch%26aufirst%3DJana%26date%3D2021%26date%3D2021%26volume%3D49%26issue%3D11%26spage%3D6027%26epage%3D6042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Henni-Karoliina  Ropponen</span>, <span class="hlFld-ContribAuthor ">Robert  Richter</span>, <span class="hlFld-ContribAuthor ">Anna K.H.  Hirsch</span>, <span class="hlFld-ContribAuthor ">Claus-Michael  Lehr</span>. </span><span class="cited-content_cbyCitation_article-title">Mastering the Gram-negative bacterial barrier – Chemical approaches to increase bacterial bioavailability of antibiotics. </span><span class="cited-content_cbyCitation_journal-name">Advanced Drug Delivery Reviews</span><span> <strong>2021,</strong> <em>172 </em>, 339-360. <a href="https://doi.org/10.1016/j.addr.2021.02.014" title="DOI URL">https://doi.org/10.1016/j.addr.2021.02.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.addr.2021.02.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.addr.2021.02.014%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Drug%2520Delivery%2520Reviews%26atitle%3DMastering%252Bthe%252BGram-negative%252Bbacterial%252Bbarrier%252B%2525E2%252580%252593%252BChemical%252Bapproaches%252Bto%252Bincrease%252Bbacterial%252Bbioavailability%252Bof%252Bantibiotics%26aulast%3DRopponen%26aufirst%3DHenni-Karoliina%26date%3D2021%26volume%3D172%26spage%3D339%26epage%3D360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 4-(Aminomethyl)quinolin-2(1H)-ones. </span><span class="cited-content_cbyCitation_journal-name">Synfacts</span><span> <strong>2020,</strong>,, 1135. <a href="https://doi.org/10.1055/s-0040-1705898" title="DOI URL">https://doi.org/10.1055/s-0040-1705898</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1055/s-0040-1705898&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1055%2Fs-0040-1705898%26sid%3Dliteratum%253Aachs%26jtitle%3DSynfacts%26atitle%3DSynthesis%252Bof%252B4-%252528Aminomethyl%252529quinolin-2%2525281H%252529-ones%26date%3D2020%26date%3D2020%26volume%3D16%26issue%3D10%26spage%3D1135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0136.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0136.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00347&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of the fluoroquinolone antibiotic ciprofloxacin, quinazolinedione PD 0305970 (Pfizer), Novartis phenotypic hit <b>3</b>, and initial lead compounds <b>4</b> and <b>5</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00347&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Binding site view of the topoisomerase IV cleavage complex from <i>K. pneumoniae</i> with compound <b>34</b> bound (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6WAA">6WAA</a>). DNA nucleotides of the cleavage site are shown in gray. ParC and ParE residues of one ParE-ParC fusion protein are shown in green and cyan, respectively. ParC residues from the second ParE-ParC fusion protein, which provide the catalytic tyrosine, are shown in magenta. Residues further out from the binding site were omitted for clarity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00347&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Key Intermediate toward C4-Substituted Analogs</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00347&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Direct Functionalization of C4-OH</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00347&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Generation of C4-Carbon-Based Analogs via Triflate Functionalization</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00347&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Divergent Synthesis of C7 Analogs</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00347&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Adapted Synthetic Routes toward C8 Analogs</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00347&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of C3-Cl and Me Analogs</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00347&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of C3-OH and C3-F Analogs <b>32</b> and <b>34</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00347&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0015.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00347&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht2" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Chart 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0028.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0028.jpeg" id="rightTab-gr25" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00347&amp;id=cht2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht3" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Chart 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0033.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0033.jpeg" id="rightTab-gr30" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0033.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00347&amp;id=cht3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht4" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Chart 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0046.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0046.jpeg" id="rightTab-gr43" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0046.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00347&amp;id=cht4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht5" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Chart 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0059.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0059.jpeg" id="rightTab-gr56" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0059.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00347&amp;id=cht5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht6" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Chart 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0068.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0068.jpeg" id="rightTab-gr65" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0068.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00347&amp;id=cht6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht7" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Chart 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0074.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0074.jpeg" id="rightTab-gr71" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0074.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00347&amp;id=cht7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht8" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Chart 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0083.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0083.jpeg" id="rightTab-gr80" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0083.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00347&amp;id=cht8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht9" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Chart 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0091.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0091.jpeg" id="rightTab-gr88" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0091.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00347&amp;id=cht9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht10" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Chart 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0099.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0099.jpeg" id="rightTab-gr96" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0099.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00347&amp;id=cht10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht11" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Chart 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0107.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0107.jpeg" id="rightTab-gr105" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0107.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00347&amp;id=cht11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht12" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Chart 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/medium/jm0c00347_0125.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0125.jpeg" id="rightTab-gr123" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00347/20200716/images/large/jm0c00347_0125.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00347&amp;id=cht12"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i190">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73467" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73467" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 108 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bisacchi, G. S.</span></span> <span> </span><span class="NLM_article-title">Origins of the quinolone class of antibacterials: an expanded “discovery story”</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">4874</span>– <span class="NLM_lpage">4882</span>, <span class="refDoi"> DOI: 10.1021/jm501881c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501881c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjslOlt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=4874-4882&author=G.+S.+Bisacchi&title=Origins+of+the+quinolone+class+of+antibacterials%3A+an+expanded+%E2%80%9Cdiscovery+story%E2%80%9D&doi=10.1021%2Fjm501881c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Origins of the Quinolone Class of Antibacterials: An Expanded "Discovery Story"</span></div><div class="casAuthors">Bisacchi, Gregory S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4874-4882</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Published descriptions of the specific lines of research leading to the discovery of therapeutically important medicines, esp. major new class medicines, have long provided value to the biopharmaceutical community as models of success, often influencing the strategies and methods of subsequent drug research.  Quinolone antibacterials represent one of medicine's most important classes of anti-infective agents; yet in contrast to many other classes of anti-infectives, astonishingly few details concerning the origin of the class or the rationale leading to the selection of the first clin. agent, nalidixic acid, were ever published by the discoverers.  Moreover, earlier disclosures of an independent discovery of the quinolone class of antibacterials have been almost entirely overlooked by the scientific literature.  This review brings together all the available information from primary literature sources relating to both discoveries and provides for the first time a much fuller, if still partially speculative, story of the earliest years of this important class of drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRfBwGtmGfYLVg90H21EOLACvtfcHk0liwZUZ6_1cs5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjslOlt7w%253D&md5=080b765f4cce8d28967de2d3dcdbab0f</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Fjm501881c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501881c%26sid%3Dliteratum%253Aachs%26aulast%3DBisacchi%26aufirst%3DG.%2BS.%26atitle%3DOrigins%2520of%2520the%2520quinolone%2520class%2520of%2520antibacterials%253A%2520an%2520expanded%2520%25E2%2580%259Cdiscovery%2520story%25E2%2580%259D%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D4874%26epage%3D4882%26doi%3D10.1021%2Fjm501881c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Da
Silva, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Almeida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Souza, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Couri, M.</span></span> <span> </span><span class="NLM_article-title">Biological activity and synthetic methodologies for the preparation of fluoroquinolones, a class of potent antibacterial agents</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">21</span>– <span class="NLM_lpage">39</span>, <span class="refDoi"> DOI: 10.2174/0929867033368637</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.2174%2F0929867033368637" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=12570719" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BD3sXisVSrtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2003&pages=21-39&author=A.+Da%0ASilvaauthor=M.+De+Almeidaauthor=M.+De+Souzaauthor=M.+Couri&title=Biological+activity+and+synthetic+methodologies+for+the+preparation+of+fluoroquinolones%2C+a+class+of+potent+antibacterial+agents&doi=10.2174%2F0929867033368637"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Biological activity and synthetic methodologies for the preparation of fluoroquinolones, a class of potent antibacterial agents</span></div><div class="casAuthors">Da Silva, Adilson D.; De Almeida, Mauro V.; De Souza, Marcus V. N.; Couri, Mara R. C.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">21-39</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers</span>)
        </div><div class="casAbstract">A review.  We report different synthetic methodologies for the prepn. of fluoroquinolones and their biol. properties.  The appearance of the fluoroquinolones, a new class of antibacterial agents (based on nalidixic acid, 4-quinolone-3-carboxylates), in early 1980s, gave a new impulse for the international competition to synthesize more effective drugs.  Fluoroquinolones have a broad spectrum of activity against Gram-pos., Gram-neg. and mycobacterial organisms as well as anaerobes.  The fluoroquinolone ciprofloxacin HCl is an important bioterrorist weapon and also an antibiotic used to treat bacterial infection in many different parts of the body, approved for use in patients who have been exposed to the inhaled form of anthrax.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoU6ea4ovoJJLVg90H21EOLACvtfcHk0lj_Yf5anELy-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXisVSrtg%253D%253D&md5=7e8364559400f76239f6c7eb7c1a9526</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.2174%2F0929867033368637&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867033368637%26sid%3Dliteratum%253Aachs%26aulast%3DDa%2BSilva%26aufirst%3DA.%26aulast%3DDe%2BAlmeida%26aufirst%3DM.%26aulast%3DDe%2BSouza%26aufirst%3DM.%26aulast%3DCouri%26aufirst%3DM.%26atitle%3DBiological%2520activity%2520and%2520synthetic%2520methodologies%2520for%2520the%2520preparation%2520of%2520fluoroquinolones%252C%2520a%2520class%2520of%2520potent%2520antibacterial%2520agents%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2003%26volume%3D10%26spage%3D21%26epage%3D39%26doi%3D10.2174%2F0929867033368637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emmerson, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, A. M.</span></span> <span> </span><span class="NLM_article-title">The quinolones: decades of development and use</span>. <i>J. Antimicrob. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>51</i></span> (<span class="NLM_issue">Suppl. 1</span>),  <span class="NLM_fpage">13</span>– <span class="NLM_lpage">20</span>, <span class="refDoi"> DOI: 10.1093/jac/dkg208</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1093%2Fjac%2Fdkg208" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=12702699" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BD3sXktlOqu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2003&pages=13-20&issue=Suppl.+1&author=A.+M.+Emmersonauthor=A.+M.+Jones&title=The+quinolones%3A+decades+of+development+and+use&doi=10.1093%2Fjac%2Fdkg208"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The quinolones: Decades of development and use</span></div><div class="casAuthors">Emmerson, A. M.; Jones, A. M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">Suppl. S1</span>),
    <span class="NLM_cas:pages">13-20</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  The discovery of nalidixic acid in 1962, and its introduction for clin. use in 1967, marks the beginning of five decades of quinolone development and use.  It was not until the discovery and licensing of the fluoroquinolones in the 1970s and 1980s that these drugs began to establish their place in the armamentarium of clin. useful antimicrobials.  At the beginning of the 21st century, in their fifth decade of discovery and use, our understanding of structure-function relationships has improved, and better compds., in terms of both spectrum of antimicrobial cover and pharmacokinetics, have been developed.  The clin. utility of this expanding class of anti-microbial agents, and the lower propensity for the development of resistance with the "newer" fluoroquinolones will need to be continually monitored in the changing therapeutic environment.  Antibiotic drug choice will remain difficult in the presence of increasing resistance, but the introduction of the new fluoroquinolones has created a new and exciting era in antimicrobial treatment.  The role of these agents has already been acknowledged in a no. of clin. guidelines, and appropriate use of these agents may help to preserve their clin. utility, enabling them to realize their full therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0RRLOgvTYNLVg90H21EOLACvtfcHk0lj_Yf5anELy-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXktlOqu74%253D&md5=04ad837d0f1be12fa7e9944cc9502301</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkg208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkg208%26sid%3Dliteratum%253Aachs%26aulast%3DEmmerson%26aufirst%3DA.%2BM.%26aulast%3DJones%26aufirst%3DA.%2BM.%26atitle%3DThe%2520quinolones%253A%2520decades%2520of%2520development%2520and%2520use%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2003%26volume%3D51%26issue%3DSuppl.%25201%26spage%3D13%26epage%3D20%26doi%3D10.1093%2Fjac%2Fdkg208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mitscher, L. A.</span></span> <span> </span><span class="NLM_article-title">Bacterial topoisomerase inhibitors: quinolone and pyridone antibacterial agents</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">559</span>– <span class="NLM_lpage">592</span>, <span class="refDoi"> DOI: 10.1021/cr030101q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr030101q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmsValuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2005&pages=559-592&author=L.+A.+Mitscher&title=Bacterial+topoisomerase+inhibitors%3A+quinolone+and+pyridone+antibacterial+agents&doi=10.1021%2Fcr030101q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Bacterial Topoisomerase Inhibitors: Quinolone and Pyridone Antibacterial Agents</span></div><div class="casAuthors">Mitscher, Lester A.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">559-592</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review of synthesis, structure activity relationships, toxicity, mechanism of action, modes of resistance, clin. indications and pharmacokinetics of bacterial topoisomerase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcTa9lSZGTm7Vg90H21EOLACvtfcHk0li6nzh2aAur8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmsValuw%253D%253D&md5=d2545ce13157e6e5600cf13ea7866025</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Fcr030101q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr030101q%26sid%3Dliteratum%253Aachs%26aulast%3DMitscher%26aufirst%3DL.%2BA.%26atitle%3DBacterial%2520topoisomerase%2520inhibitors%253A%2520quinolone%2520and%2520pyridone%2520antibacterial%2520agents%26jtitle%3DChem.%2520Rev.%26date%3D2005%26volume%3D105%26spage%3D559%26epage%3D592%26doi%3D10.1021%2Fcr030101q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Andriole, V. T.</span></span> <span> </span><span class="NLM_article-title">The quinolones: past, present, and future</span>. <i>Clin. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>41</i></span> (<span class="NLM_issue">Suppl. 2</span>),  <span class="NLM_fpage">S113</span>– <span class="NLM_lpage">S119</span>, <span class="refDoi"> DOI: 10.1086/428051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1086%2F428051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=15942877" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmvVylsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2005&pages=S113-S119&issue=Suppl.+2&author=V.+T.+Andriole&title=The+quinolones%3A+past%2C+present%2C+and+future&doi=10.1086%2F428051"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The quinolones: Past, present, and future</span></div><div class="casAuthors">Andriole, Vincent T.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Infectious Diseases</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">Suppl. 2</span>),
    <span class="NLM_cas:pages">S113-S119</span>CODEN:
                <span class="NLM_cas:coden">CIDIEL</span>;
        ISSN:<span class="NLM_cas:issn">1058-4838</span>.
    
            (<span class="NLM_cas:orgname">University of Chicago Press</span>)
        </div><div class="casAbstract">A review.  The quinolone class of antimicrobial agents has generated considerable interest since its discovery >40 years ago.  Substantial progress has been made in our understanding of the mol. mechanisms of the action of quinolones against pathogenic bacteria, the induction of resistance to quinolones in these organisms, and the potential of each quinolone compd. to induce toxicity in treated patients.  Here, these key discoveries are reviewed; the present indications approved by regulatory agencies are described in detail, with comments on adverse events caused by quinolones in treated patients; and speculation about the future of the quinolones is proffered, even though their future is difficult to predict, because many factors may affect their clin. usefulness.  However, the emergence of bacterial resistance to the quinolones is a major factor that will det. the future clin. effectiveness of these agents, so that intense investigation of mechanisms to either prevent or curtail resistance to quinolones is of prime importance to their future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfPETsYPc-FbVg90H21EOLACvtfcHk0li6nzh2aAur8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmvVylsLg%253D&md5=f56dda06e86c1ff0f041a2be2f86cdcc</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1086%2F428051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F428051%26sid%3Dliteratum%253Aachs%26aulast%3DAndriole%26aufirst%3DV.%2BT.%26atitle%3DThe%2520quinolones%253A%2520past%252C%2520present%252C%2520and%2520future%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2005%26volume%3D41%26issue%3DSuppl.%25202%26spage%3DS113%26epage%3DS119%26doi%3D10.1086%2F428051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wagman, A. S.</span>; <span class="NLM_string-name">Wentland, M. P.</span></span> <span> </span><span class="NLM_article-title">Quinolone antibacterial agents</span>. In  <i>Comprehensive Medicinal Chemistry II</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, J. B.</span>, <span class="NLM_string-name">Triggle, D. J.</span></span>, Eds.; <span class="NLM_publisher-name">Elsevier</span>: <span class="NLM_publisher-loc">Oxford, U.K.</span>, <span class="NLM_year">2007</span>; pp  <span class="NLM_fpage">567</span>– <span class="NLM_lpage">596</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1016%2FB0-08-045044-X%2F00220-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=567-596&author=A.+S.+Wagman&author=M.+P.+Wentlandauthor=J.+B.+Taylor&author=D.+J.+Triggle&title=Comprehensive+Medicinal+Chemistry+II"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FB0-08-045044-X%2F00220-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB0-08-045044-X%252F00220-0%26sid%3Dliteratum%253Aachs%26aulast%3DWagman%26aufirst%3DA.%2BS.%26atitle%3DQuinolone%2520antibacterial%2520agents%26btitle%3DComprehensive%2520Medicinal%2520Chemistry%2520II%26aulast%3DTaylor%26aufirst%3DJ.%2BB.%26pub%3DElsevier%26date%3D2007%26spage%3D567%26epage%3D596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jacoby, G. A.</span>; <span class="NLM_string-name">Hooper, D. C.</span></span> <span> </span><span class="NLM_article-title">Review of the quinolone family</span>. In  <i>Antibiotic Discovery and Development</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dougherty, T. J.</span>, <span class="NLM_string-name">Pucci, M. J.</span></span>, Eds.; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Boston, MA</span>, <span class="NLM_year">2012</span>; pp  <span class="NLM_fpage">119</span>– <span class="NLM_lpage">146</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1007%2F978-1-4614-1400-1_4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&pages=119-146&author=G.+A.+Jacoby&author=D.+C.+Hooperauthor=T.+J.+Dougherty&author=M.+J.+Pucci&title=Antibiotic+Discovery+and+Development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1007%2F978-1-4614-1400-1_4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-4614-1400-1_4%26sid%3Dliteratum%253Aachs%26aulast%3DJacoby%26aufirst%3DG.%2BA.%26atitle%3DReview%2520of%2520the%2520quinolone%2520family%26btitle%3DAntibiotic%2520Discovery%2520and%2520Development%26aulast%3DDougherty%26aufirst%3DT.%2BJ.%26pub%3DSpringer%26date%3D2012%26spage%3D119%26epage%3D146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Naeem, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badshah, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muska, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, K.</span></span> <span> </span><span class="NLM_article-title">The current case of quinolones: synthetic approaches and antibacterial activity</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">268</span>, <span class="refDoi"> DOI: 10.3390/molecules21040268</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.3390%2Fmolecules21040268" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=27043501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A280%3ADC%252BC28fmvV2ktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=268&author=A.+Naeemauthor=S.+L.+Badshahauthor=M.+Muskaauthor=N.+Ahmadauthor=K.+Khan&title=The+current+case+of+quinolones%3A+synthetic+approaches+and+antibacterial+activity&doi=10.3390%2Fmolecules21040268"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The Current Case of Quinolones: Synthetic Approaches and Antibacterial Activity</span></div><div class="casAuthors">Naeem Abdul; Badshah Syed Lal; Muska Mairman; Badshah Syed Lal; Ahmad Nasir; Khan Khalid</div><div class="citationInfo"><span class="NLM_cas:title">Molecules (Basel, Switzerland)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">268</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Quinolones are broad-spectrum synthetic antibacterial drugs first obtained during the synthesis of chloroquine.  Nalidixic acid, the prototype of quinolones, first became available for clinical consumption in 1962 and was used mainly for urinary tract infections caused by Escherichia coli and other pathogenic Gram-negative bacteria.  Recently, significant work has been carried out to synthesize novel quinolone analogues with enhanced activity and potential usage for the treatment of different bacterial diseases.  These novel analogues are made by substitution at different sites--the variation at the C-6 and C-8 positions gives more effective drugs.  Substitution of a fluorine atom at the C-6 position produces fluroquinolones, which account for a large proportion of the quinolones in clinical use.  Among others, substitution of piperazine or methylpiperazine, pyrrolidinyl and piperidinyl rings also yields effective analogues.  A total of twenty six analogues are reported in this review.  The targets of quinolones are two bacterial enzymes of the class II topoisomerase family, namely gyrase and topoisomerase IV.  Quinolones increase the concentration of drug-enzyme-DNA cleavage complexes and convert them into cellular toxins; as a result they are bactericidal.  High bioavailability, relative low toxicity and favorable pharmacokinetics have resulted in the clinical success of fluoroquinolones and quinolones.  Due to these superior properties, quinolones have been extensively utilized and this increased usage has resulted in some quinolone-resistant bacterial strains.  Bacteria become resistant to quinolones by three mechanisms: (1) mutation in the target site (gyrase and/or topoisomerase IV) of quinolones; (2) plasmid-mediated resistance; and (3) chromosome-mediated quinolone resistance.  In plasmid-mediated resistance, the efflux of quinolones is increased along with a decrease in the interaction of the drug with gyrase (topoisomerase IV).  In the case of chromosome-mediated quinolone resistance, there is a decrease in the influx of the drug into the cell.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS8xPmZ_CaUiIqdXsLcGTEUfW6udTcc2eYeqFpRw4kYj7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28fmvV2ktg%253D%253D&md5=c36d558a9ff78e34c09ff7d725abdd5b</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.3390%2Fmolecules21040268&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules21040268%26sid%3Dliteratum%253Aachs%26aulast%3DNaeem%26aufirst%3DA.%26aulast%3DBadshah%26aufirst%3DS.%2BL.%26aulast%3DMuska%26aufirst%3DM.%26aulast%3DAhmad%26aufirst%3DN.%26aulast%3DKhan%26aufirst%3DK.%26atitle%3DThe%2520current%2520case%2520of%2520quinolones%253A%2520synthetic%2520approaches%2520and%2520antibacterial%2520activity%26jtitle%3DMolecules%26date%3D2016%26volume%3D21%26spage%3D268%26doi%3D10.3390%2Fmolecules21040268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Drlica, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerns, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X.</span></span> <span> </span><span class="NLM_article-title">Quinolone-mediated bacterial death</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">385</span>– <span class="NLM_lpage">392</span>, <span class="refDoi"> DOI: 10.1128/AAC.01617-06</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1128%2FAAC.01617-06" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=17724149" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlSqtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=385-392&author=K.+Drlicaauthor=M.+Malikauthor=R.+J.+Kernsauthor=X.+Zhao&title=Quinolone-mediated+bacterial+death&doi=10.1128%2FAAC.01617-06"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Quinolone-mediated bacterial death</span></div><div class="casAuthors">Drlica, Karl; Malik, Muhammad; Kerns, Robert J.; Zhao, Xilin</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">385-392</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A review.  In the present review we consider cell death through a two-part "poison" hypothesis in which quinolones form reversible drug-topoisomerase-DNA complexes that subsequently lead to several types of irreversible (lethal) damage.  Topics discussed include: quinolone-topoisomerase-DNA complexes; inhibition of DNA replication; SOS response and cell filamentation; toxin-antitoxin modules and programmed cell death; chromosome fragmentation; and destabilization of cleaved complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowBOqyJ-TV4bVg90H21EOLACvtfcHk0lhpu-m-DQ3PQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlSqtLc%253D&md5=eef420d64b9f28336fb0cc5f6c42a803</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1128%2FAAC.01617-06&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01617-06%26sid%3Dliteratum%253Aachs%26aulast%3DDrlica%26aufirst%3DK.%26aulast%3DMalik%26aufirst%3DM.%26aulast%3DKerns%26aufirst%3DR.%2BJ.%26aulast%3DZhao%26aufirst%3DX.%26atitle%3DQuinolone-mediated%2520bacterial%2520death%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D385%26epage%3D392%26doi%3D10.1128%2FAAC.01617-06" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Drlica, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiasa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerns, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mustaev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X.</span></span> <span> </span><span class="NLM_article-title">Quinolones: action and resistance updated</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">981</span>– <span class="NLM_lpage">998</span>, <span class="refDoi"> DOI: 10.2174/156802609789630947</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.2174%2F156802609789630947" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=19747119" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFWisb%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=981-998&author=K.+Drlicaauthor=H.+Hiasaauthor=R.+Kernsauthor=M.+Malikauthor=A.+Mustaevauthor=X.+Zhao&title=Quinolones%3A+action+and+resistance+updated&doi=10.2174%2F156802609789630947"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Quinolones: action and resistance updated</span></div><div class="casAuthors">Drlica, Karl; Hiasa, Hiroshi; Kerns, Robert; Malik, Muhammad; Mustaev, Arkady; Zhao, Xilin</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">981-998</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The quinolones trap DNA gyrase and DNA topoisomerase IV on DNA as complexes in which the DNA is broken but constrained by protein.  Early studies suggested that drug binding occurs largely along helix-4 of the GyrA (gyrase) and ParC (topoisomerase IV) proteins.  However, recent X-ray crystallog. shows drug intercalating between the -1 and +1 nucleotides of cut DNA, with only one end of the drug extending to helix-4.  These two models may reflect distinct structural steps in complex formation.  A consequence of drug-enzyme-DNA complex formation is reversible inhibition of DNA replication; cell death arises from subsequent events in which bacterial chromosomes are fragmented through two poorly understood pathways.  In one pathway, chromosome fragmentation stimulates excessive accumulation of highly toxic reactive oxygen species that are responsible for cell death.  Quinolone resistance arises stepwise through selective amplification of mutants when drug concns. are above the MIC and below the MPC, as obsd. with static agar plate assays, dynamic in vitro systems, and exptl. infection of rabbits.  The gap between MIC and MPC can be narrowed by compd. design that should restrict the emergence of resistance.  Resistance is likely to become increasingly important, since three types of plasmid-borne resistance have been reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwqmNnQ2e72rVg90H21EOLACvtfcHk0lhh5xCToYkE4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFWisb%252FF&md5=e8f8b87460d826d75acd11efceb1a7f4</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2174%2F156802609789630947&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802609789630947%26sid%3Dliteratum%253Aachs%26aulast%3DDrlica%26aufirst%3DK.%26aulast%3DHiasa%26aufirst%3DH.%26aulast%3DKerns%26aufirst%3DR.%26aulast%3DMalik%26aufirst%3DM.%26aulast%3DMustaev%26aufirst%3DA.%26aulast%3DZhao%26aufirst%3DX.%26atitle%3DQuinolones%253A%2520action%2520and%2520resistance%2520updated%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2009%26volume%3D9%26spage%3D981%26epage%3D998%26doi%3D10.2174%2F156802609789630947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laponogov, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sohi, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veselkov, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, X.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawhney, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McAuley, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanderson, M. R.</span></span> <span> </span><span class="NLM_article-title">Structural insight into the quinolone–DNA cleavage complex of type IIA topoisomerases</span>. <i>Nat. Struct. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">667</span>, <span class="refDoi"> DOI: 10.1038/nsmb.1604</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1038%2Fnsmb.1604" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=19448616" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtVOqsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=667&author=I.+Laponogovauthor=M.+K.+Sohiauthor=D.+A.+Veselkovauthor=X.-S.+Panauthor=R.+Sawhneyauthor=A.+W.+Thompsonauthor=K.+E.+McAuleyauthor=L.+M.+Fisherauthor=M.+R.+Sanderson&title=Structural+insight+into+the+quinolone%E2%80%93DNA+cleavage+complex+of+type+IIA+topoisomerases&doi=10.1038%2Fnsmb.1604"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Structural insight into the quinolone-DNA cleavage complex of type IIA topoisomerases</span></div><div class="casAuthors">Laponogov, Ivan; Sohi, Maninder K.; Veselkov, Dennis A.; Pan, Xiao-Su; Sawhney, Ritica; Thompson, Andrew W.; McAuley, Katherine E.; Fisher, L. Mark; Sanderson, Mark R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">667-669</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Type II topoisomerases alter DNA topol. by forming a covalent DNA-cleavage complex that allows DNA transport through a double-stranded DNA break.  We present the structures of cleavage complexes formed by the Streptococcus pneumoniae ParC breakage-reunion and ParE TOPRIM domains of topoisomerase IV stabilized by moxifloxacin and clinafloxacin, two antipneumococcal fluoroquinolones.  These structures reveal two drug mols. intercalated at the highly bent DNA gate and help explain antibacterial quinolone action and resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDXhjTPq1GlrVg90H21EOLACvtfcHk0lhh5xCToYkE4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtVOqsrc%253D&md5=cd4c757dbb5d50c8113e658837d44a34</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.1604&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.1604%26sid%3Dliteratum%253Aachs%26aulast%3DLaponogov%26aufirst%3DI.%26aulast%3DSohi%26aufirst%3DM.%2BK.%26aulast%3DVeselkov%26aufirst%3DD.%2BA.%26aulast%3DPan%26aufirst%3DX.-S.%26aulast%3DSawhney%26aufirst%3DR.%26aulast%3DThompson%26aufirst%3DA.%2BW.%26aulast%3DMcAuley%26aufirst%3DK.%2BE.%26aulast%3DFisher%26aufirst%3DL.%2BM.%26aulast%3DSanderson%26aufirst%3DM.%2BR.%26atitle%3DStructural%2520insight%2520into%2520the%2520quinolone%25E2%2580%2593DNA%2520cleavage%2520complex%2520of%2520type%2520IIA%2520topoisomerases%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2009%26volume%3D16%26spage%3D667%26doi%3D10.1038%2Fnsmb.1604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laponogov, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, X.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veselkov, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McAuley, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanderson, M. R.</span></span> <span> </span><span class="NLM_article-title">Structural basis of gate-DNA breakage and resealing by type II topoisomerases</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>5</i></span>, <span class="NLM_elocation-id">e11338</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0011338</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1371%2Fjournal.pone.0011338" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=20596531" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A280%3ADC%252BC3cnksVagsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&author=I.+Laponogovauthor=X.-S.+Panauthor=D.+A.+Veselkovauthor=K.+E.+McAuleyauthor=L.+M.+Fisherauthor=M.+R.+Sanderson&title=Structural+basis+of+gate-DNA+breakage+and+resealing+by+type+II+topoisomerases&doi=10.1371%2Fjournal.pone.0011338"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of gate-DNA breakage and resealing by type II topoisomerases</span></div><div class="casAuthors">Laponogov Ivan; Pan Xiao-Su; Veselkov Dennis A; McAuley Katherine E; Fisher L Mark; Sanderson Mark R</div><div class="citationInfo"><span class="NLM_cas:title">PloS one</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e11338</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Type II DNA topoisomerases are ubiquitous enzymes with essential functions in DNA replication, recombination and transcription.  They change DNA topology by forming a transient covalent cleavage complex with a gate-DNA duplex that allows transport of a second duplex though the gate.  Despite its biological importance and targeting by anticancer and antibacterial drugs, cleavage complex formation and reversal is not understood for any type II enzyme.  To address the mechanism, we have used X-ray crystallography to study sequential states in the formation and reversal of a DNA cleavage complex by topoisomerase IV from Streptococcus pneumoniae, the bacterial type II enzyme involved in chromosome segregation.  A high resolution structure of the complex captured by a novel antibacterial dione reveals two drug molecules intercalated at a cleaved B-form DNA gate and anchored by drug-specific protein contacts.  Dione release generated drug-free cleaved and resealed DNA complexes in which the DNA gate instead adopts an unusual A/B-form helical conformation with a Mg(2+) ion repositioned to coordinate each scissile phosphodiester group and promote reversible cleavage by active-site tyrosines.  These structures, the first for putative reaction intermediates of a type II topoisomerase, suggest how a type II enzyme reseals DNA during its normal reaction cycle and illuminate aspects of drug arrest important for the development of new topoisomerase-targeting therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcShiG7Hb50Ehd0Q2ypr7jHkfW6udTcc2eZqwCCrOND7L7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cnksVagsA%253D%253D&md5=fcddd6c8ad69c0bc09137d484aad638d</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0011338&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0011338%26sid%3Dliteratum%253Aachs%26aulast%3DLaponogov%26aufirst%3DI.%26aulast%3DPan%26aufirst%3DX.-S.%26aulast%3DVeselkov%26aufirst%3DD.%2BA.%26aulast%3DMcAuley%26aufirst%3DK.%2BE.%26aulast%3DFisher%26aufirst%3DL.%2BM.%26aulast%3DSanderson%26aufirst%3DM.%2BR.%26atitle%3DStructural%2520basis%2520of%2520gate-DNA%2520breakage%2520and%2520resealing%2520by%2520type%2520II%2520topoisomerases%26jtitle%3DPLoS%2520One%26date%3D2010%26volume%3D5%26doi%3D10.1371%2Fjournal.pone.0011338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bax, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eggleston, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fosberry, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gentry, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorrec, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giordano, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hann, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hennessy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hibbs, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">May, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saunders, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spitzfaden, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shillings, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Theobald, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wohlkonig, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearson, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gwynn, M. N.</span></span> <span> </span><span class="NLM_article-title">Type IIA topoisomerase inhibition by a new class of antibacterial agents</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>466</i></span>,  <span class="NLM_fpage">935</span>, <span class="refDoi"> DOI: 10.1038/nature09197</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1038%2Fnature09197" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=20686482" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A280%3ADC%252BC3cjmtFaktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=466&publication_year=2010&pages=935&author=B.+D.+Baxauthor=P.+F.+Chanauthor=D.+S.+Egglestonauthor=A.+Fosberryauthor=D.+R.+Gentryauthor=F.+Gorrecauthor=I.+Giordanoauthor=M.+M.+Hannauthor=A.+Hennessyauthor=M.+Hibbsauthor=J.+Huangauthor=E.+Jonesauthor=J.+Jonesauthor=K.+K.+Brownauthor=C.+J.+Lewisauthor=E.+W.+Mayauthor=M.+R.+Saundersauthor=O.+Singhauthor=C.+E.+Spitzfadenauthor=C.+Shenauthor=A.+Shillingsauthor=A.+J.+Theobaldauthor=A.+Wohlkonigauthor=N.+D.+Pearsonauthor=M.+N.+Gwynn&title=Type+IIA+topoisomerase+inhibition+by+a+new+class+of+antibacterial+agents&doi=10.1038%2Fnature09197"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Type IIA topoisomerase inhibition by a new class of antibacterial agents</span></div><div class="casAuthors">Bax Benjamin D; Chan Pan F; Eggleston Drake S; Fosberry Andrew; Gentry Daniel R; Gorrec Fabrice; Giordano Ilaria; Hann Michael M; Hennessy Alan; Hibbs Martin; Huang Jianzhong; Jones Emma; Jones Jo; Brown Kristin Koretke; Lewis Ceri J; May Earl W; Saunders Martin R; Singh Onkar; Spitzfaden Claus E; Shen Carol; Shillings Anthony; Theobald Andrew J; Wohlkonig Alexandre; Pearson Neil D; Gwynn Michael N</div><div class="citationInfo"><span class="NLM_cas:title">Nature</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">466</span>
        (<span class="NLM_cas:issue">7309</span>),
    <span class="NLM_cas:pages">935-40</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Despite the success of genomics in identifying new essential bacterial genes, there is a lack of sustainable leads in antibacterial drug discovery to address increasing multidrug resistance.  Type IIA topoisomerases cleave and religate DNA to regulate DNA topology and are a major class of antibacterial and anticancer drug targets, yet there is no well developed structural basis for understanding drug action.  Here we report the 2.1 A crystal structure of a potent, new class, broad-spectrum antibacterial agent in complex with Staphylococcus aureus DNA gyrase and DNA, showing a new mode of inhibition that circumvents fluoroquinolone resistance in this clinically important drug target.  The inhibitor 'bridges' the DNA and a transient non-catalytic pocket on the two-fold axis at the GyrA dimer interface, and is close to the active sites and fluoroquinolone binding sites.  In the inhibitor complex the active site seems poised to cleave the DNA, with a single metal ion observed between the TOPRIM (topoisomerase/primase) domain and the scissile phosphate.  This work provides new insights into the mechanism of topoisomerase action and a platform for structure-based drug design of a new class of antibacterial agents against a clinically proven, but conformationally flexible, enzyme class.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTzBPk2FYUX-kBuFdjgVNKSfW6udTcc2eZqwCCrOND7L7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cjmtFaktA%253D%253D&md5=006fef200c7a44f0671829b2a5fbddef</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnature09197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09197%26sid%3Dliteratum%253Aachs%26aulast%3DBax%26aufirst%3DB.%2BD.%26aulast%3DChan%26aufirst%3DP.%2BF.%26aulast%3DEggleston%26aufirst%3DD.%2BS.%26aulast%3DFosberry%26aufirst%3DA.%26aulast%3DGentry%26aufirst%3DD.%2BR.%26aulast%3DGorrec%26aufirst%3DF.%26aulast%3DGiordano%26aufirst%3DI.%26aulast%3DHann%26aufirst%3DM.%2BM.%26aulast%3DHennessy%26aufirst%3DA.%26aulast%3DHibbs%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DJones%26aufirst%3DE.%26aulast%3DJones%26aufirst%3DJ.%26aulast%3DBrown%26aufirst%3DK.%2BK.%26aulast%3DLewis%26aufirst%3DC.%2BJ.%26aulast%3DMay%26aufirst%3DE.%2BW.%26aulast%3DSaunders%26aufirst%3DM.%2BR.%26aulast%3DSingh%26aufirst%3DO.%26aulast%3DSpitzfaden%26aufirst%3DC.%2BE.%26aulast%3DShen%26aufirst%3DC.%26aulast%3DShillings%26aufirst%3DA.%26aulast%3DTheobald%26aufirst%3DA.%2BJ.%26aulast%3DWohlkonig%26aufirst%3DA.%26aulast%3DPearson%26aufirst%3DN.%2BD.%26aulast%3DGwynn%26aufirst%3DM.%2BN.%26atitle%3DType%2520IIA%2520topoisomerase%2520inhibition%2520by%2520a%2520new%2520class%2520of%2520antibacterial%2520agents%26jtitle%3DNature%26date%3D2010%26volume%3D466%26spage%3D935%26doi%3D10.1038%2Fnature09197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wohlkonig, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fosberry, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Homes, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kranz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leydon, V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miles, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearson, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perera, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shillings, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gwynn, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bax, B. D.</span></span> <span> </span><span class="NLM_article-title">Structural basis of quinolone inhibition of type IIA topoisomerases and target-mediated resistance</span>. <i>Nat. Struct. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1152</span>, <span class="refDoi"> DOI: 10.1038/nsmb.1892</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1038%2Fnsmb.1892" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=20802486" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVyiu7zM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=1152&author=A.+Wohlkonigauthor=P.+F.+Chanauthor=A.+P.+Fosberryauthor=P.+Homesauthor=J.+Huangauthor=M.+Kranzauthor=V.+R.+Leydonauthor=T.+J.+Milesauthor=N.+D.+Pearsonauthor=R.+L.+Pereraauthor=A.+J.+Shillingsauthor=M.+N.+Gwynnauthor=B.+D.+Bax&title=Structural+basis+of+quinolone+inhibition+of+type+IIA+topoisomerases+and+target-mediated+resistance&doi=10.1038%2Fnsmb.1892"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of quinolone inhibition of type IIA topoisomerases and target-mediated resistance</span></div><div class="casAuthors">Wohlkonig, Alexandre; Chan, Pan F.; Fosberry, Andrew P.; Homes, Paul; Huang, Jianzhong; Kranz, Michael; Leydon, Vaughan R.; Miles, Timothy J.; Pearson, Neil D.; Perera, Rajika L.; Shillings, Anthony J.; Gwynn, Michael N.; Bax, Benjamin D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1152-1153</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Quinolone antibacterials have been used to treat bacterial infections for over 40 years.  A crystal structure of moxifloxacin in complex with Acinetobacter baumannii topoisomerase IV now shows the wedge-shaped quinolone stacking between base pairs at the DNA cleavage site and binding conserved residues in the DNA cleavage domain through chelation of a noncatalytic magnesium ion.  This provides a mol. basis for the quinolone inhibition mechanism, resistance mutations and invariant quinolone antibacterial structural features.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpI2l3ADVYI8LVg90H21EOLACvtfcHk0lgi6VvtRnugLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVyiu7zM&md5=f976bba2c8333f7a59eacd8833fddcec</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.1892&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.1892%26sid%3Dliteratum%253Aachs%26aulast%3DWohlkonig%26aufirst%3DA.%26aulast%3DChan%26aufirst%3DP.%2BF.%26aulast%3DFosberry%26aufirst%3DA.%2BP.%26aulast%3DHomes%26aufirst%3DP.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DKranz%26aufirst%3DM.%26aulast%3DLeydon%26aufirst%3DV.%2BR.%26aulast%3DMiles%26aufirst%3DT.%2BJ.%26aulast%3DPearson%26aufirst%3DN.%2BD.%26aulast%3DPerera%26aufirst%3DR.%2BL.%26aulast%3DShillings%26aufirst%3DA.%2BJ.%26aulast%3DGwynn%26aufirst%3DM.%2BN.%26aulast%3DBax%26aufirst%3DB.%2BD.%26atitle%3DStructural%2520basis%2520of%2520quinolone%2520inhibition%2520of%2520type%2520IIA%2520topoisomerases%2520and%2520target-mediated%2520resistance%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2010%26volume%3D17%26spage%3D1152%26doi%3D10.1038%2Fnsmb.1892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aldred, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McPherson, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerns, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graves, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turnbough, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osheroff, N.</span></span> <span> </span><span class="NLM_article-title">Drug interactions with <i>Bacillus anthracis</i> topoisomerase IV: biochemical basis for quinolone action and resistance</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">370</span>– <span class="NLM_lpage">381</span>, <span class="refDoi"> DOI: 10.1021/bi2013905</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi2013905" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFCmsrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=370-381&author=K.+J.+Aldredauthor=S.+A.+McPhersonauthor=P.+Wangauthor=R.+J.+Kernsauthor=D.+E.+Gravesauthor=C.+L.+Turnboughauthor=N.+Osheroff&title=Drug+interactions+with+Bacillus+anthracis+topoisomerase+IV%3A+biochemical+basis+for+quinolone+action+and+resistance&doi=10.1021%2Fbi2013905"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Drug Interactions with Bacillus anthracis Topoisomerase IV: Biochemical Basis for Quinolone Action and Resistance</span></div><div class="casAuthors">Aldred, Katie J.; McPherson, Sylvia A.; Wang, Pengfei; Kerns, Robert J.; Graves, David E.; Turnbough, Charles L., Jr.; Osheroff, Neil</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">370-381</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Bacillus anthracis, the causative agent of anthrax, is considered a serious threat as a bioweapon.  The drugs most commonly used to treat anthrax are quinolones, which act by increasing the levels of DNA cleavage mediated by topoisomerase IV and gyrase.  Quinolone resistance most often is assocd. with specific serine mutations in these enzymes.  Therefore, to det. the basis for quinolone action and resistance, we characterized wild-type B. anthracis topoisomerase IV, the GrlAS81F and GrlAS81Y quinolone-resistant mutants, and the effects of quinolones and a related quinazolinedione on these enzymes.  Ser81 is believed to anchor a water-Mg2+ bridge that coordinates quinolones to the enzyme through the C3/C4 keto acid.  Consistent with this hypothesized bridge, ciprofloxacin required increased Mg2+ concns. to support DNA cleavage by GrlAS81F topoisomerase IV.  The three enzymes displayed similar catalytic activities in the absence of drugs.  However, the resistance mutations decreased the affinity of topoisomerase IV for ciprofloxacin and other quinolones, diminished quinolone-induced inhibition of DNA religation, and reduced the stability of the enzyme-quinolone-DNA ternary complex.  Wild-type DNA cleavage levels were generated by mutant enzymes at high quinolone concns., suggesting that increased drug potency could overcome resistance.  8-Methyl-quinazoline-2,4-dione, which lacks the quinolone keto acid (and presumably does not require the water-Mg2+ bridge to mediate protein interactions), was more potent than quinolones against wild-type topoisomerase IV and was equally efficacious.  Moreover, it maintained high potency and efficacy against the mutant enzymes, effectively inhibited DNA religation, and formed stable ternary complexes.  Our findings provide an underlying biochem. basis for the ability of quinazolinediones to overcome clin. relevant quinolone resistance mutations in bacterial type II topoisomerases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvcIuUvZ7BNbVg90H21EOLACvtfcHk0lgi6VvtRnugLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFCmsrbM&md5=0be648ba3469ab016e6d52ee18b8ea94</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fbi2013905&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi2013905%26sid%3Dliteratum%253Aachs%26aulast%3DAldred%26aufirst%3DK.%2BJ.%26aulast%3DMcPherson%26aufirst%3DS.%2BA.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DKerns%26aufirst%3DR.%2BJ.%26aulast%3DGraves%26aufirst%3DD.%2BE.%26aulast%3DTurnbough%26aufirst%3DC.%2BL.%26aulast%3DOsheroff%26aufirst%3DN.%26atitle%3DDrug%2520interactions%2520with%2520Bacillus%2520anthracis%2520topoisomerase%2520IV%253A%2520biochemical%2520basis%2520for%2520quinolone%2520action%2520and%2520resistance%26jtitle%3DBiochemistry%26date%3D2012%26volume%3D51%26spage%3D370%26epage%3D381%26doi%3D10.1021%2Fbi2013905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aldred, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McPherson, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turnbough, C. L.,  Jr</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerns, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osheroff, N.</span></span> <span> </span><span class="NLM_article-title">Topoisomerase IV-quinolone interactions are mediated through a water-metal ion bridge: mechanistic basis of quinolone resistance</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">4628</span>– <span class="NLM_lpage">4639</span>, <span class="refDoi"> DOI: 10.1093/nar/gkt124</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1093%2Fnar%2Fgkt124" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=23460203" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmt1Ogtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2013&pages=4628-4639&author=K.+J.+Aldredauthor=S.+A.+McPhersonauthor=C.+L.+Turnboughauthor=R.+J.+Kernsauthor=N.+Osheroff&title=Topoisomerase+IV-quinolone+interactions+are+mediated+through+a+water-metal+ion+bridge%3A+mechanistic+basis+of+quinolone+resistance&doi=10.1093%2Fnar%2Fgkt124"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Topoisomerase IV-quinolone interactions are mediated through a water-metal ion bridge: mechanistic basis of quinolone resistance</span></div><div class="casAuthors">Aldred, Katie J.; McPherson, Sylvia A.; Turnbough, Charles L., Jr.; Kerns, Robert J.; Osheroff, Neil</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4628-4639</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Although quinolones are the most commonly prescribed antibacterials, their use is threatened by an increasing prevalence of resistance.  The most common causes of quinolone resistance are mutations of a specific serine or acidic residue in the A subunit of gyrase or topoisomerase IV.  These amino acids are proposed to serve as a crit. enzyme-quinolone interaction site by anchoring a water-metal ion bridge that coordinates drug binding.  To probe the role of the proposed water-metal ion bridge, we characterized wild-type, GrlAE85K, GrlAS81F/E85K, GrlAE85A, GrlAS81F/E85A and GrlAS81F Bacillus anthracis topoisomerase IV, their sensitivity to quinolones and related drugs and their use of metal ions.  Mutations increased the Mg2+ concn. required to produce maximal quinolone-induced DNA cleavage and restricted the divalent metal ions that could support quinolone activity.  Individual mutation of Ser81 or Glu85 partially disrupted bridge function, whereas simultaneous mutation of both residues abrogated protein-quinolone interactions.  Results provide functional evidence for the existence of the water-metal ion bridge, confirm that the serine and glutamic acid residues anchor the bridge, demonstrate that the bridge is the primary conduit for interactions between clin. relevant quinolones and topoisomerase IV and provide a likely mechanism for the most common causes of quinolone resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPSuOqUa7W0rVg90H21EOLACvtfcHk0lh_Kd-ebNtVjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmt1Ogtrs%253D&md5=0fa21970393a30f462874f0f1e8ee381</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkt124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkt124%26sid%3Dliteratum%253Aachs%26aulast%3DAldred%26aufirst%3DK.%2BJ.%26aulast%3DMcPherson%26aufirst%3DS.%2BA.%26aulast%3DTurnbough%26aufirst%3DC.%2BL.%26aulast%3DKerns%26aufirst%3DR.%2BJ.%26aulast%3DOsheroff%26aufirst%3DN.%26atitle%3DTopoisomerase%2520IV-quinolone%2520interactions%2520are%2520mediated%2520through%2520a%2520water-metal%2520ion%2520bridge%253A%2520mechanistic%2520basis%2520of%2520quinolone%2520resistance%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2013%26volume%3D41%26spage%3D4628%26epage%3D4639%26doi%3D10.1093%2Fnar%2Fgkt124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aldred, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breland, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vlckova, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strub, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neuman, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerns, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osheroff, N.</span></span> <span> </span><span class="NLM_article-title">Role of the water-metal ion bridge in mediating interactions between quinolones and <i>Escherichia coli</i> topoisomerase IV</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">5558</span>– <span class="NLM_lpage">5567</span>, <span class="refDoi"> DOI: 10.1021/bi500682e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi500682e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlagu7jJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=5558-5567&author=K.+J.+Aldredauthor=E.+J.+Brelandauthor=V.+Vlckovaauthor=M.+P.+Strubauthor=K.+C.+Neumanauthor=R.+J.+Kernsauthor=N.+Osheroff&title=Role+of+the+water-metal+ion+bridge+in+mediating+interactions+between+quinolones+and+Escherichia+coli+topoisomerase+IV&doi=10.1021%2Fbi500682e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Role of the Water-Metal Ion Bridge in Mediating Interactions between Quinolones and Escherichia coli Topoisomerase IV</span></div><div class="casAuthors">Aldred, Katie J.; Breland, Erin J.; Vlckova, Vladislava; Strub, Marie-Paule; Neuman, Keir C.; Kerns, Robert J.; Osheroff, Neil</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">5558-5567</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Although quinolones have been in clin. use for decades, the mechanism underlying drug activity and resistance has remained elusive.  However, recent studies indicate that clin. relevant quinolones interact with Bacillus anthracis (Gram-pos.) topoisomerase IV through a crit. water-metal ion bridge and that the most common quinolone resistance mutations decrease drug activity by disrupting this bridge.  As a first step toward detg. whether the water-metal ion bridge is a general mechanism of quinolone-topoisomerase interaction, the authors characterized drug interactions with wild-type Escherichia coli (Gram-neg.) topoisomerase IV and a series of ParC enzymes with mutations (S80L, S80I, S80F, and E84K) in the predicted bridge-anchoring residues.  Results strongly suggest that the water-metal ion bridge is essential for quinolone activity against E. coli topoisomerase IV.  Although the bridge represents a common and crit. mechanism that underlies broad-spectrum quinolone function, it appears to play different roles in B. anthracis and E. coli topoisomerase IV.  The water-metal ion bridge is the most important binding contact of clin. relevant quinolones with the Gram-pos. enzyme.  However, it primarily acts to properly align clin. relevant quinolones with E. coli topoisomerase IV.  Finally, even though ciprofloxacin is unable to increase levels of DNA cleavage mediated by several of the Ser 80 and Glu 84 mutant E. coli enzymes, the drug still retains the ability to inhibit the overall catalytic activity of these topoisomerase IV proteins.  Inhibition parallels drug binding, suggesting that the presence of the drug in the active site is sufficient to diminish DNA relaxation rates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUy9fHVTEfFrVg90H21EOLACvtfcHk0lh_Kd-ebNtVjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlagu7jJ&md5=a8f8cdb8a0930907dc398b69dda65449</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fbi500682e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi500682e%26sid%3Dliteratum%253Aachs%26aulast%3DAldred%26aufirst%3DK.%2BJ.%26aulast%3DBreland%26aufirst%3DE.%2BJ.%26aulast%3DVlckova%26aufirst%3DV.%26aulast%3DStrub%26aufirst%3DM.%2BP.%26aulast%3DNeuman%26aufirst%3DK.%2BC.%26aulast%3DKerns%26aufirst%3DR.%2BJ.%26aulast%3DOsheroff%26aufirst%3DN.%26atitle%3DRole%2520of%2520the%2520water-metal%2520ion%2520bridge%2520in%2520mediating%2520interactions%2520between%2520quinolones%2520and%2520Escherichia%2520coli%2520topoisomerase%2520IV%26jtitle%3DBiochemistry%26date%3D2014%26volume%3D53%26spage%3D5558%26epage%3D5567%26doi%3D10.1021%2Fbi500682e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Veselkov, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laponogov, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, X.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selvarajah, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skamrova, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Branstrom, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narasimhan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prasad, J. V. N. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanderson, M. R.</span></span> <span> </span><span class="NLM_article-title">Structure of a quinolone-stabilized cleavage complex of topoisomerase IV from <i>Klebsiella pneumoniae</i> and comparison with a related <i>Streptococcus pneumoniae</i> complex</span>. <i>Acta Cryst. D Struct. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">488</span>– <span class="NLM_lpage">496</span>, <span class="refDoi"> DOI: 10.1107/S2059798316001212</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1107%2FS2059798316001212" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=27050128" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC28XlsFSkuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2016&pages=488-496&author=D.+A.+Veselkovauthor=I.+Laponogovauthor=X.-S.+Panauthor=J.+Selvarajahauthor=G.+B.+Skamrovaauthor=A.+Branstromauthor=J.+Narasimhanauthor=J.+V.+N.+V.+Prasadauthor=L.+M.+Fisherauthor=M.+R.+Sanderson&title=Structure+of+a+quinolone-stabilized+cleavage+complex+of+topoisomerase+IV+from+Klebsiella+pneumoniae+and+comparison+with+a+related+Streptococcus+pneumoniae+complex&doi=10.1107%2FS2059798316001212"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of a quinolone-stabilized cleavage complex of topoisomerase IV from Klebsiella pneumoniae and comparison with a related Streptococcus pneumoniae complex</span></div><div class="casAuthors">Veselkov, Dennis A.; Laponogov, Ivan; Pan, Xiao-Su; Selvarajah, Jogitha; Skamrova, Galyna B.; Branstrom, Arthur; Narasimhan, Jana; Prasad, Josyula V. N. Vara; Fisher, L. Mark; Sanderson, Mark R.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Structural Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">488-496</span>CODEN:
                <span class="NLM_cas:coden">ACSDAD</span>;
        ISSN:<span class="NLM_cas:issn">2059-7983</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">K. pneumoniae is a Gram-neg. bacterium that is responsible for a range of common infections, including pulmonary pneumonia, bloodstream infections, and meningitis.  Certain strains of Klebsiella have become highly resistant to antibiotics.  Despite the vast amt. of research carried out on this class of bacteria, the mol. structure of its DNA topoisomerase IV, a type II topoisomerase essential for catalyzing chromosomal segregation, has remained unknown.  Here, the structure of its DNA-cleavage complex is reported at 3.35 Å resoln.  The complex was comprised of ParC breakage-reunion and ParE TOPRIM domains of K. pneumoniae topoisomerase IV with DNA stabilized by levofloxacin, a broad-spectrum fluoroquinolone antimicrobial agent.  This complex was compared with a similar complex from S. pneumoniae, which was recently solved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUi0Htw72iMrVg90H21EOLACvtfcHk0lgfCA336JTaaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlsFSkuro%253D&md5=82280462273a279587a0c279ea7104e0</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1107%2FS2059798316001212&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS2059798316001212%26sid%3Dliteratum%253Aachs%26aulast%3DVeselkov%26aufirst%3DD.%2BA.%26aulast%3DLaponogov%26aufirst%3DI.%26aulast%3DPan%26aufirst%3DX.-S.%26aulast%3DSelvarajah%26aufirst%3DJ.%26aulast%3DSkamrova%26aufirst%3DG.%2BB.%26aulast%3DBranstrom%26aufirst%3DA.%26aulast%3DNarasimhan%26aufirst%3DJ.%26aulast%3DPrasad%26aufirst%3DJ.%2BV.%2BN.%2BV.%26aulast%3DFisher%26aufirst%3DL.%2BM.%26aulast%3DSanderson%26aufirst%3DM.%2BR.%26atitle%3DStructure%2520of%2520a%2520quinolone-stabilized%2520cleavage%2520complex%2520of%2520topoisomerase%2520IV%2520from%2520Klebsiella%2520pneumoniae%2520and%2520comparison%2520with%2520a%2520related%2520Streptococcus%2520pneumoniae%2520complex%26jtitle%3DActa%2520Cryst.%2520D%2520Struct.%2520Biol.%26date%3D2016%26volume%3D72%26spage%3D488%26epage%3D496%26doi%3D10.1107%2FS2059798316001212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Domagala, J. M.</span>; <span class="NLM_string-name">Hagen, S. E.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationships of the quinolone antibacterials in the new millenium: some things change and some do not</span>. In  <i>Quinolone Antimicrobial Agents</i>, <span class="NLM_edition">3</span>rd ed.; <span class="NLM_contrib-group"><span class="NLM_string-name">Hooper, D. C.</span>, <span class="NLM_string-name">Rubinstein, E.</span></span>, Eds.; <span class="NLM_publisher-name">ASM Press</span>: <span class="NLM_publisher-loc">Washington, D.C.</span>, <span class="NLM_year">2003</span>; pp  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">18</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1128%2F9781555817817.ch1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&pages=3-18&author=J.+M.+Domagala&author=S.+E.+Hagenauthor=D.+C.+Hooper&author=E.+Rubinstein&title=Quinolone+Antimicrobial+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1128%2F9781555817817.ch1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1128%252F9781555817817.ch1%26sid%3Dliteratum%253Aachs%26aulast%3DDomagala%26aufirst%3DJ.%2BM.%26atitle%3DStructure-activity%2520relationships%2520of%2520the%2520quinolone%2520antibacterials%2520in%2520the%2520new%2520millenium%253A%2520some%2520things%2520change%2520and%2520some%2520do%2520not%26btitle%3DQuinolone%2520Antimicrobial%2520Agents%26aulast%3DHooper%26aufirst%3DD.%2BC.%26pub%3DASM%2520Press%26date%3D2003%26spage%3D3%26epage%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aldred, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerns, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osheroff, N.</span></span> <span> </span><span class="NLM_article-title">Mechanism of quinolone action and resistance</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">1565</span>– <span class="NLM_lpage">1574</span>, <span class="refDoi"> DOI: 10.1021/bi5000564</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi5000564" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjt1ymtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=1565-1574&author=K.+J.+Aldredauthor=R.+J.+Kernsauthor=N.+Osheroff&title=Mechanism+of+quinolone+action+and+resistance&doi=10.1021%2Fbi5000564"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of quinolone action and resistance</span></div><div class="casAuthors">Aldred, Katie J.; Kerns, Robert J.; Osheroff, Neil</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1565-1574</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Quinolones are one of the most commonly prescribed classes of antibacterials in the world and are used to treat a variety of bacterial infections in humans.  Because of the wide use (and overuse) of these drugs, the no. of quinolone-resistant bacterial strains has been growing steadily since the 1990s.  As is the case with other antibacterial agents, the rise in quinolone resistance threatens the clin. utility of this important drug class.  Quinolones act by converting their targets, gyrase and topoisomerase IV, into toxic enzymes that fragment the bacterial chromosome.  This review describes the development of the quinolones as antibacterials, the structure and function of gyrase and topoisomerase IV, and the mechanistic basis for quinolone action against their enzyme targets.  It will then discuss the following three mechanisms that decrease the sensitivity of bacterial cells to quinolones.  Target-mediated resistance is the most common and clin. significant form of resistance.  It is caused by specific mutations in gyrase and topoisomerase IV that weaken interactions between quinolones and these enzymes.  Plasmid-mediated resistance results from extrachromosomal elements that encode proteins that disrupt quinolone-enzyme interactions, alter drug metab., or increase quinolone efflux.  Chromosome-mediated resistance results from the underexpression of porins or the overexpression of cellular efflux pumps, both of which decrease cellular concns. of quinolones.  Finally, this review discusses recent advancements in our understanding of how quinolones interact with gyrase and topoisomerase IV and how mutations in these enzymes cause resistance.  These last findings suggest approaches to designing new drugs that display improved activity against resistant strains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro57dziddbmLVg90H21EOLACvtfcHk0liydVXgFXHaFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjt1ymtrk%253D&md5=38134014d5acd1d5c807095eaba34e3b</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fbi5000564&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi5000564%26sid%3Dliteratum%253Aachs%26aulast%3DAldred%26aufirst%3DK.%2BJ.%26aulast%3DKerns%26aufirst%3DR.%2BJ.%26aulast%3DOsheroff%26aufirst%3DN.%26atitle%3DMechanism%2520of%2520quinolone%2520action%2520and%2520resistance%26jtitle%3DBiochemistry%26date%3D2014%26volume%3D53%26spage%3D1565%26epage%3D1574%26doi%3D10.1021%2Fbi5000564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hooper, D. C.</span>; <span class="NLM_string-name">Jacoby, G. A.</span></span> <span> </span><span class="NLM_article-title">Topoisomerase inhibitors: fluoroquinolone mechanisms of action and resistance</span>.  <i>Cold Spring Harbor Perspect. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume">6</span>, <span class="refDoi"> DOI: 10.1101/cshperspect.a025320</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1101%2Fcshperspect.a025320" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=27449972" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&author=D.+C.+Hooper&author=G.+A.+Jacoby&title=Topoisomerase+inhibitors%3A+fluoroquinolone+mechanisms+of+action+and+resistance&doi=10.1101%2Fcshperspect.a025320"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1101%2Fcshperspect.a025320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fcshperspect.a025320%26sid%3Dliteratum%253Aachs%26aulast%3DHooper%26aufirst%3DD.%2BC.%26atitle%3DTopoisomerase%2520inhibitors%253A%2520fluoroquinolone%2520mechanisms%2520of%2520action%2520and%2520resistance%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspect.%2520Med.%26date%3D2016%26volume%3D6%26doi%3D10.1101%2Fcshperspect.a025320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span> </span><span class="NLM_article-title">Antibiotic Resistance Threats in the United
States. 2019</span>. <a href="https://www.cdc.gov/drugresistance/pdf/threats-report/2019-ar-threats-report-508.pdf" class="extLink">https://www.cdc.gov/drugresistance/pdf/threats-report/2019-ar-threats-report-508.pdf</a> (accessed Mar 25, <span class="NLM_year">2020</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Antibiotic+Resistance+Threats+in+the+United%0AStates.+2019.+https%3A%2F%2Fwww.cdc.gov%2Fdrugresistance%2Fpdf%2Fthreats-report%2F2019-ar-threats-report-508.pdf+%28accessed+Mar+25%2C+2020%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DAntibiotic%2520Resistance%2520Threats%2520in%2520the%2520United%250AStates.%25202019%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span> </span><span class="NLM_article-title">Antimicrobial
Resistance: Global Report on Surveillance 2014</span>. <a href="http://www.who.int/drugresistance/documents/surveillancereport/en/" class="extLink">http://www.who.int/drugresistance/documents/surveillancereport/en/</a> (accessed May 24, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Antimicrobial%0AResistance%3A+Global+Report+on+Surveillance+2014.+http%3A%2F%2Fwww.who.int%2Fdrugresistance%2Fdocuments%2Fsurveillancereport%2Fen%2F+%28accessed+May+24%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DAntimicrobial%250AResistance%253A%2520Global%2520Report%2520on%2520Surveillance%25202014%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span> </span><span class="NLM_article-title">A Scientific
Roadmap for Antibiotic Discovery</span>. <a href="https://www.pewtrusts.org/en/research-and-analysis/reports/2016/05/a-scientific-roadmap-for-antibiotic-discovery" class="extLink">https://www.pewtrusts.org/en/research-and-analysis/reports/2016/05/a-scientific-roadmap-for-antibiotic-discovery</a> (accessed Mar 20, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=A+Scientific%0ARoadmap+for+Antibiotic+Discovery.+https%3A%2F%2Fwww.pewtrusts.org%2Fen%2Fresearch-and-analysis%2Freports%2F2016%2F05%2Fa-scientific-roadmap-for-antibiotic-discovery+%28accessed+Mar+20%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DA%2520Scientific%250ARoadmap%2520for%2520Antibiotic%2520Discovery%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alanis, A. J.</span></span> <span> </span><span class="NLM_article-title">Resistance to antibiotics: are we in the post-antibiotic era?</span>. <i>Arch. Med. Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">697</span>– <span class="NLM_lpage">705</span>, <span class="refDoi"> DOI: 10.1016/j.arcmed.2005.06.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1016%2Fj.arcmed.2005.06.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=16216651" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A280%3ADC%252BD2MrktVCjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2005&pages=697-705&author=A.+J.+Alanis&title=Resistance+to+antibiotics%3A+are+we+in+the+post-antibiotic+era%3F&doi=10.1016%2Fj.arcmed.2005.06.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Resistance to antibiotics: are we in the post-antibiotic era?</span></div><div class="casAuthors">Alanis Alfonso J</div><div class="citationInfo"><span class="NLM_cas:title">Archives of medical research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">697-705</span>
        ISSN:<span class="NLM_cas:issn">0188-4409</span>.
    </div><div class="casAbstract">Serious infections caused by bacteria that have become resistant to commonly used antibiotics have become a major global healthcare problem in the 21st century.  They not only are more severe and require longer and more complex treatments, but they are also significantly more expensive to diagnose and to treat.  Antibiotic resistance, initially a problem of the hospital setting associated with an increased number of hospital-acquired infections usually in critically ill and immunosuppressed patients, has now extended into the community causing severe infections difficult to diagnose and treat.  The molecular mechanisms by which bacteria have become resistant to antibiotics are diverse and complex.  Bacteria have developed resistance to all different classes of antibiotics discovered to date.  The most frequent type of resistance is acquired and transmitted horizontally via the conjugation of a plasmid.  In recent times new mechanisms of resistance have resulted in the simultaneous development of resistance to several antibiotic classes creating very dangerous multidrug-resistant (MDR) bacterial strains, some also known as "superbugs".  The indiscriminate and inappropriate use of antibiotics in outpatient clinics, hospitalized patients and in the food industry is the single largest factor leading to antibiotic resistance.  In recent years, the number of new antibiotics licensed for human use in different parts of the world has been lower than in the recent past.  In addition, there has been less innovation in the field of antimicrobial discovery research and development.  The pharmaceutical industry, large academic institutions or the government are not investing the necessary resources to produce the next generation of newer safe and effective antimicrobial drugs.  In many cases, large pharmaceutical companies have terminated their anti-infective research programs altogether due to economic reasons.  The potential negative consequences of all these events are relevant because they put society at risk for the spread of potentially serious MDR bacterial infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRgpn0xJW6vgQpJitSxOdIlfW6udTcc2eaB9V1BnouolLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MrktVCjuw%253D%253D&md5=f743e06f1cb080a86bebf66a6b6e6eec</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.arcmed.2005.06.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.arcmed.2005.06.009%26sid%3Dliteratum%253Aachs%26aulast%3DAlanis%26aufirst%3DA.%2BJ.%26atitle%3DResistance%2520to%2520antibiotics%253A%2520are%2520we%2520in%2520the%2520post-antibiotic%2520era%253F%26jtitle%3DArch.%2520Med.%2520Res.%26date%3D2005%26volume%3D36%26spage%3D697%26epage%3D705%26doi%3D10.1016%2Fj.arcmed.2005.06.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gums, J. G.</span></span> <span> </span><span class="NLM_article-title">The emergence and evolution of antimicrobial resistance: Impact on a global scale</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">6440</span>– <span class="NLM_lpage">6445</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2016.04.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1016%2Fj.bmc.2016.04.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=27117692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC28XmslSntbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=6440-6445&author=A.+Y.+Hwangauthor=J.+G.+Gums&title=The+emergence+and+evolution+of+antimicrobial+resistance%3A+Impact+on+a+global+scale&doi=10.1016%2Fj.bmc.2016.04.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">The emergence and evolution of antimicrobial resistance: Impact on a global scale</span></div><div class="casAuthors">Hwang, Andrew Y.; Gums, John G.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6440-6445</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The evolution of antimicrobial resistance is a multifaceted issue that is influenced by numerous factors.  This growing healthcare problem has significantly impacted the public welfare and has substantially burdened the economic system on a global scale.  In an effort to combat this rising problem, several strategies have been implemented in the recent years to stall the progression and decrease the emergence of antimicrobial resistance.  The aim of this review article is to describe the various factors that have contributed to the current state of antimicrobial resistance and to evaluate potential strategies developed to reduce the burden of antimicrobial resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCVm82PSc2ybVg90H21EOLACvtfcHk0ljXEqHf3V4PIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmslSntbg%253D&md5=895c0fe91316bd399483d2c76f67242d</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.04.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.04.027%26sid%3Dliteratum%253Aachs%26aulast%3DHwang%26aufirst%3DA.%2BY.%26aulast%3DGums%26aufirst%3DJ.%2BG.%26atitle%3DThe%2520emergence%2520and%2520evolution%2520of%2520antimicrobial%2520resistance%253A%2520Impact%2520on%2520a%2520global%2520scale%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26spage%3D6440%26epage%3D6445%26doi%3D10.1016%2Fj.bmc.2016.04.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Overbye, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrett, J.</span></span> <span> </span><span class="NLM_article-title">Antibiotics: Where did we go wrong?</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">45</span>– <span class="NLM_lpage">52</span>, <span class="refDoi"> DOI: 10.1016/S1359-6446(04)03285-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1016%2FS1359-6446%2804%2903285-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=15676298" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A280%3ADC%252BD2M%252FkvFOhtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2005&pages=45-52&author=K.+Overbyeauthor=J.+Barrett&title=Antibiotics%3A+Where+did+we+go+wrong%3F&doi=10.1016%2FS1359-6446%2804%2903285-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Antibiotics: where did we go wrong?</span></div><div class="casAuthors">Overbye Karen M; Barrett John F</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45-52</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">In the late 1960s, the medical need for new antibiotics began to be questioned, and the pharmaceutical industry shifted its emphasis of antibacterials from that of a therapeutic leader to a low-priority research area.  Although infectious diseases, in particular those caused by bacterial infections, are still among the top causes of mortality in the world, industrial support continues to wane.  The shift from this important area of antimicrobial research has been attributed to a combination of science, medical, marketing and business reasons.  This decline in antibacterial drug discovery, coupled with increasing risk as a result of infections caused by drug-resistant bacterial pathogens, represents a clear public health threat.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS--fo71XGN1X6CEoQgWY10fW6udTcc2eaB9V1BnouolLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2M%252FkvFOhtA%253D%253D&md5=9d48b7cd2b497d8db69f0fae744f7baf</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903285-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903285-4%26sid%3Dliteratum%253Aachs%26aulast%3DOverbye%26aufirst%3DK.%26aulast%3DBarrett%26aufirst%3DJ.%26atitle%3DAntibiotics%253A%2520Where%2520did%2520we%2520go%2520wrong%253F%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2005%26volume%3D10%26spage%3D45%26epage%3D52%26doi%3D10.1016%2FS1359-6446%2804%2903285-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spellberg, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guidos, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boucher, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheld, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartlett, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, J.,  Jr</span></span> <span> </span><span class="NLM_article-title">The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America</span>. <i>Clin. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">155</span>– <span class="NLM_lpage">164</span>, <span class="refDoi"> DOI: 10.1086/524891</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1086%2F524891" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=18171244" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A280%3ADC%252BD1c%252FgslGitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2008&pages=155-164&author=B.+Spellbergauthor=R.+Guidosauthor=D.+Gilbertauthor=J.+Bradleyauthor=H.+W.+Boucherauthor=W.+M.+Scheldauthor=J.+G.+Bartlettauthor=J.+Edwards&title=The+epidemic+of+antibiotic-resistant+infections%3A+a+call+to+action+for+the+medical+community+from+the+Infectious+Diseases+Society+of+America&doi=10.1086%2F524891"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America</span></div><div class="casAuthors">Spellberg Brad; Guidos Robert; Gilbert David; Bradley John; Boucher Helen W; Scheld W Michael; Bartlett John G; Edwards John Jr</div><div class="citationInfo"><span class="NLM_cas:title">Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">155-64</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The ongoing explosion of antibiotic-resistant infections continues to plague global and US health care.  Meanwhile, an equally alarming decline has occurred in the research and development of new antibiotics to deal with the threat.  In response to this microbial "perfect storm," in 2001, the federal Interagency Task Force on Antimicrobial Resistance released the "Action Plan to Combat Antimicrobial Resistance; Part 1: Domestic" to strengthen the response in the United States.  The Infectious Diseases Society of America (IDSA) followed in 2004 with its own report, "Bad Bugs, No Drugs: As Antibiotic Discovery Stagnates, A Public Health Crisis Brews," which proposed incentives to reinvigorate pharmaceutical investment in antibiotic research and development.  The IDSA's subsequent lobbying efforts led to the introduction of promising legislation in the 109 th US Congress (January 2005-December 2006).  Unfortunately, the legislation was not enacted.  During the 110 th Congress, the IDSA has continued to work with congressional leaders on promising legislation to address antibiotic-resistant infection.  Nevertheless, despite intensive public relations and lobbying efforts, it remains unclear whether sufficiently robust legislation will be enacted.  In the meantime, microbes continue to become more resistant, the antibiotic pipeline continues to diminish, and the majority of the public remains unaware of this critical situation.  The result of insufficient federal funding; insufficient surveillance, prevention, and control; insufficient research and development activities; misguided regulation of antibiotics in agriculture and, in particular, for food animals; and insufficient overall coordination of US (and international) efforts could mean a literal return to the preantibiotic era for many types of infections.  If we are to address the antimicrobial resistance crisis, a concerted, grassroots effort led by the medical community will be required.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ5IgYdIVkSKVf1XRtfYM0dfW6udTcc2eYAJjH-5VPZnbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c%252FgslGitw%253D%253D&md5=52bb108e9c29dc9da3031f7127cba99f</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1086%2F524891&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F524891%26sid%3Dliteratum%253Aachs%26aulast%3DSpellberg%26aufirst%3DB.%26aulast%3DGuidos%26aufirst%3DR.%26aulast%3DGilbert%26aufirst%3DD.%26aulast%3DBradley%26aufirst%3DJ.%26aulast%3DBoucher%26aufirst%3DH.%2BW.%26aulast%3DScheld%26aufirst%3DW.%2BM.%26aulast%3DBartlett%26aufirst%3DJ.%2BG.%26aulast%3DEdwards%26aufirst%3DJ.%26atitle%3DThe%2520epidemic%2520of%2520antibiotic-resistant%2520infections%253A%2520a%2520call%2520to%2520action%2520for%2520the%2520medical%2520community%2520from%2520the%2520Infectious%2520Diseases%2520Society%2520of%2520America%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2008%26volume%3D46%26spage%3D155%26epage%3D164%26doi%3D10.1086%2F524891" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tse-Dinh, Y. C.</span></span> <span> </span><span class="NLM_article-title">Targeting bacterial topoisomerases: how to counter mechanisms of resistance</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1085</span>– <span class="NLM_lpage">1100</span>, <span class="refDoi"> DOI: 10.4155/fmc-2016-0042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.4155%2Ffmc-2016-0042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=27285067" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVyns7nP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=1085-1100&author=Y.+C.+Tse-Dinh&title=Targeting+bacterial+topoisomerases%3A+how+to+counter+mechanisms+of+resistance&doi=10.4155%2Ffmc-2016-0042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting bacterial topoisomerases: how to counter mechanisms of resistance</span></div><div class="casAuthors">Tse-Dinh, Yuk-Ching</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1085-1100</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">DNA gyrase and topoisomerase IV are type IIA bacterial topoisomerases that are targeted by highly effective antibiotics.  However, resistance via multiple mechanisms arises to limit the efficacies of these drugs.  Continued research on type IIA bacterial topoisomerases has provided novel approaches to counter the most common resistance mechanism for utilization of these proven targets in antibacterial therapy.  Bacterial topoisomerase I is being explored as an alternative target that is not expected to show cross-resistance.  Dual targeting or combination therapy could be strategies for circumventing the development of resistance to topoisomerase-targeting antibiotics.  Bacterial topoisomerases are high-value bactericidal targets that could continue to be exploited for antibacterial therapy, if new tactics to counter resistance can be adopted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6tp1yqm4-ZLVg90H21EOLACvtfcHk0lhPtOefc7KDow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVyns7nP&md5=1fa7d5675deea48e8a61581000818365</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.4155%2Ffmc-2016-0042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc-2016-0042%26sid%3Dliteratum%253Aachs%26aulast%3DTse-Dinh%26aufirst%3DY.%2BC.%26atitle%3DTargeting%2520bacterial%2520topoisomerases%253A%2520how%2520to%2520counter%2520mechanisms%2520of%2520resistance%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2016%26volume%3D8%26spage%3D1085%26epage%3D1100%26doi%3D10.4155%2Ffmc-2016-0042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Basarab, G. S.</span></span> <span> </span><span class="NLM_article-title">Four ways to skin a cat: inhibition of bacterial topoisomerases leading to the clinic</span>. In  <i>Topics in Medicinal Chemistry: Antibacterials</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, J. F.</span>, <span class="NLM_string-name">Mobashery, S.</span>, <span class="NLM_string-name">Miller, M. J.</span></span>, Eds.; <span class="NLM_publisher-name">Springer International Publishing</span>: <span class="NLM_publisher-loc">Cham, Switzerland</span>, <span class="NLM_year">2017</span>; Vol.  <span class="NLM_volume">25</span>, pp  <span class="NLM_fpage">165</span>– <span class="NLM_lpage">188</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&pages=165-188&author=G.+S.+Basarabauthor=J.+F.+Fisher&author=S.+Mobashery&author=M.+J.+Miller&title=Topics+in+Medicinal+Chemistry%3A+Antibacterials"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DBasarab%26aufirst%3DG.%2BS.%26atitle%3DFour%2520ways%2520to%2520skin%2520a%2520cat%253A%2520inhibition%2520of%2520bacterial%2520topoisomerases%2520leading%2520to%2520the%2520clinic%26btitle%3DTopics%2520in%2520Medicinal%2520Chemistry%253A%2520Antibacterials%26aulast%3DFisher%26aufirst%3DJ.%2BF.%26pub%3DSpringer%2520International%2520Publishing%26date%3D2017%26volume%3D25%26spage%3D165%26epage%3D188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mayer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janin, Y. L.</span></span> <span> </span><span class="NLM_article-title">Non-quinolone inhibitors of bacterial type IIA topoisomerases: a feat of bioisosterism</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">2313</span>– <span class="NLM_lpage">2342</span>, <span class="refDoi"> DOI: 10.1021/cr4003984</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr4003984" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFegsrfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2014&pages=2313-2342&author=C.+Mayerauthor=Y.+L.+Janin&title=Non-quinolone+inhibitors+of+bacterial+type+IIA+topoisomerases%3A+a+feat+of+bioisosterism&doi=10.1021%2Fcr4003984"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Non-quinolone Inhibitors of Bacterial Type IIA Topoisomerases: A Feat of Bioisosterism</span></div><div class="casAuthors">Mayer, Claudine; Janin, Yves L.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2313-2342</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  DNA gyrase and topoisomerase IV are the bacterial type IIA topoisomerases.  These are ubiquitous nucleic acid-dependent nanomachines, essential to cell life, that solve DNA topol. problems resulting from the replication, transcription, and recombination of DNA.  From the discovery that novobiocin and fluoroquinolone antibiotics were selectively acting on bacterial type IIA topoisomerases, a remarkable no. of series of inhibitors of these enzymes has been reported.  The design of biochem. or cellular assays, amenable to high-throughput screenings, along with X-ray-derived structures of the early inhibitors bound to DNA gyrase, were instrumental in this.  From these structures, an array of strategies, which are today called fragment-based approaches, provided quite a no. of addnl. starting points for medicinal chemists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF-y7YT9Lg6rVg90H21EOLACvtfcHk0lia7XDvcgEnxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFegsrfO&md5=8559c27866d96e85cc08763e0cae1c01</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fcr4003984&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr4003984%26sid%3Dliteratum%253Aachs%26aulast%3DMayer%26aufirst%3DC.%26aulast%3DJanin%26aufirst%3DY.%2BL.%26atitle%3DNon-quinolone%2520inhibitors%2520of%2520bacterial%2520type%2520IIA%2520topoisomerases%253A%2520a%2520feat%2520of%2520bioisosterism%26jtitle%3DChem.%2520Rev.%26date%3D2014%26volume%3D114%26spage%3D2313%26epage%3D2342%26doi%3D10.1021%2Fcr4003984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tran, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellsworth, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stier, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Domagala, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollis
Showalter, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gracheck, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shapiro, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joannides, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, R.</span></span> <span> </span><span class="NLM_article-title">Synthesis and structural–activity relationships of 3-hydroxyquinazoline-2,4-dione antibacterial agents</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">4405</span>– <span class="NLM_lpage">4409</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2004.06.063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1016%2Fj.bmcl.2004.06.063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=15357962" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmt1KitLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=4405-4409&author=T.+P.+Tranauthor=E.+L.+Ellsworthauthor=M.+A.+Stierauthor=J.+M.+Domagalaauthor=H.+D.+Hollis%0AShowalterauthor=S.+J.+Gracheckauthor=M.+A.+Shapiroauthor=T.+E.+Joannidesauthor=R.+Singh&title=Synthesis+and+structural%E2%80%93activity+relationships+of+3-hydroxyquinazoline-2%2C4-dione+antibacterial+agents&doi=10.1016%2Fj.bmcl.2004.06.063"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and structural-activity relationships of 3-hydroxyquinazoline-2,4-dione antibacterial agents</span></div><div class="casAuthors">Tran, Tuan P.; Ellsworth, Edmund L.; Stier, Michael A.; Domagala, John M.; Showalter, H. D. Hollis; Gracheck, Stephen J.; Shapiro, Martin A.; Joannides, Themis E.; Singh, Rajeshwar</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4405-4409</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of 3-hydroxyquinazoline-2,4-diones, e.g., I, was synthesized and evaluated for antibacterial activity.  This series represents an addn. to the DNA gyrate inhibitor class of antibacterials.  Appropriated substitution onto the core template yielded compds. with excellent potency against E. coli gyrate and significant in vitro Gram-neg. and Gram-pos. antibacterial activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0oq3x_pGYZ7Vg90H21EOLACvtfcHk0livvUeVXPnN-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmt1KitLk%253D&md5=7a3899e210962634fe181c8c5c13853d</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2004.06.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2004.06.063%26sid%3Dliteratum%253Aachs%26aulast%3DTran%26aufirst%3DT.%2BP.%26aulast%3DEllsworth%26aufirst%3DE.%2BL.%26aulast%3DStier%26aufirst%3DM.%2BA.%26aulast%3DDomagala%26aufirst%3DJ.%2BM.%26aulast%3DHollis%2BShowalter%26aufirst%3DH.%2BD.%26aulast%3DGracheck%26aufirst%3DS.%2BJ.%26aulast%3DShapiro%26aufirst%3DM.%2BA.%26aulast%3DJoannides%26aufirst%3DT.%2BE.%26aulast%3DSingh%26aufirst%3DR.%26atitle%3DSynthesis%2520and%2520structural%25E2%2580%2593activity%2520relationships%2520of%25203-hydroxyquinazoline-2%252C4-dione%2520antibacterial%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D4405%26epage%3D4409%26doi%3D10.1016%2Fj.bmcl.2004.06.063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ellsworth, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Showalter, H. D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stier, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Domagala, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gracheck, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joannides, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shapiro, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunham, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanna, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huband, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gage, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bronstein, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, D. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, R.</span></span> <span> </span><span class="NLM_article-title">3-Aminoquinazolinediones as a new class of antibacterial agents demonstrating excellent antibacterial activity against wild-type and multidrug resistant organisms</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">6435</span>– <span class="NLM_lpage">6438</span>, <span class="refDoi"> DOI: 10.1021/jm060505l</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060505l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVegtrnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6435-6438&author=E.+L.+Ellsworthauthor=T.+P.+Tranauthor=H.+D.+H.+Showalterauthor=J.+P.+Sanchezauthor=B.+M.+Watsonauthor=M.+A.+Stierauthor=J.+M.+Domagalaauthor=S.+J.+Gracheckauthor=E.+T.+Joannidesauthor=M.+A.+Shapiroauthor=S.+A.+Dunhamauthor=D.+L.+Hannaauthor=M.+D.+Hubandauthor=J.+W.+Gageauthor=J.+C.+Bronsteinauthor=J.+Y.+Liuauthor=D.+Q.+Nguyenauthor=R.+Singh&title=3-Aminoquinazolinediones+as+a+new+class+of+antibacterial+agents+demonstrating+excellent+antibacterial+activity+against+wild-type+and+multidrug+resistant+organisms&doi=10.1021%2Fjm060505l"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">3-Aminoquinazolinediones as a New Class of Antibacterial Agents Demonstrating Excellent Antibacterial Activity Against Wild-Type and Multidrug Resistant Organisms</span></div><div class="casAuthors">Ellsworth, Edmund L.; Tran, Tuan P.; Showalter, H. D. Hollis; Sanchez, Joseph P.; Watson, Brian M.; Stier, Michael A.; Domagala, John M.; Gracheck, Stephen J.; Joannides, E. Themis; Shapiro, Martin A.; Dunham, Steve A.; Hanna, Debra L.; Huband, Michael D.; Gage, Jeffrey W.; Bronstein, Joel C.; Liu, Jia Yeu; Nguyen, Dai Q.; Singh, Rajeshwar</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6435-6438</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The 3-aminoquinzolinediones represent a new series of antibacterial agents structurally related to the fluoroquinolones.  They are inhibitors of bacterial gyrase and topoisomerase IV and demonstrate clin. useful antibacterial activity against fastidious Gram-neg. and Gram-pos. organisms, including multidrug- and fluoroquinolone-resistant organisms.  These agents also demonstrate in vivo efficacy in murine systemic infection models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4grB_LlTcb7Vg90H21EOLACvtfcHk0livvUeVXPnN-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVegtrnL&md5=d1628ee7be9b48db5c785c5d6b8c1611</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm060505l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060505l%26sid%3Dliteratum%253Aachs%26aulast%3DEllsworth%26aufirst%3DE.%2BL.%26aulast%3DTran%26aufirst%3DT.%2BP.%26aulast%3DShowalter%26aufirst%3DH.%2BD.%2BH.%26aulast%3DSanchez%26aufirst%3DJ.%2BP.%26aulast%3DWatson%26aufirst%3DB.%2BM.%26aulast%3DStier%26aufirst%3DM.%2BA.%26aulast%3DDomagala%26aufirst%3DJ.%2BM.%26aulast%3DGracheck%26aufirst%3DS.%2BJ.%26aulast%3DJoannides%26aufirst%3DE.%2BT.%26aulast%3DShapiro%26aufirst%3DM.%2BA.%26aulast%3DDunham%26aufirst%3DS.%2BA.%26aulast%3DHanna%26aufirst%3DD.%2BL.%26aulast%3DHuband%26aufirst%3DM.%2BD.%26aulast%3DGage%26aufirst%3DJ.%2BW.%26aulast%3DBronstein%26aufirst%3DJ.%2BC.%26aulast%3DLiu%26aufirst%3DJ.%2BY.%26aulast%3DNguyen%26aufirst%3DD.%2BQ.%26aulast%3DSingh%26aufirst%3DR.%26atitle%3D3-Aminoquinazolinediones%2520as%2520a%2520new%2520class%2520of%2520antibacterial%2520agents%2520demonstrating%2520excellent%2520antibacterial%2520activity%2520against%2520wild-type%2520and%2520multidrug%2520resistant%2520organisms%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6435%26epage%3D6438%26doi%3D10.1021%2Fjm060505l" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tran, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellsworth, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stier, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Showalter, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Domagala, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shapiro, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joannides, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gracheck, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, D. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bird, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yip, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharadendu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ha, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramezani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, R.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationships of 3-aminoquinazolinediones, a new class of bacterial type-2 topoisomerase (DNA gyrase and topo IV) inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1312</span>– <span class="NLM_lpage">1320</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2006.12.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1016%2Fj.bmcl.2006.12.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=17196390" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvVyjtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=1312-1320&author=T.+P.+Tranauthor=E.+L.+Ellsworthauthor=J.+P.+Sanchezauthor=B.+M.+Watsonauthor=M.+A.+Stierauthor=H.+D.+Showalterauthor=J.+M.+Domagalaauthor=M.+A.+Shapiroauthor=E.+T.+Joannidesauthor=S.+J.+Gracheckauthor=D.+Q.+Nguyenauthor=P.+Birdauthor=J.+Yipauthor=A.+Sharadenduauthor=C.+Haauthor=S.+Ramezaniauthor=X.+Wuauthor=R.+Singh&title=Structure-activity+relationships+of+3-aminoquinazolinediones%2C+a+new+class+of+bacterial+type-2+topoisomerase+%28DNA+gyrase+and+topo+IV%29+inhibitors&doi=10.1016%2Fj.bmcl.2006.12.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationships of 3-aminoquinazolinediones, a new class of bacterial type-2 topoisomerase (DNA gyrase and topo IV) inhibitors</span></div><div class="casAuthors">Tran, Tuan P.; Ellsworth, Edmund L.; Sanchez, Joseph P.; Watson, Brian M.; Stier, Michael A.; Showalter, H. D. Hollis; Domagala, John M.; Shapiro, Martin A.; Joannides, E. Themis; Gracheck, Stephen J.; Nguyen, Dai Q.; Bird, Paul; Yip, Judy; Sharadendu, Anurag; Ha, Chan; Ramezani, Saeed; Wu, Xiujuan; Singh, Rajeshwar</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1312-1320</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A series of 3-aminoquinazolinediones was synthesized and evaluated for its antibacterial and DNA gyrase activity.  The SAR around the quinazolinedione core was explored and the optimal substitutions were combined to give two compds., I (R = H, Me), with exceptional enzyme potency (IC50 = 0.2 μM) and activity against Gram-pos. organisms (MIC's = 0.015-0.06 μ g/mL).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfmuSmpkFLIrVg90H21EOLACvtfcHk0ljU1xsPrHD52w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvVyjtr4%253D&md5=321843f9392b62fd1ba0f44dc8d00e66</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DTran%26aufirst%3DT.%2BP.%26aulast%3DEllsworth%26aufirst%3DE.%2BL.%26aulast%3DSanchez%26aufirst%3DJ.%2BP.%26aulast%3DWatson%26aufirst%3DB.%2BM.%26aulast%3DStier%26aufirst%3DM.%2BA.%26aulast%3DShowalter%26aufirst%3DH.%2BD.%26aulast%3DDomagala%26aufirst%3DJ.%2BM.%26aulast%3DShapiro%26aufirst%3DM.%2BA.%26aulast%3DJoannides%26aufirst%3DE.%2BT.%26aulast%3DGracheck%26aufirst%3DS.%2BJ.%26aulast%3DNguyen%26aufirst%3DD.%2BQ.%26aulast%3DBird%26aufirst%3DP.%26aulast%3DYip%26aufirst%3DJ.%26aulast%3DSharadendu%26aufirst%3DA.%26aulast%3DHa%26aufirst%3DC.%26aulast%3DRamezani%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DSingh%26aufirst%3DR.%26atitle%3DStructure-activity%2520relationships%2520of%25203-aminoquinazolinediones%252C%2520a%2520new%2520class%2520of%2520bacterial%2520type-2%2520topoisomerase%2520%2528DNA%2520gyrase%2520and%2520topo%2520IV%2529%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D1312%26epage%3D1320%26doi%3D10.1016%2Fj.bmcl.2006.12.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pan, X. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gould, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, L. M.</span></span> <span> </span><span class="NLM_article-title">Probing the differential interactions of quinazolinedione PD 0305970 and quinolones with gyrase and topoisomerase IV</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">3822</span>– <span class="NLM_lpage">3831</span>, <span class="refDoi"> DOI: 10.1128/AAC.00113-09</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1128%2FAAC.00113-09" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=19564360" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFCjsrzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2009&pages=3822-3831&author=X.+S.+Panauthor=K.+A.+Gouldauthor=L.+M.+Fisher&title=Probing+the+differential+interactions+of+quinazolinedione+PD+0305970+and+quinolones+with+gyrase+and+topoisomerase+IV&doi=10.1128%2FAAC.00113-09"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Probing the differential interactions of quinazolinedione PD 0305970 and quinolones with gyrase and topoisomerase IV</span></div><div class="casAuthors">Pan, Xiao-Su; Gould, Katherine A.; Fisher, L. Mark</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3822-3831</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Quinazoline-2,4-diones, such as PD 0305970, are new DNA gyrase and topoisomerase IV (topo IV) inhibitors with potent activity against gram-pos. pathogens, including quinolone-resistant isolates.  The mechanistic basis of dione activity vis-a-vis quinolones is not understood.  We present evidence for Streptococcus pneumoniae gyrase and topo IV that PD 0305970 and quinolones interact differently with the enzyme breakage-reunion and Toprim domains, DNA, and Mg2+-four components that are juxtaposed in the topoisomerase cleavage complex to effect DNA scission.  First, PD 0305970 targets primarily gyrase in Streptococcus pneumoniae.  However, unlike quinolones, which select predominantly for gyrA (or topo IV parC) mutations in the brekage-reunion domain, unusually the dione selected for novel mutants with alterations that map to a region of the Toprim domain of GyrB (R456H and E474A or E474D) or ParE (D435H and E475A).  This "dione resistance-detg. region" overlaps the GyrB quinolone resistance-detg. region and the region that binds essential Mg2+ ions, each function involving conserved EGDSA and PLRGK motifs.  Second, dione-resistant gyrase and topo IV were inhibited by ciprofloxacin, whereas quinolone-resistant enzymes (GyrA S81F and ParC S79F) remained susceptible to PD 0305970.  Third, dione-promoted DNA cleavage by gyrase occurred at a distinct repertoire of sites, implying that structural differences with quinolones are sensed at the DNA level.  Fourth, unlike the situation with quinolones, the Mg2+ chelator EDTA did not reverse dione-induced gyrase cleavage nor did the dione promote Mg2+-dependent DNA unwinding.  It appears that PD 0305970 interacts uniquely to stabilize the cleavage complex of gyrase/topo IV perhaps via an altered orientation directed by the bidentate 3-amino-2,4-dione moiety.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfRlrk-S-cDrVg90H21EOLACvtfcHk0ljU1xsPrHD52w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFCjsrzN&md5=d4cc5ca7b61989280fa11287afb79ba1</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1128%2FAAC.00113-09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00113-09%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DX.%2BS.%26aulast%3DGould%26aufirst%3DK.%2BA.%26aulast%3DFisher%26aufirst%3DL.%2BM.%26atitle%3DProbing%2520the%2520differential%2520interactions%2520of%2520quinazolinedione%2520PD%25200305970%2520and%2520quinolones%2520with%2520gyrase%2520and%2520topoisomerase%2520IV%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2009%26volume%3D53%26spage%3D3822%26epage%3D3831%26doi%3D10.1128%2FAAC.00113-09" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aldred, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwanz, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McPherson, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turnbough, C. L.,  Jr</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerns, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osheroff, N.</span></span> <span> </span><span class="NLM_article-title">Overcoming target-mediated quinolone resistance in topoisomerase IV by introducing metal-ion-independent drug-enzyme interactions</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">2660</span>– <span class="NLM_lpage">2668</span>, <span class="refDoi"> DOI: 10.1021/cb400592n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb400592n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVOhurvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=2660-2668&author=K.+J.+Aldredauthor=H.+A.+Schwanzauthor=G.+Liauthor=S.+A.+McPhersonauthor=C.+L.+Turnboughauthor=R.+J.+Kernsauthor=N.+Osheroff&title=Overcoming+target-mediated+quinolone+resistance+in+topoisomerase+IV+by+introducing+metal-ion-independent+drug-enzyme+interactions&doi=10.1021%2Fcb400592n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Overcoming target-mediated quinolone resistance in topoisomerase IV by introducing metal-ion-independent drug-enzyme interactions</span></div><div class="casAuthors">Aldred, Katie J.; Schwanz, Heidi A.; Li, Gangqin; McPherson, Sylvia A.; Turnbough, Charles L.; Kerns, Robert J.; Osheroff, Neil</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2660-2668</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Quinolones, which target gyrase and topoisomerase IV, are the most widely prescribed antibacterials worldwide.  Unfortunately, their use is threatened by the increasing prevalence of target-mediated drug resistance.  Greater than 90% of mutations that confer quinolone resistance act by disrupting enzyme-drug interactions coordinated by a crit. water-metal ion bridge.  Quinazolinediones are quinolone-like drugs but lack the skeletal features necessary to support the bridge interaction.  These compds. are of clin. interest, however, because they retain activity against the most common quinolone resistance mutations.  We utilized a chem. biol. approach to det. how quinazolinediones overcome quinolone resistance in Bacillus anthracis topoisomerase IV.  Quinazolinediones that retain activity against quinolone-resistant topoisomerase IV do so primarily by establishing novel interactions through the C7 substituent, rather than the drug skeleton.  Because some quinolones are highly active against human topoisomerase IIα, we also detd. how clin. relevant quinolones discriminate between the bacterial and human enzymes.  Clin. relevant quinolones display poor activity against topoisomerase IIα because the human enzyme cannot support drug interactions mediated by the water-metal ion bridge.  However, the inclusion of substituents that allow quinazolinediones to overcome topoisomerase IV-mediated quinolone resistance can cause cross-reactivity against topoisomerase IIα.  Therefore, a major challenge in designing drugs that overcome quinolone resistance lies in the ability to identify substituents that mediate strong interactions with the bacterial, but not the human, enzymes.  On the basis of our understanding of quinolone-enzyme interactions, we have prepd. and identified three compds. that display high activity against quinolone-resistant B. anthracis topoisomerase IV but low activity against human topoisomerase IIα.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXYps-i9N2OrVg90H21EOLACvtfcHk0ljTuSbnY7bsdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVOhurvK&md5=d6aa61519a35422aecd686253ded7787</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fcb400592n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb400592n%26sid%3Dliteratum%253Aachs%26aulast%3DAldred%26aufirst%3DK.%2BJ.%26aulast%3DSchwanz%26aufirst%3DH.%2BA.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DMcPherson%26aufirst%3DS.%2BA.%26aulast%3DTurnbough%26aufirst%3DC.%2BL.%26aulast%3DKerns%26aufirst%3DR.%2BJ.%26aulast%3DOsheroff%26aufirst%3DN.%26atitle%3DOvercoming%2520target-mediated%2520quinolone%2520resistance%2520in%2520topoisomerase%2520IV%2520by%2520introducing%2520metal-ion-independent%2520drug-enzyme%2520interactions%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26spage%3D2660%26epage%3D2668%26doi%3D10.1021%2Fcb400592n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jeannot, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taillier, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Despeyroux, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mourez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poeverlein, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khichane, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrin, M.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Versluys, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stavenger, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Germe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maxwell, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huseby, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bacqué, E.</span></span> <span> </span><span class="NLM_article-title">Imidazopyrazinones (IPYs): non-quinolone bacterial topoisomerase inhibitors showing partial cross-resistance with quinolones</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">3565</span>– <span class="NLM_lpage">3581</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01892</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01892" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC1cXms1aru7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=3565-3581&author=F.+Jeannotauthor=T.+Taillierauthor=P.+Despeyrouxauthor=S.+Renardauthor=A.+Reyauthor=M.+Mourezauthor=C.+Poeverleinauthor=I.+Khichaneauthor=M.-A.+Perrinauthor=S.+Versluysauthor=R.+A.+Stavengerauthor=J.+Huangauthor=T.+Germeauthor=A.+Maxwellauthor=S.+Caoauthor=D.+L.+Husebyauthor=D.+Hughesauthor=E.+Bacqu%C3%A9&title=Imidazopyrazinones+%28IPYs%29%3A+non-quinolone+bacterial+topoisomerase+inhibitors+showing+partial+cross-resistance+with+quinolones&doi=10.1021%2Facs.jmedchem.7b01892"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones</span></div><div class="casAuthors">Jeannot, Frederic; Taillier, Thomas; Despeyroux, Pierre; Renard, Stephane; Rey, Astrid; Mourez, Michael; Poeverlein, Christoph; Khichane, Imene; Perrin, Marc-Antoine; Versluys, Stephanie; Stavenger, Robert A.; Huang, Jianzhong; Germe, Thomas; Maxwell, Anthony; Cao, Sha; Huseby, Douglas L.; Hughes, Diarmaid; Bacque, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3565-3581</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In the authors' quest for new antibiotics able to address the growing threat of multidrug resistant infections caused by Gram-neg. bacteria, the authors have investigated an unprecedented series of non-quinolone bacterial topoisomerase inhibitors from the Sanofi patrimony, named IPYs for imidazopyrazinones, as part of the Innovative Medicines Initiative (IMI) European Gram Neg. Antibacterial Engine (ENABLE) organization.  Hybridization of these historical compds. with the quinazolinediones, a known series of topoisomerase inhibitors, led the authors to a novel series of tricyclic IPYs that demonstrated potential for broad spectrum activity, in vivo efficacy, and a good developability profile, although later profiling revealed a genotoxicity risk.  Resistance studies revealed partial cross-resistance with fluoroquinolones (FQs) suggesting that IPYs bind to the same region of bacterial topoisomerases as FQs and interact with at least some of the keys residues involved in FQ binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZQnHBuh7YdbVg90H21EOLACvtfcHk0ljTuSbnY7bsdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXms1aru7w%253D&md5=d88d4fe5b177e8f6f6399766687ac366</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01892&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01892%26sid%3Dliteratum%253Aachs%26aulast%3DJeannot%26aufirst%3DF.%26aulast%3DTaillier%26aufirst%3DT.%26aulast%3DDespeyroux%26aufirst%3DP.%26aulast%3DRenard%26aufirst%3DS.%26aulast%3DRey%26aufirst%3DA.%26aulast%3DMourez%26aufirst%3DM.%26aulast%3DPoeverlein%26aufirst%3DC.%26aulast%3DKhichane%26aufirst%3DI.%26aulast%3DPerrin%26aufirst%3DM.-A.%26aulast%3DVersluys%26aufirst%3DS.%26aulast%3DStavenger%26aufirst%3DR.%2BA.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DGerme%26aufirst%3DT.%26aulast%3DMaxwell%26aufirst%3DA.%26aulast%3DCao%26aufirst%3DS.%26aulast%3DHuseby%26aufirst%3DD.%2BL.%26aulast%3DHughes%26aufirst%3DD.%26aulast%3DBacqu%25C3%25A9%26aufirst%3DE.%26atitle%3DImidazopyrazinones%2520%2528IPYs%2529%253A%2520non-quinolone%2520bacterial%2520topoisomerase%2520inhibitors%2520showing%2520partial%2520cross-resistance%2520with%2520quinolones%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D3565%26epage%3D3581%26doi%3D10.1021%2Facs.jmedchem.7b01892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Germe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vörös, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeannot, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taillier, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stavenger, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bacqué, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maxwell, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bax, B. D.</span></span> <span> </span><span class="NLM_article-title">A new class of antibacterials, the imidazopyrazinones, reveal structural transitions involved in DNA gyrase poisoning and mechanisms of resistance</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">4114</span>– <span class="NLM_lpage">4128</span>, <span class="refDoi"> DOI: 10.1093/nar/gky181</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1093%2Fnar%2Fgky181" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=29538767" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitlKhur3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2018&pages=4114-4128&author=T.+Germeauthor=J.+V%C3%B6r%C3%B6sauthor=F.+Jeannotauthor=T.+Taillierauthor=R.+A.+Stavengerauthor=E.+Bacqu%C3%A9author=A.+Maxwellauthor=B.+D.+Bax&title=A+new+class+of+antibacterials%2C+the+imidazopyrazinones%2C+reveal+structural+transitions+involved+in+DNA+gyrase+poisoning+and+mechanisms+of+resistance&doi=10.1093%2Fnar%2Fgky181"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">A new class of antibacterials, the imidazopyrazinones, reveal structural transitions involved in DNA gyrase poisoning and mechanisms of resistance</span></div><div class="casAuthors">Germe, Thomas; Voros, Judit; Jeannot, Frederic; Taillier, Thomas; Stavenger, Robert A.; Bacque', Eric; Maxwell, Anthony; Bax, Benjamin D.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4114-4128</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">1362-4962</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Imidazopyrazinones (IPYs) are a new class of compds. that target bacterial topoisomerases as a basis for their antibacterial activity.  We have characterized the mechanism of these compds. through structural/mechanistic studies showing they bind and stabilize a cleavage complex between DNA gyrase and DNA ('poisoning') in an analogous fashion to fluoroquinolones, but without the requirement for the water-metal-ion bridge.  Biochem. expts. and structural studies of cleavage complexes of IPYs compared with an uncleaved gyrase-DNA complex, reveal conformational transitions coupled to DNA cleavage at the DNA gate.  These involve movement at the GyrA interface and tilting of the TOPRIM domains toward the scissile phosphate coupled to capture of the catalytic metal ion.  Our expts. show that these structural transitions are involved generally in poisoning of gyrase by therapeutic compds. and resemble those undergone by the enzyme during its ATP-coupled strand-passage cycle.  In addn. to resistance mutations affecting residues that directly interact with the compds., we characterized a mutant (D82N) that inhibits formation of the cleavage complex by the unpoisoned enzyme.  The D82N mutant appears to act by stabilizing the binary conformation of DNA gyrase with uncleaved DNA without direct interaction with the compds.  This provides general insight into the resistance mechanisms to antibiotics targeting bacterial type II topoisomerases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZU-FTcML6jbVg90H21EOLACvtfcHk0ljYD4dF-g240Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitlKhur3I&md5=63afb73c75db0b4aa7fd7e43e97314fb</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgky181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgky181%26sid%3Dliteratum%253Aachs%26aulast%3DGerme%26aufirst%3DT.%26aulast%3DV%25C3%25B6r%25C3%25B6s%26aufirst%3DJ.%26aulast%3DJeannot%26aufirst%3DF.%26aulast%3DTaillier%26aufirst%3DT.%26aulast%3DStavenger%26aufirst%3DR.%2BA.%26aulast%3DBacqu%25C3%25A9%26aufirst%3DE.%26aulast%3DMaxwell%26aufirst%3DA.%26aulast%3DBax%26aufirst%3DB.%2BD.%26atitle%3DA%2520new%2520class%2520of%2520antibacterials%252C%2520the%2520imidazopyrazinones%252C%2520reveal%2520structural%2520transitions%2520involved%2520in%2520DNA%2520gyrase%2520poisoning%2520and%2520mechanisms%2520of%2520resistance%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2018%26volume%3D46%26spage%3D4114%26epage%3D4128%26doi%3D10.1093%2Fnar%2Fgky181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de Vicente Fidalgo, J.</span>; <span class="NLM_string-name">He, H.</span>; <span class="NLM_string-name">Hu, C.</span>; <span class="NLM_string-name">Jiang, Z.</span>; <span class="NLM_string-name">Li, X.</span>; <span class="NLM_string-name">Lu, P.</span>; <span class="NLM_string-name">Mergo, W.</span>; <span class="NLM_string-name">Mutnick, D.</span>; <span class="NLM_string-name">Reck, F.</span>; <span class="NLM_string-name">Rivkin, A.</span>; <span class="NLM_string-name">Skepper, C. K.</span>; <span class="NLM_string-name">Wang, X. M.</span>; <span class="NLM_string-name">Xia, J.</span>; <span class="NLM_string-name">Xu, Y.</span></span> <span> </span><span class="NLM_article-title">Quinolone derivatives as antibacterials</span>. U.S. Patent <span class="NLM_patent">10160726 B2</span>, December 25, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=J.+de+Vicente+Fidalgo&author=H.+He&author=C.+Hu&author=Z.+Jiang&author=X.+Li&author=P.+Lu&author=W.+Mergo&author=D.+Mutnick&author=F.+Reck&author=A.+Rivkin&author=C.+K.+Skepper&author=X.+M.+Wang&author=J.+Xia&author=Y.+Xu&title=Quinolone+derivatives+as+antibacterials"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BVicente%2BFidalgo%26aufirst%3DJ.%26atitle%3DQuinolone%2520derivatives%2520as%2520antibacterials%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Payne, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gwynn, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmes, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pompliano, D. L.</span></span> <span> </span><span class="NLM_article-title">Drugs for bad bugs: confronting the challenges of antibacterial discovery</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">29</span>– <span class="NLM_lpage">40</span>, <span class="refDoi"> DOI: 10.1038/nrd2201</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1038%2Fnrd2201" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=17159923" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlGktbfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=29-40&author=D.+J.+Payneauthor=M.+N.+Gwynnauthor=D.+J.+Holmesauthor=D.+L.+Pompliano&title=Drugs+for+bad+bugs%3A+confronting+the+challenges+of+antibacterial+discovery&doi=10.1038%2Fnrd2201"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Drugs for bad bugs: confronting the challenges of antibacterial discovery</span></div><div class="casAuthors">Payne, David J.; Gwynn, Michael N.; Holmes, David J.; Pompliano, David L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">29-40</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The sequencing of the first complete bacterial genome in 1995 heralded a new era of hope for antibacterial drug discoverers, who now had the tools to search entire genomes for new antibacterial targets.  Several companies, including GlaxoSmithKline, moved back into the antibacterials area and embraced a genomics-derived, target-based approach to screen for new classes of drugs with novel modes of action.  Here, we share our experience of evaluating more than 300 genes and 70 high-throughput screening campaigns over a period of 7 years, and look at what we learned and how that has influenced GlaxoSmithKline's antibacterials strategy going forward.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqH1tM2BSZbWLVg90H21EOLACvtfcHk0lgTOSElvrUvXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlGktbfM&md5=18100253f9868af578ea621ab98a5c86</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1038%2Fnrd2201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2201%26sid%3Dliteratum%253Aachs%26aulast%3DPayne%26aufirst%3DD.%2BJ.%26aulast%3DGwynn%26aufirst%3DM.%2BN.%26aulast%3DHolmes%26aufirst%3DD.%2BJ.%26aulast%3DPompliano%26aufirst%3DD.%2BL.%26atitle%3DDrugs%2520for%2520bad%2520bugs%253A%2520confronting%2520the%2520challenges%2520of%2520antibacterial%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D29%26epage%3D40%26doi%3D10.1038%2Fnrd2201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Silver, L. L.</span></span> <span> </span><span class="NLM_article-title">Challenges of antibacterial discovery</span>. <i>Clin. Microbiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">71</span>– <span class="NLM_lpage">109</span>, <span class="refDoi"> DOI: 10.1128/CMR.00030-10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1128%2FCMR.00030-10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=21233508" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjtFSgu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2011&pages=71-109&author=L.+L.+Silver&title=Challenges+of+antibacterial+discovery&doi=10.1128%2FCMR.00030-10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Challenges of antibacterial discovery</span></div><div class="casAuthors">Silver, Lynn L.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Microbiology Reviews</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">71-109</span>CODEN:
                <span class="NLM_cas:coden">CMIREX</span>;
        ISSN:<span class="NLM_cas:issn">0893-8512</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A review.  The discovery of novel small-mol. antibacterial drugs has been stalled for many years.  The purpose of this review is to underscore and illustrate those scientific problems unique to the discovery and optimization of novel antibacterial agents that have adversely affected the output of the effort.  The major challenges fall into two areas: (i) proper target selection, particularly the necessity of pursuing mol. targets that are not prone to rapid resistance development, and (ii) improvement of chem. libraries to overcome limitations of diversity, esp. that which is necessary to overcome barriers to bacterial entry and proclivity to be effluxed, esp. in Gram-neg. organisms.  Failure to address these problems has led to a great deal of misdirected effort.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsTDYwtK6vHbVg90H21EOLACvtfcHk0lgTOSElvrUvXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjtFSgu7s%253D&md5=a77b7a1f2763b73d4bd63daf67f78cc7</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1128%2FCMR.00030-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FCMR.00030-10%26sid%3Dliteratum%253Aachs%26aulast%3DSilver%26aufirst%3DL.%2BL.%26atitle%3DChallenges%2520of%2520antibacterial%2520discovery%26jtitle%3DClin.%2520Microbiol.%2520Rev.%26date%3D2011%26volume%3D24%26spage%3D71%26epage%3D109%26doi%3D10.1128%2FCMR.00030-10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tommasi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walkup, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manchester, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, A. A.</span></span> <span> </span><span class="NLM_article-title">ESKAPEing the labyrinth of antibacterial discovery</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">529</span>– <span class="NLM_lpage">542</span>, <span class="refDoi"> DOI: 10.1038/nrd4572</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1038%2Fnrd4572" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=26139286" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFyks77M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=529-542&author=R.+Tommasiauthor=D.+G.+Brownauthor=G.+K.+Walkupauthor=J.+I.+Manchesterauthor=A.+A.+Miller&title=ESKAPEing+the+labyrinth+of+antibacterial+discovery&doi=10.1038%2Fnrd4572"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">ESKAPEing the labyrinth of antibacterial discovery</span></div><div class="casAuthors">Tommasi, Ruben; Brown, Dean G.; Walkup, Grant K.; Manchester, John I.; Miller, Alita A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">529-542</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Antimicrobial drug resistance is a growing threat to global public health.  Multidrug resistance among the 'ESKAPE' organisms - encompassing Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp. - is of particular concern because they are responsible for many serious infections in hospitals.  Although some promising agents are in the pipeline, there is an urgent need for new antibiotic scaffolds.  However, antibacterial researchers have struggled to identify new small mols. with meaningful cellular activity, esp. those effective against multidrug-resistant Gram-neg. pathogens.  This difficulty ultimately stems from an incomplete understanding of efflux systems and compd. permeation through bacterial membranes.  This Opinion article describes findings from target-based and phenotypic screening efforts carried out at AstraZeneca over the past decade, discusses some of the subsequent chem. challenges and concludes with a description of new approaches comprising a combination of computational modeling and advanced biol. tools which may pave the way towards the discovery of new antibacterial agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolJg6HXnn7BLVg90H21EOLACvtfcHk0lgTOSElvrUvXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFyks77M&md5=0d3159250e27926ab280c305ea5fb9ef</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1038%2Fnrd4572&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4572%26sid%3Dliteratum%253Aachs%26aulast%3DTommasi%26aufirst%3DR.%26aulast%3DBrown%26aufirst%3DD.%2BG.%26aulast%3DWalkup%26aufirst%3DG.%2BK.%26aulast%3DManchester%26aufirst%3DJ.%2BI.%26aulast%3DMiller%26aufirst%3DA.%2BA.%26atitle%3DESKAPEing%2520the%2520labyrinth%2520of%2520antibacterial%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2015%26volume%3D14%26spage%3D529%26epage%3D542%26doi%3D10.1038%2Fnrd4572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nikaido, H.</span></span> <span> </span><span class="NLM_article-title">Prevention of drug access to bacterial targets: permeability barriers and active efflux</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>264</i></span>,  <span class="NLM_fpage">382</span>– <span class="NLM_lpage">388</span>, <span class="refDoi"> DOI: 10.1126/science.8153625</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1126%2Fscience.8153625" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=8153625" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADyaK2cXis1Ggurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=264&publication_year=1994&pages=382-388&author=H.+Nikaido&title=Prevention+of+drug+access+to+bacterial+targets%3A+permeability+barriers+and+active+efflux&doi=10.1126%2Fscience.8153625"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Prevention of drug access to bacterial targets: permeability barriers and active efflux</span></div><div class="casAuthors">Nikaido, Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">264</span>
        (<span class="NLM_cas:issue">5157</span>),
    <span class="NLM_cas:pages">382-8</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">A review with 79 refs.  Some species of bacteria have low-permeability membrane barriers and are thereby intrinsically resistant to many antibiotics.  Some strains of originally antibiotic-susceptible species may also acquire resistance through decreases in the permeability of membrane barriers.  Another mechanism for preventing access of drugs to targets is the membrane-assocd. energy-driven efflux, which plays a major role in drug resistance, esp. in combination with the permeation barrier.  Recent results indicate the existence of bacterial efflux systems of extremely broad substrate specificity, in many ways reminiscent of the multidrug resistance pump of mammalian cells.  One such system seems to play a major role in the intrinsic resistance of Pseudomonas aeruginosa, a common opportunistic pathogen.  As the pharmacol. industry succeeds in producing agents that can overcome specific mechanisms of bacterial resistance, less specific resistance mechanisms such as permeability barriers and multidrug active efflux may become increasingly significant in the clin. setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYpbgrhsj0ZrVg90H21EOLACvtfcHk0likJ9ixEpNVNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXis1Ggurc%253D&md5=84eedec2b82bfc061f17d0d5b4e6973d</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1126%2Fscience.8153625&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.8153625%26sid%3Dliteratum%253Aachs%26aulast%3DNikaido%26aufirst%3DH.%26atitle%3DPrevention%2520of%2520drug%2520access%2520to%2520bacterial%2520targets%253A%2520permeability%2520barriers%2520and%2520active%2520efflux%26jtitle%3DScience%26date%3D1994%26volume%3D264%26spage%3D382%26epage%3D388%26doi%3D10.1126%2Fscience.8153625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hancock, R. E. W.</span></span> <span> </span><span class="NLM_article-title">The bacterial outer membrane as a drug barrier</span>. <i>Trends Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">37</span>– <span class="NLM_lpage">42</span>, <span class="refDoi"> DOI: 10.1016/S0966-842X(97)81773-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1016%2FS0966-842X%2897%2981773-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=9025234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A280%3ADyaK2s7nslOhug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1997&pages=37-42&author=R.+E.+W.+Hancock&title=The+bacterial+outer+membrane+as+a+drug+barrier&doi=10.1016%2FS0966-842X%2897%2981773-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">The bacterial outer membrane as a drug barrier</span></div><div class="casAuthors">Hancock R E</div><div class="citationInfo"><span class="NLM_cas:title">Trends in microbiology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">37-42</span>
        ISSN:<span class="NLM_cas:issn">0966-842X</span>.
    </div><div class="casAbstract">The outer membranes of Gram-negative bacteria constitute a semi-permeable barrier, as indicated by the corresponding alterations in outer membrane permeability and in antibiotic susceptibility resulting from mutation or polycation action.  Restricted outer membrane permeability works in synergy with co-determinant resistance mechanisms, such as the periplasmic enzyme beta-lactamase or active efflux mechanisms, bringing about antibiotic resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR01tkjdQJB8hpyrDyM_m9cfW6udTcc2eYMe2PM23oKIbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2s7nslOhug%253D%253D&md5=84cb78b3dd93745be4923d8bc6e297c7</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2FS0966-842X%2897%2981773-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0966-842X%252897%252981773-8%26sid%3Dliteratum%253Aachs%26aulast%3DHancock%26aufirst%3DR.%2BE.%2BW.%26atitle%3DThe%2520bacterial%2520outer%2520membrane%2520as%2520a%2520drug%2520barrier%26jtitle%3DTrends%2520Microbiol.%26date%3D1997%26volume%3D5%26spage%3D37%26epage%3D42%26doi%3D10.1016%2FS0966-842X%2897%2981773-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nikaido, H.</span></span> <span> </span><span class="NLM_article-title">Molecular basis of bacterial outer membrane permeability revisited</span>. <i>Microbiol. Mol. Biol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">593</span>– <span class="NLM_lpage">656</span>, <span class="refDoi"> DOI: 10.1128/MMBR.67.4.593-656.2003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1128%2FMMBR.67.4.593-656.2003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=14665678" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmt1Sqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2003&pages=593-656&author=H.+Nikaido&title=Molecular+basis+of+bacterial+outer+membrane+permeability+revisited&doi=10.1128%2FMMBR.67.4.593-656.2003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular basis of bacterial outer membrane permeability revisited</span></div><div class="casAuthors">Nikaido, Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Microbiology and Molecular Biology Reviews</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">593-656</span>CODEN:
                <span class="NLM_cas:coden">MMBRF7</span>;
        ISSN:<span class="NLM_cas:issn">1092-2172</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A review.  Gram-neg. bacteria characteristically are surrounded by an addnl. membrane layer, the outer membrane.  Although outer membrane components often play important roles in the interaction of symbiotic or pathogenic bacteria with their host organisms, the major role of this membrane must usually be to serve as a permeability barrier to prevent the entry of noxious compds. and at the same time to allow the influx of nutrient mols.  This review summarizes the development in the field since our previous review (H. Nikaido and M. Vaara, Microbiol. Rev. 49:1-32, 1985) was published.  With the discovery of protein channels, structural knowledge enables us to understand in mol. detail how porins, specific channels, TonB-linked receptors, and other proteins function.  We are now beginning to see how the export of large proteins occurs across the outer membrane.  With our knowledge of the lipopolysaccharide phospholipid asym. bilayer of the outer membrane, we are finally beginning to understand how this bilayer can retard the entry of lipophilic compds., owing to our increasing knowledge about the chem. of lipopolysaccharide from diverse organisms and the way in which lipopolysaccharide structure is modified by environmental conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroTpomI_d5ErVg90H21EOLACvtfcHk0lhz-rrS-FBoXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmt1Sqsg%253D%253D&md5=6b2e709a18bc697e20070aafb412b06f</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1128%2FMMBR.67.4.593-656.2003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMMBR.67.4.593-656.2003%26sid%3Dliteratum%253Aachs%26aulast%3DNikaido%26aufirst%3DH.%26atitle%3DMolecular%2520basis%2520of%2520bacterial%2520outer%2520membrane%2520permeability%2520revisited%26jtitle%3DMicrobiol.%2520Mol.%2520Biol.%2520Rev.%26date%3D2003%26volume%3D67%26spage%3D593%26epage%3D656%26doi%3D10.1128%2FMMBR.67.4.593-656.2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.-Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikaido, H.</span></span> <span> </span><span class="NLM_article-title">Efflux-mediated drug resistance in bacteria</span>. <i>Drugs</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">159</span>– <span class="NLM_lpage">204</span>, <span class="refDoi"> DOI: 10.2165/00003495-200464020-00004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.2165%2F00003495-200464020-00004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=14717618" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhvVGntL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=159-204&author=X.-Z.+Liauthor=H.+Nikaido&title=Efflux-mediated+drug+resistance+in+bacteria&doi=10.2165%2F00003495-200464020-00004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Efflux-mediated drug resistance in bacteria</span></div><div class="casAuthors">Li, Xian-Zhi; Nikaido, Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Drugs</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">159-204</span>CODEN:
                <span class="NLM_cas:coden">DRUGAY</span>;
        ISSN:<span class="NLM_cas:issn">0012-6667</span>.
    
            (<span class="NLM_cas:orgname">Adis International Ltd.</span>)
        </div><div class="casAbstract">A review.  Drug resistance in bacteria, and esp. resistance to multiple antibacterials, has attracted much attention in recent years.  In addn. to the well known mechanisms, such as inactivation of drugs and alteration of targets, active efflux is now known to play a major role in the resistance of many species to antibacterials.  Drug-specific efflux (e.g., that of tetracycline) has been recognized as the major mechanism of resistance to this drug in Gram-neg. bacteria.  In addn., we now recognize that multidrug efflux pumps are becoming increasingly important.  Such pumps play major roles in the antiseptic resistance of Staphylococcus aureus, and fluoroquinolone resistance of S. aureus and Streptococcus pneumoniae.  Multidrug pumps, often with very wide substrate specificity, are not only essential for the intrinsic resistance of many Gram-neg. bacteria but also produce elevated levels of resistance when overexpressed.  Paradoxically, 'advanced' agents for which resistance is unlikely to be caused by traditional mechanisms, such as fluoroquinolones and β-lactams of the latest generations, are likely to select for overprodn. mutants of these pumps and make the bacteria resistant in one step to practically all classes of antibacterial agents.  Such overprodn. mutants are also selected for by the use of antiseptics and biocides, increasingly incorporated into consumer products, and this is also of major concern.  We can consider efflux pumps as potentially effective antibacterial targets.  Inhibition of efflux pumps by an efflux pump inhibitor would restore the activity of an agent subject to efflux.  An alternative approach is to develop antibacterials that would bypass the action of efflux pumps.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr748rN_mRyP7Vg90H21EOLACvtfcHk0lhz-rrS-FBoXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhvVGntL0%253D&md5=a8e38065f32933d3d92b09995cbb6d42</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.2165%2F00003495-200464020-00004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00003495-200464020-00004%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.-Z.%26aulast%3DNikaido%26aufirst%3DH.%26atitle%3DEfflux-mediated%2520drug%2520resistance%2520in%2520bacteria%26jtitle%3DDrugs%26date%3D2004%26volume%3D64%26spage%3D159%26epage%3D204%26doi%3D10.2165%2F00003495-200464020-00004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schweizer, H. P.</span></span> <span> </span><span class="NLM_article-title">Bacterial resistance to antibiotics: active efflux and reduced uptake</span>. <i>Adv. Drug Delivery Rev.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">1486</span>– <span class="NLM_lpage">1513</span>, <span class="refDoi"> DOI: 10.1016/j.addr.2005.04.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1016%2Fj.addr.2005.04.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=15939505" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlvFant70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2005&pages=1486-1513&author=A.+Kumarauthor=H.+P.+Schweizer&title=Bacterial+resistance+to+antibiotics%3A+active+efflux+and+reduced+uptake&doi=10.1016%2Fj.addr.2005.04.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Bacterial resistance to antibiotics: Active efflux and reduced uptake</span></div><div class="casAuthors">Kumar, Ayush; Schweizer, Herbert P.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1486-1513</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Antibiotic resistance of bacterial pathogens is a fast emerging global crisis and an understanding of the underlying resistance mechanisms is paramount for the design and development of new therapeutic strategies.  Permeability barriers for and active efflux of drug mols. are 2 resistance mechanisms that have been implicated in various infectious outbreaks of antibiotic-resistant pathogens, suggesting that these mechanisms may be good targets for new drugs.  The synergism of reduced uptake and efflux is most evident in the multiplicative action of the outer membrane permeability barrier and active efflux, which results in high-level intrinsic and(or) acquired resistance in many clin. important gram-neg. bacteria.  This review summarizes the current knowledge of these 2 important resistance mechanisms and potential strategies to overcome them.  Recent advances in understanding the phys. structures, function, and regulation of efflux systems will facilitate exploitation of pumps as new drug targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDE1hxxbXPQrVg90H21EOLACvtfcHk0ljZat9jHDCJTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlvFant70%253D&md5=b1b9bed1deab6c70f83062d73abafc4f</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.addr.2005.04.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.addr.2005.04.004%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DA.%26aulast%3DSchweizer%26aufirst%3DH.%2BP.%26atitle%3DBacterial%2520resistance%2520to%2520antibiotics%253A%2520active%2520efflux%2520and%2520reduced%2520uptake%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2005%26volume%3D57%26spage%3D1486%26epage%3D1513%26doi%3D10.1016%2Fj.addr.2005.04.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lomovskaya, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zgurskaya, H. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Totrov, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watkins, W. J.</span></span> <span> </span><span class="NLM_article-title">Waltzing transporters and ‘the dance macabre’ between humans and bacteria</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">56</span>– <span class="NLM_lpage">65</span>, <span class="refDoi"> DOI: 10.1038/nrd2200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1038%2Fnrd2200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=17159924" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlGktbbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=56-65&author=O.+Lomovskayaauthor=H.+I.+Zgurskayaauthor=M.+Totrovauthor=W.+J.+Watkins&title=Waltzing+transporters+and+%E2%80%98the+dance+macabre%E2%80%99+between+humans+and+bacteria&doi=10.1038%2Fnrd2200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Waltzing transporters and 'the dance macabre' between humans and bacteria</span></div><div class="casAuthors">Lomovskaya, Olga; Zgurskaya, Helen I.; Totrov, Maxim; Watkins, William J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">56-65</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Multi-drug-resistance efflux pumps - in particular those belonging to the resistance-nodulation-cell-division (RND) family of transporters, with their unusually high degree of substrate promiscuity - significantly restrict the effectiveness of antibacterial therapy.  Recent years have heralded remarkable insights into the structure and mechanisms of these fascinating mol. machines.  Here, we review recent advances in the field and describe various approaches used in combating efflux-mediated resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovMk_rinojGLVg90H21EOLACvtfcHk0ljZat9jHDCJTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlGktbbF&md5=8acc67c9ee16f8853ba52f4a667181a2</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1038%2Fnrd2200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2200%26sid%3Dliteratum%253Aachs%26aulast%3DLomovskaya%26aufirst%3DO.%26aulast%3DZgurskaya%26aufirst%3DH.%2BI.%26aulast%3DTotrov%26aufirst%3DM.%26aulast%3DWatkins%26aufirst%3DW.%2BJ.%26atitle%3DWaltzing%2520transporters%2520and%2520%25E2%2580%2598the%2520dance%2520macabre%25E2%2580%2599%2520between%2520humans%2520and%2520bacteria%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D56%26epage%3D65%26doi%3D10.1038%2Fnrd2200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Delcour, A. H.</span></span> <span> </span><span class="NLM_article-title">Outer membrane permeability and antibiotic resistance</span>. <i>Biochim. Biophys. Acta, Proteins Proteomics</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>1794</i></span>,  <span class="NLM_fpage">808</span>– <span class="NLM_lpage">816</span>, <span class="refDoi"> DOI: 10.1016/j.bbapap.2008.11.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1016%2Fj.bbapap.2008.11.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=19100346" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkvVSrtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1794&publication_year=2009&pages=808-816&author=A.+H.+Delcour&title=Outer+membrane+permeability+and+antibiotic+resistance&doi=10.1016%2Fj.bbapap.2008.11.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Outer membrane permeability and antibiotic resistance</span></div><div class="casAuthors">Delcour, Anne H.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Proteins and Proteomics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">1794</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">808-816</span>CODEN:
                <span class="NLM_cas:coden">BBAPBW</span>;
        ISSN:<span class="NLM_cas:issn">1570-9639</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">A review.  To date most antibiotics are targeted at intracellular processes, and must be able to penetrate the bacterial cell envelope.  In particular, the outer membrane of gram-neg. bacteria provides a formidable barrier that must be overcome.  There are essentially two pathways that antibiotics can take through the outer membrane: a lipid-mediated pathway for hydrophobic antibiotics, and general diffusion porins for hydrophilic antibiotics.  The lipid and protein compns. of the outer membrane have a strong impact on the sensitivity of bacteria to many types of antibiotics, and drug resistance involving modifications of these macromols. is common.  This review describes the mol. mechanisms for permeation of antibiotics through the outer membrane, and the strategies that bacteria have deployed to resist antibiotics by modifications of these pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnujySVWxi3bVg90H21EOLACvtfcHk0lj54UoUou_VMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkvVSrtr4%253D&md5=b32db36960e4c0d122bef0c3648462e8</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.bbapap.2008.11.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbapap.2008.11.005%26sid%3Dliteratum%253Aachs%26aulast%3DDelcour%26aufirst%3DA.%2BH.%26atitle%3DOuter%2520membrane%2520permeability%2520and%2520antibiotic%2520resistance%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Proteins%2520Proteomics%26date%3D2009%26volume%3D1794%26spage%3D808%26epage%3D816%26doi%3D10.1016%2Fj.bbapap.2008.11.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zgurskaya, H. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gnanakaran, S.</span></span> <span> </span><span class="NLM_article-title">Permeability barrier of Gram-negative cell envelopes and approaches to bypass it</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">512</span>– <span class="NLM_lpage">522</span>, <span class="refDoi"> DOI: 10.1021/acsinfecdis.5b00097</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.5b00097" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFWqur%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2015&pages=512-522&author=H.+I.+Zgurskayaauthor=C.+A.+Lopezauthor=S.+Gnanakaran&title=Permeability+barrier+of+Gram-negative+cell+envelopes+and+approaches+to+bypass+it&doi=10.1021%2Facsinfecdis.5b00097"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Permeability Barrier of Gram-Negative Cell Envelopes and Approaches To Bypass It</span></div><div class="casAuthors">Zgurskaya, Helen I.; Lopez, Cesar A.; Gnanakaran, S.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">512-522</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Gram-neg. bacteria are intrinsically resistant to many antibiotics.  Species that have acquired multidrug resistance and cause infections that are effectively untreatable present a serious threat to public health.  The problem is broadly recognized and tackled at both the fundamental and applied levels.  This paper summarizes current advances in understanding the mol. bases of the low permeability barrier of Gram-neg. pathogens, which is the major obstacle in discovery and development of antibiotics effective against such pathogens.  Gaps in knowledge and specific strategies to break this barrier and to achieve potent activities against difficult Gram-neg. bacteria are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0vgfVHZir5bVg90H21EOLACvtfcHk0lj54UoUou_VMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFWqur%252FM&md5=fd65ac8b7277ad540733ede53e168d9a</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.5b00097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.5b00097%26sid%3Dliteratum%253Aachs%26aulast%3DZgurskaya%26aufirst%3DH.%2BI.%26aulast%3DLopez%26aufirst%3DC.%2BA.%26aulast%3DGnanakaran%26aufirst%3DS.%26atitle%3DPermeability%2520barrier%2520of%2520Gram-negative%2520cell%2520envelopes%2520and%2520approaches%2520to%2520bypass%2520it%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2015%26volume%3D1%26spage%3D512%26epage%3D522%26doi%3D10.1021%2Facsinfecdis.5b00097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Silver, L. L.</span></span> <span> </span><span class="NLM_article-title">A Gestalt approach to Gram-negative entry</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">6379</span>– <span class="NLM_lpage">6389</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2016.06.044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1016%2Fj.bmc.2016.06.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=27381365" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVaqur%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=6379-6389&author=L.+L.+Silver&title=A+Gestalt+approach+to+Gram-negative+entry&doi=10.1016%2Fj.bmc.2016.06.044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">A Gestalt approach to Gram-negative entry</span></div><div class="casAuthors">Silver, Lynn L.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6379-6389</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  A major obstacle confronting the discovery and development of new antibacterial agents to combat resistant Gram-neg. (GN) organisms is the lack of a rational process for endowing compds. with properties that allow (or promote) entry into the bacterial cytoplasm.  The major permeability difference between GN and Gram-pos. (GP) bacteria is the GN outer membrane (OM) which is a permeability barrier itself and potentiates efflux pumps that expel compds.  Based on the fact that OM-permeable and efflux-deleted GNs are sensitive to many anti-GP drugs, recent efforts to approach the GN entry problem have focused on ways of avoiding efflux and transiting or compromising the OM, with the tacit assumption that this could allow entry of compds. into the GN cytoplasm.  But bypassing the OM and efflux obstacles does not take into account the addnl. requirement of penetrating the cytoplasmic membrane (CM) whose sieving properties appear to be orthogonal to that of the OM.  That is, tailoring compds. to transit the OM may well compromise their ability to enter the cytoplasm.  Thus, a Gestalt approach to understanding the chem. requirements for GN entry seems a useful adjunct.  This might consist of characterizing compds. which reach the cytoplasm, grouping (or binning) by routes of entry and formulating chem. rules for those bins.  This will require acquisition of data on large nos. of compds., using non-activity-dependent methods of measuring accumulation in the cytoplasm.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqs-T6vYmkrrVg90H21EOLACvtfcHk0lipXzBfaQdulg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVaqur%252FP&md5=08ca97526e7f3c8c8781307e52e96e9a</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.06.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.06.044%26sid%3Dliteratum%253Aachs%26aulast%3DSilver%26aufirst%3DL.%2BL.%26atitle%3DA%2520Gestalt%2520approach%2520to%2520Gram-negative%2520entry%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26spage%3D6379%26epage%3D6389%26doi%3D10.1016%2Fj.bmc.2016.06.044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Shea, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moser, H. E.</span></span> <span> </span><span class="NLM_article-title">Physicochemical properties of antibacterial compounds: implications for drug discovery</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">2871</span>– <span class="NLM_lpage">2878</span>, <span class="refDoi"> DOI: 10.1021/jm700967e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm700967e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlvFCrsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=2871-2878&author=R.+O%E2%80%99Sheaauthor=H.+E.+Moser&title=Physicochemical+properties+of+antibacterial+compounds%3A+implications+for+drug+discovery&doi=10.1021%2Fjm700967e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Physicochemical properties of antibacterial compounds: implications for drug discovery</span></div><div class="casAuthors">O'Shea, Rosemarie; Moser, Heinz E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2871-2878</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">With the rise of multidrug-resistant pathogens and the need for novel antibiotics, it is crit. to understand as much as possible from prior efforts and to apply learned lessons to the discovery of future antibiotics.  One important parameter in particular has previously been mentioned but, in the view, not sufficiently analyzed: the physicochem. property space of antibacterial drugs.  The authors selected 147 antibacterially active compds. that encompass both currently used drugs and compds. that are still under clin. investigation (see Methods for details).  Where available, other property values were extd. from the literature, including protein binding and oral bioavailability in humans.  This anal. suggests that natural products should be increasingly investigated again to identify novel antibacterial hits.  Besides their high level of structural diversity, they are likely to better cover the required physicochem. property space for antibacterial compds. compared to synthetic mols. because of an increased d. of polar functionalities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo25EGWMkWdk7Vg90H21EOLACvtfcHk0lipXzBfaQdulg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlvFCrsLw%253D&md5=8aae7d962df53b70113e0fe6169abd68</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjm700967e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm700967e%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DR.%26aulast%3DMoser%26aufirst%3DH.%2BE.%26atitle%3DPhysicochemical%2520properties%2520of%2520antibacterial%2520compounds%253A%2520implications%2520for%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D2871%26epage%3D2878%26doi%3D10.1021%2Fjm700967e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Manchester, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buurman, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bisacchi, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLaughlin, R. E.</span></span> <span> </span><span class="NLM_article-title">Molecular determinants of AcrB-mediated bacterial efflux implications for drug discovery</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">2532</span>– <span class="NLM_lpage">2537</span>, <span class="refDoi"> DOI: 10.1021/jm201275d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201275d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC38XktVKhsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=2532-2537&author=J.+I.+Manchesterauthor=E.+T.+Buurmanauthor=G.+S.+Bisacchiauthor=R.+E.+McLaughlin&title=Molecular+determinants+of+AcrB-mediated+bacterial+efflux+implications+for+drug+discovery&doi=10.1021%2Fjm201275d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Determinants of AcrB-Mediated Bacterial Efflux Implications for Drug Discovery</span></div><div class="casAuthors">Manchester, John I.; Buurman, Ed T.; Bisacchi, Gregory S.; McLaughlin, Robert E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2532-2537</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Retrospective anal. on antibacterial compds. from discovery programs targeting Gram-neg. pathogens. We used antimicrobial activities, measured as minimal inhibitory concns. Important implication for drug discovery is that targeting specific ranges of phys. properties is not enough to guarantee antibacterial activity. We incorporated structural motifs that exploit one or more avenues for circumventing efflux in the design and selection of novel compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVBaNXOZf6j7Vg90H21EOLACvtfcHk0ljSqnxHb5EGIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktVKhsw%253D%253D&md5=2e2b7f1fb2d4a3c84b91ecb11b24c999</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fjm201275d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201275d%26sid%3Dliteratum%253Aachs%26aulast%3DManchester%26aufirst%3DJ.%2BI.%26aulast%3DBuurman%26aufirst%3DE.%2BT.%26aulast%3DBisacchi%26aufirst%3DG.%2BS.%26aulast%3DMcLaughlin%26aufirst%3DR.%2BE.%26atitle%3DMolecular%2520determinants%2520of%2520AcrB-mediated%2520bacterial%2520efflux%2520implications%2520for%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D2532%26epage%3D2537%26doi%3D10.1021%2Fjm201275d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">May-Dracka, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gagnon, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tommasi, R.</span></span> <span> </span><span class="NLM_article-title">Trends and exceptions of physical properties on antibacterial activity for Gram-positive and Gram-negative pathogens</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">10144</span>– <span class="NLM_lpage">10161</span>, <span class="refDoi"> DOI: 10.1021/jm501552x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501552x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFehtbvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=10144-10161&author=D.+G.+Brownauthor=T.+L.+May-Drackaauthor=M.+M.+Gagnonauthor=R.+Tommasi&title=Trends+and+exceptions+of+physical+properties+on+antibacterial+activity+for+Gram-positive+and+Gram-negative+pathogens&doi=10.1021%2Fjm501552x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Trends and Exceptions of Physical Properties on Antibacterial Activity for Gram-Positive and Gram-Negative Pathogens</span></div><div class="casAuthors">Brown, Dean G.; May-Dracka, Tricia L.; Gagnon, Moriah M.; Tommasi, Ruben</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10144-10161</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To better understand the difficulties surrounding the identification of novel antibacterial compds. from corporate screening collections, phys. properties of ∼3200 antibacterial project compds. with whole cell activity against Gram-neg. or Gram-pos. pathogens were profiled and compared to actives found from high throughput (HTS) screens conducted on both biochem. and phenotypic bacterial targets.  The output from 23 antibacterial HTS screens illustrated that when compared to the properties of the antibacterial project compds., the HTS actives were significantly more hydrophobic than antibacterial project compds. (typically 2-4 log units higher), and furthermore, for 14/23 HTS screens, the av. clogD was higher than the screening collection av. (screening collection clogD = 2.45).  It was found that the consequences of this were the following: (a) lead identification programs often further gained hydrophobic character with increased biochem. potency, making the sepn. even larger between the physicochem. properties of known antibacterial agents and the HTS active starting point, (b) the probability of plasma protein binding and cytotoxicity are often increased, and (c) cell-based activity in Gram-neg. bacteria was severely limited or, if present, demonstrated significant efflux.  Our anal. illustrated that compds. least susceptible to efflux were those which were highly polar and small in MW or very large and typically zwitterionic.  Hydrophobicity was often the dominant driver for HTS actives but, more often than not, precluded whole cell antibacterial activity.  However, simply designing polar compds. was not sufficient for antibacterial activity and pointed to a lack of understanding of complex and specific bacterial penetration mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-f01NZg_bsbVg90H21EOLACvtfcHk0ljSqnxHb5EGIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFehtbvN&md5=e107961414dc8cbf696e2287ddf9362d</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fjm501552x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501552x%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DD.%2BG.%26aulast%3DMay-Dracka%26aufirst%3DT.%2BL.%26aulast%3DGagnon%26aufirst%3DM.%2BM.%26aulast%3DTommasi%26aufirst%3DR.%26atitle%3DTrends%2520and%2520exceptions%2520of%2520physical%2520properties%2520on%2520antibacterial%2520activity%2520for%2520Gram-positive%2520and%2520Gram-negative%2520pathogens%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D10144%26epage%3D10161%26doi%3D10.1021%2Fjm501552x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tommasi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iyer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, A. A.</span></span> <span> </span><span class="NLM_article-title">Antibacterial drug discovery: some assembly required</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">686</span>– <span class="NLM_lpage">695</span>, <span class="refDoi"> DOI: 10.1021/acsinfecdis.8b00027</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.8b00027" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjtlOqurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2018&pages=686-695&author=R.+Tommasiauthor=R.+Iyerauthor=A.+A.+Miller&title=Antibacterial+drug+discovery%3A+some+assembly+required&doi=10.1021%2Facsinfecdis.8b00027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Antibacterial Drug Discovery: Some Assembly Required</span></div><div class="casAuthors">Tommasi, Ruben; Iyer, Ramkumar; Miller, Alita A.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">686-695</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Our limited understanding of the mol. basis for compd. entry into and efflux out of Gram-neg. bacteria is now recognized as a key bottleneck for the rational discovery of novel antibacterial compds.  Traditional, large-scale biochem. or target-agnostic phenotypic antibacterial screening efforts have, as a result, not been very fruitful.  A main driver of this knowledge gap has been the historical lack of predictive cellular assays, tools, and models that provide structure-activity relationships to inform optimization of compd. accumulation.  A variety of recent approaches has recently been described to address this conundrum.  This Perspective explores these approaches and considers ways in which their integration could successfully redirect antibacterial drug discovery efforts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonfRBE2Xs8GrVg90H21EOLACvtfcHk0ljSqnxHb5EGIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjtlOqurk%253D&md5=57ab82ebe1d0d39199581344414e6c94</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.8b00027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.8b00027%26sid%3Dliteratum%253Aachs%26aulast%3DTommasi%26aufirst%3DR.%26aulast%3DIyer%26aufirst%3DR.%26aulast%3DMiller%26aufirst%3DA.%2BA.%26atitle%3DAntibacterial%2520drug%2520discovery%253A%2520some%2520assembly%2520required%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2018%26volume%3D4%26spage%3D686%26epage%3D695%26doi%3D10.1021%2Facsinfecdis.8b00027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Richter, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hergenrother, P. J.</span></span> <span> </span><span class="NLM_article-title">The challenge of converting Gram-positive-only compounds into broad-spectrum antibiotics</span>. <i>Ann. N. Y. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>1435</i></span>,  <span class="NLM_fpage">18</span>– <span class="NLM_lpage">38</span>, <span class="refDoi"> DOI: 10.1111/nyas.13598</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1111%2Fnyas.13598" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=29446459" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlyktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1435&publication_year=2019&pages=18-38&author=M.+F.+Richterauthor=P.+J.+Hergenrother&title=The+challenge+of+converting+Gram-positive-only+compounds+into+broad-spectrum+antibiotics&doi=10.1111%2Fnyas.13598"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">The challenge of converting Gram-positive-only compounds into broad-spectrum antibiotics</span></div><div class="casAuthors">Richter, Michelle F.; Hergenrother, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the New York Academy of Sciences</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">1435</span>
        (<span class="NLM_cas:issue">1, Antimicrobial Therapeutics Reviews</span>),
    <span class="NLM_cas:pages">18-38</span>CODEN:
                <span class="NLM_cas:coden">ANYAA9</span>;
        ISSN:<span class="NLM_cas:issn">0077-8923</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Multidrug resistant Gram-neg. bacterial infections are on the rise, and there is a lack of new classes of drugs to treat these pathogens.  This drug shortage is largely due to the challenge of finding antibiotics that can permeate and persist inside Gram-neg. species.  Efforts to understand the mol. properties that enable certain compds. to accumulate in Gram-neg. bacteria based on retrospective studies of known antibiotics have not been generally actionable in the development of new antibiotics.  A recent assessment of the ability of >180 diverse small mols. to accumulate in Escherichia coli led to predictive guidelines for compd. accumulation in E. coli.  These "eNTRy rules" state that compds. are most likely to accumulate if they contain a nonsterically encumbered ionizable Nitrogen (primary amines are the best), have low Three-dimensionality (globularity ≤ 0.25), and are relatively Rigid (rotatable bonds ≤ 5).  In this review, we look back through 50+ years of antibacterial research and 1000s of derivs. and assess this historical data set through the lens of these predictive guidelines.  The results are consistent with the eNTRy rules, suggesting that the eNTRy rules may provide an actionable and general roadmap for the conversion of Gram-pos.-only compds. into broad-spectrum antibiotics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqX3zbgiAcHdbVg90H21EOLACvtfcHk0lj8bvxIMAjDSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlyktw%253D%253D&md5=12fffe0d10e7d3e5c134ac28ce929ab3</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1111%2Fnyas.13598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fnyas.13598%26sid%3Dliteratum%253Aachs%26aulast%3DRichter%26aufirst%3DM.%2BF.%26aulast%3DHergenrother%26aufirst%3DP.%2BJ.%26atitle%3DThe%2520challenge%2520of%2520converting%2520Gram-positive-only%2520compounds%2520into%2520broad-spectrum%2520antibiotics%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2019%26volume%3D1435%26spage%3D18%26epage%3D38%26doi%3D10.1111%2Fnyas.13598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reck, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jansen, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moser, H. E.</span></span> <span> </span><span class="NLM_article-title">Challenges of antibacterial drug discovery</span>. <i>ARKIVOC</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">227</span>– <span class="NLM_lpage">244</span>, <span class="refDoi"> DOI: 10.24820/ark.5550190.p010.955</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.24820%2Fark.5550190.p010.955" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2020&pages=227-244&author=F.+Reckauthor=J.+M.+Jansenauthor=H.+E.+Moser&title=Challenges+of+antibacterial+drug+discovery&doi=10.24820%2Fark.5550190.p010.955"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.24820%2Fark.5550190.p010.955&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.24820%252Fark.5550190.p010.955%26sid%3Dliteratum%253Aachs%26aulast%3DReck%26aufirst%3DF.%26aulast%3DJansen%26aufirst%3DJ.%2BM.%26aulast%3DMoser%26aufirst%3DH.%2BE.%26atitle%3DChallenges%2520of%2520antibacterial%2520drug%2520discovery%26jtitle%3DARKIVOC%26date%3D2020%26volume%3D4%26spage%3D227%26epage%3D244%26doi%3D10.24820%2Fark.5550190.p010.955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schümann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boudon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulrich, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loll, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaffner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Streich, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kittel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, D.</span></span> <span> </span><span class="NLM_article-title">Integrated preclinical photosafety testing strategy for systemically applied pharmaceuticals</span>. <i>Toxicol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>139</i></span>,  <span class="NLM_fpage">245</span>– <span class="NLM_lpage">256</span>, <span class="refDoi"> DOI: 10.1093/toxsci/kfu026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1093%2Ftoxsci%2Fkfu026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=24519524" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmsVGktrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=2014&pages=245-256&author=J.+Sch%C3%BCmannauthor=S.+Boudonauthor=P.+Ulrichauthor=N.+Lollauthor=D.+Garciaauthor=R.+Schaffnerauthor=J.+Streichauthor=B.+Kittelauthor=D.+Bauer&title=Integrated+preclinical+photosafety+testing+strategy+for+systemically+applied+pharmaceuticals&doi=10.1093%2Ftoxsci%2Fkfu026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Integrated Preclinical Photosafety Testing Strategy for Systemically Applied Pharmaceuticals</span></div><div class="casAuthors">Schuemann, Jens; Boudon, Stephanie; Ulrich, Peter; Loll, Nathalie; Garcia, Deborah; Schaffner, Rene; Streich, Jeannine; Kittel, Birgit; Bauer, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Toxicological Sciences</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">139</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">245-256</span>CODEN:
                <span class="NLM_cas:coden">TOSCF2</span>;
        ISSN:<span class="NLM_cas:issn">1096-0929</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Phototoxic properties of systemically applied pharmaceuticals may be the cause of serious adverse drug reactions.  Therefore, a reliable preclin. photosafety assessment strategy, combining in vitro and in vivo approaches in a quant. manner, is important and has not been described so far.  Here, we report the establishment of an optimized modified murine local lymph node assay (LLNA), adapted for phototoxicity assessment of systemically applied compds., as well as the test results for 34 drug candidates in this in vivo photo-LLNA.  The drug candidates were selected based on their ability to absorb UV/visible light and the photo irritation factors (PIFs) detd. in the well-established in vitro 3T3 neutral red uptake phototoxicity test.  An in vivo phototoxic potential was identified for 13 of these drug candidates.  The use of multiple dose levels in the described murine in vivo phototoxicity studies enabled the establishment of no- and/or lowest-obsd.-adverse-effect levels (NOAELs/LOAELs), also supporting human photosafety assessment.  An in vitro-in vivo correlation demonstrated that a drug candidate classified as "phototoxic" in vitro is not necessarily phototoxic in vivo.  However, the probability for a drug candidate to cause phototoxicity in vivo clearly correlated with the magnitude of the phototoxicity identified in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp36qqelnD-u7Vg90H21EOLACvtfcHk0ljs5YCeP0yXpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmsVGktrw%253D&md5=4dd2cac32d7e03eae065b3b402f19187</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1093%2Ftoxsci%2Fkfu026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Ftoxsci%252Fkfu026%26sid%3Dliteratum%253Aachs%26aulast%3DSch%25C3%25BCmann%26aufirst%3DJ.%26aulast%3DBoudon%26aufirst%3DS.%26aulast%3DUlrich%26aufirst%3DP.%26aulast%3DLoll%26aufirst%3DN.%26aulast%3DGarcia%26aufirst%3DD.%26aulast%3DSchaffner%26aufirst%3DR.%26aulast%3DStreich%26aufirst%3DJ.%26aulast%3DKittel%26aufirst%3DB.%26aulast%3DBauer%26aufirst%3DD.%26atitle%3DIntegrated%2520preclinical%2520photosafety%2520testing%2520strategy%2520for%2520systemically%2520applied%2520pharmaceuticals%26jtitle%3DToxicol.%2520Sci.%26date%3D2014%26volume%3D139%26spage%3D245%26epage%3D256%26doi%3D10.1093%2Ftoxsci%2Fkfu026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Owens, R. C.,  Jr</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambrose, P. G.</span></span> <span> </span><span class="NLM_article-title">Antimicrobial safety: focus on fluoroquinolones</span>. <i>Clin. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">S144</span>– <span class="NLM_lpage">S157</span>, <span class="refDoi"> DOI: 10.1086/428055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1086%2F428055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=15942881" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmvVylsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2005&pages=S144-S157&author=R.+C.+Owensauthor=P.+G.+Ambrose&title=Antimicrobial+safety%3A+focus+on+fluoroquinolones&doi=10.1086%2F428055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Antimicrobial safety: Focus on fluoroquinolones</span></div><div class="casAuthors">Owens, Robert C., Jr.; Ambrose, Paul G.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Infectious Diseases</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">Suppl. 2</span>),
    <span class="NLM_cas:pages">S144-S157</span>CODEN:
                <span class="NLM_cas:coden">CIDIEL</span>;
        ISSN:<span class="NLM_cas:issn">1058-4838</span>.
    
            (<span class="NLM_cas:orgname">University of Chicago Press</span>)
        </div><div class="casAbstract">A review.  Background/purpose. Infrequent toxicities assocd. with certain drugs and drug classes have recently gained much attention from different health-care perspectives.  To protect the patient, continued surveillance of safety and tolerability data is essential.  Data from preclin. testing, phase 1-3 trials, and postmarketing surveillance may be used to objectively assess the risks assocd. with a specific drug or family of compds.  This review summarizes safety and tolerability data for the quinolones.  Main findings. The most common adverse events assocd. with the quinolone class involve the gastrointestinal tract (nausea and diarrhea) and central nervous system (CNS) (headache and dizziness).  These adverse events are usually mild and do not require discontinuation of therapy.  Uncommon and potentially serious quinolone-related adverse events involve the cardiovascular system (rate-cor. electrocardiog. QT interval prolongation), musculoskeletal system (tendinitis and tendon rupture), endocrine system (glucose homeostasis dysregulation), renal system (crystalluria, interstitial nephritis, and acute renal failure), and the CNS (seizures).  Severe idiosyncratic adverse events are specific to individual agents that may share some structural congruity, such as the 1-(2,4)-difluorophenyl group shared by trovafloxacin (assocd. with hepatitis), temafloxacin (assocd. with hemolytic-uremic syndrome), and tosufloxacin (assocd. with eosinophilic pneumonitis).  Overall, discontinuation rates from clin. trials were <4% for the currently marketed quinolones.  Quinolones with higher discontinuation rates, such as trovafloxacin (7.0%) and grepafloxacin (6.4%), are no longer available for general use.  Conclusions. The currently marketed quinolones are well tolerated, with safety profiles similar to those of other antimicrobial classes.  Although adverse effects are unusual, some, including tendinitis and CNS-related effects, are more common with quinolones than with other antimicrobial classes.  Rare adverse effects attributed to some members of the quinolone family (e.g., Torsades de Pointes, hepatotoxicity, and dysglycemias) are more likely to occur in select "susceptible" populations.  These adverse events can often be circumvented by avoiding exposure to the specific quinolone.  In some cases, the therapeutic value offered by a quinolone may outweigh its potential risks.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWdbldgEkRtrVg90H21EOLACvtfcHk0ljs5YCeP0yXpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmvVylsb8%253D&md5=f721e7d77b8799baa96336ad54fa5d53</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1086%2F428055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F428055%26sid%3Dliteratum%253Aachs%26aulast%3DOwens%26aufirst%3DR.%2BC.%26aulast%3DAmbrose%26aufirst%3DP.%2BG.%26atitle%3DAntimicrobial%2520safety%253A%2520focus%2520on%2520fluoroquinolones%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2005%26volume%3D41%26spage%3DS144%26epage%3DS157%26doi%3D10.1086%2F428055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stahlmann, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lode, H.</span></span> <span> </span><span class="NLM_article-title">Toxicity of quinolones</span>. <i>Drugs</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">37</span>– <span class="NLM_lpage">42</span>, <span class="refDoi"> DOI: 10.2165/00003495-199958002-00007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.2165%2F00003495-199958002-00007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10553703" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADyaK1MXntFeiur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1999&pages=37-42&author=R.+Stahlmannauthor=H.+Lode&title=Toxicity+of+quinolones&doi=10.2165%2F00003495-199958002-00007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Toxicity of quinolones</span></div><div class="casAuthors">Stahlmann, Ralf; Lode, Hartmut</div><div class="citationInfo"><span class="NLM_cas:title">Drugs</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">Suppl. 2</span>),
    <span class="NLM_cas:pages">37-42</span>CODEN:
                <span class="NLM_cas:coden">DRUGAY</span>;
        ISSN:<span class="NLM_cas:issn">0012-6667</span>.
    
            (<span class="NLM_cas:orgname">Adis International Ltd.</span>)
        </div><div class="casAbstract">A review with 37 refs. Reactions of the gastrointestinal tract, the central nervous system and the skin are the most often obsd. adverse effects during therapy with fluoroquinolones.  At least for some of the newer fluoroquinolones a steep dose-response relationship of adverse effects seems to exist.  Pathogenesis of the neurotoxic effects of fluoroquinolones is still unknown.  Among the newer drugs, trovafloxacin causes mild central nervous reactions such as dizziness and lightheadedness in a considerable proportion of patients.  Young females seem to be esp. sensitive to this effect, which diminishes during treatment or if the drug is taken together with food.  Cardiotoxic potentials of sparfloxacin and grepafloxacin are higher than those of other fluoroquinolones, but during therapy no clear-cut drug-related serious reactions have been reported, apart from a slight prolongation of the QT interval.  However, to avoid risks these drugs should not be prescribed to patients with known prolongation of the QT interval (e.g., patients on antiarrhythmics).  Phototoxicity has been described for all the quinolones, but derivs. with a halogen atom at position 8 show the highest potential for such reactions.  Fleroxacin, sparfloxacin, clinafloxacin and lomefloxacin belong to this group of fluoroquinolones.  The phototoxic potential of the other new fluoroquinolones is considerably lower, but extensive exposure to UV light should generally be avoided during therapy with all quinolones.  Chondrotoxicity of quinolones, as obsd. in immature animals, can affect articular cartilage and/or the epiphyseal growth plate, depending on the developmental stage.  The chondrotoxicity can probably be explained by the magnesium-chelating properties of these drugs.  As juveniles are esp. sensitive, use of these drugs in pediatrics should be restricted to carefully selected indications (such as the use of ciprofloxacin in cystic fibrosis).  Another manifestation of the toxic effects of quinolones on connective tissue structures is tendopathies.  Tendonitis and tendon ruptures have occurred as late as several months after quinolone treatment.  Overall, quinolones are well-tolerated drugs.  Their specific toxic potentials have to be considered when they are chosen for treatment of bacterial infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGons4CApvryWrVg90H21EOLACvtfcHk0lhVmDF05ih10Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntFeiur8%253D&md5=bc0907936e9caf3803652f9580893e46</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.2165%2F00003495-199958002-00007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00003495-199958002-00007%26sid%3Dliteratum%253Aachs%26aulast%3DStahlmann%26aufirst%3DR.%26aulast%3DLode%26aufirst%3DH.%26atitle%3DToxicity%2520of%2520quinolones%26jtitle%3DDrugs%26date%3D1999%26volume%3D58%26spage%3D37%26epage%3D42%26doi%3D10.2165%2F00003495-199958002-00007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Albini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monti, S.</span></span> <span> </span><span class="NLM_article-title">Photophysics and photochemistry of fluoroquinolones</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">238</span>– <span class="NLM_lpage">250</span>, <span class="refDoi"> DOI: 10.1039/b209220b</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1039%2Fb209220b" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=12875030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkt1emt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2003&pages=238-250&author=A.+Albiniauthor=S.+Monti&title=Photophysics+and+photochemistry+of+fluoroquinolones&doi=10.1039%2Fb209220b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Photophysics and photochemistry of fluoroquinolones</span></div><div class="casAuthors">Albini, Angelo; Monti, Sandra</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">238-250</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  The photo-behavior of fluoroquinolone antibiotics, one of the most successful classes of drugs in therapeutic applications, has recently been the object of increasing interest due to the finding of their photo-toxic and photo-carcinogenic properties.  The main results obtained for a series of structurally related, representative fluoroquinolone drugs is reviewed.  Both activation of oxygen and various degrdn. pathways have been identified and the effects of medium and structure have been rationalized.  The results can help in the understanding of the photochem. occurring in biol. environments and in the assessing of the correlation between structural characteristics and biol. photo-damage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDMZr6DgpbOrVg90H21EOLACvtfcHk0lhVmDF05ih10Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkt1emt7Y%253D&md5=96bba8ea1c99cee9b5d77e9518b70d06</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1039%2Fb209220b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb209220b%26sid%3Dliteratum%253Aachs%26aulast%3DAlbini%26aufirst%3DA.%26aulast%3DMonti%26aufirst%3DS.%26atitle%3DPhotophysics%2520and%2520photochemistry%2520of%2520fluoroquinolones%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2003%26volume%3D32%26spage%3D238%26epage%3D250%26doi%3D10.1039%2Fb209220b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Soldevila, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuquerella, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosca, F.</span></span> <span> </span><span class="NLM_article-title">Understanding of the Photoallergic Properties of Fluoroquinolones: Photoreactivity of Lomefloxacin with Amino Acids and Albumin</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">514</span>– <span class="NLM_lpage">523</span>, <span class="refDoi"> DOI: 10.1021/tx400377s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx400377s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisFWqt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2014&pages=514-523&author=S.+Soldevilaauthor=M.+C.+Cuquerellaauthor=F.+Bosca&title=Understanding+of+the+Photoallergic+Properties+of+Fluoroquinolones%3A+Photoreactivity+of+Lomefloxacin+with+Amino+Acids+and+Albumin&doi=10.1021%2Ftx400377s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Understanding of the Photoallergic Properties of Fluoroquinolones: Photoreactivity of Lomefloxacin with Amino Acids and Albumin</span></div><div class="casAuthors">Soldevila, Sonia; Cuquerella, M. Consuelo; Bosca, Francisco</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">514-523</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Although the phototoxic and photoallergic properties of fluoroquinolone antibiotics (FQ) are remarkable, the mechanisms involved in these processes are not completely understood.  For this reason, it is considered worthwhile to study in detail the photochem. interactions of lomefloxacin (LFX) and its N-acetyl deriv. ALFX, two 6,8-dihalogenated fluoroquinolones, with the most abundant protein in human plasma (human serum albumin, HSA) to analyze their covalent binding.  Fluorescence measurements and laser flash photolysis expts. performed in this work have revealed that N-acetylation of the LFX piperazinyl moiety produces an important increase of the drug affinity to albumin.  Thus, while the assocn. const. (Ka) for the LFX···HSA complex is below 103 M-1, the Ka for the HSA···ALFX complex resulted in ca. 5 × 103 M-1.  Interestingly, LFX is mainly located at site I of HSA, while ALFX shows no preference for site I or II.  A high reactivity between the aryl cations generated from (A)LFX dehalogenation and Trp and Tyr together with the generation of covalent adducts between the FQ and these amino acids was obsd.  However, the interactions between the FQ singlet excited state and albumin in FQ···HSA complexes seem to be the key process of FQ covalent binding to albumin.  Moreover, our findings have shown a correlation between the photobinding properties of dihalogenated fluoroquinolones to HSA and their FQ···HSA assocn. consts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvoxf0eAejX7Vg90H21EOLACvtfcHk0lhMD_nylzEGOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisFWqt7k%253D&md5=35fb7ce63e89e2effeb25f80933d86d5</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Ftx400377s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx400377s%26sid%3Dliteratum%253Aachs%26aulast%3DSoldevila%26aufirst%3DS.%26aulast%3DCuquerella%26aufirst%3DM.%2BC.%26aulast%3DBosca%26aufirst%3DF.%26atitle%3DUnderstanding%2520of%2520the%2520Photoallergic%2520Properties%2520of%2520Fluoroquinolones%253A%2520Photoreactivity%2520of%2520Lomefloxacin%2520with%2520Amino%2520Acids%2520and%2520Albumin%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2014%26volume%3D27%26spage%3D514%26epage%3D523%26doi%3D10.1021%2Ftx400377s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Soldevila, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosca, F.</span></span> <span> </span><span class="NLM_article-title">Photoreactivity of Fluoroquinolones: Nature of Aryl Cations Generated in Water</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">3940</span>– <span class="NLM_lpage">3943</span>, <span class="refDoi"> DOI: 10.1021/ol301694p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol301694p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtV2gsb3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=3940-3943&author=S.+Soldevilaauthor=F.+Bosca&title=Photoreactivity+of+Fluoroquinolones%3A+Nature+of+Aryl+Cations+Generated+in+Water&doi=10.1021%2Fol301694p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Photoreactivity of Fluoroquinolones: Nature of Aryl Cations Generated in Water</span></div><div class="casAuthors">Soldevila, Sonia; Bosca, Francisco</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3940-3943</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The nature of stabilized aryl cations generated from photodehalogenations of fluoroquinolones in aq. media has been studied by comparing the photophys. and photochem. behavior of lomefloxacin (LFX) and its N(4')-acetylated form (ALFX).  Photoproduct studies, laser flash photolysis, and emission measurements have shown that this small peripheral modification produces important changes in the properties of the singlet aryl cations generated.  Also, in basic medium, a new photodehalogenation pathway for 6,8-dihalogenated fluoroquinolones has been obsd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKLNFDtAytZLVg90H21EOLACvtfcHk0lhMD_nylzEGOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtV2gsb3O&md5=619baa0f7d89af8abb18420a632f3c6f</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fol301694p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol301694p%26sid%3Dliteratum%253Aachs%26aulast%3DSoldevila%26aufirst%3DS.%26aulast%3DBosca%26aufirst%3DF.%26atitle%3DPhotoreactivity%2520of%2520Fluoroquinolones%253A%2520Nature%2520of%2520Aryl%2520Cations%2520Generated%2520in%2520Water%26jtitle%3DOrg.%2520Lett.%26date%3D2012%26volume%3D14%26spage%3D3940%26epage%3D3943%26doi%3D10.1021%2Fol301694p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cuquerella, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miranda, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boscá, F.</span></span> <span> </span><span class="NLM_article-title">Generation of Detectable Singlet Aryl Cations by Photodehalogenation of Fluoroquinolones</span>. <i>J. Phys. Chem. B</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">6441</span>– <span class="NLM_lpage">6443</span>, <span class="refDoi"> DOI: 10.1021/jp060634d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jp060634d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BD28XitVyns70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2006&pages=6441-6443&author=M.+C.+Cuquerellaauthor=M.+A.+Mirandaauthor=F.+Bosc%C3%A1&title=Generation+of+Detectable+Singlet+Aryl+Cations+by+Photodehalogenation+of+Fluoroquinolones&doi=10.1021%2Fjp060634d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Generation of Detectable Singlet Aryl Cations by Photodehalogenation of Fluoroquinolones</span></div><div class="casAuthors">Cuquerella, M. Consuelo; Miranda, Miguel A.; Bosca, Francisco</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physical Chemistry B</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">6441-6443</span>CODEN:
                <span class="NLM_cas:coden">JPCBFK</span>;
        ISSN:<span class="NLM_cas:issn">1520-6106</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Nanosecond laser flash photolysis (λexc = 355 nm) of neutral aq. solns. of lomefloxacin (LFX, a 8-fluorinated 7-amino-4-quinolone-3-carboxylic acid deriv.) produces a detectable transient species, which shows an absorption max. at 490 nm and can be assigned to an aryl cation.  This intermediate has a lifetime of ca.  200 Ns in net water, reacts with Br- and Cl- with rate consts. of 3.6 × 109 M-1 s-1 and 4.1 × 108 M-1 s-1, resp., and shows a lack of reactivity toward mol. oxygen.  From the photolysis of BAY y3118 (BAY, a 8-chlorinated analog), an aryl cation is also generated, showing absorption max. at 480 nm (lifetime of ca. 1 μs in net water) and a reaction rate const. of 9 × 109 M-1 s-1 with Br-.  The existence of these highly reactive species arising from direct photolysis of LFX and BAY can justify the photogenotoxic properties assocd. with these antibacterial drugs likely due to direct reaction of their cations with DNA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9HTFXNawsl7Vg90H21EOLACvtfcHk0lhMD_nylzEGOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XitVyns70%253D&md5=4cccf5653e80cfb01049a29d2021ab8c</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Fjp060634d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjp060634d%26sid%3Dliteratum%253Aachs%26aulast%3DCuquerella%26aufirst%3DM.%2BC.%26aulast%3DMiranda%26aufirst%3DM.%2BA.%26aulast%3DBosc%25C3%25A1%26aufirst%3DF.%26atitle%3DGeneration%2520of%2520Detectable%2520Singlet%2520Aryl%2520Cations%2520by%2520Photodehalogenation%2520of%2520Fluoroquinolones%26jtitle%3DJ.%2520Phys.%2520Chem.%2520B%26date%3D2006%26volume%3D110%26spage%3D6441%26epage%3D6443%26doi%3D10.1021%2Fjp060634d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="note"><p class="first last">Compound <b>34</b> was tested in the hERG QPatch assay using a nonstandard long incubation protocol (see <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> for details). Under the standard conditions, steady state was not reached for some recordings. This can result in underestimation of the true IC<sub>50</sub>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Triggle, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rampe, D.</span></span> <span> </span><span class="NLM_article-title">Interactions of a series of fluoroquinolone antibacterial drugs with the human cardiac K+ channel HERG</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">122</span>– <span class="NLM_lpage">126</span>, <span class="refDoi"> DOI: 10.1124/mol.59.1.122</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1124%2Fmol.59.1.122" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=11125032" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BD3MXns1CktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2001&pages=122-126&author=J.+Kangauthor=L.+Wangauthor=X.-L.+Chenauthor=D.+J.+Triggleauthor=D.+Rampe&title=Interactions+of+a+series+of+fluoroquinolone+antibacterial+drugs+with+the+human+cardiac+K%2B+channel+HERG&doi=10.1124%2Fmol.59.1.122"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Interactions of a series of fluoroquinolone antibacterial drugs with the human cardiac K+ channel HERG</span></div><div class="casAuthors">Kang, Jiesheng; Wang, Lin; Chen, Xiao-Liang; Triggle, David J.; Rampe, David</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">122-126</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Administration of certain fluoroquinolone antibacterials has been assocd. with prolongation of the QT interval on the ECG and, on rare occasions, ventricular arrhythmia.  Blockade of the human cardiac K+ channel HERG often underlies such clin. findings.  Therefore, we examd. a series of seven fluoroquinolones for their ability to interact with this channel.  Using patch-clamp electrophysiol., we found that all of the drugs tested inhibited HERG channel currents, but with widely differing potencies.  Sparfloxacin was the most potent compd., displaying an IC50 value of 18 μM, whereas ofloxacin was the least potent compd., with an IC50 value of 1420 μM.  Other IC50 values were as follows: grepafloxacin, 50 μM; moxifloxacin, 129 μM; gatifloxacin, 130 μM; levofloxacin, 915 μM; and ciprofloxacin, 966 μM.  Block of HERG by sparfloxacin displayed a pos. voltage dependence.  In contrast to HERG, the KvLQT1/minK K+ channel was not a target for block by the fluoroquinolones.  These results provide a mechanism for the QT prolongation obsd. clin. with administration of sparfloxacin and certain other fluoroquinolones because free plasma levels of these drugs after therapeutic doses approx. those concns. that inhibit HERG channel current.  In the cases of levofloxacin, ciprofloxacin, and ofloxacin, inhibition of HERG occurs at concns. much greater than those obsd. clin.  The data indicate that clin. relevant HERG channel inhibition is not a class effect of the fluoroquinolone antibacterials but is highly dependent upon specific substitutions within this series of compds.  HERG channel affinity should be an important criterion for the development of newer fluoroquinolones.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlnqmtGDeBjrVg90H21EOLACvtfcHk0lgdSsrFEQbd2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXns1CktA%253D%253D&md5=e566698168741c8ccd6cb2fccf3655aa</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1124%2Fmol.59.1.122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.59.1.122%26sid%3Dliteratum%253Aachs%26aulast%3DKang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DX.-L.%26aulast%3DTriggle%26aufirst%3DD.%2BJ.%26aulast%3DRampe%26aufirst%3DD.%26atitle%3DInteractions%2520of%2520a%2520series%2520of%2520fluoroquinolone%2520antibacterial%2520drugs%2520with%2520the%2520human%2520cardiac%2520K%252B%2520channel%2520HERG%26jtitle%3DMol.%2520Pharmacol.%26date%3D2001%26volume%3D59%26spage%3D122%26epage%3D126%26doi%3D10.1124%2Fmol.59.1.122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Culley, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lacy, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klutman, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, B.</span></span> <span> </span><span class="NLM_article-title">Moxifloxacin: clinical efficacy and safety</span>. <i>Am. J. Health-Syst. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">379</span>– <span class="NLM_lpage">388</span>, <span class="refDoi"> DOI: 10.1093/ajhp/58.5.379</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1093%2Fajhp%2F58.5.379" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=11258173" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhvFensbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2001&pages=379-388&author=C.+M.+Culleyauthor=M.+K.+Lacyauthor=N.+Klutmanauthor=B.+Edwards&title=Moxifloxacin%3A+clinical+efficacy+and+safety&doi=10.1093%2Fajhp%2F58.5.379"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Moxifloxacin: Clinical efficacy and safety</span></div><div class="casAuthors">Culley, Colleen M.; Lacy, Melinda K.; Klutman, Neil; Edwards, Brian</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Health-System Pharmacy</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">379-388</span>CODEN:
                <span class="NLM_cas:coden">AHSPEK</span>;
        ISSN:<span class="NLM_cas:issn">1079-2082</span>.
    
            (<span class="NLM_cas:orgname">American Society of Health-System Pharmacists</span>)
        </div><div class="casAbstract">A review with 84 refs.  The activity, pharmacokinetics, pharmacodynamics, efficacy, safety, drug interactions, and dosage and administration of moxifloxacin are reviewed.  Moxifloxacin is an oral 8-methoxyquinolone antimicrobial approved in Dec. 1999 for use in the treatment of acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and community-acquired pneumonia.  This fluoroquinolone is active against common community-acquired respiratory pathogens (Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis), atypical pathogens, and many anaerobes.  Moxifloxacin has an abs. bioavailability of 90% after oral administration and a mean elimination half-life of 12 h.  The drug is not a substrate or inhibitor of the hepatic cytochrome P 450 isoenzyme system, thereby avoiding many potential drug interactions.  Moxifloxacin has limited phototoxic potential.  In clin. trials, moxifloxacin had clin. success rates of 88-97% and bacteriol. eradication rates of 90-97%.  Reported adverse effects were primarily gastrointestinal (nausea, diarrhea) and were mild to moderate in severity.  Moxifloxacin prolongs the QT interval by a mean + S.D. of 6 ± 26 ms above baseline and should be used with caution in patients with proarrhythmic conditions and avoided in patients receiving antiarrhythmia agents, such as quinidine, procainamide, amiodarone, and sotalol.  The std. oral dosage is 400 mg once a day.  Dosage adjustment is unnecessary in patients with renal dysfunction or mild to moderate hepatic dysfunction.  Moxifloxacin is a safe and effective antimicrobial that will be useful for treating acute sinusitis, acute bacterial exacerbations of chronic bronchitis, and community-acquired pneumonia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7WYGx_emHprVg90H21EOLACvtfcHk0lgdSsrFEQbd2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhvFensbo%253D&md5=3ea3d2268a9b540e46dcd0a364a1415a</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1093%2Fajhp%2F58.5.379&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fajhp%252F58.5.379%26sid%3Dliteratum%253Aachs%26aulast%3DCulley%26aufirst%3DC.%2BM.%26aulast%3DLacy%26aufirst%3DM.%2BK.%26aulast%3DKlutman%26aufirst%3DN.%26aulast%3DEdwards%26aufirst%3DB.%26atitle%3DMoxifloxacin%253A%2520clinical%2520efficacy%2520and%2520safety%26jtitle%3DAm.%2520J.%2520Health-Syst.%2520Pharm.%26date%3D2001%26volume%3D58%26spage%3D379%26epage%3D388%26doi%3D10.1093%2Fajhp%2F58.5.379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Darpo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nebout, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sager, P. T.</span></span> <span> </span><span class="NLM_article-title">Clinical evaluation of QT/QTc prolongation and proarrhythmic potential for nonantiarrhythmic drugs: the international conference on harmonization of technical requirements for registration of pharmaceuticals for human use E14 guideline</span>. <i>J. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">498</span>– <span class="NLM_lpage">507</span>, <span class="refDoi"> DOI: 10.1177/0091270006286436</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1177%2F0091270006286436" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=16638733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BD28Xksl2ms7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2006&pages=498-507&author=B.+Darpoauthor=T.+Neboutauthor=P.+T.+Sager&title=Clinical+evaluation+of+QT%2FQTc+prolongation+and+proarrhythmic+potential+for+nonantiarrhythmic+drugs%3A+the+international+conference+on+harmonization+of+technical+requirements+for+registration+of+pharmaceuticals+for+human+use+E14+guideline&doi=10.1177%2F0091270006286436"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical evaluation of QT/QTc prolongation and proarrhythmic potential for nonantiarrhythmic drugs: the international conference on harmonization of technical requirements for registration of pharmaceuticals for human use E14 guideline</span></div><div class="casAuthors">Darpo, Borje; Nebout, Thierry; Sager, Philip T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">498-507</span>CODEN:
                <span class="NLM_cas:coden">JCPCBR</span>;
        ISSN:<span class="NLM_cas:issn">0091-2700</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">A review.  Proarrhythmias due to drug-induced QT prolongation are the second most common cause for drug withdrawal and have caused increasing concern.  Two new International Conference on Harmonization of Tech. Requirements for Registration of Pharmaceuticals for Human Use (ICH) guidelines were recently endorsed in which nonclin. (S7B) and clin. (E14) methodologies are discussed and guidance is given to the industry.  This commentary describes the key components of the E14 document, the impact of nonclin. testing on the clin. program, the thorough QT study, and the impact of its result on late-stage development.  The studies described in S7B and E14 will contribute to a better understanding of the link between nonclin. assays and QT prolongation in humans.  Differences in interpretation among individual regulators in the major regions with respect to measures proposed in the E14 guideline might impact regional regulatory decisions.  These differences include the value of nonclin. assays for the subsequent clin. testing and how predictive a neg. thorough QT study result is for proarrhythmic risk in patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKkKjZVVnnv7Vg90H21EOLACvtfcHk0lgeA8kk30aqoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xksl2ms7w%253D&md5=973ab92f1528ecc5e09b85cb489fb269</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1177%2F0091270006286436&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0091270006286436%26sid%3Dliteratum%253Aachs%26aulast%3DDarpo%26aufirst%3DB.%26aulast%3DNebout%26aufirst%3DT.%26aulast%3DSager%26aufirst%3DP.%2BT.%26atitle%3DClinical%2520evaluation%2520of%2520QT%252FQTc%2520prolongation%2520and%2520proarrhythmic%2520potential%2520for%2520nonantiarrhythmic%2520drugs%253A%2520the%2520international%2520conference%2520on%2520harmonization%2520of%2520technical%2520requirements%2520for%2520registration%2520of%2520pharmaceuticals%2520for%2520human%2520use%2520E14%2520guideline%26jtitle%3DJ.%2520Clin.%2520Pharmacol.%26date%3D2006%26volume%3D46%26spage%3D498%26epage%3D507%26doi%3D10.1177%2F0091270006286436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Redfern, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlsson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacKenzie, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palethorpe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegl, P. K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strang, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camm, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, T. G.</span></span> <span> </span><span class="NLM_article-title">Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development</span>. <i>Cardiovasc. Res.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">32</span>– <span class="NLM_lpage">45</span>, <span class="refDoi"> DOI: 10.1016/S0008-6363(02)00846-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1016%2FS0008-6363%2802%2900846-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=12667944" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BD3sXit12gsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2003&pages=32-45&author=W.+S.+Redfernauthor=L.+Carlssonauthor=A.+S.+Davisauthor=W.+G.+Lynchauthor=I.+MacKenzieauthor=S.+Palethorpeauthor=P.+K.+S.+Sieglauthor=I.+Strangauthor=A.+T.+Sullivanauthor=R.+Wallisauthor=A.+J.+Cammauthor=T.+G.+Hammond&title=Relationships+between+preclinical+cardiac+electrophysiology%2C+clinical+QT+interval+prolongation+and+torsade+de+pointes+for+a+broad+range+of+drugs%3A+evidence+for+a+provisional+safety+margin+in+drug+development&doi=10.1016%2FS0008-6363%2802%2900846-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development</span></div><div class="casAuthors">Redfern, W. S.; Carlsson, L.; Davis, A. S.; Lynch, W. G.; MacKenzie, I.; Palethorpe, S.; Siegl, P. K. S.; Strang, I.; Sullivan, A. T.; Wallis, R.; Camm, A. J.; Hammond, T. G.</div><div class="citationInfo"><span class="NLM_cas:title">Cardiovascular Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">32-45</span>CODEN:
                <span class="NLM_cas:coden">CVREAU</span>;
        ISSN:<span class="NLM_cas:issn">0008-6363</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review discussing attempts to det. the relative value of preclin. cardiac electrophysiol. data (in vitro and in vivo) for predicting risk of torsades de pointes (TdP) in clin. use.  Published data on human ether-a-go-go-related gene-encoded voltage-dependent potassium channel (hERG) (or IKr) activity, cardiac action potential duration (at 90% repolarization; APD90), and QT prolongation in dogs were compared against QT effects and reports of TdP in humans for 100 drugs.  These data were set against the free plasma concns. attained during clin. use (effective therapeutic plasma concns.; ETPCunbound).  The drugs were divided into five categories: (1) Class Ia and III antiarrhythmics; (2) withdrawn from market due to TdP; (3) measurable incidence/numerous reports of TdP in humans; (4) isolated reports of TdP in humans; (5) no reports of TdP in humans.  Data from hERG (or IKr) assays in addn. to ETPCunbound data were available for 52 drugs.  For Category 1 drugs, data for hERG/IKr IC50, APD90, QTc in animals and QTc in humans were generally close to or superimposed on the ETPCunbound values.  This relationship was uncoupled in the other categories, with more complex relationships between the data.  In Category 1 (except amiodarone), the ratios between hERG/IKr IC50 and ETPCunbound (max) ranged 0.1-31-fold.  Similar ranges were obtained for drugs in Category 2 (0.31-13-fold) and Category 3 (0.03-35-fold).  A large spread was found for Category 4 drugs (0.13-35,700-fold); this category embraced an assortment of mechanisms ranging from drugs which may well be affecting IKr currents in clin. use (e.g., sparfloxacin) to others such as nifedipine (35,700-fold) where channel block is not involved.  Finally, for the majority of Category 5 drugs there was a >30-fold sepn. between hERG/IKr activity and ETPCunbound values, with the notable exception of verapamil (1.7-fold), which is free from QT prolongation in man; this is probably explained by its multiple interactions with cardiac ion channels.  The dataset confirms the widely held belief that most drugs assocd. with TdP in humans are also assocd. with hERG K+ channel block at concns. close to or superimposed upon the free plasma concns. found in clin. use.  A 30-fold margin between Cmax and hERG IC50 may suffice for drugs currently undergoing clin. evaluation, but for future drug discovery programs, pharmaceutical companies should consider increasing this margin, particularly for drugs aimed at nondebilitating diseases.  However, interactions with multiple cardiac ion channels can either mitigate or exacerbate the prolongation of APD and QT that would ensue from block of IKr currents alone, and delay of repolarization per se is not necessarily torsadogenic.  Clearly, an integrated assessment of in vitro and in vivo data is required in order to predict the torsadogenic risk of a new candidate drug in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkpRDUH0rhyrVg90H21EOLACvtfcHk0lgeA8kk30aqoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXit12gsb8%253D&md5=a236c07febd2e05fe70e61604619bf2e</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2FS0008-6363%2802%2900846-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0008-6363%252802%252900846-5%26sid%3Dliteratum%253Aachs%26aulast%3DRedfern%26aufirst%3DW.%2BS.%26aulast%3DCarlsson%26aufirst%3DL.%26aulast%3DDavis%26aufirst%3DA.%2BS.%26aulast%3DLynch%26aufirst%3DW.%2BG.%26aulast%3DMacKenzie%26aufirst%3DI.%26aulast%3DPalethorpe%26aufirst%3DS.%26aulast%3DSiegl%26aufirst%3DP.%2BK.%2BS.%26aulast%3DStrang%26aufirst%3DI.%26aulast%3DSullivan%26aufirst%3DA.%2BT.%26aulast%3DWallis%26aufirst%3DR.%26aulast%3DCamm%26aufirst%3DA.%2BJ.%26aulast%3DHammond%26aufirst%3DT.%2BG.%26atitle%3DRelationships%2520between%2520preclinical%2520cardiac%2520electrophysiology%252C%2520clinical%2520QT%2520interval%2520prolongation%2520and%2520torsade%2520de%2520pointes%2520for%2520a%2520broad%2520range%2520of%2520drugs%253A%2520evidence%2520for%2520a%2520provisional%2520safety%2520margin%2520in%2520drug%2520development%26jtitle%3DCardiovasc.%2520Res.%26date%3D2003%26volume%3D58%26spage%3D32%26epage%3D45%26doi%3D10.1016%2FS0008-6363%2802%2900846-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cavalluzzi, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imbrici, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gualdani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefanachi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mangiatordi, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lentini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicolotti, O.</span></span> <span> </span><span class="NLM_article-title">Human ether-à-go-go-related potassium channel: exploring SAR to improve drug design</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">344</span>– <span class="NLM_lpage">366</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2019.11.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1016%2Fj.drudis.2019.11.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=31756511" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitF2lsbrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2020&pages=344-366&author=M.+M.+Cavalluzziauthor=P.+Imbriciauthor=R.+Gualdaniauthor=A.+Stefanachiauthor=G.+F.+Mangiatordiauthor=G.+Lentiniauthor=O.+Nicolotti&title=Human+ether-%C3%A0-go-go-related+potassium+channel%3A+exploring+SAR+to+improve+drug+design&doi=10.1016%2Fj.drudis.2019.11.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Human ether-´a-go-go-related potassium channel: exploring SAR to improve drug design</span></div><div class="casAuthors">Cavalluzzi, Maria Maddalena; Imbrici, Paola; Gualdani, Roberta; Stefanachi, Angela; Mangiatordi, Giuseppe Felice; Lentini, Giovanni; Nicolotti, Orazio</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">344-366</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">HERG is best known as a primary anti-target, the inhibition of which is responsible for serious side effects.  A renewed interest in hERG as a desired target, esp. in oncol., was sparked because of its role in cellular proliferation and apoptosis.  In this study, we survey the most recent advances regarding hERG by focusing on SAR in the attempt to elucidate, at a mol. level, off-target and on-target actions of potential hERG binders, which are highly promiscuous and largely varying in structure.  Understanding the rationale behind hERG interactions and the mol. determinants of hERG activity is a real challenge and comprehension of this is of the utmost importance to prioritize compds. in early stages of drug discovery and to minimize cardiotoxicity attrition in preclin. and clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqz70JpKug31LVg90H21EOLACvtfcHk0limNzYjyb94Xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitF2lsbrL&md5=08e27e9c7f92394046dbc9bbf72c76eb</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2019.11.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2019.11.005%26sid%3Dliteratum%253Aachs%26aulast%3DCavalluzzi%26aufirst%3DM.%2BM.%26aulast%3DImbrici%26aufirst%3DP.%26aulast%3DGualdani%26aufirst%3DR.%26aulast%3DStefanachi%26aufirst%3DA.%26aulast%3DMangiatordi%26aufirst%3DG.%2BF.%26aulast%3DLentini%26aufirst%3DG.%26aulast%3DNicolotti%26aufirst%3DO.%26atitle%3DHuman%2520ether-%25C3%25A0-go-go-related%2520potassium%2520channel%253A%2520exploring%2520SAR%2520to%2520improve%2520drug%2520design%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2020%26volume%3D25%26spage%3D344%26epage%3D366%26doi%3D10.1016%2Fj.drudis.2019.11.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span> <i>Performance Standards for Antimicrobial Susceptibility Testing</i>, <span class="NLM_edition">28</span>th ed.; <span class="NLM_publisher-name">Clinical Laboratory
Standards Institute (CLSI)</span>, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Performance+Standards+for+Antimicrobial+Susceptibility+Testing%2C+28th+ed.%3B+Clinical+Laboratory%0AStandards+Institute+%28CLSI%29%2C+2018."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DPerformance%2520Standards%2520for%2520Antimicrobial%2520Susceptibility%2520Testing%26pub%3DClinical%2520Laboratory%250AStandards%2520Institute%2520%2528CLSI%2529%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukuda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kishii, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosaka, M.</span></span> <span> </span><span class="NLM_article-title">Target preference of 15 quinolones against <i>Staphylococcus aureus</i> based on antibacterial activities and target inhibition</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">3544</span>– <span class="NLM_lpage">3547</span>, <span class="refDoi"> DOI: 10.1128/AAC.45.12.3544-3547.2001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1128%2FAAC.45.12.3544-3547.2001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=11709337" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BD3MXovVOlu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2001&pages=3544-3547&author=M.+Takeiauthor=H.+Fukudaauthor=R.+Kishiiauthor=M.+Hosaka&title=Target+preference+of+15+quinolones+against+Staphylococcus+aureus+based+on+antibacterial+activities+and+target+inhibition&doi=10.1128%2FAAC.45.12.3544-3547.2001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Target preference of 15 quinolones against Staphylococcus aureus, based on antibacterial activities and target inhibition</span></div><div class="casAuthors">Takei, Masaya; Fukuda, Hideyuki; Kishii, Ryuta; Hosaka, Masaki</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3544-3547</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The antibacterial activities and target inhibition of 15 quinolones against grlA and gyrA mutant strains were studied.  The strains were obtained from wild-type Staphylococcus aureus MS5935 by selection with norfloxacin and nadifloxacin, resp.  The antibacterial activities of most quinolones against both mutant strains were lower than those against the wild-type strain.  The ratios of MICs for the gyrA mutant strain to those for the grlA mutant strain (MIC ratio) varied from 0.125 to 4.  The ratios of 50% inhibitory concns. (IC50s) of quinolones against topoisomerase IV to those against DNA gyrase (IC50 ratios) also varied, from 0.177 to 5.52.  A significant correlation between the MIC ratios and the IC50 ratios was obsd. (r = 0.919; P < 0.001).  These results suggest that the antibacterial activities of quinolones against the wild-type strain are involved not only in topoisomerase IV inhibition but also in DNA gyrase inhibition and that the target preference in the wild-type strain can be anticipated by the MIC ratios.  Based on the MIC ratios, the quinolones were classified into three categories.  Type I quinolones (norfloxacin, enoxacin, fleroxacin, ciprofloxacin, lomefloxacin, trovafloxacin, grepafloxacin, ofloxacin, and levofloxacin) had MIC ratios of <1, type II quinolones (sparfloxacin and nadifloxacin) had MIC ratios of >1, and type III quinolones (gatifloxacin, pazufloxacin, moxifloxacin, and clinafloxacin) had MIC ratios of 1.  Type I and type II quinolones seem to prefer topoisomerase IV and DNA gyrase, resp.  Type III quinolones seem to target both enzymes at nearly the same level in bacterial cells (a phenomenon known as the dual-targeting property), and their IC50 ratios were approx. 2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRQ8VysHG-CLVg90H21EOLACvtfcHk0lir1Knmr3KHjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXovVOlu70%253D&md5=01d6f8a5fb349338600a2c3656f2e0c8</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1128%2FAAC.45.12.3544-3547.2001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.45.12.3544-3547.2001%26sid%3Dliteratum%253Aachs%26aulast%3DTakei%26aufirst%3DM.%26aulast%3DFukuda%26aufirst%3DH.%26aulast%3DKishii%26aufirst%3DR.%26aulast%3DHosaka%26aufirst%3DM.%26atitle%3DTarget%2520preference%2520of%252015%2520quinolones%2520against%2520Staphylococcus%2520aureus%2520based%2520on%2520antibacterial%2520activities%2520and%2520target%2520inhibition%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2001%26volume%3D45%26spage%3D3544%26epage%3D3547%26doi%3D10.1128%2FAAC.45.12.3544-3547.2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emrich, N.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heisig, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stubbings, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labischinski, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heisig, P.</span></span> <span> </span><span class="NLM_article-title">Antibacterial activity of finafloxacin under different pH conditions against isogenic strains of <i>Escherichia coli</i> expressing combinations of defined mechanisms of fluoroquinolone resistance</span>. <i>J. Antimicrob. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">2530</span>– <span class="NLM_lpage">2533</span>, <span class="refDoi"> DOI: 10.1093/jac/dkq375</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1093%2Fjac%2Fdkq375" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=20940181" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVektrjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2010&pages=2530-2533&author=N.-C.+Emrichauthor=A.+Heisigauthor=W.+Stubbingsauthor=H.+Labischinskiauthor=P.+Heisig&title=Antibacterial+activity+of+finafloxacin+under+different+pH+conditions+against+isogenic+strains+of+Escherichia+coli+expressing+combinations+of+defined+mechanisms+of+fluoroquinolone+resistance&doi=10.1093%2Fjac%2Fdkq375"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Antibacterial activity of finafloxacin under different pH conditions against isogenic strains of Escherichia coli expressing combinations of defined mechanisms of fluoroquinolone resistance</span></div><div class="casAuthors">Emrich, Nadine-C.; Heisig, Anke; Stubbings, Will; Labischinski, Harald; Heisig, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2530-2533</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Finafloxacin is an investigational fluoroquinolone exhibiting broad-spectrum activity that is enhanced under slightly acidic conditions (pH 5.0-6.5).  The impact of individual and combinations of chromosomal mutations (gyrA, parC and marR) and the plasmid-mediated fluoroquinolone resistance mechanisms QepA1, QnrA1, QnrB1, QnrS1 and AAC(6')-Ib-cr were investigated.  The MICs of finafloxacin, compared with those of ciprofloxacin, levofloxacin and moxifloxacin, were detd. at pH 5.8 and 7.2.  MICs of finafloxacin compared with other fluoroquinolones at pH 5.8 were lower by a factor of 2-256.  MICs of finafloxacin were unaffected by QepA1.  Moreover, finafloxacin appeared not to be a substrate for AAC(6')-Ib-cr.  Compared with ciprofloxacin, levofloxacin and moxifloxacin, finafloxacin shows higher activity esp. at pH 5.8 against Escherichia coli mutants expressing known fluoroquinolone resistance determinants alone and in combinations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptfUqkmYZB0LVg90H21EOLACvtfcHk0lir1Knmr3KHjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVektrjM&md5=bf41b4be27c1a2c16dbfbaf5d9402fe9</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkq375&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkq375%26sid%3Dliteratum%253Aachs%26aulast%3DEmrich%26aufirst%3DN.-C.%26aulast%3DHeisig%26aufirst%3DA.%26aulast%3DStubbings%26aufirst%3DW.%26aulast%3DLabischinski%26aufirst%3DH.%26aulast%3DHeisig%26aufirst%3DP.%26atitle%3DAntibacterial%2520activity%2520of%2520finafloxacin%2520under%2520different%2520pH%2520conditions%2520against%2520isogenic%2520strains%2520of%2520Escherichia%2520coli%2520expressing%2520combinations%2520of%2520defined%2520mechanisms%2520of%2520fluoroquinolone%2520resistance%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2010%26volume%3D65%26spage%3D2530%26epage%3D2533%26doi%3D10.1093%2Fjac%2Fdkq375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chan, D. M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monaco, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winters, M. P.</span></span> <span> </span><span class="NLM_article-title">New N- and O-arylations with phenylboronic acids and cupric acetate</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">2933</span>– <span class="NLM_lpage">2936</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(98)00503-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1016%2FS0040-4039%2898%2900503-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADyaK1cXjtVOlu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1998&pages=2933-2936&author=D.+M.+T.+Chanauthor=K.+L.+Monacoauthor=R.-P.+Wangauthor=M.+P.+Winters&title=New+N-+and+O-arylations+with+phenylboronic+acids+and+cupric+acetate&doi=10.1016%2FS0040-4039%2898%2900503-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">New N- and O-arylation with phenylboronic acids and cupric acetate</span></div><div class="casAuthors">Chan, Dominic M. T.; Monaco, Kevin L.; Wang, Ru-Ping; Winters, Michael P.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">2933-2936</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A new method of arylating N-H and O-H contg. compds. at room temp. with phenylboronic acids and cupric acetate in the presence of a tertiary amine promoter is described.  Substrates include phenols, amines, anilines, amides, imides, ureas, carbamates, and sulfonamides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQZxWi8FJntLVg90H21EOLACvtfcHk0lgvGGW8ZDKAyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjtVOlu7w%253D&md5=56efb58adc883aba3ca4ab908f6864ec</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2898%2900503-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252898%252900503-6%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DD.%2BM.%2BT.%26aulast%3DMonaco%26aufirst%3DK.%2BL.%26aulast%3DWang%26aufirst%3DR.-P.%26aulast%3DWinters%26aufirst%3DM.%2BP.%26atitle%3DNew%2520N-%2520and%2520O-arylations%2520with%2520phenylboronic%2520acids%2520and%2520cupric%2520acetate%26jtitle%3DTetrahedron%2520Lett.%26date%3D1998%26volume%3D39%26spage%3D2933%26epage%3D2936%26doi%3D10.1016%2FS0040-4039%2898%2900503-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lam, P. Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saubern, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winters, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, D. M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Combs, A.</span></span> <span> </span><span class="NLM_article-title">New aryl/heteroaryl C-N bond cross-coupling reactions via arylboronic acid/cupric acetate arylation</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">2941</span>– <span class="NLM_lpage">2944</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(98)00504-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1016%2FS0040-4039%2898%2900504-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADyaK1cXjtVOlu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1998&pages=2941-2944&author=P.+Y.+S.+Lamauthor=C.+G.+Clarkauthor=S.+Saubernauthor=J.+Adamsauthor=M.+P.+Wintersauthor=D.+M.+T.+Chanauthor=A.+Combs&title=New+aryl%2Fheteroaryl+C-N+bond+cross-coupling+reactions+via+arylboronic+acid%2Fcupric+acetate+arylation&doi=10.1016%2FS0040-4039%2898%2900504-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">New aryl/heteroaryl C-N bond cross-coupling reactions via arylboronic acid/cupric acetate arylation</span></div><div class="casAuthors">Lam, Patrick Y. S.; Clark, Charles G.; Saubern, Simon; Adams, Jessica; Winters, Michael P.; Chan, Dominic M. T.; Combs, Andrew</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">2941-2944</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A new aryl/heteroaryl C-N bond cross-coupling reaction via the arylboronic acid/cupric acetate arylation of N-H contg. heteroarenes has been discovered.  This new methodol. is mild, proceeds at room temp. exposed to air, and works for many heteroarenes and arylboronic acid providing good yields of N-arylated heteroarenes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFzQpNQ18m0LVg90H21EOLACvtfcHk0lgvGGW8ZDKAyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjtVOlu7k%253D&md5=86155b6f6d3f9765b3270cb3aa9fd509</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2898%2900504-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252898%252900504-8%26sid%3Dliteratum%253Aachs%26aulast%3DLam%26aufirst%3DP.%2BY.%2BS.%26aulast%3DClark%26aufirst%3DC.%2BG.%26aulast%3DSaubern%26aufirst%3DS.%26aulast%3DAdams%26aufirst%3DJ.%26aulast%3DWinters%26aufirst%3DM.%2BP.%26aulast%3DChan%26aufirst%3DD.%2BM.%2BT.%26aulast%3DCombs%26aufirst%3DA.%26atitle%3DNew%2520aryl%252Fheteroaryl%2520C-N%2520bond%2520cross-coupling%2520reactions%2520via%2520arylboronic%2520acid%252Fcupric%2520acetate%2520arylation%26jtitle%3DTetrahedron%2520Lett.%26date%3D1998%26volume%3D39%26spage%3D2941%26epage%3D2944%26doi%3D10.1016%2FS0040-4039%2898%2900504-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Evans, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katz, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, T. R.</span></span> <span> </span><span class="NLM_article-title">Synthesis of diaryl ethers through the copper-promoted arylation of phenols with arylboronic acids. An expedient synthesis of thyroxine</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">2937</span>– <span class="NLM_lpage">2940</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(98)00502-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1016%2FS0040-4039%2898%2900502-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADyaK1cXjtVOlu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1998&pages=2937-2940&author=D.+A.+Evansauthor=J.+L.+Katzauthor=T.+R.+West&title=Synthesis+of+diaryl+ethers+through+the+copper-promoted+arylation+of+phenols+with+arylboronic+acids.+An+expedient+synthesis+of+thyroxine&doi=10.1016%2FS0040-4039%2898%2900502-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of diaryl ethers through the copper-promoted arylation of phenols with arylboronic acids. An expedient synthesis of thyroxine</span></div><div class="casAuthors">Evans, David A.; Katz, Jeffrey L.; West, Theodore R.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">2937-2940</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Diaryl ethers are readily synthesized in high yield at room temp. through the copper(II)-promoted coupling of arylboronic acids and phenols.  The reaction is tolerant of a wide range of substituents on both coupling partners.  These reaction conditions permit the racemization-free arylation of phenolic amino acids, methodol. that has been applied to an efficient synthesis of thyroxine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGof3Tcq7LBLpLVg90H21EOLACvtfcHk0lgvGGW8ZDKAyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjtVOlu7o%253D&md5=201a8d8742f73d5249058a91dc2f6309</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2898%2900502-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252898%252900502-4%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DD.%2BA.%26aulast%3DKatz%26aufirst%3DJ.%2BL.%26aulast%3DWest%26aufirst%3DT.%2BR.%26atitle%3DSynthesis%2520of%2520diaryl%2520ethers%2520through%2520the%2520copper-promoted%2520arylation%2520of%2520phenols%2520with%2520arylboronic%2520acids.%2520An%2520expedient%2520synthesis%2520of%2520thyroxine%26jtitle%3DTetrahedron%2520Lett.%26date%3D1998%26volume%3D39%26spage%3D2937%26epage%3D2940%26doi%3D10.1016%2FS0040-4039%2898%2900502-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guram, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rennels, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchwald, S. L.</span></span> <span> </span><span class="NLM_article-title">A simple catalytic method for the conversion of aryl bromides to arylamines</span>. <i>Angew. Chem., Int. Ed. Engl.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">1348</span>– <span class="NLM_lpage">1350</span>, <span class="refDoi"> DOI: 10.1002/anie.199513481</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1002%2Fanie.199513481" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADyaK2MXmvV2msr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1995&pages=1348-1350&author=A.+S.+Guramauthor=R.+A.+Rennelsauthor=S.+L.+Buchwald&title=A+simple+catalytic+method+for+the+conversion+of+aryl+bromides+to+arylamines&doi=10.1002%2Fanie.199513481"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">A simple catalytic method for the conversion of aryl bromides to arylamines</span></div><div class="casAuthors">Guram, Anil S.; Rennels, Roger A.; Buchwald, Stephen L.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition in English</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1348-50</span>CODEN:
                <span class="NLM_cas:coden">ACIEAY</span>;
        ISSN:<span class="NLM_cas:issn">0570-0833</span>.
    
            (<span class="NLM_cas:orgname">VCH</span>)
        </div><div class="casAbstract">Aryl bromides reacted with amines in the presence of NaOCMe3 and a catalytic amt. of PdCl2[P(o-tolyl)3]2 or Pd(dba)2/2P(o-tolyl)3 to give arylamines in good yields.  Also, cyclization of 2-XC6H4CH2(CH2)nNHCH2Ph (X = Br, iodo; n = 1, 2, 3) in the presence of NaOCMe3 and a catalytic amt. of Pd(PPh3)4 gave good yields of the N heterocycles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXDC5Vhs2d57Vg90H21EOLACvtfcHk0lg7mrztnfegSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmvV2msr8%253D&md5=d435e21c3f535757455d53e12417596b</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1002%2Fanie.199513481&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.199513481%26sid%3Dliteratum%253Aachs%26aulast%3DGuram%26aufirst%3DA.%2BS.%26aulast%3DRennels%26aufirst%3DR.%2BA.%26aulast%3DBuchwald%26aufirst%3DS.%2BL.%26atitle%3DA%2520simple%2520catalytic%2520method%2520for%2520the%2520conversion%2520of%2520aryl%2520bromides%2520to%2520arylamines%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%2520Engl.%26date%3D1995%26volume%3D34%26spage%3D1348%26epage%3D1350%26doi%3D10.1002%2Fanie.199513481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Louie, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartwig, J. F.</span></span> <span> </span><span class="NLM_article-title">Palladium-catalyzed synthesis of arylamines from aryl halides. Mechanistic studies lead to coupling in the absence of tin reagents</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">3609</span>– <span class="NLM_lpage">3612</span>, <span class="refDoi"> DOI: 10.1016/0040-4039(95)00605-C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1016%2F0040-4039%2895%2900605-C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADyaK2MXmtFCjtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1995&pages=3609-3612&author=J.+Louieauthor=J.+F.+Hartwig&title=Palladium-catalyzed+synthesis+of+arylamines+from+aryl+halides.+Mechanistic+studies+lead+to+coupling+in+the+absence+of+tin+reagents&doi=10.1016%2F0040-4039%2895%2900605-C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium-catalyzed synthesis of arylamines from aryl halides. Mechanistic studies lead to coupling in the absence of tin reagents</span></div><div class="casAuthors">Louie, Janis; Hartwig, John F.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">3609-12</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The reaction of aryl halides with secondary amines in the presence of silylamide base and tri-o-tolyphospshine palladium complexes gives arylamine products.  This process provides a convenient method for performing these heterocross coupling reactions without the necessity for forming tin amides and disposing of tin halides.  This reaction follows from a mechanistic anal. of the coupling reaction with tin amides and occurs as a result of the cleavage of palladium aryl halide dimers with secondary amines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAKpHJAivoR7Vg90H21EOLACvtfcHk0lg7mrztnfegSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmtFCjtLo%253D&md5=7c4567c3e54efc05049d539c682696b2</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1016%2F0040-4039%2895%2900605-C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0040-4039%252895%252900605-C%26sid%3Dliteratum%253Aachs%26aulast%3DLouie%26aufirst%3DJ.%26aulast%3DHartwig%26aufirst%3DJ.%2BF.%26atitle%3DPalladium-catalyzed%2520synthesis%2520of%2520arylamines%2520from%2520aryl%2520halides.%2520Mechanistic%2520studies%2520lead%2520to%2520coupling%2520in%2520the%2520absence%2520of%2520tin%2520reagents%26jtitle%3DTetrahedron%2520Lett.%26date%3D1995%26volume%3D36%26spage%3D3609%26epage%3D3612%26doi%3D10.1016%2F0040-4039%2895%2900605-C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wolfe, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagaw, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchwald, S. L.</span></span> <span> </span><span class="NLM_article-title">An improved catalyst system for aromatic carbon-nitrogen bond formation: the possible involvement of bis(phosphine) palladium complexes as key intermediates</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>118</i></span>,  <span class="NLM_fpage">7215</span>– <span class="NLM_lpage">7216</span>, <span class="refDoi"> DOI: 10.1021/ja9608306</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja9608306" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADyaK28XktFyitrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=1996&pages=7215-7216&author=J.+P.+Wolfeauthor=S.+Wagawauthor=S.+L.+Buchwald&title=An+improved+catalyst+system+for+aromatic+carbon-nitrogen+bond+formation%3A+the+possible+involvement+of+bis%28phosphine%29+palladium+complexes+as+key+intermediates&doi=10.1021%2Fja9608306"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">An Improved Catalyst System for Aromatic Carbon-Nitrogen Bond Formation: The Possible Involvement of Bis(Phosphine) Palladium Complexes as Key Intermediates</span></div><div class="casAuthors">Wolfe, John P.; Wagaw, Seble; Buchwald, Stephen L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">7215-7216</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The combination of Pd2(dba)3 (dba=dibenzylideneacetone) and BINAP in the presence of NaOtBu constitutes a superior catalyst system for the cross coupling of amines with aryl bromides.  Its success also suggests the viability of bis(phosphine)palladium intermediates in the key steps of the catalytic cycle.  Two complexes, (BINAP)Pd(dba) and (BINAP)Pd(4-t-butylphenyl)(Br), were prepd. and were found to be chem. and kinetically competent as intermediates in the catalytic sequence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgGvKEAtlQNLVg90H21EOLACvtfcHk0lgnhxt9IcUeJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XktFyitrg%253D&md5=f88e68db1a437b9462e105d6d036bc68</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1021%2Fja9608306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja9608306%26sid%3Dliteratum%253Aachs%26aulast%3DWolfe%26aufirst%3DJ.%2BP.%26aulast%3DWagaw%26aufirst%3DS.%26aulast%3DBuchwald%26aufirst%3DS.%2BL.%26atitle%3DAn%2520improved%2520catalyst%2520system%2520for%2520aromatic%2520carbon-nitrogen%2520bond%2520formation%253A%2520the%2520possible%2520involvement%2520of%2520bis%2528phosphine%2529%2520palladium%2520complexes%2520as%2520key%2520intermediates%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1996%26volume%3D118%26spage%3D7215%26epage%3D7216%26doi%3D10.1021%2Fja9608306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guari, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Es, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reek, J. N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamer, P. C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van
Leeuwen, P. W. N. M.</span></span> <span> </span><span class="NLM_article-title">An efficient, palladium-catalysed, amination of aryl bromides</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">3789</span>– <span class="NLM_lpage">3790</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(99)00527-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1016%2FS0040-4039%2899%2900527-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADyaK1MXivFKis7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1999&pages=3789-3790&author=Y.+Guariauthor=D.+S.+van+Esauthor=J.+N.+H.+Reekauthor=P.+C.+J.+Kamerauthor=P.+W.+N.+M.+van%0ALeeuwen&title=An+efficient%2C+palladium-catalysed%2C+amination+of+aryl+bromides&doi=10.1016%2FS0040-4039%2899%2900527-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">An efficient, palladium-catalyzed amination of aryl bromides</span></div><div class="casAuthors">Guari, Yannick; Van Es, Daan S.; Reek, Joost N. H.; Kamer, Paul C. J.; Van Leeuwen, Piet W. N. M.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">3789-3790</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Aryl bromides are coupled to primary aliph. amines, anilines and cyclic secondary amines in an efficient and selective procedure using catalytic amts. of Pd(OAc)2 and the chelating ligand 9,9-dimethyl-4,6-bis(diphenylphosphino)xanthene (xantphos).  This catalyst system, accommodating low catalyst loadings (0.5 mol % Pd), allows amination of both electron-poor and electron-rich aryl bromides.  Even sterically crowded substrates show good reactivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9X_0uTjeHdrVg90H21EOLACvtfcHk0lgnhxt9IcUeJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXivFKis7o%253D&md5=559ff08877c70c05f5a97ad6ee6118c3</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2899%2900527-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252899%252900527-4%26sid%3Dliteratum%253Aachs%26aulast%3DGuari%26aufirst%3DY.%26aulast%3Dvan%2BEs%26aufirst%3DD.%2BS.%26aulast%3DReek%26aufirst%3DJ.%2BN.%2BH.%26aulast%3DKamer%26aufirst%3DP.%2BC.%2BJ.%26aulast%3Dvan%2BLeeuwen%26aufirst%3DP.%2BW.%2BN.%2BM.%26atitle%3DAn%2520efficient%252C%2520palladium-catalysed%252C%2520amination%2520of%2520aryl%2520bromides%26jtitle%3DTetrahedron%2520Lett.%26date%3D1999%26volume%3D40%26spage%3D3789%26epage%3D3790%26doi%3D10.1016%2FS0040-4039%2899%2900527-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, N.-F. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hallberg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larhed, M.</span></span> <span> </span><span class="NLM_article-title">In situ generation of carbon monoxide from solid molybdenum hexacarbonyl. A convenient and fast route to palladium-catalyzed carbonylation reactions</span>. <i>J. Comb. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">109</span>– <span class="NLM_lpage">111</span>, <span class="refDoi"> DOI: 10.1021/cc010085f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cc010085f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BD38Xht1Gktr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2002&pages=109-111&author=N.-F.+K.+Kaiserauthor=A.+Hallbergauthor=M.+Larhed&title=In+situ+generation+of+carbon+monoxide+from+solid+molybdenum+hexacarbonyl.+A+convenient+and+fast+route+to+palladium-catalyzed+carbonylation+reactions&doi=10.1021%2Fcc010085f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">In Situ Generation of Carbon Monoxide from Solid Molybdenum Hexacarbonyl. A Convenient and Fast Route to Palladium-Catalyzed Carbonylation Reactions</span></div><div class="casAuthors">Kaiser, Nils-Fredrik K.; Hallberg, Anders; Larhed, Mats</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Combinatorial Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">109-111</span>CODEN:
                <span class="NLM_cas:coden">JCCHFF</span>;
        ISSN:<span class="NLM_cas:issn">1520-4766</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A protocol utilizing molybdenum hexacarbonyl (Mo(CO)6) as a condensed source of carbon monoxide has been developed for performing carbonylation reactions.  Under microwave heating in the presence of palladium and Mo(CO)6, aryl halides, e.g., I, underwent carbonylative coupling with unhindered aliph. primary and secondary amines to produce aryl amides, e.g., II, in moderate to good yields (66-83%).  Microwave heating liberates carbon monoxide from the solid Mo(CO)6 avoiding the trouble of using gaseous carbon monoxide in carbonylation reactions.  Substitution of water for amine provides a rapid process for making the corresponding benzoic acid.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3WYDAfNgvaLVg90H21EOLACvtfcHk0lhxIm5w8A38vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xht1Gktr0%253D&md5=6cbf95e36ea635b4fc58f5854c52b5ad</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1021%2Fcc010085f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcc010085f%26sid%3Dliteratum%253Aachs%26aulast%3DKaiser%26aufirst%3DN.-F.%2BK.%26aulast%3DHallberg%26aufirst%3DA.%26aulast%3DLarhed%26aufirst%3DM.%26atitle%3DIn%2520situ%2520generation%2520of%2520carbon%2520monoxide%2520from%2520solid%2520molybdenum%2520hexacarbonyl.%2520A%2520convenient%2520and%2520fast%2520route%2520to%2520palladium-catalyzed%2520carbonylation%2520reactions%26jtitle%3DJ.%2520Comb.%2520Chem.%26date%3D2002%26volume%3D4%26spage%3D109%26epage%3D111%26doi%3D10.1021%2Fcc010085f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Georgsson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hallberg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larhed, M.</span></span> <span> </span><span class="NLM_article-title">Rapid palladium-catalyzed synthesis of esters from aryl halides utilizing Mo(CO)6 as a solid carbon monoxide source</span>. <i>J. Comb. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">350</span>– <span class="NLM_lpage">352</span>, <span class="refDoi"> DOI: 10.1021/cc0201086</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cc0201086" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BD3sXktlaiurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=350-352&author=J.+Georgssonauthor=A.+Hallbergauthor=M.+Larhed&title=Rapid+palladium-catalyzed+synthesis+of+esters+from+aryl+halides+utilizing+Mo%28CO%296+as+a+solid+carbon+monoxide+source&doi=10.1021%2Fcc0201086"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid Palladium-Catalyzed Synthesis of Esters from Aryl Halides Utilizing Mo(CO)6 as a Solid Carbon Monoxide Source</span></div><div class="casAuthors">Georgsson, Jennie; Hallberg, Anders; Larhed, Mats</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Combinatorial Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">350-352</span>CODEN:
                <span class="NLM_cas:coden">JCCHFF</span>;
        ISSN:<span class="NLM_cas:issn">1520-4766</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of arom. esters R1CO2R2 (R1 = 3-BrC6H4, 2-MeC6H4, 4-MeOC6H4, 4-F3CC6H4, 1-naphthyl; R2 = Bu, Me3SiCH2CH2, PhCH2) was synthesized in moderate to high yields (52-89%) via palladium-catalyzed carbonylation of aryl halides R1X (X = Br, iodo) in the presence of excess of a primary alc. R2OH under microwave irradn. using Mo(CO)6 as a solid carbon monoxide source.  The reactions with sterically hindered tert-butanol as an alc. failed or gave low yields of the desired products.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqS1k1kMsuaA7Vg90H21EOLACvtfcHk0lhxIm5w8A38vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXktlaiurk%253D&md5=7ee6bd650c0c7cfd98b9fc83045e70d2</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1021%2Fcc0201086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcc0201086%26sid%3Dliteratum%253Aachs%26aulast%3DGeorgsson%26aufirst%3DJ.%26aulast%3DHallberg%26aufirst%3DA.%26aulast%3DLarhed%26aufirst%3DM.%26atitle%3DRapid%2520palladium-catalyzed%2520synthesis%2520of%2520esters%2520from%2520aryl%2520halides%2520utilizing%2520Mo%2528CO%25296%2520as%2520a%2520solid%2520carbon%2520monoxide%2520source%26jtitle%3DJ.%2520Comb.%2520Chem.%26date%3D2003%26volume%3D5%26spage%3D350%26epage%3D352%26doi%3D10.1021%2Fcc0201086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tschaen, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desmond, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, A. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fortin, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pipik, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhoeven, T. R.</span></span> <span> </span><span class="NLM_article-title">An improved procedure for aromatic cyanation</span>. <i>Synth. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">887</span>– <span class="NLM_lpage">890</span>, <span class="refDoi"> DOI: 10.1080/00397919408011310</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1080%2F00397919408011310" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADyaK2cXktVyrsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1994&pages=887-890&author=D.+M.+Tschaenauthor=R.+Desmondauthor=A.+O.+Kingauthor=M.+C.+Fortinauthor=B.+Pipikauthor=S.+Kingauthor=T.+R.+Verhoeven&title=An+improved+procedure+for+aromatic+cyanation&doi=10.1080%2F00397919408011310"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">An improved procedure for aromatic cyanation</span></div><div class="casAuthors">Tschaen, D. M.; Desmond, R.; King, A. O.; Fortin, M. C.; Pipik, B.; King, S.; Verhoeven, T. R.</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">887-90</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    </div><div class="casAbstract">An effective method for conversion of aryl bromides to aryl cyanides is described.  The procedure involves treatment of the aryl halide with zinc cyanide in the presence of a catalytic amt. of Pd(PPh3)4.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkwjVF7zhEyrVg90H21EOLACvtfcHk0lhXcalvsXj7bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXktVyrsb8%253D&md5=f56e0d59d6ff886e3d549832dce904f3</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1080%2F00397919408011310&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397919408011310%26sid%3Dliteratum%253Aachs%26aulast%3DTschaen%26aufirst%3DD.%2BM.%26aulast%3DDesmond%26aufirst%3DR.%26aulast%3DKing%26aufirst%3DA.%2BO.%26aulast%3DFortin%26aufirst%3DM.%2BC.%26aulast%3DPipik%26aufirst%3DB.%26aulast%3DKing%26aufirst%3DS.%26aulast%3DVerhoeven%26aufirst%3DT.%2BR.%26atitle%3DAn%2520improved%2520procedure%2520for%2520aromatic%2520cyanation%26jtitle%3DSynth.%2520Commun.%26date%3D1994%26volume%3D24%26spage%3D887%26epage%3D890%26doi%3D10.1080%2F00397919408011310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maiti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fors, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchwald, S. L.</span></span> <span> </span><span class="NLM_article-title">Palladium-catalyzed coupling of functionalized primary and secondary amines with aryl and heteroaryl halides: two ligands suffice in most cases</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">57</span>– <span class="NLM_lpage">68</span>, <span class="refDoi"> DOI: 10.1039/C0SC00330A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1039%2FC0SC00330A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=22384311" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFWqsbjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=57-68&author=D.+Maitiauthor=B.+P.+Forsauthor=J.+L.+Hendersonauthor=Y.+Nakamuraauthor=S.+L.+Buchwald&title=Palladium-catalyzed+coupling+of+functionalized+primary+and+secondary+amines+with+aryl+and+heteroaryl+halides%3A+two+ligands+suffice+in+most+cases&doi=10.1039%2FC0SC00330A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium-catalyzed coupling of functionalized primary and secondary amines with aryl and heteroaryl halides: two ligands suffice in most cases</span></div><div class="casAuthors">Maiti, Debabrata; Fors, Brett P.; Henderson, Jaclyn L.; Nakamura, Yoshinori; Buchwald, Stephen L.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-68</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A study on the use of two catalyst systems is reported here.  The ligands used in this study were BrettPhos [i.e., dicyclohexyl[3,6-dimethoxy-2',4',6'-tris(1-methylethyl)[1,1'-biphenyl]-2-yl]phosphine] and RuPhos [i.e., [2',6'-bis(1-methylethoxy)[1,1'-biphenyl]-2-yl]dicyclohexylphosphine].  These ligands provide a wide scope for Pd-catalyzed C-N cross-coupling reactions.  Often low catalyst loadings and short reaction times can be used with functionalized aryl and heteroaryl coupling partners.  The reactions are highly robust and can be set up and performed without the use of a glove box.  These catalysts should find wide application in the synthesis of complex mols. including pharmaceuticals, natural products and functional materials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7MMWmsn65tLVg90H21EOLACvtfcHk0lhXcalvsXj7bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFWqsbjF&md5=217f0d978b9cc44b2b3c468fd291c2b2</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1039%2FC0SC00330A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC0SC00330A%26sid%3Dliteratum%253Aachs%26aulast%3DMaiti%26aufirst%3DD.%26aulast%3DFors%26aufirst%3DB.%2BP.%26aulast%3DHenderson%26aufirst%3DJ.%2BL.%26aulast%3DNakamura%26aufirst%3DY.%26aulast%3DBuchwald%26aufirst%3DS.%2BL.%26atitle%3DPalladium-catalyzed%2520coupling%2520of%2520functionalized%2520primary%2520and%2520secondary%2520amines%2520with%2520aryl%2520and%2520heteroaryl%2520halides%253A%2520two%2520ligands%2520suffice%2520in%2520most%2520cases%26jtitle%3DChem.%2520Sci.%26date%3D2011%26volume%3D2%26spage%3D57%26epage%3D68%26doi%3D10.1039%2FC0SC00330A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bruno, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tudge, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchwald, S. L.</span></span> <span> </span><span class="NLM_article-title">Design and preparation of new palladium precatalysts for C–C and C–N cross-coupling reactions</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">916</span>– <span class="NLM_lpage">920</span>, <span class="refDoi"> DOI: 10.1039/C2SC20903A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1039%2FC2SC20903A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=23667737" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFKjtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=916-920&author=N.+C.+Brunoauthor=M.+T.+Tudgeauthor=S.+L.+Buchwald&title=Design+and+preparation+of+new+palladium+precatalysts+for+C%E2%80%93C+and+C%E2%80%93N+cross-coupling+reactions&doi=10.1039%2FC2SC20903A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Design and preparation of new palladium precatalysts for C-C and C-N cross-coupling reactions</span></div><div class="casAuthors">Bruno, Nicholas C.; Tudge, Matthew T.; Buchwald, Stephen L.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">916-920</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A series of easily prepd., phosphine-ligated palladium precatalysts based on the 2-aminobiphenyl scaffold have been prepd.  The role of the precatalyst-assocd. labile halide (or pseudohalide) in the formation and stability of the palladacycle has been examd.  It was found that replacing the chloride in the previous version of the precatalyst with a mesylate leads to a new class of precatalysts with improved soln. stability and that are readily prepd. from a wider range of phosphine ligands.  The differences between the previous version of precatalyst and that reported here are explored.  In addn., the reactivity of the latter is examd. in a range of C-C and C-N bond forming reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfHp6oyg4k_bVg90H21EOLACvtfcHk0lgX8ALbSRVDkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFKjtr0%253D&md5=5b50ac18cb67251e5439199c6746dba8</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1039%2FC2SC20903A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC2SC20903A%26sid%3Dliteratum%253Aachs%26aulast%3DBruno%26aufirst%3DN.%2BC.%26aulast%3DTudge%26aufirst%3DM.%2BT.%26aulast%3DBuchwald%26aufirst%3DS.%2BL.%26atitle%3DDesign%2520and%2520preparation%2520of%2520new%2520palladium%2520precatalysts%2520for%2520C%25E2%2580%2593C%2520and%2520C%25E2%2580%2593N%2520cross-coupling%2520reactions%26jtitle%3DChem.%2520Sci.%26date%3D2013%26volume%3D4%26spage%3D916%26epage%3D920%26doi%3D10.1039%2FC2SC20903A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, A.</span></span> <span> </span><span class="NLM_article-title">Overview of the Suzuki protocol with B</span>. In  <i>Handbook of Organopalladium Chemistry for Organic Synthesis</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Negishi, E.</span></span>, Ed.; <span class="NLM_publisher-name">John Wiley & Sons</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">2003</span>; pp  <span class="NLM_fpage">249</span>– <span class="NLM_lpage">262</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&pages=249-262&author=A.+Suzukiauthor=E.+Negishi&title=Handbook+of+Organopalladium+Chemistry+for+Organic+Synthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DA.%26atitle%3DOverview%2520of%2520the%2520Suzuki%2520protocol%2520with%2520B%26btitle%3DHandbook%2520of%2520Organopalladium%2520Chemistry%2520for%2520Organic%2520Synthesis%26aulast%3DNegishi%26aufirst%3DE.%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%26date%3D2003%26spage%3D249%26epage%3D262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miyaura, N.</span></span> <span> </span><span class="NLM_article-title">Metal-catalyzed cross-coupling reactions of organoboron compounds with organic halides</span>. In  <i>Metal-Catalyzed Cross-Coupling Reactions</i>, <span class="NLM_edition">2</span>nd ed.; <span class="NLM_contrib-group"><span class="NLM_string-name">de Meijere, A.</span>, <span class="NLM_string-name">Diederich, F.</span></span>, Eds.; <span class="NLM_publisher-name">Wiley-VCH</span>: <span class="NLM_publisher-loc">Weinheim, Germany</span>, <span class="NLM_year">2004</span>; pp  <span class="NLM_fpage">41</span>– <span class="NLM_lpage">123</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1002%2F9783527619535.ch2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&pages=41-123&author=N.+Miyauraauthor=A.+de+Meijere&author=F.+Diederich&title=Metal-Catalyzed+Cross-Coupling+Reactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1002%2F9783527619535.ch2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9783527619535.ch2%26sid%3Dliteratum%253Aachs%26aulast%3DMiyaura%26aufirst%3DN.%26atitle%3DMetal-catalyzed%2520cross-coupling%2520reactions%2520of%2520organoboron%2520compounds%2520with%2520organic%2520halides%26btitle%3DMetal-Catalyzed%2520Cross-Coupling%2520Reactions%26aulast%3Dde%2BMeijere%26aufirst%3DA.%26pub%3DWiley-VCH%26date%3D2004%26spage%3D41%26epage%3D123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laroche, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertus, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szymoniak, J.</span></span> <span> </span><span class="NLM_article-title">Titanium-mediated synthesis of bicyclic cyclopropylamines from unsaturated nitriles</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">2485</span>– <span class="NLM_lpage">2487</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(03)00325-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1016%2FS0040-4039%2803%2900325-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhs1amu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2003&pages=2485-2487&author=C.+Larocheauthor=P.+Bertusauthor=J.+Szymoniak&title=Titanium-mediated+synthesis+of+bicyclic+cyclopropylamines+from+unsaturated+nitriles&doi=10.1016%2FS0040-4039%2803%2900325-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Titanium-mediated synthesis of bicyclic cyclopropylamines from unsaturated nitriles</span></div><div class="casAuthors">Laroche, Christophe; Bertus, Philippe; Szymoniak, Jan</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2485-2487</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">An easy synthesis of bicyclic primary cyclopropylamines directly from unsatd. nitriles was reported.  The described reaction involves Ti(II)-mediated intramol. coupling of alkene and nitrile moieties.  The titanium tetraisopropoxide-mediated coupling of [(phenylmethyl)-2-propenylamino]acetonitrile with ethylmagnesium bromide gave only N-[(1-aminocyclopropyl)methyl]-N-(2-propenyl)benzenemethanamine and none of the desired bicyclic amine, (1R,5S)-rel-3-(phenylmethyl)-3-azabicyclo[3.1.0]hexan-1-amine (I).  Under optimized conditions, the titanium tetraisopropoxide/trifluoroborate di-Et etherate-mediated coupling of [(phenylmethyl)-2-propenylamino]acetonitrile with cyclohexylmagnesium chloride gave I in 69% yield.  The reaction of β-(2-propenyl)benzenepropanenitrile gave (1R,3R,5S)-rel-3-phenylbicyclo[3.1.0]hexan-1-amine as major product.  The reaction of [3-butenyl(phenylmethyl)amino]acetonitrile gave (1R,6R)-rel-3-(phenylmethyl)-3-azabicyclo[4.1.0]heptan-1-amine.  The reaction of [(phenylmethyl)(4-pentenyl)amino]acetonitrile gave (1R,7R)-rel-3-(phenylmethyl)-3-azabicyclo[5.1.0]octan-1-amine.  Dichlorotitanium diisopropoxide and chlorotitanium triisopropoxide were also investigated as catalysts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAmQA2M74bMbVg90H21EOLACvtfcHk0lgX8ALbSRVDkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhs1amu7k%253D&md5=5b083fb579bb3ad306a3d47ffd614e43</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2803%2900325-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252803%252900325-3%26sid%3Dliteratum%253Aachs%26aulast%3DLaroche%26aufirst%3DC.%26aulast%3DBertus%26aufirst%3DP.%26aulast%3DSzymoniak%26aufirst%3DJ.%26atitle%3DTitanium-mediated%2520synthesis%2520of%2520bicyclic%2520cyclopropylamines%2520from%2520unsaturated%2520nitriles%26jtitle%3DTetrahedron%2520Lett.%26date%3D2003%26volume%3D44%26spage%3D2485%26epage%3D2487%26doi%3D10.1016%2FS0040-4039%2803%2900325-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heaney, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millar, I. T.</span></span> <span> </span><span class="NLM_article-title">Triphenylene</span>. <i>Org. Synth.</i> <span class="NLM_year" style="font-weight: bold;">1960</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">105</span>, <span class="refDoi"> DOI: 10.15227/orgsyn.040.0105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.15227%2Forgsyn.040.0105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADyaF3MXit1ehsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1960&pages=105&author=H.+Heaneyauthor=I.+T.+Millar&title=Triphenylene&doi=10.15227%2Forgsyn.040.0105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Triphenylene</span></div><div class="casAuthors">Heaney, H.; Millar, I. T.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Syntheses</span>
        (<span class="NLM_cas:date">1960</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">105-8</span>CODEN:
                <span class="NLM_cas:coden">ORSYAT</span>;
        ISSN:<span class="NLM_cas:issn">0078-6209</span>.
    </div><div class="casAbstract">Reviews with many references.  Cf. CA 54, 3166h.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSdhlWJWjV7rVg90H21EOLACvtfcHk0liuiiksy68ITQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF3MXit1ehsg%253D%253D&md5=167a27ba419a38572a6bacbb135eb5c7</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.15227%2Forgsyn.040.0105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.15227%252Forgsyn.040.0105%26sid%3Dliteratum%253Aachs%26aulast%3DHeaney%26aufirst%3DH.%26aulast%3DMillar%26aufirst%3DI.%2BT.%26atitle%3DTriphenylene%26jtitle%3DOrg.%2520Synth.%26date%3D1960%26volume%3D40%26spage%3D105%26doi%3D10.15227%2Forgsyn.040.0105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clive, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angoh, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, S. M.</span></span> <span> </span><span class="NLM_article-title">Radical spirocyclization: synthesis of an appropriately oxygenated spiro compound related to the antitumor antibiotic fredericamycin A</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">1339</span>– <span class="NLM_lpage">1342</span>, <span class="refDoi"> DOI: 10.1021/jo00383a032</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00383a032" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADyaL2sXhslKjs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1987&pages=1339-1342&author=D.+Cliveauthor=A.+G.+Angohauthor=S.+M.+Bennett&title=Radical+spirocyclization%3A+synthesis+of+an+appropriately+oxygenated+spiro+compound+related+to+the+antitumor+antibiotic+fredericamycin+A&doi=10.1021%2Fjo00383a032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Radical spirocyclization:  synthesis of an appropriately oxygenated spiro compound related to the antitumor antibiotic fredericamycin A</span></div><div class="casAuthors">Clive, Derrick, L. J.; Angoh, A. Gaetan; Bennett, Sharon M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1339-42</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">The spiro compd. I, that represents the central 4 rings of the antitumor agent, fredericamycin A, has been synthesized by using the general technique of radical spirocyclization.  The key intermediate II was assembled from 7-methoxyindancarboxaldehyde and 2,3,6-Br(MeO)2C6H2C≡CPh, followed by oxidn. of the resulting alc.  Phenylselenylation of II and treatment with Ph3SnH gave the spirocycle which on ozonolysis and deprotection with BBr3 gave I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIQK7qjibUxbVg90H21EOLACvtfcHk0liuiiksy68ITQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXhslKjs78%253D&md5=86fd8aabf82a87d5dd71c39e5c5de513</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1021%2Fjo00383a032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00383a032%26sid%3Dliteratum%253Aachs%26aulast%3DClive%26aufirst%3DD.%26aulast%3DAngoh%26aufirst%3DA.%2BG.%26aulast%3DBennett%26aufirst%3DS.%2BM.%26atitle%3DRadical%2520spirocyclization%253A%2520synthesis%2520of%2520an%2520appropriately%2520oxygenated%2520spiro%2520compound%2520related%2520to%2520the%2520antitumor%2520antibiotic%2520fredericamycin%2520A%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1987%26volume%3D52%26spage%3D1339%26epage%3D1342%26doi%3D10.1021%2Fjo00383a032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Molander, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, I.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Suzuki–Miyaura cross-coupling reactions of potassium Boc-protected aminomethyltrifluoroborate with aryl and hetaryl halides</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">3956</span>– <span class="NLM_lpage">3959</span>, <span class="refDoi"> DOI: 10.1021/ol2014768</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol2014768" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC3MXosFCnsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2011&pages=3956-3959&author=G.+A.+Molanderauthor=I.+Shin&title=Synthesis+and+Suzuki%E2%80%93Miyaura+cross-coupling+reactions+of+potassium+Boc-protected+aminomethyltrifluoroborate+with+aryl+and+hetaryl+halides&doi=10.1021%2Fol2014768"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Suzuki-Miyaura Cross-Coupling Reactions of Potassium Boc-Protected Aminomethyltrifluoroborate with Aryl and Heteroaryl Halides</span></div><div class="casAuthors">Molander, Gary A.; Shin, Inji</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3956-3959</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Potassium Boc-protected aminomethyltrifluoroborate, a primary aminomethyl equiv., was synthesized successfully through a "one-pot" process.  With this trifluoroborate, Suzuki-Miyaura cross-coupling reactions were investigated with a variety of both aryl and heteroaryl chlorides in good to excellent yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjZClUfp08GLVg90H21EOLACvtfcHk0liuiiksy68ITQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXosFCnsro%253D&md5=0a108d35646711c17294531a8942183d</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1021%2Fol2014768&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol2014768%26sid%3Dliteratum%253Aachs%26aulast%3DMolander%26aufirst%3DG.%2BA.%26aulast%3DShin%26aufirst%3DI.%26atitle%3DSynthesis%2520and%2520Suzuki%25E2%2580%2593Miyaura%2520cross-coupling%2520reactions%2520of%2520potassium%2520Boc-protected%2520aminomethyltrifluoroborate%2520with%2520aryl%2520and%2520hetaryl%2520halides%26jtitle%3DOrg.%2520Lett.%26date%3D2011%26volume%3D13%26spage%3D3956%26epage%3D3959%26doi%3D10.1021%2Fol2014768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J.</span></span> <span> </span><span class="NLM_article-title">2-Chloro-2,2-difluoroacetophenone: a non-ODS-based difluorocarbene precursor and its use in the difluoromethylation of phenol derivatives</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">9845</span>– <span class="NLM_lpage">9848</span>, <span class="refDoi"> DOI: 10.1021/jo061799l</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo061799l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Clu73K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2006&pages=9845-9848&author=L.+Zhangauthor=J.+Zhengauthor=J.+Hu&title=2-Chloro-2%2C2-difluoroacetophenone%3A+a+non-ODS-based+difluorocarbene+precursor+and+its+use+in+the+difluoromethylation+of+phenol+derivatives&doi=10.1021%2Fjo061799l"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">2-Chloro-2,2-difluoroacetophenone: A Non-ODS-based difluorocarbene precursor and its use in the difluoromethylation of phenol derivatives</span></div><div class="casAuthors">Zhang, Laijun; Zheng, Ji; Hu, Jinbo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">9845-9848</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel and non-ODS-based (ODS = ozone-depleting substance) prepn. of 2-chloro-2,2-difluoroacetophenone I was achieved in high yield by using 2,2,2-trifluoroacetophenone as the starting material.  Compd. I was found to act as a good difluorocarbene reagent, which readily reacted with a variety of structurally diverse phenol derivs. in the presence of potassium hydroxide or potassium carbonate to produce aryl difluoromethyl ethers II (R = H, Cl, Br, I or F) in good yields.  This new and easy-to-handle synthetic methodol. offered an environmentally friendly alternative to other Freon- or Halon-based difluoromethylating approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqC_65gXcPdsrVg90H21EOLACvtfcHk0lg3bmTXi3f6Jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Clu73K&md5=785fc9ca8ee19a94ca9e61ef413fd349</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1021%2Fjo061799l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo061799l%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZheng%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DJ.%26atitle%3D2-Chloro-2%252C2-difluoroacetophenone%253A%2520a%2520non-ODS-based%2520difluorocarbene%2520precursor%2520and%2520its%2520use%2520in%2520the%2520difluoromethylation%2520of%2520phenol%2520derivatives%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2006%26volume%3D71%26spage%3D9845%26epage%3D9848%26doi%3D10.1021%2Fjo061799l" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span> <i>Methods for Dilution Antimicrobial Susceptibility
Tests for Bacteria
That Grow Aerobically</i>, <span class="NLM_edition">11</span>th ed.; <span class="NLM_publisher-name">Clinical Laboratory Standards Institute (CLSI)</span>, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Methods+for+Dilution+Antimicrobial+Susceptibility%0ATests+for+Bacteria%0AThat+Grow+Aerobically%2C+11th+ed.%3B+Clinical+Laboratory+Standards+Institute+%28CLSI%29%2C+2018."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DMethods%2520for%2520Dilution%2520Antimicrobial%2520Susceptibility%250ATests%2520for%2520Bacteria%250AThat%2520Grow%2520Aerobically%26pub%3DClinical%2520Laboratory%2520Standards%2520Institute%2520%2528CLSI%2529%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bruchmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dötsch, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nouri, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaberny, I. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Häussler, S.</span></span> <span> </span><span class="NLM_article-title">Quantitative contributions of target alteration and decreased drug accumulation to <i>Pseudomonas aeruginosa</i> fluoroquinolone resistance</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">1361</span>, <span class="refDoi"> DOI: 10.1128/AAC.01581-12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1128%2FAAC.01581-12" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=23274661" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC3sXltV2htLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2013&pages=1361&author=S.+Bruchmannauthor=A.+D%C3%B6tschauthor=B.+Nouriauthor=I.+F.+Chabernyauthor=S.+H%C3%A4ussler&title=Quantitative+contributions+of+target+alteration+and+decreased+drug+accumulation+to+Pseudomonas+aeruginosa+fluoroquinolone+resistance&doi=10.1128%2FAAC.01581-12"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative contributions of target alteration and decreased drug accumulation to Pseudomonas aeruginosa fluoroquinolone resistance</span></div><div class="casAuthors">Bruchmann, Sebastian; Doetsch, Andreas; Nouri, Bianka; Chaberny, Iris F.; Haeussler, Susanne</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1361-1368</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Quinolone antibiotics constitute a clin. successful and widely used class of broad-spectrum antibiotics; however, the emergence and spread of resistance increasingly limits the use of fluoroquinolones in the treatment and management of microbial disease.  In this study, the authors evaluated the quant. contributions of quinolone target alteration and efflux pump expression to fluoroquinolone resistance in Pseudomonas aeruginosa.  They generated isogenic mutations in hot spots of the quinolone resistance-detg. regions (QRDRs) of gyrA, gyrB, and parC and inactivated the efflux regulator genes so as to overexpress the corresponding multidrug resistance (MDR) efflux pumps.  They then introduced the resp. mutations into the ref. strain PA14 singly and in various combinations.  Whereas the combined inactivation of two efflux regulator-encoding genes did not lead to resistance levels higher than those obtained by inactivation of only one efflux regulator-encoding gene, the combination of mutations leading to increased efflux and target alteration clearly exhibited an additive effect.  This combination of target alteration and overexpression of efflux pumps was commonly obsd. in clin. P. aeruginosa isolates; however, these two mechanisms were frequently found not to be sufficient to explain the level of fluoroquinolone resistance.  The results suggest that there are addnl. mechanisms, independent of the expression of the MexAB-OprM, MexCD-OprJ, MexEF-OprN, and/or MexXY-OprM efflux pump, that increase ciprofloxacin resistance in isolates with mutations in the QRDRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVUhN1kwRgYrVg90H21EOLACvtfcHk0lg3bmTXi3f6Jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXltV2htLw%253D&md5=bba5206049b5a05ce76f08c84f11de99</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1128%2FAAC.01581-12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01581-12%26sid%3Dliteratum%253Aachs%26aulast%3DBruchmann%26aufirst%3DS.%26aulast%3DD%25C3%25B6tsch%26aufirst%3DA.%26aulast%3DNouri%26aufirst%3DB.%26aulast%3DChaberny%26aufirst%3DI.%2BF.%26aulast%3DH%25C3%25A4ussler%26aufirst%3DS.%26atitle%3DQuantitative%2520contributions%2520of%2520target%2520alteration%2520and%2520decreased%2520drug%2520accumulation%2520to%2520Pseudomonas%2520aeruginosa%2520fluoroquinolone%2520resistance%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2013%26volume%3D57%26spage%3D1361%26doi%3D10.1128%2FAAC.01581-12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoang, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karkhoff-Schweizer, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kutchma, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schweizer, H. P.</span></span> <span> </span><span class="NLM_article-title">A broad-host-range Flp-<i>FRT</i> recombination system for site-specific excision of chromosomally-located DNA sequences: application for isolation of unmarked <i>Pseudomonas aeruginosa</i> mutants</span>. <i>Gene</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>212</i></span>,  <span class="NLM_fpage">77</span>– <span class="NLM_lpage">86</span>, <span class="refDoi"> DOI: 10.1016/S0378-1119(98)00130-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1016%2FS0378-1119%2898%2900130-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=9661666" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADyaK1cXjvFSgu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=212&publication_year=1998&pages=77-86&author=T.+T.+Hoangauthor=R.+R.+Karkhoff-Schweizerauthor=A.+J.+Kutchmaauthor=H.+P.+Schweizer&title=A+broad-host-range+Flp-FRT+recombination+system+for+site-specific+excision+of+chromosomally-located+DNA+sequences%3A+application+for+isolation+of+unmarked+Pseudomonas+aeruginosa+mutants&doi=10.1016%2FS0378-1119%2898%2900130-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">A broad-host-range Flp-FRT recombination system for site-specific excision of chromosomally-located DNA sequences: application for isolation of unmarked Pseudomonas aeruginosa mutants</span></div><div class="casAuthors">Hoang, Tung T.; Karkhoff-Schweizer, RoxAnn R.; Kutchma, Alecksandr J.; Schweizer, Herbert P.</div><div class="citationInfo"><span class="NLM_cas:title">Gene</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">212</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">77-86</span>CODEN:
                <span class="NLM_cas:coden">GENED6</span>;
        ISSN:<span class="NLM_cas:issn">0378-1119</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">An improved method for gene replacement in Pseudomonas aeruginosa was developed.  The method employs several new gene replacement vectors that incorporate (1) the counter-selectable sacB marker, (2) a lacZα-allele for blue-white screening, (3) the pUC18/19 vectors multiple cloning site with 10 unique restriction sites, (4) an oriT for conjugation-mediated plasmid transfer and (5) carbenicillin, gentamicin (Gm) and tetracycline selectable markers.  A cassette was constructed that contains a GmR selectable marker next to the green fluorescent protein structural gene, with both markers being flanked by Flp recombinase target (FRT) sites.  The FRT cassette was used to insertionally inactivate the cloned P. aeruginosa pabC gene encoding aminodeoxychorismate lyase.  After conjugal transfer into P. aeruginosa, plasmid integrants were selected, and deletion of unwanted DNA sequences was promoted by sucrose counter-selection.  The FRT cassette was excised with high frequencies (close to 100%) from the chromosome after conjugal transfer of a Flp recombinase-expressing plasmid; this sacB-contg. plasmid was subsequently cured by sucrose counterselection, resulting in an unmarked P. aeruginosa ΔpabC strain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm-AkpBaY4U7Vg90H21EOLACvtfcHk0ljs3Gw6KCWgBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjvFSgu7Y%253D&md5=cd8b05d0fc01f93fa8db43e1332bdebc</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1016%2FS0378-1119%2898%2900130-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0378-1119%252898%252900130-9%26sid%3Dliteratum%253Aachs%26aulast%3DHoang%26aufirst%3DT.%2BT.%26aulast%3DKarkhoff-Schweizer%26aufirst%3DR.%2BR.%26aulast%3DKutchma%26aufirst%3DA.%2BJ.%26aulast%3DSchweizer%26aufirst%3DH.%2BP.%26atitle%3DA%2520broad-host-range%2520Flp-FRT%2520recombination%2520system%2520for%2520site-specific%2520excision%2520of%2520chromosomally-located%2520DNA%2520sequences%253A%2520application%2520for%2520isolation%2520of%2520unmarked%2520Pseudomonas%2520aeruginosa%2520mutants%26jtitle%3DGene%26date%3D1998%26volume%3D212%26spage%3D77%26epage%3D86%26doi%3D10.1016%2FS0378-1119%2898%2900130-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Caughlan, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sriram, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daigle, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woods, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buco, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dzink-Fox, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dean, C. R.</span></span> <span> </span><span class="NLM_article-title">Fmt bypass in <i>Pseudomonas aeruginosa</i> causes induction of MexXY efflux pump expression</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">5015</span>, <span class="refDoi"> DOI: 10.1128/AAC.00253-09</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1128%2FAAC.00253-09" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=19786597" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsF2gs7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2009&pages=5015&author=R.+E.+Caughlanauthor=S.+Sriramauthor=D.+M.+Daigleauthor=A.+L.+Woodsauthor=J.+Bucoauthor=R.+L.+Petersonauthor=J.+Dzink-Foxauthor=S.+Walkerauthor=C.+R.+Dean&title=Fmt+bypass+in+Pseudomonas+aeruginosa+causes+induction+of+MexXY+efflux+pump+expression&doi=10.1128%2FAAC.00253-09"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Fmt bypass in Pseudomonas aeruginosa causes induction of MexXY efflux pump expression</span></div><div class="casAuthors">Caughlan, Ruth E.; Sriram, Shubha; Daigle, Denis M.; Woods, Angela L.; Buco, Jennifer; Peterson, Ron L.; Dzink-Fox, JoAnn; Walker, Susan; Dean, Charles R.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5015-5022</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The intrinsic resistance of P. aeruginosa PAO1 to the peptide deformylase inhibitor (PDF-I) LBM415 was mediated by the MexAB-OprM and MexXY-OprM efflux pumps, the latter of which was strongly induced by LBM415.  Single-step exposure of PAO1 deleted for mexAB-oprM (therefore lacking both MexAB-OprM and MexXY-OprM functions) to PDF-Is selected for nfxB mutants, which express the MexCD-OprJ efflux pump, indicating that these compds. are also substrates for this pump.  Selection of resistant mutants by use of levels of LBM415 greater than that accommodated by efflux yielded two addnl. groups of mutations, in the methionyl-tRNAfmet formyltransferase (fmt) and folD genes.  Both mechanisms are known to impose an in vitro growth deficit (also obsd. here), presumably due to impairment of protein synthesis.  The authors surmised that this inherent impairment of protein synthesis would upregulate expression of mexXY in a fashion similar to upregulation by LBM415 or by ribosome inhibitory compds.  Transcriptional profiling and/or mexX::lux promoter fusion anal. revealed that fmt and folD mutants were strongly upregulated for mexXY and another gene known to be required for upregulation of the pump, PA5471.  Complementation of the fmt mutation in trans reversed this constitutive expression.  This supports the notion that MexXY has a natural physiol. function responding to impairment of ribosome function or protein synthesis and that fmt mutation (Fmt bypass) and folD mutation generate the intracellular mexXY-inducing signal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqc6UeDhofIMLVg90H21EOLACvtfcHk0ljs3Gw6KCWgBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsF2gs7jN&md5=6b8360ce51719e13e9e376cdcb76fdff</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1128%2FAAC.00253-09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00253-09%26sid%3Dliteratum%253Aachs%26aulast%3DCaughlan%26aufirst%3DR.%2BE.%26aulast%3DSriram%26aufirst%3DS.%26aulast%3DDaigle%26aufirst%3DD.%2BM.%26aulast%3DWoods%26aufirst%3DA.%2BL.%26aulast%3DBuco%26aufirst%3DJ.%26aulast%3DPeterson%26aufirst%3DR.%2BL.%26aulast%3DDzink-Fox%26aufirst%3DJ.%26aulast%3DWalker%26aufirst%3DS.%26aulast%3DDean%26aufirst%3DC.%2BR.%26atitle%3DFmt%2520bypass%2520in%2520Pseudomonas%2520aeruginosa%2520causes%2520induction%2520of%2520MexXY%2520efflux%2520pump%2520expression%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2009%26volume%3D53%26spage%3D5015%26doi%3D10.1128%2FAAC.00253-09" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baba, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasegawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okumura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baba, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Datsenko, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wanner, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, H.</span></span> <span> </span><span class="NLM_article-title">Construction of <i>Escherichia coli</i> K-12 in-frame, single-gene knockout mutants: the Keio collection</span>. <i>Mol. Syst. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">2006.0008</span>, <span class="refDoi"> DOI: 10.1038/msb4100050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1038%2Fmsb4100050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=16738554" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2006&pages=2006.0008&author=T.+Babaauthor=T.+Araauthor=M.+Hasegawaauthor=Y.+Takaiauthor=Y.+Okumuraauthor=M.+Babaauthor=K.+A.+Datsenkoauthor=M.+Tomitaauthor=B.+L.+Wannerauthor=H.+Mori&title=Construction+of+Escherichia+coli+K-12+in-frame%2C+single-gene+knockout+mutants%3A+the+Keio+collection&doi=10.1038%2Fmsb4100050"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1038%2Fmsb4100050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fmsb4100050%26sid%3Dliteratum%253Aachs%26aulast%3DBaba%26aufirst%3DT.%26aulast%3DAra%26aufirst%3DT.%26aulast%3DHasegawa%26aufirst%3DM.%26aulast%3DTakai%26aufirst%3DY.%26aulast%3DOkumura%26aufirst%3DY.%26aulast%3DBaba%26aufirst%3DM.%26aulast%3DDatsenko%26aufirst%3DK.%2BA.%26aulast%3DTomita%26aufirst%3DM.%26aulast%3DWanner%26aufirst%3DB.%2BL.%26aulast%3DMori%26aufirst%3DH.%26atitle%3DConstruction%2520of%2520Escherichia%2520coli%2520K-12%2520in-frame%252C%2520single-gene%2520knockout%2520mutants%253A%2520the%2520Keio%2520collection%26jtitle%3DMol.%2520Syst.%2520Biol.%26date%3D2006%26volume%3D2%26spage%3D2006.0008%26doi%3D10.1038%2Fmsb4100050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Masuda, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohya, S.</span></span> <span> </span><span class="NLM_article-title">Cross-resistance to meropenem, cephems, and quinolones in Pseudomonas aeruginosa</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">1847</span>– <span class="NLM_lpage">1851</span>, <span class="refDoi"> DOI: 10.1128/AAC.36.9.1847</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1128%2FAAC.36.9.1847" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1416876" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADyaK38Xmt12qtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1992&pages=1847-1851&author=N.+Masudaauthor=S.+Ohya&title=Cross-resistance+to+meropenem%2C+cephems%2C+and+quinolones+in+Pseudomonas+aeruginosa&doi=10.1128%2FAAC.36.9.1847"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Cross-resistance to meropenem, cephems, and quinolones in Pseudomonas aeruginosa</span></div><div class="casAuthors">Masuda, Nobuhisa; Ohya, Satoshi</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1847-51</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    </div><div class="casAbstract">Multiple-drug-resistant mutants were isolated from P. aeruginosa PAO1 on agar plates contg. ofloxacin and cefsulodin.  These mutants were 4-8-times more resistant to meropenem, cephems, carbenicillin, quinolones, tetracycline, and chloramphenicol than the parent strain was.  In contrast, these mutants showed no significant changes in their susceptibilities to all carbapenems except meropenem.  In these mutants, the amts. of an outer membrane protein with an apparent mol. wt. of 49,000 (designated OprM) were increased compared with the amt. in PAO1.  Multiple-drug-resistant mutants of this type were also isolated from PAO1 on agar plates contg. meropenem.  Approx. 5% of clin. isolates showed cross-resistance to meropenem, cephems, and quinolones, concomitant with overprodn. of OprM.  Moreover, these two phenotypes, i.e., multiple-drug resistance and overprodn. of OprM, were cotransferable by transduction.  These data suggest that overprodn. of OprM is assocd. with cross-resistance to meropenem, cephems, and quinolones in P. aeruginosa.  The ofloxacin-cefsulodin-resistant mutant required higher concns. of meropenem to induce β-lactamase than PAO1 did, indicating the possibility that this mutation involves decreased outer membrane permeability to meropenem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZpPIJs2-HTLVg90H21EOLACvtfcHk0lgZaR4CTPxC3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xmt12qtLY%253D&md5=4a4b357437616267618772b0d6ba8d8c</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1128%2FAAC.36.9.1847&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.36.9.1847%26sid%3Dliteratum%253Aachs%26aulast%3DMasuda%26aufirst%3DN.%26aulast%3DOhya%26aufirst%3DS.%26atitle%3DCross-resistance%2520to%2520meropenem%252C%2520cephems%252C%2520and%2520quinolones%2520in%2520Pseudomonas%2520aeruginosa%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1992%26volume%3D36%26spage%3D1847%26epage%3D1851%26doi%3D10.1128%2FAAC.36.9.1847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fraud, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campigotto, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poole, K.</span></span> <span> </span><span class="NLM_article-title">MexCD-OprJ multidrug efflux system of <i>Pseudomonas aeruginosa</i>: involvement in chlorhexidine resistance and induction by membrane-damaging agents dependent upon the AlgU stress response sigma factor</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">4478</span>– <span class="NLM_lpage">4482</span>, <span class="refDoi"> DOI: 10.1128/AAC.01072-08</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1128%2FAAC.01072-08" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=18838593" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsV2mu7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=4478-4482&author=S.+Fraudauthor=A.+J.+Campigottoauthor=Z.+Chenauthor=K.+Poole&title=MexCD-OprJ+multidrug+efflux+system+of+Pseudomonas+aeruginosa%3A+involvement+in+chlorhexidine+resistance+and+induction+by+membrane-damaging+agents+dependent+upon+the+AlgU+stress+response+sigma+factor&doi=10.1128%2FAAC.01072-08"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">MexCD-OprJ multidrug efflux system of Pseudomonas aeruginosa: Involvement in chlorhexidine resistance and induction by membrane-damaging agents dependent upon the AlgU stress response sigma factor</span></div><div class="casAuthors">Fraud, Sebastien; Campigotto, Aaron J.; Chen, Zhilin; Poole, Keith</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4478-4482</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The biocide chlorhexidine (CHX) as well as addnl. membrane-active agents were shown to induce expression of the mexCD-oprJ multidrug efflux operon, dependent upon the AlgU stress response sigma factor.  Hyperexpression of this efflux system in nfxB mutants was also substantially AlgU dependent.  CHX resistance correlated with efflux gene expression in various mutants, consistent with MexCD-OprJ being a determinant of CHX resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNf6yoV0CAKrVg90H21EOLACvtfcHk0lhlWIgbWiTh5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsV2mu7%252FK&md5=3758ebcb9c7302486fe056d3345e56c5</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1128%2FAAC.01072-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01072-08%26sid%3Dliteratum%253Aachs%26aulast%3DFraud%26aufirst%3DS.%26aulast%3DCampigotto%26aufirst%3DA.%2BJ.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DPoole%26aufirst%3DK.%26atitle%3DMexCD-OprJ%2520multidrug%2520efflux%2520system%2520of%2520Pseudomonas%2520aeruginosa%253A%2520involvement%2520in%2520chlorhexidine%2520resistance%2520and%2520induction%2520by%2520membrane-damaging%2520agents%2520dependent%2520upon%2520the%2520AlgU%2520stress%2520response%2520sigma%2520factor%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D4478%26epage%3D4482%26doi%3D10.1128%2FAAC.01072-08" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ross, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benton, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Pascale, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leeds, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reck, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richie, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaMarche, M. J.</span></span> <span> </span><span class="NLM_article-title">Synthesis of ciprofloxacin dimers for evaluation of bacterial permeability in atypical chemical space</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">3468</span>– <span class="NLM_lpage">3475</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.07.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1016%2Fj.bmcl.2015.07.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=26189081" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFCqtb%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=3468-3475&author=A.+G.+Rossauthor=B.+M.+Bentonauthor=D.+Chinauthor=G.+De+Pascaleauthor=J.+Fullerauthor=J.+A.+Leedsauthor=F.+Reckauthor=D.+L.+Richieauthor=J.+Voauthor=M.+J.+LaMarche&title=Synthesis+of+ciprofloxacin+dimers+for+evaluation+of+bacterial+permeability+in+atypical+chemical+space&doi=10.1016%2Fj.bmcl.2015.07.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of ciprofloxacin dimers for evaluation of bacterial permeability in atypical chemical space</span></div><div class="casAuthors">Ross, Audrey G.; Benton, Bret M.; Chin, Donovan; De Pascale, Gianfranco; Fuller, John; Leeds, Jennifer A.; Reck, Folkert; Richie, Daryl L.; Vo, Jason; LaMarche, Matthew J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">3468-3475</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We describe the synthesis and evaluation of a library of variably-linked ciprofloxacin dimers.  These structures unify and expand on the use of fluoroquinolones as probes throughout the antibiotic literature.  A dimeric analog I showed enhanced inhibition of its intracellular target (DNA gyrase), and translation to antibacterial activity in whole cells was demonstrated.  Overall, cell permeation was governed by physicochem. properties and bacterial type.  A principal component anal. demonstrated that the dimers occupy a unique and privileged region of chem. space most similar to the macrolide class of antibiotics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDwllxOFolkbVg90H21EOLACvtfcHk0lhlWIgbWiTh5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFCqtb%252FF&md5=43c68073c4bb423a1deb4ffacfe5557a</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.07.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.07.010%26sid%3Dliteratum%253Aachs%26aulast%3DRoss%26aufirst%3DA.%2BG.%26aulast%3DBenton%26aufirst%3DB.%2BM.%26aulast%3DChin%26aufirst%3DD.%26aulast%3DDe%2BPascale%26aufirst%3DG.%26aulast%3DFuller%26aufirst%3DJ.%26aulast%3DLeeds%26aufirst%3DJ.%2BA.%26aulast%3DReck%26aufirst%3DF.%26aulast%3DRichie%26aufirst%3DD.%2BL.%26aulast%3DVo%26aufirst%3DJ.%26aulast%3DLaMarche%26aufirst%3DM.%2BJ.%26atitle%3DSynthesis%2520of%2520ciprofloxacin%2520dimers%2520for%2520evaluation%2520of%2520bacterial%2520permeability%2520in%2520atypical%2520chemical%2520space%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D3468%26epage%3D3475%26doi%3D10.1016%2Fj.bmcl.2015.07.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gedeck, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skolnik, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodde, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dollinger, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berellini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vianello, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faller, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lombardo, F.</span></span> <span> </span><span class="NLM_article-title">Benefit of retraining pKa models studied using internally measured data</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">1449</span>– <span class="NLM_lpage">1459</span>, <span class="refDoi"> DOI: 10.1021/acs.jcim.5b00172</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jcim.5b00172" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVShtrvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2015&pages=1449-1459&author=P.+Gedeckauthor=Y.+Luauthor=S.+Skolnikauthor=S.+Roddeauthor=G.+Dollingerauthor=W.+Jiaauthor=G.+Berelliniauthor=R.+Vianelloauthor=B.+Fallerauthor=F.+Lombardo&title=Benefit+of+retraining+pKa+models+studied+using+internally+measured+data&doi=10.1021%2Facs.jcim.5b00172"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Benefit of Retraining pKa Models Studied Using Internally Measured Data</span></div><div class="casAuthors">Gedeck, Peter; Lu, Yipin; Skolnik, Suzanne; Rodde, Stephane; Dollinger, Gavin; Jia, Weiping; Berellini, Giuliano; Vianello, Riccardo; Faller, Bernard; Lombardo, Franco</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1449-1459</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The ionization state of drugs influences many pharmaceutical properties such as their soly., permeability, and biol. activity.  It is therefore important to understand the structure property relation for the acid-base dissocn. const. pKa during the lead optimization process to make better-informed design decisions.  Computational approaches, such as implemented in MoKa, can help with this; however, they often predict with too large error esp. for proprietary compds.  In this contribution, the authors look at how retraining helps to greatly improve prediction error.  Using a longitudinal study with data measured over 15 years in a drug discovery environment, the authors assess the impact of model training on prediction accuracy and look at model degrdn. over time.  Using the MoKa software, regular retraining is required to address changes in chem. space leading to model degrdn. over six to nine months.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNCUz-ylPu6bVg90H21EOLACvtfcHk0lh1DOTPGstEmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVShtrvJ&md5=6a178b50d5ac0a597391cc2b19af8e32</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1021%2Facs.jcim.5b00172&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jcim.5b00172%26sid%3Dliteratum%253Aachs%26aulast%3DGedeck%26aufirst%3DP.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DSkolnik%26aufirst%3DS.%26aulast%3DRodde%26aufirst%3DS.%26aulast%3DDollinger%26aufirst%3DG.%26aulast%3DJia%26aufirst%3DW.%26aulast%3DBerellini%26aufirst%3DG.%26aulast%3DVianello%26aufirst%3DR.%26aulast%3DFaller%26aufirst%3DB.%26aulast%3DLombardo%26aufirst%3DF.%26atitle%3DBenefit%2520of%2520retraining%2520pKa%2520models%2520studied%2520using%2520internally%2520measured%2520data%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2015%26volume%3D55%26spage%3D1449%26epage%3D1459%26doi%3D10.1021%2Facs.jcim.5b00172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Allen, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Box, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Comer, J. E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peake, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tam, K. Y.</span></span> <span> </span><span class="NLM_article-title">Multiwavelength spectrophotometric determination of acid dissociation constants of ionizable drugs</span>. <i>J. Pharm. Biomed. Anal.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">699</span>– <span class="NLM_lpage">712</span>, <span class="refDoi"> DOI: 10.1016/S0731-7085(98)00010-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1016%2FS0731-7085%2898%2900010-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=9682153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADyaK1cXkvFWhtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1998&pages=699-712&author=R.+I.+Allenauthor=K.+J.+Boxauthor=J.+E.+A.+Comerauthor=C.+Peakeauthor=K.+Y.+Tam&title=Multiwavelength+spectrophotometric+determination+of+acid+dissociation+constants+of+ionizable+drugs&doi=10.1016%2FS0731-7085%2898%2900010-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Multiwavelength spectrophotometric determination of acid dissociation constants of ionizable drugs</span></div><div class="casAuthors">Allen, R. I.; Box, K. J.; Comer, J. E. A.; Peake, C.; Tam, K. Y.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical and Biomedical Analysis</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4,5</span>),
    <span class="NLM_cas:pages">699-712</span>CODEN:
                <span class="NLM_cas:coden">JPBADA</span>;
        ISSN:<span class="NLM_cas:issn">0731-7085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A multiwavelength spectrophotometry was used to det. acid dissocn. consts. (pKa) of sparingly sol. drugs.  UV absorption spectra of the drug solns. were acquired using a versatile device based on a fiber optic dip probe, a light source, and a photodiode array (PDA) detector, while the pH and the ionic strength of the chem. system was manipulated by a com. available titrator.  Target factor anal. (TFA) was applied to deduce the pKa values from the multiwavelength UV absorption data recorded at different pH values.  We call this multiwavelength approach the WApH technique because the pKa values are detd. from changes in Wavelength and Absorbance as a function of pH (WApH).  The WApH technique is exemplified by using pure niflumic acid, nitrazepam, pyridoxine, quinine, and terbutaline.  The WApH pKa values obtained agree well with those derived from pH-metric titrns.  The WApH technique is able to deduce pKa values with high accuracy even if the absorption spectra of the reacting species are very similar.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqckQEYX9u_PLVg90H21EOLACvtfcHk0lh1DOTPGstEmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXkvFWhtrw%253D&md5=5a1b3d3d724ac3991dc14e571ac92834</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1016%2FS0731-7085%2898%2900010-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0731-7085%252898%252900010-7%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DR.%2BI.%26aulast%3DBox%26aufirst%3DK.%2BJ.%26aulast%3DComer%26aufirst%3DJ.%2BE.%2BA.%26aulast%3DPeake%26aufirst%3DC.%26aulast%3DTam%26aufirst%3DK.%2BY.%26atitle%3DMultiwavelength%2520spectrophotometric%2520determination%2520of%2520acid%2520dissociation%2520constants%2520of%2520ionizable%2520drugs%26jtitle%3DJ.%2520Pharm.%2520Biomed.%2520Anal.%26date%3D1998%26volume%3D17%26spage%3D699%26epage%3D712%26doi%3D10.1016%2FS0731-7085%2898%2900010-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmqvist, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ni, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikhailov, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hogan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Digan, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urban, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erdemli, G.</span></span> <span> </span><span class="NLM_article-title">Cardiac ion channel safety profiling on the IonWorks Quattro automated patch clamp system</span>. <i>Assay Drug Dev. Technol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">766</span>– <span class="NLM_lpage">780</span>, <span class="refDoi"> DOI: 10.1089/adt.2010.0333</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1089%2Fadt.2010.0333" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=21133679" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFOjsLrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2010&pages=766-780&author=X.+Caoauthor=Y.+T.+Leeauthor=M.+Holmqvistauthor=Y.+Linauthor=Y.+Niauthor=D.+Mikhailovauthor=H.+Zhangauthor=C.+Hoganauthor=L.+Zhouauthor=Q.+Luauthor=M.+E.+Diganauthor=L.+Urbanauthor=G.+Erdemli&title=Cardiac+ion+channel+safety+profiling+on+the+IonWorks+Quattro+automated+patch+clamp+system&doi=10.1089%2Fadt.2010.0333"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Cardiac Ion Channel Safety Profiling on the IonWorks Quattro Automated Patch Clamp System</span></div><div class="casAuthors">Cao, Xue-Ying; Lee, Yan Tony; Holmqvist, Mats; Lin, Ying-Xin; Ni, Yu-Cheng; Mikhailov, Dmitri; Zhang, Hai-Yan; Hogan, Christopher; Zhou, Li-Ping; Lu, Qiang; Digan, Mary Ellen; Urban, Laszlo; Erdemli, Gul</div><div class="citationInfo"><span class="NLM_cas:title">Assay and Drug Development Technologies</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">766-780</span>CODEN:
                <span class="NLM_cas:coden">ADDTAR</span>;
        ISSN:<span class="NLM_cas:issn">1540-658X</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">The normal electrophysiol. behavior of the heart is detd. by the integrated activity of specific cardiac ionic currents.  Mutations in genes encoding the mol. components of individual cardiac ion currents have been shown to result in multiple cardiac arrhythmia syndromes.  Presently, 12 genes assocd. with inherited long QT syndrome (LQTS) have been identified, and the most common mutations are in the hKCNQ1 (LQT1, Jervell and Lange-Nielson syndrome), hKCNH2 (LQT2), and hSCN5A (LQT3, Brugada syndrome) genes.  Several drugs have been withdrawn from the market or received black box labeling due to clin. cases of QT interval prolongation, ventricular arrhythmias, and sudden death.  Other drugs have been denied regulatory approval owing to their potential for QT interval prolongation.  Further, off-target activity of drugs on cardiac ion channels has been shown to be assocd. with increased mortality in patients with underlying cardiovascular diseases.  Since clin. arrhythmia risk is a major cause for compd. termination, preclin. profiling for off-target cardiac ion channel interactions early in the drug discovery process has become common practice in the pharmaceutical industry.  In the present study, we report assay development for three cardiac ion channels (hKCNQ1/minK, hCav1.2, and hNav1.5) on the IonWorks Quattro system.  We demonstrate that these assays can be used as reliable pharmacol. profiling tools for cardiac ion channel inhibition to assess compds. for cardiac liability during drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFmRplOzjI47Vg90H21EOLACvtfcHk0lg0vBQeClWO-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFOjsLrE&md5=a75376567e33156b80fd7632e163bf3d</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1089%2Fadt.2010.0333&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fadt.2010.0333%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DX.%26aulast%3DLee%26aufirst%3DY.%2BT.%26aulast%3DHolmqvist%26aufirst%3DM.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DNi%26aufirst%3DY.%26aulast%3DMikhailov%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DHogan%26aufirst%3DC.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DLu%26aufirst%3DQ.%26aulast%3DDigan%26aufirst%3DM.%2BE.%26aulast%3DUrban%26aufirst%3DL.%26aulast%3DErdemli%26aufirst%3DG.%26atitle%3DCardiac%2520ion%2520channel%2520safety%2520profiling%2520on%2520the%2520IonWorks%2520Quattro%2520automated%2520patch%2520clamp%2520system%26jtitle%3DAssay%2520Drug%2520Dev.%2520Technol.%26date%3D2010%26volume%3D8%26spage%3D766%26epage%3D780%26doi%3D10.1089%2Fadt.2010.0333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winn, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storoni, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span> <span> </span><span class="NLM_article-title">Phaser crystallographic software</span>. <i>J. Appl. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">658</span>– <span class="NLM_lpage">674</span>, <span class="refDoi"> DOI: 10.1107/S0021889807021206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1107%2FS0021889807021206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=19461840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2007&pages=658-674&author=A.+J.+McCoyauthor=R.+W.+Grosse-Kunstleveauthor=P.+D.+Adamsauthor=M.+D.+Winnauthor=L.+C.+Storoniauthor=R.+J.+Read&title=Phaser+crystallographic+software&doi=10.1107%2FS0021889807021206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Phaser crystallographic software</span></div><div class="casAuthors">McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.; Winn, Martyn D.; Storoni, Laurent C.; Read, Randy J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">658-674</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Phaser is a program for phasing macromol. crystal structures by both mol. replacement and exptl. phasing methods.  The novel phasing algorithms implemented in Phaser have been developed using max. likelihood and multivariate statistics.  For mol. replacement, the new algorithms have proved to be significantly better than traditional methods in discriminating correct solns. from noise, and for single-wavelength anomalous dispersion exptl. phasing, the new algorithms, which account for correlations between F+ and F-, give better phases (lower mean phase error with respect to the phases given by the refined structure) than those that use mean F and anomalous differences ΔF.  One of the design concepts of Phaser was that it be capable of a high degree of automation.  To this end, Phaser (written in C++) can be called directly from Python, although it can also be called using traditional CCP4 keyword-style input.  Phaser is a platform for future development of improved phasing methods and their release, including source code, to the crystallog. community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPeVyjN_FMGbVg90H21EOLACvtfcHk0lg0vBQeClWO-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D&md5=c63b722ae97e0a74e6a5a079d388f09f</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1107%2FS0021889807021206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889807021206%26sid%3Dliteratum%253Aachs%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DStoroni%26aufirst%3DL.%2BC.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26atitle%3DPhaser%2520crystallographic%2520software%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2007%26volume%3D40%26spage%3D658%26epage%3D674%26doi%3D10.1107%2FS0021889807021206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K.</span></span> <span> </span><span class="NLM_article-title">Coot: model-building tools for molecular graphics</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2126</span>– <span class="NLM_lpage">2132</span>, <span class="refDoi"> DOI: 10.1107/S0907444904019158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1107%2FS0907444904019158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=15572765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=2126-2132&author=P.+Emsleyauthor=K.+Cowtan&title=Coot%3A+model-building+tools+for+molecular+graphics&doi=10.1107%2FS0907444904019158"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Coot: model-building tools for molecular graphics</span></div><div class="casAuthors">Emsley, Paul; Cowtan, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">D60</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">2126-2132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">CCP4mg is a project that aims to provide a general-purpose tool for structural biologists, providing tools for x-ray structure soln., structure comparison and anal., and publication-quality graphics.  The map-fitting tools are available as a stand-alone package, distributed as 'Coot'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMisM42468k7Vg90H21EOLACvtfcHk0ljFcgGTuSd-vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P&md5=1be390f3bb6fd584468499ad0921161e</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1107%2FS0907444904019158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904019158%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DCoot%253A%2520model-building%2520tools%2520for%2520molecular%2520graphics%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D2126%26epage%3D2132%26doi%3D10.1107%2FS0907444904019158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohkamp, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K.</span></span> <span> </span><span class="NLM_article-title">Features and development of Coot</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">486</span>– <span class="NLM_lpage">501</span>, <span class="refDoi"> DOI: 10.1107/S0907444910007493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=20383002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=486-501&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+development+of+Coot&doi=10.1107%2FS0907444910007493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0ljFcgGTuSd-vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520development%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D486%26epage%3D501%26doi%3D10.1107%2FS0907444910007493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Afonine, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunkoczi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, I. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Echols, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Headd, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, L.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapral, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moriarty, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oeffner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terwilliger, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwart, P. H.</span></span> <span> </span><span class="NLM_article-title">PHENIX: a comprehensive Python-based system for macromolecular structure solution</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">213</span>– <span class="NLM_lpage">221</span>, <span class="refDoi"> DOI: 10.1107/S0907444909052925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1107%2FS0907444909052925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=20124702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=213-221&author=P.+D.+Adamsauthor=P.+V.+Afonineauthor=G.+Bunkocziauthor=V.+B.+Chenauthor=I.+W.+Davisauthor=N.+Echolsauthor=J.+J.+Headdauthor=L.-W.+Hungauthor=G.+J.+Kapralauthor=R.+W.+Grosse-Kunstleveauthor=A.+J.+McCoyauthor=N.+W.+Moriartyauthor=R.+Oeffnerauthor=R.+J.+Readauthor=D.+C.+Richardsonauthor=J.+S.+Richardsonauthor=T.+C.+Terwilligerauthor=P.+H.+Zwart&title=PHENIX%3A+a+comprehensive+Python-based+system+for+macromolecular+structure+solution&doi=10.1107%2FS0907444909052925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">PHENIX: a comprehensive Python-based system for macromolecular structure solution</span></div><div class="casAuthors">Adams, Paul D.; Afonine, Pavel V.; Bunkoczi, Gabor; Chen, Vincent B.; Davis, Ian W.; Echols, Nathaniel; Headd, Jeffrey J.; Hung, Li Wei; Kapral, Gary J.; Grosse-Kunstleve, Ralf W.; McCoy, Airlie J.; Moriarty, Nigel W.; Oeffner, Robert; Read, Randy J.; Richardson, David C.; Richardson, Jane S.; Terwilliger, Thomas C.; Zwart, Peter H.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">213-221</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  Macromol. X-ray crystallog. is routinely applied to understand biol. processes at a mol. level.  However, significant time and effort are still required to solve and complete many of these structures because of the need for manual interpretation of complex numerical data using many software packages and the repeated use of interactive three-dimensional graphics.  PHENIX has been developed to provide a comprehensive system for macromol. crystallog. structure soln. with an emphasis on the automation of all procedures.  This has relied on the development of algorithms that minimize or eliminate subjective input, the development of algorithms that automate procedures that are traditionally performed by hand and, finally, the development of a framework that allows a tight integration between the algorithms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm_HgKRpa-ObVg90H21EOLACvtfcHk0li6MrE8wX9L9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D&md5=67b439ff4bd61c659cae37ca4209b7bc</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1107%2FS0907444909052925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909052925%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DAfonine%26aufirst%3DP.%2BV.%26aulast%3DBunkoczi%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DV.%2BB.%26aulast%3DDavis%26aufirst%3DI.%2BW.%26aulast%3DEchols%26aufirst%3DN.%26aulast%3DHeadd%26aufirst%3DJ.%2BJ.%26aulast%3DHung%26aufirst%3DL.-W.%26aulast%3DKapral%26aufirst%3DG.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DOeffner%26aufirst%3DR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DRichardson%26aufirst%3DD.%2BC.%26aulast%3DRichardson%26aufirst%3DJ.%2BS.%26aulast%3DTerwilliger%26aufirst%3DT.%2BC.%26aulast%3DZwart%26aufirst%3DP.%2BH.%26atitle%3DPHENIX%253A%2520a%2520comprehensive%2520Python-based%2520system%2520for%2520macromolecular%2520structure%2520solution%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D213%26epage%3D221%26doi%3D10.1107%2FS0907444909052925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liebschner, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Afonine, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunkoczi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Croll, T. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hintze, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, L.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moriarty, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oeffner, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poon, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prisant, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sammito, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sobolev, O. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stockwell, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terwilliger, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urzhumtsev, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Videau, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span> <span> </span><span class="NLM_article-title">Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix</span>. <i>Acta Cryst. D Struct. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">861</span>– <span class="NLM_lpage">877</span>, <span class="refDoi"> DOI: 10.1107/S2059798319011471</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=10.1107%2FS2059798319011471" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=31588918" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvFWkurrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2019&pages=861-877&author=D.+Liebschnerauthor=P.+V.+Afonineauthor=M.+L.+Bakerauthor=G.+Bunkocziauthor=V.+B.+Chenauthor=T.+I.+Crollauthor=B.+Hintzeauthor=L.-W.+Hungauthor=S.+Jainauthor=A.+J.+McCoyauthor=N.+W.+Moriartyauthor=R.+D.+Oeffnerauthor=B.+K.+Poonauthor=M.+G.+Prisantauthor=R.+J.+Readauthor=J.+S.+Richardsonauthor=D.+C.+Richardsonauthor=M.+D.+Sammitoauthor=O.+V.+Sobolevauthor=D.+H.+Stockwellauthor=T.+C.+Terwilligerauthor=A.+G.+Urzhumtsevauthor=L.+L.+Videauauthor=C.+J.+Williamsauthor=P.+D.+Adams&title=Macromolecular+structure+determination+using+X-rays%2C+neutrons+and+electrons%3A+recent+developments+in+Phenix&doi=10.1107%2FS2059798319011471"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix</span></div><div class="casAuthors">Liebschner, Dorothee; Afonine, Pavel V.; Baker, Matthew L.; Bunkoczi, Gabor; Chen, Vincent B.; Croll, Tristan I.; Hintze, Bradley; Hung, Li-Wei; Jain, Swati; McCoy, Airlie J.; Moriarty, Nigel W.; Oeffner, Robert D.; Poon, Billy K.; Prisant, Michael G.; Read, Randy J.; Richardson, Jane S.; Richardson, David C.; Sammito, Massimo D.; Sobolev, Oleg V.; Stockwell, Duncan H.; Terwilliger, Thomas C.; Urzhumtsev, Alexandre G.; Videau, Lizbeth L.; Williams, Christopher J.; Adams, Paul D.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Structural Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">861-877</span>CODEN:
                <span class="NLM_cas:coden">ACSDAD</span>;
        ISSN:<span class="NLM_cas:issn">2059-7983</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Diffraction (X-ray, neutron and electron) and electron cryo-microscopy are powerful methods to det. three-dimensional macromol. structures, which are required to understand biol. processes and to develop new therapeutics against diseases.  The overall structure-soln. workflow is similar for these techniques, but nuances exist because the properties of the reduced exptl. data are different.  Software tools for structure detn. should therefore be tailored for each method.  Phenix is a comprehensive software package for macromol. structure detn. that handles data from any of these techniques.  Tasks performed with Phenix include data-quality assessment, map improvement, model building, the validation/rebuilding/refinement cycle and deposition.  Each tool caters to the type of exptl. data.  The design of Phenix emphasizes the automation of procedures, where possible, to minimize repetitive and time-consuming manual tasks, while default parameters are chosen to encourage best practice.  A graphical user interface provides access to many command-line features of Phenix and streamlines the transition between programs, project tracking and re-running of previous tasks.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolHnU8ECe2CrVg90H21EOLACvtfcHk0li6MrE8wX9L9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvFWkurrO&md5=e60be65abece48923abf937a4c2640a6</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1107%2FS2059798319011471&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS2059798319011471%26sid%3Dliteratum%253Aachs%26aulast%3DLiebschner%26aufirst%3DD.%26aulast%3DAfonine%26aufirst%3DP.%2BV.%26aulast%3DBaker%26aufirst%3DM.%2BL.%26aulast%3DBunkoczi%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DV.%2BB.%26aulast%3DCroll%26aufirst%3DT.%2BI.%26aulast%3DHintze%26aufirst%3DB.%26aulast%3DHung%26aufirst%3DL.-W.%26aulast%3DJain%26aufirst%3DS.%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DOeffner%26aufirst%3DR.%2BD.%26aulast%3DPoon%26aufirst%3DB.%2BK.%26aulast%3DPrisant%26aufirst%3DM.%2BG.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DRichardson%26aufirst%3DJ.%2BS.%26aulast%3DRichardson%26aufirst%3DD.%2BC.%26aulast%3DSammito%26aufirst%3DM.%2BD.%26aulast%3DSobolev%26aufirst%3DO.%2BV.%26aulast%3DStockwell%26aufirst%3DD.%2BH.%26aulast%3DTerwilliger%26aufirst%3DT.%2BC.%26aulast%3DUrzhumtsev%26aufirst%3DA.%2BG.%26aulast%3DVideau%26aufirst%3DL.%2BL.%26aulast%3DWilliams%26aufirst%3DC.%2BJ.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26atitle%3DMacromolecular%2520structure%2520determination%2520using%2520X-rays%252C%2520neutrons%2520and%2520electrons%253A%2520recent%2520developments%2520in%2520Phenix%26jtitle%3DActa%2520Cryst.%2520D%2520Struct.%2520Biol.%26date%3D2019%26volume%3D75%26spage%3D861%26epage%3D877%26doi%3D10.1107%2FS2059798319011471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6WAA" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6WAA','PDB','6WAA'); return false;">PDB: 6WAA</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EIX" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EIX','PDB','5EIX'); return false;">PDB: 5EIX</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i185"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00347">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_28223"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c00347?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00347</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Crystallographic data table for the structure of <i>K. pneumoniae</i> topoisomerase IV bound to compound <b>34</b>; unbiased electron-density difference map (<i>F</i><sub>obs</sub> – <i>F</i><sub>calc</sub>) for <b>34</b> bound to <i>K. pneumoniae</i> topoisomerase IV; interaction diagram of compound <b>34</b> bound to topoisomerase IV from <i>K. pneumoniae</i>; plot of CFU/thigh determined for each dose of compound <b>34</b> in the neutropenic murine thigh infection model; SEC chromatograms showing separation of supercoiled and relaxed DNA and detection of decatenated kDNA; LC/MS traces of all final compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00347/suppl_file/jm0c00347_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00347/suppl_file/jm0c00347_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00347/suppl_file/jm0c00347_si_001.pdf">jm0c00347_si_001.pdf (3.03 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00347/suppl_file/jm0c00347_si_002.csv">jm0c00347_si_002.csv (2.73 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Structural coordinates for compound <b>34</b> have been deposited in the RCSB Protein Data Bank under the accession code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6WAA">6WAA</a>. Authors will release the atomic coordinates and experimental data upon article publication.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c00347&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-14%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c00347" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c00347" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                9MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67991d495e1b2390","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
